false2020FY000156341100015634112020-01-012020-12-310001563411dei:OtherAddressMember2020-01-012020-12-310001563411dei:BusinessContactMember2020-01-012020-12-31xbrli:shares00015634112020-12-31iso4217:EUR00015634112019-01-012019-12-3100015634112018-01-012018-12-31iso4217:EURxbrli:shares00015634112019-12-310001563411ifrs-full:IssuedCapitalMember2019-12-310001563411ifrs-full:SharePremiumMember2019-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2019-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2019-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2019-12-310001563411ifrs-full:OtherReservesMember2019-12-310001563411ifrs-full:RetainedEarningsMember2019-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2019-12-310001563411ifrs-full:NoncontrollingInterestsMember2019-12-310001563411ifrs-full:RetainedEarningsMember2020-01-012020-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2020-01-012020-12-310001563411ifrs-full:NoncontrollingInterestsMember2020-01-012020-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2020-01-012020-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2020-01-012020-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-01-012020-12-310001563411ifrs-full:OtherReservesMember2020-01-012020-12-310001563411ifrs-full:IssuedCapitalMember2020-12-310001563411ifrs-full:SharePremiumMember2020-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2020-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2020-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-12-310001563411ifrs-full:OtherReservesMember2020-12-310001563411ifrs-full:RetainedEarningsMember2020-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2020-12-310001563411ifrs-full:NoncontrollingInterestsMember2020-12-310001563411ifrs-full:IssuedCapitalMember2018-12-310001563411ifrs-full:SharePremiumMember2018-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2018-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2018-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2018-12-310001563411ifrs-full:OtherReservesMember2018-12-310001563411ifrs-full:RetainedEarningsMember2018-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2018-12-310001563411ifrs-full:NoncontrollingInterestsMember2018-12-3100015634112018-12-310001563411ifrs-full:RetainedEarningsMember2019-01-012019-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2019-01-012019-12-310001563411ifrs-full:NoncontrollingInterestsMember2019-01-012019-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2019-01-012019-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2019-01-012019-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2019-01-012019-12-310001563411ifrs-full:OtherReservesMember2019-01-012019-12-310001563411ifrs-full:IssuedCapitalMember2017-12-310001563411ifrs-full:SharePremiumMember2017-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2017-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2017-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2017-12-310001563411ifrs-full:OtherReservesMember2017-12-310001563411ifrs-full:RetainedEarningsMember2017-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2017-12-310001563411ifrs-full:NoncontrollingInterestsMember2017-12-3100015634112017-12-310001563411ifrs-full:RetainedEarningsMemberifrs-full:FinancialEffectOfChangesInAccountingPolicyMember2018-01-012018-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMemberifrs-full:FinancialEffectOfChangesInAccountingPolicyMember2018-01-012018-12-310001563411ifrs-full:FinancialEffectOfChangesInAccountingPolicyMember2018-01-012018-12-310001563411ifrs-full:IssuedCapitalMembercstm:RestatedBalanceMember2017-12-310001563411ifrs-full:SharePremiumMembercstm:RestatedBalanceMember2017-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMembercstm:RestatedBalanceMember2017-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMembercstm:RestatedBalanceMember2017-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMembercstm:RestatedBalanceMember2017-12-310001563411ifrs-full:OtherReservesMembercstm:RestatedBalanceMember2017-12-310001563411ifrs-full:RetainedEarningsMembercstm:RestatedBalanceMember2017-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMembercstm:RestatedBalanceMember2017-12-310001563411ifrs-full:NoncontrollingInterestsMembercstm:RestatedBalanceMember2017-12-310001563411cstm:RestatedBalanceMember2017-12-310001563411ifrs-full:RetainedEarningsMember2018-01-012018-12-310001563411ifrs-full:EquityAttributableToOwnersOfParentMember2018-01-012018-12-310001563411ifrs-full:NoncontrollingInterestsMember2018-01-012018-12-310001563411ifrs-full:ReserveOfRemeasurementsOfDefinedBenefitPlansMember2018-01-012018-12-310001563411cstm:ReserveOfCashFlowHedgesAndNetInvestmentHedgesMember2018-01-012018-12-310001563411ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2018-01-012018-12-310001563411ifrs-full:OtherReservesMember2018-01-012018-12-31cstm:facilitycstm:centercstm:sitecstm:employeexbrli:pure0001563411currency:USD2020-01-012020-12-310001563411currency:USD2019-01-012019-12-310001563411currency:USD2018-01-012018-12-310001563411currency:USD2020-12-310001563411currency:USD2019-12-310001563411currency:USD2018-12-310001563411currency:CHF2020-01-012020-12-310001563411currency:CHF2019-01-012019-12-310001563411currency:CHF2018-01-012018-12-310001563411currency:CHF2020-12-310001563411currency:CHF2019-12-310001563411currency:CHF2018-12-310001563411currency:CZK2020-01-012020-12-310001563411currency:CZK2019-01-012019-12-310001563411currency:CZK2018-01-012018-12-310001563411currency:CZK2020-12-310001563411currency:CZK2019-12-310001563411currency:CZK2018-12-310001563411ifrs-full:BuildingsMemberifrs-full:BottomOfRangeMember2020-01-012020-12-310001563411ifrs-full:BuildingsMemberifrs-full:TopOfRangeMember2020-01-012020-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:BottomOfRangeMember2020-01-012020-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:TopOfRangeMember2020-01-012020-12-310001563411ifrs-full:VehiclesMemberifrs-full:BottomOfRangeMember2020-01-012020-12-310001563411ifrs-full:TopOfRangeMemberifrs-full:VehiclesMember2020-01-012020-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2020-01-012020-12-310001563411cstm:CustomerRelationships1Member2020-01-012020-12-310001563411ifrs-full:ComputerSoftwareMemberifrs-full:BottomOfRangeMember2020-01-012020-12-310001563411ifrs-full:ComputerSoftwareMemberifrs-full:TopOfRangeMember2020-01-012020-12-310001563411cstm:PackagingRolledProductsMember2020-01-012020-12-310001563411cstm:PackagingRolledProductsMember2019-01-012019-12-310001563411cstm:PackagingRolledProductsMember2018-01-012018-12-310001563411cstm:AutomotiveRolledProductsMember2020-01-012020-12-310001563411cstm:AutomotiveRolledProductsMember2019-01-012019-12-310001563411cstm:AutomotiveRolledProductsMember2018-01-012018-12-310001563411cstm:SpecialtyAndOtherThinrolledProductsMember2020-01-012020-12-310001563411cstm:SpecialtyAndOtherThinrolledProductsMember2019-01-012019-12-310001563411cstm:SpecialtyAndOtherThinrolledProductsMember2018-01-012018-12-310001563411cstm:AerospaceRolledProductsMember2020-01-012020-12-310001563411cstm:AerospaceRolledProductsMember2019-01-012019-12-310001563411cstm:AerospaceRolledProductsMember2018-01-012018-12-310001563411cstm:TransportationIndustryAndOtherRolledProductsMember2020-01-012020-12-310001563411cstm:TransportationIndustryAndOtherRolledProductsMember2019-01-012019-12-310001563411cstm:TransportationIndustryAndOtherRolledProductsMember2018-01-012018-12-310001563411cstm:AutomotiveExtrudedProductsMember2020-01-012020-12-310001563411cstm:AutomotiveExtrudedProductsMember2019-01-012019-12-310001563411cstm:AutomotiveExtrudedProductsMember2018-01-012018-12-310001563411cstm:OtherExtrudedProductsMember2020-01-012020-12-310001563411cstm:OtherExtrudedProductsMember2019-01-012019-12-310001563411cstm:OtherExtrudedProductsMember2018-01-012018-12-310001563411cstm:OtherProductsMember2020-01-012020-12-310001563411cstm:OtherProductsMember2019-01-012019-12-310001563411cstm:OtherProductsMember2018-01-012018-12-310001563411country:DE2020-01-012020-12-310001563411country:DE2019-01-012019-12-310001563411country:DE2018-01-012018-12-310001563411country:FR2020-01-012020-12-310001563411country:FR2019-01-012019-12-310001563411country:FR2018-01-012018-12-310001563411country:GB2020-01-012020-12-310001563411country:GB2019-01-012019-12-310001563411country:GB2018-01-012018-12-310001563411country:CH2020-01-012020-12-310001563411country:CH2019-01-012019-12-310001563411country:CH2018-01-012018-12-310001563411cstm:OtherEuropeMember2020-01-012020-12-310001563411cstm:OtherEuropeMember2019-01-012019-12-310001563411cstm:OtherEuropeMember2018-01-012018-12-310001563411srt:EuropeMember2020-01-012020-12-310001563411srt:EuropeMember2019-01-012019-12-310001563411srt:EuropeMember2018-01-012018-12-310001563411country:US2020-01-012020-12-310001563411country:US2019-01-012019-12-310001563411country:US2018-01-012018-12-310001563411cstm:AsiaAndOtherPacificMember2020-01-012020-12-310001563411cstm:AsiaAndOtherPacificMember2019-01-012019-12-310001563411cstm:AsiaAndOtherPacificMember2018-01-012018-12-310001563411cstm:OtherCountriesMember2020-01-012020-12-310001563411cstm:OtherCountriesMember2019-01-012019-12-310001563411cstm:OtherCountriesMember2018-01-012018-12-310001563411ifrs-full:GoodsOrServicesTransferredOverTimeMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMember2020-12-31cstm:country0001563411cstm:AerospaceAndTransportationMember2020-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2019-01-012019-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:PackagingAndAutomotiveRolledProductsMember2019-01-012019-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMember2019-01-012019-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2018-01-012018-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:PackagingAndAutomotiveRolledProductsMember2018-01-012018-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMember2018-01-012018-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2019-01-012019-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:AerospaceAndTransportationMember2019-01-012019-12-310001563411cstm:AerospaceAndTransportationMember2019-01-012019-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2018-01-012018-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:AerospaceAndTransportationMember2018-01-012018-12-310001563411cstm:AerospaceAndTransportationMember2018-01-012018-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2019-01-012019-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:AutomotiveStructuresAndIndustryMember2019-01-012019-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2019-01-012019-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2018-01-012018-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:AutomotiveStructuresAndIndustryMember2018-01-012018-12-310001563411cstm:AutomotiveStructuresAndIndustryMember2018-01-012018-12-310001563411ifrs-full:OperatingSegmentsMembercstm:HoldingsAndCorporateMember2020-01-012020-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:HoldingsAndCorporateMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:HoldingsAndCorporateMember2019-01-012019-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:HoldingsAndCorporateMember2019-01-012019-12-310001563411cstm:HoldingsAndCorporateMember2019-01-012019-12-310001563411ifrs-full:OperatingSegmentsMembercstm:HoldingsAndCorporateMember2018-01-012018-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMembercstm:HoldingsAndCorporateMember2018-01-012018-12-310001563411cstm:HoldingsAndCorporateMember2018-01-012018-12-310001563411ifrs-full:OperatingSegmentsMember2020-01-012020-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMember2019-01-012019-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMember2019-01-012019-12-310001563411ifrs-full:OperatingSegmentsMember2018-01-012018-12-310001563411ifrs-full:EliminationOfIntersegmentAmountsMember2018-01-012018-12-310001563411cstm:NovelisMember2018-07-012018-07-310001563411cstm:NovelisMember2018-01-012018-12-310001563411cstm:COVID19PandemicMember2020-01-012020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:PackagingAndAutomotiveRolledProductsMember2019-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AerospaceAndTransportationMember2019-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:AutomotiveStructuresAndIndustryMember2019-12-310001563411ifrs-full:OperatingSegmentsMembercstm:HoldingsAndCorporateMember2020-12-310001563411ifrs-full:OperatingSegmentsMembercstm:HoldingsAndCorporateMember2019-12-310001563411ifrs-full:OperatingSegmentsMember2020-12-310001563411ifrs-full:OperatingSegmentsMember2019-12-310001563411ifrs-full:UnallocatedAmountsMember2020-12-310001563411ifrs-full:UnallocatedAmountsMember2019-12-310001563411cstm:OneLargestCustomerMembercstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411cstm:OneLargestCustomerMembercstm:PackagingAndAutomotiveRolledProductsMember2018-01-012018-12-310001563411cstm:OneLargestCustomerMembercstm:PackagingAndAutomotiveRolledProductsMember2019-01-012019-12-310001563411country:US2020-12-310001563411country:US2019-12-310001563411country:FR2020-12-310001563411country:FR2019-12-310001563411country:DE2020-12-310001563411country:DE2019-12-310001563411country:CZ2020-12-310001563411country:CZ2019-12-310001563411cstm:OtherCountriesMember2020-12-310001563411cstm:OtherCountriesMember2019-12-310001563411cstm:COVID19PandemicMembercstm:AerospaceAndTransportationAndAutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:RevenueFromContractWithCustomersMember2020-01-012020-12-310001563411cstm:RevenueFromContractWithCustomersMember2019-01-012019-12-310001563411cstm:RevenueFromContractWithCustomersMember2018-01-012018-12-310001563411cstm:CostOfSales1Member2020-01-012020-12-310001563411cstm:CostOfSales1Member2019-01-012019-12-310001563411cstm:CostOfSales1Member2018-01-012018-12-310001563411cstm:OtherGainsAndLossesNetMember2020-01-012020-12-310001563411cstm:OtherGainsAndLossesNetMember2019-01-012019-12-310001563411cstm:OtherGainsAndLossesNetMember2018-01-012018-12-31iso4217:USD0001563411cstm:ConstelliumSESeniorNotesMember2020-01-012020-12-310001563411cstm:MuscleShoalsSeniorNotesMember2020-01-012020-12-310001563411cstm:ConstelliumSESeniorNotesMember2019-01-012019-12-310001563411cstm:PanUSABLFacilityMember2019-01-012019-12-310001563411cstm:ConstelliumUACJLoanModificationMember2018-01-012018-12-310001563411cstm:ConstelliumUACJABSLLCMember2019-01-100001563411cstm:ConstelliumUACJABSLLCMember2018-01-012018-12-310001563411cstm:SubsidiariesInCapitalControlRestrictionsCountriesMember2020-12-310001563411ifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:AccumulatedImpairmentMember2020-12-310001563411ifrs-full:AccumulatedImpairmentMember2019-12-310001563411cstm:UnbilledToolingCostsMember2020-12-310001563411cstm:UnbilledToolingCostsMember2019-12-310001563411cstm:OtherCostMember2020-12-310001563411cstm:OtherCostMember2019-12-310001563411ifrs-full:CurrentMember2020-12-310001563411ifrs-full:CurrentMember2019-12-310001563411cstm:PastDueOneToThirtyDaysMember2020-12-310001563411cstm:PastDueOneToThirtyDaysMember2019-12-310001563411ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2020-12-310001563411ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember2019-12-310001563411ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2020-12-310001563411ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember2019-12-310001563411ifrs-full:LaterThanThreeMonthsMember2020-12-310001563411ifrs-full:LaterThanThreeMonthsMember2019-12-310001563411currency:EUR2020-12-310001563411currency:EUR2019-12-310001563411cstm:OtherCurrenciesMember2020-12-310001563411cstm:OtherCurrenciesMember2019-12-310001563411ifrs-full:FactoringOfReceivablesMembercstm:MuscleShoalsFactoringFacilityMembercountry:US2020-01-012020-12-310001563411ifrs-full:FactoringOfReceivablesMembercountry:UScstm:ConstelliumAutomotiveMember2020-01-012020-12-310001563411ifrs-full:FactoringOfReceivablesMembercountry:FR2020-01-012020-12-310001563411cstm:FactoringReceivableRecourseLineMembercountry:FR2020-01-012020-12-310001563411ifrs-full:FactoringOfReceivablesMembercstm:GermanySwitzerlandAndCzechRepublicMember2020-01-012020-12-310001563411cstm:LandAndPropertyRightsMembercstm:RestatedBalanceMember2019-12-310001563411ifrs-full:BuildingsMembercstm:RestatedBalanceMember2019-12-310001563411cstm:MachineryAndEquipment1Membercstm:RestatedBalanceMember2019-12-310001563411ifrs-full:ConstructionInProgressMembercstm:RestatedBalanceMember2019-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMembercstm:RestatedBalanceMember2019-12-310001563411cstm:RestatedBalanceMember2019-12-310001563411cstm:LandAndPropertyRightsMember2020-01-012020-12-310001563411ifrs-full:BuildingsMember2020-01-012020-12-310001563411cstm:MachineryAndEquipment1Member2020-01-012020-12-310001563411ifrs-full:ConstructionInProgressMember2020-01-012020-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2020-01-012020-12-310001563411cstm:LandAndPropertyRightsMember2020-12-310001563411ifrs-full:BuildingsMember2020-12-310001563411cstm:MachineryAndEquipment1Member2020-12-310001563411ifrs-full:ConstructionInProgressMember2020-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2020-12-310001563411cstm:LandAndPropertyRightsMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2020-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:LandAndPropertyRightsMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:BuildingsMember2020-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:ConstructionInProgressMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:OtherPropertyPlantAndEquipmentMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310001563411cstm:LandAndPropertyRightsMemberifrs-full:PreviouslyStatedMember2018-12-310001563411ifrs-full:BuildingsMemberifrs-full:PreviouslyStatedMember2018-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:PreviouslyStatedMember2018-12-310001563411ifrs-full:PreviouslyStatedMemberifrs-full:ConstructionInProgressMember2018-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:PreviouslyStatedMember2018-12-310001563411ifrs-full:PreviouslyStatedMember2018-12-310001563411cstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMembercstm:LandAndPropertyRightsMember2018-12-310001563411cstm:IFRS16Memberifrs-full:BuildingsMemberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember2018-12-310001563411cstm:MachineryAndEquipment1Membercstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember2018-12-310001563411cstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMemberifrs-full:ConstructionInProgressMember2018-12-310001563411cstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2018-12-310001563411cstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember2018-12-310001563411cstm:LandAndPropertyRightsMembercstm:RestatedBalanceMember2018-12-310001563411ifrs-full:BuildingsMembercstm:RestatedBalanceMember2018-12-310001563411cstm:MachineryAndEquipment1Membercstm:RestatedBalanceMember2018-12-310001563411ifrs-full:ConstructionInProgressMembercstm:RestatedBalanceMember2018-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMembercstm:RestatedBalanceMember2018-12-310001563411cstm:RestatedBalanceMember2018-12-310001563411cstm:LandAndPropertyRightsMember2019-01-012019-12-310001563411ifrs-full:BuildingsMember2019-01-012019-12-310001563411cstm:MachineryAndEquipment1Member2019-01-012019-12-310001563411ifrs-full:ConstructionInProgressMember2019-01-012019-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2019-01-012019-12-310001563411cstm:LandAndPropertyRightsMember2019-12-310001563411ifrs-full:BuildingsMember2019-12-310001563411cstm:MachineryAndEquipment1Member2019-12-310001563411ifrs-full:ConstructionInProgressMember2019-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMember2019-12-310001563411cstm:LandAndPropertyRightsMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:BuildingsMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:ConstructionInProgressMember2019-12-310001563411ifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:LandAndPropertyRightsMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:BuildingsMember2019-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:ConstructionInProgressMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:OtherPropertyPlantAndEquipmentMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2019-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMember2019-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2019-12-310001563411ifrs-full:RightofuseAssetsMember2019-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2020-01-012020-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMember2020-01-012020-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2020-01-012020-12-310001563411ifrs-full:RightofuseAssetsMember2020-01-012020-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2020-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMember2020-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2020-12-310001563411ifrs-full:RightofuseAssetsMember2020-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2020-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:RightofuseAssetsMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:RightofuseAssetsMember2020-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMemberifrs-full:PreviouslyStatedMember2018-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMemberifrs-full:PreviouslyStatedMember2018-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:PreviouslyStatedMember2018-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:PreviouslyStatedMember2018-12-310001563411cstm:IFRS16Memberifrs-full:BuildingsMemberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMemberifrs-full:RightofuseAssetsMember2018-12-310001563411cstm:MachineryAndEquipment1Membercstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMemberifrs-full:RightofuseAssetsMember2018-12-310001563411cstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMemberifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2018-12-310001563411cstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMemberifrs-full:RightofuseAssetsMember2018-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMembercstm:RestatedBalanceMember2018-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMembercstm:RestatedBalanceMember2018-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMembercstm:RestatedBalanceMember2018-12-310001563411ifrs-full:RightofuseAssetsMembercstm:RestatedBalanceMember2018-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2019-01-012019-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMember2019-01-012019-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2019-01-012019-12-310001563411ifrs-full:RightofuseAssetsMember2019-01-012019-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMembercstm:RestatedBalanceMember2019-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMembercstm:RestatedBalanceMember2019-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMembercstm:RestatedBalanceMember2019-12-310001563411ifrs-full:RightofuseAssetsMembercstm:RestatedBalanceMember2019-12-310001563411ifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:BuildingsMemberifrs-full:RightofuseAssetsMember2019-12-310001563411cstm:MachineryAndEquipment1Memberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:RightofuseAssetsMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:RightofuseAssetsMemberifrs-full:OtherPropertyPlantAndEquipmentMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:RightofuseAssetsMember2019-12-310001563411ifrs-full:RightofuseAssetsMemberifrs-full:PreviouslyStatedMember2019-12-310001563411cstm:IFRS16Memberifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember2019-01-010001563411cstm:SellingAndAdministrativeExpenses1Member2020-01-012020-12-310001563411cstm:SellingAndAdministrativeExpenses1Member2019-01-012019-12-310001563411cstm:SellingAndAdministrativeExpenses1Member2018-01-012018-12-310001563411cstm:ResearchAndDevelopmentExpensesMember2020-01-012020-12-310001563411cstm:ResearchAndDevelopmentExpensesMember2019-01-012019-12-310001563411cstm:ResearchAndDevelopmentExpensesMember2018-01-012018-12-31cstm:cash_generating_unit0001563411cstm:MontreuilJuignMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:UsselMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:NanjingPlantMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:WhiteGeorgiaMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:WhiteGeorgiaMember2020-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2019-12-310001563411ifrs-full:ComputerSoftwareMember2019-12-310001563411cstm:CustomerRelationships1Member2019-12-310001563411cstm:WorkInProgressMember2019-12-310001563411ifrs-full:OtherIntangibleAssetsMember2019-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2020-01-012020-12-310001563411ifrs-full:ComputerSoftwareMember2020-01-012020-12-310001563411cstm:CustomerRelationships1Member2020-01-012020-12-310001563411cstm:WorkInProgressMember2020-01-012020-12-310001563411ifrs-full:OtherIntangibleAssetsMember2020-01-012020-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2020-12-310001563411ifrs-full:ComputerSoftwareMember2020-12-310001563411cstm:CustomerRelationships1Member2020-12-310001563411cstm:WorkInProgressMember2020-12-310001563411ifrs-full:OtherIntangibleAssetsMember2020-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2020-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:CustomerRelationships1Member2020-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:WorkInProgressMember2020-12-310001563411ifrs-full:OtherIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:TechnologybasedIntangibleAssetsMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:ComputerSoftwareMember2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:CustomerRelationships1Member2020-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:WorkInProgressMember2020-12-310001563411ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2020-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2018-12-310001563411ifrs-full:ComputerSoftwareMember2018-12-310001563411cstm:CustomerRelationships1Member2018-12-310001563411cstm:WorkInProgressMember2018-12-310001563411ifrs-full:OtherIntangibleAssetsMember2018-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMember2019-01-012019-12-310001563411ifrs-full:ComputerSoftwareMember2019-01-012019-12-310001563411cstm:CustomerRelationships1Member2019-01-012019-12-310001563411cstm:WorkInProgressMember2019-01-012019-12-310001563411ifrs-full:OtherIntangibleAssetsMember2019-01-012019-12-310001563411ifrs-full:TechnologybasedIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2019-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:CustomerRelationships1Member2019-12-310001563411ifrs-full:GrossCarryingAmountMembercstm:WorkInProgressMember2019-12-310001563411ifrs-full:OtherIntangibleAssetsMemberifrs-full:GrossCarryingAmountMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:TechnologybasedIntangibleAssetsMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMemberifrs-full:ComputerSoftwareMember2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:CustomerRelationships1Member2019-12-310001563411ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMembercstm:WorkInProgressMember2019-12-310001563411ifrs-full:OtherIntangibleAssetsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2019-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMemberifrs-full:TopOfRangeMember2020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMemberifrs-full:BottomOfRangeMember2020-12-310001563411cstm:LongTermAssetsMember2019-12-310001563411cstm:LongTermAssetsMember2020-01-012020-12-310001563411cstm:LongTermAssetsMember2020-12-310001563411cstm:InventoryMember2019-12-310001563411cstm:InventoryMember2020-01-012020-12-310001563411cstm:InventoryMember2020-12-310001563411cstm:PensionsMember2019-12-310001563411cstm:PensionsMember2020-01-012020-12-310001563411cstm:PensionsMember2020-12-310001563411cstm:DerivativeValuationMember2019-12-310001563411cstm:DerivativeValuationMember2020-01-012020-12-310001563411cstm:DerivativeValuationMember2020-12-310001563411cstm:TaxLossesCarriedForwardMember2019-12-310001563411cstm:TaxLossesCarriedForwardMember2020-01-012020-12-310001563411cstm:TaxLossesCarriedForwardMember2020-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2019-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2020-01-012020-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2020-12-310001563411cstm:LongTermAssetsMember2018-12-310001563411cstm:LongTermAssetsMember2019-01-012019-12-310001563411cstm:InventoryMember2018-12-310001563411cstm:InventoryMember2019-01-012019-12-310001563411cstm:PensionsMember2018-12-310001563411cstm:PensionsMember2019-01-012019-12-310001563411cstm:DerivativeValuationMember2018-12-310001563411cstm:DerivativeValuationMember2019-01-012019-12-310001563411cstm:TaxLossesCarriedForwardMember2018-12-310001563411cstm:TaxLossesCarriedForwardMember2019-01-012019-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2018-12-310001563411cstm:OtherDeferredTaxAssetsAndLiabilitiesMember2019-01-012019-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberifrs-full:UnusedTaxLossesMember2020-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMemberifrs-full:UnusedTaxLossesMember2019-12-310001563411cstm:LaterThanFiveYearsAndLimitedMemberifrs-full:UnusedTaxLossesMember2020-12-310001563411cstm:LaterThanFiveYearsAndLimitedMemberifrs-full:UnusedTaxLossesMember2019-12-310001563411cstm:UnlimitedMemberifrs-full:UnusedTaxLossesMember2020-12-310001563411cstm:UnlimitedMemberifrs-full:UnusedTaxLossesMember2019-12-310001563411ifrs-full:UnusedTaxLossesMember2020-12-310001563411ifrs-full:UnusedTaxLossesMember2019-12-310001563411cstm:LongTermAssetsMember2020-12-310001563411cstm:LongTermAssetsMember2019-12-310001563411cstm:PensionsMember2020-12-310001563411cstm:PensionsMember2019-12-310001563411ifrs-full:OtherTemporaryDifferencesMember2020-12-310001563411ifrs-full:OtherTemporaryDifferencesMember2019-12-310001563411ifrs-full:TemporaryDifferenceMember2020-12-310001563411ifrs-full:TemporaryDifferenceMember2019-12-310001563411cstm:DeferredToolingRevenueMember2020-12-310001563411cstm:DeferredToolingRevenueMember2019-12-310001563411cstm:AdvancePaymentFromCustomersMember2020-12-310001563411cstm:AdvancePaymentFromCustomersMember2019-12-310001563411cstm:UnrecognizedVariableConsiderationMember2020-12-310001563411cstm:UnrecognizedVariableConsiderationMember2019-12-310001563411cstm:OtherContractLiabilitiesMember2020-12-310001563411cstm:OtherContractLiabilitiesMember2019-12-310001563411cstm:PanUsAblFacilityDueTwoThousandTwentyTwoMember2020-12-310001563411cstm:PanUsAblFacilityDueTwoThousandTwentyTwoMember2019-12-310001563411cstm:U.S.DDTLMember2020-12-310001563411cstm:U.S.DDTLMember2019-12-310001563411cstm:FrenchPGEMember2020-12-310001563411cstm:FrenchPGEMember2019-12-310001563411cstm:SecuredGermanFacilityDueTwentyTwentyTwoMember2020-01-012020-12-310001563411cstm:SecuredGermanFacilityDueTwentyTwentyTwoMember2020-12-310001563411cstm:SecuredGermanFacilityDueTwentyTwentyTwoMember2019-12-310001563411cstm:SecuredInventoryBasedFacilityDueTwoThousandNineteenMember2020-12-310001563411cstm:SecuredInventoryBasedFacilityDueTwoThousandNineteenMember2019-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyFourMember2020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyFourMember2020-01-012020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyFourMember2019-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyOneMember2020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyOneMember2020-01-012020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyOneMember2019-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMember2020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMember2020-01-012020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMember2019-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember2020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember2020-01-012020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixMember2019-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixOneMember2020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixOneMember2020-01-012020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedNovemberTwoThousandSeventeenDueTwoThousandTwentySixOneMember2019-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2020-01-012020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2019-12-310001563411cstm:UnsecuredRevolvingCreditFacilitiesDueInTwoThousandTwentyOneMember2020-12-310001563411cstm:UnsecuredRevolvingCreditFacilitiesDueInTwoThousandTwentyOneMember2019-12-31iso4217:CHF0001563411cstm:UnsecuredCreditFacilitySwitzerlandMember2020-12-310001563411cstm:UnsecuredCreditFacilitySwitzerlandMember2020-01-012020-12-310001563411cstm:UnsecuredCreditFacilitySwitzerlandMember2019-12-310001563411cstm:UnsecuredCreditFacilityGermanyMember2020-01-012020-12-310001563411cstm:UnsecuredCreditFacilityGermanyMember2020-12-310001563411cstm:UnsecuredCreditFacilityGermanyMember2019-12-310001563411cstm:OtherLoansMember2020-12-310001563411cstm:OtherLoansMember2019-12-310001563411cstm:U.S.DDTLMember2020-04-240001563411cstm:FrenchPGEMembercstm:FrenchGovernmentMember2020-05-130001563411cstm:FrenchPGEMembercstm:FrenchGovernmentMemberifrs-full:SubsidiariesMember2020-05-130001563411cstm:EuropeanInterbankOfferedRateEURIBORMembercstm:FrenchPGEMembercstm:FrenchGovernmentMember2020-05-132020-05-130001563411cstm:FrenchPGEMembercstm:FrenchGovernmentMember2020-05-132020-05-130001563411cstm:BorrowingsRedemptionPeriodOneMembercstm:EuropeanInterbankOfferedRateEURIBORMembercstm:FrenchPGEMembercstm:FrenchGovernmentMember2020-05-132020-05-130001563411cstm:BorrowingsRedemptionPeriodTwoMembercstm:EuropeanInterbankOfferedRateEURIBORMembercstm:FrenchPGEMembercstm:FrenchGovernmentMember2020-05-132020-05-130001563411cstm:BorrowingRedemptionPeriodFiveMembercstm:FrenchPGEMembercstm:FrenchGovernmentMember2020-05-130001563411cstm:FrenchPGEMembercstm:FrenchGovernmentMembercstm:BorrowingRedemptionPeriodFourMember2020-05-130001563411cstm:BorrowingRedemptionPeriodThreeMembercstm:FrenchPGEMembercstm:FrenchGovernmentMember2020-05-130001563411cstm:BorrowingRedemptionPeriodSixMembercstm:FrenchPGEMembercstm:FrenchGovernmentMember2020-05-130001563411cstm:FrenchPGEMembercstm:FrenchGovernmentMembercstm:BorrowingRedemptionPeriodSevenMember2020-05-130001563411cstm:FrenchPGEMembercstm:FrenchGovernmentMembercstm:BorrowingRedemptionPeriodEightMember2020-05-13cstm:credit_facility0001563411cstm:GermanStateMembercstm:SecuredAndUnsecuredGermanFacilitiesDueTwentyTwentyTwoMember2020-07-150001563411cstm:SecuredAndUnsecuredGermanFacilitiesDueTwentyTwentyTwoFacilityOneMembercstm:GermanStateMember2020-07-150001563411cstm:SecuredAndUnsecuredGermanFacilitiesDueTwentyTwentyTwoFacilityTwoMembercstm:GermanStateMember2020-07-150001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2020-06-300001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMember2020-01-012020-06-300001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyOneMember2020-06-302020-06-300001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyOneMember2020-01-012020-06-300001563411cstm:UnsecuredRevolvingCreditFacilitiesDueInTwoThousandTwentyOneMemberifrs-full:SubsidiariesMember2020-01-012020-12-310001563411cstm:SwissGovernmentMembercstm:UnsecuredCreditFacilitySwitzerlandMember2020-05-220001563411cstm:FinancingArrangementsMember2020-12-310001563411cstm:PanUsAblFacilityDueTwoThousandTwentyTwoMember2020-01-012020-12-3100015634112019-01-012019-06-300001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyOneMember2019-08-082019-08-080001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyOneMember2019-08-080001563411ifrs-full:FinancialAssetsAtAmortisedCostMembercstm:CashandCashEquivalentsMember2020-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembercstm:CashandCashEquivalentsMember2020-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMembercstm:CashandCashEquivalentsMember2020-12-310001563411cstm:CashandCashEquivalentsMember2020-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMembercstm:CashandCashEquivalentsMember2019-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMembercstm:CashandCashEquivalentsMember2019-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMembercstm:CashandCashEquivalentsMember2019-12-310001563411cstm:CashandCashEquivalentsMember2019-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMemberifrs-full:TradeReceivablesMember2020-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:TradeReceivablesMember2020-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-12-310001563411ifrs-full:TradeReceivablesMember2020-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMemberifrs-full:TradeReceivablesMember2019-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMemberifrs-full:TradeReceivablesMember2019-12-310001563411ifrs-full:TradeReceivablesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-12-310001563411ifrs-full:TradeReceivablesMember2019-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMembercstm:OtherFinancialAssetsMember2020-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2020-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-12-310001563411cstm:OtherFinancialAssetsMember2020-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMembercstm:OtherFinancialAssetsMember2019-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2019-12-310001563411cstm:OtherFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-12-310001563411cstm:OtherFinancialAssetsMember2019-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMember2020-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2020-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-12-310001563411ifrs-full:FinancialAssetsAtAmortisedCostMember2019-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2019-12-310001563411ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:TradePayablesMember2020-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:TradePayablesMember2020-12-310001563411cstm:TradePayablesMembercstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-12-310001563411cstm:TradePayablesMember2020-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:TradePayablesMember2019-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:TradePayablesMember2019-12-310001563411cstm:TradePayablesMembercstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-12-310001563411cstm:TradePayablesMember2019-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:Borrowings1Member2020-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:Borrowings1Member2020-12-310001563411cstm:Borrowings1Membercstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-12-310001563411cstm:Borrowings1Member2020-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:Borrowings1Member2019-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:Borrowings1Member2019-12-310001563411cstm:Borrowings1Membercstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-12-310001563411cstm:Borrowings1Member2019-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:OtherFinancialLiabilitiesMember2020-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:OtherFinancialLiabilitiesMember2020-12-310001563411cstm:OtherFinancialLiabilitiesMembercstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-12-310001563411cstm:OtherFinancialLiabilitiesMember2020-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMembercstm:OtherFinancialLiabilitiesMember2019-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMembercstm:OtherFinancialLiabilitiesMember2019-12-310001563411cstm:OtherFinancialLiabilitiesMembercstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-12-310001563411cstm:OtherFinancialLiabilitiesMember2019-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMember2020-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember2020-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-12-310001563411ifrs-full:FinancialLiabilitiesAtAmortisedCostMember2019-12-310001563411ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember2019-12-310001563411cstm:FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedMayTwoThousandFourteenDueTwoThousandTwentyFourMemberifrs-full:AtFairValueMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310001563411ifrs-full:AtFairValueMemberifrs-full:Level1OfFairValueHierarchyMembercstm:ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMember2020-12-310001563411cstm:ConstelliumSEEURandUSDseniorunsecurednotesissuedNovembertwothousandseventeenDueTwoThousandTwentySixMemberifrs-full:AtFairValueMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedJuneTwoThousandTwentyDueTwoThousandTwentyEightMemberifrs-full:AtFairValueMemberifrs-full:Level1OfFairValueHierarchyMember2020-12-310001563411cstm:AluminiumAndPremiumFutureContractMember2020-12-310001563411cstm:AluminiumAndPremiumFutureContractMember2019-12-310001563411cstm:OtherFutureContractMember2020-12-310001563411cstm:OtherFutureContractMember2019-12-310001563411cstm:CurrencyCommercialContractsMember2020-12-310001563411cstm:CurrencyCommercialContractsMember2019-12-310001563411cstm:CurrencyNetDebtDerivativesMember2020-12-310001563411cstm:CurrencyNetDebtDerivativesMember2019-12-310001563411cstm:MarginCallMember2020-12-310001563411cstm:MarginCallMember2019-12-310001563411cstm:AluminiumAndPremiumFutureContractMember2020-12-310001563411cstm:AluminiumAndPremiumFutureContractMember2019-12-310001563411cstm:EnergyFutureContractMember2020-12-310001563411cstm:EnergyFutureContractMember2019-12-310001563411cstm:OtherFutureContractMember2020-12-310001563411cstm:OtherFutureContractMember2019-12-310001563411cstm:CurrencyCommercialContractsMember2020-12-310001563411cstm:CurrencyCommercialContractsMember2019-12-310001563411cstm:CurrencyNetDebtDerivativesMember2020-12-310001563411cstm:CurrencyNetDebtDerivativesMember2019-12-310001563411ifrs-full:Level1OfFairValueHierarchyMember2020-12-310001563411ifrs-full:Level2OfFairValueHierarchyMember2020-12-310001563411ifrs-full:Level3OfFairValueHierarchyMember2020-12-310001563411ifrs-full:Level1OfFairValueHierarchyMember2019-12-310001563411ifrs-full:Level2OfFairValueHierarchyMember2019-12-310001563411ifrs-full:Level3OfFairValueHierarchyMember2019-12-310001563411ifrs-full:CurrencyRiskMember2020-01-012020-12-31cstm:EUR_0001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:UsdEurForwardDerivativesSalesMember2020-12-310001563411ifrs-full:LaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:UsdEurForwardDerivativesSalesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:EurChfForwardDerivativesSalesMember2020-12-310001563411ifrs-full:LaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:EurChfForwardDerivativesSalesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:EURCZKForwardDerivativesSalesMember2020-12-310001563411ifrs-full:LaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:EURCZKForwardDerivativesSalesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:OtherCurrenciesForwardDerivativesSalesMember2020-12-310001563411ifrs-full:LaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:OtherCurrenciesForwardDerivativesSalesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:UsdEurForwardDerivativesPurchasesMember2020-12-310001563411ifrs-full:LaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:UsdEurForwardDerivativesPurchasesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:EurChfForwardDerivativesPurchasesMember2020-12-310001563411ifrs-full:LaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:EurChfForwardDerivativesPurchasesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:ForwardDerivativesPurchasesEurCzkMember2020-12-310001563411ifrs-full:LaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:ForwardDerivativesPurchasesEurCzkMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:OtherCurrenciesForwardDerivativesPurchasesMember2020-12-310001563411ifrs-full:LaterThanOneYearMemberifrs-full:CurrencyRiskMembercstm:OtherCurrenciesForwardDerivativesPurchasesMember2020-12-310001563411cstm:DerivativeClassifiedAsCashFlowHedgeMember2020-12-310001563411cstm:DerivativeClassifiedAsCashFlowHedgeMember2019-12-310001563411cstm:NonqualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2020-01-012020-12-310001563411cstm:NonqualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2019-01-012019-12-310001563411cstm:NonqualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2018-01-012018-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2020-01-012020-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2019-01-012019-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember2018-01-012018-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2020-01-012020-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2019-01-012019-12-310001563411cstm:QualifyingHedgesMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2018-01-012018-12-310001563411cstm:ForwardPurchaseContractsVersusEuroMember2020-01-012020-12-310001563411cstm:ForwardPurchaseContractsVersusEuroMembercstm:CrossCurrencySwapsMember2020-01-012020-12-310001563411cstm:ForeignExchangeForwardContractsMembercstm:ForwardPurchaseContractsVersusEuroMember2020-01-012020-12-310001563411ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2020-01-012020-12-310001563411ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2019-01-012019-12-310001563411ifrs-full:CurrencyRiskMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2018-01-012018-12-310001563411cstm:OtherCurrenciesMember2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMemberifrs-full:TradeReceivablesMember2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:TradePayablesMember2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:DerivativesOnCommercialTransactionMember2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:CommercialTransactionExposureMember2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:CashInBankAndIntercompanyLoansMember2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:Borrowings1Member2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:DerivativesOnFinancingTransactionMember2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMembercstm:FinancingTransactionExposureMember2020-01-012020-12-310001563411cstm:TenPercentageStrengtheningUsDollarEuroMember2020-01-012020-12-310001563411ifrs-full:ForwardContractMember2019-06-300001563411ifrs-full:ForwardContractMember2020-01-012020-12-310001563411ifrs-full:CommodityPriceRiskMember2020-01-012020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:AluminiumMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:LaterThanOneYearMembercstm:AluminiumMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:PremiumsMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:LaterThanOneYearMembercstm:PremiumsMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:CopperMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:LaterThanOneYearMembercstm:CopperMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:SilverMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:LaterThanOneYearMembercstm:SilverMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411cstm:NaturalGasMemberifrs-full:NotLaterThanOneYearMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411cstm:NaturalGasMemberifrs-full:LaterThanOneYearMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411cstm:ZincMemberifrs-full:NotLaterThanOneYearMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411cstm:ZincMemberifrs-full:LaterThanOneYearMemberifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:CommodityPriceRiskMember2019-01-012019-12-310001563411ifrs-full:CommodityPriceRiskMember2018-01-012018-12-310001563411cstm:AluminiumMembercstm:TenPercentageIncreaseOrDecreaseInTheMarketPriceMember2020-01-012020-12-310001563411ifrs-full:CommodityPriceRiskMember2020-12-310001563411ifrs-full:CommodityPriceRiskMember2019-12-310001563411ifrs-full:TopOfRangeMembercstm:FiftyBasisPointIncreaseOrDecreaseInTheLiborOrEuriborInterestRatesMember2019-01-012019-12-310001563411ifrs-full:TopOfRangeMembercstm:FiftyBasisPointIncreaseOrDecreaseInTheLiborOrEuriborInterestRatesMember2020-01-012020-12-31cstm:counterparty0001563411cstm:RatedAaOrBetterMember2020-12-310001563411cstm:RatedAaOrBetterMember2019-12-310001563411cstm:RatedAMember2020-12-310001563411cstm:RatedAMember2019-12-310001563411cstm:RatedBaaMember2020-12-310001563411cstm:RatedBaaMember2019-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetDebtDerivativeAssetsMember2020-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMembercstm:NetDebtDerivativeAssetsMember2020-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetDebtDerivativeAssetsMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetDebtDerivativeAssetsMember2019-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMembercstm:NetDebtDerivativeAssetsMember2019-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetDebtDerivativeAssetsMember2019-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember2020-12-310001563411cstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2020-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember2019-12-310001563411cstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2019-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetCashFlowsFromDerivativeAssetsRelatedToCurrenciesAndCommoditiesMember2019-12-310001563411ifrs-full:NotLaterThanOneYearMember2020-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2020-12-310001563411ifrs-full:LaterThanFiveYearsMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMember2019-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2019-12-310001563411ifrs-full:LaterThanFiveYearsMember2019-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:Borrowings1Member2020-12-310001563411cstm:Borrowings1Memberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2020-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:Borrowings1Member2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:Borrowings1Member2019-12-310001563411cstm:Borrowings1Memberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2019-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:Borrowings1Member2019-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:InterestsMember2020-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMembercstm:InterestsMember2020-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:InterestsMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:InterestsMember2019-12-310001563411ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMembercstm:InterestsMember2019-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:InterestsMember2019-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetDebtDerivativeLiabilitiesMember2020-12-310001563411cstm:NetDebtDerivativeLiabilitiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2020-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetDebtDerivativeLiabilitiesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetDebtDerivativeLiabilitiesMember2019-12-310001563411cstm:NetDebtDerivativeLiabilitiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2019-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetDebtDerivativeLiabilitiesMember2019-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMember2020-12-310001563411cstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2020-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMember2019-12-310001563411cstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2019-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:NetCashFlowsFromDerivativesLiabilitiesRelatedToCurrenciesAndCommoditiesMember2019-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:TradePayablesAndOtherExcludingDeferredRevenueAndContractLiabilitiesMember2020-12-310001563411cstm:TradePayablesAndOtherExcludingDeferredRevenueAndContractLiabilitiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2020-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:TradePayablesAndOtherExcludingDeferredRevenueAndContractLiabilitiesMember2020-12-310001563411ifrs-full:NotLaterThanOneYearMembercstm:TradePayablesAndOtherExcludingDeferredRevenueAndContractLiabilitiesMember2019-12-310001563411cstm:TradePayablesAndOtherExcludingDeferredRevenueAndContractLiabilitiesMemberifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2019-12-310001563411ifrs-full:LaterThanFiveYearsMembercstm:TradePayablesAndOtherExcludingDeferredRevenueAndContractLiabilitiesMember2019-12-310001563411ifrs-full:ActuarialAssumptionOfDiscountRatesMember2020-01-012020-12-310001563411ifrs-full:ActuarialAssumptionOfDiscountRatesMember2020-12-310001563411country:FRifrs-full:ActuarialAssumptionOfDiscountRatesMember2020-12-310001563411country:DEifrs-full:ActuarialAssumptionOfDiscountRatesMember2020-12-310001563411country:CHifrs-full:ActuarialAssumptionOfDiscountRatesMember2020-12-310001563411country:USifrs-full:ActuarialAssumptionOfDiscountRatesMember2020-12-310001563411country:CH2020-12-310001563411country:CH2019-12-310001563411cstm:HourlyPensionMembercountry:US2020-12-310001563411cstm:HourlyPensionMemberifrs-full:BottomOfRangeMembercountry:US2020-12-310001563411cstm:HourlyPensionMemberifrs-full:TopOfRangeMembercountry:US2020-12-310001563411cstm:HourlyPensionMembercountry:US2019-12-310001563411cstm:HourlyPensionMemberifrs-full:BottomOfRangeMembercountry:US2019-12-310001563411cstm:HourlyPensionMemberifrs-full:TopOfRangeMembercountry:US2019-12-310001563411country:UScstm:SalariedPensionMember2020-12-310001563411country:UScstm:SalariedPensionMember2019-12-310001563411cstm:OtherPostEmploymentBenefitMembercountry:US2020-12-310001563411cstm:OtherPostEmploymentBenefitMemberifrs-full:BottomOfRangeMembercountry:US2020-12-310001563411ifrs-full:TopOfRangeMembercstm:OtherPostEmploymentBenefitMembercountry:US2020-12-310001563411cstm:OtherPostEmploymentBenefitMembercountry:US2019-12-310001563411cstm:OtherPostEmploymentBenefitMemberifrs-full:BottomOfRangeMembercountry:US2019-12-310001563411ifrs-full:TopOfRangeMembercstm:OtherPostEmploymentBenefitMembercountry:US2019-12-310001563411country:UScstm:OtherEmployeeBenefitsMember2020-12-310001563411ifrs-full:BottomOfRangeMembercountry:UScstm:OtherEmployeeBenefitsMember2020-12-310001563411ifrs-full:TopOfRangeMembercountry:UScstm:OtherEmployeeBenefitsMember2020-12-310001563411country:UScstm:OtherEmployeeBenefitsMember2019-12-310001563411ifrs-full:BottomOfRangeMembercountry:UScstm:OtherEmployeeBenefitsMember2019-12-310001563411ifrs-full:TopOfRangeMembercountry:UScstm:OtherEmployeeBenefitsMember2019-12-310001563411country:FRifrs-full:BottomOfRangeMember2020-12-310001563411country:FRifrs-full:TopOfRangeMember2020-12-310001563411country:FRifrs-full:BottomOfRangeMember2019-12-310001563411country:FRifrs-full:TopOfRangeMember2019-12-310001563411cstm:RetirementBenefitsMembercountry:FR2020-12-310001563411cstm:RetirementBenefitsMembercountry:FR2019-12-310001563411cstm:OtherPostRetirementBenefitsMembercountry:FR2020-12-310001563411cstm:OtherPostRetirementBenefitsMembercountry:FR2019-12-310001563411cstm:OtherPostEmploymentBenefitMembercstm:PreSixtyFiveMembercstm:TwoThousandTwentyMember2020-12-310001563411cstm:TwoThousandTwentyNineMembercstm:OtherPostEmploymentBenefitMembercstm:PreSixtyFiveMember2020-12-310001563411cstm:PostSixtyFiveMembercstm:OtherPostEmploymentBenefitMembercstm:TwoThousandTwentyMember2020-12-310001563411cstm:PostSixtyFiveMembercstm:TwoThousandTwentyNineMembercstm:OtherPostEmploymentBenefitMember2020-12-310001563411ifrs-full:PensionDefinedBenefitPlansMember2020-12-310001563411cstm:OtherBenefitPlansMember2020-12-310001563411ifrs-full:PensionDefinedBenefitPlansMember2019-12-310001563411cstm:OtherBenefitPlansMember2019-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2019-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMembercstm:OtherBenefitPlansMember2019-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2019-12-310001563411ifrs-full:PlanAssetsMember2019-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMembercstm:OtherBenefitPlansMember2020-01-012020-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2020-01-012020-12-310001563411ifrs-full:PlanAssetsMember2020-01-012020-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2020-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMembercstm:OtherBenefitPlansMember2020-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2020-12-310001563411ifrs-full:PlanAssetsMember2020-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2018-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMembercstm:OtherBenefitPlansMember2018-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2018-12-310001563411ifrs-full:PlanAssetsMember2018-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMemberifrs-full:PensionDefinedBenefitPlansMember2019-01-012019-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMembercstm:OtherBenefitPlansMember2019-01-012019-12-310001563411ifrs-full:PresentValueOfDefinedBenefitObligationMember2019-01-012019-12-310001563411ifrs-full:PlanAssetsMember2019-01-012019-12-3100015634112019-07-012019-09-300001563411cstm:OtherBenefitPlansMember2020-10-012020-12-310001563411cstm:OtherBenefitPlansMember2020-01-012020-12-310001563411cstm:OtherBenefitPlansMember2020-07-012020-09-300001563411country:FR2020-12-310001563411country:FR2019-12-310001563411country:DE2020-12-310001563411country:DE2019-12-310001563411country:CH2020-12-310001563411country:CH2019-12-310001563411country:US2020-12-310001563411country:US2019-12-310001563411cstm:OtherCountriesMember2020-12-310001563411cstm:OtherCountriesMember2019-12-310001563411cstm:PlanAssetCategoriesQuotedInAnActiveMarketMember2020-12-310001563411cstm:PlanAssetCategoriesUnquotedInAnActiveMarketMember2020-12-310001563411cstm:PlanAssetCategoriesQuotedInAnActiveMarketMember2019-12-310001563411cstm:PlanAssetCategoriesUnquotedInAnActiveMarketMember2019-12-310001563411ifrs-full:PensionDefinedBenefitPlansMember2020-01-012020-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2019-12-310001563411ifrs-full:RestructuringProvisionMember2019-12-310001563411ifrs-full:LegalProceedingsProvisionMember2019-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2020-01-012020-12-310001563411ifrs-full:RestructuringProvisionMember2020-01-012020-12-310001563411ifrs-full:LegalProceedingsProvisionMember2020-01-012020-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2020-12-310001563411ifrs-full:RestructuringProvisionMember2020-12-310001563411ifrs-full:LegalProceedingsProvisionMember2020-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2018-12-310001563411ifrs-full:RestructuringProvisionMember2018-12-310001563411ifrs-full:LegalProceedingsProvisionMember2018-12-310001563411ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember2019-01-012019-12-310001563411ifrs-full:RestructuringProvisionMember2019-01-012019-12-310001563411ifrs-full:LegalProceedingsProvisionMember2019-01-012019-12-310001563411ifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMemberifrs-full:BottomOfRangeMember2020-01-012020-12-310001563411ifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMemberifrs-full:TopOfRangeMember2020-01-012020-12-31cstm:claim0001563411ifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMember2020-01-012020-12-310001563411ifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMember2019-01-012019-12-310001563411ifrs-full:LegalProceedingsProvisionMembercstm:DiseaseClaimsMemberifrs-full:TopOfRangeMember2019-01-012019-12-310001563411ifrs-full:OrdinarySharesMember2020-12-310001563411ifrs-full:OrdinarySharesMember2019-12-310001563411ifrs-full:OrdinarySharesMembercstm:EmployeesMember2020-01-012020-12-310001563411ifrs-full:IssuedCapitalMember2020-01-012020-12-310001563411ifrs-full:SharePremiumMember2020-01-012020-12-310001563411ifrs-full:ComputerSoftwareMember2020-12-310001563411ifrs-full:ComputerSoftwareMember2019-12-310001563411ifrs-full:PropertyPlantAndEquipmentMember2020-12-310001563411ifrs-full:PropertyPlantAndEquipmentMember2019-12-310001563411cstm:UnsecuredRevolvingCreditFacilitiesDueInTwoThousandTwentyOneMemberifrs-full:SubsidiariesMember2018-03-282018-03-280001563411cstm:PerformanceShareUnitsMember2020-01-012020-12-310001563411cstm:PerformanceShareUnitsGrantedInTwoThousandAndSixteenMemberifrs-full:BottomOfRangeMember2020-01-012020-12-310001563411cstm:PerformanceShareUnitsGrantedInTwoThousandAndSixteenMemberifrs-full:TopOfRangeMember2020-01-012020-12-310001563411ifrs-full:BottomOfRangeMembercstm:PerformanceShareUnitsMember2020-01-012020-12-310001563411ifrs-full:TopOfRangeMembercstm:PerformanceShareUnitsMember2020-01-012020-12-310001563411cstm:SharebasedPaymentArrangementTrancheOne1Membercstm:PerformanceShareUnitsGrantedInMarchTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:SharebasedPaymentArrangementTrancheOne1Membercstm:PerformanceShareUnitsGrantedInMayTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:SharebasedPaymentArrangementTrancheOne1Membercstm:PerformanceShareUnitsGrantedInAugustTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:PerformanceShareUnitsGrantedInNovemberTwoThousandAndSixteenMembercstm:SharebasedPaymentArrangementTrancheOne1Member2016-01-012016-12-310001563411cstm:SharebasedPaymentArrangementTrancheTwo1Membercstm:PerformanceShareUnitsGrantedInMarchTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:SharebasedPaymentArrangementTrancheTwo1Membercstm:PerformanceShareUnitsGrantedInMayTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:SharebasedPaymentArrangementTrancheTwo1Membercstm:PerformanceShareUnitsGrantedInAugustTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:PerformanceShareUnitsGrantedInNovemberTwoThousandAndSixteenMembercstm:SharebasedPaymentArrangementTrancheTwo1Member2016-01-012016-12-310001563411cstm:SharebasedPaymentArrangementTrancheThree1Membercstm:PerformanceShareUnitsGrantedInMarchTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:SharebasedPaymentArrangementTrancheThree1Membercstm:PerformanceShareUnitsGrantedInMayTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:SharebasedPaymentArrangementTrancheThree1Membercstm:PerformanceShareUnitsGrantedInAugustTwoThousandAndSixteenMember2016-01-012016-12-310001563411cstm:PerformanceShareUnitsGrantedInNovemberTwoThousandAndSixteenMembercstm:SharebasedPaymentArrangementTrancheThree1Member2016-01-012016-12-310001563411cstm:PerformanceShareUnitsGrantedInTwoThousandAndSixteenMember2017-01-012017-12-310001563411cstm:PerformanceShareUnitsGrantedInTwoThousandAndSixteenMember2018-01-012018-12-310001563411cstm:PerformanceShareUnitsGrantedInTwoThousandAndSixteenMember2019-01-012019-12-310001563411cstm:PerformanceshareunitsvestedinMarchtwothousandandnineteenMember2019-01-012019-12-310001563411cstm:PerformanceshareunitsvestedinMaytwothousandandnineteenMember2019-01-012019-12-310001563411cstm:PerformanceshareunitsvestedinAugusttwothousandandnineteenMember2019-01-012019-12-310001563411cstm:PerformanceshareunitsvestedinNovembertwothousandandnineteenMember2019-01-012019-12-310001563411cstm:PerformanceShareUnitsGrantedInJulyTwoThousandAndSeventeenMember2017-01-012017-12-310001563411cstm:PerformanceShareUnitsVestedInJulyTwoThousandAndTwentyMember2020-01-012020-12-310001563411cstm:PerformanceShareUnitsMember2019-01-012019-12-310001563411cstm:RestrictedStockUnitsMember2020-01-012020-12-310001563411ifrs-full:KeyManagementPersonnelOfEntityOrParentMembercstm:RestrictedStockUnitsMember2019-01-012019-12-310001563411ifrs-full:KeyManagementPersonnelOfEntityOrParentMembercstm:RestrictedStockUnitsMember2020-01-012020-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2018-12-310001563411cstm:RestrictedStockUnitsMember2018-12-310001563411cstm:EquityAwardsPlanMember2018-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2019-01-012019-12-310001563411cstm:RestrictedStockUnitsMember2019-01-012019-12-310001563411cstm:EquityAwardsPlanMember2019-01-012019-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2019-12-310001563411cstm:RestrictedStockUnitsMember2019-12-310001563411cstm:EquityAwardsPlanMember2019-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2020-01-012020-12-310001563411cstm:EquityAwardsPlanMember2020-01-012020-12-310001563411cstm:PerformanceBasedRestrictedStockUnitsMember2020-12-310001563411cstm:RestrictedStockUnitsMember2020-12-310001563411cstm:EquityAwardsPlanMember2020-12-310001563411cstm:ConstelliumSingenGmbHMembercstm:CrossOperatingSegmentMember2020-01-012020-12-310001563411cstm:ConstelliumValaisSAMembercstm:CrossOperatingSegmentMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumAutomotiveUSALLCMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumEngleyChangchunAutomotiveStructuresCoLtdMember2020-01-012020-12-310001563411cstm:ConstelliumExtrusionsDecinSroMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumExtrusionsDeutschlandGmbHMember2020-01-012020-12-310001563411cstm:ConstelliumExtrusionsLandauGmbHMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:ConstelliumExtrusionsBurgGmbHMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:ConstelliumExtrusionsFranceSASMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumExtrusionsLeviceSroMember2020-01-012020-12-310001563411cstm:ConstelliumAutomotiveMexicoSDERLDECVMembercstm:AutomotiveStructuresAndIndustryMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumAutomotiveMexicoTradingSDERLDECVMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:AstrexIncMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumAutomotiveZilinaSroMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumAutomotiveNanjingCoLtdMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumAutomotiveSpainSLMember2020-01-012020-12-310001563411cstm:AutomotiveStructuresAndIndustryMembercstm:ConstelliumUKLimitedMember2020-01-012020-12-310001563411cstm:ConstelliumIssoireSASMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:ConstelliumMontreuilJuigneMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:ConstelliumChinaLimitedMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:AerospaceAndTransportationMembercstm:ConstelliumJapanKKMember2020-01-012020-12-310001563411cstm:ConstelliumRolledProductsRavenswoodLLCMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:AerospaceAndTransportationMembercstm:ConstelliumUsselSASMember2020-01-012020-12-310001563411cstm:AluinfraServicesSAMembercstm:AerospaceAndTransportationMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumDeutschlandGmbHMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumRolledProductsSingenGmbHKGMember2020-01-012020-12-310001563411cstm:ConstelliumPropertyAndEquipmentCompanyLLCMembercstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411cstm:ConstelliumNeufBrisachMembercstm:PackagingAndAutomotiveRolledProductsMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumMuscleShoalsLLCMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumHoldingMuscleShoalsLLCMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumMuscleShoalsFundingTwoLLCMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ListerhillTotalMaintenanceCenterLlcMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumMetalProcurementLLCMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:ConstelliumUACJABSLLCMember2020-01-012020-12-310001563411cstm:PackagingAndAutomotiveRolledProductsMembercstm:RhenarollMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:CtecConstelliumTechnologyCenterSASMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumFinanceSASMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumFranceIIIMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumFranceHoldcoSASMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumInternationalMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumParisSASMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumGermanyHoldcoGmbHAndCoKGMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumGermanyVerwaltungsGmbhMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumUSHoldingsILLCMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumUSIntermediateHoldingsLLCMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumSwitzerlandAGMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:ConstelliumTreuhandUGMember2020-01-012020-12-310001563411cstm:HoldingsAndCorporateMembercstm:EngineeredProductsInternationalSASMember2020-01-012020-12-310001563411ifrs-full:ParentMember2020-12-310001563411ifrs-full:ParentMember2019-12-310001563411ifrs-full:ParentMember2020-01-012020-12-310001563411ifrs-full:ParentMember2019-01-012019-12-310001563411ifrs-full:ParentMember2018-01-012018-12-310001563411ifrs-full:ParentMember2018-12-310001563411ifrs-full:ParentMember2017-12-310001563411cstm:ConstelliumUACJABSLLCMember2019-01-092019-01-090001563411cstm:ConstelliumUACJABSLLCMember2019-01-012019-12-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Membercstm:OfferingOfSeniorNotesMember2021-03-310001563411cstm:ConstelliumSESeniorSustainabilityLinkedNotesIssuedFebruary2021DueFebruary2029Membercstm:OfferingOfSeniorNotesMember2021-01-012021-03-310001563411cstm:ConstelliumSESeniorUnsecuredNotesIssuedFebruaryTwoThousandSeventeenDueTwoThousandTwentyFiveMembercstm:RedemptionOfSeniorNotesMember2021-01-012021-03-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________________________________________________
FORM 20-F
__________________________________________________________________________
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-35931
__________________________________________________________________________
Constellium SE
(Exact Name of Registrant as Specified in its Charter)
__________________________________________________________________________
Constellium SE
(Translation of Registrant’s name into English)
__________________________________________________________________________
France
(Jurisdiction of incorporation or organization)
__________________________________________________________________________
Washington Plaza, 300 East Lombard Street
40-44 rue Washington Suite 1710
75008 Paris
Baltimore, MD, 21202
France United States
(Head Office)
(Address of principal executive offices)
Rina E. Teran
Chief Securities Counsel
300 East Lombard Street, Suite 1710, Baltimore, MD, 21202
United States
Tel: (443) 420-7861
E-mail: rina.teran@constellium.com
(Name, telephone, e-mail and/or facsimile number and address of company contact person)
__________________________________________________________________________
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class Trading Symbol Name of each exchange on which registered
Ordinary Shares CSTM New York Stock Exchange
Securities registered or to be registered pursuant to Section 12(g) of the Act:
None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
None
_____________________________
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report:
139,962,672 Ordinary Shares, Nominal Value €0.02 per share
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.   x  Yes    ☐  No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.     ☐  Yes     x  No
Note—Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ☐  No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
x   Yes     ☐   No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer”, "accelerated filer", and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  x            Accelerated filer  ☐            Non-accelerated filer  ☐            Emerging growth company  ☐
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
U.S. GAAP   ☐ International Financial Reporting Standards Other   ☐
as issued by the International Accounting Standards Board   x
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:    Item 17  ☐        Item 18  ☐
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   ☐   Yes   x   No



TABLE OF CONTENTS
Page
ii
1
1
1
1
15
37
37
56
76
80
82
82
103
Item 12. Description of Securities Other than Equity Securities
103
103
103
103
103
104
104
104
105
105
105
105
110
111
111
111
111
F-1

-i-


SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS
This annual report on Form 20-F (this “Annual Report”) of Constellium SE ("Constellium SE" or "the Company", and when referred to together with its subsidiaries, "the Group" or "Constellium") contains “forward-looking statements” with respect to our business, results of operations and financial condition, and our expectations or beliefs concerning future events and conditions. You can identify certain forward-looking statements because they contain words such as, but not limited to, “believes,” “expects,” “may,” “should,” “approximately,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “likely,” “will,” “would,” “could” and similar expressions (or the negative of these terminologies or expressions). All forward-looking statements involve risks and uncertainties. Many risks and uncertainties are inherent in our industry and markets. Others are more specific to our business and operations. The occurrence of the events described and the achievement of the expected results depend on many events, some or all of which are not predictable or within our control. Actual results may differ materially from the forward-looking statements contained in this Annual Report.
Important factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements are disclosed under “Item 3. Key Information—D. Risk Factors” and elsewhere in this Annual Report, including, without limitation, in conjunction with the forward-looking statements included in this Annual Report. All forward-looking statements in this Annual Report and subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements. Some of the factors that we believe could materially affect our results include:
We may not be able to compete successfully in the highly competitive markets in which we operate, and new competitors could emerge, which could negatively impact our share of industry sales, sales volumes and selling prices.
Aluminium may become less competitive with alternative materials, which could reduce our sales volumes, or lower our selling prices.
A significant portion of our revenue is derived from international operations, which exposes us to certain risks inherent in doing business globally.
Widespread public health pandemics, including COVID-19, could have a material and adverse effect on our business, financial condition and results of operations.
The cyclical and seasonal nature of the metals industry, our end-use markets and our customers’ industries could adversely affect our financial condition and results of operations.
Our failure to meet customer manufacturing and quality requirements, standards and demand, or changing market conditions could have a material adverse impact on our business, reputation and financial results.
We are dependent on a limited number of customers for a substantial portion of our sales and a failure to successfully renew or renegotiate our agreements with such customers may adversely affect our results of operations, financial condition and cash flows.
If we are unable to substantially pass on to our customers the cost of price increases of our raw materials, which may be subject to volatility, our profitability could be adversely affected.
We are dependent on a limited number of suppliers for a substantial portion of our aluminium supply and a failure to successfully renew or renegotiate our agreements with our suppliers may adversely affect our results of operations, financial condition and cash flows.
The price volatility of energy costs may adversely affect our profitability.
Disruptions or failures in our IT systems, or failure to protect our IT systems against cyber-attacks or information security breaches, could have a material adverse effect on our business and financial results.
We may be affected by global climate change or by legal, regulatory, or market responses to such change, and our efforts to meet ESG standards or to enhance the sustainability of our businesses may not meet the expectations of our stakeholders or regulators.
The loss of certain key members of our management team may have a material adverse effect on our operating results.
Our level of indebtedness could limit cash flow available for our operations and capital expenditures and could adversely affect our net income, our ability to service our debt or obtain additional financing, and our business relationships.
We are a foreign private issuer under the U.S. securities laws and within the meaning of the New York Stock Exchange (“NYSE”) rules. As a result, we qualify for and rely on exemptions from certain corporate governance requirements and may rely on other exemptions available to us in the future.
Any inability of the Company to continue to benefit from French provisions applicable to registered intermediaries (“intermédiaires inscrits”) could adversely affect the rights of shareholders.
The other factors presented under “Item 3. Key Information-D. Risk Factors.”
-ii-


We caution you that the foregoing list may not contain all of the factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this Annual Report may not in fact occur. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as required by law.

-iii-


PART I
Item 1. Identity of Directors, Senior Management and Advisers
Not applicable.
Item 2. Offer Statistics and Expected Timetable
Not applicable.
Item 3. Key Information
A. Selected Financial Data
The following tables set forth our selected historical financial and operating data.
The selected historical financial information as of December 31, 2020 and 2019 and for each of the three years in the period ended December 31, 2020 has been derived from our audited consolidated financial statements (the “Consolidated Financial Statements”) included elsewhere in this Annual Report. The selected historical financial information as of December 31, 2018, 2017 and 2016 and for each of the two years in the period ended December 31, 2017 has been derived from our audited consolidated financial statements not included in this Annual Report.
The audited Consolidated Financial Statements included elsewhere in this Annual Report have been prepared in a manner that complies, in all material respects, with the International Financial Reporting Standards (“IFRS”), as issued by the International Accounting Standards Board (the “IASB”), and as endorsed by the European Union (“EU”).
References to “tons” throughout this Annual Report are to metric tons.
As of and for the year ended
December 31,
(in millions of Euros other than per share data) 2020 2019 2018 2017 2016
Statement of income data:
Revenue 4,883  5,907  5,686  5,237  4,743 
Gross profit 490  602  538  555  535 
Income from operations 125  255  404  338  267 
Net (loss) / income for the period (17) 64  190  (31) (4)
(Loss) / earnings per share—basic (0.15) 0.43  1.40  (0.28) (0.04)
(Loss) / earnings per share—diluted (0.15) 0.41  1.37  (0.28) (0.04)
Weighted average number of shares outstanding (diluted) 138,739,635  142,645,619  138,145,914  110,164,320  105,500,327 
Dividends per ordinary share (Euro) —  —  —  —  — 
-1-


As of and for the year ended
December 31,
(in millions of Euros other than per ton data) 2020 2019 2018 2017 2016
Balance sheet data:
Total assets 4,129  4,184  3,901  3,711  3,787 
Net liabilities or total equity (101) (85) (114) (319) (570)
Share capital
Other operational and financial data (unaudited):
Capital expenditures(1)
182  271  277  276  355 
Volumes (in kt) 1,431  1,589  1,534  1,482  1,470 
Revenue per ton (€ per ton) 3,412  3,717  3,707  3,534  3,227 
__________________
(1)Represents purchases of property, plant, and equipment.
B. Capitalization and Indebtedness
Not applicable.
C. Reasons for the Offer and Use of Proceeds
Not applicable.
D.
Risk Factors
You should carefully consider the risks and uncertainties described below and the other information in this Annual Report. Our business, financial condition or results of operations could be materially and adversely affected if any of these risks occurs, and as a result, the market price of our outstanding securities could decline. This Annual Report also contains forward-looking statements that involve risks and uncertainties. See “Special Note About Forward-Looking Statements.” Our actual results could differ materially and adversely from those anticipated in these forward-looking statements as a result of certain factors.
BUSINESS AND OPERATIONAL RISKS
We may not be able to compete successfully in the highly competitive markets in which we operate, and new competitors could emerge, which could negatively impact our market share, sales volumes and selling prices.
We are engaged in a highly competitive industry and compete in the production and sale of rolled and extruded aluminium products with a number of other producers, some of which are larger and have greater financial and technical resources than we do. As a result, these competitors may have an advantage over us in their abilities to research and develop technology, pursue acquisitions, investments and other business opportunities, market and sell their products and services, capitalize on market opportunities, enter new markets and withstand business interruptions, pricing reductions, or adverse industry or economic conditions. In addition, producers with a lower cost basis may, in certain circumstances, have a competitive pricing advantage. Further, a current or new competitor may add or build new capacity, which could diminish our profitability by decreasing prices in our markets. New competitors could emerge within aluminium, steel or other materials, that may seek to compete in our industry. Emerging or transitioning markets in regions with abundant natural resources, low-cost labor and energy, and lower environmental and other standards may pose a significant competitive threat to our business. Moreover, technological innovation is important to our customers who require us to lead or keep pace with new innovations to address their needs. If we do not compete successfully, our market share, sales volumes and selling prices may be negatively impacted.
-2-


Aluminium may become less competitive with alternative materials, which could reduce our sales volumes, or lower our selling prices.
Our products compete with products made from other materials, such as steel, glass, plastics and composite materials, for various applications. Higher aluminium prices relative to substitute materials tend to make aluminium products less competitive with these alternative materials. Environmental and other regulations may also make our products less competitive as compared to materials that are subject to fewer regulations. Customers in our end-markets use and continue to evaluate the further use of alternative materials to aluminium in order to reduce the weight and increase the efficiency of their products. The willingness of customers to accept substitutions for aluminium, or the ability of large customers to exert leverage in the market to reduce the pricing for our aluminium products, could materially adversely affect our financial position, results of operations and cash flows.
A significant portion of our revenue is derived from international operations, which exposes us to certain risks inherent in doing business globally.
We are a global company with our head office in Paris, France, with operations in France, the United States, Germany, Switzerland, the Czech Republic, Slovakia, China, Spain, Canada and Mexico, and we sell our products primarily across Europe, North America and Asia. Economic downturns in regional and global economies, or a prolonged recession in our principal industry segments, have had a negative impact on our operations in the past by reducing overall demand of our products, and could have a negative impact on our future financial condition or results of operations.
We also continue to explore opportunities to expand our international operations. We generally are subject to financial, political, economic, regulatory and business risks in connection with our global operations, including:
changes in international governmental regulations, trade restrictions and laws, including those relating to taxes, employment and repatriation of earnings;
compliance with sanctions regimes and export control laws of multiple jurisdictions;
currency restrictions, currency exchange rate and interest rate fluctuations;
the potential for nationalization of enterprises or government policies favoring local production;
renegotiation or nullification of existing agreements;
high rates of, or excessive inflation;
differing protections for intellectual property and enforcement thereof;
divergent environmental laws and regulations;
uncertain social, political, regulatory, or trade conditions (e.g. U.K. Brexit; U.S. duties, tariffs and trade negotiations);
sustained economic downturns;
significant supply/demand imbalances impacting our industry; and
public health crises, pandemics and epidemics, such as the outbreak of COVID-19.
The occurrence of any of these events could cause our costs to rise, limit growth opportunities or have a negative effect on our operations and our ability to plan for future periods.
Widespread public health pandemics, including COVID-19, could have a material and adverse effect on our business, financial condition and results of operations.
Any public health pandemic and other disease outbreaks in countries where we, our customers or our suppliers operate could have a material and adverse effect on our business, financial conditions and results of operations. COVID-19 has affected our operations globally. As a result of this pandemic and resulting disruption in our customers’ production and operations, our sales have been negatively affected, which has adversely impacted our revenues and operating margins. In response to the COVID-19 pandemic, in 2020, we adjusted operating levels at our manufacturing sites, including implementing temporary workforce reductions and other cost cutting measures, to match the demand from our customers. We cannot predict when all of our manufacturing sites will return to pre-COVID-19 operating levels, any conditions that may need to be implemented to facilitate a return to normal operations, and the effects and costs associated with any such conditions and changes to operating levels. Our operating results and financial condition may also be materially adversely affected by laws, regulations, orders or
-3-


other governmental or regulatory actions addressing the COVID-19 pandemic, or any future outbreaks, that place restrictions on, or require us to make changes to, our operations.
With respect to our suppliers, disruptions resulting from the COVID-19 pandemic resulted and may result in cancellations or delays and increased transport times for delivery of materials to our facilities, which may affect our ability to timely manufacture and ship our products to customers. If such difficulties arise, we may need to seek alternate suppliers, which may be more expensive, may not be available or may result in delays in shipments to us and subsequently to our customers. Alternatively, suppliers may require that we take metal in excess of our needs based on our reduced operating rates, which could negatively affect our financial position. Decreases in our operating levels may also impact our hedging strategy which could adversely impact our financial results.
The nature and extent of COVID-19’s continuing impact on the global economy, our business, financial condition and results of operations is beyond our control, and depends on various uncertain factors, including the duration and severity of the outbreak and the possibility of new outbreaks, the ability to develop and distribute a vaccine or other preventative measures, and the actions to contain or treat its impact, including quarantine orders, business restrictions and closures and other similar restrictions and limitations. The foregoing and other continued disruptions to our business as a result of the COVID-19 pandemic, as well as any global recession resulting from the impact of COVID-19, could materially adversely affect our business, financial condition and results of operations.
The cyclical and seasonal nature of the metals industry, our end-use markets and our customers’ industries could adversely affect our financial condition and results of operations.
Our end markets are cyclical and tend to directly correlate with changes in general and local economic conditions. These conditions include the level of economic growth, the availability of financing, affordable energy sources, employment levels, interest rates, consumer confidence and housing demand. We are particularly sensitive to cycles in the aerospace, automotive, defense, industrial and transportation end-markets, which are highly cyclical. During recessions or periods of low growth, these industries typically experience major cutbacks in production, resulting in decreased demand for aluminium products. This leads to significant fluctuations in demand and pricing for our products and services. Because our operations are capital intensive and we generally have high fixed costs and may not be able to reduce costs and production capacity on a sufficiently rapid basis, our near-term profitability may be significantly affected by decreased processing volumes. Customer demand is also affected by holiday seasons, seasonal slowdowns, weather conditions, economic and other factors beyond our control. Accordingly, cyclical fluctuations, reduced demand and pricing pressures may significantly reduce our profitability and materially adversely affect our financial condition, results of operations and cash flows.
Our business requires substantial capital investments that we may be unable to carry out. We may be unable to execute and timely complete our expected capital investments, or may be unable to achieve the anticipated benefits of such investments.
Our operations are capital intensive. We may not generate sufficient operating cash flows and our external financing sources may not be available in sufficient amounts to enable us to make anticipated capital expenditures, or to complete them on a timely basis. If we are unable to, or determine not to, complete our expected investments, or such investments are delayed, we will not realize the anticipated benefits of such investments. In addition, if we are unable to make investments for upgrades and repairs or purchase new plants and equipment, our financial condition and results of operations could be materially adversely affected by higher maintenance costs, lower sales volumes due to the impact of reduced product quality, operational disruptions, reduced production capacity and other competitive factors. Demand for our products produced on new investments may be slow to materialize, and we may not receive customer orders or revenue for such products as quickly as we may anticipate. Such delays could adversely affect our results of operations.
 We may fail to implement or execute our business strategy, successfully develop and implement new technology initiatives and other strategic investments.
Our future financial performance and success depend in large part on our ability to successfully implement and execute our business strategy, including investing in high-return opportunities in our core markets, focusing on higher-margin, technologically advanced products, differentiating our products, expanding our strategic relationships with customers, fixed-cost containment and cash management, and executing on our manufacturing productivity improvement programs. Any inability to execute on our strategy could reduce our expected earnings and could adversely affect our operations overall. In January 2019, we purchased UACJ Corporation’s (UACJ) indirectly held stake in Constellium-UACJ ABS, LLC, our joint venture with UACJ to manufacture Auto Body Sheet (ABS) products in the United States, at our facility located in Bowling Green, Kentucky. We may not realize the intended benefits of the acquisition of Bowling Green, as rapidly as, or to the extent,
-4-


anticipated by our management, which could have a material adverse effect on our business, results of operations and financial condition.
In addition, being at the forefront of technological development is important to remain competitive. We have invested in, and are involved with, a number of technology and process initiatives. Several technical aspects of certain of these initiatives are still unproven and the eventual commercial outcomes and feasibility cannot be assessed with any certainty. Even if we are successful with these initiatives, we may not be able to bring them to market as planned before our competitors or at all, and the initiatives may end up costing more than expected. As a result, the costs and benefits from our investments in new technologies and the impact on our financial results may vary from present expectations. Further, we have undertaken and may continue to undertake strategic growth, streamlining and productivity initiatives and investments to improve performance. We cannot assure you that these initiatives will be completed or that they will have their intended benefits. Capital investments in debottlenecking or other organic growth initiatives may not produce the returns we anticipate.
Our failure to meet customer manufacturing and quality requirements, standards and demand, or changing market conditions could have a material adverse impact on our business, reputation and financial results.
Product manufacturing in our business is a highly complex process. Our customers specify quality, performance and reliability standards that we must meet. If our products do not meet these standards or are defective, we may be required to replace or rework the products. We have experienced product quality, performance or reliability problems and defects from time to time and similar defects or failures may occur in the future.
Some additional factors that could adversely impact our ability to meet our customer requirements and demand, or changing market conditions include:
Meeting such demand may require us to make substantial capital investments to repair, maintain, upgrade, and expand our facilities and equipment. Notwithstanding our ongoing plans and investments to increase our capacity, we may not be able to expand our production capacity quickly enough to meet our customer requirements.
Our operations may experience unplanned business interruptions caused by events such as explosions, fires, inclement weather, natural disasters, accidents, equipment failure and breakdown, IT systems and process failures, electrical blackouts or outages, transportation and supply interruptions. Any such disruption at one or more of our production facilities could cause substantial losses or delays in our production capacity, increase our operating costs and have a negative financial impact on the Company and our customers. Business interruptions may also harm our reputation among actual and potential customers, and the reputation of our customers.
The qualification of our products by many of our customers can be lengthy and unpredictable as many of these customers have extensive sourcing and qualification processes, which require substantial time and financial resources, with no certainty of success or recovery of our related expenses. Failure to qualify or re-qualify our products may result in us losing such customers or customer contracts.
As we begin manufacturing processes in our new locations, or for new equipment or newly introduced products, we may experience difficulties, including operational and manufacturing disruptions, delays or other complications, which could adversely affect our ability to timely launch or ramp-up productions and serve our customers.
If these or any other similar manufacturing or quality failures occur, they could result in losses or product recalls, customer penalties, contract cancellation and product liability exposure. Further, they could adversely affect product demand, result in negative publicity, damage to our reputation and could lead to a loss of customer confidence in our products, which could have a material adverse impact on our business, financial position and results of operations.
We are dependent on a limited number of customers for a substantial portion of our sales and a failure to successfully renew or renegotiate our agreements with such customers may adversely affect our results of operations, financial condition and cash flows.
Our business is exposed to customer concentration risk. A significant downturn in the business, credit or financial condition of our largest customers could expose us to the risk of default on contractual agreements.
Some of our customer contracts and related arrangements have provisions that may become less favorable to us over time, are subject to renewal, renegotiation or re-pricing at periodic intervals or upon changes in competitive and regulatory supply conditions, or provide termination rights to our customers. If we fail to successfully renew or renegotiate these contracts or arrangements, or if we are not successful in replacing business lost from such customers, then our results of operations, financial condition and cash flows could be materially adversely affected. Any material deterioration in, or termination of, these
-5-


customer relationships could result in a reduction or loss in sales volume or revenue which could materially adversely affect our results of operations, financial condition and cash flows.
Relatedly, we have dedicated facilities serving certain of our customers which subjects us to the inherent risk of increased dependence on such customers with respect to these facilities. In such cases, the loss of such a customer, or the reduction of that customer’s business at these facilities, or the deterioration of such customer’s credit or financial condition, could materially adversely affect our financial condition and results of operations, and we may be unable to timely replace, or replace at all, lost order volumes and revenue.
Customers in our end-markets, including the packaging, automotive, and aerospace sectors, may consolidate and grow in a manner that could affect their relationships with us. For example, if our customers become larger and more concentrated, they could exert financial pressure on all suppliers, including us. Accordingly, our ability to maintain or raise prices in the future may be limited, including during periods of raw material and other cost increases. If we are forced to reduce prices or maintain prices during periods of increased costs, or if we lose customers because of consolidation, pricing or other methods of competition, our financial position, results of operations and cash flows may be adversely affected. If as a result of consolidation in our industry, our competitors are able to exert financial pressure on suppliers, obtain more favorable terms or otherwise take actions that could increase their competitive strengths, our competitive position may be materially adversely affected.
If we are unable to substantially pass on to our customers the cost of price increases of our raw materials, which may be subject to volatility, our profitability could be adversely affected.
Prices for the raw materials we require are subject to continuous volatility and may increase from time to time. The overall price of primary aluminium consists of several components: (1) the underlying base metal component, which is typically based on quoted prices from the London Metal Exchange (“LME”); (2) the regional premium, which represents an incremental price over the base LME component that is associated with the physical delivery of metal to a particular region (e.g., the Midwest premium for metal sold in the United States or the Rotterdam premium for metal sold in Europe); and (3) the product premium, which represents a separate incremental price for receiving physical metal in a particular shape (e.g., billet, slab, rod, etc.), alloy, or purity. Each of these three components has its own drivers of variability. The LME price is typically driven by macroeconomic factors, including the global supply and demand of aluminium. Regional premiums tend to vary based on the supply and demand for metal in a particular region, changes in tariffs and associated warehousing and transportation costs. Product premiums generally are a function of supply and demand as well as production and raw material costs for a given primary aluminium shape and alloy combination in a particular region.
Sustained high aluminium prices, increases in aluminium prices, the inability to meaningfully hedge our exposure to aluminium prices, or the inability to pass through any fluctuation in regional premiums or product premiums to our customers, could have a material adverse effect on our business, financial condition, and results of operations and cash flow. In addition, although our sales are generally made on a “margin over metal price” basis, if metal prices increase, we may not be able to pass on the entire increase to our customers. There could also be a time lag between when changes in metal prices under our purchase contracts are effective and the point when we can implement corresponding changes under our sales contracts with our customers. As a result, we may be exposed to the effects of fluctuations in raw material prices, including metal, due to time lag. Further, although most of our contracts allow us to substantially pass through metal prices to our customers, we have certain contracts that are based on fixed metal pricing, where pass through is not available. Similarly, in certain contracts we have ineffective pass through mechanisms related to regional premium fluctuation. We attempt to mitigate these risks through hedging, but we may not be able to successfully reduce or eliminate any resulting impact, which could have a material adverse effect on our financial results and cash flows.
We are dependent on a limited number of suppliers for a substantial portion of our aluminium supply and a failure to successfully renew or renegotiate our agreements with our suppliers may adversely affect our results of operations, financial condition and cash flows.
Our ability to produce competitively priced aluminium products depends on our ability to procure competitively priced aluminium in a timely manner and in sufficient quantities to meet our production needs. We have supply arrangements with a limited number of suppliers for aluminium. Increasing aluminium demand levels have caused regional supply constraints in the industry, and further increases in demand could exacerbate these issues. We maintain long-term contracts for a majority of our supply requirements and depend on annual and spot purchases for the remainder of such requirements. There can be no assurance that we will be able to renew, or obtain replacements for, such contracts when they expire on terms that are as favorable as our existing agreements or at all. Additionally, if any of our key suppliers is unable to deliver sufficient quantities on a timely basis, our production may be disrupted, and we could be forced to purchase primary metal from alternative sources,
-6-


which may not be available in sufficient quantities or may only be available on terms that are less favorable to us. An interruption in key supplies required for our operations could have a material adverse effect on our ability to produce and deliver products on a timely or cost-efficient basis and therefore on our financial condition, results of operations and cash flows. Moreover, a significant downturn in the business or financial condition of our significant suppliers exposes us to the risk of default by the supplier on our contractual agreements.
We depend on scrap aluminium for our operations and acquire our scrap inventory from numerous sources. Our suppliers generally are not bound by long-term contracts and have no obligation to sell scrap metal to us. A decrease in the supply of used beverage containers could negatively impact our supply of aluminium. In addition, when using recycled material, we benefit from the difference between the price of primary aluminium and scrap aluminium. Consequently, if this difference is narrow for a considerable period of time or if an adequate supply of scrap aluminium is not available to us, we would be unable to recycle metals at desired volumes and our results of operations, financial condition and cash flows could be materially adversely affected.
The price volatility of energy costs may adversely affect our profitability.
Our operations use natural gas and electricity, which represent the fourth largest component of our cost of sales, after metal, labor costs, and depreciation. We typically purchase the majority of our natural gas and energy requirements on a forward basis under fixed price commitments or long term contracts with suppliers which provides increased visibility on costs. However, the volatility in costs of fuel, principally natural gas, and other utility services used by our production facilities affects operating costs. Fuel and utility prices are affected by factors outside our control, such as supply and demand for fuel and utility services in both local and regional markets as well as governmental regulation and imposition of taxes on energy. As a significant purchaser of energy, existing and future regulations relating to the emissions by our energy suppliers could result in materially increased energy costs for our operations, which we may be unable to pass along to our customers. Although we have secured a large part of our natural gas and electricity under fixed price commitments or long-term contracts with suppliers, future increases in fuel and utility prices, or disruptions in energy supply, may have an adverse effect on our financial position, results of operations and cash flows.
Disruptions or failures in our IT systems, or failure to protect our IT systems against cyber-attacks or information security breaches, could have a material adverse effect on our business and financial results.
We rely on our IT systems to effectively manage and operate our business, including such processes as data collection, accounting, financial reporting, communications, supply chain, order entry and fulfillment, other business processes, and in operating our equipment. The failure of our IT systems to perform efficiently could disrupt our business and could result in transaction errors, processing inefficiencies, limited equipment utilization, and the loss of sales and customers, causing our business and financial results to suffer. A failure in, or breach of, our IT systems as a result of cyber-attacks or information security breaches could disrupt our business, result in the disclosure or misuse of confidential or proprietary information, damage our reputation, increase our costs or cause losses. As cyber threats continue to evolve, we are expending additional resources to continue to enhance our information security measures and be able to investigate and remediate promptly any information security vulnerabilities. We experienced a few security incidents in 2020, but they were successfully detected and handled and did not have a material negative impact on the Company, our business or our operations.
We continue to make investments and adopt measures designed to enhance our protection, detection, response, and recovery capabilities, and to mitigate potential risks to our technology, products, services and operations from potential cyber-attacks. However, given the unpredictability, nature and scope of cyber-attacks, it is possible that potential vulnerabilities could go undetected for an extended period. We could potentially be subject to production downtime, operational delays, other detrimental impacts on our operations or ability to provide products and services to our customers, the compromise of confidential or otherwise protected information, misappropriation, destruction or corruption of data, security breaches, other manipulation or improper use of our or third-party systems, networks or products, financial losses from remedial actions, loss of business or potential liability, and/or damage to our reputation, any of which could have a material adverse effect on our competitive position, results of operations, cash flows or financial condition.
Information security risks have increased in recent years because of the proliferation of new technologies and the increased sophistication and activities of perpetrators of cyber-attacks. We continuously evaluate our IT systems and requirements and have implemented upgrades to our IT systems that support our business. As a result of system failures, viruses, computer “hackers” or other forms of cyber-attacks, we may experience operational disruptions to our information systems, which could cause information losses, including data related to customer orders, limited utilization of our equipment, or operational outages. These could adversely affect our business, financial condition or results of operations.
-7-


We may be affected by global climate change or by legal, regulatory, or market responses to such change, and our efforts to meet ESG standards or to enhance the sustainability of our businesses may not meet the expectations of our stakeholders or regulators.
Climate change is receiving increasing attention worldwide which has led to new and proposed legislative and regulatory initiatives. New or revised laws and regulations in this area could directly and indirectly affect us and our customers and suppliers, including by increasing the costs of production or impacting demand for certain products, which could result in an adverse effect on our financial condition, results of operations and cash flows. Compliance with any new or more stringent laws or regulations or stricter interpretations of existing laws, could require additional expenditures by us or our customers or suppliers. Our operations result in the emission of substantial quantities of carbon dioxide, a greenhouse gas that is regulated under the EU’s Emissions Trading System (“ETS”). Although compliance with ETS to date has not resulted in material costs to our business, compliance with ETS requirements currently being developed for the 2021-2030 period, and increased energy costs due to ETS requirements imposed on our energy suppliers, could have a material adverse effect on our business, financial condition or results of operations.
We may also be liable for personal injury claims or workers’ compensation claims relating to exposure to hazardous substances. In addition, we are, from time to time, subject to environmental reviews and investigations by relevant governmental authorities. We also rely on natural gas, electricity, fuel oil and transport fuel to operate our facilities. Any increased costs of these energy sources in response to new laws could be passed through to us and our customers and suppliers, which could also have a negative impact on our financial condition and profitability.
In addition, some of our shareholders, investors, customers, or those considering such a relationship with us, may evaluate our business or other practices according to a variety of environmental, social, and governance (“ESG”) standards and expectations. Further, we define our own corporate purpose, in part, by the sustainability of our practices and our impact on all our stakeholders. As a result, our efforts to conduct our business in accordance with some or all these expectations may involve trade-offs, and may not satisfy all stakeholders. Our policies and processes to evaluate and manage ESG standards in coordination with other business priorities may not prove completely effective. As a result, we may face adverse regulatory, investor, media, or public scrutiny that may adversely affect our business, our results of operations, or our financial condition.
We may be exposed to fraud, misconduct, corruption or other illegal activity which could harm our reputation and our financial results.
We may be exposed to fraud, misconduct, corruption or other illegal activity by our employees, independent contractors, consultants, commercial partners, and vendors. Despite our internal controls and procedures, misconduct by these parties could include intentional, reckless and negligent conduct, which can be difficult to detect. In addition, regulators and enforcement agencies continue to devote greater resources to the enforcement of the Foreign Corrupt Practices Act, Loi Sapin II, and other anti-money laundering laws and anti-corruption laws. We have developed and implemented policies and procedures designed to ensure strict compliance with anti-bribery, anti-money laundering, anti-corruption and other laws, however, such policies and procedures may not be effective in all instances to prevent violations.
Any determination that any of our employees have committed fraud or have violated corruption or other criminal laws of any jurisdictions in which we do business, could subject us to, among other things, civil and criminal penalties, material fines, profit disgorgement, injunction on future conduct, securities litigation and reputational damage, any one of which could adversely affect our business, financial position or results of operations.
We could be required to make unexpected contributions to our defined benefit pension plans as a result of adverse changes in interest rates and the capital markets.
We have substantial pension and other post-employment benefit obligations. Most of our pension obligations relate to funded defined benefit pension plans for our employees in the United States and Switzerland, unfunded pension benefits in France and Germany, and lump sum indemnities payable to our employees in France and Germany upon retirement or termination. Our estimates of liabilities and expenses for pensions and other post-retirement benefits incorporate a number of assumptions, including interest rates used to discount future benefits. Our liquidity or shareholders’ equity in a particular period could be materially adversely affected by capital market returns that are less than their assumed long-term rate of return or a decline in the rate used to discount future benefits. Our pension plan assets consist primarily of funds invested in diversified portfolios. If the assets of our pension plans do not achieve assumed investment returns for any period, such deficiency could result in one or more charges against shareholders’ equity for that period. In addition, changing economic conditions, poor pension investment returns or other factors may require us to make unexpected cash contributions to the pension plans in the future, preventing the use of such cash for other purposes.
-8-


We also participate in various “multi-employer” pension plans in one of our facilities in the United States administered by labor unions representing some of our employees. Our withdrawal liability for any multi-employer plan would depend on the extent of the plan’s funding of vested benefits. In the ordinary course of our renegotiation of collective bargaining agreements with labor unions that maintain these plans, we could decide to discontinue participation in a plan, and in that event we could face a withdrawal liability. We could also be treated as withdrawing from participation in one of these plans if the number of our employees participating in these plans is reduced to a certain degree, or over certain periods of time. Such reductions in the number of our employees participating in these plans could occur as a result of changes in our business operations, such as facility closures or consolidations. Any withdrawal liability could have an adverse effect on our results of operations or financial condition.
We could experience labor disputes and work stoppages, or be unable to renegotiate collective bargaining agreements, which could disrupt our business and have a negative impact on our financial condition and results of operations.
A significant number of our employees are represented by unions or equivalent bodies or are covered by collective bargaining or similar agreements that are subject to periodic renegotiation. Although we believe that we will be able to successfully negotiate new collective bargaining agreements when the current agreements expire, these negotiations may not prove successful, and may result in a significant increase in the cost of labor, or may break down and result in the disruption or cessation of our operations.
From time to time, we may experience labor disputes and work stoppages at our facilities generally, and at times in connection with collective bargaining agreement negotiations. Reasons for stoppages include disapproval of governmental measures, solidarity with a dismissed employee, wage claims, protests against working conditions and/or strikes. These disruptions can have a duration ranging from hours to weeks. Existing collective bargaining agreements may not prevent a strike or work stoppage at our facilities. Any such stoppages or disturbances may adversely affect our financial condition and results of operations by limiting plant production, sales volumes, profitability and operating costs.
The loss of certain key members of our management team may have a material adverse effect on our operating results.
Our success depends, in part, on the efforts of our senior management and other key employees. These individuals, including our Chief Executive Officer and Chief Financial Officer, possess sales, marketing, engineering, technical, manufacturing, financial and administrative skills that are critical to the operation of our business. If we lose or suffer an extended interruption in the services of one or more of our senior officers or other key employees, our ability to operate and expand our business, improve our operations, develop new products, and, as a result, our financial condition and results of operations, may be adversely affected. Moreover, the hiring of qualified individuals is highly competitive in our industry, and we may not be able to attract and retain qualified personnel to replace or succeed members of our senior management or other key employees.
FINANCIAL RISKS
Our level of indebtedness could limit cash flow available for our operations and capital expenditures and could adversely affect our net income, our ability to service our debt or obtain additional financing, and our business relationships.
We have a significant amount of indebtedness. To service such debt, we require a significant amount of cash. We believe that the cash provided by our operations will be sufficient to provide for our cash requirements for the foreseeable future. However, our ability to satisfy our obligations depends on our future operating performance and financial results, which are subject, in part, to factors beyond our control, including interest rates and general economic, financial and business conditions. We cannot assure you that our business will generate sufficient cash flow from operations or that future borrowings will be available to us in an amount sufficient to enable us to pay our indebtedness or to fund our other liquidity needs.
In addition, our level of indebtedness could adversely affect our operations. Among other things, our substantial indebtedness could:
require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures, research and development efforts and other general corporate purposes;
-9-


make it more difficult for us to satisfy leverage and fixed charge coverage ratios required for us to incur additional indebtedness under our existing indebtedness;
make it more difficult for us to satisfy our financial obligations;
increase our vulnerability to general adverse economic and industry conditions;
adversely affect the terms under which suppliers provide goods and services to us, and under which we supply products to our customers;
limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we compete, including limiting our ability to make strategic acquisitions; and
place us at a competitive disadvantage compared to our competitors that have less debt.
If we are unable to meet our debt service obligations and pay our expenses, we may be forced to reduce or delay business activities and capital expenditures, sell assets, obtain additional debt or equity capital, restructure or refinance all or a portion of our debt before maturity or take other measures. Such measures may materially adversely affect our business. If these alternative measures are unsuccessful, we could default on our obligations, which could result in the acceleration of our outstanding debt obligations and could have a material adverse effect on our business, results of operations and financial condition.
A failure to comply with our debt covenants could result in an event of default. If we default under our indebtedness, we may not be able to borrow additional amounts, and our lenders could elect to declare all outstanding borrowings, plus accrued and unpaid interest and fees, to be due and payable, or take other remedial actions. Our indebtedness also contains cross-default provisions, which means that if an event of default occurs under certain material indebtedness, such event of default could trigger an event of default under our other indebtedness. If our debt payments were to be accelerated, we cannot assure you that our assets would be sufficient to repay such debt in full and our lenders could consequently foreclose on our pledged assets.
In addition, a deterioration in our financial position or a downgrade of our credit ratings could adversely affect our financing levels, limit access to the capital or credit markets or our liquidity facilities, or otherwise adversely affect the availability of other new financing on favorable terms or at all, result in more restrictive covenants in agreements governing the terms of any future indebtedness that we incur, increase our borrowing costs, or otherwise impair our business, financial condition and results of operations. Such deterioration or downgrade of our credit ratings could also have an adverse effect on our business relationships with customers, suppliers and hedging counterparties.
 Our results of operations, cash flows and liquidity could be adversely affected if we are unable to execute on our hedging policy, if counterparties to our derivative instruments fail to honor their agreements or if we are unable to enter into certain derivative instruments.
We purchase and sell forwards, futures and options contracts as part of our efforts to reduce our exposure to changes in currency exchange rates, aluminium prices and other raw materials and energy prices. If we are unable to enter into such derivative instruments to manage those risks due to the cost or availability of such instruments or other factors, or if we are not successful in passing through the costs of our risk management activities, our results of operations, cash flows and liquidity could be adversely affected. Our ability to realize the benefit of our hedging program is dependent upon many factors, including factors that are beyond our control. For example, our foreign exchange hedges are scheduled to mature on the expected payment date by the customer; therefore, if the customer fails to pay an invoice on time and does not warn us in advance, we may be unable to reschedule the maturity date of the foreign exchange hedge, which could result in an outflow of foreign currency that will not be offset until the customer makes the payment. We may realize a gain or a loss in unwinding such hedges. In addition, our metal-price hedging program depends on our ability to match our monthly exposure to sold and purchased metal, which can be made difficult by seasonal variations in metal demand, unplanned changes in metal delivery dates by either us, our suppliers, or by our customers and other disruptions to our inventories. We may also be exposed to losses if the counterparties to our derivative instruments fail to honor their agreements.
To the extent our hedging transactions fix prices or exchange rates, and if primary aluminium prices, energy costs or foreign exchange rates are below the fixed prices or rates established by our hedging transactions, then our income and cash flows will be lower than they otherwise would have been. Similarly, if we do not effectively manage and adequately hedge our exposure to price and regional premium fluctuations on aluminium and other raw materials, our financial results may also be adversely affected. Further, with the exception of hedge accounting on certain long-term aerospace contracts and on our net investment in certain of our subsidiaries, we do not apply hedge accounting to our forwards, futures or option contracts. Unrealized gains and losses on our derivative financial instruments that do not qualify for hedge accounting are reported in our consolidated results of operations, or in the case of hedges relating to our indebtedness, in Finance cost - net. The inclusion of
-10-


such unrealized gains and losses in earnings may produce significant period-over-period earnings volatility that is not necessarily reflective of our underlying operating performance. In addition, in certain scenarios when market price movements result in a decline in value of our current derivatives position, our mark-to-market expense may exceed our credit line and counterparties may request the posting of cash collateral which, in turn, can be a significant demand on our liquidity.
At certain times, hedging instruments may simply be unavailable or not available on terms acceptable to us. In addition, current legislation increases the regulatory oversight of over-the-counter derivatives markets and derivative transactions. The companies and transactions that are subject to these regulations may change. If future regulations subject us to additional capital or margin requirements or other restrictions on our trading and commodity positions, this could have an adverse effect on our financial condition and results of operations.
Our cash flows and liquidity could be adversely affected as a result of the maturity mismatch between certain of our derivative instruments and the underlying exposure.
We use financial derivatives to hedge the foreign currency risk associated with the repayment of a portion of our U.S. Dollar-denominated debt. These financial derivatives may have a shorter maturity than either the maturity or call date of the hedged debt instrument. This could result in an adverse impact on our cash flows and liquidity as the impact from changes in foreign exchange rates on the hedging instruments could result in a cash outflow before the corresponding favorable impact on the underlying hedged debt results in a cash inflow.
Changes in income tax rates or income tax laws, additional income tax liabilities due to unfavorable resolution of tax audits, and challenges to our tax position could have a material adverse impact on our financial results.
We operate in multiple tax jurisdictions and believe that we file our tax returns in compliance with the tax laws and regulations of these jurisdictions. Various factors determine our effective tax rate and/or the amount we are required to pay, including changes in or interpretations of tax laws and regulations in any given jurisdiction or global- and EU-based initiatives. Some such tax laws and regulations aim, among other things, to address tax avoidance by multinational companies, changes in geographical allocation of income and expense, the ability to use net operating loss and other tax attributes, and the evaluation of deferred tax assets that requires significant judgment. Any resulting changes to our effective tax rate could materially adversely affect our financial position, liquidity, results of operations and cash flows.
In addition, due to the size and nature of our business, we are subject to ongoing reviews by tax authorities on various tax matters, including challenges to positions we assert on our income tax and withholding tax returns. We accrue income tax liabilities and tax contingencies based upon our best estimate of the taxes ultimately expected to be paid after considering our knowledge of all relevant facts and circumstances, existing tax laws and regulations and how the tax authorities and courts view certain issues. Such amounts are included in income taxes payable or deferred income tax liabilities, as appropriate, and updated over time. Any material adverse review could impact our financial position and result of operations.

LEGAL, GOVERNANCE AND COMPLIANCE RISKS
We may be exposed to significant legal proceedings and investigations, proprietary claims, regulatory and compliance costs, including on environmental matters, which could increase our operating costs and adversely affect our financial condition and results of operations.
We may from time-to-time be involved in, or be the subject of, disputes, proceedings and investigations with respect to a variety of matters, including matters related to personal injury and product liability, intellectual property rights or defending claims of infringement, employees, taxes, contracts, anti-competitive or anti-corruption practices as well as other disputes and proceedings that arise in the ordinary course of business. It could be costly to address these claims or any investigations involving them, whether meritorious or not, and legal proceedings and investigations could divert management’s attention as well as operational resources, adversely affecting our financial position, results of operations and cash flows.
If any of the products that we sell are defective or cause harm to any of our customers, we could be exposed to product liability lawsuits and/or warranty claims. If we were found liable under product liability claims or are obligated under warranty claims, we could be required to pay substantial monetary damages. Even if we successfully defend ourselves against these types of claims, we could incur substantial litigation expenses, our management could be required to devote significant time and attention to defending against these claims, and our reputation could suffer, any of which could harm our business.
-11-


We believe that our intellectual property has significant value and is important to the marketing of our products and maintaining our competitive advantage. Although we attempt to protect our intellectual property rights both in the United States and in foreign countries through a combination of patent, trademark, trade secret and copyright laws, as well as through confidentiality and nondisclosure agreements and other measures, these measures may not be adequate to fully protect our rights. For example, we have a presence in China, which historically has afforded less protection to intellectual property rights than the United States or Europe. Our failure to obtain or maintain adequate protection of our intellectual property rights for any reason could have a material adverse effect on our business, results of operations and financial condition, we therefore may incur significant costs protecting such rights.
Our operations are subject to international, national, state and local laws and regulations in the jurisdictions where we do business, which govern, among other things, air emissions, wastewater discharges, the handling, storage and disposal of hazardous substances and wastes, the remediation of contaminated sites, and employee health and safety. At December 31, 2020, we had close down and environmental remediation costs provisions of €88 million. Future environmental regulations, requirements or more aggressive enforcement of existing regulations could impose stricter compliance requirements on us and on the industries in which we operate, such as legislative efforts to limit greenhouse gas emissions, including carbon dioxide. If we are unable to comply with these laws and regulations, we could incur substantial costs, including fines and civil or criminal sanctions, or costs associated with upgrades to our facilities or changes in our manufacturing processes in order to achieve and maintain compliance.  
We are a foreign private issuer under the U.S. securities laws and within the meaning of the New York Stock Exchange (“NYSE”) rules. As a result, we qualify for and rely on exemptions from certain corporate governance requirements and may rely on other exemptions available to us in the future.
As a “foreign private issuer,” as defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”), we are permitted to follow our home country practice in lieu of certain corporate governance requirements of the NYSE. Foreign private issuers are also exempt from certain U.S. securities law requirements applicable to U.S. domestic issuers, including the requirement to file quarterly reports on Form 10-Q, requirements relating to the solicitation of proxies for shareholder meetings under Section 14 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 16 filings.
We rely on the exemptions for foreign private issuers in lieu of some of the NYSE corporate governance rules. We may change the home country corporate governance practices we follow, and, accordingly, which exemptions we rely on from the NYSE requirements. So long as we qualify as a foreign private issuer, you may not have the same protections applicable to companies that are subject to all of the NYSE corporate governance requirements.
If we were to lose our status as a foreign private issuer, the regulatory and compliance costs to the Company could be significantly more than the costs we currently incur. We would be required to file periodic reports and registration statements on U.S. domestic issuer forms with the U.S. Securities and Exchange Commission (the “SEC”), including proxy statements pursuant to Section 14 of the Exchange Act, which are more detailed and extensive than the forms available to a foreign private issuer, and on a more abbreviated timetable than is applicable to our current filings with the SEC. In addition, our directors and executive officers would become subject to insider short-swing profit disclosure and recovery rules under Section 16 of the Exchange Act and we would lose our ability to rely upon exemptions from certain NYSE corporate governance requirements as described above. Any of these changes would likely increase our regulatory and compliance costs and expenses, which could have a material adverse effect on our business, financial condition and results of operations.
Any shareholder acquiring 30% or more of our voting rights may be required to make a mandatory takeover bid or be subject to claims for damages.
According to the Articles of Association, any person, acting alone or in concert within the meaning of Article L. 233-10 of the French Commercial Code, who comes into possession, other than following a voluntary takeover bid, directly or indirectly, of more than 30% of the capital or voting rights of the Company, shall launch a takeover bid on all the shares and securities granting access to the shares or voting rights, and on terms that comply with applicable U.S. securities laws, and SEC and NYSE rules and regulations. The same requirement applies to persons, acting alone or in concert, who directly or indirectly own a number between 30% and half of the total number of equity securities or voting rights of the Company and who, in less than twelve consecutive months, increase the holding, in capital or voting rights, of at least 1% of the total number of equity securities or voting rights of the Company.
-12-


The rights of our shareholders may be different from the rights of shareholders of U.S. companies and provisions of our organizational documents and applicable law may impede or discourage a takeover, which could deprive our investors of the opportunity to receive a premium for their ordinary shares or to make changes in our Board.
Our corporate affairs are governed by the Articles of Association and by the laws governing companies incorporated in France. The rights of shareholders and the responsibilities of members of our Board may be different from the rights and obligations of shareholders in companies governed by the laws of U.S. jurisdictions. In the performance of its duties, our Board is required by French law to consider the interests of the Company, its shareholders, its employees and other stakeholders, in all cases with due consideration to the principles of reasonableness and fairness. It is possible that some of these parties could have interests that are different from, or in addition to, your interests as a shareholder.
If a third party is liable to a French company, under French law, shareholders generally do not have the right to bring a derivative action on behalf of a company or to bring an action on their own behalf to recover damages sustained as a result of a decrease in value, or loss of an increase in value, of their stock. Only in the event that the cause of liability of such third party to the company also constitutes a tortious act directly against such shareholder causing him direct, personal and definite harm, may such shareholder have an individual right of action against such third party on its own behalf to recover damages.
The French Consumer Code provides for the possibility to initiate class actions (actions en représentation conjointe); however, such class action is not applicable to acts which can affect the rights of shareholders. Approved associations of shareholders or investors are allowed to bring claims in respect of wrongful acts harming the “collective interest” of the investors or of certain categories of investors. Such associations may request that the court orders the responsible person to comply with the legal provisions to end the irregularity or eliminate its effects. They may seek indemnification in the name of individual investors who have suffered individual damages if mandated by at least two such investors.
The provisions of French corporate law and the Articles of Association have the effect of concentrating control over certain corporate decisions and transactions in the hands of our Board. As a result, holders of our shares may have more difficulty in protecting their interests in the face of actions by members of the Board than if we were incorporated in the United States.
In addition, several provisions of the Articles of Association and the laws of France may discourage, delay or prevent a merger, consolidation or acquisition that shareholders may consider favorable, such as the obligation to disclose the crossing of ownership thresholds or the possibility for our Board to issue equity securities, including during a takeover bid. Under French law, our general meeting of shareholders may empower our Board to issue shares, or warrants to subscribe new shares, and restrict or exclude preemptive rights on those shares. These provisions could impede the ability of our shareholders to benefit from a change in control and, as a result, may materially adversely affect the market price of our ordinary shares and your ability to realize any potential change of control premium. French law does not grant appraisal rights to a company’s shareholders who wish to challenge the consideration to be paid upon a domestic legal merger or demerger of a company.
United States civil liabilities may not be enforceable against the Company.
We are incorporated under the laws of France and a substantial portion of our assets are located outside the United States. In addition, certain of our directors and officers, and experts, reside outside the United States. As a result, it may be difficult for investors to effect service of process within the United States upon the Company or other persons residing outside the United States. It may also be difficult to enforce judgments obtained against persons in U.S. courts in any action, including actions predicated upon the civil liability provisions of the U.S. federal securities laws, outside the United States. In addition, it may be difficult for investors to enforce, in original actions brought in courts in jurisdictions located outside the United States, rights predicated upon the U.S. federal securities laws.
There is no treaty between the United States and France for the mutual recognition and enforcement of judgments (other than arbitration awards) in civil and commercial matters. Therefore, a final judgment for the payment of money rendered by any federal or state court in the United States based on civil liability, whether or not predicated solely upon the U.S. federal securities laws, would not be enforceable in France unless it is recognized by French courts. Moreover, an SEC decision ordering the payment of a fine would not be enforceable in France as it constitutes a foreign decision of a public law authority.
If a U.S. judgment is not recognized in France, the parties would have to re-litigate their dispute before a French court, provided such court has jurisdiction over the dispute. Based on the foregoing, there can be no assurance that U.S. investors will be able to enforce any judgments obtained in U.S. courts in civil and commercial matters, including judgments under the U.S. federal securities laws, against the Company, members of our Board, officers or certain experts named herein, who are residents of France or countries other than the United States. In addition, there is doubt as to whether a French court would impose civil
-13-


liability on the Company, the members of our Board, our officers or certain experts in an original action predicated solely upon the U.S. federal securities laws brought in a court of competent jurisdiction in France against us or such members, officers or experts, respectively.
Any inability of the Company to continue to benefit from French provisions applicable to registered intermediaries (“intermédiaires inscrits”) could adversely affect the rights of shareholders.
Article 198 of the Pacte Act, that came into full force and effect on June 10, 2019, amended the French Commercial Code in a way that allows us to maintain our current shareholder ownership structure in the United States . The French Commercial Code (as amended by the Pacte Act) allows an intermediary to be registered for the account of holders of shares of companies which are admitted to trading solely on a market in a non-EU country that is considered equivalent to a regulated market pursuant to paragraph (a) of Article 25(4) of Directive EC2014/65/EU (which, pursuant to the European Commission decision dated December 13, 2017, includes the NYSE).
We use a French registered intermediary for the account of our beneficial owners (the “French Intermediary”). If the French Intermediary fails to comply with the French provisions applicable to registered intermediaries (intermédiaires inscrits), and if we are unable to find an appropriate substitute, or if the European Commission no longer considered the NYSE as equivalent to a regulated market as described above, we might not be able to comply with existing French laws regarding the holding of shares in the “au porteur” (bearer) form, and shares would have to be held in “au nominatif” (registered) form. In such a case, the Company would need to maintain at all times a register with the name of (and number of shares held by) each shareholder, which could adversely affect the rights of our shareholders, including potentially the right to exercise their voting rights as Company shareholders as only shareholders registered on such register would be entitled to vote.
Transactions in our ordinary shares could be subject to the European financial transaction tax, if adopted.
On February 14, 2013, the European Commission adopted a proposal for a directive on a common financial transaction tax (the “FTT”) to be implemented under the enhanced cooperation procedure by several EU Member States (Austria, Belgium, France, Germany, Greece, Italy, Portugal, Slovenia, Slovakia and Spain). The proposed FTT has a very broad scope and could, if introduced in its current form, apply to certain dealings in our ordinary shares (including secondary market transactions) in certain circumstances. The mechanism by which the tax would be applied and collected is not yet known, but if the proposed directive or any similar tax is adopted, transactions in our ordinary shares would be subject to higher costs, and the liquidity of the market for our ordinary shares may be diminished.
In the case where dividends are paid by our Company, it is uncertain whether our shareholders will actually obtain the elimination or reduction of the French domestic dividend withholding tax to which they are entitled.
General comments on the French withholding tax treatment of dividends paid on our ordinary shares are set out under section “Item 10. Additional Information - E - Taxation - French Withholding Tax Treatment of Dividends Distributed by the Company” herein. In accordance with domestic or double tax treaty provisions, shareholders may be entitled to an elimination or reduction of the default French withholding tax on dividends distributed by the Company (i.e., 30% or 75% in the case where the dividends are paid in non-cooperative States or territories within the meaning of article 238-0 A 1, 2 and 2 bis-1° of the French tax code), subject to the French paying agent of the dividends being provided with the required information and documentation relating to the tax status of the shareholders. Numerous intermediaries would be involved in the process of transmitting the relevant information and documentation from our shareholders to the French paying agent in case of distribution of dividends by the Company. As a result, this process may potentially jeopardize the ability for our shareholders to obtain the elimination or reduction of French withholding tax to which they are entitled.
The French Ruling could be revoked if the description and legal analysis of the holding structure of the shares of the Company after the completion of the Transfer was inaccurate.
The various confirmations obtained from the French tax authorities on October 11, 2019 (the “French Ruling”) (set forth under section “Item 10. Additional Information - E - Taxation” below) are based on the description and legal analysis of the holding structure of the shares of the Company made by the Company to the French tax authorities in its ruling request. If the French tax authorities were to consider that the description or legal analysis in the ruling request with regards to the holding structure of the shares of the Company is inaccurate, notably to the extent that such description and analysis are based on US securities law notions that are foreign to French law, the French tax authorities could decide to revoke the French ruling and such decision could have adverse tax consequences to our shareholders.
-14-


Purchases of our ordinary shares could be subject to the French financial transaction tax, if the NYSE were to be formally recognized as a foreign regulated market by the French Financial Market Authority or the applicable provisions of the French tax code were amended.
Pursuant to Article 235 ter ZD of the French tax code, purchases of equity instruments or similar securities of a French company listed on a regulated market of the EU or on a foreign regulated market formally recognized as such by the French Financial Market Authority (the “AMF”) are subject to a 0.3% French tax on financial transactions provided that the issuer’s market capitalization exceeds 1 billion euros as of December 1 of the year preceding the taxation year (See “Item 10. Additional Information - E - Taxation - French Financial Transaction Tax and Registration Duties on Disposition of our Shares”). On the date hereof, the NYSE is not formally recognized as a foreign regulated market by the AMF.
If the NYSE were to be formally recognized as a foreign regulated market by the AMF in the future, or if Article 235 ter ZD of the French tax code were amended to include the NYSE as a foreign regulated market, the French financial transaction tax could be due on purchases of ordinary shares of the Company.

Item 4. Information on the Company
A. History and Development of the Company
Constellium Holdco B.V. (formerly known as Omega Holdco B.V.) was incorporated as a Dutch private limited liability company on May 14, 2010 (incorporated and governed under the Dutch Civil Code). Constellium Holdco B.V. was formed to serve as the holding company for various entities comprising Alcan's Engineered Aluminum Product business unit, which Constellium acquired from affiliates of Rio Tinto on January 4, 2011 (the “Acquisition”). On May 21, 2013, Constellium Holdco B.V. was converted into a Dutch public limited liability company and renamed Constellium N.V. On May 29, 2013, we completed our initial public offering and began trading our shares as Constellium N.V., a Dutch company, on the New York Stock Exchange (the “NYSE”) under the symbol “CSTM”.
On June 28, 2019, Constellium N.V. converted its corporate form from a Dutch public limited liability company (Naamloze Vennootschap) into a Societas Europaea (SE) and changed its name to Constellium SE, with its head office remaining in Amsterdam, the Netherlands (the “Conversion”).
On December 12, 2019, Constellium SE completed its re-domicile and the relocation of its head office to Paris, France (the “Transfer”). The Conversion and the Transfer were each approved by the Company’s shareholders. Effective as of December 12, 2019, the Company’s existing Articles of Association were amended by means of a deed of amendment to reflect the Company’s re-domicile to Paris, France (as further amended from time to time, the “Articles of Association”).
As of the effectiveness of the Transfer, each outstanding Class A ordinary share of Constellium SE with its head office in Amsterdam, the Netherlands, automatically became an ordinary share of Constellium SE with its head office in Paris, France. The Company’s ordinary shares continue to be listed on the NYSE under the symbol “CSTM” and we began trading our shares under Constellium SE, a French company, on December 13, 2019.
Since the Transfer, any references to French law and the Articles of Association herein are references to French law and the Articles of Association of the Company, respectively, following the Conversion and Transfer.
For information on our historical capital expenditures, see “Item 5. Operating and Financial Review and Prospects—Cash Flows—Historical Capital Expenditures.” For information on our capital expenditures currently in process, see “—B. Business Overview—Our Operating Segments” and “—D. Property, Plants and Equipment.” We expect to finance our capital expenditures currently in process with a combination of internal and external financing sources.
The business address (head office) of Constellium SE is Washington Plaza, 40-44 rue Washington, 75008 Paris, France, and our telephone number is +33 1 73 01 46 20. The address for our agent for service of process in the United States is Corporation Service Company, 80 State Street, Albany, New York 12207-2543, and its telephone number is + 1(302) 636-5400.
The SEC maintains an Internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that site is www.sec.gov. We also make available on our website, free of charge,
-15-


our annual reports on Form 20-F and the text of our reports on Form 6-K, including any amendments to these reports, as well as certain other SEC filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website address is www.constellium.com. The information contained on our website is not incorporated by reference in this document.
B.
Business Overview
The Company
Overview
We are a global leader in the design and manufacture of a broad range of innovative rolled and extruded aluminium products, serving primarily the packaging, aerospace and automotive end-markets. Our business model is to add value by converting aluminium into semi-fabricated and in some instances fabricated products. We supply numerous blue-chip customers with value-added products for performance-critical applications. Our product portfolio generally commands higher margins as compared to less differentiated, more commoditized fabricated aluminium products, such as common alloy coils, paintstock, foilstock and soft alloys for construction and distribution.
As of December 31, 2020, we operated 29 production facilities, we had three R&D centers and we had three administrative centers in Baltimore, Maryland, Paris, France and Zürich, Switzerland. We believe our portfolio of flexible, integrated and strategically located facilities is among the most technologically advanced in the industry and that the significant growth investments we have made now position us well to capture expected demand growth in each of our end markets. It is our view that our established presence in Europe, North America and China combined with more than 50 years of manufacturing experience, quality and innovation, strategically position us to be a leading supplier to our global customer base. The Company had approximately 12,000 employees as of December 31, 2020.
We seek to sell to end-markets that have attractive characteristics for aluminium, including (i) stability through economic cycles as seen in our North American and European packaging businesses, (ii) rigorous and complex technical requirements as seen in our global aerospace and automotive businesses, and (iii) favorable growth fundamentals supported by demand for sustainable packaging and by the vehicle lightweighting trend seen in global automotive business, and the growth in electric vehicles.
We have invested capital not only to maintain the condition of our assets which have significant replacement value, but also to take advantage of a number of attractive growth opportunities including: (i) Auto Body Sheet capabilities in Muscle Shoals, Alabama, in Bowling Green, Kentucky, in Neuf-Brisach, France, and in Singen, Germany (ii) new Automotive Structures operations in San Luis Potosi, Mexico, in White, Georgia, in Vigo, Spain, and in Zilina, Slovakia and facility expansions to produce battery enclosures for electric vehicles in Gottmadingen, Germany and advanced body structure capabilities in Dahenfeld, Germany and in Van Buren, Michigan as well as in a new Automotive press in Singen, Germany and (iii) new cast houses and additional extrusion capability in Děčín, Czech Republic as well as a number of growth initiatives through R&D and debottlenecking efforts.
Our unique platform has enabled us to develop a stable and diversified customer base and to enjoy long-standing relationships with our largest customers. Our customer base includes market leading firms in packaging, aerospace, and automotive, such as AB InBev, Ball Corporation, Crown Holdings, Inc., Airbus, Boeing, and several premium automotive OEMs, including BMW AG, Daimler AG and Ford Motor Company. We believe that we are a critical supplier to many of our customers due to our technological and R&D capabilities as well as the long and complex qualification process required for many of our products. Our core products require close collaboration and, in many instances, joint development with our customers. We believe that this integrated collaboration with our customers for high value-added products reduces substitution risk, supports our competitive position and is difficult to replicate.
For the years ended December 31, 2020, 2019 and 2018, the Company’s key financials were as follows:
For the years ended December 31,
2020 2019 2018
Shipments (kt) 1,431  1,589  1,534 
Revenue (in millions of Euros) 4,883  5,907  5,686 
Net (loss)/income (in millions of Euros) (17) 64  190 
Adjusted EBITDA (in millions of Euros) 465  562  498 
-16-


Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
For information on our Revenue by geographic market, see Note 3 to the Consolidated Financial Statements.
Our Strategy
Our mission is to meet customers’ and society’s need for lightweighting, efficiency and sustainability while generating attractive returns for our shareholders.
We aim to achieve our mission by expanding our leading position as an innovative, go-to-supplier of technologically advanced and responsible fabricated aluminium solutions. We are committed to building a safe and sustainable company. This means reducing our emissions and our waste, investing in our people, supporting our communities, adhering to sound governance principles, developing, manufacturing and promoting products that are sustainable for the benefit of our customers and end consumers, and creating shareholders value. Our goal is to become the safest and the most exciting company in our industry.
To achieve these objectives, we have built a business strategy centered around six core principles:
(i)Focus on High Value-added and Responsible Product
We are primarily focused on our three strategic end-markets—packaging, aerospace and automotive—in which we have leading positions and established relationships with many of the main manufacturers. These are also markets where we believe that we can differentiate ourselves through our high value-added and specialty products which make up the majority of our product portfolio. We have made substantial investments to develop unique R&D and technological capabilities and to increase our recycling capacity, which we believe give us a competitive advantage in quality, design, innovation and sustainability. We leverage aluminium’s inherent sustainability characteristics — lightweight, durable, and infinitely recyclable – to produce environmentally responsible products. We believe our differentiated products provide significant benefits to our customers in many areas such as weight reduction, higher strength and better formability, and contribute to their objective of reducing carbon emissions. In addition, these products typically command higher margins than more commoditized products, and are supplied to end-markets that we believe have highly attractive characteristics and long-term growth trends. We intend to continue to invest in our R&D and technological capabilities and develop a high value-added and responsible product portfolio.
(ii)Increase Customer Connectivity
We regard our relationships with our customers as partnerships in which we work closely together to leverage our unique knowledge of the attributes of aluminium, our industry leading R&D and technological capabilities, and our integrated industrial platform to develop customized solutions. Our diverse teams globally aim to deepen our ties with our customers by consistently providing best-in-class quality, sustainable products and services and joint product development projects.
In addition, through market leading supply chain integration we are able to better anticipate customer demands, optimize supply and more efficiently manage our working capital needs. We also seek to strengthen customer connectivity through customer technical support and closed-loop scrap recycling programs. We will aim to continue to further foster and enhance the relationships with our customers and position our company as a preferred supplier to our customers.
(iii)Optimize Margins and Asset Utilization Through Rigorous Product Portfolio Management
We are highly focused on maximizing the throughput of our facilities to increase the tons per machine hour and profitability per machine hour. We believe there are significant opportunities to do so through rigorous focus on the products we choose to make and optimizing the throughput of these products in our facilities. For example, given our manufacturing configurations, there are certain products that our facilities are better equipped to manufacture. As a consequence, we can not only manufacture them more efficiently and at a lower cost, but also reduce our energy consumption and improve our environmental footprint. This rigor encompasses both the existing portfolio as well as new product development. In addition, we strive to increase our throughput through our investments in asset integrity, and through continuous improvements in our operations such as debottlenecking and optimizing equipment uptime, recovery and mill speed. Finally, we intend to continue to increase our recycling activities which will result in more responsible, sustainable and profitable products.
(iv)Strictly Control Cost, Continuously Improve and Manage Resource Responsibly
-17-


We believe that there are significant opportunities to reduce our operating costs and improve our operations by implementing manufacturing excellence initiatives, metal management programs and other cost, energy reduction, waste and water management initiatives. We aim to establish best-in-class operations and achieve cost reductions by standardizing manufacturing processes and reducing waste, while still allowing the flexibility to respond to local market demands. In addition, we believe it is critical to continuously focus on responsible resource management as part of our continuous improvement program, including minimizing energy and water usage, maximizing scrap input, optimizing capital allocation and efficiently managing other resources available to the Company.
(v)Manage Capital Through a Disciplined Approach and Increase Financial Flexibility
We have invested capital in a number of attractive growth opportunities to enhance our production capabilities, product offering and sustainability objectives including eco mobility with our lighter solutions for the automotive market. We are highly focused on realizing their expected contributions to our earnings, manufacturing capabilities and corporate profile. Our overall capital management approach will remain disciplined in order to drive responsible capital allocation decisions and maximize returns on investments.
In addition, we are highly focused on increasing our financial flexibility through earnings growth and free cash flow conversion which will enable us to reduce our debt. This includes strict cost control but also working capital management and disciplined capital spending. We believe having increased financial flexibility is critical to achieving our long-term objective of investing in our people and our operations such that we are the supplier-of-choice of high value-added, specialized, technologically-advanced and responsible products and that we are playing our part as an industry leader in the fight against climate change.
(vi)Commit to Our People and Communities
We believe our people are among the best in the industry; this is a competitive strength which allows us to be a leader in our industry. We strive to promote a safe and inclusive environment where everyone is valued, can contribute and thrive. Safety is our highest priority. Our safety results are among the best in the industry and we remain committed to continuous improvement. We are also committed to recruiting and retaining a qualified and diverse pool of talent and ensuring opportunities for everyone to learn and grow. Lastly, we strive to be socially responsible operators in our communities and are committed to supporting the communities around us.
Recent Developments
On February 24, 2021, we completed a private offering of $500 million in aggregate principal amount of 3.750% Sustainability-Linked Senior Notes due 2029 (the “February 2021 Notes”), as further described under “Item 8. Financial Information—B. Significant Changes” and “Item 10. Additional Information—C. Material Contracts—February 2021 Notes.” We used the net proceeds from the offering, together with cash on hand, to repurchase or redeem our 6.625% Senior Notes due 2025 (the “February 2017 Notes”), and to pay related fees and expenses. See “Item 8. Financial Information—B. Significant Changes” for more information on this recent development.
Our Operating Segments
Our business is organized into three operating segments:
(i) Packaging & Automotive Rolled Products (P&ARP) includes the production of rolled aluminium products in our European and North American facilities. We supply the packaging market with canstock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. In addition, we supply the automotive market with a number of technically sophisticated applications such as ABS and heat exchanger materials.
(ii) Aerospace & Transportation (A&T) includes the production of rolled aluminium products in our European and North American facilities (and very limited volumes of extruded products) for the aerospace market, as well as rolled products for transport, industry and defense end-uses.
(iii) Automotive Structures & Industry (AS&I) includes the production of technologically advanced structural components for the automotive industry including crash-management systems, body structures, side impact beams and battery enclosures in our European, North American and Chinese facilities. In addition, we fabricate hard and soft aluminium alloy extruded profiles in a number of our other European facilities for a range of high demand industry applications in the automotive, engineering, rail and other transportation end markets.
-18-


Table: Overview of Operating Segments (as of December 31, 2020)
Packaging & Automotive
Rolled Products
Aerospace &
Transportation
Automotive Structures &
Industry
Manufacturing Facilities
• 4 (France, Germany, U.S.)
• 6 (France, U.S., Switzerland)
• 19 (France, Germany, Switzerland, Czech Republic, Slovakia, Spain, U.S., Canada, Mexico, China)
Employees • 3,900 • 3,300 • 4,600
Key Products
• Can stock
• Can end stock
• Closure stock
• Auto Body Sheet
• Rolled products for heat exchangers
• Specialty reflective sheet (Bright)
• Aerospace plates, sheets and extrusions
• Aerospace wing skins
• Plate and sheet for transportation, industry and defense applications
• Automotive structures
• Other extruded products including:
Soft alloys
Hard alloys
Large profiles
Key Customers
Packaging: AB InBev, Ball Corporation, Can-Pack, Amcor, Ardagh Group, Coca-Cola, Crown
Automotive: Audi, BMW AG, Daimler AG, Stellantis, Valeo, Volkswagen

Aerospace: Airbus, Boeing, Bombardier, Dassault
Transportation, Industry, Defense and Distribution: Amari, Nexter Systems, Ryerson, ThyssenKrupp

Automotive: Audi, BMW AG, Daimler AG, Ford, Porsche, Stellantis
Rail: CAF, Hitachi, Stadler
Select Key Facilities
• Neuf-Brisach (France)
• Singen (Germany)
• Muscle Shoals (Alabama, U.S.)
• Bowling Green (Kentucky, U.S.)
• Issoire (France)
• Sierre (Switzerland)
• Ravenswood (West Virginia, U.S.)
• Děčín (Czech Republic)
• Singen (Germany)
• Gottmadingen (Germany)
• Van Buren (Michigan, U.S.)
% of total Revenue
(for the twelve months ended December 31, 2020)
56%
20%
24%
% of Adjusted EBITDA2
(for the twelve months ended December 31, 2020)
63%
23%
19%
1Our 29 manufacturing facilities are located in 27 sites, two of which are shared between two operating segments.
2The difference between the sum of Adjusted EBITDA for our three segments and the Company’s Adjusted EBITDA is attributable to our fourth segment Holdings and Corporate which is not presented here.

-19-


The following table presents our shipments by product lines:
(in thousand metric tons) For the year ended
December 31,
2020 2019 2018
Packaging rolled products 785  822  799 
Automotive rolled products 207  234  196 
Specialty and other thin-rolled products 27  41  44 
Aerospace rolled products 78  120  111 
Transportation, industry, and other rolled products 105  122  135 
Automotive extruded products 108  123  114 
Other extruded products 121  127  135 
Total shipments 1,431  1,589  1,534 

Packaging & Automotive Rolled Products Operating Segment
In our Packaging & Automotive Rolled Products operating segment, we develop and produce customized aluminium sheet and coil solutions. For the year ended December 31, 2020:
approximately 77% of operating segment volume was in packaging rolled products, which primarily includes beverage and food canstock as well as closure stock and foil stock,
approximately 20% of operating segment volume was in automotive rolled products, and
approximately 3% of operating segment volume was in specialty and other thin-rolled products, which include technologically advanced products for the industrial sector.
We are a leading European and North American supplier of canstock and the leading worldwide supplier of closure stock. We are also a major player in automotive rolled products for ABS in both Europe and North America, and for heat exchangers in Europe. These products are subject to the exacting requirements and qualification processes of our customers which we consider to provide us with a competitive advantage and to represent a barrier to entry for new competitors. We have a diverse customer base, consisting of many of the world’s largest beverage and food can manufacturers, specialty packaging producers, leading automotive firms and global industrial companies. Our customers include AB InBev, Ball Corporation, Crown Holdings, Inc., Ardagh Group S.A., Can-Pack S.A., Coca-Cola, Amcor Ltd., VW Group, Daimler AG, Ford, and Stellantis. Our customer contracts in packaging usually have a duration of three to five years. Our customer contracts in automotive are usually valid for the lifetime of a model, which is typically five to seven years.
We have two integrated rolling operations located in Europe and one in the U.S. Neuf-Brisach, our facility on the border of France and Germany, is a fully integrated aluminium recycling, rolling and finishing facility producing both canstock and ABS. Singen, located in Germany, is a rolling and finishing facility specialized in high-margin niche applications. Muscle Shoals, Alabama, is a fully integrated aluminium recycling, rolling and finishing facility producing both canstock and ABS. We also operate a finishing line for ABS in Bowling Green, Kentucky.
Our Packaging & Automotive Rolled Products operating segment serves the packaging market which has historically been relatively resilient during periods of economic downturn and has had relatively limited exposure to economic cycles and periods of financial instability. See “-Our Key End-Markets- Packaging.”
-20-


The following table summarizes our volume, revenue and Adjusted EBITDA for our Packaging & Automotive Rolled Products operating segment for the periods presented:
For the year ended December 31,
(in millions of euros, unless otherwise noted) 2020 2019 2018
Packaging & Automotive Rolled Products:
Segment Revenue 2,734  3,149  3,059 
Segment Shipments (kt) 1,019  1,097  1,039 
Segment Revenue (€/ton) 2,683  2,871  2,944 
Segment Adjusted EBITDA(1)
291  273  243 
Segment Adjusted EBITDA(€/ton) 286  249  234 
Segment Adjusted EBITDA margin 11  % % %
__________________
(1)Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
Aerospace & Transportation Operating Segment
Our Aerospace & Transportation operating segment has market leadership positions in technologically advanced aluminium and specialty material products with wide applications across the global aerospace, defense, transportation, and industrial sectors. We offer a wide range of products including plate, sheet, extrusions and a few precision cast products which allow us to offer tailored solutions to our customers. We seek to differentiate our products and act as a key partner to our customers through our broad product range, supply-chain solutions, advanced R&D capabilities, extensive recycling capabilities and a portfolio of plants with an extensive range of capabilities across Europe and North America. Approximately 43% of the segment volume for the year ended December 31, 2020 was in aerospace rolled products and approximately 57% was in transportation, industry, defense and other rolled product applications.
Our most significant facilities in the Aerospace & Transportation operating segment are located in Issoire, France, Ravenswood, West Virginia and Sierre, Switzerland and offer a broad spectrum of products required by the aerospace industry. These integrated facilities have extensive capabilities such as producing wide and very high gauge plates required for certain civil and commercial aerospace programs.
Downstream aluminium products for the aerospace market require relatively high levels of R&D investment and advanced technological capabilities, and therefore tend to command higher margins compared to more commoditized products. We work in close collaboration with our customers to develop highly engineered solutions to fulfill their specific requirements. For example, we developed Airware®, a lightweight specialty aluminium-lithium alloy, for our aerospace customers to address increasing demand for lighter and more environmentally friendly aircraft. The majority of our contracts with our largest aerospace customers have a term of five to ten years, which provides visibility on volumes and profitability. We expect demand for our aerospace products to directly correlate with aircraft backlogs and build rates. As of December 2020, the backlog reported by Airbus and Boeing for commercial aircraft reached 11,407 units on a combined basis.
Additionally, aerospace products are generally subject to long qualification periods. Aerospace production sites are regularly audited by external certification organizations including the National Aerospace and Defense Contractors Accreditation Program (“NADCAP”) and/or the International Organization for Standardization. NADCAP is a cooperative organization of a number of aerospace OEMs that defines industry-wide manufacturing standards. NADCAP appoints private auditors who grant suppliers like Constellium a NADCAP certification, which customers tend to require. New products or alloys are separately certified by the OEM that uses the product. Our sites have been qualified by external certification organizations and our products have been qualified by our customers. We are typically able to obtain qualification within 6 months to one year mainly because: (i) due to our long history of working with the main aircraft OEMs, we have an existing range of qualifications including in excess of 100 specifications regarding alloy, temper or shape, which we can build on to obtain new product qualifications; and (ii) we have invested in a number of capital intensive equipment and R&D programs to be able to qualify to the current industry norms and standards.
We also serve the transportation and defense industries. Our product portfolio in these segments include both specialty products as well as standard products. Specialty products are differentiated products, which are engineered to meet specific
-21-


customer needs and as such have specific properties (e.g., mechanical properties, dimensions, surface aspect, etc.). Standard products typically face higher levels of competition in the regions that we serve. The majority of our contracts in the transportation and defense industry typically last between one to three years.
The following table summarizes our volume, revenue and Adjusted EBITDA for our Aerospace & Transportation operating segment for the periods presented:
For the year ended December 31,
(in millions of Euros, unless otherwise noted) 2020 2019 2018
Aerospace & Transportation:
Segment Revenue 1,025  1,462  1,389 
Segment Shipments (kt) 183  242  246 
Segment Revenue (€/ton) 5,601  6,041  5,646 
Segment Adjusted EBITDA(1)
106  204  152 
Segment Adjusted EBITDA(€/ton) 580  843  619 
Segment Adjusted EBITDA margin 10  % 14  % 11  %
__________________
(1)Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
Automotive Structures & Industry Operating Segment
Our Automotive Structures & Industry operating segment produces (i) technologically advanced structures for the automotive industry including crash management systems, body structures, side impact beams and battery enclosures and (ii) soft and hard alloy extrusions for automotive, road, energy and building and large profiles for rail and industrial applications. We complement our products with a comprehensive offering of downstream technology and services, which include pre-machining, surface treatment, R&D and technical support services. Approximately 47% of the segment volume for the year ended December 31, 2020 was in automotive extruded products and approximately 53% was in other extruded product applications.
In our automotive structures business, a series of aluminium extrusions are consolidated into a system for specific automotive applications. Due to the unique combination of strength and weight, aluminium extrusions are increasingly favored in this segment. We believe that we are one of the largest providers of aluminium automotive crash management systems globally. We manufacture automotive structural products for some of the largest European and North American car manufacturers supplying the global market, including Daimler AG, BMW AG, VW Group, Stellantis and Ford. Our automotive structures contracts are typically five to seven years in duration, which usually represent a lifetime of a model.
We are a leading supplier of hard alloys for the automotive market and of large structural profiles for rail, industrial and other transportation markets in Europe. Our two integrated remelt and casting centers in Switzerland and the Czech Republic utilize significant amounts of recycled aluminium and help provide security of metal supply. We also produce soft alloy extrusions for customers primarily in Germany and France, with customized solutions for a diverse number of end markets. Our other extruded products business is tied to contracts that typically last up to one year on average.
Nineteen of our facilities, located in Germany, North America, the Czech Republic, Slovakia, France, Switzerland, China and Spain manufacture products sold in our Automotive Structures & Industry operating segment. We believe our local presence, downstream services and industry leading cycle times help to ensure that we respond to our customer demands in a timely and consistent fashion.
We operate a joint venture, Astrex Inc., which produces automotive extruded profiles in Ontario, Canada, for our North American operations, and a joint venture, Engley Automotive Structures Co., Ltd., which produces aluminium crash management systems in China.
We believe that we have strong market positions given our R&D and manufacturing capability in Automotive Structures. Led by our partnership with Brunel University, London, United Kingdom, we have developed proprietary alloy and
-22-


manufacturing technology which enables us to deliver differentiated design, engineering and manufacturing capabilities to our customers, and to accelerate time to market.
The following table summarizes our volume, revenue and Adjusted EBITDA for our Automotive Structures & Industry operating segment for the periods presented:
For the year ended December 31,
(in millions of Euros, unless otherwise noted) 2020 2019 2018
Automotive Structures & Industry:
Segment Revenue 1,167  1,351  1,290 
Segment Shipments (kt) 229  250  249 
Segment Revenue (€/ton) 5,096  5,404  5,181 
Segment Adjusted EBITDA(1)
88  106  125 
Segment Adjusted EBITDA(€/ton) 382  423  502 
Segment Adjusted EBITDA margin % % 10  %
__________________
(1)Adjusted EBITDA is not a measure defined under IFRS. Adjusted EBITDA is defined and discussed in “Item 5. Operating and Financial Review and Prospects—Segment Results.”
Our Industry
Aluminium Sector Value Chain
The global aluminium industry consists of (i) mining companies that produce bauxite, the ore from which aluminium is ultimately derived, (ii) primary aluminium producers that refine bauxite into alumina and smelt alumina into aluminium, (iii) aluminium semi-fabricated products manufacturers, including aluminium casters, extruders and rollers, (iv) aluminium recyclers and remelters and (v) integrated companies that are present across multiple stages of the aluminium production chain.
Our business is primarily focused on rolling and extruding semi-fabricated products for a variety of value added end markets. We recycle aluminium, both for our own use and as a service to our customers. We do not participate in upstream activities such as mining, refining bauxite or smelting alumina into aluminium.
Constellium’s Position in the Aluminium Sector Value Chain
Aluminium value chain
CSTM-20201231_G1.JPG
Rolled and extruded aluminium product prices are based generally on the price of aluminium (which is based on the LME quoted price plus a regional premium) plus a conversion margin (i.e., the cost incurred to convert the aluminium into a semi-finished product). The price of aluminium is not a significant driver of our financial performance because we typically pass
-23-


through the cost of aluminium either to our customers or the financial market. Instead, the financial performance of producers of rolled and extruded aluminium products, such as Constellium, is driven by the dynamics in the end markets that they serve, their relative positioning in those markets and the efficiency of their industrial operations.
The aluminium rolled products industry is characterized by economies of scale, as significant capital investments are required to achieve and maintain technological capabilities and demanding customer qualification standards. The service and efficiency demands of large customers have encouraged consolidation among suppliers of aluminium rolled products.
The aluminium extruded product industry is relatively fragmented and generally more regional. The business also requires significant capital investments in order to achieve and maintain technological capabilities and meeting demanding customer qualification standards.
The supply of aluminium rolled and extruded products has historically been affected by production capacity, alternative technology substitution and trade flows between regions. The demand for these products has historically been affected by economic growth, substitution trends, cyclicality and seasonality and aluminium rolled products in particular by down-gauging.
There are two main sources of input aluminium metal for our rolled or extruded products:
Slabs or billets we cast from a combination of primary and recycled aluminium. The primary aluminium is typically in the form of standard ingots. The recycled aluminium comes either from scrap from fabrication processes, known as recycled process material, or from recycled end products in their end of life phase, such as used beverage cans.
Slabs or billets purchased from smelters or metal trading companies.
Primary aluminium, sheet ingot and extrusion billets can generally be purchased at prices set on the LME plus a premium that varies by geographic region on delivery, alloying material, form (ingot or molten metal) and purity.
Recycled aluminium is also tied to LME pricing (typically sold at a discount to LME). Aluminium is infinitely recyclable and recycling aluminium requires only approximately 5% of the energy required to produce primary aluminium. As a result, in regions where aluminium is widely used, manufacturers and customers are active in setting up collection processes in which used beverage cans and other end-of-life aluminium products are collected for remelting at purpose-built plants. Manufacturers may also enter into agreements with customers who return recycled process material and pay to have it re-melted and rolled into the same product again.
Aluminium Rolled Products Overview
The rolling process consists of passing aluminium through a hot-rolling mill and then transferring it to a cold-rolling mill, which gradually reduces the thickness of the metal down to approximately 6 mm for plates and to approximately 0.2-6 mm for sheet.
Aluminium rolled products, including sheet, plate and foil, are semi-finished products that provide the raw material for the manufacture of finished goods ranging from packaging to automotive body panels to fuselage sheet to aircraft wing parts. The packaging industry is a major consumer of the majority of sheet and foil for making beverage cans, foil containers and foil wrapping. Sheet is also used extensively in transport for airframes, road and rail vehicles, in marine applications, including offshore platforms, and superstructures and hulls of boats and in building for roofing and siding. Plate is used for airframes, military vehicles and bridges, ships and other large vessels and as tooling plate for the production of plastic products. Foil applications outside packaging include electrical equipment, insulation for buildings and foil for heat exchangers.
The following chart illustrates expected global demand for aluminium rolled products according to CRU International Limited (“CRU”). The compound annual growth rate (“CAGR”) between 2019 and 2025 for the flat rolled products market is expected to be 3.1% according to CRU.
-24-


Projected Aluminium Flat Rolled Products Demand 2019-2025 (in kt)
CSTM-20201231_G2.JPG
Source: CRU International Ltd.
(Asia Pacific includes Japan, China, India, South Korea, Australia, Middle East and other Asia. Other includes Central and South America, and Africa)
Aluminium Extrusions and Automotive Structures Overview
Aluminium extrusion is a technique used to transform aluminium billets into objects with a defined cross-sectional profile for a wide range of uses. In the extrusion process, heated aluminium billet is forced through a die. Extrusions can be manufactured in many sizes and in almost any shape for which a die can be created. The extrusion process makes the most of aluminium’s unique combination of physical characteristics. Its malleability allows it to be easily machined and cast, and yet aluminium is one-third the density and stiffness of steel so the resulting products offer strength and stability, particularly when alloyed with other metals.
Extruded profiles can be produced in solid or hollow form, while additional complexities can be applied using advanced die designs. After the extrusion process, a variety of options are available to adjust the color, texture and brightness of the aluminium’s finish. This may include aluminium anodizing or painting.
Today, aluminium extrusions are used for a wide range of purposes, including building, transportation and industrial markets. Virtually every type of vehicle contains aluminium extrusions, including cars, boats, bicycles and trains. Home appliances and tools take advantage of aluminium’s excellent strength-to-weight ratio. The increased focus on green building is also leading contractors and architects to use more extruded aluminium products, as aluminium extrusions are flexible and corrosion-resistant. These diverse applications are possible due to the advantageous attributes of aluminium, including its particular blend of strength and ductility, its conductivity, its non-magnetic properties and its ability to be recycled repeatedly without loss of integrity. We believe that all of these capabilities make aluminium extrusions a viable and adaptable solution for a growing number of manufacturing needs.
Our Key End-markets
We have a significant presence in (i) the packaging end-markets, which have historically proven to be relatively stable and recession-resilient and are now growing with the increased demand for sustainable packaging, (ii) the automotive end market which has exhibited steady growth based on the light weight and strength attributes of aluminium and the aerospace end-markets which continues to have attractive longer term growth prospects and (iii) a number of niche specialty end markets including transportation, industry, defense and bright products that diversify our exposure to economic trends.
Packaging
Aluminium beverage cans represented approximately 20% of the total European aluminium flat rolled demand by volume and 37% of total U.S. and Canada aluminium flat rolled demand in 2020. According to CRU, aluminium demand for the canstock market in Europe and North America is expected to grow by 3.5% and 3.9% per year between 2019 and 2025, respectively.
-25-


Aluminium is a preferred material for beverage packaging as it allows drinks to chill faster, can be stacked for transportation and storage more densely than competing formats (such as glass bottles), is highly formable for unique or differentiated branding, and offers the environmental advantage of easy, cost- and energy-efficient recycling. As a result of these benefits, aluminium is displacing tinplate, glass and plastics as the preferred packaging material in certain markets. In Europe, aluminium is replacing tinplate (steel) as the standard for beverage cans, and we believe that aluminium's penetration of the canstock market versus tinplate will be close to 100% by 2024. In the United States, we believe aluminium’s penetration has been at 100% for many years. In addition, we are benefiting from increased can consumption in Eastern Europe and Mexico and from growth in specialty products such as cans used for craft beers, seltzers and energy drinks.
Total European Rolled Products Consumption
Can Stock (kt)
Total North American Rolled Products
Consumption Can Stock (kt)
CSTM-20201231_G3.JPG
CSTM-20201231_G4.JPG
Source: CRU International Ltd., Aluminium Rolled Products Market Outlook November 2020 Source: CRU International Ltd., Aluminium Products Market Outlook November 2020

-26-


Automotive
We supply the automotive sector with rolled products out of our Packaging & Automotive Rolled Products operating segment and extruded and fabricated products out of our Automotive Structures & Industry operating segment. Our automotive products are predominantly used in premium models, light trucks and sport utility vehicles manufactured by the European and North American OEMs.
In our view, the main drivers of automotive sales are overall economic growth, credit availability, consumer prices and consumer confidence. According to CRU, global vehicle production is expected to grow by approximately 1.9% per annum from 2019 to 2025.

Vehicle Production(1)
CSTM-20201231_G5.JPG
Source: CRU International Ltd, Global & Economic Outlook December 2020
(1) Represents both car and commercial vehicle production, including light trucks, heavy trucks and, except in the U.S. and Canada, coaches
Within the automotive sector, the demand for aluminium has been increasing faster than the underlying demand for light vehicles due to recent growth in the use of aluminium products in automotive applications. We believe the main reasons for this are aluminium’s high strength-to-weight ratio in comparison to steel and a need for increased energy efficiency. This lightweighting facilitates better fuel economy, improves emissions performance and enhances vehicle safety. As a result, manufacturers are seeking additional applications where aluminium can be used in place of steel and an increased number of cars are being manufactured with aluminium panels and crash management systems.
We believe that the vehicle lightweighting trend will continue as increasingly stringent EU and U.S. regulations relating to reductions in carbon emissions will force the automotive industry to increase its use of aluminium to “lightweight” vehicles. In Europe, European Union legislation has set mandatory emission reduction targets for new cars such that by 2021, the fleet average to be achieved by all new cars is 95 grams of CO2 emissions per kilometer (g/km) compared to an average target of 130g/km in 2015. In the United States, we expect that U.S. regulations requiring reductions in carbon emissions and fuel efficiency, as well as fluctuating fuel prices, will continue to drive aluminium demand in the automotive industry.
In the longer term, as electric vehicles become more prevalent, we believe the demand for aluminium in the automotive industry will increase due to the greater importance of lightweighting. Aluminium thermal conductivity is a significant inherent advantage for battery boxes in electric vehicles and aluminium also has superior energy absorption as compared to steel. Whereas growth in aluminium use in vehicles has historically been driven by increased use of aluminium castings, we anticipate that future growth will be primarily in the kinds of extruded and rolled products that we supply to the OEMs.
-27-


According to CRU, the consumption of ABS between 2019 and 2025 will grow 7.5% per annum in Europe, 8% per annum in North America and 21.5% per annum in China.
Automotive Body Sheet Flat Rolled Products Consumption (kt)
CSTM-20201231_G6.JPG
Source: CRU International Ltd., Aluminium Rolled Products Market Outlook November 2020

Aerospace
Demand for aerospace plates is primarily driven by the build rate of commercial aircraft, which we believe will be supported for the foreseeable future by (i) necessary replacement of aging fleets by airline operators, particularly in the United States and Western Europe, and (ii) increasing global passenger air traffic. Both factors have been impacted in 2020 due to the global pandemic caused by COVID-19 and IATA expects demand to reach only pre-COVID-19 levels in 2023, after which pre-COVID-19 growth can be assumed. Between 2019 and 2039, Boeing predicts approximately 43,110 new aircraft across all categories of large commercial aircraft of which 41% of sales of new airplanes will be to Asia Pacific, 41% to Europe and North America and the remaining 18% delivered to the Middle East, Latin America, Russia, Central Asia and Africa.
Further, demand for aluminium aerospace plates is also influenced by alternative materials becoming more mature in the aerospace market (e.g., composites). According to CRU, aluminium demand for the aerospace rolled products markets in North America and Europe is expected to decrease by 2.2% between 2019 and 2025 due to the continued effects from the COVID-19 pandemic.
-28-


World’s Commercial Aircraft Fleet (thousands)  Fleet Development Driven by Passenger Demand and Aging Fleet (units) 
CSTM-20201231_G7.JPG
CSTM-20201231_G8.JPG
Source: Boeing 2020 current market outlook Source: Boeing 2020 current market outlook

Aerospace Flat Rolled Products Consumption (kt)
CSTM-20201231_G9.JPG
Source: CRU International Ltd., Aluminium Rolled Products Market Outlook November 2020

-29-


Our Business Operations
Our business model is to add value by converting aluminium into semi-fabricated products. It is our policy not to speculate on metal price movements.
Managing Our Metal Price Exposure
For all contracts, we seek to minimize the impact of aluminium price fluctuations in order to protect our cash flows against variations in the LME price, regional and other premiums that we buy and sell, with the following methods:
In cases where we are able to align the price and quantity of physical aluminium purchases with that of physical aluminium sales to our customers, we enter into back-to-back arrangements with our customers.
When we are unable to align the price and quantity of physical aluminium purchases with that of physical aluminium sales to our customers, we enter into derivative financial instruments to pass through the exposure to financial institutions at the time the price is set.
For a small portion of our volumes, the aluminium we process is owned by our customers and we bear no aluminium price risk.
Sales and Marketing
Our sales force is based in Europe (France, Germany, Czech Republic, United Kingdom and Switzerland), the U.S. and Asia (Tokyo, Shanghai and Seoul). We serve our customers primarily directly and in some cases through distributors.
Raw Materials and Supplies
Approximately 69% of our rolling slab demand and approximately 54% of our extrusion billet demand are produced in our own internal cast-houses. In addition, our external rolling slab and extrusion billet supplies are secured through long-term contracts with several upstream companies. All of our top 10 overall metal suppliers (covering rolling slabs, extrusion billets, primary, high purity, scrap and hardeners) have been long-standing suppliers to our plants (in many cases for more than 10 years) and, in aggregate, accounted for approximately 54% of our total metal purchases (in terms of volumes) for the year ended December 31, 2020. We typically enter into annual or multi-year contracts with these metal suppliers pursuant to which we purchase various types of metal, including:
Primary metal from smelters or metal traders in the form of ingots, rolling slabs or extrusion billets.
Remelted metal in the form of rolling slabs or extrusion billets from external cast-houses, as an addition to our own internal cast-houses.
Production scrap from customers and scrap traders.
End-of-life scrap (e.g., used beverage cans) from customers, collectors and scrap traders.
Specific alloying elements and primary ingots from producers and metal traders.
Our operations use natural gas and electricity, which represents the fourth largest component of our cost of sales, after metal, labor costs and depreciation. We purchase natural gas and electricity from the market and typically we secure a large part of our natural gas and electricity needs pursuant to fixed-price commitments. To reduce the risks associated with our natural gas and electricity requirements, we use forward contracts or financial futures with our suppliers to fix the commodity component of the energy costs. Furthermore, in our longer-term sales contracts, we try to include indexation clauses on energy prices.
Our Customers
Our customer base includes some of the leading manufacturers in the packaging, aerospace and automotive end-markets. We have a relatively diverse customer base with our 10 largest customers representing approximately 52% of our revenue for year ended December 31, 2020. We generally have long-term relationships with our significant customers, many of which span decades.
A substantial portion of our volumes is sold under multi-year contracts, as we generally have three- to five-year terms in contracts with our packaging customers, five- to ten-year terms in contracts with our largest aerospace customers, and five- to seven-year terms in our “life of a car platform/car model” contracts with our automotive customers. This provides us with a certain visibility into our future volumes and earnings.
-30-


We see our relationships with our customers as partnerships where we work together to find customized solutions to meet their evolving requirements. In addition, we collaborate with our customers to complete a rigorous process for qualifying our products in each of our end-markets, which requires substantial time and investment and creates high switching costs, resulting in longer-term, mutually beneficial relationships with our customers.
Our product portfolio is predominantly focused on high value-added products, which tend to require close collaboration with our customers to develop tailored solutions. The significant effort and investment to adhere to rigorous qualification procedures enables us to foster long-term relationships with our customers. Our customized products typically command higher margins than more commoditized products, and are supplied to end-markets that we believe have highly attractive characteristics and long-term growth trends.
Competition
The worldwide rolled and extruded aluminium industry is highly competitive, and we expect this dynamic to continue for the foreseeable future. We believe the most important competitive factors in our industry are: product quality, price, timeliness of delivery and customer service, geographic coverage and product innovation. Aluminium competes with other materials such as steel, plastic, composite materials and glass for various applications. Our key competitors in our Packaging & Automotive Rolled Products operating segment are Novelis Inc., Norsk Hydro ASA, Alcoa Corporation, Arconic Inc. and Tri-Arrows Aluminum Inc. Our key competitors in our Aerospace & Transportation operating segment are Arconic Inc., Novelis Inc., Kaiser Aluminum Corp., Austria Metall AG, and Universal Alloy Corporation. Our key competitors in our Automotive Structures & Industry operating segment are Norsk Hydro ASA, Sankyo Tateyama, Inc., Eural Gnutti S.p.A., Gestamp, Otto Fuchs KG, Impol Aluminium Corp., Benteler International AG, Whitehall Industries, Step-G, and Metra Aluminum.
Seasonality
Customer demand in the aluminium industry is seasonal due to a variety of factors, including holiday seasons, weather conditions, economic and other factors beyond our control. Our volumes are impacted by the timing of the holiday seasons in particular, with the lowest volumes typically delivered in August and December and highest volumes delivered in January to June. Our business is also impacted by seasonal slowdowns and upturns in certain of our customers’ industries. Historically, the can industry is strongest in the spring and summer seasons and the automotive and aerospace sectors encounter slowdowns in both the third and fourth quarters of the calendar year.
Research and Development (“R&D”)
We believe that our research and development capabilities coupled with our integrated, longstanding customer relationships create a distinctive competitive advantage versus our competition. Our three R&D centers are based in Voreppe, France, Brunel University, London, United Kingdom and Plymouth, Michigan.
We invested €39 million in R&D in the year ended December 31, 2020, €48 million in R&D in the year ended December 31, 2019 and €40 million in R&D in the year ended December 31, 2018.
Our R&D center based in Voreppe, France provides services and support to all of our facilities, focusing on product and process development, providing technical assistance to our plants and working with our customers to develop new products. In developing new products, we focus on increased performance that aims to lower the total cost of ownership for the end users of our products, for example, by developing materials that decrease maintenance costs of aircraft or increase fuel efficiency in cars. At the Voreppe facility, we also work on the development, improvement, and testing of processes used in our plants such as melting, casting, rolling, extruding, finishing and recycling. We also develop and test technologies used by our customers, such as friction stir welding, and provide technological support to our customers.
Additionally, in the Constellium University Technology Center inaugurated in 2016 at Brunel University London, a dedicated team of R&D engineers and project managers translate technology from the lab to new customer programs and to our plants for production. The facility features industrial scale casting and extrusion equipment, forming technology and extensive joining methods, enabling us to leverage our proprietary alloys and strong manufacturing innovation capabilities to develop engineered solutions adapted to customer needs, and accelerate time to market.
Our R&D center located in Plymouth, Michigan opened in 2016 in order to improve our support to North American automotive customers by addressing specific market requirements related to our aluminium based light weighting solutions.
-31-


As of December 31, 2020, the research and development center in Voreppe employed 226 people, of which 203 were scientists and technicians. The research technology center in Brunel, England, employs 58 people, 35 Constellium employees, including 5 engineering apprentices and 23 Brunel University employees working on Constellium innovation programs, including 10 PhD studentships and 13 postdoctoral research fellows. The research and development center in Plymouth employed 6 people.
Trademarks, Patents, Licenses and IT
We actively review intellectual property arising from our operations and our research and development activities and, when appropriate, apply for patents in the appropriate jurisdictions. We currently hold more than 200 active patent families and regularly apply for new ones. While these patents and patent applications are important to the business on an aggregate basis, we do not believe any single patent family or patent application is critical to the business.
We are from time to time involved in opposition and re-examination proceedings that we consider to be part of the ordinary course of our business, in particular at the European Patent Office and the U.S. Patent and Trademark Office. We believe that the outcome of existing proceedings would not have a material adverse effect on our financial position, results of operations or cash flows.
In connection with our collaborations with universities and other third parties, we occasionally obtain royalty-bearing licenses for the use of third-party technologies in the ordinary course of business.
Insurance
We have implemented a corporate-wide insurance program consisting of both master policies with worldwide coverage and local policies where required by applicable regulations. Our insurance coverage includes: (i) property damage and business interruption; (ii) general liability including operation, professional, product and environment liability; (iii) aviation product liability; (iv) marine cargo (transport); (v) business travel and personal accident; (vi) construction all risk; (vii) automobile liability; (viii) trade credit; (ix) cyber risk; (x) workers' compensation in the U.S.; and (xi) other specific coverages for executive and special risks.
We believe that our insurance coverage terms and conditions are customary for a business such as Constellium and are sufficient to protect us against catastrophic losses.
We also purchase and maintain insurance on behalf of our directors and officers.
Governmental Regulations and Environmental, Health and Safety Matters
Our operations are subject to a number of international, national, state and local regulations relating to the protection of the environment and to workplace health and safety. Our operations involve the use, handling, storage, transportation and disposal of hazardous substances, and accordingly we are subject to extensive laws and regulations governing emissions to air, discharges to water emissions, the generation, storage, transportation, treatment or disposal of hazardous materials or wastes and employee health and safety matters. In addition, prior operations at certain of our properties have resulted in contamination of soil and groundwater which we are required to investigate and remediate pursuant to applicable environmental, health and safety (“EHS”) laws and regulations. Environmental compliance at our key facilities is supervised by the Direction Régionale de l’Environnement de l’Aménagement et du Logement in France, the Umweltbundesamt in Germany, the Service de la Protection de l’Environnement du Canton du Valais in Switzerland, the United States Environmental Protection Agency, West Virginia Department of Environmental Protection, the Alabama Department of Environmental Management, the Kentucky Department for Environmental Protection, Georgia Environmental Protection Division and Michigan Department of Environment, Great Lakes and Energy in the United States, the Regional Authority of the Usti Region in the Czech Republic, the Slovenká Insvpekcia zvivotného prostredia in Slovakia, Secretaria de Medio Ambiente y Recursos Naturales in Mexico,the Environmental Monitoring Agency in China, Consellería de Medioambiente, Territorio y Vivienda in Spain and Enforcement Branch Ontario region in Canada. Violations of EHS laws and regulations, and remediation obligations arising under such laws and regulations, may result in restrictions being imposed on our operating activities as well as fines, penalties, damages or other costs. Accordingly, we have implemented EHS policies and procedures to protect the environment and ensure compliance with these laws, and incorporate EHS considerations into our planning for new projects. We perform regular risk assessments and EHS reviews. We closely and systematically monitor and manage situations of noncompliance with EHS laws and regulations and cooperate with authorities to redress any noncompliance issues. We believe that we have made adequate reserves with respect to our remediation and compliance obligations. Nevertheless, new regulations or other unforeseen increases in the
-32-


number of our non-compliant situations may impose costs on us that may have a material adverse effect on our financial condition, results of operations or liquidity.
Our operations also result in the emission of substantial quantities of carbon dioxide, a greenhouse gas that is regulated under the EU’s Emissions Trading System (“ETS”). Although compliance with ETS to date has not resulted in material costs to our business, compliance with ETS requirements currently being developed for the 2021-2030 period, and increased energy costs due to ETS requirements imposed on our energy suppliers, could have a material adverse effect on our business, financial condition or results of operations. We may also be liable for personal injury claims or workers’ compensation claims relating to exposure to hazardous substances. In addition, we are, from time to time, subject to environmental reviews and investigations by relevant governmental authorities.
E.U. Directive 2010/75 titled “Industrial Emissions” regulates some of our European activities as recycling or melting/casting. With the revision of the Best Available Technics Reference of Non Ferrous Metals in 2016, which defines associated emissions limits values for these activities applicable in 2020 at the latest, staying in compliance with the law requires significant expenditures to tune our processes or implement abatement installations.
Additionally, some of the chemicals we use in our fabrication processes are subject to REACH in the EU. Under REACH, we are required to register some of the substances contained in our products with the European Chemicals Agency, and this process could cause significant delays or costs. We are currently compliant with REACH, and expect to stay in compliance, but if the nature of the regulation changes in the future, or if the perimeter of REACH is changing (e.g. Brexit) or if substances we use currently in our process, considered as Substances of Very High Concern, fall under need of authorization for use, we may be required to make significant expenditures to reformulate the chemicals that we use in our products and materials or incur costs to register such chemicals to gain and/or regain compliance. Future noncompliance could also subject us to significant fines or other civil and criminal penalties. Obtaining regulatory approvals for chemical products used in our facilities is an important part of our operations.
We accrue for costs associated with environmental investigations and remedial efforts when it becomes probable that we are liable and the associated costs can be reasonably estimated. The aggregate close down and environmental remediation costs provisions at December 31, 2020 were €88 million. All accrued amounts have been recorded without giving effect to any possible future recoveries. With respect to ongoing environmental compliance costs, including maintenance and monitoring, we expense the costs when incurred.
We have incurred, and in the future will continue to incur, operating expenses related to environmental compliance. As part of our general capital expenditure plan, we expect to incur capital expenditures for other capital projects that may, in addition to improving operations, reduce certain environmental impacts as energy consumption, air emissions, water releases, waste streams optimization.
Litigation and Legal Proceedings
The Company is involved, and may become involved, in various lawsuits, claims and proceedings relating to customer claims, product liability, employee and retiree benefit matters, and other commercial matters. The Company records provisions for pending litigation matters when it determines that it is probable that an outflow of resources will be required to settle the obligation, and such amounts can be reasonably estimated. In some proceedings, the issues raised are or can be highly complex and subject to significant uncertainties and amounts claimed are and can be substantial. As a result, the probability of loss and an estimation of damages are and can be difficult to ascertain. The Group was subject to an arbitration by a customer claiming that Constellium had supplied defective products as a result of which the customer alleged it had suffered significant damages. The Group considered that this claim was without merit on both technical and legal grounds and believed it was not probable that the claim would result in a loss. This matter was satisfactorily resolved in 2020. From time to time, asbestos-related claims are also filed against us, relating to historic asbestos exposure in our production process. We have made reserves for potential occupational disease claims for a total of €5 million as of December 31, 2020. It is not anticipated that any of our currently pending litigation and proceedings will have a material effect on the future results of the Company.
-33-


C. Organizational Structure
The following diagram reflects our simplified corporate legal entity structure as of March 12, 2021. Percentages reflect ownership interest where ownership interest is less than 100%. The country listed for each legal entity below depicts such entity’s jurisdiction of incorporation.
CSTM-20201231_G10.JPG
-34-


D. Property, Plants and Equipment
At December 31, 2020, we operated 29 manufacturing facilities serving both global and local customers, three R&D centers, two in Europe and one in the United States. Among our production sites, we have seven major facilities (Muscle Shoals, Alabama, Neuf-Brisach, France, Issoire, France, Ravenswood, West Virginia, Singen, Germany, Déčín, Czech Republic and Sierre, Switzerland) catering to the needs of our Packaging & Automotive Rolled Products, Aerospace & Transportation and Automotive Structures & Industry operating segments:
The Muscle Shoals, Alabama facility operates one of the largest and most efficient can reclamation facilities in the world. In addition, the facility utilizes multi-station electromagnetic casting, houses the widest hot line in North America and has the fastest can end stock coating line in the world. Production capabilities include body stock, tab stock, and end stock. In addition, we are producing automotive cold coils for body sheet. The capital expenditures invested in the facility were €37 million and €40 million for the years ended December 31, 2020 and 2019, respectively.
The Neuf-Brisach, France plant is an integrated recycling, casting, rolling and finishing facility. With its state-of-the-art automotive finishing capabilities, the plant is well positioned as a major supplier of aluminium Auto Body Sheet. The plant also enjoys a strong position in heat exchanger material for the automotive market. The plant is one of the biggest recyclers of aluminium in Europe, capable of proposing sheets to the beverage and food can industries, with high levels of recycled content. The capital expenditures invested in the facility were €23 million and €31 million in the years ended December 31, 2020 and 2019, respectively.
The Issoire, France facility is one of the world’s two leading aerospace plate mills based on volumes. The plant operates two Airware® industrial casthouses and currently uses recycling capabilities to take back scrap along the entire fabrication chain. Issoire produces high-technology materials for space market. Issoire works as an integrated platform with Ravenswood, West Virginia and Sierre, Switzerland, providing a significant competitive advantage for us as a global supplier to the aerospace industry. Issoire also delivers Industry, transportation and defense markets with significant capabilities. The capital expenditures invested in the facility were €17 million and €32 million in the years ended December 31, 2020 and 2019, respectively.
The Ravenswood, West Virginia facility has significant capability to produce aerospace plates and transportation coil and is a recognized supplier to the defense industry. The facility has stretchers and wide-coil capabilities that make it one of the few facilities in the world capable of producing plates of a size needed for the largest commercial aircrafts. The capital expenditures invested in the facility were €20 million and €31 million in the years ended December 31, 2020 and 2019, respectively.
The Singen, Germany rolling plant has more than 100 years of experience, industry leading cycle times and high-grade cold mills with special surfaces capabilities to serve automotive and other markets. It has one of the largest extrusion presses in Europe as well as advanced and highly productive integrated automotive bumper manufacturing lines. In 2020, we extended our capacity with a new press-line to support increasing demand for crash management applications, battery enclosures for electric vehicles as well as other automotive structural parts ready for the OEM assembly lines. The capital expenditures invested in the facility were €27 million and €38 million in the years ended December 31, 2020 and 2019, respectively.
The Děčín, Czech Republic facility is a large integrated extrusion facility, mainly focusing on hard alloy extrusions for automotive and industrial applications, with significant recycling capabilities. It is located near the German border, strategically positioning it to supply the German, Czech and French Tier 1 suppliers and OEMs. Its integrated casthouse allows it to offer high value-add customized hard alloys to our customers. The capital expenditures invested in the facility were €6 million and €13 million in the years ended December 31, 2020 and 2019, respectively.
The Sierre, Switzerland facility is dedicated to precision plates for general engineering, aerospace plates and slabs and is a leading supplier of extruded products for high-speed train railway manufacturers and a wide range of applications. The Sierre facility includes the Steg casthouse that produces automotive, general engineering and aerospace slabs and the Chippis casthouse that has the capacity to produce non-standard billets for a wide range of extrusions. Its qualification as an aerospace plate and slabs plant increases our aerospace production capabilities. The capital expenditures invested in the facility were €9 million and €15 million in the years ended December 31, 2020 and 2019, respectively.
-35-


Our current production facilities are listed below by operating segment:
Operating Segment Location Country Owned/
Leased
Packaging & Automotive Rolled Products Biesheim, Neuf-Brisach France Owned
Packaging & Automotive Rolled Products Singen Germany Owned
Packaging & Automotive Rolled Products Muscle Shoals, AL United States Owned
Packaging & Automotive Rolled Products Bowling Green, KY United States Owned
Aerospace & Transportation Ravenswood, WV United States Owned
Aerospace & Transportation Issoire France Owned
Aerospace & Transportation Montreuil-Juigné France Owned
Aerospace & Transportation Ussel France Owned
Aerospace & Transportation Steg Switzerland Owned
Aerospace & Transportation Sierre Switzerland Owned
Automotive Structures & Industry Van Buren, MI United States Leased
Automotive Structures & Industry
Changchun, Jilin Province (JV)(1)
China Leased
Automotive Structures & Industry Děčín Czech Republic Owned
Automotive Structures & Industry Nuits-Saint-Georges France Owned
Automotive Structures & Industry Burg Germany Owned
Automotive Structures & Industry Crailsheim Germany Owned
Automotive Structures & Industry Neckarsulm Germany Owned
Automotive Structures & Industry Gottmadingen Germany Owned
Automotive Structures & Industry Landau/Pfalz Germany Owned
Automotive Structures & Industry Singen Germany Owned
Automotive Structures & Industry Levice Slovakia Owned
Automotive Structures & Industry Chippis Switzerland Owned
Automotive Structures & Industry Sierre Switzerland Owned
Automotive Structures & Industry White, GA United States Leased
Automotive Structures & Industry
Lakeshore, Ontario (JV)(2)
Canada Leased
Automotive Structures & Industry San Luis Potosi Mexico Leased
Automotive Structures & Industry Zilina Slovakia Leased
Automotive Structures & Industry Vigo Spain Leased
Automotive Structures & Industry Nanjing China Leased
(1)Constellium Engley (Changchun) Automotive Structures Co Ltd is a Constellium joint venture with Changchun Engley Auto Parts Co. Ltd.
(2)Astrex Inc. is a Constellium joint venture with Can Art Aluminium Extrusions Inc.

-36-


The production capacity and utilization rate for our main plants as of December 31, 2020 are listed below:
Plant Capacity Utilization Rate
Neuf-Brisach 450 kt 82%
Muscle Shoals
500-550 kt
80-90%
Issoire 110 kt 69%
Ravenswood 175 kt 70%
Děčín 106 kt 62%
Singen  290-310 kt 80-85%
Sierre
70-75 kt
47%
__________________
Production capacity and utilization rates presented above are estimates based in a theoretical output capacity assuming the plant operates with currently operating equipment and current staffing levels and product mix.
For information concerning the material plans to construct, expand or improve facilities, see “Item 5. Operating and Financial Review and Prospects—Liquidity and Capital Resources.”
Item 4A. Unresolved Staff Comments
None.
Item 5. Operating and Financial Review and Prospects
The following discussion and analysis is based principally on our audited Consolidated Financial Statements as of December 31, 2020 and 2019 and for each of the three years in the period ended December 31, 2020 included elsewhere in this Annual Report and is provided to supplement the audited Consolidated Financial Statements and the related notes to help provide an understanding of our financial condition, changes in financial condition, results of our operations, and liquidity. The following discussion is to be read in conjunction with Selected Financial Data and our audited Consolidated Financial Statements and the notes thereto, included elsewhere in this Annual Report.
The following discussion and analysis includes forward-looking statements. These forward-looking statements are subject to risks, uncertainties and other factors that could cause our actual results to differ materially from those expressed or implied by our forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, those discussed below and elsewhere in this Annual Report. See in particular “Special Note about Forward-Looking Statements” and “Item 3. Key Information—D. Risk Factors.”
Overview
We are a global leader in the development, manufacture and sale of a broad range of highly engineered, value-added specialty rolled and extruded aluminium products to the packaging, aerospace, automotive, other transportation and industrial end-markets. As of December 31, 2020, we had approximately 12,000 employees, 29 production facilities, three R&D centers, and three administrative centers.
We serve a diverse set of customers across a broad range of end-markets with very different product needs, specifications and requirements. As a result, we have organized our business into three segments to better serve our customer base:
Our Packaging & Automotive Rolled Products segment produces aluminium sheet and coils, which primarily includes beverage and food can stock, closure stock and foil stock, as well as automotive rolled products.
Our Aerospace & Transportation segment produces technologically advanced aluminium and specialty material products, including plate and sheet, with applications across the global aerospace, defense, transportation, and industrial sectors.
Our Automotive Structures & Industry segment produces technologically advanced structures for the automotive industry, (including crash-management systems, body structures, side impact beams and battery enclosures), soft and hard alloy extrusions and large extruded profiles for automotive, railroad, energy, building and industrial applications.
-37-


For the twelve months ended December 31, 2020 our segments represented the following percentages of total Revenue and total Adjusted EBITDA:
For the year ended December 31, 2020
(as a % of total) Revenue Adjusted EBITDA
P&ARP 56  % 63  %
A&T 20  % 23  %
AS&I 24  % 19  %
Holdings and Corporate —  % (5) %
Total 100  % 100  %
Acquisitions
On January 10, 2019, pursuant to a purchase agreement with UACJ and its U.S. subsidiary, Tri-Arrows Aluminum Holding Inc. (“TAAH”), we acquired TAAH’s 49% stake in Constellium-UACJ ABS, LLC, which was renamed Constellium Bowling Green LLC, ("Bowling Green"), for $100 million plus the assumption of 49% of approximately $80 million of third party debt at Bowling Green. In connection with the agreement with UACJ and TAAH, we and TAAH agreed to certain transitional commercial arrangements connected to the continuing operations and the business, including an agreement for a multiyear supply of cold coils. Bowling Green, which was previously accounted for under the equity method, is consolidated in our results since the acquisition date.
Discontinued Operations and Disposals
In July 2018, we sold the North Building Assets of our Sierre plant in Switzerland to Novelis and contributed the plant’s shared infrastructure to a 50-50 joint venture with Novelis, in exchange for cash consideration of €200 million. This transaction also resulted in the termination of the existing lease agreement for the North Building Assets which had been leased and operated by Novelis since 2015.
Management Review of 2020 and Outlook
Review
The outbreak of COVID-19 and measures to prevent its spread began to impact customer demand in Europe and in North America during March 2020 and, in many instances, continued for the remainder of the year. Automotive OEMs in both North America and Europe curtailed their operations starting in mid-March and resumed production in late May or June. In the second half of 2020, automotive demand rebounded to levels near the prior year. Aerospace OEMs reduced their build rates, which remained at depressed levels through 2020. In contrast, demand from our packaging customers was not significantly impacted by the pandemic. Overall, our shipments declined 10% compared to 2019, with aerospace shipments most affected at a level approximately 35% lower than the prior year.
Constellium reacted quickly to the crisis and took a number of actions to combat the adverse financial impacts of the COVID-19 pandemic. These actions included reducing input purchases, discretionary spending, and labor costs, utilizing governmental aid programs where available, managing trade working capital, and limiting capital spending in 2020. We also took actions to improve our financial flexibility by increasing liquidity by approximately €400 million euros and refinancing our 4.625% Notes due 2021 with new 5.625% Notes due 2029. Despite the headwinds from the pandemic, Constellium generated Adjusted EBITDA of €465 million and strong Free Cash Flow of €157 million in 2020.
Outlook
Looking forward to 2021, Constellium expects many of the trends from the second half of 2020 to continue. Packaging demand is expected to remain very strong in both North America and Europe. This demand is underpinned by strong consumer demand for infinitely recyclable aluminium cans, which has led our customers to announce new can lines in both North America and Europe. While demand from automotive customers has started the year strong, some of our customers have announced reductions in production due to a lack of semiconductors. These temporary production shutdowns could delay demand for our automotive products into the second half of 2021 or beyond. Demand from our aerospace customers is expected to remain muted through at least the first half of 2021 as the supply chain continues to destock.
-38-


Key Factors Influencing Constellium’s Financial Condition and Results from Operations
Impact of COVID-19
The COVID-19 pandemic reduced demand from our customers across each of our segments. Many of our relationships with our customers are governed by requirements contracts, under which we supply based on our customers’ needs. Reduced production by our customers during the COVID-19 pandemic therefore had a direct impact on our revenues. As demand for our products and our resulting production levels declined, our operating margins were adversely impacted.
Management remains confident in its ability to navigate through this global crisis. Despite increases in infection rates in the fourth quarter of 2020, demand from our customers was not materially affected. Many of the actions taken to combat the adverse financial impacts from the pandemic remain in place. In response to potential macroeconomic uncertainty, Constellium maintains a significant liquidity position, with €981 million at December 31, 2020, as compared to €516 million at December 31, 2019.
The Company continues to evaluate the impact that this global pandemic may have on its future results of operations, cash flows, financial position and liquidity, and the foregoing preliminary views are based on currently available information. See “Risk Factors—Risks Related to Our Business—Widespread public health pandemics, including COVID-19, could materially adversely affect our business, financial condition and results of operations” for additional information regarding the potential effects of COVID-19.
Economic Conditions and Markets
We are directly impacted by the economic conditions that affect our customers and the markets in which they operate. General economic conditions such as the level of disposable income, the level of inflation, the rate of economic growth, the rate of unemployment, exchange rates and currency devaluation or revaluation—influence consumer confidence and consumer purchasing power. These factors, in turn, influence the demand for our products in terms of total volumes and prices that can be charged. In some cases we are able to mitigate the risk of a downturn in our customers’ businesses by building committed minimum volume thresholds into our commercial contracts. We further seek to mitigate the risk of a downturn by utilizing a temporary workforce for certain operations, which allows us to match our resources with the demand for our services.
Although the metals industry and our end-markets are cyclical in nature and expose us to related risks, we believe that the diversity of our portfolio helps the Company weather these economic cycles in each of our three main end-markets of packaging, aerospace and automotive:
Can packaging is not highly correlated to the general economic cycle. In addition, we believe can has an attractive long-term growth outlook due to increased consumer preference for cans as a package and the sustainable attributes of aluminium.
While aerospace demand is currently weak, we believe the longer term trends including increasing passenger traffic and the fleet replacement towards newer and more fuel efficient aircrafts are still intact.
In the automotive market, demand for aluminium has been increasing in recent years triggered by a light-weighting trend for new car models, which increases fuel efficiency, reduces emissions and increases vehicle safety, and for electric vehicles.
Aluminium Consumption
The aluminium industry is cyclical and is affected by global economic conditions, industry competition and product development. Aluminium is increasingly seen as the material of choice in a number of applications, including packaging, automotive and aerospace. Aluminium is lightweight, has a high strength-to-weight ratio and is resistant to corrosion. It compares favorably to several alternative materials, such as steel, in these respects. Aluminium is also unique in that it is infinitely recyclable without any material decline in performance or quality. The recycling of aluminium delivers energy and capital investment savings relative to the cost of producing both primary aluminium and many other competing materials. Due to these qualities, the penetration of aluminium in a wide variety of applications continues to increase. We believe that long-term growth in aluminium consumption generally, and demand for those products we produce specifically, will be supported by factors that include growing populations, greater purchasing power and increasing focus on sustainability and environmental issues, globally.
-39-


Aluminium Prices
Aluminium prices are determined by worldwide forces of supply and demand and, can be volatile. We operate a pass–through model and therefore, to the extent possible, avoid taking aluminium price risk. In the case significant sustained increases in the price of aluminium, the demand for our products may be affected over time.
The price we pay for aluminium includes regional premiums, such as the Rotterdam premium for metal purchased in Europe or the Midwest premium for metal purchased in the U.S. The regional premiums, which had historically been fairly stable, have been more volatile in recent years. Like LME prices, we seek to pass-through this regional premium price risk to our customers or to hedge it in the financial markets. However, in certain instances, we are not able to pass through or hedge this cost.
We believe our cash flows are largely protected from variations in LME prices due to the fact that we hedge our sales based on their replacement cost, by matching the price paid for our aluminium purchases with the price received from our aluminium sales, at a given time, using hedges when necessary. As a result, when LME prices increase, we have limited additional cash requirements to finance the increased replacement cost of our inventory.
The average LME transaction price, Midwest Premium and Rotterdam Premium per ton of primary aluminium in the years ended December 31, 2020, 2019 and 2018 are presented below:
Average transaction prices per ton using U.S. dollar prices converted to Euros at the applicable European Central Bank rates:
Year ended December 31, Percent changes
(Euros per ton) 2020 2019 2018 2020 vs 2019 2019 vs 2018
Average LME transaction price
1,491  1,600  1,786  (7) % (10) %
Average Midwest Premium 238  357  354  (33) % %
Average all-in aluminium price U.S.
1,729  1,957  2,140  (12) % (9) %
Average LME transaction price
1,491  1,600  1,786  (7) % (10) %
Average Rotterdam Premium 111  127  139  (13) % (9) %
Average all-in aluminium price Europe
1,602  1,727  1,925  (7) % (10) %

Product Price and Margin
Our products are typically priced based on three components: (i) the LME price, (ii) a regional premiums and (iii) a conversion margin.
Our risk management practices aim to reduce, but do not entirely eliminate, our exposure to changing primary aluminium and regional premium prices. Moreover, while we limit our exposure to unfavorable price changes, we also limit our ability to benefit from favorable price changes. We do not apply hedge accounting for the derivative instruments entered into to hedge our exposure to changes in metal prices and the mark-to-market movements for these instruments are recognized in “Other gains and losses—net.”
Our results are also impacted by differences between changes in the prices of primary and scrap aluminium. As we price our product using the prevailing price of primary aluminium but purchase large amounts of scrap aluminium to manufacture our products, we benefit when primary aluminium price increases exceed scrap price increases. Conversely, when scrap price increases exceed primary aluminium price increases, our results are negatively impacted. The difference between the price of primary aluminium and scrap prices is referred to as the “scrap spread” and is impacted by the effectiveness of our scrap purchasing activities, the supply of scrap available and movements in the terminal commodity markets.
-40-


Volumes
The profitability of our businesses is determined, in part, by the volume of tons processed and sold. Increased production volumes will generally result in lower per unit costs. Higher volumes sold will generally result in additional revenue and associated margins.
Personnel Costs
Our operations are labor intensive. Our personnel costs represented 19%, 18% and 17% of our cost of sales, selling and administrative expenses and R&D expenses for the years ended December 31, 2020, 2019, and 2018, respectively.
Personnel costs generally increase and decrease proportionately with the expansion, addition, closing or changes in production levels of operating facilities. Personnel costs include the salaries, wages and benefits of our employees, as well as costs related to temporary labor. During our seasonal peaks and especially during the summer months, we have historically increased our temporary workforce to compensate for staff on vacation and increased volume of activity.
Currency
We are a global company with operations in France, the United States, Germany, Switzerland, the Czech Republic, Slovakia, Spain, Mexico, Canada and China, as of December 31, 2020. As a result, our revenue and earnings have exposure to a number of currencies, primarily the euro, the U.S. dollar and the Swiss Franc. As our presentation currency is the euro, and the functional currencies of the businesses located outside of the Eurozone are primarily the U.S. dollar and the Swiss franc, the results of the businesses located outside of the Eurozone must be translated each period to euros. Accordingly, fluctuations in the exchange rate of the functional currencies of our businesses located outside of the Eurozone against the euro impacts our results of operations.
We engage in significant hedging activity to attempt to mitigate the effects of foreign currency transactions on our profitability. Transaction impacts arise when our businesses transact in a currency other than their own functional currency. As a result, we are exposed to foreign exchange risk on payments and receipts in multiple currencies. In Europe, a portion of our revenue is denominated in U.S. dollars while the majority of our costs incurred are denominated in local currencies.
Where we have multiple-year sales agreements for the sale of fabricated metal products in U.S. dollars by euro-functional currency entities, we have entered into derivative contracts to forward sell U.S. dollars to match these future sales. With the exception of certain derivative instruments entered into to hedge the foreign currency risk associated with the cash flows of certain highly probable forecasted sales, which we have designated for hedge accounting, hedge accounting is not applied to such ongoing commercial transactions and therefore the mark-to-market impact is recorded in “Other gains and losses —net”.

-41-


Results of Operations
For the year ended December 31,
(in millions of Euros and as a % of revenue) 2020 2019 2018
Revenue 4,883  100  % 5,907  100  % 5,686  100  %
Cost of sales (4,393) 90  % (5,305) 90  % (5,148) 91  %
Gross profit 490  10  % 602  10  % 538  9  %
Selling and administrative expenses (237) % (276) % (247) %
Research and development expenses (39) % (48) % (40) %
Other gains and losses - net (89) % (23) —  % 153  %
Income from operations 125  3  % 255  4  % 404  7  %
Finance costs - net (159) % (175) % (149) %
Share of income / (loss) of joint ventures —  —  % —  % (33) %
Income before income taxes (34) (1) % 82  1  % 222  4  %
Income tax benefit / (expense) 17  —  % (18) —  % (32) %
Net (loss) / income (17)   % 64  1  % 190  3  %
Shipment volumes (in kt) 1,431  n/a 1,589  n/a 1,534  n/a
Revenue per ton (€ per ton) 3,412  n/a 3,717  n/a 3,707  n/a
Results of Operations for the years ended December 31, 2020 and 2019
Revenue
Revenue decreased by 17% to €4,883 million for the year ended December 31, 2020 compared to the year ended December 31, 2019. This decrease reflects a 10% decrease in shipments and lower revenue per ton due to lower metal prices.
Sales volumes decreased by 10% to 1,431 kt for the year ended December 31, 2020. This decrease impacted our P&ARP segment by 7%, our A&T segment by 24% and our AS&I segment by 9%. The drop in volume was mostly driven by the fall in demand and production disruptions resulting from the COVID-19 pandemic.
Our revenue is discussed in more detail in the “Segment Results” section.
Cost of Sales
Cost of sales decreased by 17% to €4,393 million for the year ended December 31, 2020 compared to the year ended 2019. This decrease in cost of sales was primarily driven by a decrease of €703 million, or 20%, in raw materials and consumables used, due to lower volumes and lower metal prices, a decrease of €108 million, or 13%, in labor costs compared to the prior year due to reduced headcounts and COVID-19 related subsidies, a €34 million decrease in freight out costs as a result of lower shipments and a €22 million decrease in energy costs as a result of lower production volumes.
Selling and Administrative Expenses
Selling and administrative expenses decreased by 14% to €237 million for the year ended December 31, 2020 compared to the year ended December 31, 2019. The decrease reflected primarily the cost reduction initiatives implemented in response to the COVID-19 pandemic, including a reduction of employee benefit expenses by €24 million and professional fees by €13 million.
-42-


Research and Development Expenses
Research and development expenses decreased by 19% to €39 million for the year ended December 31, 2020 compared to the year ended December 31, 2019. Research and development expenses are presented net of €10 million and €12 million of research and development tax credits received in France for the years ended December 31, 2020 and 2019, respectively. In the year ended December 31, 2020, research and development expenses, excluding tax credits received were €19 million, €14 million, €13 million and €3 million for the P&ARP, A&T, AS&I and Holding & Corporate segments, respectively. In the year ended December 31, 2019, research and development expenses, excluding tax credits received were €22 million, €19 million, €15 million and €4 million for the P&ARP, A&T, AS&I and Holding & Corporate segments, respectively.
Other Gains and losses, net
For the year ended December 31,
(in millions of Euros) 2020 2019
Realized losses on derivatives (35) (49)
Losses reclassified from OCI as a result of hedge accounting discontinuation (6) — 
Unrealized gains on derivatives at fair value through profit and loss—net 16  33 
Unrealized exchange gains from the remeasurement of monetary assets and liabilities—net — 
Impairment of assets (43) — 
Restructuring costs (13) (4)
(Losses) / gains on pension plan amendments (2)
Losses on disposal (4) (3)
Other (3) (1)
Total other gains and losses, net (89) (23)
Other losses, net were €89 million for the year ended December 31, 2020 compared to €23 million for the year ended December 31, 2019.
The Group uses financial derivatives to hedge underlying commercial transactions. The realized gains or losses recognized in Other gains and losses, net are offset by the commercial transactions accounted for in Cost of sales. In the year ended December 31, 2020, realized losses recognized upon the settlement of derivative instruments were €35 million, of which realized losses on metal derivatives were €30 million and realized losses on foreign exchange derivatives were €5 million. In the year ended December 31, 2019, realized losses recognized upon the settlement of derivative instruments were €49 million, of which realized losses on metal derivatives were €56 million and realized gains on foreign exchange derivatives were €7 million.
The Group also uses financial derivatives to hedge forecasted commercial transactions. The unrealized gains or losses recognized in Other gains and losses, net are offset by the change in the value of forecasted transactions which are not yet accounted for. In the year ended December 31, 2020, unrealized gains on derivative instruments were €16 million and were primarily comprised of gains of €25 million related to metal derivatives and of losses of €9 million related to foreign exchange derivatives. In the year ended December 31, 2019, unrealized gains on derivative instruments were €33 million and were primarily comprised of gains of €31 million related to metal derivatives and of gains of €2 million related to foreign exchange derivatives.
In addition, in 2020, we determined that a portion of the hedged forecasted sales for the remainder of 2020 and for 2021 to which hedge accounting was applied were no longer expected to occur. Consequently, the fair value of the related derivatives accumulated in equity was reclassified to the income statement, which resulted in a €6 million loss.
In the year ended December 31, 2020, impairment charges of €43 million were recorded. The impairment charges recorded in 2020 were primarily comprised of a €9 million and a €7 million impairment related to long lived assets of our Montreuil-Juigné and Ussel operations, respectively, within our A&T segment, a €13 million and €12 million impairment related to long lived assets of our White, GA and Nanjing, China operations, respectively, within the AS&I segment.
-43-


In the year ended December 31, 2020, restructuring costs were €13 million, and were primarily related to restructuring plans in the U.S. and in Europe in our A&T segment. In the year ended December 31, 2019, restructuring costs were €4 million, and were primarily related to restructuring activities in our AS&I segment.
Finance Costs, net
Finance costs, net decreased by €16 million, to €159 million for the year ended December 31, 2020 compared to the year ended December 31, 2019. This decrease was primarily driven by a decrease in factoring fees by €9 million and in interest on borrowings by €7 million.
In the year ended December 31, 2020, foreign exchange net gains from the revaluation of the portion of our U.S. dollar-denominated debt held by Euro functional currency entities were €37 million and were offset by losses on derivative instruments entered into to hedge this exposure. In the year ended December 31, 2019, foreign exchange net losses from the revaluation of the portion of our U.S. dollar-denominated debt held by Euro functional currency entities were €3 million and were offset by gains on derivative instruments entered into to hedge this exposure.
Income Tax
Income tax for the year ended December 31, 2020 was a benefit of €17 million compared to an expense of €18 million for the year ended December 31, 2019.
For the year ended December 31, 2020, our effective tax rate was 49% of our loss before income tax compared to a statutory tax rate of 32%. Our effective tax rate was higher than the statutory rate, primarily reflecting the impact of the CARES Act and certain clarifications of tax law in the U.S. which allowed for the recognition of additional deferred tax assets on prior year loss carryforwards.
For the year ended December 31, 2019, our effective tax rate was 22% of our income before income tax compared to a statutory rate of 34.4%. Our effective tax rate was lower than the statutory rate, primarily reflecting a positive impact from the Swiss Tax Reform, partially offset by the effect of unrecognized deferred tax assets from losses in jurisdictions where we believe it is not probable that these losses will be utilized.
The statutory tax rate decreased from 34.4% in the year ended December 31, 2019 to 32% in the year ended December 31, 2020 as a result of changes in the applicable tax rates in France.
Net Income / loss
As a result of the foregoing factors, we recognized a net loss of €17 million, in the year ended December 31, 2020 compared to a net income of €64 million in the year ended December 31, 2019.
-44-


Results of Operations for the years ended December 31, 2019 and 2018
For the year ended December 31,
(in millions of euros and as a % of revenue) 2019 2018
Revenue 5,907  100  % 5,686  100  %
Cost of sales (5,305) 90  % (5,148) 91  %
Gross profit 602  10  % 538  9  %
Selling and administrative expenses (276) % (247) %
Research and development expenses (48) % (40) %
Other gains / (losses) net (23) —  % 153  %
Income from operations 255  4  % 404  7  %
Finance costs, net (175) % (149) %
Share of income / (loss) of joint ventures —  % (33) %
Income before income taxes 82  1  % 222  4  %
Income tax expense (18) —  % (32) %
Net income / (loss) 64  1  % 190  3  %
Shipment volumes (in kt) 1,589  n/a 1,534  n/a
Revenue per ton (€ per ton) 3,717  n/a 3,707  n/a
Revenue
Revenue increased by 4% to €5,907 million for the year ended December 31, 2019 compared to the year ended December 31, 2018. This increase reflects an 4% increase in shipments.
Sales volumes increased by 4% to 1,589 kt for the year ended December 31, 2019. This increase is mostly driven by higher shipment volumes in P&ARP, in large part due to the consolidation of Bowling Green in 2019.
Revenue per ton increased by €10 per ton to €3,717, reflecting improved conversion prices and a better product mix offset by lower metal prices.
Our revenue is discussed in more detail in the “Segment Results” section.
Cost of Sales
Cost of sales increased by 3% to €5,305 million for the year ended December 31, 2019 compared to the year ended December 31, 2018. This increase in cost of sales reflected the consolidation of Bowling Green and was primarily driven by an increase of €91 million in labor costs compared to the prior year, a €54 million increase in depreciation (of which €18 million was attributable to the implementation of IFRS 16 - Leases) and a €23 million increase in energy costs.
Selling and Administrative Expenses
Selling and administrative expenses increased by 12% to €276 million for the year ended December 31, 2019 compared to the year ended December 31, 2018. The increase resulted from a €20 million increase in employee benefit expenses reflecting €8 million for increased headcount in the U.S. and in Europe, €5 million for the consolidation of Bowling Green and a €9 million increase in professional fees for process improvements and IT projects.
-45-


Research and Development Expenses
Research and development expenses increased by 20% to €48 million for the year ended December 31, 2019 compared to the year ended December 31, 2018. These expenses are presented net of €12 million and €10 million of research and development tax credits received in France for the years ended December 31, 2019 and 2018, respectively. In the year ended December 31, 2019, research and development expenses, excluding tax credits received were €22 million, €19 million, €15 million and €4 million for the P&ARP, A&T, AS&I and Holding & Corporate segments, respectively. In the year ended December 31, 2018, research and development expenses, excluding tax credits received were €18 million, €21 million, and €11 million for the P&ARP, A&T, and AS&I segments, respectively.
Other Gains and losses, net
For the year ended December 31,
(in millions of Euros) 2019 2018
Realized (losses) / gains on derivatives (49) 14 
Unrealized gains / (losses) on derivatives at fair value through profit and loss—net 33  (84)
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities—net —  — 
Restructuring costs (4) (1)
Gains on pension plan amendments 36 
(Losses) / gains on disposal (3) 186 
Other (1)
Total other gains and losses, net (23) 153 
Other losses, net were €23 million for the year ended December 31, 2019 compared to Other gains, net of €153 million for the year ended December 31, 2018.
The Group uses financial derivatives to hedge underlying commercial transactions. The realized gains or losses recognized in Other gains and losses, net are offset by the commercial transactions accounted for in Cost of sales. In the year ended December 31, 2019, realized losses recognized upon the settlement of derivative instruments were €49 million, of which realized losses on metal derivatives were €56 million and realized gains on foreign exchange derivatives were €7 million. In the year ended December 31, 2018, realized gains recognized upon the settlement of derivative instruments were €14 million, of which realized gains on metal derivatives were €7 million and realized gains on foreign exchange derivatives were €7 million.
The Group also uses financial derivatives to also hedge forecasted commercial transactions. The unrealized gains or losses recognized in Other gains and losses, net are offset by the change in the value of forecasted transactions which are not yet accounted for. In the year ended December 31, 2019, unrealized gains on derivative instruments were €33 million and were primarily comprised of gains of €31 million related to metal derivatives and of gains of €2 million related to foreign exchange derivatives. In the year ended December 31, 2018, unrealized losses on derivative instruments were €84 million and were primarily comprised of €83 million of losses related to metal derivatives and €1 million of losses related to foreign exchange derivatives.
In the year ended December 31, 2019, restructuring costs were €4 million and were primarily related to restructuring activities in our AS&I segment. In the year ended December 31, 2018, restructuring costs were €1 million and were primarily incurred in connection with restructuring activities at our German operations.
In the year ended December 31, 2018, we recognized a €36 million net gain relating to an OPEB plan amendment in the United States.
In the year ended December 31, 2018, gains on disposal were primarily related to the sale of North Building Assets of our Sierre plant in Switzerland.
-46-


Finance Costs, net
Finance costs, net increased by €26 million to €175 million for the year ended December 31, 2019 compared to the year ended December 31, 2018. This increase primarily reflects higher interest expense as a result of the implementation of IFRS 16 - Leases for €8 million and the effect of a stronger U.S. dollar. In addition, in the year ended December 31, 2018, Finance costs, net included €7 million of interest received from Bowling Green which was accounted for at the time under the equity method. In the year ended December 31, 2019, there was no interest received from Bowling Green as the entity was consolidated.
In the year ended December 31, 2019, foreign exchange net losses from the revaluation of the portion of our U.S. dollar-denominated debt held by Euro functional currency entities were €3 million and were offset by gains on derivative instruments entered into to hedge this exposure. In the year ended December 31, 2018, foreign exchange net losses from the revaluation of the portion of our U.S. dollar-denominated debt held by Euro functional currency entities were €22 million and were offset by gains on derivative instruments entered into to hedge this exposure.
Share of loss of joint-ventures
For the year ended December 31, 2018, our share of loss of joint-ventures was €33 million and was primarily comprised of our share in the net results of Bowling Green, which was accounted for under the equity method until January 10, 2019. On January 10, 2019, we acquired the 49% of Bowling Green that we did not previously own, and we began consolidating the entity as of that date.
Income Tax
Income tax expense was €18 million for the year ended December 31, 2019 compared to €32 million for the year ended December 31, 2018.
For the year ended December 31, 2019 our effective tax rate was 22% of our income before income tax compared to a statutory tax rate of 34%. Our effective tax rate was lower than the statutory rate, primarily reflecting a positive impact from the Swiss Tax Reform, partially offset by the effect of unrecognized deferred tax assets from losses in jurisdictions where we believe it is not probable that these losses will be utilized.
For the year ended December 31, 2018 our effective tax rate was 14% of our income before income tax compared to a statutory tax rate of 25%. Our effective tax rate was lower than the statutory rate, primarily as a result of the favorable effect of previously unrecognized tax losses carried forward in Switzerland which were used in the year ended December 31, 2018 to offset the taxable profit generated by the sale of the North Building Assets of our Sierre plant in Switzerland.
Our statutory tax rate increased from 25% in the year ended December 31, 2018 to 34% in the year ended December 31, 2019 as a result of the transfer of Constellium SE from the Netherlands to France in 2019.
Net Income / loss
As a result of the foregoing factors, we recognized a net income of €64 million, in the year ended December 31, 2019 compared to a net income of €190 million in the year ended December 31, 2018.

-47-


Segment Results
Segment Revenue
The following table sets forth the revenue for our operating segments for the periods presented:
For the year ended December 31,
(in millions of Euros and as a % of revenue) 2020 2019 2018
P&ARP 2,734  56  % 3,149  53  % 3,059  54  %
A&T 1,025  20  % 1,462  24  % 1,389  23  %
AS&I 1,167  24  % 1,351  23  % 1,290  23  %
Holdings and Corporate —  —  % —  —  % 10  —  %
Inter-segment eliminations (43) n.m. (55) n.m. (62) n.m.
Total revenue 4,883  100  % 5,907  100  % 5,686  100  %
n.m. not meaningful
P&ARP
For the year ended December 31, 2020, revenue in our P&ARP segment decreased 13% to €2,734 million compared to the year ended December 31, 2019, primarily due to lower shipments and lower revenue per ton. P&ARP shipments were down 7% or 78 kt, due to lower shipments across packaging, automotive and specialty products as a result of impacts from the COVID-19 pandemic. Revenue per ton decreased by 7% to €2,683 per ton in the year ended December 31, 2020 from €2,871 per ton in the year ended December 31, 2019, driven by lower metal prices.
For the year ended December 31, 2019, revenue in our P&ARP segment increased by 3% to €3,149 million compared to the year ended December 31, 2018, reflecting primarily higher shipments partially due to the consolidation of Bowling Green, despite lower revenue per ton driven by lower metal prices. P&ARP shipments were up 58 kt, reflecting a 38 kt, or 19%, increase in Automotive rolled products shipments partially due to the consolidation of Bowling Green and a 23kt, or 3% increase in Packaging rolled products shipments. Revenue per ton decreased by 3% to €2,871 per ton in the year ended December 31, 2019, primarily as a result of lower metal prices.
A&T
For the year ended December 31, 2020, revenue in our A&T segment decreased 30% to €1,025 million compared to the year ended December 31, 2019, due to lower shipments and lower metal prices. A&T shipments were down 24%, due to lower shipments of aerospace and transportation, industry, defense and other rolled products as a result of impacts from the COVID-19 pandemic. Revenue per ton decreased by 7% to €5,601 per ton in the year ended December 31, 2020 from €6,041 per ton in the year ended December 31, 2019, primarily reflecting lower metal prices and a less favorable mix with lower Aerospace product shipments and higher Transportation, industry, defense and other rolled product shipments.
For the year ended December 31, 2019, revenue in our A&T segment increased by €73 million to €1,462 million compared to the year ended December 31, 2018, reflecting higher revenue per ton driven by improved price and a better mix partially offset by lower metal prices. A&T shipments decreased by 2%, reflecting a 9kt increase in Aerospace rolled products shipments offset by a 13kt decrease in Transportation, industry, defense and other rolled products shipments. Revenue per ton increased by 7% to €6,041 per ton in the year ended December 31, 2019, primarily reflecting better Aerospace rolled products mix, and higher prices on Transportation, industry, defense and other rolled products despite lower metal prices.
AS&I
For the year ended December 31, 2020, revenue in our AS&I segment decreased 14% to €1,167 million due to lower shipments and lower metal prices compared to the year ended December 31, 2019. AS&I shipments were down 9%, or 21 kt, on lower shipments of automotive and other extruded products as a result of the COVID-19 pandemic. Revenue per ton decreased by 6% to €5,096 per ton in the year ended December 31, 2020 from €5,404 per ton in the year ended December 31, 2019, reflecting lower metal prices.
-48-


For the year ended December 31, 2019, revenue in our AS&I segment increased by 5% to €1,351 million compared to the year ended December 31, 2018, reflecting higher revenue per ton driven by improved price and a better mix partially offset by lower metal prices. AS&I shipments were stable with a 1kt increase, reflecting an 8% or 9kt increase in Automotive extruded products shipments partially offset by a 6% or 8kt decrease in Other extruded products shipments. Revenue per ton increased by 4% to €5,404 per ton in the year ended December 31, 2019, reflecting a more favorable Automotive extruded product mix.
Holdings & Corporate
For the year ended 2018, revenue in the Holdings and Corporate segment was primarily related to metal sales that were incidental to our core business.
Segment Adjusted EBITDA
The following table sets forth the Adjusted EBITDA for our operating segments for the periods presented:
For the year ended December 31,
(in millions of Euros and as a % of revenue) 2020 2019 2018
P&ARP 291 11  % 273 % 243 %
A&T 106  10  % 204  14  % 152  11  %
AS&I 88  % 106  % 125  10  %
Holdings and Corporate (20) n.m. (21) n.m. (22) n.m.
Total Adjusted EBITDA 465  10  % 562  10  % 498  9  %
n.m. not meaningful
Adjusted EBITDA is not a measure defined by IFRS. We believe the most directly comparable IFRS measure to Adjusted EBITDA is our net income or loss for the relevant period.
In considering the financial performance of the business, management analyzes the primary financial performance measure of Adjusted EBITDA in all of our business segments. Our Chief Operating Decision Maker (“CODM”) measures the profitability and financial performance of our operating segments based on Adjusted EBITDA. Adjusted EBITDA is defined as income/(loss) from continuing operations before income taxes, results from joint ventures, net finance costs, other expenses and depreciation and amortization as adjusted to exclude restructuring costs, impairment charges, unrealized gains or losses on derivatives and on foreign exchange differences on transactions that do not qualify for hedge accounting, metal price lag, share-based compensation expense, effects of certain purchase accounting adjustments, start-up and development costs or acquisition, integration and separation costs, certain incremental costs and other exceptional, unusual or generally non-recurring items.
We believe Adjusted EBITDA, as defined above, is useful to investors as it illustrates the underlying performance of continuing operations by excluding non-recurring and non-operating items. Similar concepts of adjusted EBITDA are frequently used by securities analysts, investors and other interested parties in their evaluation of our company and in comparison to other companies, many of which present an adjusted EBITDA-related performance measure when reporting their results.
Adjusted EBITDA has limitations as an analytical tool. It is not a measure defined by IFRS and therefore does not purport to be an alternative to operating profit or net income as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Adjusted EBITDA is not necessarily comparable to similarly titled measures used by other companies. As a result, you should not consider Adjusted EBITDA in isolation from, or as a substitute analysis for, our results prepared in accordance with IFRS.
-49-



The following table reconciles our net (loss) / income for each of the three years in the period ending December 31, 2020, to our Adjusted EBITDA:
For the year ended December 31,
(in millions of Euros) 2020 2019 2018
Net (loss) / income (17) 64  190 
Income tax (benefit) / expense (17) 18  32 
Finance costs, net 159  175  149 
Share of (income) / loss of joint ventures —  (2) 33 
Depreciation and amortization 259  256  197 
Impairment of assets(a)
43  —  — 
Restructuring costs(b)
13 
Unrealized (gains) / losses on derivatives (16) (33) 84 
Unrealized exchange gains from remeasurement of monetary assets and liabilities—net (1) —  — 
Losses / (gains) on pension plan amendments(c)
(1) (36)
Share-based compensation 15  16  12 
Metal price lag(d)
46  — 
Start-up and development costs(e)
11  21 
Losses / (gains) on disposals (f)
(186)
Bowling Green one-time costs related to the acquisition(g)
—  — 
Other(h)
— 
Adjusted EBITDA 465  562  498 
__________________
(a)For the year ended December 31, 2020, an impairment charge of €43 million was recognized related to some A&T cash generating units due to the downturn in the aerospace industry resulting from the COVID-19 pandemic and some AS&I cash generating units as a result of the review of their long-term business perspectives.
(b)For the year ended December 31, 2020, restructuring costs amounted to €13 million related to headcount reductions in Europe and in the U.S.
(c)The Group amended one of its OPEB plans in the U.S. in 2018, which resulted in a €36 million gain for the year ended December 31, 2018.
(d)Metal price lag represents the financial impact of the timing difference between when aluminium prices included within Constellium revenue are established and when aluminium purchase prices included in Cost of sales are established. The Group accounts for inventory using a weighted average price basis and this adjustment aims to remove the effect of volatility in LME prices. The calculation of the Group metal price lag adjustment is based on an internal standardized methodology calculated at each of Constellium’s manufacturing sites and is primarily calculated as the average value of product recorded in inventory, which approximates the spot price in the market, less the average value transferred out of inventory, which is the weighted average of the metal element of cost of sales, based on the quantity sold in the period.
(e)Start-up and development costs, for the years ended December 31, 2020, 2019 and 2018, were related to new projects in our AS&I operating segment.
(f)In July 2018, Constellium completed the sale of the North Building assets of its Sierre plant in Switzerland to Novelis and contributed the Sierre site shared infrastructure to a joint-venture with Novelis, in exchange for cash consideration of €200 million. This transaction also resulted in the termination of the existing lease agreement for the North Building assets which had been leased and operated by Novelis since 2005. For the year ended December 31, 2018, the transaction generated a €190 million net gain.
(g)Bowling Green one-time costs related to the acquisition, for the year ended December 2019, was the non-cash reversal of the inventory step-up.
-50-


(h)Other, in the year ended December 31, 2020, includes €2 million of procurement penalties and termination fees incurred because of the Group's inability to fulfill certain commitments due to the COVID-19 pandemic and a €6 million loss resulting from the discontinuation of hedge accounting for certain forecasted sales that were determined to be no longer expected to occur in light of the COVID-19 pandemic effects.
The following table presents the primary drivers for changes in Adjusted EBITDA from the year ended December 31, 2018 to the year ended December 31, 2020 for each one of our three segments:
(in millions of Euros) P&ARP A&T AS&I
Adjusted EBITDA for the year ended December 31, 2018 243  152  125 
Volume 27  (5) 24 
Price and product mix (10) 65  (1)
Costs 21  (14) (51)
Consolidation of Bowling Green (15) —  — 
Impact of IFRS 16 adoption 12 
Foreign exchange and other (3)
Adjusted EBITDA for the year ended December 31, 2019 273  204  106 
Volume (47) (150) (36)
Price and product mix 18  (3) (3)
Costs 51  55  23 
Foreign exchange and other (4) —  (2)
Adjusted EBITDA for the year ended December 31, 2020 291  106  88 
P&ARP
For the year ended December 31, 2020, Adjusted EBITDA in our P&ARP segment increased 7% to €291 million compared to the year ended December 31, 2019, on strong cost control and improved product price and mix despite lower shipments. Adjusted EBITDA per metric ton increased by 15% to €286 for the year ended December 31, 2020 from €249 for the year ended December 31, 2019.
For the year ended December 31, 2019, Adjusted EBITDA in our P&ARP segment increased 12% to €273 million compared to the year ended December 31, 2018, reflecting primarily higher volumes, favorable metal costs partially offset by weaker price and mix, incremental costs from maintenance and the ramp up of our automotive programs and the consolidation of Bowling Green. Adjusted EBITDA per metric ton for the year ended December 31, 2019 was 6% higher at €249 compared to €234 for the year ended December 31, 2018.
A&T
For the year ended December 31, 2020, Adjusted EBITDA in our A&T segment decreased 48% to €106 million compared to the year ended December 31, 2019, primarily due to lower shipments as a result of impacts from the COVID-19 pandemic and weaker mix partially offset by strong cost control. Adjusted EBITDA per metric ton decreased by 31% to €580 from €843 in the year ended December 31, 2019.
For the year ended December 31, 2019, Adjusted EBITDA in our A&T segment increased 34% to €204 million compared to the year ended December 31, 2018, primarily reflecting better price and mix, partially offset by higher costs. Adjusted EBITDA per metric ton increased 36% to €843.
AS&I
For the year ended December 31, 2020, Adjusted EBITDA in our AS&I segment decreased 18% to €88 million compared to the year ended December 31, 2019, primarily due to lower shipments as a result of impacts from the COVID-19 pandemic,
-51-


partially offset by strong cost control. Adjusted EBITDA per metric ton decreased 10% to €382 per ton from €423 per ton in the year ended December 31, 2019.
For the year ended December 31, 2019, Adjusted EBITDA in our AS&I segment decreased 15% to €106 million compared to the year ended December 31, 2018, reflecting higher costs largely related to our footprint expansion and operational challenges on some of our newer automotive programs despite strong automotive shipments. Adjusted EBITDA per metric ton decreased 16% to €423 per ton in the year ended December 31, 2019.
Holdings & Corporate
Our Holdings and Corporate segment generated Adjusted EBITDA losses of €20 million, €21 million and €22 million in the years ended December 31, 2020, 2019 and 2018, respectively.
Liquidity and Capital Resources
Our primary sources of cash flow have historically been cash flows from operating activities and funding or borrowings from external parties.
Based on our current and anticipated levels of operations, and the condition in our markets and industry, we believe that our cash flows from operations, cash on hand, new debt issuances or refinancing of existing debt facilities, and availability under our factoring and revolving credit facilities will enable us to meet our working capital, capital expenditures, debt service and other funding requirements for the foreseeable future.
It is our policy to hedge all highly probable or committed foreign currency operating cash flows. As we have significant third party future receivables denominated in U.S. dollars, we generally enter into combinations of forward contracts with financial institutions, selling forward U.S. dollars against Euros. In addition, as discussed in “Item 4. Information on the Company—B. Business Overview—Managing our Metal Price Exposure,” when we are unable to align the price and quantity of physical aluminium purchases with that of physical aluminium sales, we enter into derivative financial instruments to pass through the exposure to metal price fluctuations to financial institutions at the time the price is set. As the U.S. dollar appreciates versus the Euro or the LME price for aluminium falls, the derivative contracts related to transactional hedging entered into with financial institution counterparties will have a negative mark-to-market. We borrow in a combination of Euros and U.S. Dollars. When the external currency mix of our debt does not match exactly the mix of our assets, we use a combination of cross-currency interest rate swaps and cross-currency swaps to balance the risk. We have bought forward significant U.S. Dollars versus the Euro for this purpose. As the U.S. Dollar depreciates against the Euro, the derivative contracts entered into with financial institutions will have a negative mark-to-market.
Our financial institution counterparties may require margin calls should our negative mark-to-market exceed a pre-agreed contractual limit. In order to protect the Group from the potential margin calls for significant market movements, we maintain additional cash or availability under our various borrowing facilities, we enter into derivatives with a large number of financial counterparties and we monitor potential margin requirements on a daily basis for adverse movements in the U.S. dollar versus the Euro and in aluminium prices. A €3 million margin call was posted at December 31, 2020. No margin calls were posted at December 31, 2019. A €5 million margin call was posted at December 31, 2018.
At December 31, 2020, we had €981 million of total liquidity, comprised of €439 million in cash and cash equivalents, €255 million of undrawn availability under our Pan-U.S. ABL Facility, €135 million of undrawn availability under our Delayed Draw Term Loan, €74 million of undrawn availability under our French Inventory Facility, €50 million of undrawn availability under our new German facilities, €22 million availability under our factoring arrangements, and €6 million of undrawn availability under other credit facilities, of which €3 million was with Bpifrance Financement, a related party.
-52-


Cash Flows
The following table summarizes our operating, investing and financing activities for the years ended December 31, 2020, 2019 and 2018:
For the year ended December 31,  
(in millions of Euros) 2020 2019 2018
Net Cash Flows from / (used) in:
Operating activities 334  447  66 
Investing activities (176) (353) (91)
Financing activities 101  (76) (82)
Net increase / (decrease) in cash and cash equivalents, excluding the effect of exchange rate changes 259  18  (107)
Net cash Flows from Operating Activities
For the year ended December 31, 2020, net cash flows from operating activities were an inflow of €334 million, a €113 million decrease from an inflow of €447 million in the year ended December 31, 2019. This decrease primarily reflects a €88 million decrease in changes from working capital and a €25 million decrease from the change in cash flows from operating activities before working capital. For the year ended December 31, 2020, factored receivables under non-recourse arrangements decreased by €65 million.
For the year ended December 31, 2019, net cash flows from operating activities increased by €381 million to €447 million. This increase in operating cash flows reflects a €378 million increase in cash flows from changes in working capital and stable cash flows from operating activities before working capital changes. In the year ended December 31, 2019, factored receivables under non-recourse arrangements increased by €17 million.
Net Cash Flows used in Investing Activities
For the year ended December 31, 2020, net cash flows used in investing activities were €176 million. Capital expenditures net of grants received were €177 million and related primarily to recurring investment in our manufacturing facilities and growth projects.
For the year ended December 31, 2019, net cash flows used in investing activities were €353 million. Capital expenditures were €271 million and related primarily to recurring investment in our manufacturing facilities and growth projects. For the year ended December 31, 2019, net cash flows used in investing activities also reflected the acquisition of our partner’s 49% interest in the Bowling Green joint venture for €83 million.
For the year ended December 31, 2018, net cash flows used in investing activities were €91 million. Capital expenditures of €277 million primarily related to recurring investment in our manufacturing facilities and our growth projects. Net cash flows used in investing activities included €198 million of net proceeds from the sale of our assets in Sierre and €24 million of equity contributions and loans to joint ventures, related to our 51% share in Bowling Green.
For further details on capital expenditures projects, see the “—Historical Capital Expenditures” section below.
Net Cash flows used in Financing Activities
For the year ended December 31, 2020, net cash flows from financing activities were €101 million. In the year ended December 31, 2020, Constellium raised $325 million of 5.625% Senior Notes due 2028, using a portion of the proceeds to redeem the remaining balance of the 4.625% Senior Notes due 2021 and repay amounts drawn under the Pan-U.S. ABL. In addition, Constellium entered into a €180 million loan partially guaranteed by the French State and drew CHF20 million on a facility partially guaranteed by the Swiss Government.
For the year ended December 31, 2019, net cash flows used in financing activities were €76 million. In the year ended December 31, 2019, net cash flows used in financing activities primarily reflected the €100 million partial redemption of the €300 million 4.625% Senior Notes due 2021 in August 2019 and a €54 million lease repayment upon the acquisition of Bowling Green, partially offset by €109 million of proceeds from revolving credit facilities and other loans.
-53-


For the year ended December 31, 2018, net cash used in financing activities were €82 million and primarily reflected €68 million in repayments made on revolving credit facilities and other loans.
Historical Capital Expenditures
The following table provides a breakdown of the historical capital expenditures by segment for the periods indicated:
For the year ended December 31,
(in millions of Euros) 2020 2019 2018
P&ARP 73  96  97 
A&T 45  72  70 
AS&I 61  97  105 
Holdings and Corporate
Total capital expenditures 182  271  277 
For the year ended December 31, 2020, capital expenditures net of grants received were €177 million and related primarily to asset-sustaining investments across all segments. The decrease in capital expenditures results from the measures taken in response to the COVID-19 downturn.
The main projects undertaken during the year ended December 31, 2020 were to support our growth and reliability initiatives and primarily included investments in our AS&I segment.
For the year ended December 31, 2019, our capital expenditures related primarily to asset-sustaining investments and selective growth projects, across all segments.
The main projects undertaken during the year ended December 31, 2019 were to support our growth and reliability initiatives and included our Auto Body Sheet investments in Europe and in the U.S., within the P&ARP segment, automotive structures and industry investments in our AS&I segment and manufacturing efficiency investments in our A&T segment.
As of December 31, 2020, we had €132 million of construction in progress, which primarily related to our continued maintenance, modernization and expansion projects at our Neuf Brisach, Levice, Issoire, Ravenswood and Singen facilities.
As of December 31, 2019, we had €203 million of construction in progress, which primarily related to our continued maintenance, modernization and expansion projects at our Neuf Brisach, Děčín, Ravenswood, Levice, Issoire, Singen and Muscle Shoals facilities.
As of December 31, 2018, we had €194 million of construction in progress which, primarily related to our continued maintenance, modernization and expansion projects at our Děčín, Muscle Shoals, Neuf Brisach, Ravenswood, Issoire, Singen and Van Buren facilities.
Covenant Compliance
The indentures governing our outstanding debt securities contain no maintenance covenants but contain customary affirmative and negative covenants that, among other things, restrict, subject to certain exceptions, our ability and the ability of our subsidiaries, to incur or guarantee indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations and make dividends and other restricted payments.
The Pan-U.S. ABL Facility and U.S. Delayed Draw Term Loan (“U.S. DDTL”) contain a financial covenant that provides that at any time during which borrowing availability thereunder is below 10% of the aggregate commitments under the Pan-U.S. ABL Facility, we will be required to maintain a minimum fixed charge coverage ratio of 1.0 to 1.0 and a minimum Borrower EBITDA Contribution of 25%, in each case calculated on a trailing twelve-month basis. “Borrower EBITDA Contribution” means, for any period, the ratio of the combined EBITDA of the borrowers under the Pan-U.S. ABL Facility and their subsidiaries for such period, to the consolidated EBITDA of the Company and its subsidiaries for such period. The Pan-U.S. ABL Facility and DDTL also contain customary negative covenants on liens, investments and restricted payments related to Ravenswood, Muscle Shoals, and Bowling Green.
-54-


The PGE French Facility contains a net debt leverage covenant and an interest coverage ratio covenant with semi-annual testing dates beginning on June 30, 2021.
The PGE French Facility also contains customary terms and conditions, including, negative covenants and limitations on incurring additional indebtedness, on selling assets, on certain corporate transactions and reorganizations, on making loans and advances and on entering into certain derivative transactions.
The unsecured German Facility has an interest coverage covenant applicable if the facility is drawn.
The Wise Factoring Facility contains customary covenants and the factors’ commitment to purchase the receivables is subject to the maintainance of certain credit rating levels.
The European Factoring Facilities contain customary covenants.
We were in compliance with our covenants at and for the years ended December 31, 2020 and 2019.
See “Item 10. Additional Information—C. Material Contracts” for a description of our significant financing arrangements.
Off-Balance Sheet Arrangements
As of December 31, 2020, except as otherwise disclosed in our consolidated financial statements, we have no significant off-balance sheet arrangements.
Contractual Obligations
The following table summarizes our estimated material contractual cash obligations and other commercial commitments at December 31, 2020:
Cash payments due by period
(in millions of Euros) Total Less
than
1 year
1-3
years
3-5
years
After 5
years
Borrowings 2,192  10  200  889  1,093 
Interest(1)
572  114  223  175  60 
Net debt derivatives 40  10  30  —  — 
Derivatives relating to currencies and commodities 39  32  —  — 
Capital expenditures(2)
49  44  —  — 
Leases 245  41  68  42  94 
Operating lease obligations(3)
22 
Total(4)
3,159  257  538  1,112  1,252 
__________________
1.Interest accrues under the 2024 U.S. Dollar Notes at a rate of 5.750% per annum, under the February 2017 Notes at a rate of 6.625% per annum, under the 2026 U.S. Dollar Notes at a rate of 5.875%, per annum, under the 2026 Euro Notes at a rate of 4.250% per annum and under the June 2020 Notes at a rate of 5.625% per annum.
2.We currently expect all of our capital expenditures to be financed with cash on hand and external financing.
3.Operating leases relate to buildings, machinery and equipment leased under short term leases or low-value asset leases.
4.Estimating when pension and other post-employment obligations will require settlement is not practicable and therefore these have not been included in the Contractual Obligations table above.
Environmental Contingencies
Our operations, like those of many other industries, are subject to federal, state, local and international laws, regulations and ordinances. These laws and regulations (i) govern activities or operations that may have adverse environmental effects,
-55-


such as discharges to air and water, as well as waste handling and disposal practices and (ii) impose liability for costs of cleaning up, and certain damages resulting from, spills, disposals or other releases or regulated materials. From time to time, our operations have resulted, or may result, in certain noncompliance with applicable requirements under such environmental laws. To date, any such noncompliance with such environmental laws has not had a material adverse effect on our financial position or results of operations.
Pension Obligations
Constellium operates various pension plans for the benefit of its employees across a number of countries. Some of these plans are defined benefit plans and others are defined contribution plans. The largest of these plans are in the United States, Switzerland, Germany and France. Pension benefits are generally based on the employee’s length of service and highest average eligible compensation before retirement, and are periodically adjusted for cost of living increases, either by practice, collective agreement or statutory requirement. Finally, we also participate in various multi-employer pension plans in one of our facilities in the United States.
We also provide health and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents. These plans are predominantly in the United States.
The total expense recognized in the income statement in relation to all our pension and post-retirement benefits was €45 million and €43 million for the years ended December 31, 2020 and 2019, respectively. The fair value of the plans assets was €458 million and €445 million for the years ended December 31, 2020 and 2019, respectively. The present value of our obligations was €1,122 million and €1,115 million for the years ended December 31, 2020 and 2019, respectively. This resulted in aggregate plan deficits of €664 million and €670 million as of December 31, 2020 and 2019, respectively.
Our estimated funding for our funded pension plans and other post-retirement benefit plans is based on actuarial estimates using benefit assumptions for discount rates, rates of compensation increases, and health care cost trend rates. The deficit related to the funded pension plan and the present value of the unfunded obligations as of December 31, 2020 were €314 million and €350 million, respectively. The deficit related to the funded pension plan and the present value of the unfunded obligations as of December 31, 2019 were €323 million and €347 million, respectively.
Contributions to pension and other benefit plans were €53 million and €50 million for the year ended December 31, 2020, and 2019, respectively.
Contributions to our multi-employer plans were approximately €2 million for each of the two years ended December 31, 2020 and 2019.
Principal Accounting Policies, Critical Accounting Estimates and Key Judgments
Our principal accounting policies are set out in Note 2 to the audited Consolidated Financial Statements, which appear elsewhere in this Annual Report. New standards and interpretations not yet adopted are also disclosed in Note 2.3 to our audited Consolidated Financial Statements. Critical accounting estimates and key judgments are described in Note 2.7 to our audited Consolidated Financial Statements, this note includes notably considerations around key estimates and uncertainty in light of the current Covid-19 pandemic.

Item 6. Directors, Senior Management and Employees
A. Directors and Senior Management
According to the Articles of Association, our Board of Directors is composed of natural or legal persons between 3 and 18 in number, appointed by the general meeting.
The following table provides information regarding the members of our board of directors as of the date of this Annual Report (ages are given as of December 31, 2020). The business address of each of our directors listed below is c/o Constellium, Washington Plaza, 40-44 rue Washington, 75008 Paris, France.
-56-


Name Age Position Date of Appointment Current Term
Richard B. Evans 73 Chairman January 5, 2011 2019-2022
Guy Maugis 67 Director January 5, 2011 2020-2023
Werner P. Paschke 70 Director May 21, 2013 2019-2021
Michiel Brandjes 66 Director June 11, 2014 2019-2021
Peter F. Hartman 71 Director June 11, 2014 2020-2023
John Ormerod 71 Director June 11, 2014 2019-2021
Lori A. Walker 63 Director June 11, 2014 2019-2022
Martha Brooks 61 Director June 15, 2016 2019-2022
Jean-Marc Germain 54 Director and CEO June 15, 2016 2020-2023
Stéphanie Frachet 43 Director May 24, 2018 2019-2022
Pursuant to a shareholders agreement between the Company and Bpifrance Participations (f/k/a Fonds Stratégique d'Investissement) ("Bpifrance"), in 2018, Ms. Frachet was designated by Bpifrance as a nominee, and was then appointed by the shareholders to serve as a director of the Company.
Richard B. Evans. Mr. Evans has served as a director since January 2011 and as Chairman of our Board of Directors since December 2012. Mr. Evans is currently an independent director and a member of the Audit Committee of CGI Group, Inc., an IT consulting and outsourcing company. In 2016, Mr. Evans resigned as a non-executive director of Noranda Aluminum Holding Corporation following its successful liquidation through the Chapter 11 bankruptcy process. He retired in May 2013 as non-executive Chairman of Resolute Forest Products, a Forest Products company based in Montreal. He retired in April 2009 as an executive director of London-based Rio Tinto plc and Melbourne-based Rio Tinto Ltd., and as Chief Executive Officer of Rio Tinto Alcan Inc., a wholly owned subsidiary of Rio Tinto. Previously, Mr. Evans was President and Chief Executive Officer of Montreal based Alcan Inc. from March 2006 to October 2007, and led the negotiation of the acquisition of Alcan by Rio Tinto in October 2007. He was Alcan’s Executive Vice President and Chief Operating Officer from September 2005 to March 2006. Prior to joining Alcan in 1997, he held various senior management positions with Kaiser Aluminum and Chemical Company during his 27 years with that company. Mr. Evans is a past Chairman of the International Aluminum Institute (IAI) and is a past Chairman of the Washington, DC-based U.S. Aluminum Association. He previously served as Co-Chairman of the Environmental and Climate Change Committee of the Canadian Council of Chief Executives and as a member of the Board of USCAP, a Washington, DC-based coalition concerned with climate change.
Guy Maugis. Mr. Maugis has served as a non-executive director since 2011. Mr. Maugis served as advisor of the Board of Robert Bosch GmbH from 2016 to 2018, after being President of Robert Bosch France SAS for 12 years. The French subsidiary covers all the activities of the Bosch Group, a leader in the domains of Automotive Equipments, Industrial Techniques and Consumer Goods and Building Techniques. He is President of the French-German Chamber of Commerce and Industry. Mr. Maugis serves as a senior advisor to IAC Partners and Loccioni S.P.a, is a member of the European Advisory Board of KPS Capital Partners, and a member of the Advisory Board of Melcofin & Co. Mr. Maugis worked for several years at the Equipment Ministry. At Pechiney, he managed the flat rolled products factory of Rhenalu Neuf-Brisach. At PPG Industries, he became President of the European Flat Glass activities. With the purchase of PPG Glass Europe by ASAHI Glass, Mr. Maugis assumed the function of Vice-President in charge of the business development and European activities of the automotive branch of the Japanese group. Mr. Maugis is a graduate of Ecole Polytechnique, Engineer of “Corps des Ponts et Chaussées.”
Werner P. Paschke. Mr. Paschke has served as a non-executive director since May 2013. From 2008 until April 2017, he served as an independent director of Braas Monier Building Group, Luxembourg, where he chaired the Audit Committee. In previous years, he served on the Supervisory Boards of Conergy Aktiengesellschaft, Hamburg, Coperion GmbH, Stuttgart and several smaller companies. From 2003 to 2006, he was Managing Director and Chief Financial Officer of Demag Holding in Luxembourg, where he enhanced the value of seven former Siemens and Mannesmann units. From 1992 to 2003, he worked for Continental Aktiengesellschaft in Hannover/Germany, and since 1993 as Generalbevollmächtigter responsible for corporate controlling plus later, accounting. From 1989 to 1992, he served as Chief Financial Officer for General Tire Inc., in Akron/Ohio, USA. From 1973 to 1987, he held different positions at Continental AG in finance, distribution, marketing and controlling. Mr. Paschke is an Advisory Board Member for Weber Automotive GmbH, and a senior advisor of Adrian Germany. Mr. Paschke studied economics at Universities Hannover, Hamburg and Münster/Westphalia, where he graduated as Diplomkaufmann in 1973. He is a 1993 graduate of the International Senior Management Program at Harvard Business School.
Michiel Brandjes. Mr. Brandjes has served as a non-executive director since June 2014. He served as Company Secretary and General Counsel Corporate of Royal Dutch Shell plc from 2005 to 2017. Mr. Brandjes formerly served as Company
-57-


Secretary and General Counsel Corporate of Royal Dutch Petroleum Company. He served for 25 years on numerous legal and non-legal jobs in the Shell Group within the Netherlands and abroad, including as head of the legal department in Singapore and as head of the legal department for North East Asia based in Beijing and Hong Kong. Before he joined Shell, Mr. Brandjes worked at a law firm in Chicago. Mr. Brandjes serves in a number of advisory and director positions of charitable foundations. He has published a number of articles on legal and business topics, is a regular speaker on corporate legal and governance topics. Mr. Brandjes graduated from law school at the University of Rotterdam and at Berkeley, California.
Peter F. Hartman. Mr. Hartman has served as a non-executive director since June 2014. Mr. Hartman has been a member of the Supervisory Board of Royal KPN N.V. since April 2015 and is currently Chair of the Remuneration Committee and a member of the Nominating & Corporate Governance Committee. Mr. Hartman serves as Chairman of the Supervisory Board of Texel Airport N.V. and is a member of the Advisory Board of Aviation Glass & Technology, and Mainblades, a drone-application start-up. He served as Chairman of the Supervisory Board of Fokker Technologies Group B.V until May 2020, and as member of the supervisory boards of Kenya Airways from 2004 to 2013, Stork B.V. from 2008 to 2013, CAI Compagnia Aerea Italiana S.p.A. from 2009 to January 2014, Delta Lloyd Group N.V. from 2010 to May 2014 and Royal Ten Cate N.V. from July 2013 to February 2016. He served as Vice Chairman of Air France KLM from July 2013 until May 2017. Mr. Hartman served as member of the supervisory board of Air France KLM S.A. from 2010, and as member of the Audit Committee from July 2016, until May 2017. Previously, Mr. Hartman served as President and CEO of KLM Royal Dutch Airlines from 2007 to 2013. Mr. Hartman received a Bachelor’s degree in Mechanical Engineering from HTS Amsterdam, Amsterdam and a Master’s degree in Business Economics from Erasmus University, Rotterdam.
John Ormerod. Mr. Ormerod has served as a non-executive director since June 2014. Mr. Ormerod is a chartered accountant and worked for over 30 years in public accounting firms. He served for 32 years at Arthur Andersen, serving in various client service and management positions, with last positions held from 2001 to 2002 serving as Regional Managing Partner UK and Ireland, and Managing Partner (UK). From 2002 to 2004, he was Practice Senior Partner for London at Deloitte (UK) and was member of the UK executives and Board. Until May 2018, Mr. Ormerod served in the following director positions: since 2006, as a non-executive director, member of the Audit Committee (of which he also served as its Chairman until September 2017), and as member of the Compensation Committee of Gemalto N.V.; since 2008, as non-executive director of ITV plc, and as member of the Remuneration and Nominations Committees, and as Chairman of the Audit Committee since 2010. Until December 31, 2015, Mr. Ormerod served as a non-executive director of Tribal Group plc., as member of the Audit, Remuneration and Nominations Committees and as Chairman of the board. Mr. Ormerod served as non-executive director and Chairman of the Audit Committee of Computacenter plc., and as member of the Remuneration and Nominations Committees until April 1, 2015. Mr. Ormerod also served as a senior independent director of Misys plc. from 2006 to 2012, and as Chairman of the Audit Committee from 2005 to 2012. Mr. Ormerod is Chairman of Bloodwise, a UK charity. Mr. Ormerod is a graduate of Oxford University.
Lori A. Walker. Ms. Walker has served as a non-executive director since June 2014. Ms. Walker previously served as Chief Financial Officer and Senior Vice President of The Valspar Corporation from 2008 to 2013, where she led the Finance, IT and Communications teams. Prior to that position, Ms. Walker served as Valspar’s Vice President, Controller and Treasurer from 2004 to 2008, and as Vice President and Controller from 2001 to 2004. Prior to joining Valspar, Ms. Walker held a number of roles with progressively increasing responsibility at Honeywell Inc. during a 20-year tenure, with her last position there serving as director of Global Financial Risk Management. Ms. Walker currently serves as the Audit Committee Chair of Southwire Company, LLC and is also a member of its Human Resources Committee. She also serves as the Audit Committee Chair of Compass Minerals International, Inc. and is a member of its Compensation Committee. Ms. Walker holds a Bachelor of Science of Finance from Arizona State University and attended the Executive Institute Program and the Director’s College at Stanford University.
Martha Brooks. Ms. Brooks has served as a non-executive director since June 2016. Ms. Brooks was until her retirement in May 2009, President and Chief Operating Officer of Novelis Inc, where she held senior positions since 2005. From 2002 to 2005, she served as Corporate Senior Vice President and President and Chief Executive Officer of Alcan Rolled Products, Americas and Asia. Before she joined Alcan, Ms. Brooks served 16 years with Cummins, the global leader in diesel engine and power generation from 1986 to 2002, ultimately running the truck and bus engine business. She is currently a director at Bombardier Inc., where she serves as a member of the Audit Committee; a director at Jabil Circuit Inc., where she serves as a member of the Compensation Committee, and the Nominating and Governance Committee; and a director of CARE Enterprises Inc., a for profit subsidiary of CARE USA, where she serves as board Co-Chair. She has previously served as a director of Harley Davidson and International Paper. Ms. Brooks holds a BA in Economics and Political Science and a Master’s in Public and Private Management from Yale University.
Jean-Marc Germain. Mr. Germain has served as an executive director since June 2016 and as our Chief Executive Officer since July 2016. Prior to joining Constellium, Mr. Germain was Chief Executive Officer of Algeco Scotsman, a
-58-


Baltimore-based leading global business services provider focused on modular space and secure portable storages. Previously, Mr. Germain held numerous leadership positions in the aluminium industry, including senior executive roles in operations, sales & marketing, financial planning and strategy with Pechiney, Alcan and Novelis. His last position with Novelis from 2008 to 2012 was as President for North American operations. Earlier in his career, he held a number of international positions with Bain & Company and GE Capital. Mr. Germain is a graduate of Ecole Polytechnique in Paris, France and a dual French and American citizen.
Stéphanie Frachet. Ms. Frachet has served as a non-executive director since May 2018. Ms. Frachet is currently Managing Director and member of the Bpifrance Capital Development Executive Committee at Bpifrance Investissement that she joined in 2009. Ms. Frachet is also, as permanent representative of Bpifrance, a director of Eutelsat Communications, Valeo, and Sulo, and a director of Sabena Technics, as well as an observer on the Board of Paprec. Until recently, she was also an observer on the Board of Horizon Parent Holdings Sarl (from 2015 to 2017). Previously, Ms. Frachet served for Bpifrance as a member of the Board of Carso (from 2013 to 2016), Cylande (from 2010 to 2017) and Sarenza (from 2014 to 2018), and as an independent director of Eurosic (from 2015 to 2017). From 2002 to 2009, Ms. Frachet held various positions in auditing and financial consulting on mergers & acquisitions and LBOs at Ernst &Young, Pricewaterhouse Coopers and Société Générale CIB in Paris. Ms. Frachet graduated from ESSEC Business School in Paris in 2002.
The following persons are our executive officers as of the date of this Annual Report (ages are given as of December 31, 2020). The business address of each of our officers listed below is c/o Constellium, Washington Plaza, 40-44 rue Washington, 75008 Paris, France.
Name Age Title
Jean-Marc Germain 54  Chief Executive Officer
Peter R. Matt 58  Executive Vice President and Chief Financial Officer
Peter Basten 45  President, Packaging and Automotive Rolled Products business unit
Ingrid Joerg 51  President, Aerospace and Transportation business unit
Philippe Hoffmann 55  President, Automotive Structures and Industry business unit
Jack Clark 61  Senior Vice President Manufacturing Excellence and Chief Technical Officer
Philip Ryan Jurkovic 49  Senior Vice President and Chief Human Resources Officer
Nicolas Brun 54  Senior Vice President, Public Affairs, Communications and Sustainability
Jeremy Leach 58  Senior Vice President and Group General Counsel
The following paragraphs set forth biographical information regarding our officers (other than Mr. Germain, whose biographical information is set forth above in the description of biographical information of our directors):
Peter R. Matt. Mr. Matt has served as our Executive Vice President and Chief Financial Officer since January 1, 2017. From November 2016 to December 2016 he served as our Chief Financial Officer Designate. Prior to joining Constellium, he spent 30 years in investment banking at First Boston/Credit Suisse where he built leading Metals and Diversified Industrials coverage practices. From 2010 to 2015, he was the Managing Director and Group Head at Credit Suisse responsible for managing the firm’s Global Industrials business in the Americas. Since June 2020, Mr. Matt serves on the Board of Commercial Metals Corporation. He is a graduate of Amherst College.
Peter Basten. Mr. Basten has served as President of our Packaging and Automotive Rolled Products business unit since September 2017. He previously served as our Executive Vice President, Strategy, Business Development, Research & Development since 2016, and prior to that as our Vice President, Strategy and Business Planning, the Managing Director of Soft Alloys Europe at our Automotive Structures and Industry Business Unit and our Vice President Strategic Planning & Business Development. Mr. Basten joined Alcan in 2005 as the Director of Strategy and Business Planning at Alcan Specialty Sheet, and became Director of Sales and Marketing in 2008, responsible for the aluminium packaging applications markets. Prior to joining Alcan, Mr. Basten worked as a consultant at Monitor Group, a Strategy Consulting firm. His assignments ranged from developing marketing, corporate, pricing and competitive strategy to M&A and optimizing manufacturing operations. Mr. Basten holds degrees in Applied Physics (Delft University of Technology, Netherlands) and Economics & Corporate Management (ENSPM, France).
Ingrid Joerg. Ms. Joerg has served as President of our Aerospace and Transportation business unit since June 2015. Previously, Ms. Joerg served as Chief Executive Officer of Aleris Rolled Products Europe. Prior to joining Aleris, Ms. Joerg held leadership positions with Alcoa where she was President of its European and Latin American Mill Products business unit,
-59-


and commercial positions with Amag Austria. Ms. Joerg joined the Board of voestalpine AG in July 2019. She received a Master’s Degree in Business Administration from the University of Linz, Austria.
Philippe Hoffman. Mr. Hoffmann has served as President of our Automotive and Industry business unit since October 2020. He previously held numerous leadership positions in the company, including Managing Director for Constellium’s Hard Alloys and Large Extrusion business, Vice President Rolled Products Europe for our Aerospace and Transportation business unit, and Vice President and Managing Director Automotive Structures. During his extensive career in the aluminium industry, Mr. Hoffmann held various manufacturing, strategic, and management roles, serving our automotive, industry, transportation and aerospace customers across Europe and North America. Mr. Hoffmann is a graduate of INSEAD Business School and of the École Nationale Supérieure des Mines with a Master in Physics and Material Science. He holds a Master of International Management from the International Master Program for Managers (IMPM), which includes studies at McGill (Canada), Lancaster University (UK), IIMB (India), KDI School (Korea), INSEAD (France) and JAIST (Japan).
Jack Clark. Mr. Clark has served as our Senior Vice President Manufacturing Excellence and Chief Technical Officer since October 2016. In this role, Mr. Clark is responsible for research and technology at Constellium and supervises all EHS, Lean continuous improvement activities as well as engineering, reliability and capital expenditures planning and execution. Prior to joining Constellium, Mr. Clark was Senior Vice President and Chief Technical Officer of Novelis. Mr. Clark graduated from Purdue University in Engineering and has more than 30 years of industry experience with Alcoa and Novelis on three continents.
Philip Ryan Jurkovic. Mr. Jurkovic has served as our Senior Vice President and Chief Human Resources Officer since November 2016. Prior to joining Constellium, Mr. Jurkovic was Senior Vice President and Chief Human Resources Officer of Algeco Scotsman. He started his career as a financial analyst before taking on various HR leadership roles in Europe, Asia and the U.S. with United Technologies and Novelis. Mr. Jurkovic has a BS from Allegheny College and an MBA from Purdue University.
Nicolas Brun. Mr. Brun has served as our Senior Vice President, Public Affairs, Communications and Sustainability since January 2018, and was previously Senior Vice President, Communications from September 2017 to January 2018, and Vice President, Communications from January 2011 to January 2017. He previously held the same role at Alcan Engineered Products since June 2008. From 2005 through June 2008, Mr. Brun served in the roles of Vice President, Communications for Thales Alenia Space and also as Head of Communications for Thales’ Space division. Prior to 2005, Mr. Brun held senior global communications positions as Vice President External Communications with Alcatel, Vice President Communications Framatome ANP/AREVA, and with the Carlson Wagonlit Travel Group. Mr. Brun currently serves as President of Constellium Neuf Brisach SAS since January 2015, and was appointed President of Constellium France Holdco on December 30, 2019. Mr. Brun attended University of Paris-La Sorbonne and received a degree in economics. He has a master’s degree in corporate communications from Ecole Française des Attachés de Presse and a certificate in marketing management for distribution networks from the Ecole Supérieure de Commerce in Paris.
Jeremy Leach. Mr. Leach has served as our Senior Vice President and Group General Counsel and Secretary to the Board of Constellium since January 2011 and previously was Vice President and General Counsel at Alcan Engineered Products. Mr. Leach joined Pechiney in 1991 from the international law firm Richards Butler (now Reed Smith). Prior to becoming General Counsel at Alcan Engineered Products, he was the General Counsel of Alcan Packaging and held various senior legal positions in Rio Tinto, Alcan and Pechiney. He has been admitted in a number of jurisdictions, holds a law degree from Oxford University (MA Jurisprudence) and an MBA from the London Business School.
B. Compensation
COVID-19 Pandemic
Despite the difficulties posed to the business by the COVID-19 pandemic, Constellium did not make any major structural changes or adjustments to its remuneration plans in 2020. Areas where we did take action (i.e., in support of the business) and just as importantly, did not, are disclosed below within each relevant section.

Non-Executive Director Compensation
In response to the COVID-19 pandemic, and as a measure of solidarity, our non-executive directors voluntarily agreed to a reduction of 30% of their Retainer/Membership/Chair fees for the period of April 1 to September 30.
-60-


In 2020, the compensation structure for our non-executive directors consisted of (i) Annual retainer fees, (ii) Committee membership fees, (iii) Committee Chair fees following a formulaic approach (200% of the Committee membership fee), and (iv) cash paid in lieu of the former annual RSU grant:
Annual Retainer
an annual fee of €65,000 for the Chairman of the Board and €70,000 for each other non-executive director
an additional annual fee of €65,000 for the Chairman of the Board
Audit Committee
an annual fee of €12,000 for members of the Audit Committee
an additional annual fee of €12,000 for the Chair of the Audit Committee
Human Resources and Remuneration Committee
an annual fee of €8,000 for members of the Human Resources and Remuneration Committee
an additional annual fee of €8,000 for the Chair of the Human Resources and Remuneration Committee
Nominating and Governance Committee
an annual fee of €6,000 for members of the Nominating and Governance Committee
an additional annual fee of €6,000 for the Chair of the Nominating and Governance Committee
Environment, Health and Safety Committee
an annual fee of €4,000 for members of the Environment, Health and Safety Committee
an additional annual fee of €4,000 for the Chair of the Environment, Health and Safety Committee
Cash paid in lieu of the former annual RSU grant
annual cash of $95,000 for the Chairman of the Board
annual cash of $75,000 for our other non-executive directors
Upon the Transfer, the equivalent of the RSU grant that had been previously granted on an annual basis was replaced with quarterly cash payments, starting in the third quarter 2020.
The non-executive directors of the Board have not entered into any service contracts with the Company that provide either for benefits upon termination of employment or pension-related benefits.
The following table sets forth the remuneration due in respect of our 2020 fiscal year to our non-executive directors:
Name
Annual
Retainer
Fees (1)
Chair Fees (1)
Membership Fees (1)
Cash paid in lieu of the former RSU grant (2)
Total
Richard B. Evans 55,250  60,350  11,900  41,191  168,691 
Guy Maugis 59,500  3,400  10,200  32,519  105,619 
Michiel Brandjes 59,500  —  8,500  32,519  100,519 
Werner P. Paschke 59,500  —  10,200  32,519  102,219 
Peter F. Hartman 59,500  —  10,200  32,519  102,219 
John Ormerod 59,500  —  15,300  32,519  107,319 
Lori A. Walker 59,500  10,200  15,300  32,519  117,519 
Martha Brooks 59,500  6,800  17,000  32,519  115,819 
Stéphanie Frachet(3)
—  —  —  —  — 
Total 471,750  80,750  98,600  268,824  919,924 
-61-


__________________
(1)In response to the COVID-19 pandemic, the non-executive directors reduced their fees by 30% for the period of April 1 - September 30, 2020. The savings to Constellium due to this fee reduction was €114,900.
(2)Exchange rate of the date of Board meeting used to reflect the equivalent of $23,750 (per quarter) for the Chairman and $18,750 (per quarter) for each other non-executive director in Euros: 3rd quarter: 0.89052; 4th quarter: 0.84385. See also Note 30 of the Consolidated Financial Statements.
(3)Ms. Frachet does not receive any fees for her services as a non-executive director.
Share Ownership Guidelines for Non-Executive Directors
In 2019, we adopted Share-Ownership Guidelines (SOGs) for our non-executive directors to further encourage minimum levels of ownership and to foster additional alignment between the non-executive directors and shareholder interests (does not apply to Ms Frachet, who does not receive compensation in respect of her services as a non-executive director). The non-executive directors are required to hold a fixed value in Constellium shares as follows:
$500,000        Chairman of the Board
$250,000        Other non-executive directors
The SOGs give the non-executive directors five years to achieve guideline levels of ownership. All of our non-executive directors who are subject to the SOGs met them in 2020.
Officer Compensation
In response to the COVID-19 pandemic, base salary increases were deferred by six months, from the annual April 1 effective date, to October 1. In addition, our CEO, CFO and our Other Executive Officers (as defined below) voluntarily agreed to reduce their compensation as follows (these amounts were not later repaid):
Jean-Marc Germain - voluntary compensation reduction of 30% for the period of April 1 to September 30 (savings to the Company: €142,701)
Peter Matt - voluntary compensation reduction of 15% for the period of April 1 to September 30 (savings to the Company: €42,744)
Other Executive Officers - voluntary compensation reduction of 15% for the period of April 1 to September 30 (savings to the Company: €123,318)
Also as an outcome to the COVID-19 pandemic:
The Adjusted EBITDA component of the 2020 annual bonus (paid out in 2021), which constitutes 50% of the overall target bonus, was 0% for Jean-Marc Germain, Peter Matt and the Other Executive Officers
Jean-Marc Germain, Peter Matt and our Other Executive Officers had the value of their equity awards reduced by 30%
The table below sets forth the remuneration paid during our 2020 fiscal year to certain of our executive officers. They include Jean-Marc Germain, our Chief Executive Officer, Peter Matt, our Executive Vice President and Chief Financial Officer, Peter Basten, our President Packaging & Automotive Rolled Products, Ingrid Joerg, our President Aerospace & Transportation and Paul Warton, who served as our President, Automotive Structures & Industry until October 1, 2020. Philippe Hoffmann was appointed President, Automotive Structures & Industry effective October 1, 2020, upon Mr. Warton’s resignation of such position. The remuneration information for our executive officers other than our Chief Executive Officer Jean-Marc Germain
-62-


and our Executive Vice President and Chief Financial Officer Peter Matt (which include Peter Basten, Ingrid Joerg, Paul Warton and Philippe Hoffmann) is presented on an aggregate basis in the row “Other Executive Officers” in the table below.
Name Base Salary
Paid
Bonus (EPA)
Paid
Equity
Awards(1)
Retirement /Pension(2)
Other
Compensation(3)
Total(4)
Jean-Marc Germain 815,213  1,226,083  2,817,633  22,490  209,731  5,091,150 
Peter Matt 538,141  556,019  989,983  22,490  94,386  2,201,019 
Other Executive Officers(5)
1,605,697  1,417,539  1,260,154  209,339  92,669  4,585,398 
_________________
(1)The amount reported as Equity Awards represents the grant date fair value of the awards granted in 2020, computed in accordance with IFRS 2. Jean-Marc Germain was granted the following in April 2020: (a) 312,481 performance-based restricted stock units (“PSUs”) (which can become a maximum of 624,962 shares); and (b) 159,404 RSUs. Peter Matt was granted the following in April 2020: (a) 109,791 PSUs (which can become a maximum of 219,582 shares); and (b) 56,007 RSUs.Our other executive officers listed were granted, in the aggregate, 139,754 PSUs (which can become a maximum of 279,508) and 71,291 RSUs. The PSUs vest on the third anniversary of the date of grant, subject to continued service and certain market-related performance conditions being satisfied, and have a vesting range of 0-200%. RSUs vest 100% on the third anniversary of the date of grant, subject to continued service. See hereafter “2020 Long-Term Incentive Plan” for description of market-related performance conditions. See also Note 30 to the Consolidated Financial Statements for more information.
(2)Retirement / Pension represents amounts contributed by the Company during the 2020 fiscal year in the US and Switzerland as part of the overall employer retirement / pension requirements apportioned to the base salary of these individuals.
(3)Other compensation for Jean-Marc Germain and Peter Matt includes car allowance, parking and premium for health, life and long-term disability insurance as well as non-qualified restoration contributions under the Constellium US Holdings I, LLC U.S. Non-qualified Deferred Compensation and Restoration Plan. Other compensation for Ms. Joerg as well as for Messrs. Warton, Basten and Hoffmann include car allowance, lunch allowance, tax and medical services, exchange rate compensation and premiums for life and long-term disability insurance.
(4)The total compensation paid to such executive officers, including Mr. Germain and Mr. Matt, during our 2020 fiscal year amounted to €6,809,797, consisting of (a) an aggregate base salary of €2,959,051, (b) aggregate short-term incentive compensation of €3,199,641, and (c) aggregate other compensation in an amount equal to €396,786. The total amount contributed to the value of the retirement / pensions for such executive officers was €254,319. All compensation amounts for the CEO, CFO and the US-based executive officers were converted to euros using an exchange rate of 0.87681. All compensation amounts for the Swiss-based executive officers were converted to euros using an exchange rate of 0.93423.
(5)Compensation for Philippe Hoffmann presented as of October 1, 2020.
Below is a brief description of the compensation and benefit plans as well as share ownership guidelines in which our executive officers participate.
Share Ownership Guidelines for Executive Officers
In 2018, we adopted Share-Ownership Guidelines (SOGs) for our executive officers to further encourage minimum levels of ownership and to further foster alignment between the Executive Committee and shareholder interests. The SOGs are as follows:
400% of base salary    CEO
200% of base salary    CFO and Business Unit Presidents
100% of base salary    Other executive officers
-63-


The SOGs give the executive officers five years to achieve guideline percentages. With the exception of Mr. Philippe Hoffmann, our new executive officer, all of our executive officers met the SOGs in 2020.
Non-qualified Deferred Compensation and Restoration Plan
A select group of highly compensated employees of Constellium US Holdings I, LLC and certain other subsidiaries and affiliates (including Messrs. Germain and Matt) are eligible to participate in the Constellium US Holdings I, LLC U.S. Non-qualified Deferred Compensation and Restoration Plan (“DCRP”). The DCRP allows such employees to defer up to 85% of their annual Employee Performance Award. The DCRP is also a non-qualified restoration plan for employer contributions that cannot be made to our 401(k) plan due to the Code Section 401(a)(17) annual limit on compensation paid under a qualified plan. The restoration contribution equals 9% of total eligible 2020 pay (base salary plus bonus award paid in 2020) in excess of this limit. The 9% consists of the 6% employer matching contribution and the 3% non-elective retirement contribution. Restoration contributions are 100% vested.
Distributions are made as a lump sum after separation from service, unless the participant elects to receive one to 10 annual payments beginning at least one year after separation from service.
Each participant directs investment of his or her individual account under the DCRP. The DCRP provides a broad range of market-based investments that may be changed daily. Benefits due under the DCRP are paid from our general assets, although we also maintain a rabbi trust that may be used to pay benefits. The trust and the funds held in it are Company assets. In the event of our bankruptcy, DCRP participants would be unsecured general creditors.
Say-On-Pay
As a foreign private issuer listed on the NYSE and a company not listed on a regulated French stock exchange, the Company is not subject to the Say-On-Pay regime for French listed companies.
2020 Employee Performance Award Plan
Despite the difficulties posed to the business by the COVID-19 pandemic, the Company:
did not make any adjustments to the 2020 Employee Performance Award Plan performance metrics, goals (threshold, target or maximum levels) or the measurement period
did not apply positive discretion with respect to the 2020 Employee Performance Award Plan payouts
Each of our executive officers, among other selected employees, participates in the Employee Performance Award Plan (which we refer to as the “EPA”). The EPA is an annual cash bonus plan intended to provide performance-related award opportunities to employees contributing substantially to the success of Constellium. Under the EPA, participants are provided opportunities to earn cash bonuses (expressed as a percentage of base salary, and paid in the year following the performance period) based on the level of achievement of certain Financial and EHS Objectives as approved by our Human Resources and Remuneration Committee for the applicable annual performance period, as well as Individual Objectives established by the applicable participant’s supervisor (as described below).
The three components of bonuses awarded under the EPA for 2020 had the following weights:
Financial Objectives — 70%
EHS Objective — 10%*
Individual Objectives — 20%
*EHS constitutes an ESG component
The Financial Objectives are calculated on an annual basis and take into account two components as defined and reported by the Company’s corporate controller: Adjusted EBITDA (50%) and Trade Working Capital Days (20%). To promote synergies throughout the Company, the EPA is designed to encourage individual plants, business units and our corporate division to work closely together to achieve common strategic, operating and financial goals. Therefore, the Financial Objectives are defined, depending on the level of the employee, as a combination of the financial results of the Company, the business unit and / or operating unit/site. The threshold performance level for the Financial Objectives is set at 80% of the target level. If threshold performance is not achieved, there is no payout for the Financial Objectives. Between threshold performance and target performance, payouts increase linearly from 0% to 100%. The maximum performance level is set at 120% of the
-64-


target level. Achieving 120% of the target level results in a payout of 200%, with linear interpolation (meaning each percentage point higher than 100% adds additional payout of 5%).
The EHS Objective, which represents the ESG component in our annual incentive plan, is measured on a quarterly basis for Constellium and its subsidiaries. In case of a fatality or type I (major) environmental event, the payout for the EHS Objective is zero for (i) employees of the operating site, (ii) the associated business unit leadership as well as (iii) the members of the Executive Committee. This substantial impact on EPA payout reflects the fact that the safety for our employees is our number one priority. Payout for EHS Objectives can range from 0% to 200%.
The Individual Objectives are evaluated annually via the Performance Management Program, and achievement against these objectives is used to determine the percentage attained of the Individual Objectives target.
The payout scale defines the performance levels and resulting payouts. Achieving target performance results in a payout at 100% of the target amount. Overall payout can range from 0% to 150% of the target amount.
The EPA 2020 was applicable to approximately 1,900 employees worldwide, including all of our executive officers. For its payout in 2021, the following results were earned by our employees:
Financial Objectives: The payouts ranged from 0% to 200%*;
EHS Objective: The payouts ranged from 50% to 200%;
Individual Objectives: The payouts ranged from 0% to 150%. The payout for Mr. Germain was 132%.
*Payout at the Group level for the Adjusted EBITDA component of the 2020 EPA, which constitutes 50% of the overall target bonus for Jean-Marc Germain, Peter Matt and the Other Executive Officers, was 0%.

Constellium SE 2013 Equity Incentive Plan
Our share-based compensation plan is the Constellium SE 2013 Equity Incentive Plan (the “Plan”). The principal purposes of the Plan are to focus our officers and employees on business performance to help create shareholder value, to encourage innovative approaches to the business of the Company and to encourage ownership of our ordinary shares by officers and employees. The Plan is also intended to recognize and retain our key employees needed to sustain and ensure our future and business competitiveness.
The Plan provides for a variety of awards, including “incentive stock options” (within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) (“ISOs”), nonqualified stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), performance-based restricted stock units (“PSUs”), other stock-based awards or any combination of those awards. To date, we have only awarded RSUs and PSUs under the Plan.
The Plan provides that awards may be made under the Plan for 10 years following approval by the Company's board of directors (the “Board of Directors”) of the Plan in 2013. We have reserved a total of 14,292,291 ordinary shares (of which 7,292,291 ordinary shares were originally reserved, and an additional 7,000,000 ordinary shares were reserved to be awarded under the Plan, following approval at our annual general meeting of shareholders in 2018 (the “2018 Share Authorization”)). The number of ordinary shares authorized and available is subject to adjustment in certain circumstances to prevent dilution or enlargement.
At the Company’s shareholders meeting held on November 25, 2019, we ratified the 2018 Share Authorization in order to make new awards under the Plan following the Transfer. Following such ratification, the authorization is valid until January 24, 2022. Awards made following such ratification and Transfer are subject to compliance with mandatory provisions of the French Commercial Code that now apply, as further described below.
Administration
The Plan is administered by the Human Resources and Remuneration Committee of our Board of Directors. The Board of Directors or the Human Resources and Remuneration Committee may delegate administration to one or more members of our Board of Directors. The Human Resources and Remuneration Committee has the power to interpret the Plan and to adopt rules for the administration, interpretation and application of the Plan according to its terms. The Board of Directors, acting on the recommendation of our Human Resources and Remuneration Committee, determines the number of our ordinary shares that will be subject to each award granted under the Plan and may take into account the recommendations of our senior management in determining the award recipients and the terms and conditions of such awards. Subject to certain exceptions as may be
-65-


required pursuant to Rule 16b-3 under the Exchange Act, if applicable, our Board of Directors may, at any time and from time to time, exercise any and all rights and duties of the Human Resources and Remuneration Committee under the Plan.
Following the Transfer, in accordance with the French Commercial Code:
the Human Resources and Remuneration Committee no longer has the power to make awards of any type;
the Board of Directors has exclusive power to make awards that are to be settled with shares;
the Board of Directors has exclusive power to make awards to the Company’s CEO and to any deputy chief executive officer (Directeur Général Délégué), irrespective of the form of settlement; and
the Company’s senior management has exclusive power to make awards to officers and employees that are cash-settled (other than to the Company’s CEO and any deputy chief executive officer (Directeur Général Délégué)).
Eligibility
Officers and employees are eligible to be granted awards under the Plan. Our Human Resources and Remuneration Committee makes recommendations regarding:
which officers and employees are to be granted awards;
the type of award that is granted;
the number of our ordinary shares subject to the awards; and
the terms and conditions of such awards, consistent with the Plan.
Following the Transfer, the power to make new awards and set their terms are as described above under “Administration.” Furthermore, in accordance with the French Commercial Code, following the Transfer, the Company is no longer permitted to grant restricted stock, and only officers (including the CEO), the Chairman of the Board of Directors and employees are eligible to receive share-settled awards after the Transfer. Except for the Chairman of the Board of Directors, other non-executive members of the Board of Directors and consultants are no longer eligible to receive share-settled awards.
Stock Options
Subject to the terms and provisions of the Plan, stock options to purchase our ordinary shares may be granted to eligible individuals at any time and from time to time as determined by our Board of Directors. Stock options may be granted as ISOs, which are intended to qualify for favorable treatment to the recipient under U.S. federal tax law, or as nonqualified stock options, which do not qualify for this favorable tax treatment. Subject to the limits provided in the Plan, our Board of Directors has the authority to determine the number of stock options granted to each recipient. Each stock option award is evidenced by a stock option agreement that specifies the stock option exercise price, whether the stock options are intended to be incentive stock options or nonqualified stock options, the duration of the stock options, the number of shares to which the stock options pertain, and such additional limitations, terms and conditions as our Board of Directors may determine.
Our Board of Directors determines the exercise price for each stock option granted, except that the stock option exercise price may not be less than 100% of the fair market value of an ordinary share on the date of grant. All stock options granted under the Plan expire no later than 10 years from the date of grant. Stock options are nontransferable except by will or by the laws of descent and distribution or, in the case of nonqualified stock options, as otherwise expressly permitted by our Board of Directors. The granting of a stock option does not accord the recipient the rights of a shareholder, and such rights accrue only after the exercise of a stock option and the registration of ordinary shares in the recipient’s name. Following the Transfer, stock options may only be granted if the Company’s shareholders specifically authorize the Board of Directors to make such grants. As of the date of this annual report, we have not requested such shareholders’ authorization, but may do so at a future date.
Stock Appreciation Rights
The Company's senior management may grant SARs under the Plan. SARs may be “tandem SARs,” which are granted in conjunction with a stock option, or “free-standing SARs,” which are not granted in conjunction with a stock option. A SAR entitles the holder to receive from us, upon exercise, an amount equal to the excess, if any, of the aggregate fair market value of a specified number of our ordinary shares to which such SAR pertains over the aggregate exercise price for the underlying shares. The exercise price of a free-standing SAR may not be less than 100% of the fair market value of an ordinary share on the date of grant.
A tandem SAR may be granted at the grant date of the related stock option. A tandem SAR may be exercised only at such time or times and to the extent that the related stock option is exercisable and has the same exercise price as the related stock
-66-


option. A tandem SAR terminates or is forfeited upon the exercise or forfeiture of the related stock option, and the related stock option terminates or is forfeited upon the exercise or forfeiture of the tandem SAR.
Each SAR is evidenced by an award agreement that specifies the exercise price, the number of ordinary shares to which the SAR pertains and such additional limitations, terms and conditions as the Company's senior management may determine. We may make payment of the amount to which the participant exercising the SARs is entitled by delivering ordinary shares, cash or a combination of stock and cash as set forth in the award agreement relating to the SARs. SARs are not transferable except by will or the laws of descent and distribution or, with respect to SARs that are not granted in “tandem” with a stock option, as expressly permitted by the Company’s senior management.
Following the Transfer, the power to make new grants of free-standing SARs and set the terms of free-standing SARs are as described above under “Administration” with respect to cash-settled awards. No tandem SARs may be granted unless the shareholders specifically authorize the Board of Directors to make grants of stock options, as described above under “Stock Options”.
Restricted Stock
The Plan provides for the award of ordinary shares that are subject to forfeiture and restrictions on transferability to the extent permitted by applicable law and as set forth in the Plan, the applicable award agreement and as may be otherwise determined by our Board of Directors. Except for these restrictions and any others imposed by our Board of Directors to the extent permitted by applicable law, upon the grant of restricted stock, the recipient will have rights of a shareholder with respect to the restricted stock, including the right to vote the restricted stock and to receive all dividends and other distributions paid or made with respect to the restricted stock on such terms as set forth in the applicable award agreement. During the restriction period set by our Board of Directors, the recipient is prohibited from selling, transferring, pledging, exchanging or otherwise encumbering the restricted stock to the extent permitted by applicable law.
Following the Transfer, under the terms of the French Commercial Code, the Company is no longer permitted to grant restricted stock.
Restricted Stock Units (RSUs)
The Plan authorizes our Board of Directors to grant RSUs. RSUs are not ordinary shares and do not entitle the recipient to the rights of a shareholder, although the award agreement may provide for rights with respect to dividend equivalents. The recipient may not sell, transfer, pledge or otherwise encumber RSUs granted under the Plan prior to their vesting. RSUs may be settled in cash, ordinary shares or a combination thereof as provided in the applicable award agreement, in an amount based on the fair market value of an ordinary share on the settlement date.
Following the Transfer, the Board of Directors has exclusive power to make new grants of RSUs and set their terms, in accordance with the French Commercial Code and as described above under “Administration” and “Eligibility”.
Performance-Based Restricted Stock Units (PSUs)
The Plan authorizes the Board of Directors to grant PSUs. The value of a PSU is conditioned upon the achievement of performance goals set by our Board of Directors in granting the PSUs and may be paid in cash, ordinary shares, other property or a combination thereof. Each PSU award is evidenced by an award agreement, which may contain terms relating to the termination of a participant’s employment.
Following the Transfer, the Board of Directors has exclusive power to make new grants of PSUs and set their terms, in accordance with the French Commercial Code and as described above under “Administration” and “Eligibility”.
Other Stock-Based Awards
The Plan provides for the award of ordinary shares and other awards that are valued by reference to our ordinary shares, including unrestricted stock, dividend equivalents and convertible debentures.
Following the Transfer, grants of other stock-based awards may only be made in accordance with the French Commercial Code.
-67-


Performance Goals
The Plan provides that performance goals may be established by our Board of Directors in connection with the grant of any award under the Plan.
Termination without Cause following a Change in Control
The Company has a double trigger in place for its awards. Upon a termination of employment by the Company without “cause” (as defined in the Plan) of a plan participant occurring upon or during the two years immediately following the date of a “change in control”, unless otherwise provided in the applicable award agreement, (i) all awards held by such participant will vest in full (in the case of any awards that are subject to performance goals, at target) and be free of restrictions, and (ii) any option or SAR held by the participant as of the date of the change in control that remains outstanding as of the date of such termination of employment may thereafter be exercised until (A) in the case of ISOs, the last date on which such ISOs would otherwise be exercisable or (B) in the case of nonqualified options and SARs, the later of (x) the last date on which such nonqualified option or SAR would otherwise be exercisable and (y) the earlier of (I) the second anniversary of such change in control and (II) the expiration of the term of such nonqualified option or SAR. With respect to new share-settled awards made following the Transfer, the Company’s ability to deliver shares is subject to the minimum vesting and, if applicable, holding period requirements set forth under the French Commercial Code, as described below.
Application of the French Commercial Code
Following the Transfer, the French Commercial Code applies to new share-settled awards and requires in particular that:
awards be made by the Board of Directors, pursuant to an authorization of the shareholders which may be valid for a maximum of up to 38 months;
the total number of shares subject to outstanding awards plus shares subject to a mandatory holding condition under French tax law (if any) may not exceed 10% of share capital, as measured on the relevant grant date;
only officers (including the CEO), the Chairman of the Board of Directors and employees are eligible to receive share-settled awards (as described above under “Eligibility”); and
persons holding more than 10% of the Company's share capital prior to grant or as a result of the award are ineligible.
Pursuant to the French Commercial Code, awards are subject to a two-year minimum vesting period, or a one-year minimum vesting period followed by a mandatory one-year holding period, subject in both cases to exceptions for death and disability. The foregoing requirement pursuant to the French Commercial Code is satisfied with respect to awards under the Plan, which are subject to a minimum 36-month vesting period.
Amendments
Our Board of Directors or our Human Resources and Remuneration Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation will be made that would materially impair the rights of a participant with respect to a previously granted award without such participant’s consent, unless such an amendment is made to comply with applicable law, including, without limitation, Section 409A of the Code, stock exchange rules or accounting rules. In addition, no such amendment will be made without the approval of the Company’s shareholders to the extent such approval is required by applicable law or the listing standards of the applicable stock exchange.
2020 Long-Term Incentive Plan
Despite the difficulties posed to the business by the COVID-19 pandemic, the Company:
did not make any adjustments to any unvested or in-flight long-term incentive awards;
did not use any positive discretion upon the vesting of any long-term incentive awards;
did not shorten the vesting or shorten the performance period of any long-term incentive awards;
did not grant any retention awards, one-time special awards or replacement awards for long-term incentive awards which did not vest;
did not change the long-term incentive award design by adjusting the long-term incentive mix or by increasing the amount or percentage of time-vested awards;
reduced the value of all 2020 Long-Term Incentive Plan grants by 30%.
-68-


The 2020 Long-Term Incentive Plan (which we refer to as the “2020 LTIP”) had mainly the same plan design as the 2017-2019 Long-Term Incentive Plans. For our executive officers, as well as for other selected employees, awards consisted of PSUs and RSUs. These awards were granted on April 7, 2020, and are subject to a three-year cliff vesting period, subject to the participant’s continued service through the applicable vesting date, and for PSUs, certain market-related performance conditions being satisfied. For other selected employees, awards consisted of RSUs only.
With regard to PSUs, for the purposes of computing the Constellium Total Shareholder Return (the “Constellium TSR”), (i) the stock price at the beginning of the performance period is deemed to be the average closing share price for the 20 trading days preceding the grant date, and (ii) the stock price at the end of the performance period is deemed to be the average closing share price for the 20 trading days preceding the third anniversary of the grant date. Constellium measures itself against a peer group consisting of the S&P MidCap 400 Materials Index and the S&P SmallCap 600 Materials Index (the “Comparator Group”), which represents approximately 60 constituents. The 20-day average starting point of a Constellium share for the April 7, 2020 grant date is $5.61. The level of achievement shall be determined by comparing the Constellium TSR to the average of the TSRs of the two indices indicated above as follows:
If the Constellium TSR is below the average of the two 25th percentile TSRs of the Comparator Group, no PSUs will vest
If the Constellium TSR is at the average of the two 25th percentile TSRs of the Comparator Group, 25% of the target PSUs will vest
If the Constellium TSR is at the average of the two median TSRs of the Comparator Group, 100% of the target PSUs will vest
If the Constellium TSR is between the average of the two 25th percentile TSRs and the average of the two median TSRs of the Comparator Group, then the number of PSUs will be determined by linear interpolation on a straight line basis (between 25% and 100%)
If the Constellium TSR is at or above the average of the two 75th percentile TSRs of the Comparator Group, 200% of the target PSUs will vest
If the Constellium TSR is between the average of the two median TSRs and the average of the two 75th percentile TSRs of the Comparator Group, then the number of PSUs will be determined by linear interpolation on a straight line basis (between 100% and 200%)
If the Constellium TSR is negative, the number of PSUs that vest will be capped at 100% of target

Consistent with the 2018 and 2019 Long-Term Incentive Plans (the “2018 LTIP” and the “2019 LTIP”), the 2020 LTIP contains a double trigger with respect to the vesting of RSUs and PSUs upon a change in control (i.e. shares do not automatically vest upon a change in control, as vesting requires two triggers: (i) change in control as well as (ii) termination of employment without cause or voluntary termination for good reason). In the event of such a double trigger being applied at any time prior to vesting, unvested RSUs and PSUs will be converted into cash-denominated rights that vest on the date of employment termination. For both RSUs and PSUs, the reference date for the share price will be the date immediately preceding the change in control. For PSUs, the rights will be based on the higher of (I) the base amount (i.e., at target) or (II) the measured TSR on the reference date.
For the 2020 LTIP, 1,049,839 PSUs at target (which can become 2,099,678 shares at maximum) and 910,047 RSUs were granted on April 7, 2020. Under the 2020 LTIP, 99 participants were granted both PSUs and RSUs and an additional 108 participants were granted RSUs only. On December 31, 2020, 1,003,712 PSUs at target (which can become 2,007,424 shares at maximum) and 876,764 RSUs were outstanding. Under the 2020 LTIP, 96 participants held both PSUs and RSUs and an additional 102 participants held RSUs only.
For the 2019 LTIP, 1,028,342 PSUs at target (which can become 2,056,684 shares at maximum) and 899,926 RSUs were granted on April 1, 2019. Under the 2019 LTIP, 101 participants were granted both PSUs and RSUs and an additional 99 participants were granted RSUs only. On December 31, 2020, 954,831 PSUs at target (which can become 1,909,662 shares at maximum) and 830,850 RSUs were outstanding. Under the 2019 LTIP, 94 participants held both PSUs and RSUs and an additional 82 participants held RSUs only.
For the 2018 LTIP, 701,109 PSUs at target (which can become 1,402,218 shares at maximum) and 587,687 RSUs were granted on May 25, 2018. Under the 2018 LTIP, 90 participants were granted both PSUs and RSUs and an additional 74 participants were granted RSUs only. On December 31, 2020, 635,784 PSUs at target (which can become 1,271,568 shares at maximum) and 524,297 RSUs were outstanding. Under the 2018 LTIP, 78 participants held both PSUs and RSUs and an additional 56 participants held RSUs only.
-69-


Employment and Service Arrangements
Constellium is party to employment or services agreements with each of its officers. In general, Constellium may terminate its officers’ employment or services for “cause” upon advance written notice, without compensation, for certain acts of the officer. Each officer may terminate his or her employment at any time upon advance written notice to Constellium. In the event that the officer’s employment or services is terminated by Constellium without cause or, in the case of certain executives, by him for “good reason,” the officer is entitled to certain payments as provided by applicable laws or collective bargaining agreements or as otherwise provided under the applicable employment or services agreements. Except for the foregoing, our officers are not entitled to any severance payments upon the termination of their employment or services for any reason.
Under such employment and services agreements, each of the officers has also agreed not to engage or participate in any business activities that compete with Constellium or solicit its employees or customers for (depending on the officer) up to two years after the termination of the employment or services. The officers have further agreed not to use or disseminate any confidential information concerning Constellium as a result of performing their duties or using Constellium resources during their employment or services.
Contracts with certain of our executive officers are described below.
Employment Agreement with Jean-Marc Germain
Jean-Marc Germain's employment agreement is dated April 25, 2016. The employment agreement with Mr. Germain provides for an annual base salary of $1,085,000 per year until March 31, 2020. Mr. Germain's salary was temporarily decreased to $759,500 per year from April 1, 2020 until September 30, 2020, based on a voluntary salary reduction of 30% in response to the COVID-19 pandemic. On October 1, 2020, Mr. Germain's salary was raised to $1,115,000 per year, inclusive of his merit increase for 2020. The employment agreement also provides for a target annual bonus of 120% of base salary (equal to $1,338,000), and a maximum annual bonus of 180% of base salary (equal to $2,007,000). In addition, as described above, Mr. Germain was granted the following equity awards in April 2020: (1) 312,481 PSUs (which can become a maximum of 624,962 shares) and (2) 159,404 RSUs. The PSUs vest on the third anniversary of the grant date, subject to continued service and certain market-related performance conditions being satisfied, and have a vesting range of 0-200%. RSUs vest 100% on the third anniversary of the date of grant, subject to continued service.
If Mr. Germain is terminated without “cause” or he resigns for “good reason” (each as defined in the employment agreement), he will be entitled to receive, subject to his execution and non-revocation of a general release of claims, cash severance in an amount equal to the product of (1) one (two, if such termination occurs within the 12-month period following a “change in control” (as defined in the employment agreement)) multiplied by (2) the sum of his base salary and target annual bonus, which severance will be payable over the 12-month (24-month, in the case of a termination within the 12-month period following a change in control) period following his termination of employment. The employment agreement also includes a perpetual confidentiality covenant, a perpetual mutual non-disparagement covenant, and 12-month post-termination non-competition and non-solicitation covenants.
Employment Agreement with Peter Matt
Peter Matt's employment agreement is dated as of October 26, 2016. The employment agreement with Mr. Matt provides for an annual base salary of $650,000 per year until March 31, 2020. Mr. Matt's salary was decreased to $552,500 per year from April 1, 2020, until September 30, 2020, based on a voluntary salary reduction of 15% in response to the COVID-19 pandemic. On October 1, 2020, Mr. Matt's salary was raised to $700,000 per year, inclusive of his merit increase for 2020. The employment agreement also provides for a target annual bonus of 90% of base salary (equal to $630,000), and a maximum annual bonus of 135% (equal to $945,000) of base salary. In addition, Mr. Matt was granted the following equity awards in April 2020: (1) 109,791 PSUs (which can become a maximum of 219,582 shares) and (2) 56,007 RSUs. The PSUs vest on the third anniversary of the grant date, subject to continued service and certain market-related performance conditions being satisfied, and have a vesting range of 0-200%. RSUs vest 100% on the third anniversary of the date of grant, subject to continued service.
If Mr. Matt is terminated without “cause” or he resigns for “good reason” (each as defined in the employment agreement), he will be entitled to receive, subject to his execution and non-revocation of a general release of claims, (1) cash severance in an amount equal to the sum of his annual base salary, target annual bonus and vacation pay (multiple of 1 year) and (2) six months of continued welfare benefits. The employment agreement also includes a perpetual confidentiality covenant and 12-month post-termination non-competition and non-solicitation covenants. If Mr. Matt’s employment is terminated without “cause”,
-70-


Mr. Matt will be offered an additional amount equal to 50% of the sum of his annual base salary, target annual bonus, and vacation pay (multiple of 1.5 years) in consideration for his agreeing to not compete.
C. Board Practices
Our Board of Directors currently consists of 10 directors, less than a majority of whom are citizens or residents of the United States. In 2020, the Board held five regular meetings, and a number of additional meetings on matters regarding the COVID-19 pandemic and strategic initiatives with almost 100% director attendance at all meetings.
Upon the effectiveness of the Transfer, the Company ceased to be governed by the laws of the Netherlands and its pre-Transfer governing documents but instead became governed by the laws of France and the Articles of Association that became effective upon the Transfer. The Transfer resulted in changes to the rights of shareholders and the governance of the Company.
Directors
In France, a company organized as a "Societas Europaea" can have a two-tier board structure: a management board comprising managing directors (Directoire) and a supervisory board comprising the non-executive directors (Conseil de Surveillance), or a single-tier board of directors (Conseil d’Administration). The single-tier board of directors of such French company will be comprised of non-executive directors and, if any, executive directors (see “Management” below).
Under French law, the board of directors supervises the management of the executive officers, sets the guidelines for the company’s activities and oversees their implementation. Subject to the powers expressly assigned by law to the shareholders’ meetings and within the limit of the corporate purpose, it hears any issue relevant to the company’s smooth operation and, by means of its deliberations, settles the matters of concern to it, taking into consideration the social and environmental impact of the company's activity. The board of directors proceeds with the controls and checks what it deems advisable. Moreover, the board of directors exercises the special powers conferred on it by law.
We currently have a one tier Board of Directors consisting of one executive director (the CEO) and nine non-executive directors. For a listing of the current terms of service of our Directors, see “A. Directors and Senior Management” above.
Under French law, each director has a duty towards the company to properly perform his/her duties. Furthermore, each director has a duty to act in the corporate interest of the company.
The corporate interest extends to the interests of all corporate stakeholders, such as shareholders, creditors, employees, customers and suppliers.
In its relations with third parties, the company shall be bound even by the decisions of the board of directors that do not come under the corporate purpose, unless the company can prove that the third party knew that the decision exceeded that purpose or that it could not have been unaware of this in light of the circumstances; publication of the articles of association alone does not constitute sufficient proof.
Any board resolution regarding a change in the company’s Articles of Association requires shareholders’ approval. The board of directors may decide in its sole discretion, within the confines of French law and the Articles of Association, to incur additional indebtedness subject to any contractual restrictions pursuant to existing financing arrangements.
There is no obligation for directors to hold shares in the company unless required by the articles of association. According to our Articles of Association, there is no such obligation.
Management
Following the Transfer, our Board of Directors has maintained the separation of the functions of Chairman of the Board of Directors (Président du conseil d’administration) and Chief Executive Officer (Directeur Général).
The Chief Executive Officer is appointed by the board of directors and may (but is not required to) be a director. He or she is vested with the broadest powers to act in all circumstances in the company's name. He or she exercises his or her powers within the scope of the corporate purpose and subject to those that the law expressly assigns to shareholders' meetings and the board of directors.
-71-


He or she represents the company in its relations with third parties. The company is bound by the actions of its Chief Executive Officer, even if such actions are not in line with the corporate purpose, unless it can be proven that the third party knew that the decision exceeded that purpose or that it could not have been aware of this in light of the circumstances; publication of the articles of association alone does not constitute sufficient proof.
According to our Articles of Association, our Chief Executive Officer shall not be more than seventy (70) years of age. If our Chief Executive Officer reaches that age limit, he or she shall be considered to have resigned. However, his or her term of office shall be extended until the next meeting of the Board of Directors during which a new Chief Executive Officer shall be appointed.
On a proposal made by the Chief Executive Officer, the Board of Directors may appoint one or more natural persons to assist the Chief Executive Officer as Deputy Chief Executive Officer(s) (Directeur Général Délégué), who may (but are not required to) be Directors. The Chief Executive Officer and, if any, the Deputy Chief Executive Officer(s) would be the executive corporate officers ("mandataires sociaux dirigeants"), under French law.
In agreement with the Chief Executive Officer, the Board of Directors shall define the scope and duration of the powers conferred on the Deputy Chief Executive Officer(s). The Board of Directors shall define such Deputy Chief Executive Officer’s additional compensation. If a Deputy Chief Executive Officer is a director, his or her duties as Deputy Chief Executive Officer cannot outlast his or her directorship.
With regard to representation vis-à-vis third parties, Deputy Chief Executive Officers may have the same powers as the Chief Executive Officer. The number of Deputy Chief Executive Officers may not exceed five at the same time.
Director Terms and Remuneration
Under French law, a director of a company is appointed for a maximum term of six years. In practice, the articles of association set the directors’ precise term. According to our Articles of Association, the term of office of a Director is of three (3) years and can be renewed without limitation. Directors may be appointed for a shorter term so that the renewal of the Directors’ terms of office may be spread out over time. According to our Articles of Association, the number of Directors who are more than seventy-five (75) years old may not exceed one third of the directors in office.
The board of directors determines the remuneration of executive directors (i.e. the CEO (“Directeur Général”) and, if any, Deputy Chief Executive Officers (“Directeurs Généraux Délégués”), who may (but are not required to) be directors). French law does not provide for any specific rules on remuneration of executive directors for French companies not listed on a EU-regulated market. Executive directors may be granted free shares and stock options of the Company.
With respect to the remuneration of non-executive directors, the ordinary shareholders’ meeting votes an envelope of fixed annual fees to be allocated to directors for each year. The board of directors will then decide the allocation of these fees among directors. These fees include all cash remunerations granted to directors in such capacity. Non-executive directors may not be granted any share-settled awards (such as free shares or stock options) in such capacity. In addition to the fixed amount of fees approved at the shareholders meeting, the board of directors may grant fees to the chairman of the board in such capacity, and may also, exceptionally, grant additional fees to certain directors in remuneration for separate, specific missions or tasks assigned to them. Non-executive directors are not eligible to receive awards that are to be settled with shares. However, the board of directors may grant share-settled awards (such as free shares or stock options) to the chairman of the board in such capacity.
Removal of Directors
Under French law, directors may be removed from office, with or without cause, at any shareholders’ meeting without notice or justification, by a simple majority vote of shareholders.
Directors cannot be suspended or removed by the board of directors.
An executive corporate officer appointed by the board of directors (CEO (Directeur Général) or, if any, deputy chief executive officer (Directeur Général Délégué)) can have his or her executive duties suspended at any time by the board of directors. If such executive corporate officer is also a director, he or she will remain non-executive director as his or her duties as a director can only be removed by a shareholders’ meeting.
Director Election and Vacancies
-72-


Under French law, new members of the board of directors of a company are appointed by the general meeting of shareholders by a simple majority. The board of directors which convenes the shareholders' meeting proposes candidates; shareholders may also propose candidates under certain conditions. The shareholders at the meeting may vote for other candidates than those proposed on the agenda, by a simple majority.
Vacancies on the board of directors occurring between shareholders’ meetings may be filled at a board meeting by a majority of the remaining directors, subject to ratification at the next shareholders’ meeting.
Conflict of Interest Transactions
Pursuant to French law and the Articles of Association, any agreement between (directly or through an intermediary) a company and any of its directors, its executive corporate officers (“Directeur Général” or any “Directeur Général Délégué”), its shareholders holding more than 10% of its voting rights or companies controlling such shareholders, that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions, is subject to a prior authorization of the board of directors, excluding the participation and vote of the interested director. Such agreement is also subject to approval at the next ordinary shareholders’ meeting (by a simple majority), excluding the votes of any interested persons. The foregoing requirements also apply to agreements between the company and another entity if one of the company’s directors, or executive corporate officers (“Directeur Général” or any “Directeur Général Délégué”) is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the company’s directors, executive corporate officers (“Directeur Général” or any “Directeur Général Délégué”), shareholders holding more than 10% of its voting rights or companies controlling such shareholders has an indirect interest. If the transaction has not been pre-approved by the board of directors, it can be nullified if it has prejudicial consequences for the company. If an agreement is not then approved by the shareholders, the interested person may be held liable for any prejudicial consequences for the company of the unapproved transaction; such transaction will nevertheless remain valid unless it is nullified in case of fraud. Aside from the above rule, there are no specific provisions prohibiting conflicted directors to participate or vote at board meetings. However, as a general rule, directors must act in the interest of the company.
Action by Written Consent and Quorum Requirements
According to French law and the Articles of Association, certain decisions of the Board of Directors may be adopted in writing. These decisions include interim appointment of directors, authorization of certain security interests and guarantees, amendment of the articles of association to comply with legal provisions, convening of shareholder meetings and decisions to transfer the registered office within the same department. According to French law and our Articles of Association, a director may grant to another director a proxy to represent him or her at a meeting of the board of directors. No director can hold more than one proxy at any meeting.
According to French law and the Articles of Association, for the board’s deliberations to be valid, more than half of the board members must be present or represented. The board of directors’ decisions shall be taken by a majority vote; if the votes are tied, the chairman’s vote shall be decisive.
Board Composition and Diversity
According to Article L. 225-17 of the French Commercial Code, the appointment of members of the board of directors must seek to achieve a balanced representation of men and women. In addition, if the number of permanent employees of the company exceeds 1,000 (including its direct and indirect French subsidiaries) or 5,000 (including its direct and indirect subsidiaries worldwide) for two consecutive fiscal years, an amendment of the articles of association may be required for the board of directors to include at least two directors representing the employees (in companies having more than eight directors) or at least one director representing the employees (in companies having no more than eight directors).
Chairman of the Board
Pursuant to French law, companies with a single-tier board of directors can choose between the separation of functions of the chairman of the board of directors (Président du conseil d'administration) and chief executive officer (Directeur Général) of the company and the aggregation of such duties. According to our Articles of Association, our Board of Directors can decide to or not to separate the functions of the Chairman of the Board of Directors and Chief Executive Officer.
Under French law, the board of directors elects a chairman among its members who must be a natural person. The board of directors determines the term of office of the chairman, which cannot exceed his or her tenure as director, and may revoke him or her at any time.
-73-


The chairman organizes and directs the work of the board of directors, on which he or she reports to the general shareholders’ meeting, and ensures the proper functioning of the corporate bodies and, in particular, that the directors are able to fulfill their mission.
According to our Articles of Association, our Chairman of the Board cannot be older than seventy-five (75) years. If our Chairman of the Board reaches this age limit during his or her term as Chairman, he or she is automatically deemed to have resigned from his or her directorship. His or her mandate would extend however, until the next meeting of the Board of Directors during which his or her successor is appointed. Subject to this provision, the Chairman of the Board is always eligible for re-election.
Director Independence
Under French law, there are no director independence requirements for French companies not listed on an EU-regulated market, so we defer to the NYSE requirements. As a foreign private issuer under the NYSE rules, we are not required to have independent Directors on our Board, except to the extent that our Audit Committee is required to consist of independent Directors. However, our Board has determined that, under current NYSE listing standards regarding independence (which we are not currently subject to), and taking into account any applicable committee standards, as of December 31, 2020, Messrs. Evans, Brandjes, Hartman, Maugis, Ormerod, Paschke and Mmes. Walker, Brooks and Frachet are deemed independent directors. Under these standards, Mr. Germain is not deemed independent as he serves as the CEO of the Company.
Committees
Under French law, the board of directors may appoint, from within, one or more special committees, of which it sets the composition and powers and which carry out their activity under its responsibility. Each committee shall report on its missions at meetings of the board of directors. Our Board of Directors has currently four committees: the Audit Committee, the Human Resources and Remuneration Committee, the Nominating and Governance Committee and the Environment, Health and Safety Committee.
Audit Committee
As of December 31, 2020, our Audit Committee consisted of four independent directors under the NYSE requirements: Lori Walker (Chair), Martha Brooks, John Ormerod and Werner Paschke. Our Board has determined that at least one member is an “audit committee financial expert” as defined by the SEC and also meets the additional criteria for independence of audit committee members set forth in Rule 10A-3(b)(1) under the Exchange Act. The Audit Committee held 10 meetings in 2020, with 100% director attendance at all meetings.
The principal duties and responsibilities of our Audit Committee are to oversee and monitor the following:
our financial reporting process and internal control system;
the integrity of our consolidated financial statements;
the independence, qualifications and performance of our independent registered public accounting firm;
the performance of our internal audit function; and
our compliance with legal, ethical and regulatory matters.
Human Resources and Remuneration Committee
As of December 31, 2020, our Human Resources and Remuneration Committee consisted of four directors: Martha Brooks (Chair), Richard Evans, Peter Hartman and Guy Maugis. The Human Resources and Remuneration Committee held 4 meetings in 2020, with 100% director attendance at all meetings.
The principal duties of our Human Resources and Remuneration Committee are as follows:
to provide oversight concerning selection of officers, management succession planning, expense accounts, indemnification and insurance matters, and separation packages;
to review the peer groups and criteria for benchmarking used to assess performance and compensation levels;
to review, evaluate and make recommendations to the full Board regarding our compensation policies and establish performance-based incentives that support our long-term goals, objectives and interests;
-74-


to review and make recommendations to the Board with respect to our incentive compensation plans and equity-based compensation plans;
to review and approve the compensation of our Chief Executive Officer, and the compensation structure for all employees who report directly to our Chief Executive Officer;
to set and review the compensation of and reimbursement policies for members of the Board;
to provide regular reports to the Board and take such other actions as are necessary and consistent with our Articles of Association.
Nominating and Governance Committee
As of December 31, 2020, our Nominating and Governance Committee consisted of four directors: Richard Evans (Chair), Michiel Brandjes, John Ormerod, and Lori Walker. The Nominating and Governance Committee held 7 meetings in 2020, with 100% director attendance at all meetings.
The principal duties and responsibilities of the Nominating and Governance Committee are as follows:
to establish criteria for Board and committee membership and recommend to our Board proposed nominees for election to the Board and for membership on committees of our Board;
to make recommendations to our Board regarding board governance matters and practices;
to oversee the annual self-assessment of the Board and its committees; and
to review conflicts of interest, related party matters and director independence.
Environment, Health and Safety Committee
As of December 31, 2020, our Environment, Health and Safety Committee consisted of three directors: Guy Maugis (Chair), Michiel Brandjes and Peter Hartman. The Environment, Health and Safety Committee held 2 meetings in 2020, with 100% director attendance at all meetings.
The principal duties and responsibilities of the Environment, Health and Safety Committee are to review and monitor the following:
the Company’s policies, practices and programs with respect to the management of EHS affairs, including sustainability;
the adequacy of the Company’s policies, practices and programs for ensuring compliance with EHS laws and regulations; and
any significant EHS litigation and regulatory proceedings in which the Company is or may become involved.
D. Employees
As of December 31, 2020, we employed approximately 12,000 employees, including approximately 700 fixed-term contractors as well as approximately 400 temporary employees. Approximately 90% of our employees were engaged in production and maintenance activities and approximately 10% were employed in support functions. Approximately 36% of our permanent employees were employed in France, 27% in the United States, 21% in Germany, 6% in Switzerland, and 10% in Eastern Europe and other regions, which percentages are comparable to the distribution of employees geographically in 2019.
A vast majority of non-U.S. employees and approximately 53% of U.S. employees are covered by collective bargaining agreements. These agreements are negotiated on site, regionally or on a national level, and are of different durations.
E. Share Ownership
Information with respect to share ownership of members of our Board of Directors and our senior management is included in “Item 7. Major Shareholders and Related Party Transactions.”
Equity Incentive Plans
The Company has adopted the Constellium 2013 Equity Plan and the 2020 LTIP thereunder pursuant to which certain of our directors, executive officers, employees, and consultants are eligible to receive equity awards. See “—Constellium SE 2013 Equity Incentive Plan” and “—2020 Long-Term Incentive Plan” above.
-75-


Item 7. Major Shareholders and Related Party Transactions
A. Major Shareholders
The following table sets forth the major shareholders of Constellium SE as known by us or ascertained from public filings made by our major shareholders (each person or group of affiliated persons who is known to be the beneficial owner of more than 5% of ordinary shares) and the number and percentage of ordinary shares owned by each such shareholder, in each case as of March 12, 2021.
Under the rules of the SEC, a person is deemed to be a “beneficial owner” of a security if that person has or shares “voting power,” which includes the power to vote or to direct the voting of such security, or “investment power,” which includes the power to dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60 days. Under these rules, more than one person may be deemed to be a beneficial owner of such securities as to which such person has voting or investment power.
The beneficial ownership percentages in this table have been calculated on the basis of the total number of ordinary shares.
Name of beneficial owner
Number of
ordinary
shares
Beneficial
ownership
percentage
T. Rowe Price Associates, Inc. 17,374,741  (1) 12.4  %
Caisse des Dépôts (f/k/a Caisse des Dépôts et Consignations),
Bpifrance Participations S.A., Bpifrance S.A. (f/k/a BPI-Groupe), EPIC Bpifrance (f/k/a EPIC BPI-Groupe)
16,393,903  (2) 11.7  %
Janus Henderson Group plc 7,579,444  (3) 5.4  %
Directors and Senior Management
Richard B. Evans 252,434  (4) *
Guy Maugis 31,226  (5) *
Werner P. Paschke 107,201  (6) *
Michiel Brandjes 43,749  (7) *
Peter F. Hartman 28,221  (8) *
John Ormerod 21,758  (9) *
Lori A. Walker 30,481  (10) *
Martha Brooks 57,973  (11) *
Stéphanie Frachet —  (12) *
Jean-Marc Germain 654,424  (13) *
Peter R. Matt 331,949  (14) *
Ingrid Joerg 193,121  (15) *
Peter Basten 139,025  (16) *
Philippe Hoffmann 25,306  (17) *
__________________
*Represents beneficial ownership of less than 1%.
(1)This information is based on a Schedule 13G/A filed with the SEC on February 16, 2021 reporting beneficial ownership as of December 31, 2020. T.Rowe Price Associates, Inc. has sole dispositive power with respect to 17,374,741 ordinary shares and sole voting power with respect to 4,776,073 ordinary shares. The principal business address of T.Rowe Price Associates, Inc. is 100 E. Pratt Street, Baltimore, MD 21202.
(2)This information is based on a Schedule 13D/A filed with the SEC on November 8, 2017, which share amount is reconfirmed in a Form 13F dated February 12, 2021. Bpifrance Participations S.A. (f/k/a Fonds Stratégique d'Investissement, “Bpifrance”) is a French public investment fund specializing in the business of equity financing via
-76-


direct investments or fund and a wholly owned subsidiary of Bpifrance S.A., a French financial institution (“Bpifrance S.A.”). Caisse des Dépôts (“CDC”) and EPIC Bpifrance (“EPIC”) each hold 50% of the share capital of Bpifrance S.A. and jointly control Bpifrance S.A. CDC is principally engaged in the business of long-term investments. EPIC is principally engaged in the business of banking finance. Bpifrance holds directly 16,393,903 ordinary shares of the Company. As of the date hereof, neither Bpifrance S.A., CDC nor EPIC holds any ordinary shares directly. Bpifrance S.A. may be deemed to be the beneficial owner of 16,393,903 ordinary shares of the Company, indirectly through its sole ownership of Bpifrance. CDC and EPIC may be deemed to be the beneficial owners of 16,393,903 ordinary shares of the Company, indirectly through their joint ownership and control of Bpifrance S.A. The principal address for CDC is 56, rue de Lille, 75007 Paris, France and for Bpifrance, Bpifrance S.A. and EPIC is 27-31 avenue du Général Leclerc, 94700 Maisons-Alfort, France.
(3)This information is based on a Schedule 13G filed with the SEC on February 12, 2021 reporting beneficial ownership as of December 31, 2020. Janus Henderson Group plc has shared dispositive power with respect to 7,579,444 ordinary shares and shared voting power with respect to 7,579,444 ordinary shares. Janus Henderson has an indirect 97% ownership stake in Intech Investment Management LLC (“Intech”) and a 100% ownership stake in Janus Capital Management LLC (“JCM”), Perkins Investment Management LLC (“Perkins”), Henderson Global Investors Limited (“HGIL”) and Janus Henderson Investors Australia Institutional Funds Management Limited (“JHIAIFML”), (each an “Asset Manager” and collectively as the “Asset Managers”). Due to the above ownership structure, holdings for the Asset Managers are aggregated for purposes of this filing. Each Asset Manager is an investment adviser registered or authorized in its relevant jurisdiction and each furnishing investment advice to various fund, individual and/or institutional clients (collectively referred to herein as “Managed Portfolios”). Janus Henderson Contrarian Fund is one of the Managed Portfolios to which JCM provides investment advice and was the beneficial owner of 7,523,036 ordinary shares. The Managed Portfolios have the right to receive all dividends from, and the proceeds from the sale of, the securities held in their respective accounts. As a result of its role as investment adviser or sub-adviser to the Managed Portfolios, JCM may be deemed to be the beneficial owner of 7,579,444 ordinary shares or 5.4% of the shares outstanding of Constellium held by such Managed Portfolios. However, JCM does not have the right to receive any dividends from, or the proceeds from the sale of, the securities held in the Managed Portfolios and disclaims any ownership associated with such rights. The principal business address of Janus Henderson Group plc is 201 Bishopsgate, EC2M 3AE, United Kingdom, and the principal business address of Janus Henderson Contrarian Fund is 151 Detroit Street, Denver, Colorado 80206.
(4)Consists of 252,434 ordinary shares held indirectly by Mr. Evans through the Evans Family Inter Vivos Revocable Trust. Excludes the remaining portions of previous grants: 3,133 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,898 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
(5)Consists of 31,226 ordinary shares held directly by Mr. Maugis. Excludes the remaining portions of previous grants: 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
(6)Consists of 107,201 ordinary shares held directly by Mr. Paschke. Excludes the remaining portions of previous grants: 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
(7)Consists of 43,749 ordinary shares held directly by Mr. Brandjes. Excludes the remaining portions of previous grants: 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
(8)Consists of 28,221 ordinary shares held directly by Mr. Hartman. Excludes the remaining portions of previous grants: 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
-77-


(9)Consists of 21,758 ordinary shares held by Mr. Ormerod. Excludes the remaining portions of previous grants: 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
(10)Consists of 30,481 ordinary shares held directly by Ms. Walker. Excludes the remaining portions of previous grants: 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
(11)Consists of 35,973 ordinary shares held directly by Ms. Brooks as well as 22,000 ordinary shares held indirectly by Ms. Brooks in her husband's brokerage account for which she is the beneficiary. Excludes the remaining portions of previous grants: 2,506 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) April 1, 2021 or (ii) the date of the annual general meeting of shareholders of that year; and 1,477 ordinary shares underlying unvested RSUs that will vest on the earlier of (i) August 14, 2021 or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
(12)No ordinary shares are held directly by Ms. Frachet and no RSUs or PSUs were granted in 2020.
(13)Consists of 654,424 ordinary shares held directly by Mr. Germain. Excludes the remaining portions of previous grants: 197,531 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 100,765 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 291,219 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 148,557 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service; 312,481 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 159,404 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service.
(14)Consists of 331,949 ordinary shares held directly by Mr. Matt. Excludes the remaining portions of previous grants: 67,901 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 34,638 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 99,847 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 50,934 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service; 109,791 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 56,007 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service.
(15)Consists of 193,121 ordinary shares held directly by Ms. Joerg. Excludes the remaining portions of previous grants: 34,462 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 17,580 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 45,669 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 23,297 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service; 50,224 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 25,620 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service.
(16)Consists of 139,025 ordinary shares held directly by Mr. Basten. Excludes the remaining portions of previous grants: 34,462 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25,
-78-


2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 17,580 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 45,669 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 23,297 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service; 50,224 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 25,620 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service.
(17)Consists of 25,306 ordinary shares held directly by Mr. Hoffmann. Excludes the remaining portions of previous grants: 11,871 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on May 25, 2021, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; 11,246 ordinary shares underlying unvested RSUs that will vest on May 25, 2021, subject to continued service; 14,081 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 1, 2022, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 13,340 ordinary shares underlying unvested RSUs that will vest on April 1, 2022, subject to continued service; 14,292 ordinary shares underlying unvested PSUs that could vest ranging from 0% to 200% of target on April 7, 2023, subject to continued service and certain market-related performance conditions being satisfied at the end of the three-year vesting period; and 13,540 ordinary shares underlying unvested RSUs that will vest on April 7, 2023, subject to continued service.
None of our principal shareholders have voting rights different from those of our other shareholders.
The registrar and transfer agent for our Company reported that, as of December 31, 2020, 139,952,113 of our ordinary shares were held by 3 holders of record in the United States.
B. Related Party Transactions
Amended and Restated Shareholders Agreement and Related Transactions
The Company, Apollo Omega, Rio Tinto and Bpifrance entered into an amended and restated shareholders agreement on May 29, 2013 (the “Shareholders Agreement”). The Shareholders Agreement terminated with respect to Apollo Omega and Rio Tinto in connection with certain of their respective sales of our ordinary shares described elsewhere in this Annual Report. The Shareholders Agreement provides for, among other things, piggyback registration rights and demand registration rights for Bpifrance for so long as Bpifrance owns any of our ordinary shares.
In addition, the Shareholders Agreement provides that, except as otherwise required by applicable law, Bpifrance will be entitled to designate for binding nomination one director to our Board of Directors so long as its percentage ownership interest is equal to or greater than 4% or it continues to hold all of the ordinary shares it subscribed for at the closing of the acquisition (such share number adjusted for the pro rata share issuance). Our directors will be elected by our shareholders acting at a general meeting upon a binding nomination by the Board of Directors as described in “Item 6. Directors, Senior Management and Employees—A. Directors and Senior Management.” A shareholder’s percentage ownership interest is derived by dividing (i) the total number of ordinary shares owned by such shareholder and its affiliates by (ii) the total number of outstanding ordinary shares. The Company agreed to share financial and other information with Bpifrance to the extent reasonably required to comply with its tax, investor or regulatory obligations and with a view to keeping Bpifrance properly informed about the financial and business affairs of the Company. The Shareholders Agreement contains provisions to the effect that Bpifrance is obliged to treat all information provided to it as confidential, and to comply with all applicable rules and regulations in relation to the use and disclosure of such information. Stéphanie Frachet, was appointed as a non-executive Director of the Company in May 2018, is currently Managing Director and member of the Bpifrance Capital Development Executive Committee of Bpifrance Investissement which she joined in 2009.
Bpifrance Investissement is a subsidiary of Bpifrance, which is a wholly owned subsidiary of Bpifrance S.A. (f/k/a BPI Groupe), a French financial institution jointly owned and controlled by the Caisse des Dépôts, a French special public entity (établissement special) and EPIC Bpifrance (f/k/a EPIC BPI-Groupe), a French public institution of industrial and commercial nature. As of March 12, 2021, Bpifrance owns approximately 11.7% of the Company’s outstanding ordinary shares. In January 2015, Bpifrance Financement, an affiliate of Bpifrance Investissement and of Bpifrance, entered into a three-year revolving credit facility with Constellium Issoire (f/k/a Constellium France) for an aggregate amount of €10 million. The facility was
-79-


subject to automatic reduction of 33% of the aggregate amount per year. The facility was undrawn and in 2018 the amount available for drawing was €3.3 million, subject to a commitment fee of 1% per year. Should any amount have been drawn under this facility, it would have borne interest at a rate equal to 3 months Euribor plus 2.5%. This facility matured on January 12, 2018. On March 28, 2018, Bpifrance Financement entered into a new three-year revolving credit facility with Constellium Issoire for an aggregate amount of €10 million for the purpose of financing various investments, subject to a commitment fee of 1% per year. The maximum amount of authorized ceiling is to be reduced each quarter by €833,333.33. Any amount drawn under this facility will bear interest at a rate equal to 3 months Euribor (with a floor of 0%) plus 2.5%. The facility may be drawn upon from time to time. As of December 31, 2020, the availability under this facility amounted to €3 million and the facility was undrawn.
One of our French entities, Constellium International S.A.S., entered into a fully committed term loan facility with a syndicate of banks (the “PGE French Facility”) on May 13, 2020 for an aggregate amount of up to €180 million, of which 80% is guaranteed by the French State. Bpifrance Financement provided €30 million of the PGE French Facility. For further information on the PGE French Facility, please refer to “Item 10. Additional Information—C. Material Contracts—PGE French Facility”.
Transactions with Joint Venture
On January 10, 2019, pursuant to a purchase agreement with UACJ Corporation (“UACJ”) and its U.S. subsidiary, Tri-Arrows Aluminum Holding Inc. (“TAAH”), we acquired TAAH’s 49% stake in Constellium-UACJ ABS, LLC (“CUA”), for $100 million plus the assumption of 49% of approximately $80 million of third party debt at CUA. In connection with the agreement with UACJ and TAAH, we and TAAH agreed to certain transitional commercial arrangements connected to the continuing operations and the business, including an agreement for a multiyear supply of cold coils. See Note 11 and 33 to the Consolidated Financial Statements attached hereto starting on Page F-1 for additional information about our transactions with CUA. Following the acquisition described above, CUA was renamed Constellium Bowling Green LLC.
C. Interests of Experts and Counsel
Not applicable.
Item 8. Financial Information
A. Consolidated Statements and Other Financial Information
Our Consolidated Financial Statements as of December 31, 2020 and 2019 and for the years ended December 31, 2020, 2019 and 2018 are included in this Annual Report at “Item 18. Financial Statements.”
Legal Proceedings
Legal proceedings are disclosed in “Item 4. Information on the Company—B. Business Overview—Litigation and Legal Proceedings.”
Dividend Policy
Our Board of Directors periodically explores the potential adoption of a dividend program; however, no assurances can be made that any future dividends will be paid on the ordinary shares. Any proposal to declare and pay future dividends to holders of our ordinary shares will be at the discretion of our Board of Directors and will depend on many factors, including our financial condition, earnings, capital requirements, level of indebtedness, statutory future prospects and contractual restrictions applying to the payment of dividends and other considerations that our Board of Directors deems relevant.
Under French law, dividends are approved by the shareholders’ meeting. All calculations to determine the amounts available for dividends or other distributions will be based on our statutory financial statements which are, as a holding company, different from our consolidated financial statements and which are prepared in accordance with French GAAP because we are a French company. Dividends may only be paid by a French Societas Europaea out of “distributable profits,” plus any distributable reserves and “distributable premium” that the shareholders decide to make available for distribution, other than those reserves that are specifically required by law.
-80-


“Distributable profits” consist of the unconsolidated net profits of the relevant company for each fiscal year, as increased or reduced by any profit or loss carried forward from prior years.
“Distributable premium” refers to the contribution paid by the shareholders in addition to the par value of their shares for their subscription that the shareholders decide to make available for distribution.
Except in the case of a share capital reduction, no distribution can be made to the shareholders when the net equity is, or would become, lower than the amount of the share capital plus the reserves which cannot be distributed in accordance with the law or the by-laws.
Dividends may be paid in cash or, if the shareholders’ meeting so decides, in kind, provided that all the shareholders receive a whole number of assets of the same nature paid in lieu of cash.
Our Articles of Association provide that each shareholder may be given the choice to receive his dividend in cash or in shares subject to a decision of the shareholders’ meeting taken by ordinary resolution.
Under French law, the board of directors may distribute interim dividends after the end of the fiscal year but before the approval by the shareholders of the financial statements for the relevant fiscal year when the interim balance sheet, established during such year and certified by the auditors, reflects that the company has earned distributable profits since the close of the last fiscal year, after recognizing the necessary depreciation and provisions and after deducting prior losses, if any, and the sums to be allocated to reserves, as required by French law or articles of association, and including any retained earnings. The amount of such interim dividends may not exceed the amount of the profit so defined.
Generally, we rely on dividends paid to Constellium SE, or funds otherwise distributed or advanced to Constellium SE by its subsidiaries to fund the payment of dividends, if any, to our shareholders. In addition, restrictions contained in the agreements governing our outstanding indebtedness limit our ability to pay dividends on our ordinary shares and limit the ability of our subsidiaries to pay dividends to us. Future indebtedness that we may incur may contain similar restrictions. According to our Articles of Association, distributions payable in cash shall be approved in euros and paid (i) in euros for all the holders of shares under the French Register and (ii) in USD for all the holders of shares under the U.S. Register. For the purposes of the payment of the dividend in dollars, the general shareholders’ meeting or, as the case may be, our Board of Directors, shall set the reference date to be considered for the EUR/USD exchange rate.
Cash dividends and other distributions that have not been collected within five years after the date on which they became due and payable will revert to the French State.
We have historically not paid dividends to our shareholders.
B. Significant Changes
February 2021 Notes
On February 24, 2021, we completed a private offering of $500 million in aggregate principal amount of February 2021 Notes (the “February 2021 Notes”) pursuant to an indenture among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. Interest on the February 2021 Notes initially accrues at a rate of 3.750% per annum and is payable semi-annually on April 15 and October 15, beginning on October 15, 2021. The February 2021 Notes mature on April 15, 2029. See “Item 10. Additional Information—C. Material Contracts—February 2021 Notes” for more detail on the terms of the February 2021 Notes.
Tender Offer and Redemption of February 2017 Notes
Substantially concurrently with the launch of the February 2021 Notes Offering (as defined below), we (i) commenced a cash tender offer (the “2021 Tender Offer”) for any and all of our outstanding February 2017 Notes, and (ii) issued a notice of redemption for all of the outstanding February 2017 Notes (the “2021 Redemption”), at a redemption price equal to 101.656% of the principal amount of the February 2017 Notes redeemed plus accrued and unpaid interest, if any, to the redemption date (the “2021 Redemption Price”). Pursuant to the 2021 Tender Offer, holders of February 2017 Notes who validly tendered (and did not validly withdraw) their February 2017 Notes at or prior to 5:00 p.m., New York City time, on February 19, 2021 (such time and date, the “Expiration Time”) were eligible to receive an amount in cash equal to $1,018.25 per $1,000 principal amount of February 2017 Notes on the settlement date (the “2021 Settlement Date”), which occurred on February 24, 2021. $165,681,000 in aggregate principal amount of the February 2017 Notes were repurchased pursuant to the 2021 Tender Offer
-81-


on the Settlement Date. On March 11, 2021 (the “2021 Redemption Date”), the remaining $484,319,000 in aggregate principal amount of the February 2017 Notes were redeemed in accordance with the indenture governing the February 2017 Notes.
Substantially concurrently with the issuance of the February 2021 Notes, we satisfied and discharged (the “Satisfaction and Discharge”) the indenture governing the February 2017 Notes by depositing with the trustee for the February 2017 Notes an amount in cash sufficient to pay on the 2021 Redemption Date the 2021 Redemption Price for all February 2017 Notes not repurchased pursuant to the 2021 Tender Offer.
We used the net proceeds from the February 2021 Notes Offering, together with cash on hand, to fund the 2021 Tender Offer and the 2021 Redemption and to pay related fees and expenses.
Item 9. The Offer and Listing
A. Offer and Listing Details
Our ordinary shares are listed on the NYSE under the symbol CSTM.
B. Plan of Distribution
Not applicable.
C. Markets
We began trading on the NYSE on May 23, 2013 and on the professional segment of Euronext Paris on May 27, 2013 through a public offering in the United States. Trading on the NYSE is under the symbol “CSTM.” In February 2018, we voluntarily delisted our ordinary shares from Euronext Paris to reduce costs and complexity associated with listing in multiple jurisdictions. We continue to be listed on the NYSE. For more information on our shares see “Item 10. Additional Information—B. Memorandum and Articles of Association.”
D. Selling Shareholders
Not applicable.
E. Dilution
Not applicable.
F. Expenses of the Issue
Not applicable.
Item 10. Additional Information
A. Share Capital
Not applicable.
B. Memorandum and Articles of Association
The information called for by this Item has been reported previously under the heading “Description of Capital Stock” in the prospectus, dated as of November 13, 2020, included in Constellium SE’s Registration Statement on Form F-3 filed on November 13, 2020 (File No. 333-250089), as amended thereafter from time to time, which description is incorporated by reference into this Annual Report.
-82-


C. Material Contracts
The following is a summary of each material contract, other than material contracts entered into in the ordinary course of business, to which we are a party, for the two years immediately preceding the date of this Annual Report:
Employment Agreements and Benefit Plans. See “Item 6. Directors, Senior Management and Employees—E. Share Ownership” for a description of the material terms of our employment agreements and benefits plans.
Amended and Restated Shareholders Agreement. See “Item 7. Major Shareholders and Related Party Transactions” for a description of material terms of this contract.
Notes, Pan-U.S. ABL Facility, PGE French Facility, Swiss Facilities, German Facilities, French Inventory Facility and Factoring Agreements. As disclosed below.
May 2014 Notes
On May 7, 2014, the Company completed a private offering of $400 million in aggregate principal amount of 5.750% Senior Notes due 2024 (the “2024 U.S. Dollar Notes”) and €300 million in aggregate principal amount of 4.625% Senior Notes due 2021 (the “2021 Euro Notes,” and together with the 2024 U.S. Dollar Notes, the “May 2014 Notes”) pursuant to indentures among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. A portion of the net proceeds of the May 2014 Notes were used to repay amounts outstanding under our senior secured term loan B facility, including related transaction fees, expenses, and prepayment premium thereon. We used the remaining net proceeds for general corporate purposes, including to put additional cash on our balance sheet.
Interest on the 2024 U.S. Dollar Notes accrues at a rate of 5.750% per annum and is payable semi-annually on May 15 and November 15 of each year, beginning November 15, 2014. The 2024 U.S. Dollar Notes mature on May 15, 2024.
Prior to May 15, 2019, we were permitted to redeem some or all of the 2024 U.S. Dollar Notes at a price equal to 100% of the principal amount of the 2024 U.S. Dollar Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after May 15, 2019, we may redeem the 2024 U.S. Dollar Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.875% during the 12-month period commencing on May 15, 2019, 101.917% during the 12-month period commencing on May 15, 2020, 100.958% during the 12-month period commencing on May 15, 2021, and par on or after May 15, 2022, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to May 15, 2017, we were permitted to, within 90 days of a qualified equity offering, redeem the 2024 U.S. Dollar Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount of the 2024 U.S. Dollar Notes (after giving effect to any issuance of additional 2024 U.S. Dollar Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 5.750% for the 2024 U.S. Dollar Notes, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of 2024 U.S. Dollar Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company is required to make an offer to purchase all outstanding 2024 U.S. Dollar Notes at a price in cash equal to 101% of the principal amount of the 2024 U.S. Dollar Notes, plus accrued and unpaid interest, if any, to the purchase date.
The 2024 U.S. Dollar Notes are senior unsecured obligations of Constellium and are guaranteed on a senior unsecured basis by Constellium International, Constellium France Holdco, Constellium Neuf Brisach, Constellium Issoire, Constellium Finance, Engineered Products International, Constellium Germany Holdco GmbH & Co. KG, Constellium Deutschland GmbH, Constellium Singen GmbH, Constellium Rolled Products Singen GmbH & Co. KG, Constellium Switzerland AG, Constellium US Holdings I, LLC, Constellium Rolled Products Ravenswood, LLC, Constellium Holdings Muscle Shoals LLC (f/k/a Wise Metal Group LLC), Constellium Muscle Shoals LLC (f/k/a Wise Alloys LLC), Constellium Bowling Green LLC, and Constellium Property and Equipment Company, LLC. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guarantees certain indebtedness of Constellium (including the November 2017 Notes, the June 2020 Notes, and the February 2021 Notes) or certain indebtedness of any of the guarantors of the 2024 U.S. Dollar Notes must also guarantee the 2024 U.S. Dollar Notes.
-83-


The indenture governing the 2024 U.S. Dollar Notes contains customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indenture governing the 2024 U.S. Dollar Notes also contains customary events of default.
Interest on the 2021 Euro Notes accrued at a rate of 4.625% per annum and was payable semi-annually beginning November 15, 2014. The 2021 Euro Notes were scheduled to mature on May 15, 2021. On August 8, 2019, we redeemed €100 million plus accrued and unpaid interest. On July 16, 2020, all of the outstanding 2021 Euro Notes were redeemed in accordance with the terms of the indenture governing the 2021 Euro Notes.
Prior to May 15, 2017, we were permitted to redeem some or all of the 2021 Euro Notes at a price equal to 100% of the principal amount of the 2021 Euro Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after May 15, 2017, we were permitted to redeem the 2021 Euro Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.313% during the 12-month period commencing on May 15, 2017, 101.156% during the 12-month period commencing on May 15, 2018, and par on or after May 15, 2019, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to May 15, 2017, we were permitted to, within 90 days of a qualified equity offering, redeem the 2021 Euro Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount of the 2021 Euro Notes (after giving effect to any issuance of additional 2021 Euro Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 4.625%, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of 2021 Euro Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company was required to make an offer to purchase all outstanding 2021 Euro Notes at a price in cash equal to 101% of the principal amount of the 2021 Euro Notes, plus accrued and unpaid interest, if any, to the purchase date.
The 2021 Euro Notes were senior unsecured obligations of Constellium and were guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the 2024 U.S. Dollar Notes. While the 2021 Euro Notes were outstanding, each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guaranteed certain indebtedness of Constellium or certain indebtedness of any of the guarantors of the 2021 Euro Notes was required to guarantee the 2021 Euro Notes.
The indenture governing the 2021 Euro Notes contained customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indenture governing the 2021 Euro Notes also contained customary events of default.
February 2017 Notes
On February 16, 2017, the Company completed a private offering of $650 million in aggregate principal amount of 6.625% Senior Notes due 2025 (the “February 2017 Notes”) pursuant to an indenture among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. The Company used the net proceeds from the offering, together with cash on hand, to retire all of the outstanding 8.75% Senior Secured Notes due 2018 and used the remaining net proceeds, if any, for general corporate purposes.
Interest on the February 2017 Notes accrued at rate of 6.625% per annum and was payable semi-annually beginning September 1, 2017. The February 2017 Notes were scheduled to mature on March 1, 2025. The February 2017 Notes were repurchased or redeemed in full as described under “Item 8. Financial Information—B. Significant Changes.”
Prior to March 1, 2020, we were permitted to redeem some or all of the February 2017 Notes at a price equal to 100% of the principal amount of the February 2017 Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after March 1, 2020, we were permitted to redeem the February 2017 Notes at redemption
-84-


prices (expressed as a percentage of the principal amount thereof) equal to 103.313% during the 12-month period commencing on March 1, 2020, 101.656% during the 12-month period commencing on March 1, 2021, and par on or after March 1, 2022, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to March 1, 2020, we were permitted to, within 90 days of a qualified equity offering, redeem February 2017 Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount thereof (after giving effect to any issuance of additional February 2017 Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 6.625%, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of February 2017 Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company was required to make an offer to purchase all outstanding February 2017 Notes at a price in cash equal to 101% of the principal amount of the February 2017 Notes, plus accrued and unpaid interest, if any, to the purchase date.
The February 2017 Notes were senior unsecured obligations of Constellium and were guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the 2024 U.S. Dollar Notes. While the February 2017 Notes were outstanding, each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guaranteed certain indebtedness of Constellium or certain indebtedness of any of the guarantors of the February 2017 Notes was also required to guarantee the February 2017 Notes.
The indenture governing the February 2017 Notes contained customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indenture governing the February 2017 Notes also contained customary events of default.
November 2017 Notes
On November 9, 2017, the Company completed a private offering (the “November 2017 Notes Offering”) of $500 million in aggregate principal amount of 5.875% Senior Notes due 2026 (the “2026 U.S. Dollar Notes”) and €400 million in aggregate principal amount of 4.250% Senior Notes due 2026 (the “2026 Euro Notes” and together with the 2026 U.S. Dollar Notes, the “November 2017 Notes”) pursuant to indentures among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. The Company used the net proceeds from an equity offering and the November 2017 Notes Offering, together with cash on hand, to fund the cash tender offers (the “2017 Tender Offers”) for any and all of the $400 million in aggregate principal amount of 8.00% Senior Notes due 2023 (the “2023 U.S. Dollar Notes”), €240 million in aggregate principal amount of 7.00% Senior Notes due 2023 (the “2023 Euro Notes,”), and $425 million in aggregate principal amount of 7.875% Senior Secured Notes due 2021 (the “Senior Secured Notes”, and together with the 2023 Euro Notes and the 2023 U.S. Dollar Notes, the “2017 Tender Offer Notes”) and the redemption (the “2017 Redemption”) of the 2017 Tender Offer Notes not purchased in the 2017 Tender Offers, with the remaining net proceeds being used for general corporate purposes.
Interest on the 2026 U.S. Dollar Notes and 2026 Euro Notes accrues at rates of 5.875% and 4.250% per annum, respectively, and is payable semi-annually on February 15 and August 15 of each year, beginning February 15, 2018. The November 2017 Notes mature on February 15, 2026.
Prior to November 15, 2020, we may redeem some or all of the 2026 U.S. Dollar Notes at a price equal to 100% of the principal amount of the 2026 U.S. Dollar Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after November 15, 2020, we may redeem the 2026 U.S. Dollar Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.938% during the 12-month period commencing on November 15, 2020, 101.469% during the 12-month period commencing on November 15, 2021, and par on or after November 15, 2022, in each case plus accrued and unpaid interest, if any, to the redemption date.
Prior to November 15, 2020, we may redeem some or all of the 2026 Euro Notes at a price equal to 100% of the principal amount of the 2026 Euro Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after November 15, 2020, we may redeem the 2026 Euro Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.125% during the 12-month period commencing on November 15,
-85-


2020, 101.063% during the 12-month period commencing on November 15, 2021, and par on or after November 15, 2022, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to November 15, 2020, we may, within 90 days of a qualified equity offering, redeem November 2017 Notes of either series in an aggregate amount equal to up to 35% of the original aggregate principal amount of the November 2017 Notes of the applicable series (after giving effect to any issuance of additional November 2017 Notes of such series) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 5.875% for the 2026 U.S. Dollar Notes and 4.250% for the 2026 Euro Notes, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of November 2017 Notes of the series being redeemed would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company is required to make an offer to purchase all outstanding November 2017 Notes at a price in cash equal to 101% of the principal amount of the November 2017 Notes, plus accrued and unpaid interest, if any, to the purchase date.
The November 2017 Notes are senior unsecured obligations of Constellium and are guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the 2024 U.S. Dollar Notes, the June 2020 Notes, and the February 2021 Notes. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guarantees certain indebtedness of Constellium (including the 2024 U.S. Dollar Notes, the June 2020 Notes, and the February 2021 Notes) or certain indebtedness of any of the guarantors of the November 2017 Notes must also guarantee the November 2017 Notes.
The indentures governing the November 2017 Notes contain customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indentures governing the November 2017 Notes also contain customary events of default.
June 2020 Notes
On June 30, 2020, the Company completed a private offering (the “June 2020 Notes Offering”) of $325 million in aggregate principal amount of 5.625% Senior Notes due 2028 (the “June 2020 Notes”) pursuant to an indenture among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee. The Company used the net proceeds from the offering to retire all of the outstanding 2021 Euro Notes and used the remaining net proceeds, for general corporate purposes and to pay related fees and expenses.
Interest on the June 2020 Notes accrues at a rate of 5.625% per annum, and is payable semi-annually on June 15 and December 15 of each year, beginning December 15, 2020. The June 2020 Notes mature on June 15, 2028.
Prior to June 15, 2023, we may redeem some or all of the June 2020 Notes at a price equal to 100% of the principal amount of the June 2020 Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after June 15, 2023, we may redeem the June 2020 Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102.813% during the 12-month period commencing on June 15, 2023, 101.406% during the 12-month period commencing on June 15, 2024, and par on or after June 15, 2025, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to June 15, 2023, we may, within 90 days of a qualified equity offering, redeem the June 2020 Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount thereof (after giving effect to any issuance of additional June 2020 Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 5.625% plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of June 2020 Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company is required to make an offer to purchase all outstanding June 2020 Notes at a price in cash equal to 101% of the principal amount of the June 2020 Notes, plus accrued and unpaid interest, if any, to the purchase date.
-86-


The June 2020 Notes are senior unsecured obligations of Constellium and are guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the 2024 U.S. Dollar Notes, the November 2017 Notes, and the February 2021 Notes. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guarantee certain indebtedness of Constellium (including the 2024 U.S. Dollar Notes, the November 2017 Notes, and the February 2021 Notes) or certain indebtedness of any of the guarantors of the June 2020 Notes must also guarantee the June 2020 Notes.
The indenture governing the June 2020 Notes contains customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The indenture governing the June 2020 Notes also contains customary events of default.
February 2021 Notes
On February 24, 2021, the Company completed a private offering (the “February 2021 Notes Offering”) of $500 million in aggregate principal amount of 3.750% Sustainability-Linked Senior Notes due 2029 (the “February 2021 Notes”) pursuant to an indenture among the Company, the guarantors party thereto, and Deutsche Bank Trust Company Americas, as trustee (the “February 2021 Indenture”). The Company used the net proceeds from the offering, together with cash on hand, to repurchase the outstanding February 2017 Notes that were validly tendered and accepted for payment pursuant to a cash tender offer and to redeem the February 2017 Notes that were not validly tendered and accepted for payment in such cash tender offer, and to pay related fees and expenses.
Interest on the February 2021 Notes initially accrues at a rate of 3.750% per annum and is payable semi-annually on April 15 and October 15 of each year, beginning October 15, 2021. From and including April 15, 2026, the interest rate payable on the February 2021 Notes shall be increased by +0.125% to 3.875% per annum (the “Target 1 Step-Up”), unless the Company has notified the trustee of the February 2021 Notes in writing, at least 15 days prior to April 15, 2026, that it has determined that the Company has attained Sustainability Performance Target 1 (as defined in the February 2021 Indenture) and received an Assurance Letter (as defined in the February 2021 Indenture). From and including April 15, 2027, the interest rate payable on the February 2021 Notes shall be increased by +0.125% to (x) 4.000% per annum, if the Target 1 Step-Up took effect or (y) 3.875% per annum, if the Target 1 Step-Up did not take effect, in each case unless the Company has notified the trustee of the February 2021 Notes in writing, at least 15 days prior to April 15, 2027, that it has determined that the Company has attained Sustainability Performance Target 2 (as defined in the February 2021 Indenture) and received an Assurance Letter. The February 2021 Notes mature on April 15, 2029.
Prior to April 15, 2024, we may redeem some or all of the February 2021 Notes at a price equal to 100% of the principal amount of the February 2021 Notes redeemed plus accrued and unpaid interest, if any, to the redemption date plus a “make-whole” premium. On or after April 15, 2024, we may redeem the February 2021 Notes at redemption prices (expressed as a percentage of the principal amount thereof) equal to 102% during the 12-month period commencing on April 15, 2024, 101% during the 12-month period commencing on April 15, 2025, and par on or after April 15, 2026, in each case plus accrued and unpaid interest, if any, to the redemption date.
In addition, at any time or from time to time prior to April 15, 2024, we may, within 90 days of a qualified equity offering, redeem the February 2021 Notes in an aggregate amount equal to up to 35% of the original aggregate principal amount thereof (after giving effect to any issuance of additional February 2021 Notes) at a redemption price equal to 100% of the principal amount thereof plus a premium (expressed as a percentage of the principal amount thereof) equal to 3.750%, plus accrued and unpaid interest thereon (if any) to the redemption date, with the net cash proceeds of such qualified equity offering, provided that at least 50% of the original aggregate principal amount of February 2021 Notes would remain outstanding immediately after giving effect to such redemption.
Within 30 days of the occurrence of specific kinds of changes of control, the Company is required to make an offer to purchase all outstanding February 2021 Notes at a price in cash equal to 101% of the principal amount of the February 2021 Notes, plus accrued and unpaid interest, if any, to the purchase date.
The February 2021 Notes are senior unsecured obligations of Constellium and are guaranteed on a senior unsecured basis by each of its restricted subsidiaries that guarantees the 2024 U.S. Dollar Notes, the November 2017 Notes and the June 2020 Notes. Each of Constellium’s existing or future restricted subsidiaries (other than receivables subsidiaries) that guarantee certain indebtedness of Constellium (including the 2024 U.S. Dollar Notes, the November 2017 Notes, and the June 2020
-87-


Notes) or certain indebtedness of any of the guarantors of the February 2021 Notes must also guarantee the February 2021 Notes.
The February 2021 Indenture contains customary terms and conditions, including, among other things, negative covenants limiting our and our restricted subsidiaries’ ability to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances, make acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The February 2021 Indenture also contains customary events of default.
Pan-U.S. ABL Facility
On June 21, 2017, Ravenswood and Constellium Muscle Shoals LLC (f/k/a Wise Alloys LLC) (“Muscle Shoals”), entered into a $300 million asset-based revolving credit facility (as amended, supplemented or otherwise modified as described below, the “Pan-U.S. ABL Facility”), with the lenders from time to time party thereto and Wells Fargo Bank, National Association as administrative agent (the “Administrative Agent”) and collateral agent. Concurrently with Ravenswood and Muscle Shoals’ entry into the Pan-U.S. ABL Facility, (i) the $100 million asset-based revolving credit facility entered into by Ravenswood on May 25, 2012 and (ii) the asset-based revolving credit facility entered into by Muscle Shoals, as borrower, and Constellium Holdings Muscle Shoals LLC (f/k/a Wise Metals Group LLC), Listerhill Total Maintenance Center, LLC, Wise Alloys Finance Corporation, and Alabama Electric Motor Services, LLC, as guarantors, on December 11, 2013, were each terminated. On February 20, 2019, we amended and restated the Pan-U.S. ABL Facility to, among other things, (i) join Constellium Bowling Green LLC (“Bowling Green”) as an additional borrower and Constellium Property and Equipment Company, LLC as an additional guarantor, (ii) increase the available commitments thereunder to $350 million, and (iii) make certain changes to the covenants, terms, and conditions thereof. On May 10, 2019, we amended the Pan-U.S. ABL Facility to (i) increase the available commitments thereunder to $400 million and (ii) make certain other changes to the covenants, terms and/or conditions thereof.
The Pan-U.S. ABL Facility provides Ravenswood, Muscle Shoals, and Bowling Green (the “Borrowers”) a working capital facility for their respective operations. The Pan-U.S. ABL Facility has sublimits of $35 million for letters of credit and $35 million for swingline loans.
The Pan-U.S. ABL Facility matures on the earlier of (i) June 21, 2022 and (ii) 90 days prior to the maturity date of any indebtedness (other than loans under the Pan-U.S. ABL Facility) of any Borrower or any Borrower’s subsidiaries in an aggregate amount exceeding $50.0 million (but excluding for this purpose the indebtedness of Borrowers pursuant to their guarantees of the existing unsecured notes issued by Constellium SE) (the “Pan-U.S. ABL Maturity Date”).
The Borrowers’ ability to borrow under the Pan-U.S. ABL Facility is limited to a borrowing base equal to the sum of (a) 85% of eligible accounts plus (b) up to the lesser of (i) 80% of the lesser of cost or market value of eligible inventory and (ii) 85% of the net orderly liquidation value of eligible inventory minus (c) applicable reserves, and is subject to other conditions, limitations and reserve requirements.
Interest for revolving facility loans under the Pan-U.S. ABL Facility is calculated, at the applicable Borrower’s election, based on either the LIBOR or base rate (as calculated by the Administrative Agent in accordance with the Pan-U.S. ABL Facility), as further described below. The Borrowers are required to pay a commitment fee on the unused portion of the Pan-U.S. ABL Facility of 0.25% or 0.375% per annum (determined on a ratio of unutilized revolving credit commitments to available revolving credit commitments).
Subject to customary “breakage” costs with respect to LIBOR loans, borrowings of revolving loans under the Pan-U.S. ABL Facility may be repaid from time to time without premium or penalty.
The Borrowers’ obligations under the Pan-U.S. ABL Facility are guaranteed by Constellium US Holdings I, LLC, Constellium Holdings Muscle Shoals LLC, Constellium Property and Equipment Company, LLC, and Constellium International (as successor to Holdco II). Obligations under the Pan-U.S. ABL Facility are, subject to certain exceptions, secured by substantially all assets of the Borrowers, Constellium US Holdings I, LLC, Constellium Holdings Muscle Shoals LLC, and Constellium Property and Equipment Company LLC. The guarantee by Constellium International of the Pan-U.S. ABL Facility is unsecured.
The Pan-U.S. ABL Facility contains customary terms and conditions, including, among other things, negative covenants limiting the ability of the Borrowers and their respective material subsidiaries to incur debt, grant liens, enter into sale and lease-back transactions, make investments, loans and advances (including to other Constellium group companies), make
-88-


acquisitions, sell assets, pay dividends and other restricted payments, prepay certain debt, merge, consolidate or amalgamate and engage in affiliate transactions.
The Pan-U.S. ABL Facility also contains a financial maintenance covenant that provides that at any time during which borrowing availability thereunder is below 10% of the aggregate commitments under the Pan-U.S. ABL Facility, the Borrowers will be required to maintain a minimum fixed charge coverage ratio with respect to the Company and its subsidiaries of 1.0 to 1.0 and a minimum Borrower EBITDA Contribution of 25%, in each case calculated on a trailing twelve-month basis. “Borrower EBITDA Contribution” means, for any period, the ratio of (x) the combined EBITDA of the Borrowers and their respective subsidiaries for such period, to (y) the consolidated EBITDA of the Company and its subsidiaries for such period.
The Pan-U.S. ABL Facility also contains customary events of default.
On April 24, 2020, the Borrowers entered into an Amendment No. 2 (“Amendment No. 2”) to the Pan-U.S. ABL Facility, with certain of the Constellium SE’s subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent and collateral agent. Amendment No. 2, established a new fully-committed delayed draw term loan facility (the “Delayed Draw Term Loans”) that allows the Borrowers to borrow an aggregate amount up to the lesser of $166.25 million and 50% of the net orderly liquidation value of eligible equipment, in up to three separate draws at any time until November 1, 2020 (the “Term Loan Commitment Expiration Date”), subject to quarterly amortization payments of principal (calculated on the basis of a seven year assumed life) commencing on January 1, 2021. If drawn, the proceeds of the Delayed Draw Term Loans will be used for general corporate purposes. The Delayed Draw Term Loans (if drawn) will mature on the Pan-U.S. ABL Maturity Date. Interest payable on any drawn Delayed Draw Term Loans will be calculated, at the applicable Borrower’s election, based on either the LIBOR or base rate (as calculated by the Administrative Agent in accordance with the Pan-U.S. ABL Facility), plus a margin equal to 4.00% per annum in the case of LIBOR loans and 3.00% in the case of base rate loans. The Delayed Draw Term Loans will be subject to substantially the same covenants as the Pan-U.S. ABL Facility. The Delayed Draw Term Loans replaced the committed $200 million incremental revolving facility that was available prior to the effectiveness of Amendment No. 2.
Amendment No. 2 also modified the interest rate that applies to any revolving loans under the Pan-U.S. ABL Facility to equal, at the applicable Borrower’s election, LIBOR plus a margin of 1.75%-2.25% or base rate plus a margin of 0.75%-1.25% (in each case, determined based on (i) a net leverage ratio until the Term Loan Commitment Expiration Date and the prepayment or repayment of outstanding Delayed Draw Term Loans and (ii) average quarterly excess availability thereafter). Until the Term Loan Commitment Expiration Date, the applicable margins for LIBOR and base rate loans will be 2.25% and 1.25%, respectively.
Borrowings under the Delayed Draw Term Loans may be repaid from time to time without premium or penalty, subject to customary “breakage” costs with respect to LIBOR loans and certain excess availability conditions.
On September 25, 2020, the Borrowers entered into an Amendment No. 3 (“Amendment No. 3”) to the Pan-U.S. ABL Facility with certain of the Constellium SE’s subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent and collateral agent. Amendment No. 3, among other things, extended the Term Loan Commitment Expiration Date to May 1, 2021 and changed the date of the first quarterly amortization payment of principal with respect to the Delayed Draw Term Loans from January 1, 2021 to July 1, 2021.
PGE French Facility
On May 13, 2020, Constellium International S.A.S. (the “French Borrower”) entered into a term facility agreement for a loan guaranteed by the French State (PGE Grande Entreprise) (the “PGE French Facility”) with BNP Paribas as coordinator, agent and security agent and BNP Paribas, Société Générale and Bpifrance Financement as original lenders. The PGE French Facility established a fully committed term loan (the “PGE Loan”) that allowed the French Borrower to borrow an aggregate amount of up to €180 million in one draw on May 20, 2020, which the French Borrower drew on such date. The proceeds of the PGE French Facility will be used for financing the working capital and liquidity needs of the French Borrower and its subsidiaries in France.
The PGE Loan will mature no earlier than May 20, 2021, and the French Borrower will have an option to extend for up to five years. In accordance with French law no. 2020-289 dated March 23, 2020, related ministerial order (arrêté) dated March 23, 2020, as may be amended from time to time, and pursuant to ministerial order (arrêté) dated May 15, 2020 published on May 16, 2020, 80% of the principal outstanding amount of the PGE Loan benefits from a guarantee of the French State.
-89-


Interest payable on the drawn PGE Loan will be calculated based on the EURIBOR plus a margin and the cost of the guarantee calculated in accordance with the PGE French Facility equal to at least 1.30% per annum for the margin and 0.50% for the guarantee during the first year of the PGE Loan.
The PGE French Facility contains financial covenants that provide that, on semi-annual testing dates: (i) the Leverage shall not exceed a specified ratio, beginning at 6.5x for June 30, 2021 and (ii) the Interest Cover Ratio (calculated on a twelve-month basis) is at least equal to a specified ratio, beginning at 1.75x for June 30, 2021.
“Leverage” means the ratio of total net debt on the relevant testing date to the consolidated EBITDA of Constellium SE (of which the French Borrower is a consolidated subsidiary). “Interest Cover Ratio” means the ratio of the consolidated EBITDA of Constellium SE to the aggregate of (x) the consolidated net financial interest of Constellium SE for that period and (y) the aggregate amount of any other financial expenses invoiced or paid by Constellium SE during that period.
The PGE French Facility also contains customary terms and conditions, including, among other things, negative covenants limiting the ability of the French Borrower, Constellium France Holdco S.A.S., Constellium Issoire S.A.S. and Constellium Neuf Brisach S.A.S. (and, as the case may be, any other French subsidiary of the French Borrower designated by the French Borrower as a material subsidiary), inter alia, to incur debt, grant liens, sell assets, make acquisitions, merge, demerge, amalgamate or enter into corporate reconstruction, enter into joint ventures, make loans and advances (including, in specific events, to other members of the Constellium SE group of companies) and enter into certain derivative transactions.
Borrowings under the PGE Loan may be repaid from time to time without premium or penalty, subject to customary “breakage” costs and certain mandatory prepayment events as mentioned in the PGE French Facility.
The French Borrower’s obligations under the PGE French Facility are secured by pledges of (i) the shares of Constellium Issoire S.A.S. and Constellium Neuf Brisach S.A.S. owned by Constellium France Holdco S.A.S., and (ii) certain French bank accounts of the French Borrower, Constellium Issoire S.A.S. and Constellium Neuf Brisach S.A.S.
Swiss Facilities
On April 14, 2020, Constellium Valais SA entered into term facility agreements for loans with credit support from the Swiss Federal Government. These facilities allow for the borrowing of a combined amount of CHF 20 million, which are uncommitted.
German Facilities
On July 15, 2020, two of our German entities entered into two credit facilities for a total amount of €50 million, of which 80% is guaranteed by the German government. One of the German facilities has an interest coverage covenant if the facility is drawn.
French Inventory Facility
On April 21, 2017, Constellium Issoire and Constellium Neuf Brisach (the “French Borrowers”) entered into a €100 million asset-based revolving credit facility (the “French Inventory Facility”) with the lenders from time to time party thereto and Factofrance as agent. The French Inventory Facility was amended on June 13, 2017 to, among other things, make certain changes to the procedure for calculating the Turn Ratio (as defined below). The French Inventory Facility provides the French Borrowers a working capital facility for their operations. The French Inventory Facility was amended on March 29, 2018 to, among other things, make certain changes to the inventory included in the borrowing base. The French Inventory Facility was amended on March 15, 2019 to, among other things, extend the maturity to April 21, 2021, and further amended on February 16, 2021 to, among other things, extend the maturity to April 30, 2023.
The French Borrowers’ ability to borrow under the French Inventory Facility is limited to a borrowing base equal to the lesser of (i) the sum of (A) 90% of the net orderly liquidation value of eligible inventory of the applicable French Borrower pledged and in possession of an escrow agent (the “Inventory Pledged With Dispossession” by such French Borrower), plus (B) 70% of the net orderly liquidation value of eligible inventory of the applicable French Borrower pledged without possession by the escrow agent (the “Inventory Pledged Without Dispossession” by such French Borrower), and (ii) the product of 90% of the net orderly liquidation value of the Inventory Pledged With Dispossession by the applicable French Borrower, multiplied by four.
-90-


Notwithstanding the foregoing, if on any quarterly test date the ratio of a French Borrower’s aggregate sales for the previous 365 days to the average book value of the eligible inventory pledged by such French Borrower under the French Inventory Facility (the “Turn Ratio” for such French Borrower) is less than 3, in the case of Constellium Issoire, or 6, in the case of Constellium Neuf Brisach, the borrowing base for such French Borrower will equal 70% of the net orderly liquidation value of the Inventory Pledged With Dispossession by such French Borrower until the next quarterly test date on which such French Borrower’s Turn Ratio is greater than or equal to 3, in the case of Constellium Issoire, or 6, in the case of Constellium Neuf Brisach (such period, a “Borrowing Base Event”).
Loans not in excess of 90% of the net orderly liquidation value of the Inventory Pledged with Dispossession of the applicable French Borrower at the time of borrowing bear interest at a rate of EURIBOR plus 2% per annum (“Tranche A Loans”), and loans in excess of that amount at the time of borrowing bear (“Tranche B Loans”) interest at a rate of EURIBOR plus 2.75% per annum. The French Borrowers are also required to pay a commitment fee on the unused portion of the French Inventory Facility of 0.80% per annum. Borrowings of Tranche B Loans by a French Borrower are subject to a minimum EBITDA for such French Borrower, calculated on a trailing twelve months of €40 million in the case of Constellium Issoire, and €65 million in the case of Constellium Neuf Brisach.
Subject to customary “breakage” costs, borrowings under the French Inventory Facility are permitted to be repaid from time to time without premium or penalty.
The French Borrowers’ obligations under the French Inventory Facility are guaranteed by Constellium International (as successor to Holdco II) and are secured by possessory and non-possessory pledges of the eligible inventory of the French Borrowers.
European Factoring Agreements
On January 4, 2011, certain of our French subsidiaries (the “French Sellers”) entered into a factoring agreement with GE Factofrance S.A.S., as factor (the “French Factor”), which has been amended from time to time, and has been fully restated on December 3, 2015 (the “French Factoring Agreement”). On December 16, 2010, certain of our German and Swiss subsidiaries (the “German/Swiss Sellers”) entered into factoring agreements with GE Capital Bank AG, as factor (the “German/Swiss Factor”), which have been amended from time to time or replaced with a factoring agreement entered into on March 26, 2014 (the “Original German/Swiss Factoring Agreements”). On June 26, 2015, our Czech subsidiary (the “Czech Seller,” and together with the German/Swiss Sellers and the French Sellers, the “European Factoring Sellers”) entered into a factoring agreement with GE Capital Bank AG, as factor (the “Czech Factor,” and together with the German/Swiss Factor and the French Factor, the “European Factors”), as amended from time to time (the “Czech Factoring Agreement,” and together with the German/Swiss Factoring Agreements and the French Factoring Agreement, the “European Factoring Agreements”). On May 27, 2016, one of our German subsidiaries, Constellium Rolled Products Singen GmbH & Co. KG (another “German/Swiss Seller”), entered into a factoring agreement with the German/Swiss Factor (the “Additional German/Swiss Factoring Agreement” and, together with the Original German/Swiss Factoring Agreements, the “German/Swiss Factoring Agreements”) while certain of the Original German/Swiss Factoring Agreements were amended.
On July 20, 2016, the Banque Fédérative du Crédit Mutuel purchased the Equipment Finance and Receivable Finance businesses of GE. Pursuant to this transaction, GE Factofrance S.A.S. was renamed Factofrance and GE Capital Bank AG was renamed Targo Commercial Financing AG. On August 1, 2018, Targo Commercial Finance AG was merged into Targobank AG. Both transactions had no other impact on the European Factoring Agreements.
The European Factoring Agreements provide for the sale by the European Factoring Sellers to the European Factors of receivables originated by the European Factoring Sellers, subject to a maximum financing amount of €235 million available to the French Sellers under the French Factoring Agreement and €150 million available to the German/Swiss Sellers and the Czech Seller under the German/Swiss Factoring Agreements and the Czech Factoring Agreement, respectively. The funding made available to the European Factoring Sellers by the European Factors is used by the Sellers for general corporate purposes.
The German/Swiss Factoring Agreements were amended on December 21, 2016 to, among other things, increase the maximum financing amount from €115 million to €150 million, extend the termination date from June 15, 2017 to October 29, 2021, and reduce the fees payable by the German/Swiss Sellers. The French Factoring Agreement was amended and restated on April 19, 2017 to, among other things, extend the commitment period thereunder from December 2018 to October 2021.
On April 30, 2020, the German/Swiss, and Czech Factoring Agreements were each extended to December 31, 2023.
-91-


On May 26, 2020, the French Factoring Agreement was amended to (a) extend the maturity to December 31, 2023, (b) add a €20 million euro recourse tranche to the facility to increase liquidity of the facility on the same asset base and subject to the same terms, and (c) change the interest rate margin to be EURIBOR plus 0.8%-1.4% depending on Constellium SE’s credit rating.
Generally speaking, receivables sold to the European Factors under the European Factoring Agreements are without recourse to the European Factoring Sellers in the event of a payment default by the relevant customer. The European Factors are entitled to claim the repayment of any amount financed by them in respect of a receivable by withdrawing the financing provided against such assigned receivable or requiring the European Factoring Sellers to repurchase/unwind the purchase of such receivable under certain circumstances, including when (i) the nonpayment of that receivable arises from a dispute between a European Factoring Seller and the relevant customer or (ii) the receivable proves not to have satisfied the eligibility criteria set forth in the European Factoring Agreements. Constellium International (as successor to Holdco II) has provided a performance guaranty for the Sellers’ obligations under the European Factoring Agreements.
Subject to some exceptions, the European Factoring Sellers will collect the transferred receivables on behalf of the European Factors pursuant to a receivables collection mandate under the European Factoring Agreements. The receivables collection mandate may be terminated upon the occurrence of certain events. In the event that the receivables collection mandate is terminated, the European Factors will be entitled to notify the account debtors of the assignment of receivables and collect directly from the account debtors the assigned receivables.
The European Factoring Agreements contain customary fees, including (i) a financing fee on the outstanding amount financed in respect of the assigned receivables, (ii) a non-utilization fee on the portion of the facilities not utilized by the European Factors and (iii) a factoring fee on all assigned receivables in the case of the German/Swiss Factoring Agreements and sold receivables, which were approved by the French Factor in the case of the French Factoring Agreement. In addition, the European Factoring Sellers incur the cost of maintaining the necessary credit insurance (as stipulated in the European Factoring Agreements) on assigned receivables.
The European Factoring Agreements contain certain affirmative and negative covenants, including relating to the administration and collection of the assigned receivables, the terms of the invoices and the exchange of information, but do not contain restrictive financial covenants. As of and for the fiscal year ended December 31, 2020, the European Factoring Sellers were in compliance with all applicable covenants under the European Factoring Agreements.
Wise Factoring Facility
On March 16, 2016, Wise Alloys, since renamed Constellium Muscle Shoals LLC, entered into a Receivables Purchase Agreement (the “Wise Factoring Facility”) with Wise Alloys Funding II, LLC, since renamed Constellium Muscle Shoals Funding II LLC (“New RPA Seller”), Hitachi Capital America Corp. (“Hitachi”), and Greensill Capital Inc., as purchaser agent, providing for the sale of certain receivables of Wise Alloys to Hitachi. The Wise Factoring Facility was amended on November 22, 2016 to join Intesa Sanpaolo S.p.A., New York Branch (together with Hitachi, the “Wise Factoring Purchasers”) as a purchaser. As of December 31, 2017, the Wise Factoring Facility provides for the sale of receivables to the Wise Factoring Purchasers in an amount not to exceed $325 million in the aggregate outstanding at any time. Receivables under the Wise Factoring Facility are sold at a discount based on a rate equal to a LIBOR rate plus 2.00-2.50% (based on the credit rating of the account debtor) per annum. The New Wise RPA Seller is required to pay a commitment fee in the amount of $20,000 per annum plus 1% per annum of the total commitments under the Wise Factoring Facility.
Subject to certain customary exceptions, each purchase under the Wise Factoring Facility is made without recourse to the New Wise RPA Seller. The New Wise RPA Seller has no liability to the Wise Factoring Purchasers, and the Wise Factoring Purchasers are solely responsible for the account debtor’s failure to pay any purchased receivable when it is due and payable under the terms applicable thereto. Constellium International (as successor to Holdco II) has provided a guaranty for the New Wise RPA Seller’s and Wise Alloys’ performance obligations under the Wise Factoring Facility.
The Wise Factoring Facility contains customary covenants. The Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility is subject to certain conditions, including without limitation that certain changes of control shall not have occurred, that there shall not have occurred a material adverse change in the business condition, operations or performance of the New Wise RPA Seller, Wise Alloys, or Constellium International, and that Constellium’s corporate credit rating shall not have been withdrawn by either Standard & Poor’s or Moody’s or downgraded below B- by Standard & Poor’s and B3 by Moody’s.
-92-


On June 28, 2016, the Wise Factoring Facility was amended to, among other things, change the maximum commitments thereunder to $250 million in the aggregate outstanding at any time.
On January 25, 2017, the Wise Factoring Facility was amended to extend the date on which the Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility will terminate to January 24, 2018.
On May 12, 2017, the Wise Factoring Facility was amended to permit the sale of certain receivables with due dates up to 115 days after the invoice date (increased from 90 days).
On January 2, 2018, the Wise Factoring Facility was amended to, among other things, increase the commitments thereunder to $375 million in the aggregate outstanding at any time, reduce the discount at which receivables are sold to a rate equal to a LIBOR rate plus 1.75-2.25% (based on the credit rating of the account debtor) per annum, and extend the date on which the Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility will terminate to January 24, 2020.
On October 22, 2018, the Wise Factoring Facility was amended to make certain changes to the eligibility requirements for receivables sold pursuant to the Wise Factoring Facility.
On September 30, 2019, the Wise Factoring Facility was amended to, among other things, join Deutsche Bank Trust Company America as a Wise Factoring Purchaser, release Hitachi from its commitment and remove Hitachi as a purchaser under the facility, decrease the commitments thereunder to $300 million in the aggregate outstanding at any time, reduce the discount at which receivables are sold to a rate equal to a LIBOR rate plus 1.65% per annum, permit the sale of certain receivables with due dates up to 180 days after the invoice date (increased from 135 days) and extend the date on which the Wise Factoring Purchasers’ obligation to purchase receivables under the Wise Factoring Facility will terminate to September 30, 2021.
D. Exchange Controls
French exchange control regulations currently do not limit the amount of payments that we may remit to non-residents of France. Laws and regulations concerning foreign exchange controls do require, however, that all payments or transfers of funds made by a French resident to a non-resident be handled by an accredited intermediary.
E. Taxation

General
The following discussion contains a description of certain U.S. federal income tax, French tax and Dutch tax consequences of the acquisition, ownership and disposition of our ordinary shares, but it does not purport to be a comprehensive description of all the tax considerations that may be relevant to a decision to purchase ordinary shares. The discussion is not, and should not be construed as, tax advice. The discussion is based upon the federal income tax laws of the U.S. and regulations thereunder, the tax laws of France and regulations thereunder and the tax laws of the Netherlands and regulations thereunder, all as of the date hereof, which are subject to change and possibly with retroactive effect. Prospective investors should consult their own tax advisors.

Certain Material U.S. Federal Income Tax Consequences
The following discussion describes the material U.S. federal income tax consequences relating to acquiring, owning and disposing of our ordinary shares by a U.S. Holder (as defined below) that holds the ordinary shares as “capital assets” (generally, property held for investment) under the Code. This discussion is based upon existing U.S. federal income tax law, including the Code, U.S. Treasury regulations thereunder, rulings and court decisions, all of which are subject to differing interpretations or change, possibly with retroactive effect. No ruling from the Internal Revenue Service (the “IRS”) has been sought with respect to any U.S. federal income tax consequences described below, and there can be no assurance that the IRS or a court will not take a contrary position.
-93-


This discussion does not address all aspects of U.S. federal income taxation that may be relevant to particular investors in light of their individual circumstances, including investors subject to special tax rules (for example, financial institutions, insurance companies, regulated investment companies, real estate investment trusts, broker-dealers, traders in securities that elect mark-to-market treatment, any entity or arrangement treated as a partnership or pass-through entity for U.S. federal income tax purposes and their partners and investors, tax-exempt organizations (including private foundations), individual retirement and other tax-deferred accounts, U.S. expatriates, investors who are not U.S. Holders, U.S. Holders who at any time own or owned (directly, indirectly or constructively) 5% or more of our stock (by vote or value), U.S. Holders that acquire their ordinary shares pursuant to any employee share option or otherwise as compensation, U.S. Holders that will hold their ordinary shares as part of a straddle, hedge, conversion, wash sale, constructive sale or other integrated transaction for U.S. federal income tax purposes, U.S. Holders that have a functional currency other than the U.S. dollar or persons required to accelerate the recognition of any item of gross income with respect to our ordinary shares as a result of such income being recognized on an applicable financial statement, all of whom may be subject to tax rules that differ significantly from those summarized below). In addition, this discussion does not discuss any U.S. state or local tax, any U.S. federal tax (for example, federal estate or gift tax) other than the income tax, any U.S. alternative minimum tax consequences, any tax consequences of the Medicare tax on certain investment income pursuant to the Health Care and Education Reconciliation Act of 2010, any considerations with respect to FATCA (which for this purpose means Sections 1471 through 1474 of the Code, the Treasury regulations and administrative guidance promulgated thereunder, any intergovernmental agreement entered in connection therewith, and any non-U.S. laws, rules or directives implementing or relating to any of the foregoing), or any state, local or non-U.S. tax consequences. Each U.S. Holder is urged to consult its tax advisor regarding the U.S. federal, state, local and non-U.S. income and other tax considerations of an investment in our ordinary shares.
This discussion is for general information purposes only and is not tax advice or a complete description of all tax consequences relating to the acquisition, ownership and disposition of our ordinary shares. Prospective investors should consult their own tax advisors regarding the U.S. federal, state, local and non-U.S. tax considerations relating to the purchase, ownership and disposition of our ordinary shares in light of their particular circumstances.
General
For purposes of this discussion, a “U.S. Holder” is a beneficial owner of our ordinary shares that is, for U.S. federal income tax purposes, (i) an individual who is a citizen or resident of the United States, (ii) a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created in, or organized under the laws of, the United States, any state thereof or the District of Columbia, (iii) an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source, or (iv) a trust (A) the administration of which is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust or (B) that has otherwise validly elected to be treated as a U.S. person under the Code.
If an entity or arrangement treated as a partnership or pass-through entity for U.S. federal income tax purposes is a beneficial owner of our ordinary shares, the tax treatment of an investor therein will generally depend upon the status of such investor, the activities of the entity or arrangement and certain determinations made at the investor level or the level of the entity or arrangement. Such entities or arrangements, and investors therein, are urged to consult their own tax advisors regarding their investment in our ordinary shares.
Passive Foreign Investment Company Consequences
We believe that we will not be a “passive foreign investment company” for U.S. federal income tax purposes (“PFIC”) for the current taxable year and that we have not been a PFIC for prior taxable years and we expect that we will not become a PFIC in the foreseeable future, although there can be no assurance in this regard. Because PFIC status is a fact-intensive determination, no assurance can be given that we are not, have not been, or will not become, classified as a PFIC.
If we are a PFIC for any taxable year, U.S. Holders generally will be subject to special tax rules that could result in materially adverse U.S. federal income tax consequences. In such event, a U.S. Holder may be subject to U.S. federal income tax at the highest applicable ordinary income tax rates on (i) any “excess distribution” that we make to the U.S. Holder (which generally means any distribution paid during a taxable year to a U.S. Holder that is greater than 125% of the average annual distributions paid in the three preceding taxable years or, if shorter, the U.S. Holder’s holding period for the ordinary shares), or (ii) any gain realized on the disposition of our ordinary shares. In addition, a U.S. Holder may be subject to an interest charge on such tax. Furthermore, the favorable dividend tax rates that may apply to certain U.S. Holders on our dividends will not apply if we are a PFIC during the taxable year in which such dividend was paid, or the preceding taxable year.
-94-


As an alternative to the foregoing rules, if we are a PFIC for any taxable year, a U.S. Holder may make a mark-to-market election with respect to our ordinary shares, provided that the ordinary shares are regularly traded. Although no assurances may be given, we expect that our ordinary shares should qualify as being regularly traded. If a U.S. Holder makes a valid mark-to-market election, the U.S. Holder will generally (i) include as ordinary income for each taxable year that we are a PFIC the excess, if any, of the fair market value of our ordinary shares held at the end of the taxable year over the adjusted tax basis of such ordinary shares and (ii) deduct as an ordinary loss the excess, if any, of the adjusted tax basis of the ordinary shares over the fair market value of such ordinary shares held at the end of the taxable year, but only to the extent of the net amount previously included in income as a result of the mark-to-market election. The U.S. Holder’s tax basis in the ordinary shares would be adjusted to reflect any income or loss resulting from the mark-to-market election. Gain on the sale or other disposition of our ordinary shares would be treated as ordinary income, and loss on the sale or other disposition of our ordinary shares would be treated as an ordinary loss, but only to the extent of the amount previously included in income as a result of the mark-to-market election. If a U.S. Holder makes a mark-to-market election in respect of a corporation classified as a PFIC and such corporation ceases to be classified as a PFIC, the holder will not be required to take into account the gain or loss described above during any period that such corporation is not classified as a PFIC. Because a mark-to-market election cannot be made for any lower-tier PFICs that we may own, a U.S. Holder may continue to be subject to the PFIC rules with respect to such U.S. Holder’s indirect interest in any investment held by us that is treated as an equity interest in a PFIC for U.S. federal income tax purposes.
A “qualified electing fund” election (“QEF election”), in certain limited circumstances, could serve as a further alternative to the foregoing rules with respect to an investment in a PFIC. However, in order for a U.S. Holder to be able to make a QEF election, we would need to provide such U.S. Holder with certain information. Because we do not intend to provide U.S. Holders with the information they would need to make such an election, prospective investors should assume that the QEF election will not be available in respect of an investment in our ordinary shares.
Each U.S. Holder is advised to consult its tax advisor concerning the U.S. federal income tax consequences of acquiring, owning or disposing of our ordinary shares if we are or become classified as a PFIC, including the possibility of making a mark-to-market election.
The remainder of the discussion below assumes that we are not a PFIC, have not been a PFIC and will not become a PFIC in the future.
Distributions
The gross amount of distributions with respect to our ordinary shares (including the amount of any non-U.S. withholding taxes) will be taxable as dividends, to the extent paid out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Such distributions will be includable in a U.S. Holder’s gross income as ordinary dividend income on the day actually or constructively received by the U.S. Holder. Such dividends will not be eligible for the dividends-received deduction generally allowed to U.S. corporations in respect of dividends received from other U.S. corporations.
To the extent that the amount of the distribution exceeds our current and accumulated earnings and profits for a taxable year, as determined under U.S. federal income tax principles, the distribution will be treated first as a tax-free return of capital to the extent of the U.S. Holder’s tax basis in our ordinary shares, and to the extent the amount of the distribution exceeds the U.S. Holder’s tax basis, the excess will be taxed as capital gain recognized on a sale or exchange of such ordinary shares. Because we do not expect to determine our earnings and profits in accordance with U.S. federal income tax principles, U.S. Holders should expect that a distribution will generally be reported as a dividend for U.S. federal income tax purposes, even if that distribution would otherwise be treated as a tax-free return of capital or as capital gain under the rules described above.
With respect to non-corporate U.S. Holders, certain dividends received from a qualified foreign corporation may be subject to reduced rates of U.S. federal income taxation. A non-U.S. corporation is treated as a qualified foreign corporation with respect to dividends paid by that corporation on shares that are readily tradable on an established securities market in the United States. We believe our ordinary shares, which are listed on the NYSE, are considered to be readily tradable on an established securities market in the United States, although there can be no assurance that this will continue to be the case in the future. Non-corporate U.S. Holders that do not meet a minimum holding period requirement during which they are not protected from the risk of loss, or that elect to treat the dividend income as “investment income” pursuant to Section 163(d)(4) of the Code, will not be eligible for the reduced rates of taxation regardless of our status as a qualified foreign corporation. In addition, even if the minimum holding period requirement has been met, the rate reduction will not apply to dividends if the recipient of a dividend is obligated to make related payments with respect to positions in substantially similar or related
-95-


property. You should consult your own tax advisors regarding the application of these rules given your particular circumstances.
In the event that a U.S. Holder is subject to non-U.S. withholding taxes on dividends paid to such U.S. Holder with respect to our ordinary shares, such U.S. Holder may be eligible, subject to certain conditions and limitations, to claim a foreign tax credit for such non-U.S. withholding taxes (imposed at the rate applicable to the U.S. Holder, taking into account the elimination or reduction of such non-U.S. withholding taxes under an applicable treaty) against the U.S. Holder’s U.S. federal income tax liability or alternatively deduct such non-U.S. withholding taxes in computing such U.S. Holder’s U.S. federal income tax liability. Dividends paid to a U.S. Holder with respect to our ordinary shares are expected to generally constitute “foreign source income” and to generally be treated as “passive category income,” for purposes of the foreign tax credit, except that a portion of such dividends may be treated as income from U.S. sources if (i) U.S. persons (as defined in the Code and applicable Treasury regulations) own, directly or indirectly, 50% or more of our ordinary shares (by vote or value) and (ii) we receive more than a de minimis amount of income from U.S. sources. The rules governing the foreign tax credit and ability to deduct such non-U.S. withholding taxes are complex and involve the application of rules that depend upon your particular circumstances. You are urged to consult your own tax advisors regarding the availability of, and any limits or conditions to, the foreign tax credit or deduction under your particular circumstances.
Sale, Exchange or Other Disposition
For U.S. federal income tax purposes, a U.S. Holder generally will recognize taxable gain or loss on any sale, exchange or other taxable disposition of our ordinary shares in an amount equal to the difference between the amount realized for our ordinary shares and the U.S. Holder’s tax basis in such ordinary shares. Such gain or loss will generally be capital gain or loss. Capital gains of individuals derived with respect to capital assets held for more than one year generally are eligible for reduced rates of U.S. federal income taxation. The deductibility of capital losses is subject to limitations. Any gain or loss recognized by a U.S. Holder will generally be treated as U.S. source gain or loss. You are urged to consult your tax advisors regarding the tax consequences if a non-U.S. tax is imposed on a sale, exchange or other disposition of our ordinary shares, if any, including the availability of the foreign tax credit or deduction under your particular circumstances.
Information Reporting and Backup Withholding
A U.S. Holder with interests in “specified foreign financial assets” (including, among other assets, our ordinary shares, unless such shares were held on such U.S. Holder’s behalf through certain financial institutions) may be required to file an information report with the IRS if the aggregate value of all such assets exceeds certain threshold amounts. You should consult your own tax advisor as to the possible obligation to file such information reports in light of your particular circumstances.
Moreover, information reporting generally will apply to dividends in respect of our ordinary shares and the proceeds from the sale, exchange or other disposition of our ordinary shares, in each case, that are paid to a U.S. Holder within the United States (and in certain cases, outside the United States or through certain U.S. intermediaries), unless the U.S. Holder is an exempt recipient. Backup withholding (currently at a rate of 24% for payments made before January 1, 2026) may also apply to such payments unless the U.S. Holder provides a correct taxpayer identification number, certifies as to no loss of exemption from backup withholding by providing a properly completed IRS Form W-9 and otherwise complies with applicable requirements of the backup withholding rules, or otherwise establishes an exemption. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or a credit against a U.S. Holder’s U.S. federal income tax liability provided the required information is timely furnished to the IRS. You should consult your tax advisors regarding the application of the U.S. information reporting and backup withholding rules to your particular circumstances.
Material French Tax Consequences
General
The information set out below is a summary of certain material French tax consequences in connection with the acquisition, ownership and disposition of our ordinary shares.
This summary does not purport to be a comprehensive description of all the French tax considerations that may be relevant to a particular holder of our ordinary shares. Holders may be subject to special tax treatment under any applicable law and this summary is not intended to be applicable in respect of all categories of holders of our ordinary shares.
-96-


This summary is based on the applicable tax laws of France as in effect on the date of this Annual Report and the guidelines issued by the French tax authorities within the Bulletin Officiel des Finances Publiques-Impôts (the “Guidelines”) in force as of the date of this Annual Report, as applied and interpreted by French courts. All of the foregoing is subject to change, which change could apply retroactively and could affect the continued validity of this summary.
Because it is a general summary, prospective holders of our ordinary shares should consult their own tax advisors as to the French or other tax consequences of the acquisition, holding and disposition of the ordinary shares including, in particular, the application to their particular situations of the tax considerations discussed below. This summary does not constitute legal or tax advice.
French dividend withholding tax
The comments below (i) relate exclusively to the situation of the shareholders holding ordinary shares of the Company registered on the register maintained by our transfer agent in the U.S., Computershare Trust Company, N.A. (the “U.S. Register”) that are eligible for listing (“DTC-eligible”) through The Depository Trust Company (“DTC”), and (ii) are notably based on the confirmation obtained from the French tax authorities on October 11, 2019 (the “French Ruling”). Any shareholder holding our ordinary shares in a different manner should seek advice from their tax advisor to determine the taxation mechanism applicable to them in connection with the shares of the Company.
In the case of a distribution of dividends by the Company, the French withholding tax treatment described below would apply subject to the French financial intermediary in its capacity as French paying agent of the dividends (such French paying agent and any of its successors acting in the same capacity, the “French Paying Agent”) being provided with the required information and documentation relating to the tax status of the shareholders. Failing that, the withholding tax would be levied at the “default” rate of 30% (except in the case where the dividends are paid in non-cooperative States or territories within the meaning of article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, in which case a 75% withholding tax would apply). Any tax to be withheld at source will be calculated on the amount in euros of the distribution attributable to the shareholder.
The list of non-cooperative States and territories within the meaning of article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code is published by ministerial order and normally updated annually. It was last updated by a ministerial order dated February 26, 2021 (Official Journal dated March 4, 2021) and presently includes Anguilla, the British Virgin Islands, the American Virgin Islands, Panama Seychelles, Fiji, Guam, Samoa, American Samoa, Trinidad & Tobago, Republic of Palau, Dominica and Vanuatu.
Withholding tax on dividends paid to shareholders who are residents of France
French tax resident individuals
Personal income tax
The following would only apply to individual shareholders resident of France for tax purposes, holding their shares in the Company as part of their private estate, who do not hold their shares in the Company through an equity savings plan (plan d’épargne en actions or PEA), and who do not conduct stock market transactions under conditions similar to those which define an activity carried out by a person conducting such operations on a professional basis.
Under Article 117 quater of the French tax code, subject to certain exceptions mentioned below, dividends paid to individuals who are French tax residents are subject to a withholding tax equal to 12.8% of the gross amount distributed. This withholding tax would be levied by the French Paying Agent.
However, individuals belonging to a tax household whose reference fiscal income, as defined in 1° of IV of Article 1417 of the French Tax Code, for the second year preceding the year of payment of the dividends is less than €50,000 for taxpayers who are single, divorced or widowed, or €75,000 for couples filing jointly, may request an exemption from this withholding tax under the terms and conditions of Article 242 quater of the French Tax Code, i.e., by providing to the French Paying Agent, no later than November 30 of the year preceding the year of the payment of the dividends, a sworn statement that their reference fiscal income shown on their taxation notice (avis d’imposition) issued in respect of the second year preceding the year of payment was below the above-mentioned taxable income thresholds. Taxpayers who acquire new shares after the deadline for providing the aforementioned exemption request could provide such exemption request to the French Paying Agent upon acquisition of such new shares pursuant to paragraph 320 of the Guidelines BOI-RPPM-RCM-30-20-10-20/12/2019.
-97-


The 12.8% withholding constitutes an installment on account of the taxpayer’s final income tax and is creditable against the final personal income tax due by the taxpayer with respect to the year during which it is withheld, the surplus, if any, being refunded to the taxpayer.
The taxpayer is then subject to income tax at a flat rate of 12.8% on the dividends (except if he elects to be taxed at the progressive income tax rates). Because the rate of the withholding tax is aligned on the rate of the final personal income tax due by the recipient of the dividend (except if he elects to be taxed at the progressive income tax rates), the total amount of the personal income tax charge related to the dividend is in practice withheld at source.
Shareholders concerned should seek advice from their usual tax advisor to determine the taxation mechanism applicable to them in connection with dividends paid on the shares of the Company.
Moreover, regardless of the shareholder’s tax residence or place of residence, pursuant to Article 119 bis 2 of the French Tax Code, if dividends are paid outside France in a non-cooperative State or territory within the meaning of Article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, a 75% withholding tax would be applicable on the gross dividend distributed unless the shareholder provides evidence that the distributions have neither the object nor the effect to enable, for tax evasion purpose, the location of income in such a State or territory.
Relevant shareholders are advised to consult their usual tax advisor to determine the method by which this withholding tax will be credited against the amount of their income tax.
Social contributions
Whether or not the 12.8% withholding tax described above is applicable, the gross amount of the dividends paid by the Company to French tax resident individuals would also be subject to social contributions at an overall rate of 17.2%, which breaks down as follows:
the contribution sociale généralisée at a rate of 9.2%;
the contribution pour le remboursement de la dette sociale at a rate of 0.5%; and
the prélèvement de solidarité at a rate of 7.5%.
The social contributions are levied in the same manner as the 12.8% withholding tax described above.
French tax resident entities that are subject to French corporate income tax under standard conditions
Dividends paid by the Company to legal entities that are French tax residents subject to French corporate income tax under standard conditions will not, in principle, be liable to any withholding tax.
However, if the dividends distributed by the Company are paid outside France in a non-cooperative State or jurisdiction within the meaning of Article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, a 75% withholding tax will apply, unless the concerned shareholder provides evidence that the distributions have neither the object nor the effect to enable, for tax evasion purpose, the location of income in such a State or territory.
Shareholders are advised to consult their usual tax advisor to determine the tax regime that will apply to their own situation.
Other French tax residents
French tax resident shareholders who are in a different situation than those described above should seek professional advice from their usual tax advisor as to the tax treatment that will apply to their own situation.
Withholding tax on dividends paid to shareholders who are not resident of France
Under French law, dividends paid by a French corporation, such as the Company, to non-residents of France are generally subject to French withholding tax at a rate of (i) 12.8% for distributions made to individuals, (ii) 15% for distributions made to not-for-profit organizations with a head office in a Member State of the European Union or in another Member State of the European Economic Area Agreement that has concluded a tax treaty with France which includes an administrative assistance provision to address tax evasion and avoidance, that would be taxed in accordance with the provisions of Article 206, 5 of the French Tax Code had such holder had its registered office in France and that meet the criteria provided for by the Guidelines
-98-


BOI-IS-CHAMP-10-50-10-40-25/03/2013, n° 580 et seq. and BOI-RPPM-RCM-30-30-10-70-24/12/2019, n° 130, and (iii) generally 28% (it being noted that such withholding tax rate varies in line with the reduction of the rate of French corporate income tax provided for by Article 219, I of the French Tax Code) in other cases.
The French dividend withholding tax also applies to any payment made by a person established or domiciled in France to a non-resident in the context of a temporary assignment or a similar transaction giving the right or obligation to return or resell the shares or other rights relating to these shares. In accordance with Article 119 bis A, 1 of the French Tax Code, such temporary or similar transaction must be carried out for a period of less than forty-five days, including the date on which a right to receive a dividend (or assimilated income) in respect of the assigned shares (or rights related thereto) arises. The withholding tax is assessed on the payment made to the assignor by the assignee, within the limit of the amount of the dividend (or assimilated income) which the assignee acquires the right to receive over the period of assignment. If the assignor provides proof that such payment relates to a transaction the principal object and effect of which is not to avoid the application of a withholding tax or to obtain the granting of a tax benefit, then such assignor will be able to obtain reimbursement of the withholding tax from the tax office of his domicile or registered office.
Pursuant to paragraph 2 of Article 187 of the French Tax Code, dividends paid by a French corporation, such as the Company, in non-cooperative States or territories, as defined by Article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, will generally be subject to French withholding tax at a rate of 75%, irrespective of the tax residence of the beneficiary of the dividends, unless the concerned beneficiary provides evidence that the dividends have neither the object nor the effect to enable, for tax evasion purpose, the location of income in such a State or territory.
Shareholders that are legal entities having their place of effective management in a Member State of the European Union or, under certain conditions, in another Member State of the European Economic Area Agreement that has concluded with France a tax treaty including an administrative assistance provision to address tax evasion and avoidance, may benefit from a withholding tax exemption, if they hold at least 10% of the Company’s share capital, and otherwise meet all the conditions of Article 119 ter of the French Tax Code. This 10% threshold is decreased to 5% where such legal entities qualify as parent companies (sociétés mères) within the meaning of Article 145 of the French Tax Code and cannot use the withholding tax as a tax credit in the jurisdiction in which their tax residence is situated.
Moreover, under article 235 quater of the French Tax Code, legal entities (i) having their place of effective management in (a) a Member State of the European Union, (b) another Member State of the European Economic Area Agreement or (c) any third country that has concluded with France a tax treaty including an administrative assistance provision to address tax evasion and avoidance and a treaty on mutual administrative assistance for recovery and which is not a non-cooperative State or territory, as defined by Article 238-0 A of the French Tax Code (provided that, in the latter case, the shareholding held by concerned legal entity in the distributing company does not enable it to effectively take part in its management or control) and (ii) being in a tax loss position may, under certain conditions, benefit from a temporary reimbursement of the withholding tax (taking the form of a tax deferral), such withholding tax having to be paid to the French treasury under certain circumstances, including, in particular, at the time they reach a profitable tax position.
The legal entities referred to in the preceding paragraph may benefit from a withholding tax exemption provided that they are (i) in a tax loss position and (ii) the subject of a liquidation under a bankruptcy proceeding at the time of the distribution.
Furthermore, Article 119 bis 2° of the French Tax Code provides that the withholding tax does not apply to dividends distributed to collective investment undertakings governed by foreign law, located in a Member State of the European Union or another State that has concluded with France a tax treaty including an administrative assistance provision to address tax evasion and avoidance and which satisfy the following two conditions:
raising capital from a certain number of investors with the purpose of investing it in a fiduciary capacity on behalf of such investors pursuant to a defined investment policy; and
having features similar to those required from collective undertakings governed by French law under section 1, paragraphs 1, 2, 3, 5 et 6 of sub-section 2, sub-section 3, or sub-section 4 of section 2 of Chapter IV of the 1st Title of Book II of the French Monetary and Financial Code.
The conditions for this exemption are set forth in detail in the Guidelines BOI-RPPM-RCM-30-30-20-70-12/08/2020.
Double tax treaties entered into between France and the States of residence of shareholders may provide for an exemption or a reduction of the French dividend withholding tax, subject to (i) certain requirements set forth therein being met and (ii) the shareholders duly completing and providing the required information and documentation. The exemptions or reduced rates of withholding tax provided for in double tax treaties may be applied to the benefit of the shareholders of our Company, as
-99-


effective beneficiaries of the income, provided that they are identified and are entitled to the benefits provided by the double tax treaty which they avail themselves.
Dividends paid to eligible shareholders may be subject to the reduced rates from the outset provided, as the case may be, by the applicable double tax treaties if the French Paying Agent has received before the date of payment of the dividend the required information and documentation.
Shareholders who failed to file the required information and documentation with the French Paying Agent prior to the payment of the dividend may claim to the French tax authorities or the French Paying Agent the refund of the excess withholding tax by filing such information and documentation before December 31 of the second calendar year following the year during which the dividend is paid.
French Financial Transaction Tax and Registration Duties on Disposition of our Shares
In its decision of 13 December 2017 on the equivalence of the legal and supervisory framework of the United States of America for national securities exchanges and alternative trading systems in accordance with Directive 2014/65/EU of the European Parliament and of the Council, the European Commission decided that for the purposes of Article 23, paragraph 1, of Regulation (EU) No 600/2014, the legal and supervisory framework of the United States applicable to the NYSE are considered equivalent to the requirements applicable to regulated markets, within the meaning of Directive 2014/65/EU, as they result from Regulation (EU) No 596/214, Title III of Directive 2014/65/EU, Title II of Regulation (EU) No 600/2014 and Directive 2004/109/EC, together with effective supervision and sanctions regime.
Article 198 of the Pacte Act came into force on June 10, 2019 and modified Article L. 228-1 paragraph 7 of the French Commercial Code to allow an intermediary to be registered as the “registered intermediary” (intermédiaire inscrit) on behalf of any holders of shares of companies which are admitted to trading solely on a market in a non-EU country considered equivalent to a regulated market pursuant to paragraph (a) of Article 25(4) of Directive EC2014/65/EU (which includes the NYSE).
However, the NYSE is not formally recognized as a foreign regulated market by the French Minister of the Economy.
French financial transaction tax
The comments below (i) relate exclusively to the book-entry transfers of our ordinary shares within DTC and (ii) are notably based on the French Ruling.
Pursuant to Article 235 ter ZD of the French Tax Code, purchases of equity instruments or similar securities (such as American Depositary Receipts) of a French company listed on a regulated market of the EU or on a foreign regulated market formally recognized as such by the French Minister of the Economy are subject to a 0.3% French tax on financial transactions provided that the issuer’s market capitalization exceeds 1 billion of euros as of December 1 of the year preceding the taxation year.
The French financial transaction tax will not be due on the purchases of ordinary shares of the Company as long as the NYSE is not a foreign regulated market formally recognized as such by the French Minister of the Economy and Article 235 ter ZD of the French Tax Code is not modified.
French registration duties
The comments below (i) relate exclusively to the book-entry transfers of our ordinary shares within DTC and (ii) are notably based on the French Ruling. Transfers of shares issued by a French corporation for consideration are generally subject to registration duties at the rate of 0.1% (i) when the French corporation is listed on a regulated market within the meaning of Article L 421-1 of the French Monetary Code, on a multilateral trading facility within the meaning of Article L 424-1 of the French Monetary Code, or on any foreign equivalent market operating under similar conditions, when the transfer is evidenced by a written agreement, and (ii) when the French corporation is not listed on any of the above mentioned markets, irrespective of whether the transfer is evidenced by a written agreement.
The NYSE has been considered equivalent to a regulated market pursuant to paragraph (a) of Article 25(4) of Directive EC2014/65/EU. Thus, we believe that the NYSE should be deemed to be a foreign market operating under similar conditions to regulated markets within the meaning of Article L 421-1 of the French Monetary Code or multilateral trading facilities within the meaning of Article L 424-1 of the French Monetary Code.
-100-


Therefore, the following transactions on ordinary shares of the Company should not give rise to the duty provided for in Article 726 of the French Tax Code:
transactions on shares of the Company realized on the NYSE;
over-the-counter sales of ordinary shares of the Company published on the market or communicated to the regulator in application of the MIF Directive or foreign provisions equivalent to the MIF Directive, provided that they are not evidenced by a written agreement; and
over-the-counter transactions carried out on ordinary shares of the Company in connection with transactions that are the subject of the same publishing or communication obligations, provided that they are not evidenced by a written agreement.
French withholding tax treatment of the sale or other disposition of the rights on our ordinary shares
French tax residents
No French withholding tax will apply on the sale, exchange, repurchase or redemption (other than redemption proceeds which may, under certain circumstances be partially or fully characterized as dividends under French domestic tax law or administrative guidelines) of their rights on the ordinary shares of the Company by French tax residents.
Non-French tax residents
A shareholder who is not a French resident for French tax purposes will not be subject to French tax on capital gain from the sale, exchange, repurchase or redemption (other than redemption proceeds which may, under certain circumstances be partially or fully characterized as dividends under French domestic tax law or administrative guidelines) of its rights on the ordinary shares of the Company, unless (i) the shareholder is domiciled, established or incorporated out of France in a non-cooperative State or territory as defined in Article 238-0 A 1, 2 and 2 bis-1° of the French Tax Code, (ii) the rights on the shares of the Company form part of the property of a permanent establishment that the shareholder has in France or (iii) the shareholder has held, directly or indirectly, at any time during the five years preceding the date of disposal, and as relates to individuals together with their spouse, ascendants and descendants, rights to more than 25% of the profits of the Company (droits aux bénéfices sociaux).

Certain Material Dutch Tax Consequences Dutch dividend withholding tax

General
Since the Company was initially incorporated under Dutch law it is deemed to be resident of the Netherlands for Dutch dividend withholding tax purposes. Dividends paid on our ordinary shares following migration are therefore, based on Dutch domestic law, still subject to Dutch dividend withholding tax at a rate of 15%. However, since our corporate seat has been transferred to France as of December 12, 2019, our dividends paid on our ordinary shares generally should be subject to French dividend withholding tax and not to Dutch dividend withholding tax on the basis of the double tax treaty between the Netherlands and France. However, both French and Dutch dividend withholding tax may be required to be withheld from any such dividends paid, if and when paid to Dutch resident holders of our ordinary shares (and non-Dutch resident holders of our ordinary shares that have a permanent establishment in the Netherlands to which the ordinary shares are attributable). We have approached the Dutch Tax authorities (here after “Dutch Revenue”) to apply for a tax ruling confirming that no withholding of any Dutch dividend withholding tax is applicable to any dividends paid by us even if we are no longer a Dutch tax resident for treaty purposes. However, Dutch Revenue has not been willing to confirm this.
We will therefore be required to identify our shareholders in order to assess whether there are Dutch resident holders of our ordinary shares or non-Dutch resident holders of our ordinary shares with a permanent establishment in the Netherlands to which the ordinary shares are attributable in respect of which Dutch dividend withholding tax has to be withheld on dividends paid. Such identification may not always be possible in practice. According to Dutch Revenue, Dutch dividend withholding tax must also be withheld on dividends paid in as far as the identity of our shareholders cannot be assessed. Withholding of both French and Dutch dividend withholding tax may occur in certain scenarios. Once we anticipate distributing a dividend, identification of our shareholders (by ourselves or a paying agent) is typically required in order to effectuate such dividend payments and could limit the Dutch dividend withholding tax that may need to be withheld.
-101-


Generally, the Dutch dividend withholding tax will not be borne by us, but will be withheld from the gross dividends paid on our ordinary shares. A 15% Dutch dividend withholding tax will in principle be levied on the gross amount of dividend. The term “dividends” for Dutch dividend withholding tax purposes includes, but is not limited to:
distributions in cash or in kind, deemed and constructive distributions and repayments of paid-in capital not recognized for Dutch dividend withholding tax purposes;
liquidation proceeds, proceeds of redemption of ordinary shares or, generally, consideration for the repurchase of ordinary shares by us in excess of the average paid-in capital of those ordinary shares recognized for Dutch dividend withholding tax purposes;
the nominal value of ordinary shares issued to a shareholder or an increase of the nominal value of ordinary shares, as the case may be, to the extent that it does not appear that a contribution to the capital recognized for Dutch dividend withholding tax purposes was made or will be made; and
partial repayment of paid-in capital, recognized for Dutch dividend withholding tax purposes, if and to the extent that there are net profits (zuivere winst), within the meaning of the Dutch Dividend Withholding Tax Act 1965 (Wet op de dividendbelasting 1965), unless the general meeting of shareholders has resolved in advance to make such a repayment and provided that the nominal value of the ordinary shares concerned has been reduced by a corresponding amount by way of an amendment of our articles of association.
Notwithstanding the above, as part of the Multilateral Instrument of the Action Plan on Base Erosion and Profit Shifting of the OECD, a principal purpose test (“PPT”) should be applied alongside the double tax treaty between the Netherlands and France as of January 1, 2020. This PPT requires that the benefits of a tax treaty should not be available if it is reasonable to conclude, having regard to all relevant facts and circumstances, that obtaining that benefit was one of the principal purposes of any arrangement or transaction that resulted directly or indirectly in that benefit, unless it is established that granting that benefit in these circumstances would be in accordance with the object and purpose of the relevant provisions of that treaty.
In theory, the Dutch Revenue may take the position that one of the principal purposes of the transfer of the place of effective management of the Company to France was to obtain a tax benefit under the double tax treaty between the Netherlands and France, being the benefit that the Netherlands cannot levy a dividend withholding tax anymore (except for the cases as stated above). On this basis, they could argue that the PPT is met and, hence, that the treaty would effectively not apply and that the Netherlands would be allowed to levy Dutch dividend withholding tax on dividends distributed, irrespective of the shareholder. Considering the background of the Transfer it seems unlikely that the Dutch Revenue would be able to successfully take the position.
F. Dividends and Paying Agents
Not applicable.
G. Statement of Experts
Not applicable.
H. Documents on Display
The SEC maintains an Internet website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that site is www.sec.gov.
We also make available on our website, free of charge, our annual reports on Form 20-F and the text of our reports on Form 6-K, including any amendments to these reports, as well as certain other SEC filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website address is www.constellium.com. The information contained on our website is not incorporated by reference in this document.
I. Subsidiary Information
Not applicable.
-102-


Item 11. Quantitative and Qualitative Disclosures About Market Risk
Refer to the information set forth under the Notes to the Consolidated Financial Statements at “Item 18. Financial Statements”:
Note 2—Summary of Significant Accounting Policies—2.6— Principles governing the preparation of the Consolidated Financial Statements— Financial Instruments; and
Note 22—Financial Risk Management.

Item 12. Description of Securities Other than Equity Securities
Not applicable.
PART II
Item 13. Defaults, Dividend Arrearages and Delinquencies
None.
Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds
A. Material Modifications to the Rights of Security Holders
The information called for by this Item has been reported in the Current Report on Form 6-K filed on December 12, 2019, with the Securities and Exchange Commission, and all exhibits attached thereto, which is incorporated by reference into this Annual Report.
B. Use of Proceeds
None.


Item 15. Controls and Procedures
A. Disclosure Controls and Procedures
Our Chief Executive Officer and principal financial officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of the end of the period covered by this Form 20-F, have concluded that, as of such date, our disclosure controls and procedures were effective.
B. Management’s Annual Report on Internal Control over Financial Reporting
The management of the Company, including the Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in the Securities Exchange Act of 1934, as amended, Rule 13a-15(f).
The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and as endorsed by the European Union (EU).
The Company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of
-103-


the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of the effectiveness of internal control to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Constellium’s management has assessed the effectiveness of the Company’s internal controls over financial reporting as of December 31, 2020 based on the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and, based on such criteria, Constellium’s management has concluded that, as of December 31, 2020, the Company´s internal control over financial reporting is effective.
C. Attestation report of the registered public accounting firm.
The effectiveness of the Company’s internal control over financial reporting as of December 31, 2020 has been audited by PricewaterhouseCoopers Audit, an independent registered public accounting firm, as stated in their report which appears herein.
D. Changes in Internal Control over Financial Reporting
During the period covered by this report, we have not made any change to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 16.
Item 16A. Audit Committee Financial Expert
Our Board of Directors has determined that the members of our Audit Committee, Mmes. Walker and Brooks and Messrs. Paschke and Ormerod satisfy the “independence” requirements set forth in Rule 10A-3 under the Exchange Act. Our Board of Directors has also determined that each of Ms. Walker and Messrs. Paschke and Ormerod is an “audit committee financial expert” as defined in Item 16A of Form 20-F under the Exchange Act.
Item 16B. Code of Ethics
We have adopted a Worldwide Code of Employee and Business Conduct that applies to all our employees, officers and directors, including our principal executive, principal financial and principal accounting officers. Our Worldwide Code of Employee and Business Conduct addresses, among other things, competition and fair dealing, conflicts of interest, financial integrity, government relations, confidentiality and corporate opportunity requirements and the process for reporting violations of the Worldwide Code of Employee and Business Conduct, employee misconduct, conflicts of interest or other violations. Our Worldwide Code of Employee and Business Conduct is intended to meet the definition of “code of ethics” under Item 16B of Form 20-F under the Exchange Act.
A copy of our Worldwide Code of Employee and Business Conduct is available on our website at www.constellium.com. Any amendments to the Worldwide Code of Employee and Business Conduct, or any waivers of its requirements, will be disclosed on our website.
Item 16C. Principal Accountant Fees and Services
PricewaterhouseCoopers Audit has served as our independent registered public accounting firm for each of the fiscal years in the three-year period ended December 31, 2020.
-104-


The following table sets out the aggregate fees for professional services and other services rendered to us by PricewaterhouseCoopers in the years ended December 31, 2020 and 2019, and breaks down these amounts by category of service:
For the year ended December 31,
2020 2019
(€ in thousands)
Audit fees 3,682  3,948 
Audit-related fees 632  448 
Tax fees 285  202 
All other fees
Total(1)
4,601  4,600 
__________________
(1) Including out-of-pocket expenses amounting to €86,000 and €423,000 for the years ended December 31, 2020 and 2019, respectively.
Audit Fees
Audit fees consist of fees related to the annual audit of our Consolidated Financial Statements, and our statutory financial statements, the audit of the statutory financial statements of our subsidiaries, other audit or interim review services provided in connection with statutory and regulatory filings or engagements.
Audit-Related Fees
Audit-related fees consist of fees rendered for assurance and related services that are reasonably related to the performance of the audit or review of the company’s financial statements, or that are traditionally performed by the independent auditor, and include consultations concerning financial accounting and reporting standards; advice and assistance in connection with local statutory accounting requirements and due diligence related to acquisitions or disposals.
Tax Fees
Tax fees relate to tax compliance, including the preparation of tax returns and assistance with tax audits.
Pre-Approval Policies and Procedures
The advance approval of the Audit Committee or members thereof, to whom approval authority has been delegated, is required for all audit and non-audit services provided by our auditors.
Item 16D. Exemptions from the Listing Standards for Audit Committees
None.
Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers
None.
Item 16F. Change in Registrant’s Certifying Accountant
None.
Item 16G. Corporate Governance
As a foreign private issuer listed on the NYSE, we are subject to NYSE corporate governance listing standards. However, NYSE rules permit a foreign private issuer like us to follow the corporate governance practices of its home country. Following
-105-


the Transfer, we intend to rely on the NYSE Listed Company Manual with respect to our corporate governance to the extent possible under French law.
The following are the significant ways in which our corporate governance practices differ from those required for U.S. companies listed on the NYSE following the Transfer.
Audit Committee-The Board’s audit committee is responsible for selecting our statutory auditors and making a recommendation to our Board regarding the terms of their compensation. As required by French law, the actual appointment of the statutory auditors has to be made by the shareholders at a general meeting of the shareholders.
Committee Powers-While the NYSE Listed Company Manual empowers board committees with decision-making authority that can be delegated by a company’s board, under French law, committees of the Company recommend to the full Board, which will be the decision-making body (not its committees).
Executive Sessions/Communications with Independent Directors-French law does not require for our independent directors to meet regularly without management, nor does it require the independent directors to meet alone in executive session at least once a year, as required by the NYSE Listed Company Manual. However, if our independent directors decide to engage in either or both of these activities, they will be permitted to do so. In practice, our independent directors regularly meet among themselves for discussions, but we do not expect them to be under any requirement to do so under our Articles of Association or French law. In addition, French law does not require a method for interested parties to communicate with our independent directors.
Equity Compensation Plans-French law requires shareholder approval at a general meeting of the shareholders to adopt an equity compensation plan, which is consistent with the shareholder vote required by the NYSE Listed Company Manual. It is common practice after obtaining such shareholder approval for the shareholders of a French company to then delegate to such company’s board of directors the authority to decide on the specific terms of the granting of equity compensation, within the limits of the shareholders’ authorization. The shareholders of the Company at the general meeting held on November 25, 2019 voted on such an authorization (effective as of December 12, 2019) to delegate such authority to the Board of Directors.
Corporate Governance Guidelines-A Board Internal Charter is required by the NYSE Listed Company Manual for U.S. companies listed on the NYSE that would set forth certain corporate governance practices of a listed company’s board. Our Board Internal Charter after the Transfer covers all items required by the NYSE Listed Company Manual subject to certain differences set forth by French law, particularly with respect to Committee powers (as described above) and conflict of interest transactions (as described below).
Conflicts of Interest-Pursuant to French law and the Articles of Association, any agreement (directly or through an intermediary) between the Company and any director of the Company that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions will be subject to the prior authorization of the Board, excluding the participation and vote of the interested director. As required by French law, any such agreement will also be subject to approval at the next ordinary shareholders’ meeting (by a simple majority, excluding the vote of interested persons). If the transaction has not been pre-approved by the Board, it can be nullified if it has prejudicial consequences for the Company. If it is not approved by the shareholders, interested directors may be held liable for any prejudicial consequences for the Company of the unapproved transaction; such transaction will nevertheless remain valid, unless it is nullified in case of fraud. The foregoing requirements also apply to agreements between the Company and another entity if one of the Company’s directors is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the Company’s directors has an indirect interest. Aside from the foregoing requirements, there are no specific provisions prohibiting conflicted directors to participate or vote at a Board meeting. However, as a general rule under French law, directors must act in the interest of the Company.
In addition to the above differences, the following are corporate governance provisions applicable to the Company under French law and our Articles of Association:
Rights of Shareholders and Shareholders' Meetings
Under French law and in general, each shareholder is entitled to one vote per share at any general shareholders’ meeting. A general shareholders’ meeting is held annually to, inter alia, approve the annual financial statements. General shareholders’
-106-


meetings (including annual meetings) can be ordinary and/or extraordinary, depending upon the resolutions submitted to the vote.
At an extraordinary general shareholders’ meeting (which votes upon any proposal to change the articles of association, including any change in the rights of shareholders), majority is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/4 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting. If the quorum at the second meeting is not reached, the second meeting can be postponed to a date no later than two months after the date on which the second meeting was convened. The quorum for such second or postponed meeting, as the case may be, to be validly held is 1/5 of the voting shares.
At an ordinary shareholders’ meeting (which votes upon any proposal within the competence of a general shareholders’ meeting other than an extraordinary shareholders meeting such as approval of annual financial statements or appointment of directors), majority is simple majority (more than 50%) of the votes validly cast. Majority at special meetings is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/5 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting; no quorum is required for such second meeting.
Special meetings bring together the holders of shares of a specified class, should it be created, to decide on an amendment to the rights relating to the shares of this class. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/3 of the voting shares, and, failing which, 1/5 for the meeting held on the date set by the second convening notice or in the case of postponement of the second meeting.
French law does not provide for cumulative voting. The right to participate in a shareholders’ meeting is granted to all the shareholders whose shares are fully paid up and for whom a right to attend shareholders’ meetings has been established by registration of their shares in their names or names of the authorized intermediary acting on their behalf on the second business day prior to the shareholders’ meeting at 0:00 (zero hour) (Paris time) (the “French Record Date”), either in the registered (“au nominatif”) shares accounts held by the company (or an agent acting on its behalf) or in the bearer (“au porteur”) shares accounts held by the authorized intermediary.
Shareholders holding shares registered on the U.S. Register (which include all shares which are listed on the NYSE, held through a DTC participant and shares directly recorded in the name of their holder with Computershare) vote through a process similar to the one that was in place before the Transfer with the following main differences:
their voting instructions will be transmitted to the Company via the French Intermediary, acting as intermediary for the account of all shareholders registered on the U.S. Register, in accordance with articles L. 228-1 et seq. of the French Commercial Code;
the French Record Date will be set;
an additional record date will be fixed for all shareholders registered on the U.S. Register, which date will be the 25th day before the meeting (the “U.S. Mailing Record Date”); and
shareholders who purchase shares between the U.S. Mailing Record Date and the French Record Date will be entitled to participate and vote at the shareholders’ meeting as long as they continue to be shareholders on the French Record Date. However, given the short time between the French Record Date and the shareholders’ meeting date, shareholders as of the French Record Date may not have received the notices and information received by shareholders holding shares registered on the U.S. Register as of the U.S. Mailing Record Date. To the extent that shareholders as of the U.S. Mailing Record Date have sent voting instructions and sold or otherwise transferred their shares as of the French Record Date, such voting instructions will be invalidated or modified by the Company, as the case may be, in accordance with articles R. 225-85 and R. 225-86 of the French Commercial Code.
Shareholder Proposals and Action by Written Consent
Pursuant to French law, the board of directors is required to convene an annual ordinary general meeting of shareholders for approval of the annual financial statements. This meeting must be held within six months after the end of each prior fiscal year.
The board of directors may also convene an ordinary or extraordinary meeting of shareholders upon proper notice at any time during the year. If the board of directors fails to convene a shareholders’ meeting, the auditors may call the meeting. In a bankruptcy, the liquidator or court-appointed agent may also call a shareholders’ meeting in some instances. Any of the following may request the court to appoint an agent:
-107-


one or several shareholders holding at least 5% of the share capital, or
 any interested party or the workers committee in cases of urgency.
Shareholders holding a majority of the capital or voting rights after a public take-over bid or exchange offer or the transfer of a controlling block of shares may also convene a shareholders’ meeting. In general, shareholders can only take action at shareholders’ meetings on matters listed on the agenda for the meeting. As an exception to this rule, shareholders may take action with respect to the dismissal and appointment of directors.
Additional draft resolutions to be submitted for approval by the shareholders at any shareholders’ meeting may be proposed to the board of directors within the proscribed time limit (which is no later than 20 days after the publication of the convening notice (avis de réunion) and in any event no sooner than 25 days prior to the date of the shareholders’ meeting) by one or several shareholders holding a specified percentage of shares. The convening notice (avis de réunion) must be published in France with the BALO at least 35 days prior to the date of the shareholders’ meeting and can be consulted at https://www.journal-officiel.gouv.fr/balo/. As the U.S. Mailing Record Date is fixed at the 25th day before the shareholders’ meeting, shareholders wishing to submit additional resolutions will need to submit them before receiving the meeting materials sent to them on or around the U.S. Mailing Record Date, otherwise their submissions will not be considered. The percentage of shares required to be held by one or several shareholders to be able to submit additional draft resolutions depends on the amount of the share capital of the Company; based on the Company’s issued share capital of €2,799,253.44 as of December 31, 2020, this percentage would be 2.90%.
Under French law, shareholders’ action by written consent is not permitted in a Societas Europaea.
Shareholder Suits
French law provides that a shareholder, or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a company in the company’s interest if it fails to bring such legal action itself. If so, any damages awarded by the court are paid to the company and any legal fees relating to such action are borne by the relevant shareholder or the group of shareholders. The plaintiff must remain a shareholder throughout the duration of the legal action. There is no other case where shareholders may initiate a derivative action to enforce a right of a company.
A shareholder may alternatively or cumulatively bring an individual legal action against the directors, provided he or she has suffered distinct damages from those suffered by the company. In this case, any damages awarded by the court are paid to the relevant shareholder.
Repurchase of Shares; Pre-emptive Rights; Shareholder Vote on Certain Reorganizations
Under French law, a private company (which our Company is for French law purposes for so long as it is listed on the NYSE only) may not subscribe for newly issued shares in its capital but may, however, acquire its own shares for the following purposes only:
With a view to distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, restricted free share or share option plan, not to exceed 10% of the share capital;
In payment or in exchange for assets acquired by the company within two years of their repurchase, not to exceed 5% of the share capital;
To sell the relevant shares to any shareholders willing to purchase them as part of a process organized by the company within five years, not to exceed 10% of the share capital.
Shares acquired but not used in accordance with the above purposes must be cancelled.
As of today, the Company does not have in place an authorization granted to the Board of Directors to purchase its own shares.
The Company may also acquire its own shares to decrease its share capital, provided that such decision is not driven by losses and that a purchase offer is made to all shareholders on a pro rata basis, with the approval of the shareholders at the extraordinary general meeting deciding the capital reduction.
Under French law, in case of issuance of additional shares or other securities giving right, immediately or in the future, to new shares for cash or set-off against cash debts, the existing shareholders have preferential subscription rights to these securities on a pro rata basis unless such rights are waived by a two-thirds majority of the votes held by the shareholders
-108-


present, represented by proxy or voting by mail at the extraordinary meeting deciding or authorizing the capital increase. In case such rights are not waived by the extraordinary general meeting, each shareholder may individually either exercise, or assign or not exercise its preferential rights.
Generally, under French law, completion of a legal merger (fusion), demerger (scission), dissolution, sale, lease or exchange of all or substantially all of a company’s assets, requires:
 the approval of the board of directors; and
 the approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting, or in the case of a legal merger (fusion) with a non-EU company, approval of all the shareholders of the company.
Anti-Takeover Provisions and Shareholder Disclosure Thresholds
Anti-Takeover Provisions
French law does not contain provisions restricting or making difficult to change the composition of the board of directors following a change of control.
French law allows shareholders at general meetings to delegate the authority to the board of directors to issue shares or warrants to subscribe for shares, which may make it more difficult for a shareholder to obtain control over our general meeting of shareholders.
The shareholders’ meeting of June 29, 2020 delegated the authority to our Board of Directors to decide the issuance, in the event of a public bid on the Company’s shares, of warrants each enabling the subscription of one or more ordinary shares, up to €1,378,674.18 (representing 49.99% of the Company’s share capital at the time of that shareholders’ meeting) and to freely allot said warrants to all of the Company’s shareholders having that capacity before the expiration of the public offering period. The Board of Directors had decided that any such issue of free warrants to subscribe to new shares in the event of a public tender on the Company would in any event be limited to 40% of the share capital for the 12-month period.
This delegation has certain similarities to a rights plan in the U.S., both allowing the board of directors to issue free warrants to subscribe to new shares to existing shareholders in case an unsolicited public tender offer is launched on the Company. It aims to give the board of directors the possibility to negotiate with the bidder to induce the bidder to raise the offer price and/or improve the terms of the offer. It could only be triggered in the event of a public bid for the shares and if the warrants are issued, they will be issued to all those shareholders who hold shares before the expiry of the public offer period. This delegation has been given for a twelve-month period expiring on June 28, 2021.
Crossing of Threshold Notifications
According to the Articles of Association, any natural persons or legal entities acting alone or in concert, who come to own, directly or indirectly, a number of shares equal to or greater than 5%, 10%, 15%, 20%, 25%, 30%, 33 1/3%, 50%, 66 2/3% or 90% of the total number of shares or voting rights must, within five (5) trading days after the shareholding threshold is crossed, upwards or downwards, notify the Company, by certified letter with acknowledgment of receipt, of the total number of shares or voting rights that they own alone, directly or indirectly, or in concert.
The notification includes information on (i) the number of securities held giving deferred rights to the shares to be issued and the corresponding voting rights, and (ii) the number of shares already issued or the voting rights they may acquire.
Furthermore, according to the Articles of Association, any persons or entities who hold a number of shares equal to or greater than 10%, 15%, 20% or 25% of the total number of shares or voting rights in the Company shall inform the Company of the objectives they intend to pursue over the six (6) months to come.
Following a period of six (6) months, any persons or entities who continue to hold a number of shares or voting rights equal to or greater than the fractions mentioned hereinabove, shall renew their statement of intent, in compliance with the aforementioned terms, for each new period of six (6) months.
-109-


This statement shall specify whether the shareholder is acting alone or in concert, if he plans to discontinue or continue his purchases, to acquire or not the control of the Company, to request his appointment or that of one or several persons as director.
The Company reserves the right to share with the public and shareholders either the objectives that it has been notified of, or the relevant person’s failure to comply with the aforementioned obligation.
For the application of the preceding subparagraphs, the shares or voting rights listed in paragraphs 1 to 8 of Article L. 233-9 I of the French Commercial Code shall be considered equivalent to the shares or voting rights held by a shareholder.
Mandatory Takeover Bid
According to the Articles of Association, any natural or legal persons, acting alone or in concert under Article L. 233-10 of the French Commercial Code, who comes into possession, otherwise than following a voluntary takeover bid, directly or indirectly, of more than 30% of the capital or voting rights of the Company, shall file a draft takeover bid on all the capital and securities granting access to the capital or voting rights, and on terms that comply with applicable United States securities law, rules of the SEC and NYSE rules.
The same requirement applies to natural or legal persons, acting alone or in concert, who directly or indirectly own a number between 30% and half of the total number of equity securities or voting rights of the company and who, in less than twelve consecutive months, increase the holding, in capital or voting rights, of at least 1% of the total number of equity securities or voting rights of the Company.
When a draft offer is submitted, the price proposed must be at least equal to the highest price paid by the offeror, acting alone or in concert within the meaning of Article L. 233-10 of the French Commercial Code, over a period of twelve (12) months preceding the event giving rise to the obligation to submit the draft offer.
In the event of a clear change in the characteristics of the Company, if the market for its securities so justifies or in the absence of a transaction by the offeror, acting alone or in concert, over the Company’s shares during the twelve-month period mentioned in the first paragraph, the price will be fixed by an expert appointed in accordance with Article 1592 of the French Civil Code and determined according to objective evaluation criteria usually used, the characteristics of the Company and the market of its securities, it being specified that the expert will be required to take into account, in its assessment, the criteria identified by the Commission des Opérations de Bourse, the AMF and the French courts.
The obligation to file a draft public offer does not apply if the person or persons concerned justify to the Company the fulfillment of one of the conditions listed in Articles 234-7 and 234-9 of the AMF General Regulations. In the event of disagreement between the parties, an expert will be appointed by the president of the commercial court, ruling in the form of interim relief, for the purpose of determining whether or not it is necessary to file a draft public offer, it being specified that the expert will be required to apply the relevant provisions of the AMF General Regulations as well as the criteria issued by the French Conseil des Marchés Financiers, the AMF and the French courts.
Any breach of the obligation to file a takeover bid as provided in the Articles of Association may give rise to claims for damages or, as the case may be, action for injunctive relief.
Item 16H. Mine Safety Disclosure
Not applicable.
-110-


PART III
Item 17. Financial Statements
See “Item 18. Financial Statements.”
Item 18. Financial Statements
The audited Consolidated Financial Statements as required under Item 18 are attached hereto starting on page F-1 of this Annual Report. The audit report of PricewaterhouseCoopers Audit, an independent registered public accounting firm, is included herein preceding the audited Consolidated Financial Statements.
Parent Company Condensed Financial Information is included herein in Note 32 to the Consolidated Financial Statements.
Item 19. Exhibits
The following exhibits are filed as part of this Annual Report:
EXHIBIT INDEX
1.1
2.1
4.1
4.2
4.3
4.4
4.5
4.6
4.7
-111-


4.8
4.9
4.10
4.11
4.12
4.12.1
4.13
4.14
4.15
4.16
4.17
4.17.2
4.18
4.19
4.20
-112-


4.21
4.22
4.23
4.24
4.25
4.26
4.27
4.28
4.29
4.30
4.31
4.32
4.33
4.34
-113-


4.35
4.36
4.37
4.38
4.39
4.40
4.41
4.42
4.43
4.43.1
4.44
4.45
4.45.1
4.46
-114-


4.46.1
4.46.2
4.46.3
4.46.4
4.47
4.48
4.48.1
4.49
4.50
4.51
10.1
10.2
10.3
-115-


10.4
10.5
10.6
10.7
10.8
10.8.1
10.8.2
10.8.3
10.9
10.9.1
10.9.2
10.9.3
10.9.4
10.10
10.10.1
10.10.2
10.11
10.11.1
-116-


10.12
10.12.1
10.12.2
10.12.3
10.13
10.13.1
10.13.2
10.13.3
10.15
10.15.1
10.15.2
10.15.3
10.16
10.17
10.18
10.19
10.20
10.21
10.22
-117-


10.23
10.23.1
10.23.2
10.23.3
10.23.4
10.25

10.25.1

10.25.2
10.25.3
10.25.4
10.25.5
10.26
10.27
10.28
-118-


10.29
10.30.1
10.30.2
10.30.3
10.30.4
10.30.5
10.30.6
10.30.7
10.30.8
10.31
10.32
12.1
12.2
13.1
13.2
15.1
21.1
101.INS XBRL Instance Document**
101.SCH XBRL Taxonomy Extension Schema Document**
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document**
101.DEF XBRL Taxonomy Extension Definition Linkbase Document**
101.LAB XBRL Taxonomy Extension Label Linkbase Document**
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document**
__________________
**    Filed herein.
+    Confidential treatment granted as to certain portions, which portions have been provided separately to the Securities and Exchange Commission.
-119-


‡    Translated in part.


-120-


SIGNATURES
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.
CONSTELLIUM SE
By: /s/ Jean-Marc Germain
Name:  Jean-Marc Germain
Title: Chief Executive Officer
Date: March 16, 2021

-121-


INDEX TO FINANCIAL STATEMENTS
Constellium SE Audited Consolidated Financial Statements as of December 31, 2020 and 2019 and for the years ended December 31, 2020, 2019 and 2018
2
5
6
7
8
9
10

F-1


Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Constellium SE
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated statement of financial position of Constellium SE and its subsidiaries (the “Company”) as of December 31, 2020 and 2019, and the related consolidated income statement, comprehensive income/ (loss), changes in equity, and statement of cash flows for each of the three years in the period ended December 31, 2020, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board and in conformity with International Financial Reporting Standards as endorsed by the European Union. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Change in Accounting Principle
As discussed in Note 2.6 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Annual Report on Internal Control over Financial Reporting, appearing under Item 15B. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
F-2


expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Goodwill Impairment Assessment – Packaging and Automotive Rolled Products (“P&ARP”) group of cash-generating units
As described in Notes 2 and 17 to the consolidated financial statements, the Company’s consolidated goodwill balance was €417 million at December 31, 2020, and the goodwill associated with the P&ARP group of cash-generating units (the “CGU Group”) was €410 million. Management conducts an impairment test as of December 31 of each year, or more frequently if events or circumstances indicate that the carrying value of goodwill may be impaired. Potential impairment is identified by comparing the recoverable amount of the group of cash-generating units, being the higher of value-in-use and fair value less costs of disposal, to the carrying amount. At December 31, 2020, the recoverable value of the CGU Group has been determined based on its value-in-use. This value is estimated from cash flow projections based on the financial budget approved by management and covering a 5-year period. Cash flows beyond this period are estimated using a perpetual long-term growth rate for the subsequent years. The value-in-use is the sum of discounted cash flows over the projected period and the terminal value. Discount rates are determined based on the weighted-average cost of capital of each cash-generating unit.
The principal considerations for our determination that performing procedures relating to the goodwill impairment assessment of the CGU Group is a critical audit matter are (i) the significant judgment by management when developing the value-in-use of the CGU Group; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management’s significant assumptions related to cash flow projections, perpetual growth rate and the discount rate; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill impairment assessment, including controls over the valuation of the Company’s group of cash-generating units. These procedures also included, among others, (i) understanding and testing management’s process for developing the estimate; (ii) evaluating the appropriateness of the discounted cash flow model; (iii) testing the completeness, accuracy, and relevance of underlying data used in the model; and (iv) evaluating the reasonableness of the significant assumptions used by management related to the cash flow projections, perpetual growth rate and the discount rate. Evaluating management’s assumptions related to cash flows projections and perpetual growth rate involved the consideration of (i) the current and past performance of the group of cash-generating units, (ii) the consistency with external market and industry data, and (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skills and knowledge were used to assist in the evaluation of the Company’s discounted cash flow model and the evaluation of the perpetual growth rate and discount rate assumptions. The procedures also included assessment of the adequacy of the company’s disclosures on goodwill impairment assessment and assumptions used.
Recoverability of deferred tax assets
As described in Notes 2 and 18 to the consolidated financial statements, the Company recognized net deferred income tax assets in relation to recoverable tax losses and temporary differences between the accounting base and the tax base of assets and liabilities at December 31, 2020 amounting to €183 million. Of this amount, €116 million is recognized related to recoverable tax losses. Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available, against which the temporary differences can be utilized. The deferred income tax assets related to recoverable tax losses were determined based on the expected future taxable income per tax jurisdiction, the applicable tax rates and local
F-3


expiry periods of tax losses. Management exercised significant judgment in determining that, based on the expected taxable income of the entities, it is more likely than not that a total of €920 million of unused tax losses and deductible temporary differences, with a related tax impact of €224 million at December 31, 2020, will not be used.
The principal considerations for our determination that performing procedures relating to the recoverability of deferred income tax assets is a critical audit matter are (i) the significant management judgement involved in considering whether or not it is likely that deferred income tax assets will be utilized and (ii) a high degree of auditor judgment and effort in evaluating management’s assessment of the significant assumption related to forecasts of taxable profit.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the financial statements. These procedures included, among others, understanding the controls relating to management’s assessment of the recoverability of deferred income tax assets and testing their effectiveness, examining the deferred income tax assets by jurisdiction and agreeing the forecasted future taxable profits with approved business plans for each entity. They also included assessing whether the underlying assumptions in the forecasts of taxable profit were consistent with those used in the impairment tests, and the past performance against the expected future tax profits in the business plans used by the Company. The procedures also included consideration of the applicable tax rates and local expiry periods of tax losses together with any applicable restrictions in recovery for each individual jurisdiction, and assessment of the adequacy of the company’s disclosures on deferred tax assets and assumptions used.

Neuilly-sur-Seine, France

PricewaterhouseCoopers Audit

/s/ Pierre Marty
Pierre Marty
Partner

March 16, 2021
We have served as the Company’s auditor since 2011.


F-4


CONSOLIDATED INCOME STATEMENT
Year ended December 31,
(in millions of Euros) Notes 2020 2019 2018
Revenue 3 4,883  5,907  5,686 
Cost of sales (4,393) (5,305) (5,148)
Gross profit 490  602  538 
Selling and administrative expenses (237) (276) (247)
Research and development expenses (39) (48) (40)
Other gains and losses - net 8 (89) (23) 153 
Income from operations 125  255  404 
Finance costs - net 10 (159) (175) (149)
Share of income / (loss) of joint-ventures   (33)
(Loss) / income before income tax (34) 82  222 
Income tax benefit / (expense) 12 17  (18) (32)
Net (loss) / income (17) 64  190 
Net (loss) / income attributable to:
Equity holders of Constellium (21) 59  188 
Non-controlling interests 4 
Net (loss) / income (17) 64  190 
Earnings per share attributable to the equity holders of Constellium (in Euros per share)
Basic (0.15) 0.43  1.40 
Diluted (0.15) 0.41  1.37 
Weighted average shares
Basic 138,739,635  136,856,978  134,761,736 
Diluted 138,739,635  142,645,619  138,145,914 
The accompanying Notes are an integral part of these Consolidated Financial Statements.

F-5


CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME / (LOSS)
Year ended December 31,
(in millions of Euros) Notes 2020 2019 2018
Net (loss) / income (17) 64  190 
Other comprehensive (loss) / income
Items that will not be reclassified subsequently to the consolidated income statement
Remeasurement on post-employment benefit obligations (20) (61) 24 
Income tax on remeasurement on post-employment benefit obligations 18 5  13  (6)
Items that may be reclassified subsequently to the consolidated income statement
Cash flow hedges 22 26  (8) (25)
Net investment hedges 22   (4)
Income tax on hedges 18 (7)
Currency translation differences (18) 10 
Other comprehensive (loss) / income (14) (49)
Total comprehensive (loss) / income (31) 15  197 
Attributable to:
Equity holders of Constellium (34) 10  195 
Non-controlling interests 3 
Total comprehensive (loss) / income (31) 15  197 
The accompanying Notes are an integral part of these Consolidated Financial Statements.

F-6


CONSOLIDATED STATEMENT OF FINANCIAL POSITION
At December 31,
(in millions of Euros) Notes 2020 2019
Assets
Current assets
Cash and cash equivalents 13 439  184 
Trade receivables and other 14 406  474 
Inventories 15 582  670 
Other financial assets 21 39  22 
1,466  1,350 
Non-current assets
Property, plant and equipment 16 1,906  2,056 
Goodwill 17 417  455 
Intangible assets 17 61  70 
Investments accounted for under the equity method 1 
Deferred tax assets 18 193  185 
Trade receivables and other 14 67  60 
Other financial assets 21 18 
2,663  2,834 
Total Assets 4,129  4,184 
Liabilities
Current liabilities
Trade payables and other 19 905  999 
Borrowings 20 92  201 
Other financial liabilities 21 46  35 
Income tax payable 20  14 
Provisions 24 23  23 
1,086  1,272 
Non-current liabilities
Trade payables and other 19 32  21 
Borrowings 20 2,299  2,160 
Other financial liabilities 21 41  23 
Pension and other post-employment benefit obligations 23 664  670 
Provisions 24 98  99 
Deferred tax liabilities 18 10  24 
3,144  2,997 
Total Liabilities 4,230  4,269 
Equity
Share capital 26 3 
Share premium 26 420  420 
Retained deficit and other reserves (538) (519)
Equity attributable to equity holders of Constellium (115) (96)
Non-controlling interests 14  11 
Total Equity (101) (85)
Total Equity and Liabilities 4,129  4,184 
The accompanying Notes are an integral part of these Consolidated Financial Statements.
F-7


CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
(in millions of Euros) Share capital Share premium Re-
measurement
Cash flow hedges Foreign currency translation reserve Other reserves Retained losses Total Non-controlling interests Total equity
At January 1, 2020 420  (177) (10) 53  (389) (96) 11  (85)
Net (loss) / income —  —  —  —  —  —  (21) (21) (17)
Other comprehensive (loss) / income —  —  (15) 19  (17) —  —  (13) (1) (14)
Total comprehensive (loss) / income —  —  (15) 19  (17) —  (21) (34) (31)
Share-based compensation —  —  —  —  —  15  —  15  —  15 
Transactions with non-controlling interests —  —  —  —  —  —  —    —   
At December 31, 2020 3  420  (192) 9  (13) 68  (410) (115) 14  (101)

(in millions of Euros) Share capital Share premium Re-
measurement
Cash flow hedges and net investment hedges Foreign currency translation reserve Other reserves Retained losses Total Non-controlling interests Total equity
At January 1, 2019 420  (129) (8) 37  (448) (122) (114)
Net income —  —  —  —  —  —  59  59  64 
Other comprehensive (loss) / income —  —  (48) (2) —  —  (49) —  (49)
Total comprehensive (loss) / income —  —  (48) (2) —  59  10  15 
Share-based compensation —  —  —  —  —  16  —  16  —  16 
Transactions with non-controlling interests —  —  —  —  —  —  —    (2) (2)
At December 31, 2019 420  (177) (10) 53  (389) (96) 11  (85)

(in millions of Euros) Share capital Share premium Re-
measurement
Cash flow hedges and net investment hedges Foreign currency translation reserve Other reserves Retained losses Total Non-controlling interests Total equity
At January 1, 2018 420  (147) 13  (7) 25  (634) (327) (319)
Change in accounting policies —  —  —  —  —  —  (2) (2) —  (2)
At January 1, 2018, restated 420  (147) 13  (7) 25  (636) (329) (321)
Net income —  —  —  —  —  —  188  188  190 
Other comprehensive income / (loss) —  —  18  (21) 10  —  —  7  —  7 
Total comprehensive income / (loss) —  —  18  (21) 10  —  188  195  197 
Share-based compensation —  —  —  —  —  12  —  12  —  12 
Transactions with non-controlling interests —  —  —  —  —  —  —    (2) (2)
At December 31, 2018 420  (129) (8) 37  (448) (122) (114)
The accompanying Notes are an integral part of these Consolidated Financial Statements.
F-8


CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31,
(in millions of Euros) Notes 2020 2019 2018
Net (loss) / income (17) 64  190 
Adjustments
Depreciation and amortization 16, 17 259  256  197 
Impairment of assets 16, 17 43  —  — 
Pension and other post-employment benefits service costs 23 34  27  (10)
Finance costs - net 10 159  175  149 
Income tax (benefit) / expense 12 (17) 18  32 
Share of (income) / loss of joint-ventures   (2) 33 
Unrealized (gains) / losses on derivatives - net and from remeasurement of monetary assets and liabilities - net
(18) (33) 86 
Losses / (gains) on disposal 8 4  (186)
Other - net 19  16  14 
Change in working capital
Inventories 63  57  (9)
Trade receivables 36  104  (145)
Trade payables (38) (31) (27)
Other (10) (58)
Change in provisions 1  (2) (2)
Pension and other post-employment benefits paid 23 (53) (50) (46)
Interest paid (140) (158) (129)
Income tax refunded / (paid) 9  (6) (23)
Net cash flows from operating activities 334  447  66 
Purchases of property, plant and equipment 4 (182) (271) (277)
Property, plant and equipment grants received 5  —  — 
Acquisition of subsidiaries net of cash acquired   (83) — 
Proceeds from disposals, net of cash 1  200 
Equity contributions and loans to joint ventures   —  (24)
Other investing activities   (1) 10 
Net cash flows used in investing activities (176) (353) (91)
Proceeds from issuance of Senior Notes 20 290  —  — 
Repayment of Senior Notes 20 (200) (100) — 
(Repayments) / proceeds from U.S. revolving credit facilities 20 (129) 105  (67)
Proceeds from other borrowings 20 202  — 
Repayments from other borrowings 20 (10) (4) (1)
Lease repayments 20 (35) (86) (15)
Payment of financing costs (9) —  — 
Transactions with non-controlling interests   (4) — 
Other financing activities (8)
Net cash flows from / (used in) financing activities 101  (76) (82)
Net increase / (decrease) in cash and cash equivalents 259  18  (107)
Cash and cash equivalents - beginning of year 184  164  269 
Effect of exchange rate changes on cash and cash equivalents (4)
Cash and cash equivalents - end of year 13 439  184  164 
The accompanying Notes are an integral part of these Consolidated Financial Statements.
F-9


Notes to the Consolidated Financial Statements
NOTE 1 - GENERAL INFORMATION
Constellium is a global leader in the design and manufacture of a broad range of innovative specialty rolled and extruded aluminium products, serving primarily the packaging, aerospace and automotive end-markets. The Group has a strategic footprint of manufacturing facilities located in North America, Europe and China and operates 29 production facilities, 3 R&D centers and 3 administrative centers. The Group has approximately 12,000 employees.
Constellium SE, a French Societas Europaea (SE), is the parent company of the Group. The business address (head office) of Constellium SE is located at Washington Plaza, 40-44 rue Washington, 75008 Paris, France.
Unless the context indicates otherwise, when we refer to “we”, “our”, “us”, “Constellium”, the “Group” and the “Company” in this document, we are referring to Constellium SE and its subsidiaries.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.1 Statement of compliance
The Consolidated Financial Statements of Constellium SE and its subsidiaries have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and as endorsed by the European Union (EU). The Group’s application of IFRS results in no difference between IFRS as issued by the IASB and IFRS as endorsed by the EU (https://ec.europa.eu/info/law/international-accounting-standards-regulation-ec-no-1606-2002_en).
The Consolidated Financial Statements were authorized for issue on March 11, 2021 by the Board of Directors.
2.2 New and amended standards and interpretations
Several amendments and interpretations apply for the first time in 2020, but had no impact on the Consolidated Financial Statements of the Group.
Amendments to IAS 1 and IAS 8: Definition of Material
Amendments to IFRS 3: Definition of a Business
Amendments to IFRS 7, IFRS 9 and IAS 39: Interest Rate Benchmark Reform - Phase 1
2.3 New standards and interpretations not yet mandatorily applicable
The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. The following new standards and interpretations have been issued, but are not yet effective. The Group plans to adopt these new standards and interpretations on their required effective dates and does not expect any material impact as a result of their adoption.
Amendments to IAS 1: Classification of Liabilities as Current or Non-current
IFRS 9 Financial Instruments: Fees in the ‘10 per cent’ test for derecognition of financial liabilities
Amendments to IFRS 7, IFRS 9 and IAS 39: Interest Rate Benchmark Reform - Phase 2
Amendments to IFRS 16: COVID-19 Related Rent Concessions
Amendments to IAS 16: Property, Plant and Equipment: Proceeds before Intended Use
Amendments to IAS 37: Onerous Contracts – Costs of Fulfilling a Contract
Amendments to IFRS 3: Reference to the Conceptual Framework




F-10


2.4 Basis of preparation
In accordance with IAS 1- Presentation of Financial Statements, the Consolidated Financial Statements are prepared on the assumption that Constellium is a going concern and will continue in operation for the foreseeable future.
The Group's financial position, its cash flows, liquidity position and borrowing facilities are described in the Consolidated Financial Statements in NOTE 13 - Cash and Cash Equivalents, NOTE 20 - Borrowings and NOTE 22 - Financial Risk Management.
The Group’s forecasts and projections, taking account of reasonably possible changes in operating performance, including an assessment of the current macroeconomic environment, indicate that the Group should be able to operate within the level of its current facilities and related covenants.
Accordingly, the Group continues to adopt the going concern basis in preparing the Consolidated Financial Statements. Management considers that this assumption is not invalidated by the Group’s negative equity at December 31, 2020. This assessment was confirmed by the Board of Directors on March 11, 2021.
2.5 Presentation of the operating performance of each operating segment and of the Group
In accordance with IFRS 8 - Operating Segments, operating segments are based upon the product lines, markets and industries served, and are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker (“CODM”). The CODM, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer.
2.6 Principles governing the preparation of the Consolidated Financial Statements
Basis of consolidation
These Consolidated Financial Statements include all the assets, liabilities, equity, revenues, expenses and cash flows of the entities and businesses controlled by Constellium. All intercompany transactions and balances are eliminated.
Subsidiaries are entities over which the Group has control. The Group controls an entity when the Group has power over the investee, is exposed to, or has rights to variable returns from its involvement in the entity and has the ability to affect those returns through its power over the entity.
Subsidiaries are consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.
Investments over which the Group has significant influence are accounted for under the equity method. Investments over which the Group has joint control are accounted for either as joint ventures under the equity method or as joint arrangements in relation to its interest in the joint operation.
Joint venture investments are initially recorded at cost. They are subsequently increased or decreased by the Group’s share in the profit or loss, or by other movements reflected directly in the equity of the entity.
Business combinations
The Group applies the acquisition method to account for business combinations.
The consideration transferred for the acquisition of a subsidiary is the fair value of the assets transferred, the liabilities assumed and the equity interests issued by the Group. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. The amount of non-controlling interests is determined for each business combination and is either based on the fair value (full goodwill method) or the present ownership instruments’ proportionate share in the recognized amounts of the acquiree’s identifiable net assets, resulting in recognition of only the share of goodwill attributable to equity holders of the parent (partial goodwill method).
F-11


Goodwill is initially measured as the excess of the aggregate of the consideration transferred and the amount of non-controlling interest over the net identifiable assets acquired and liabilities assumed. If this consideration is lower than the fair value of the net assets of the subsidiary acquired, the difference is recognized as a gain in Other gains and losses - net in the Consolidated Income Statement.
At the acquisition date, the Group recognizes the identifiable acquired assets, liabilities and contingent liabilities (identifiable net assets) of the subsidiaries on the basis of fair value at the acquisition date. Recognized assets and liabilities may be adjusted during a maximum of 12 months from the acquisition date, depending on new information obtained about the facts and circumstances existing at the acquisition date.
Acquisition-related costs are expensed as incurred and are included in Other gains and losses - net in the Consolidated Income Statement.
Cash-generating units
The reporting units, which generally correspond to industrial sites, are the lowest level of the Group’s internal reporting and have been identified as cash-generating units.
Goodwill
Goodwill arising from a business combination is carried at cost as established at the date of the business combination less accumulated impairment losses, if any.
Goodwill is allocated at the operating segment levels, which are the groups of cash-generating units that are expected to benefit from the synergies of the combination. The operating segments represent the lowest level within the Group at which goodwill is monitored for internal management purposes.
Gains and losses on the disposal of a cash-generating unit include the carrying amount of goodwill relating to the cash-generating unit sold.
Impairment of goodwill
A group of cash-generating units to which goodwill is allocated is tested for impairment annually, or more frequently when there is an indication that it may be impaired.
The net carrying value of a group of cash-generating units is compared to its recoverable amount, which is the higher of the value in use and the fair value less costs of disposal.
Value in use calculations use cash flow projections based on financial budgets approved by management and usually covering a 5-year period. Cash flows beyond this period are estimated using a perpetual long-term growth rate for the subsequent years.
The value in use is the sum of discounted cash flows over the projected period and the terminal value. Discount rates are determined based on the weighted-average cost of capital of each operating segment.
The fair value is the price that would be received for the group of cash-generating units, in an orderly transaction, from a market participant. This value is estimated on the basis of available and relevant market data or a discounted cash flow model reflecting market participant assumptions.
An impairment loss is recognized for the amount by which the group of units carrying amount exceeds its recoverable amount.
Any impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the group of cash-generating units and then to the other assets of the group of units pro rata on the basis of the carrying amount of each asset in the group of units.
Any impairment loss is recognized in Other gains and losses - net in the Consolidated Income Statement. An impairment loss recognized for goodwill cannot be reversed in subsequent years.
F-12


Non-current assets and disposal groups classified as held for sale and discontinued operations
IFRS 5 - Non-current Assets Held for Sale and Discontinued Operations defines a discontinued operation as a component of an entity that (i) generates cash flows that are largely independent from cash flows generated by other components, (ii) is classified as held for sale or has been disposed of, and (iii) represents a separate major line of business or geographic areas of operations.
Assets and liabilities are classified as held for sale when their carrying amount will be recovered principally through a sale transaction rather than through continuing use. This condition is regarded as met only when the sale is highly probable and the non-current asset or disposal group is available for immediate sale in its present condition.
Assets and liabilities are stated at the lower of carrying amount and fair value less costs to sell if their carrying amount is to be recovered principally through a sale transaction rather than through continuing use.
Assets and liabilities held for sale are presented in separate lines in the Consolidated Statement of Financial Position of the year during which the decision to sell is made.
The results of discontinued operations are shown separately in the Consolidated Income Statement and Consolidated Statement of Cash Flows.
Foreign currency transactions and foreign operations
Functional currency
Items included in the Consolidated Financial Statements of each of the entities and businesses of Constellium are measured using their functional currency, which is the currency of the primary economic environment in which they operate.
Foreign currency transactions
Transactions denominated in currencies other than the functional currency are recorded in the functional currency at the exchange rate in effect at the date of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized in the Consolidated Income Statement, except when deferred in Other Comprehensive Income ("OCI") as qualifying cash flow hedges and qualifying net investment hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in Finance costs - net. Realized foreign exchange gains and losses that relate to commercial transactions are presented in Cost of sales. All other foreign exchange gains and losses, including those that relate to foreign currency derivatives hedging commercial transactions where hedge accounting has not been applied, are presented within Other gains and losses - net.
Foreign operations: presentation currency and foreign currency translation
In the preparation of the Consolidated Financial Statements, the year-end balances of assets, liabilities and components of equity of Constellium’s entities and businesses are translated from their functional currencies into Euros, the presentation currency of the Group, at their respective year-end exchange rates. Revenue, expenses and cash flows of Constellium’s entities and businesses are translated from their functional currencies into Euros using their respective average exchange rates for the year.
The net differences arising from exchange rate translation are recognized in the Consolidated Statement of Comprehensive Income / (Loss).
F-13


The following table summarizes the main exchange rates used for the preparation of the Consolidated Financial Statements:
Average rates Closing rates
Foreign exchange rate for 1 Euro Year ended December 31, At December 31,
2020 2019 2018 2020 2019 2018
U.S. Dollars USD 1.1405  1.1193  1.1798  1.2271  1.1234  1.1450 
Swiss Francs CHF 1.0704  1.1121  1.1546  1.0802  1.0854  1.1269 
Czech Koruna CZK 26.4337  25.6698  25.6452  26.2420  25.4080  25.7240 
Revenue from contracts with customers
Revenue is recognized in an amount that reflects the consideration to which an entity expects to be entitled in exchange for transferring goods or services to a customer.
The Group primarily contracts with customers for the sale of rolled or extruded aluminium products. For the majority of our business, performance obligations with customers begin when we acknowledge a purchase order for a specific customer order of product to be delivered in the near-term. These purchase orders are short-term in nature, although they may be governed by multi-year frame agreements.
Revenue from product sales, measured at the fair value of the consideration received or receivable, should be recognized at the point in time when control of the asset is transferred to the customer, generally upon delivery. In certain limited circumstances, the Group may be required to recognize revenue over time for products that have no alternative use and for which the Group has an enforceable right to payment for production completed to date.
Revenue from product sales, net of trade discounts, allowances and volume-based incentives, is recognized for the amount the Group expects to be entitled to, generally upon delivery, and provided there is persuasive evidence that control has transferred.
Contract liabilities consist of expected volume discounts, rebates, incentives, refunds and penalties and price concessions. Contract liabilities are presented in Trade payables and other.
The Group applies the practical expedient for disclosures on performance obligations that are part of contracts that have an original duration of one year or less.
The Group elected the practical expedient on significant financing components if the period of transfer of the product and the payment is one year or less.
Research and development costs
Costs incurred on development projects are recognized as intangible assets when the following criteria are met:
It is technically feasible to complete the intangible asset so that it will be available for use;
Management intends to complete and use the intangible asset;
There is an ability to use the intangible asset;
It can be demonstrated how the intangible asset will generate probable future economic benefits;
Adequate technical, financial and other resources to complete the development and use or sell the intangible asset are available; and
The expenditure attributable to the intangible asset during its development can be reliably measured.
Development expenditures that do not meet these criteria are expensed as incurred. Development costs previously recognized as expenses cannot be recognized as an asset in a subsequent period.


F-14


Other gains and losses - net
Other gains and losses - net includes: (i) realized and unrealized gains and losses on derivatives for those contracted where hedge accounting is not applied (ii) unrealized exchange gains and losses from the remeasurement of monetary assets and liabilities, (iii) the ineffective portion of changes in the fair value of derivatives designated for hedge accounting and (iv) impairment charges on assets.
Other gains and losses - net presents other unusual, infrequent or non-recurring items. Such items are disclosed by virtue of their size, nature or incidence. In determining whether an event or transaction is specific, management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence.
Interest income and expense
Interest expense on short and long-term financing is recorded at the relevant rates on the various borrowing agreements using the effective interest rate method.
Borrowing costs, including interest, incurred for the construction of any qualifying asset are capitalized during the period of time required to complete and prepare the asset for its intended use.
Share-based payment arrangements
Equity-settled share-based payments to employees and Board members are measured at the fair value of the equity instruments at the grant date.
The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the Group’s estimate of equity instruments that will eventually vest, with a corresponding increase in equity. At the end of each reporting period, the Group revises its estimate of the number of equity instruments expected to vest.
Property, plant and equipment
Recognition and measurement
Property, plant and equipment acquired by the Company are recorded at cost, which comprises the purchase price, including import duties and non-refundable purchase taxes, any costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management and the estimated close down and restoration costs associated with the asset. Borrowing costs, including interest, directly attributable to the acquisition or construction of property, plant and equipment are included in the cost. Subsequent to the initial recognition, Property, plant and equipment are measured at cost less accumulated depreciation and impairment, if any. Costs are capitalized into construction work-in-progress until such projects are completed and the assets are available for use.
Subsequent costs
Enhancements and replacements are capitalized as additions to Property, plant and equipment only when it is probable that future economic benefits associated with them will flow to the Company and their cost can be measured with reliability. Ongoing regular maintenance costs related to Property, plant and equipment are expensed as incurred.
Depreciation
Land is not depreciated. Property, plant and equipment are depreciated over the estimated useful lives of the related assets using the straight-line method as follows:
Buildings: 10 – 50 years;
Machinery and equipment: 3 – 40 years;
Vehicles: 5 – 8 years.


F-15


Intangible assets
Recognition and measurement
Technology and customer relationships acquired in a business combination are recognized at fair value at the acquisition date. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and impairment losses. The useful lives of the Group intangible assets are assessed to be finite.
Amortization
Intangible assets are amortized over the estimated useful lives of the related assets using the straight-line method as follows:
Technology: 20 years;
Customer relationships: 25 years;
Software: 3 – 5 years.
Impairment of property, plant and equipment and intangible assets
Property, plant and equipment and intangible assets subject to amortization are reviewed for impairment if there is any indication that the carrying amount of the asset, or cash-generating unit to which it belongs, may not be recoverable. The recoverable amount is based on the higher of fair value less cost of disposal and value in use, as determined using estimates of discounted future net cash flows of the asset or group of assets to which it belongs.
Any impairment loss is recognized in Other gains and losses - net in the Consolidated Income Statement.
Government Grants
Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions are complied with.
Government grants relating to the purchase of property, plant and equipment reduce the carrying amount of the asset. They are credited to profit or loss on a straight-line basis over the expected useful lives of the related assets. Government grants relating to costs offset the corresponding expense and are deferred and recognized in profit or loss over the period necessary to match them with the costs that they are intended to compensate.
Financial Instruments
i.Classification and measurement
Financial assets
Financial assets are classified either: (a) at amortized cost, (b) at fair value through other comprehensive income (FVOCI), or (c) at fair value through profit or loss (FVPL). The classification depends on the financial asset’s contractual cash flow characteristics and the Group’s business model for managing the financial assets. Management determines the classification of Constellium’s financial assets at initial recognition.
i.Assets at amortized cost are comprised of other receivables, non-current loans receivable and current loans receivable in the Consolidated Statement of Financial Position. The business model whose objective is to hold assets in order to collect contractual cash flows provided they give rise to cash flows that are ‘solely payments of principal and interest’ on the principal amount outstanding. They are carried at amortized cost using the effective interest rate method, less any impairment. They are classified as current or non-current assets based on their maturity date.
ii.Assets at fair value through OCI are comprised of trade receivables in the Consolidated Statement of Financial Position. The business model is to maintain liquidity for the Group, should the need arise, which leads to sales through factoring agreements that are more than infrequent and significant in value. Trade receivables are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to the factors. The portfolio of trade receivables is therefore classified as measured at fair value through OCI. Upon
F-16


derecognition, the cumulative fair value change recognized in OCI is reclassified to profit or loss. Foreign exchange revaluation and impairment losses or reversals are recognized in profit or loss and computed in the same manner as for financial assets measured at amortized cost. The remaining fair value changes are recognized in OCI. These assets are classified as current or non-current assets based on their maturity date.
iii.Assets at fair value through profit or loss are comprised of derivatives except those designated as hedging instruments that qualify for hedge accounting in accordance with IAS 39 Financial Instruments. Financial assets carried at fair value through profit or loss are initially recognized at fair value and transaction costs are expensed in the Consolidated Income Statement.
Financial liabilities
Borrowings and other financial liabilities, excluding derivative liabilities, are recognized initially at fair value, net of transaction costs incurred and directly attributable to the issuance of the liability. These financial liabilities are subsequently measured at amortized cost using the effective interest rate method. Any difference between the amounts originally received, net of transaction costs, and the redemption value is recognized in the Consolidated Income Statement using the effective interest rate method.
ii.Impairment of financial assets
Financial assets subject to IFRS 9’s expected credit loss model are cash and cash equivalents, trade receivables and other and loans to joint ventures.
iii.Offsetting financial instruments
Financial assets and liabilities are offset and the net amount is reported in the Consolidated Statement of Financial Position when there is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously.
Derivative financial instruments
Derivatives
Derivatives are initially recognized at fair value on the date a derivative contract is entered into and are subsequently re-measured to their fair value at the end of each reporting period. The accounting for subsequent changes in fair value depends on whether the derivative qualifies for hedge accounting treatment. Derivatives that qualify for hedge accounting are recognized in OCI.
Fair value is the price expected to be received in selling an asset or paid in transferring a liability in an orderly transaction between market participants at the measurement date. Where available, relevant market prices are used to determine fair values. The Group periodically estimates the impact of credit risk on its derivative instruments aggregated by counterparties and takes this into account when estimating the fair value of its derivatives.
Credit Value Adjustments are calculated for asset derivatives based on the counterparties' credit risk. Debit Value Adjustments are calculated for credit derivatives based on Constellium's own credit risk. The fair value method used is based on the historical probability of default, provided by leading rating agencies.
For derivative instruments that do not qualify for hedge accounting, changes in the fair value are recognized immediately in profit or loss and are included in Other gains and losses - net.
Hedge accounting
The Group did not adopt the disposition of IFRS 9 on hedging and will therefore continue to apply the provisions of IAS 39. For derivative instruments that are designated for hedge accounting, at the inception of the hedging transaction, the group documents the relationship between hedging instruments and hedged items, the risk management objective and the strategy for undertaking the hedge transaction. The group also documents its assessment, both at hedge inception and on an ongoing basis, of whether the derivatives that are used in hedging transactions have been and will continue to be highly effective in offsetting changes in cash flows of hedged items.
F-17


The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized in OCI and accumulated in Equity. The gain or loss relating to the ineffective portion is recognized immediately in the Consolidated Income Statement in Other gains and losses - net.
Amounts accumulated in equity are reclassified to the Consolidated Income Statement when the hedged item affects the Consolidated Income Statement. The gain or loss relating to the effective portion of derivative instruments hedging forecasted cash flows under customer agreements is recognized in Revenue. When the forecasted transaction that is hedged results in the recognition of a non-financial asset, the gains and losses previously deferred in equity are reclassified from equity and included in the initial measurement of the cost of the asset. The deferred amounts would ultimately be recognized in the Consolidated Income Statement upon the sale, depreciation or impairment of the asset.
When a hedging instrument expires or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting, any cumulative gain or loss existing in equity at that time remains in equity and is recognized when the forecasted transaction is ultimately recognized in the Consolidated Income Statement. When a forecasted transaction is no longer expected to occur, the cumulative gain or loss that was recognized in equity is immediately reclassified to the Consolidated Income Statement.
Leases (since January 1, 2019)
Right-of-use assets
The Group recognizes right-of-use assets at the commencement date of the lease. Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and are adjusted for remeasurement of lease liabilities resulting from a change in future lease payments arising from a change in an index or a rate, or a change in the assessment of whether the purchase, extension or termination options will be exercised.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are recorded in the asset category to which they relate in Property, plant and equipment. Unless the Group is reasonably certain to obtain ownership of the leased assets at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the shorter of their estimated useful life and the lease term. Right-of-use assets are subject to impairment.
Lease liabilities
At the commencement date of the lease, the Group recognizes a lease liability measured at the present value of lease payments to be made over the lease term.
In determining the lease term, management considers all facts and circumstances that create an economic incentive to exercise an extension or termination option. Extension options or periods after termination options are only included in the lease term if the lease is reasonably certain to be extended or not terminated.
The lease payments include fixed payments less any lease incentive receivables, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for terminating a lease, if the lease term reflects the Group exercising the option to terminate. Lease liabilities are presented within Borrowings. Variable lease payments that do not depend on an index or a rate are recognized as expense in the period in which the event or condition that triggers the payment occurs.
In calculating the present value of lease payments, the Group uses the incremental borrowing rate at the lease commencement date if the implicit interest rate in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced by the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, or a change in the assessment to purchase the underlying asset.



F-18


Short-term leases and leases of low-value assets
The Group applies the short-term lease recognition exemption to leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option. The Group also applies the low-value asset recognition exemption to leases of assets with a value below €5,000. Lease payments on short-term leases and low-value asset leases are recognized as expense on a straight-line basis over the lease term.
The Group also applies the practical expedients for lease and non-lease components as a single component for vehicles. The Group adopted IFRS 16 retrospectively with the cumulative effect of initially applying the standard recognized on January 1, 2019.
The Group elected the relief provision of IFRS 16 and did not apply IFRS 16 to contracts that were not previously identified as containing a lease under IAS 17 and IFRIC 4.
Leases (Prior to January 1, 2019)
Leases in which a significant portion of the risks and rewards of ownership are retained by the lessor are classified as operating leases. Various buildings, machinery and equipment are leased from third parties under operating lease agreements. Under operating leases, lease payments are recognized as rent expense on a straight-line basis over the term of the lease agreement, and are included in Cost of sales or Selling and administrative expenses, depending on the nature of the leased assets.
Leases of property, plant and equipment under which the Group has substantially all the risks and rewards of ownership are classified as finance leases. Various buildings and equipment are leased from third parties under finance lease agreements. Under such finance leases, the asset financed is recognized in Property, plant and equipment and the financing is recognized in Borrowings.
Inventories
Inventories are valued at the lower of cost and net realizable value, primarily on a weighted-average cost basis.
Weighted-average cost for raw materials, stores, work in progress and finished goods is calculated using the costs experienced in the current period based on normal operating capacity and includes the purchase price of materials, freight, duties and customs, and the costs of production, which includes labor, materials and other costs that are directly attributable to the production process and production overheads.
Trade account receivables
Recognition and measurement
Trade account receivables are recognized at fair value through OCI since they are managed under an objective that results in both collecting the contractual cash flows and selling the receivables to factors. The group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables and contract assets.
Factoring arrangements
In factoring arrangements under which the Group has transferred substantially all the risks and rewards of ownership of the receivables, the receivables are derecognized from the Consolidated Statement of Financial Position. In determining whether the Group has transferred substantially all the risks and rewards of ownership, it considers credit risk, late-payment risk, dilution risk, foreign exchange risk and tax risk. Arrangements in which the Group derecognizes receivables result in changes in trade receivables, which are reflected as cash flows from operating activities. When trade account receivables are sold with limited recourse and substantially all the risks and rewards associated with these receivables are not transferred, receivables are not derecognized. Where the Group does not derecognize the receivables, the cash received from the factor is classified as a financing cash inflow, the settlement of the receivables as an operating cash inflow and the repayment to the factor as a financing cash outflow.
F-19


Cash and cash equivalents
Cash and cash equivalents are comprised of cash in bank accounts and on hand, short-term deposits held on call with banks and other short-term highly liquid investments with original maturities of three months or less that are readily convertible into known amounts of cash and are subject to insignificant risk of changes in value, less bank overdrafts that are repayable on demand, provided there is an offset right.
Share capital
Ordinary shares are classified as equity. Costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Trade payables
Trade payables are initially recorded at fair value and classified as current liabilities if payment is due in one year or less.
Provisions
Provisions are recorded at the best estimate of expenditures required to settle liabilities of uncertain timing or amount when management determines that i) a legal or constructive obligation exists as a result of past events, ii) it is probable that an outflow of resources will be required to settle the obligation and iii) such amounts can be reasonably estimated. Provisions are measured at the present value of the expected expenditures required to settle the obligation.
The ultimate cost to settle such liabilities is uncertain, and cost estimates can vary in response to many factors. The settlement of these liabilities could materially differ from recorded amounts or the expected timing of expenditure could change. As a result, there could be significant adjustments to provisions, which could result in additional charges or recoveries.
Close down and restoration costs
Estimated close down and restoration costs are accounted for in the year when the legal or constructive obligation arising from the related disturbance occurs and it is probable that an outflow of resources will be required to settle the obligation. These costs are based on the net present value of estimated future costs. Provisions for close down and restoration costs do not include any additional obligations expected to arise from future disturbance. The costs are estimated on the basis of a closure plan including feasibility and engineering studies, are updated annually during the life of the operation to reflect known developments (e.g. revisions to cost estimates and to the estimated lives of operations) and are subject to formal review at regular intervals each year.
The initial closure provision together with subsequent movements in the provisions for close down and restoration costs, including those resulting from new disturbance, updated cost estimates, changes to the estimated lives of operations and revisions to discount rates, are capitalized in Property, plant and equipment. These costs are depreciated over the remaining useful lives of the related assets. The amortization or unwinding of the discount applied in establishing the net present value of the provisions is recorded in the Consolidated Income Statement as a financing cost.
Environmental remediation costs
Environmental remediation costs are accounted for based on the estimated present value of the costs of the Group’s environmental clean-up obligations. Changes in the environmental remediation provisions are recorded in Cost of sales.
Restructuring costs
Provisions for restructuring are recorded when Constellium’s management is demonstrably committed to the restructuring plan and the liabilities can be reasonably estimated. The Group recognizes liabilities that primarily include one-time termination benefits, severance, and contract termination costs, primarily related to equipment and facility lease obligations. These amounts are based on the remaining amounts due under various contractual agreements and are periodically adjusted for changes in circumstances that would reduce or increase these obligations.


F-20


Legal, tax and other potential claims
Provisions for legal claims are made when it is probable that liabilities will be incurred and when such liabilities can be reasonably estimated. For asserted claims and assessments, liabilities are recorded when an unfavorable outcome of a matter is deemed to be probable and the loss is reasonably estimable. Management determines the likelihood of an unfavorable outcome based on many factors such as the nature of the matter, available defenses and case strategy, progress of the matter, views and opinions of legal counsel and other advisors, applicability and success of appeals, process and outcomes of similar historical matters, amongst others. Once an unfavorable outcome is considered probable, management weights the probability of possible outcomes and the most likely loss is recorded. Legal matters are reviewed on a regular basis to determine if there have been changes in management’s judgment regarding the likelihood of an unfavorable outcome or the estimate of a potential loss. Depending on their nature, these costs may be recorded in Cost of sales or Other gains and losses - net in the Consolidated Income Statement. Included in other potential claims are provisions for product warranties and guarantees to settle the net present value portion of any settlement costs for potential future legal actions, claims and other assertions that may be brought by Constellium’s customers or the end-users of products. Provisions for product warranty and guarantees are recorded in Cost of sales in the Consolidated Income Statement.
Management establishes tax reserves and accrues interest thereon, if deemed appropriate, in expectation that certain tax positions other than income tax may be challenged and that the Group might not succeed in defending such positions, despite management’s belief that the positions taken are fully supportable.
Pension, other post-employment plans and other long-term employee benefits
For defined contribution plans, the contribution paid in respect of service rendered over the service year is recognized in the Consolidated Income Statement. This expense is included in Income / (loss) from operations.
For defined benefit plans, the retirement benefit obligation recognized in the Consolidated Statement of Financial Position represents the present value of the defined benefit obligation less the fair value of plan assets. The defined benefit obligations are assessed using the projected unit credit method. The most significant assumption is the discount rate. The amount recorded in the Consolidated Income Statement in respect of these plans is included within Income / (loss) from operations except for net interest costs, which are included in Finance costs - net.The effects of changes in actuarial assumptions and experience adjustments are presented in the Consolidated Statement of Comprehensive Income / (Loss).
Other post-employment benefit plans mainly relate to health and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents. Eligibility for coverage is dependent upon certain age and service criteria. These benefit plans are unfunded and are accounted for as defined benefit obligations, as described above.
Other long-term employee benefits mainly include jubilees and other long-term disability benefits. For these plans, actuarial gains and losses are recognized immediately in the Consolidated Income Statement.
Taxation
Income tax (expense) / benefit is calculated on the basis of the tax laws enacted or substantively enacted at the Consolidated Statement of Financial Position date in the countries where the Company and its subsidiaries operate and generate taxable income.
The Group is subject to income taxes in France, the United States, Germany and numerous other jurisdictions. Certain of Constellium’s businesses may be included in tax returns in some jurisdictions. In certain circumstances, these businesses may be jointly and severally liable with the entity filing the consolidated return, for additional taxes that may be assessed.
Deferred income tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the Consolidated Financial Statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income tax assets are also recognized for operating loss carryforwards and tax credit carryforwards.
Deferred income tax assets and liabilities are measured using tax rates that are expected to apply in the year when the asset is realized or the liability is settled. Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized.
F-21


Presentation of financial statements
The Consolidated Financial Statements are presented in millions of Euros, except Earnings per share in Euros. Certain reclassifications may have been made to prior year amounts to conform to the current year presentation.
2.7 Judgments in applying accounting policies and key sources of estimation uncertainty
The preparation of the Group’s consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures, and the disclosure of contingent liabilities. These judgments, estimates and assumptions are based on management’s best knowledge of the relevant facts and circumstances, giving consideration to previous experience. However, actual results may differ from the amounts included in the Consolidated Financial Statements. Key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year include the items presented below. The Group reviewed its significant assumptions and estimates in light of the uncertainty associated with the COVID-19 pandemic and its potential impact on its business and its financials, detailed in NOTE 4 - Operating segments, NOTE 16 - Property, plant and equipment, NOTE 20 - Borrowings, NOTE 22 - Financial risk management, NOTE 24 - Provisions, and NOTE 27 - Covid-19-related government assistance. However, there remains considerable uncertainty with respect to the duration of the crisis and its potential impact on the overall economy and our business, and there can be no guarantee that our assumptions will materialize or that actual results will not differ materially from estimates.
Impairment tests for goodwill, intangible assets and property, plant and equipment
The determination of fair value and value in use of cash-generating units or groups of cash-generating units depends on a number of assumptions, in particular market data, estimated future cash flows and discount rates.
These assumptions are subject to risk and uncertainty. Any material changes in these assumptions could result in a significant change in a cash-generating units’ recoverable value or in a goodwill impairment. Details of the key assumptions made and judgments applied are set out in NOTE 16 - Property, Plant and Equipment and in NOTE 17 - Intangible Assets and Goodwill.
Pension, other post-employment benefits and other long-term employee benefits
The present value of the defined benefit obligations depends on a number of factors that are determined on an actuarial basis using a number of assumptions and its determination requires the application of judgment. Assumptions used and judgments made in determining the defined benefit obligations and net pension costs include discount rates, rates of future compensation increase, and the criteria considered to determine when a plan amendment has occurred.
Any material changes in these assumptions could result in a significant change in Pensions and other post-employment benefit obligations and in employee benefit expenses recognized in the Consolidated Income Statement or actuarial gains and losses recognized in OCI. Details of the key assumptions made and judgments applied are set out in NOTE 23 - Pensions and Other Post-Employment Benefit Obligations.
Income Taxes
Significant judgment is sometimes required in determining the accrual for income taxes as there are many transactions and calculations for which the ultimate tax determination is uncertain during the ordinary course of business. The Group recognizes liabilities based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were recorded, such differences will impact the current and deferred income tax provisions, results of operations and possibly cash flows in the year in which such determination is made.
Significant judgment is also required to determine the extent to which deferred tax assets can be recognized. In assessing the recognition of deferred tax assets, management considers whether it is more likely than not that the deferred tax assets will be utilized. The deferred tax assets will be ultimately utilized to the extent that sufficient taxable profits will be available in the years in which the temporary differences become deductible. This assessment is conducted through a detailed review of deferred tax assets by jurisdiction and takes into account the scheduled reversals of taxable and deductible temporary differences; past, current and expected future performance deriving from the budget; the business plan and tax planning strategies. Deferred tax assets are not recognized in the jurisdictions where it is less likely than not that sufficient taxable profits
F-22


will be available against which the deductible temporary differences can be utilized. Details of the key assumptions made and judgments applied are set out in NOTE 18 - Deferred Income Taxes.
Provisions
Provisions have been recorded for: (i) close down and restoration costs; (ii) environmental remediation and monitoring costs; (iii) restructuring plans; (iv) legal and other potential claims including provisions for tax risks other than income tax, product warranty and guarantees. These provisions are recorded at amounts which represent management’s best estimates of the expenditure required to settle the obligation at the date of the Consolidated Statement of Financial Position. Expectations are revised each year until the actual liability is settled, with any difference accounted for in the Consolidated Income Statement in the year in which the revision is made. Details of the key assumptions made and judgments applied are described in NOTE 24 - Provisions.
Business combinations
Determining the fair value of purchased assets and assumed liabilities requires judgement in the selection of valuation techniques and assumptions used. Key assumptions and inputs include the determination of cash flow projections, discount rates, comparable market transactions, replacement costs and related industry indices.
NOTE 3 - REVENUE
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Packaging rolled products 1,960  2,172  2,245 
Automotive rolled products 663  816  636 
Specialty and other thin-rolled products 102  151  169 
Aerospace rolled products 560  863  773 
Transportation, industry, defense and other rolled products 442  557  566 
Automotive extruded products 665  797  714 
Other extruded products 491  551  573 
Other   —  10 
Total Revenue by product line 4,883  5,907  5,686 
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Germany 1,014  1,260  1,339 
France 362  563  554 
United Kingdom 192  194  175 
Switzerland 52  68  77 
Other Europe 923  1,078  1,038 
Total Europe 2,543  3,163  3,183 
United States 1,941  2,175  1,897 
Asia and Other Pacific 211  277  300 
All Other 188  292  306 
Total Revenue by destination of shipment 4,883  5,907  5,686 
Revenue is recognized at a point in time, except for certain products with no alternative use for which we have a right to payment, which represent less than 1% of total revenue.
F-23


NOTE 4 - OPERATING SEGMENT INFORMATION
Management has defined Constellium’s operating segments based upon the product lines, markets and industries it serves, and prepares and reports operating segment information to Constellium’s chief operating decision maker (CODM) as defined in NOTE 2 - Summary of Significant Accounting Policies on that basis.
The accounting principles used to prepare the Group’s operating segment information are the same as those used to prepare the Group’s Consolidated Financial Statements.
Packaging and Automotive Rolled Products (P&ARP)
P&ARP supplies rolled aluminium products to the packaging market with canstock and closure stock for the beverage and food industry, foil stock for the flexible packaging market and to the automotive market with a number of technically sophisticated applications, such as automotive body sheet and heat exchanger materials. P&ARP operates four facilities in three countries and had approximately 3,900 employees at December 31, 2020.
Aerospace and Transportation (A&T)
A&T supplies rolled aluminium products and very limited volumes of extruded products to the aerospace market, as well as rolled products for transportation, industry and defense end-uses. A&T operates six facilities in three countries and had approximately 3,300 employees at December 31, 2020.
Automotive Structures and Industry (AS&I)
AS&I supplies hard and soft aluminium alloy extruded profiles for a range of high demand industry applications in the automotive, engineering, rail and other transportation end markets, and technologically advanced structural components to the automotive industry. AS&I operates nineteen facilities in ten countries and had approximately 4,600 employees at December 31, 2020.
Holdings & Corporate (H&C)
Holdings & Corporate includes the net cost of Constellium’s head office and corporate support functions, including our technology centers.
Intersegment elimination
Intersegment transactions are conducted on an arm’s length basis and reflect market prices.
4.1 Segment Revenue
Year ended December 31,
2020 2019 2018
(in millions of Euros) Segment revenue Inter-segment elimination External revenue Segment revenue Inter-segment elimination External revenue Segment revenue Inter-segment elimination External revenue
P&ARP 2,734  (9) 2,725  3,149  (10) 3,139  3,059  (9) 3,050 
A&T 1,025  (23) 1,002  1,462  (42) 1,420  1,389  (50) 1,339 
AS&I 1,167  (11) 1,156  1,351  (3) 1,348  1,290  (3) 1,287 
H&C (A) —  —    —  —  —  10  —  10 
Total 4,926  (43) 4,883  5,962  (55) 5,907  5,748  (62) 5,686 
(A)For the year ended December 31, 2018, H&C included revenue from supplying metal to third parties.
F-24


4.2 Segment Adjusted EBITDA and reconciliation of Adjusted EBITDA to Net Income
Constellium’s CODM measures the profitability and financial performance of its operating segments based on Adjusted EBITDA. Adjusted EBITDA is defined as income / (loss) from continuing operations before income taxes, results from joint ventures, net finance costs, other expenses and depreciation, amortization as adjusted to exclude restructuring costs, impairment charges, unrealized gains or losses on derivatives and on foreign exchange differences on transactions that do not qualify for hedge accounting, metal price lag, share-based compensation expense, effects of certain purchase accounting adjustments, start-up and development costs or acquisition, integration and separation costs, certain incremental costs and other exceptional, unusual or generally non-recurring items.
Year ended December 31,
(in millions of Euros) Notes 2020 2019 2018
P&ARP 291  273  243 
A&T 106  204  152 
AS&I 88  106  125 
H&C (20) (21) (22)
Adjusted EBITDA 465  562  498 
Metal price lag (A) (8) (46) — 
Start-up and development costs (B) (5) (11) (21)
Bowling Green one-time cost related to the acquisition (C)   (5) — 
Share based compensation costs (15) (16) (12)
(Losses) / gains on pensions plan amendments (D) 23 (2) 36 
Depreciation and amortization 16, 17 (259) (256) (197)
Impairment of assets 16, 17 (43) —  — 
Restructuring costs 8 (13) (4) (1)
Unrealized gains / (losses) on derivatives 8 16  33  (84)
Unrealized exchange gains from the remeasurement of monetary assets and liabilities – net 8 1  —  — 
(Losses) / gains on disposals (E) 8 (4) (3) 186 
Other (F) (8) —  (1)
Income from operations 125  255  404 
Finance costs - net 10 (159) (175) (149)
Share of income / (loss) of joint-ventures   (33)
(Loss) / income before income tax (34) 82  222 
Income tax benefit / (expense) 12 17  (18) (32)
Net (loss) / income (17) 64  190 
(A)Metal price lag represents the financial impact of the timing difference between when aluminium prices included within Constellium's Revenue are established and when aluminium purchase prices included in Cost of sales are established. The Group accounts for inventory using a weighted average price basis and this adjustment aims to remove the effect of volatility in LME prices. The calculation of the Group metal price lag adjustment is based on an internal standardized methodology calculated at each of Constellium’s manufacturing sites and is primarily calculated as the average value of product recorded in inventory, which approximates the spot price in the market, less the average value transferred out of inventory, which is the weighted average of the metal element of cost of sales, based on the quantity sold in the year.
(B)Start-up and development costs, for the years ended December 31, 2020, 2019 and 2018, were related to new projects in our AS&I operating segment.
(C)Bowling Green one-time costs related to the acquisition, for the year ended December 31, 2019, was the non-cash reversal of the inventory step-up.
(D)The Group amended one of its OPEB plans in the U.S. in 2018, which resulted in a €36 million gain for the year ended December 31, 2018.
F-25


(E)In July 2018, Constellium completed the sale of the North Building assets of its Sierre plant in Switzerland to Novelis and contributed the Sierre site shared infrastructure to a joint-venture with Novelis, in exchange for cash consideration of €200 million. This transaction also resulted in the termination of the existing lease agreement for the North Building assets which had been leased and operated by Novelis since 2005. For the year ended December 31, 2018, the transaction generated a €190 million net gain. (See NOTE 31 - Subsidiaries and Operating Segments).
(F)Other, in the year ended December 31, 2020, includes €2 million of procurement penalties and termination fees incurred because of the Group's inability to fulfill certain commitments due to the COVID-19 pandemic and a €6 million loss resulting from the discontinuation of hedge accounting for certain forecasted sales that were determined to be no longer expected to occur in light of the COVID-19 pandemic effects.
4.3 Segment capital expenditures
Year ended December 31,
(in millions of Euros) 2020 2019 2018
P&ARP (73) (96) (97)
A&T (45) (72) (70)
AS&I (61) (97) (105)
H&C (3) (6) (5)
Capital expenditures (182) (271) (277)
4.4 Segment assets
At December 31,
(in millions of Euros) 2020 2019
P&ARP 1,733  1,951 
A&T 765  856 
AS&I 668  703 
H&C 274  276 
Segment assets 3,440  3,786 
Deferred income tax assets 193  185 
Cash and cash equivalents 439  184 
Other financial assets 57  29 
Total Assets 4,129  4,184 
4.5 Information about major customers
Revenue in the P&ARP segment from sales to the Group’s largest customer was €492 million and €812 million for the years ended December 31, 2020 and December 31, 2018, respectively, and no other single customer contributed 10% or more to the Group’s revenue for 2020 and 2018. No single customer contributed 10% or more to the Group's revenue for the year ended December 31, 2019.
NOTE 5 - INFORMATION BY GEOGRAPHIC AREA
Property, plant and equipment are reported based on the physical location of the assets:
At December 31,
(in millions of Euros) 2020 2019
United States 777  926 
France 646  656 
Germany 270  250 
Czech Republic 97  106 
Other 116  118 
Total 1,906  2,056 
F-26


NOTE 6 - EXPENSES BY NATURE
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Raw materials and consumables used (2,832) (3,535) (3,561)
Employee benefit expenses (902) (1,038) (927)
Energy costs (141) (162) (140)
Sub-contractors (89) (100) (92)
Freight out costs (122) (156) (143)
Professional fees (73) (97) (74)
Lease expenses (11) (13) (31)
Depreciation and amortization (259) (256) (197)
Other operating expenses (240) (272) (270)
Other gains and losses - net (89) (23) 153 
Total operating expenses (4,758) (5,652) (5,282)
NOTE 7 - EMPLOYEE BENEFIT EXPENSES
Year ended December 31,
(in millions of Euros) Notes 2020 2019 2018
Wages and salaries (855) (994) (889)
Pension costs - defined benefit plans 23 (23) (19) (20)
Other post-employment benefits 23 (9) (9) (6)
Share-based compensation 30 (15) (16) (12)
Total employee benefit expenses (902) (1,038) (927)
NOTE 8 - OTHER GAINS AND LOSSES - NET
Year ended December 31,
(in millions of Euros) Notes 2020 2019 2018
Realized (losses) / gains on derivatives (A) (35) (49) 14 
Losses reclassified from OCI as a result of hedge accounting discontinuation (B) (6) —  — 
Unrealized gains / (losses) on derivatives at fair value through profit and loss - net (A) 4 16  33  (84)
Unrealized exchange gains from the remeasurement of monetary assets and liabilities - net 4 1  —  — 
Impairment of assets (C) 16, 17 (43) —  — 
Restructuring costs (D) 24 (13) (4) (1)
(Losses) / gains on pension plan amendments (E) 23 (2) 36 
(Losses) / gains on disposal (F) (4) (3) 186 
Other (3) (1)
Total other gains and losses - net (89) (23) 153 
(A)Realized and unrealized gains and losses are related to derivatives entered into with the purpose of mitigating exposure to volatility in foreign currencies and commodity prices. Unrealized and realized gains and losses are related to derivatives that do not qualify for hedge accounting.
(B)For the year ended December 31, 2020, we determined that a portion of the hedged forecasted sales for the second half of 2020 and 2021, to which hedge accounting was applied, were no longer expected to occur. As a result, the fair value of the related derivatives accumulated in equity was reclassified in the Consolidated Income Statement and resulted in a €6 million loss.
F-27


(C)For the year ended December 31, 2020, an impairment charge of €43 million was recognized related to some A&T cash-generating units due to the downturn in the aerospace industry resulting from the COVID-19 pandemic and some AS&I cash-generating units as a result of the review of their long-term business perspectives.
(D)For the year ended December 31, 2020, restructuring costs amounted to €13 million related to headcount reductions in Europe and in the U.S.
(E)The Group amended one of its OPEB plans in the U.S. in 2018, which resulted in a €36 million gain for the year ended December 31, 2018.
(F)In July 2018, Constellium completed the sale of the North Building assets of its Sierre plant in Switzerland to Novelis and contributed the Sierre site shared infrastructure to a joint-venture with Novelis, in exchange for cash consideration of €200 million. This transaction also resulted in the termination of the existing lease agreement for the North Building assets which had been leased and operated by Novelis since 2005. For the year ended December 31, 2018, the transaction generated a €190 million net gain (See NOTE 31 - Subsidiaries and Operating Segments).
NOTE 9 - CURRENCY GAINS / (LOSSES)
Year ended December 31,
(in millions of Euros) Notes 2020 2019 2018
Included in Revenue 22 (6) (7)
Included in Cost of sales (2)
Included in Other gains and losses - net (19)
Total (27) 11 
Realized exchange (losses) / gains on foreign currency derivatives - net 22 (11) 11 
Losses reclassified from OCI as a result of hedge accounting discontinuation 22 (6) —  — 
Unrealized (losses) / gains on foreign currency derivatives - net 22 (8) (3)
Exchange (losses) / gains from the remeasurement of monetary assets and liabilities - net (2)
Total (27) 11 
See NOTE 21 - Financial Instruments and NOTE 22 - Financial Risk Management for further information regarding the Company’s foreign currency derivatives and hedging activities.
Foreign currency translation reserve
At December 31,
(in millions of Euros) 2020 2019
Foreign currency translation reserve at January 1 4 
Effect of currency translation differences (17)
Foreign currency translation reserve at December 31 (13)
F-28


NOTE 10 - FINANCE COSTS - NET
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Interest received   — 
Finance income   — 
Interest expense on borrowings (A) (117) (124) (118)
Interest expense on leases (10) (13) (5)
Interest cost on pension and other benefits (11) (16) (15)
Expenses on factoring arrangements (10) (19) (18)
Realized and unrealized (losses) / gains on debt derivatives at fair value (B) (32) 13  28 
Realized and unrealized exchange gains / (losses) on financing activities - net (B) 37  (3) (22)
Other finance expenses (C) (17) (16) (10)
Capitalized borrowing costs (D) 1 
Finance expenses (159) (175) (156)
Finance costs - net (159) (175) (149)
(A)The Group primarily incurred, for the year ended December 31, 2020, (i) €111 million of interest related to Constellium SE Senior Notes and (ii) €3 million of interest expense and fees related to the Muscle Shoals, Ravenswood and Bowling Green asset based revolving credit facility (“Pan-U.S. ABL”). The Group primarily incurred, for the year ended December 31, 2019, (i) €115 million of interest related to Constellium SE Senior Notes and (ii) €7 million of interest expense and fees related to the Pan U.S. ABL.
(B)The Group hedges the dollar exposure, relating to the principal of its Constellium SE U.S. Dollar Senior Notes, for the portion that has not been used to finance directly or indirectly U.S. Dollar functional currency entities. Changes in the fair value of these hedging derivatives are recognized within Finance costs – net in the Consolidated Income Statement and largely offset the unrealized results related to Constellium SE U.S. Dollar Senior Notes revaluation.
(C)Other finance expenses include mostly the amortization of arrangements fees related to our Senior Unsecured Notes. In addition for the year ended December 31, 2018, a €6 million net loss was incurred resulting from the modification of our loan to Constellium-UACJ ABS LLC in February 2018.
(D)Borrowing costs directly attributable to the construction of assets are capitalized. The capitalization rate was 6% for the years ended December 31, 2020, 2019 and 2018.
NOTE 11 - SHARE OF INCOME / (LOSS) OF JOINT-VENTURES
The acquisition of 49% of Constellium-UACJ ABS LLC was completed on January 10, 2019 and the entity is consolidated since the acquisition date. The information presented hereafter reflects the amounts included in the Consolidated Financial Statements of Constellium-UACJ ABS LLC for the year ended December 31, 2018, in accordance with Group accounting principles and not the Company’s share of those amounts.
(in millions of Euros) Year ended December 31, 2018
Revenue 262 
Cost of sales (309)
Selling and administrative expenses (10)
Loss from operations (57)
Finance costs (A) (7)
Net loss (64)
(A)Finance costs include a €11 million gain related to the shareholders’ loan modification for the year ended December 31, 2018.
F-29


NOTE 12 - INCOME TAX
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Current tax expense (14) (32) (30)
Deferred tax benefit / (expense) 31  14  (2)
Total income tax benefit / (expense) 17  (18) (32)
The Group's effective tax rate reconciliation is as follows:
Year ended December 31,
(in millions of Euros) 2020 2019 2018
(Loss) / income before income tax (34) 82  222 
Statutory tax rate applicable to parent company (A) 32.0  % 34.4  % 25.0  %
Income tax benefit / (expense) calculated at statutory tax rate 11  (28) (55)
Effect of foreign tax rate 2 
Changes in recognized and unrecognized deferred tax assets (B) 15  (10) 30 
Change in tax laws and rates (C)   21  — 
Other (11) (4) (9)
Income tax benefit / (expense) 17  (18) (32)
Effective income tax rate 49  % 22  % 14  %
(A)The parent company is a French company for the years ended December 31, 2020 and 2019, and was a Dutch company for the year ended December 31, 2018.
(B)For the year ended December 31, 2020, changes mainly related to recognized deferred tax assets on prior-year losses carried forward at one of our main operating entities in the United States, following some clarification on U.S. interest limitation rules in 2020, and the CARES Act. For the year ended December 31, 2018, changes mainly related to non-recurring transactions, especially the gain on the sale of the North Building of the Sierre plant and termination of an existing lease agreement, that generated a significant taxable profit offset by the use of previously unrecognized tax losses carried forward.
(C)For the year ended December 31, 2019, the change in tax laws and rates relates mainly to the application of the Swiss Federal Tax Reform voted in May 2019 and enacted in the Canton where one of our entities is located.
NOTE 13 - CASH AND CASH EQUIVALENTS
The €439 million cash in bank and on hand at December 31, 2020 included €26 million held by subsidiaries that operate in countries where capital control restrictions prevent the balances from being immediately available for general use by the other entities within the Group. At December 31, 2019, the amount subject to these restrictions was €22 million.
F-30


NOTE 14 - TRADE RECEIVABLES AND OTHER
At December 31,
2020 2019
(in millions of Euros) Non-current Current Non-current Current
Trade receivables - gross   345  —  395 
Impairment   (4) —  (2)
Total trade receivables - net —  341  —  393 
Income tax receivables 34  15  35  22 
Other taxes   33  —  35 
Contract assets 23  2  16 
Prepaid expenses 1  6 
Other 9  9  14 
Total other receivables 67  65  60  81 
Total trade receivables and other 67  406  60  474 
14.1 Contract assets
At December 31,
2020 2019
(in millions of Euros) Non-current Current Non-current Current
Unbilled tooling costs 9    16  — 
Other 14  2  — 
Total Contract assets 23  2  16 
14.2 Aging
At December 31,
(in millions of Euros) 2020 2019
Not past due 333  380 
1 – 30 days past due 7  10 
31 – 60 days past due 1 
61 – 90 days past due   — 
Greater than 90 days past due   — 
Total trade receivables - net 341  393 
Impairment allowance
Revisions to the impairment allowance arising from changes in estimates are included as either additional allowances or recoveries. An allowance was recognized for €1.9 million and €0.4 million during the years ended December 31, 2020 and 2019, respectively.
None of the amounts included in Other receivables were deemed to be impaired for the years ended December 31, 2020 and 2019.
The maximum exposure to credit risk at the reporting date is the carrying value of each class of receivable shown above. The Group does not hold any collateral from its customers or debtors as security.
F-31


14.3 Currency concentration
At December 31,
(in millions of Euros) 2020 2019
Euro 143  126 
U.S. Dollar 181  251 
Swiss franc 6 
Other currencies 11  13 
Total trade receivables - net 341  393 
14.4 Factoring arrangements
The Group factors trade receivables under committed factoring agreements in the United States, France, Germany, Switzerland and the Czech Republic:
In the United States, Constellium Muscle Shoals LLC is party to a factoring agreement with a maximum capacity of $300 million and a maturity date in September 2021 and Constellium Automotive USA LLC is party to a factoring agreement with a maximum capacity of $25 million and a maturity date in December 2021.
The factoring agreement in place for our entities in France has a maximum capacity of €255 million (including a €20 million recourse line) and a maturity date in December 2023.
Factoring agreements in place for our entities in Germany, Switzerland and the Czech Republic have a combined maximum capacity of €150 million and maturity dates in December 2023.
In addition, the Group sells receivables from one of its German customers under an uncommitted factoring facility whereby receivables sold are confirmed by the customer.
These factoring agreements contain certain customary affirmative and negative covenants, including some relating to the administration and collection of the assigned receivables, the terms of the invoices and the exchange of information, but do not contain maintenance financial covenants. In addition, the commitment of the factor to buy receivables under the Muscle Shoals factoring agreement is subject to certain credit ratings being maintained. The Group was in compliance with all applicable covenants at and for the years ended December 31, 2020 and December 31, 2019.
Under the Group’s factoring agreements, most of the trade receivables are sold without recourse. Where the Group has transferred substantially all the risks and rewards of ownership of the receivables, the receivables are derecognized. Some remaining receivables do not qualify for derecognition, as the Group retains substantially all the associated risks and rewards. At December 31, 2020, the total carrying amount of the original assets factored was €514 million of which €398 million have been derecognized. At December 31, 2019, the total carrying amount of the original assets factored was €574 million of which €463 million have been derecognized.
Amounts due to the factors in respect to trade receivables sold were nil at December 31, 2020 and 2019.
NOTE 15 - INVENTORIES
At December 31,
(in millions of Euros) 2020 2019
Finished goods 149  203 
Work in progress 280  321 
Raw materials 118  106 
Stores and supplies 80  74 
Inventories write down (45) (34)
Total inventories 582  670 
F-32


NOTE 16 - PROPERTY, PLANT AND EQUIPMENT
(in millions of Euros) Land and Property Rights Buildings Machinery and Equipment Construction Work in Progress Other Total
Net balance at January 1, 2020 19  366  1,451  203  17  2,056 
Additions —  20  76  129  228 
Disposals —  —  (3) —  —  (3)
Depreciation expense (1) (27) (211) —  (10) (249)
Impairment —  (6) (28) (8) —  (42)
Transfer and other changes 38  139  (189) (4)
Effect of changes in foreign exchange rates (1) (12) (63) (3) (1) (80)
Net balance at December 31, 2020 20  379  1,361  132  14  1,906 
Cost 35  559  2,473  145  48  3,260 
Less accumulated depreciation and impairment (15) (180) (1,112) (13) (34) (1,354)
Net balance at December 31, 2020 20  379  1,361  132  14  1,906 

(in millions of Euros) Notes Land and Property Rights Buildings Machinery and Equipment Construction Work in Progress Other Total
Net balance at December 31, 2018 18  217  1,227  194  10  1,666 
IFRS 16 Application —  82  17  —  102 
Net balance at January 1, 2019 18  299  1,244  194  13  1,768 
Property, plant and equipment acquired through business combination 33 —  40  120  165 
Additions 22  81  245  352 
Disposals —  —  (5) —  —  (5)
Depreciation expense —  (27) (208) —  (11) (246)
Transfer —  28  203  (242) 11   
Effect of changes in foreign exchange rates —  16  —  22 
Net balance at December 31, 2019 19  366  1,451  203  17  2,056 
Cost 35  527  2,407  213  46  3,228 
Less accumulated depreciation and impairment (16) (161) (956) (10) (29) (1,172)
Net balance at December 31, 2019 19  366  1,451  203  17  2,056 
Right-of-use assets
Right-of-use assets have been included within the same line item as that within which the corresponding underlying assets would be presented if they were owned.
F-33


(in millions of Euros) Buildings Machinery and Equipment Other Total
Net balance at January 1, 2020 116  71  190 
Additions 19  33  53 
Disposals —  (1) —  (1)
Depreciation expense (12) (22) (2) (36)
Impairment (4) (5) —  (9)
Transfer and other changes (4) (1) —  (5)
Effect of changes in foreign exchange rates (3) (3) —  (6)
Net balance at December 31, 2020 112  72  2  186 
Cost 142  135  281 
Less accumulated depreciation and impairment (30) (63) (2) (95)
Net balance at December 31, 2020 112  72  2  186 
The total expense relating to short-term leases, low value asset leases and variable lease payments that are still recognized as operating expenses was €11 million and €13 million for the years ended December 31, 2020 and December 31, 2019, respectively.
(in millions of Euros) Buildings Machinery and Equipment Other Total
Net balance at December 31, 2018 24  53  —  77 
IFRS 16 application (A) 82  17  102 
Net balance at January 1, 2019 106  70  179 
Additions 20  21  43 
Disposals —  —  —   
Depreciation expense (11) (18) (2) (31)
Transfer —  (3) —  (3)
Effect of changes in foreign exchange rates —  2 
Net balance at December 31, 2019 116  71  3  190 
Cost 134  113  252 
Less accumulated depreciation and impairment (18) (42) (2) (62)
Net balance at December 31, 2019 116  71  3  190 
(A)The IFRS 16 application included assets acquired through finance leases reclassified as right-of-use assets of €77 million and operating leases recognized as right-of-use assets of €102 million at January 1, 2019.
Depreciation expense
Total depreciation expense relating to property, plant and equipment and intangible assets are presented in the Consolidated Income Statement as follows:
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Cost of sales (240) (237) (184)
Selling and administrative expenses (14) (13) (9)
Research and development expenses (5) (6) (4)
Total depreciation expense (259) (256) (197)
The amount of contractual commitments for the acquisition of property, plant and equipment is disclosed in NOTE 28 - Commitments.
F-34


Impairment tests for property, plant and equipment and intangibles assets
At December 31, 2020, the downturn in the aerospace industry resulting from the COVID-19 pandemic was identified as an indicator of impairment for all the Cash Generating Units (“CGUs”) in the A&T segment.
As a result, these CGUs were tested for impairment and their value in use was calculated using discounted cash flows based on a financial forecast for the period 2021-2025 prepared by management and reflecting the following key assumptions:
Aerospace market demand is expected to be down by approximately 50% in 2021 and 2022 compared to 2019,
Reductions in costs and capital expenditures are assumed to help partially offset weak demand,
Profitability and cash-flows are assumed to recover in the 2023 to 2025 period, but remain below 2019 levels,
The terminal value was determined using a perpetuity growth calculation assuming a long term growth rate of 1.5%,
A discount rate of 9% is assumed.
This impairment test conclusion to fully impair two CGUs for €16 million (€9 million for the Montreuil-Juigné plant and €7 million for the Ussel plant) was reached in the year ended December 31, 2020.
The Group also tested the sensitivity of two other A&T CGUs to changes in cash flows, in discount rates, and in perpetuity growth rates:
With cash-flows that are 20% lower from 2021 to 2025, including the terminal year cash flow, the recoverable value would exceed the carrying value for one CGU, and equal the carrying value for the other CGU,
With an increase in the discount of 275 basis points, the recoverable value of one CGU would exceed the carrying value, and equal the carrying value for the other CGU,
With a decrease in the perpetual growth rate of 400 basis points, the recoverable value of one CGU would exceed the carrying value, and equal the carrying value for the other CGU.
At December 31, 2020, management also reviewed the CGUs in the AS&I segment and identified an indicator of impairment for two Automotive Structures plants – Nanjing, China and White Georgia, U.S.
In June 2020, one of the main customers of the Nanjing plant announced a suspension of its operations as well as a strategic reorganization and the business prospects were reviewed consequently. The White Georgia plant was tested for impairment due to lower profitability than expected as a result of operational challenges faced in the implementation of a new technology developed for one specific automotive platform leading management to reassess the long-term prospects of the plant.
As a result, these two CGUs were tested for impairment and their value in use was calculated using discounted cash flows and a discount rate of 9%. Based on this analysis the conclusion to fully impair the Nanjing plant for €12 million was reached in the year ended December 31, 2020. The White Georgia plant was partially impaired for €13 million, leading to a carrying value of €11 million at December 31, 2020.
There were no other impairment indicators identified for our other CGUs at December 31, 2020.
At December 31, 2019, a triggering event was identified for the Automotive Structure USA CGUs due to the fact that actual operating profit and net cash flows were impacted by higher than expected costs related to operational challenges on some of the newer automotive programs. The Automotive Structure USA CGUs were tested for impairment at December 31, 2019 and management concluded that no impairment charge was required. No triggering events were identified at December 31, 2019 for our other CGUs.
F-35


NOTE 17 - INTANGIBLE ASSETS AND GOODWILL
(in millions of Euros) Technology Computer Software Customer relationships Work in Progress Other Total Intangible Assets Goodwill
Net balance at January 1, 2020 21  19  14  14  70  455 
Additions —  —  —  —  4   
Amortization expense (1) (8) (1) —  —  (10)  
Impairment —  (1) —  —  —  (1)  
Transfer —  —  (4) —     
Effect of changes in foreign exchange rates (2) —  (1) —  (2) (38)
Net balance at December 31, 2020 18  15  13  13  61  417 
Cost 79  76  37  14  208  417 
Less accumulated depreciation and impairment (61) (61) (24) (1) —  (147)  
Net balance at December 31, 2020 18  15  13  13  61  417 
(in millions of Euros) Notes Technology Computer Software Customer relationships Work in Progress Other Total Intangible Assets Goodwill
Net balance at January 1, 2019 22  18  15  13  70  422 
Intangible assets acquired through business combination 33 —  —  —  —  —    24 
Additions —  —  —  9   
Amortization expense (1) (8) (1) —  —  (10)  
Transfer —  —  (7) —     
Effect of changes in foreign exchange rates —  —  —  —  1  9 
Net balance at December 31, 2019 21  19  14  14  70  455 
Cost 87  73  39  16  217  455 
Less accumulated depreciation and impairment (66) (54) (25) (2) —  (147)  
Net balance at December 31, 2019 21  19  14  14  70  455 
Impairment tests for goodwill
Goodwill in the amount of €417 million has been allocated: €410 million to P&ARP, €5 million to A&T and €2 million to AS&I.
At December 31, 2020, the recoverable amount of our operating segments has been determined based on value in use calculations, using discounted cash-flows.
The recoverable amount of the A&T and AS&I operating segments significantly exceeded their carrying value. No reasonable change in the assumptions used could lead to a potential impairment charge.
For the P&ARP operating segment, the analysis is based on forecasted cash flows that grow to management’s estimate of a normalized level by 2025 and then at a long term growth rate of 1.5% thereafter. The discount rate applied to the cash-flow projections is 9%. Based on this analysis, the carrying value of €1,203 million remained below the recoverable value of €2,290 million at December 31, 2020 and therefore there is no goodwill impairment at the P&ARP operating segment.
The key assumptions used in the determination of the value in use for the P&ARP operating segment are the discount rates and the perpetual growth rates used to extrapolate cash-flows beyond the forecast year.
The discount rate used represents the current market assessment of the risks specific to the P&ARP operating segment taking into consideration the time value of money and the risks associated with the underlying assets.
F-36


The growth rate used to extrapolate cash flows beyond the forecast year was developed internally and is consistent with external sources of information.
An increase in the discount rate by 700 basis points or a decrease in the perpetual growth rate by 900 basis points would not lead to a goodwill impairment. With cash-flows that are 40% lower from 2021 to 2025 including the terminal year cash flow, the recoverable value still exceeds the carrying value.
NOTE 18 - DEFERRED INCOME TAXES
At December 31,
(in millions of Euros) 2020 2019
Deferred income tax assets 193  185 
Deferred income tax liabilities (10) (24)
Net deferred income tax assets 183  161 
At January 1, 2020 Acquisitions Recognized in FX At December 31, 2020
(in millions of Euros) Profit or loss OCI
Long-term assets (99) —  (16) —  (106)
Inventories —  (3) —  —  5 
Pensions 127  —  (1) (5) 126 
Derivative valuation —  (4) (7) —  (5)
Tax losses carried forward 75  —  49  —  (8) 116 
Other (A) 44  —  —  (3) 47 
Net deferred income tax assets 161    31  (2) (7) 183 
(A)Other results mainly from non-deductible provisions and interest.
At January 1, 2019 Acquisitions Recognized in FX and reclassifications At December 31, 2019
(in millions of Euros) Profit or loss OCI
Long-term assets (94) (3) —  (3) (99)
Inventories —  —  8 
Pensions 116  —  (4) 13  127 
Derivative valuation 12  —  (8) —  6 
Tax losses carried forward (A) 61  —  27  —  (13) 75 
Other (B) 41  —  —  44 
Net deferred income tax assets 141  3  14  15  (12) 161 
(A)The reclassifications resulted primarily from the adoption of IFRIC 23.
(B)Other results mainly from non-deductible provisions and interest.
Recognized Deferred Tax Assets
Some deferred tax assets in respect of temporary differences and tax losses unused were recognized without being offset by deferred tax liabilities.
In accordance with the accounting policies described in Note 2.6 of the Consolidated Financial Statements, a detailed assessment was performed on net deferred tax asset recovery, with specific focus on tax jurisdictions with unused tax losses carried forward.
Management considered that recent losses are not expected to be recurring and do not challenge the profitable long term structure of its business models. In addition, tax planning opportunities are available to increase the taxable profit and the use of tax losses in the period the unused long-term limited and unlimited tax losses can be utilized.
F-37


Management concludes that it is more likely than not that the net deferred tax asset balance of €183 million and €161 million at December 31, 2020 and 2019, respectively, will be recoverable.
Unrecognized Deferred Tax Assets
Based on the expected taxable income of the entities, the Group believes that it is more likely than not that a total of €920 million and €1,009 million at December 31, 2020 and 2019, respectively, of unused tax losses and deductible temporary differences, will not be used. Consequently, net deferred tax assets have not been recognized. The related tax impact of €224 million and €259 million at December 31, 2020 and 2019, respectively, is attributable to the following:
At December 31,
(in millions of Euros) 2020 2019
Expiring within 5 years (3) (2)
Expiring after 5 years and limited (55) (62)
Unlimited (23) (20)
Tax losses (81) (84)
Long-term assets (91) (104)
Pensions (16) (20)
Other (36) (51)
Deductible temporary differences (143) (175)
Total (224) (259)
Substantially all of the tax losses not expected to be used reside in the United States at December 31, 2020.
The tax loss carryforwards limited to 20 years generated at one of our main operating entities in the United States are not expected to be utilized. Although this entity is expected to be profitable in the medium and long-term, considering notably the anticipated development of the Automotive Body Sheet business, it has significant non-cash depreciation and financial interest expenses that will result in additional tax losses in the coming years. Accordingly, it is not probable that the entity will be able to use at its level, given the absence of an overall U.S. tax group, these tax losses before they expire. Consequently, the related deferred tax assets have not been recognized.
At December 31, 2020 and 2019, most of the unrecognized deferred tax assets on deductible temporary differences on long-term assets and other differences relate to the U.S. An assessment has been performed on the recoverability of the deferred tax assets on deductible temporary differences. The related deferred tax assets on long-term assets and on other differences have not been recognized.
F-38


NOTE 19 - TRADE PAYABLES AND OTHER
At December 31,
2020 2019
(in millions of Euros) Non-current Current Non-current Current
Trade payables   626  —  711 
Fixed assets payables   27  —  43 
Employees' entitlements   143  —  171 
Taxes payable other than income tax   15  —  14 
Contract liabilities and other liabilities to customers 3  81  54 
Other payables 29  13  15 
Total Other 32  279  21  288 
Total Trade payables and other 32  905  21  999 

Contract liabilities and other liabilities to customers
At December 31,
2020 2019
(in millions of Euros) Non-current Current Non-current Current
Deferred tooling revenue 2    — 
Advance payment from customers   2 
Unrecognized variable consideration (A) 1  72  46 
Other   7  — 
Total contract liabilities and other liabilities to customers 3  81  54 
(A)Unrecognized variable consideration consists of expected volume rebates, discounts, incentives, refunds penalties and price concessions.
Revenue of €31 million that related to contract liabilities at December 31, 2019 was recognized in the year ended December 31, 2020. Revenue of €60 million generated in the year ended December 31, 2020 was deferred.
Revenue of €57 million that related to contract liabilities at January 1, 2019 was recognized in the year ended December 31, 2019. Revenue of €62 million generated in the year ended December 31, 2019 was deferred.
F-39


NOTE 20 - BORROWINGS
20.1 Analysis by nature
At December 31,
2020 2019
(in millions of Euros) Nominal Value in Currency Nominal rate Nominal Value in Euros (Arrangement fees) Accrued interests Carrying value Carrying value
Secured Pan-U.S. ABL
(due 2022)
$ —  Floating —  —  —    127 
Secured U.S. DDTL
(due 2022) (A)
$ —  Floating         — 
Secured PGE French Facility
(due 2026) (B)
180  Floating 180      180  — 
Secured German Facility
(due 2022) (C)
—  2.000  %         — 
Secured Inventory Facility
(due 2021)
—  Floating         — 
Senior Unsecured Notes (D)
Issued May 2014 and due 2024 $ 400  5.750  % 326  (3) 2  325  355 
Issued May 2014 and due 2021 —  4.625  %         200 
Issued February 2017 and due 2025 $ 650  6.625  % 530  (8) 12  534  582 
Issued November 2017 and due 2026 $ 500  5.875  % 407  (5) 9  411  449 
Issued November 2017 and due 2026 400  4.250  % 400  (5) 6  401  400 
Issued June 2020 and due 2028 (E) $ 325  5.625  % 265  (6) 1  260  — 
Unsecured Revolving Credit Facility
(due 2021) (F)
—  Floating —  —  —  —  — 
Unsecured Swiss Facility
(due 2025) (G)
CHF 20  1.180  % 18      18  — 
Unsecured German Facility
(due 2022) (C)
—  2.120  %         — 
Lease liabilities 194    1  195  188 
Other loans (H) 66    1  67  60 
Total Borrowings 2,386  (27) 32  2,391  2,361 
Of which non-current 2,299  2,160 
Of which current 92  201 
(A)The Pan-U.S. ABL was amended on April 24, 2020 to include a delayed draw term loan (the “U.S. DDTL”) of up to the lesser of $166 million and 50% of the net orderly liquidation value of certain eligible equipment (the Pan-U.S. ABL and the U.S. DDTL are collectively referred to as the “U.S. revolving credit facilities").The U.S. revolving credit facilities were further amended on September 25, 2020 to, among other things, extend the delayed draw term loan commitment expiration date to May 1, 2021.
(B)On May 13, 2020, one of our French entities entered into a fully committed term loan with a syndicate of banks (the “PGE French Facility”) for an aggregate amount of up to €180 million, of which 80% is guaranteed by the French State. Bpifrance Financement, a related party, provided €30 million of the PGE French Facility. The PGE French Facility will mature no earlier than May 20, 2021, and the borrower has the option to extend the PGE French Facility for up to five years. The facility bears interest at an annual rate equal to EURIBOR (floored at zero) plus a margin of 1.3% per annum in the first year, increasing by 0.50% per annum annually thereafter. The cost of the French State guarantee initially equals to 0.5% per annum of the total amount of the loan and will step up to 1% for each of the second and third years and to 2% for each of the fourth, fifth and sixth years. The PGE French facility has been recorded at amortized cost assuming a two-year draw resulting in an effective interest rate of 2.5%.
(C)On July 15, 2020, two of our German entities entered into two credit facilities of €25 million each of which 80% is guaranteed by the German State.
(D)Senior Unsecured Notes have been issued by Constellium SE and are guaranteed by certain subsidiaries.
F-40


(E)On June 30, 2020, Constellium SE issued $325 million of 5.625% Senior Notes due 2028. Deferred arrangement fees were €6 million. A portion of the net proceeds from the issuance was used to repurchase the remaining €200 million of the 4.625% Senior Notes due 2021.
(F)The Unsecured Revolving Credit Facility of one of our French entities has a €3 million borrowing base and is provided by Bpifrance Financement, a related party.
(G)On May 22, 2020, Constellium Valais entered into an uncommitted revolving credit facility for an amount of CHF20 million, of which 85% is guaranteed by the Swiss state. This facility may be terminated by either party at any time.
(H)Other loans include €44 million of financial liabilities relating to the sale and leaseback of assets that were considered to be financing arrangements in substance.
20.2 Securities against borrowings and covenants
Assets pledged as security
Constellium has pledged assets and financial instruments as collateral against certain of its borrowings.
Pan-U.S. ABL and U.S. DDTL ( " U.S. revolving credit facilities")
Obligations under these facilities are, subject to certain permitted liens, secured by substantially all assets of Ravenswood, Muscle Shoals, and Bowling Green.
PGE French Facility
Obligations under the PGE French Facility are secured by pledges of (i) the shares of Constellium Issoire S.A.S. and Constellium Neuf-Brisach S.A.S. owned by Constellium France Holdco S.A.S., and (ii) certain French bank accounts of Constellium International S.A.S., Constellium Issoire S.A.S. and Constellium Neuf-Brisach S.A.S.
Secured German Facility
Obligations under the Secured German Facility are secured by a charge on the land of the Constellium Singen GmbH.
French Inventory Facility
Obligations under the Secured Inventory Facility of Constellium Issoire S.A.S. and Constellium Neuf-Brisach S.A.S. (the “French Inventory Facility”) are secured by possessory and non-possessory pledges of the eligible inventory of Constellium Issoire S.A.S. and Constellium Neuf-Brisach S.A.S.
Lease liabilities
Lease liabilities are generally secured as the rights to the leased assets recognized in the financial statements revert to the lessor in the event of default.
Covenants
The Group was in compliance with all applicable debt covenants at and for the years ended December 31, 2020 and 2019.
Constellium SE Senior Notes
The indentures for our outstanding Senior Notes contain customary terms and conditions, including amongst other things, limitations on incurring or guaranteeing additional indebtedness, on paying dividends, on making other restricted payments, on creating restrictions on dividends and other payments to us from certain of our subsidiaries, on incurring certain liens, on selling assets and subsidiary stock, and on merging.
F-41


Pan-U.S. ABL and U.S. DDTL ( " U.S. revolving credit facilities")
These facilities contain a fixed charge coverage ratio covenant and an EBITDA contribution ratio covenant along with customary affirmative and negative covenants. Evaluation of compliance with the maintenance covenants is only required if the excess availability falls below 10% of the aggregate revolving loan commitment.
PGE French Facility
The PGE French Facility contains a net debt leverage covenant and an interest coverage ratio covenant with semi-annual testing dates beginning on June 30, 2021.
The PGE French Facility also contains customary terms and conditions, including, amongst other things, negative covenants and limitations on incurring additional indebtedness, on selling assets, on certain corporate transactions and reorganizations, on making loans and advances and on entering into certain derivative transactions.
Unsecured German Facility
The unsecured German Facility has an interest coverage covenant applicable if the facility is drawn.
20.3 Movements in borrowings
At December 31,
(in millions of Euros) Notes 2020 2019
At December 31, prior period 2,361  2,151 
IFRS 16 application —  102 
At January 1 2,361  2,253 
Cash flows
Proceeds from issuance of Senior Notes 290  — 
Repayment of Senior Notes (A) (200) (100)
(Repayments) / proceeds from U.S. revolving credit facilities
(129) 105 
Proceeds from other borrowings 202 
Repayments from other borrowings (10) (4)
Lease repayments (35) (86)
Payment of deferred financing costs (6) — 
Non-cash changes
Borrowings assumed through business combination 33   75 
Movement in interests accrued or capitalized (1)
Changes in leases and other loans 62  75 
Deferred arrangement fees 5 
Effects of changes in foreign exchange rates (148) 29 
At December 31 2,391  2,361 
(A)On August 8, 2019, €100 million of the €300 million outstanding aggregate principal amount of the 4.625% Senior Notes due 2021 were redeemed. On June 30, 2020, the remaining €200 million were redeemed.
20.4 Currency concentration
At December 31,
(in millions of Euros) 2020 2019
U.S. Dollar 1,602  1,597 
Euro 757  746 
Other currencies 32  18 
Total borrowings 2,391  2,361 
F-42


NOTE 21 - FINANCIAL INSTRUMENTS
21.1 Financial assets and liabilities by categories
At December 31,
2020 2019
(in millions of Euros) Notes At amortized cost At Fair Value through Profit and loss At Fair Value through OCI Total At amortized cost At Fair Value through Profit and loss At Fair Value through OCI Total
Cash and cash equivalents 13 439  —  —  439  184  —  —  184 
Trade receivables 14 —  —  341  341  —  —  393  393 
Other financial assets 40  14  57  —  29  —  29 
Total 442  40  355  837  184  29  393  606 

At December 31,
2020 2019
(in millions of Euros) Notes At amortized cost At Fair Value through Profit and loss At Fair Value through OCI Total At amortized cost At Fair Value through Profit and loss At Fair Value through OCI Total
Trade payables and fixed assets payables 19 653  —  —  653  754  —  —  754 
Borrowings 20 2,391  —  —  2,391  2,361  —  —  2,361 
Other financial liabilities —  85  87  —  44  14  58 
Total 3,044  85  3,131  3,115  44  14  3,173 
21.2 Fair values
The carrying value of the Group’s borrowings at maturity is the redemption value.
The fair value of Constellium SE Senior Notes issued in May 2014, February 2017, November 2017 and June 2020 account for 102%, 102%, 103% and 108% respectively of the nominal value and amount to €333 million, €543 million, €830 million and €285 million, respectively, at December 31, 2020.
All derivatives are presented at fair value in the Consolidated Statement of Financial Position. The fair values of the other financial assets and liabilities approximate their carrying values, as a result of their liquidity or short maturity.
F-43



At December 31,
2020 2019
(in millions of Euros) Non-current Current Total Non-current Current Total
Aluminium and premium future contracts 18  19 
Other future contracts 2  —  —  — 
Currency commercial contracts 16  17  33  12  17 
Currency net debt derivatives —  —   
Margin call (A) —  3  —  —  — 
Other financial assets - derivatives 18  39  57  7  22  29 
Aluminium and premium future contracts 9  10  14 
Energy future contracts —  —    — 
Other future contracts —  1 
Currency commercial contracts 28  32  12  16  28 
Currency net debt derivatives 34  11  45 
Other financial liabilities - derivatives 41  46  87  23  35  58 
(A) At December 31, 2020, the €3 million margin call asset position was related to foreign currency derivatives.
21.3 Valuation hierarchy
The following table provides an analysis of financial instruments measured at fair value, grouped into levels based on the degree to which the fair value is observable:
Level 1 is based on a quoted price (unadjusted) in active markets for identical financial instruments. Level 1 includes aluminium, copper and zinc futures that are traded on the LME.
Level 2 is based on inputs other than quoted prices included within Level 1 that are observable for the assets or liabilities, either directly (i.e. prices) or indirectly (i.e. derived from prices). Level 2 includes foreign exchange derivatives. The present value of future cash flows based on the forward or on the spot exchange rates at the balance sheet date is used to value foreign exchange derivatives.
Level 3 is based on inputs for the asset or liability that are not based on observable market data (unobservable inputs). Trade receivables are classified as a Level 3 measurement under the fair value hierarchy.
At December 31,
2020 2019
(in millions of Euros) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total
Other financial assets - derivatives 20  37  —  57  21  —  29 
Other financial liabilities - derivatives 78  —  87  19  39  —  58 
There was no material transfer of asset and liability categories into or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2020 and 2019.




F-44


NOTE 22 - FINANCIAL RISK MANAGEMENT
The Group’s financial risk management strategy focuses on minimizing the cash flow impacts of volatility in foreign currency exchange rates and metal prices, while maintaining the financial flexibility the Group requires in order to successfully execute the Group’s business strategy.
Due to Constellium’s capital structure and the nature of its operations, the Group is exposed to the following financial risks: (i) market risk including foreign exchange, commodity price and interest rate risks; (ii) credit risk and (iii) liquidity and capital management risk.
The Group's financial institution counterparties may require margin calls should the mark-to-market of our derivatives hedging foreign exchange and commodity price risks exceed a pre-agreed contractual limit. In order to protect from potential margin calls for significant market movements, the Group enters into derivatives with a large number of financial counterparties and monitors margin requirements on a daily basis. In addition, the Group (i) ensures that financial counterparts hedging transactional exposure are also hedging foreign currency loan and deposit exposures and (ii) holds a significant liquidity buffer in cash or in availability under its various borrowing facilities.
22.1 Foreign exchange risk
Net assets, earnings and cash flows are influenced by multiple currencies due to the geographic diversity of sales and the countries in which the Group operates.
Constellium has the following foreign exchange risk: i) transaction exposures, which include commercial transactions related to forecasted sales and purchases and on-balance sheet receivables/payables resulting from such transactions and financing transactions related to external and internal net debt, and ii) translation exposures, which relate to net investments in foreign entities that are converted in Euros in the Consolidated Financial Statements.
i. Commercial transaction exposures
The Group policy is to hedge committed and highly probable forecasted foreign currency operational transactions. The Group uses foreign exchange forwards and foreign exchange swaps for this purpose.
The following tables outline the nominal value (converted to millions of Euros at the closing rate) of derivatives for Constellium’s most significant foreign exchange exposures at December 31, 2020.
Forward derivative sales Maturity Year Less than 1 year Over 1 year
USD/EUR 2021-2025 508  246 
EUR/CHF 2021-2024 82  26 
EUR/CZK 2021 21   
Other currencies 2021 6   
Forward derivative purchases Maturity Year Less than 1 year Over 1 year
USD/EUR 2021-2024 624  61 
EUR/CHF 2021-2025 128  44 
EUR/CZK 2021-2022 85  29 
Other currencies 2021    
The Group has agreed to supply a major customer with fabricated metal products from a Euro functional currency entity and invoices in U.S. Dollars. The Group entered into significant foreign exchange derivatives that matched related highly probable future conversion sales. The Group designates these derivatives for hedge accounting, with a total nominal amount of $330 million and $233 million at December 31, 2020 and December 31, 2019 respectively, with maturities ranging from 2021 to 2025.
F-45


The table below details the effect of foreign currency derivatives in the Consolidated Income Statement and the Consolidated Statement of Comprehensive Income / (Loss):
Year ended December 31,
(in millions of Euros) Notes 2020 2019 2018
Derivatives that do not qualify for hedge accounting
Included in Other gains and losses - net
Realized (losses) / gains on foreign currency derivatives - net 9 (4)
Unrealized (losses) / gains on foreign currency derivatives - net (A) 9 (9) (1)
Derivatives that qualify for hedge accounting
Included in Other comprehensive income / (loss)
Unrealized gains / (losses) on foreign currency derivatives - net 20  (15) (23)
Gains / (losses) reclassified from cash flow hedge reserve to Consolidated Income Statement 6  (2)
Included in Revenue (B)
Realized (losses) / gains on foreign currency derivatives - net
9 (7) (6)
Unrealized gains / (losses) on foreign currency derivatives - net 9 1  (1) (2)
Derivatives discontinued from hedge accounting
Included in Other gains and losses - net
Losses reclassified from OCI as a result of hedge accounting discontinuation (C) 9 (6) —  — 
(A)Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized.
(B)Derivatives that qualify for hedge accounting are included in Revenue when the related customer invoices have been issued.
(C)In the year ended December 31, 2020, we determined that a portion of the hedged forecasted sales for 2020 and 2021, to which hedge accounting was applied, was no longer expected to occur. As a result, the fair value of the related derivatives accumulated in equity was reclassified in the Consolidated Income Statement and resulted a €6 million loss.
ii. Financing transaction exposures
When the Group enters into intercompany loans and deposits, the financing is generally provided in the functional currency of the subsidiary. The foreign currency exposure of the Group’s external funding and liquid assets is systematically hedged either naturally through external foreign currency loans and deposits or through cross-currency basis swaps and simple foreign currency swaps.
At December 31, 2020, the net position hedged related to loans and deposits was $518 million versus the Euro. This comprised of a forward purchase of $565 million versus the Euro using cross-currency basis swaps, and a forward sale of $47 million versus the Euro using simple foreign exchange forward contracts.
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Derivatives
Included in Finance costs - net
Realized gains on foreign currency derivatives - net 7 
Unrealized (losses) / gains on foreign currency derivatives - net (39) 23 
Total (32) 13  28 
F-46


In accordance with the Group policy, total realized and unrealized gains or losses on foreign currency derivatives are expected to offset the net foreign exchange result related to financing activities, both included in Finance costs - net.
Net debt derivatives settled during the year are presented in Other financing activities in the Consolidated Statement of Cash Flows.
Foreign exchange sensitivity on commercial and financing transaction exposures
The largest exposures of the Group are related to the Euro/U.S. Dollar exchange rate. The table below summarizes the impact on profit and equity (before tax effect) of a 10% strengthening of the U.S. Dollar versus the Euro for non U.S. Dollar functional currency entities.
(in millions of Euros) Effect on profit before tax Effect on pretax equity
Trade receivables 2 
Trade payables (2)
Derivatives on commercial transactions (A) 23  (30)
Net commercial transaction exposure 23  (30)
Cash in Bank and intercompany loans 123 
Borrowings (170)
Derivatives on financing transactions 47 
Net financing transaction exposure    
Total 23  (30)
(A)Gains or losses on the hedging instruments are expected to offset losses or gains on the underlying hedged forecasted sales that will be reflected in future years when these sales are recognized. The impact on pretax equity of €30 million relates to derivatives hedging future sales spread from 2021 to 2025 which are designated as cash flow hedges.
The amounts shown in the table above may not be indicative of future results since the balances of financial assets and liabilities may change.
iii. Translation exposures
Foreign exchange impacts related to the translation of net investments in foreign subsidiaries from functional currency to Euro, and of the related revenues and expenses, are not hedged as the Group operates in these various countries on permanent basis except as described below.
In June 2018, the Group entered into forward contracts with a nominal amount of CHF174 million to hedge the currency risk associated with the translation of the net assets of its Swiss operations into the Group’s presentation currency. The Group designated these derivatives as a net investment hedge. A loss of €3 million related to these forward contracts was included in Currency translation differences within Other comprehensive income since 2019.
Foreign exchange sensitivity on translation exposures
The exposure relates to foreign currency translation of net investments in foreign subsidiaries and arises mainly from operations conducted by U.S. Dollar functional currency subsidiaries.
The table below summarizes the impact on profit and equity (before tax effect) of a 10% strengthening of the U.S. Dollar versus the Euro (on average rate for profit before tax and closing rate for pretax equity) for U.S. Dollar functional currency entities.
(in millions of Euros) Effect on profit before tax Effect on pretax equity
10% strengthening U.S. Dollar/Euro 3  30 
The amounts shown in the table above may not be indicative of future results since the balances of financial assets and liabilities may change.
F-47


iv. Foreign exchange margin calls
At December 31, 2020, the margin requirement related to foreign exchange hedges amounted to €3 million paid as collateral to counterparties. At December 31, 2019, the margin requirement related to foreign exchange hedges was not material and the Group was not exposed to material margin call risk.
22.2 Commodity price risk
The Group is subject to the effects of market fluctuations in the price of aluminium, which is the Group’s primary metal input and a significant component of its output. The Group is also exposed to variation in regional premiums and in the price of zinc, natural gas, silver and copper but in a less significant way.
The Group policy is to minimize exposure to aluminium price volatility by passing through the aluminium price risk to customers and using derivatives where necessary. For most of its aluminium price exposure, sales and purchases of aluminium are converted to be on the same floating basis and then the same quantities are bought and sold at the same market price. The Group also purchases fixed price aluminium forwards to offset the exposure of LME volatility on its fixed price sales agreements for the supply of metal.
The Group also purchases fixed price copper, aluminium premium, silver and zinc forwards to offset the commodity exposure where sales contracts have embedded fixed price agreements for these commodities.
In addition, the Group also purchases natural gas fixed price forwards to lock in energy costs where a fixed price purchase contract is not possible.
At December 31, 2020, the nominal amount of commodity derivatives is as follows:
(in millions of Euros) Maturity Less than 1 year Over 1 year
Aluminium 2021-2024 238  30 
Premium 2021-2025 7  6 
Copper 2021-2022 4  4 
Silver 2021 2   
Natural gas 2021-2022 4  1 
Zinc 2021-2023 4  5 
The value of the contracts will fluctuate due to changes in market prices but our hedging strategy helps protect the Group’s margin on future conversion and fabrication activities. At December 31, 2020, these contracts were directly entered into with external counterparties.
The Group does not apply hedge accounting on commodity derivatives and therefore any mark-to-market movements are recognized in Other gains and losses - net.
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Derivatives
Included in Other gains and losses - net
Realized (losses) / gains on commodity derivatives - net
(31) (56)
Unrealized gains / (losses) on commodity derivatives - net 25  31  (83)
Commodity price sensitivity: risks associated with derivatives
The net impact on earnings and equity of a 10% increase in the market price of aluminium, based on the aluminium derivatives held by the Group at December 31, 2020 (before tax), with all other variables held constant, was estimated to be a €27 million gain. The balances of such financial instruments may change in future years, and therefore these amounts may not be indicative of future results.
F-48


Commodity Margin Calls
At December 31, 2020 and 2019, there was no margin requirement related to aluminium or any other commodity hedges.
22.3 Interest rate risk
Interest rate risk refers to the risk that the value or cash flows of financial instruments with variable rates will fluctuate. The Group’s interest rate risk arises principally from borrowings. Borrowings issued at variable rates expose the Group to cash flow interest rate risk, which is partially offset by cash and cash equivalent deposits earning interest at variable interest rates. Borrowings issued at fixed rates expose the Group to fair value interest rate risk. At December 31, 2020, the Group’s borrowings were mainly at fixed rates.
Interest rate sensitivity: risks associated with variable-rate financial instruments
The impact on income before income tax of a 50 basis point increase or decrease in the LIBOR or EURIBOR interest rates, based on the variable rate financial instruments held by the Group at December 31, 2020 and 2019, with all other variables held constant, was estimated to be approximately €1 million for the years ended December 31, 2020, and 2019. However, the balances of such financial instruments may not remain constant in future years, and therefore these amounts may not be indicative of future results.
22.4 Credit risk
Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Group is exposed to credit risk with financial institutions and other parties as a result of cash-in-bank, cash deposits, mark-to-market on derivative transactions and customer trade receivables arising from the Group’s operating activities. The maximum exposure to credit risk for the year ended December 31, 2020 is the carrying value of each class of financial asset as described in NOTE 21 - Financial Instruments. The Group does not generally hold any collateral as security.
i. Credit risk related to transactions with financial institutions
Credit risk with financial institutions is managed by the Group’s Treasury department in accordance with a Board approved policy. Management is not aware of any significant risks associated with financial institutions as a result of cash and cash equivalent deposits, including short-term investments and financial derivative transactions.
The number of financial counterparties is tabulated below showing our exposure to the counterparty by rating type (Parent company ratings from Moody’s Investor Services):
At December 31,
2020 2019
Number of financial counterparties (A) Exposure (in millions of Euros) Number of financial counterparties (A) Exposure (in millions of Euros)
Rated Aa or better 3  120  83 
Rated A 8  282  81 
Rated Baa 2  20 
Total 13  422  14  169 
(A)Financial counterparties for which the Group’s exposure is below €0.25 million have been excluded from the analysis.
ii. Credit risks related to customer trade receivables
The Group has a diverse customer base geographically and by industry. The responsibility for customer credit risk management rests with management. Payment terms vary and are set in accordance with practices in the different geographies and end-markets served. Credit limits are typically established based on internal or external rating criteria, which take into account such factors as the financial condition of the customers, their credit history and the risk associated with their industry segment.
F-49


Trade receivables are actively monitored and managed, at the business unit or site level. Business units report credit exposure information to Constellium management on a regular basis. Over 82% of the Group’s trade account receivables are insured by insurance companies rated A3 or better or sold to a factor on a non-recourse basis. In situations where collection risk is considered to be above acceptable levels, risk is mitigated through the use of advance payments, bank guarantees or letters of credit.
Historically, we have a very low level of customer default as a result of long history of dealing with our customer base and an active credit monitoring function. See NOTE 14 - Trade Receivables and Other for the aging of trade receivables.
22.5 Liquidity and capital risk management
The Group’s capital structure includes shareholder’s equity, borrowings and various third-party financing arrangements. Constellium’s total capital is defined as total equity plus net debt. Net debt includes borrowings due to third parties less cash and cash equivalents.
Constellium’s overriding objectives when managing capital are to safeguard the business as a going concern, to maximize returns for its owners and to maintain an optimal capital structure in order to minimize the weighted cost of capital.
All activities around cash funding, borrowings and financial instruments are centralized within Constellium’s Treasury department. Direct external funding or transactions with banks at the operating entity level are generally not permitted, and exceptions must be approved by Constellium’s Treasury department.
The liquidity requirements of the overall Company are funded by drawing on available credit facilities, while the internal management of liquidity is optimized by means of cash pooling agreements and/or intercompany loans and deposits between the Company’s operating entities and central Treasury.
At December 31, 2020, the borrowing base for the U.S revolving credit facilities, the French Inventory Facility, and the German Facilities were €396 million, €74 million, and €50 million, respectively. After deduction of amounts drawn and letters of credit, the Group had €514 million outstanding availability under these revolving credit facilities.
At December 31, 2020, liquidity was €981 million, comprised of €439 million of cash and cash equivalents and €542 million of available undrawn facilities, including the €514 million described above.
The tables below show undiscounted contractual financial assets and financial liabilities values by relevant maturity groupings based on the remaining periods from December 31, 2020 and 2019, respectively, to the contractual maturity date.
At December 31,
2020 2019
(in millions of Euros) Less than 1 year Between 1- 5 years Over 5 years Less than 1 year Between 1 - 5 years Over 5 years
Financial assets
Net debt derivatives       — 
Net cash flows from derivative assets related to currencies and commodities 33  13    21  — 
Total 33  13    24  13  — 
F-50


At December 31,
2020 2019
(in millions of Euros) Notes Less than 1 year Between 1 - 5 years After 5 years Less than 1 year Between 1 - 5 Years After 5 years
Financial liabilities
Borrowings (A) 10  1,089  1,093  139  589  1,438 
Leases 41  110  94  40  113  88 
Interest (B) 114  398  60  112  404  85 
Net debt derivatives 10  30    —  — 
Net cash flows from derivative liabilities related to currencies and commodities 32  7    31  25  — 
Trade payables and other (excluding contract liabilities) 19 824  29    945  15  — 
Total 1,031  1,663  1,247  1,271  1,146  1,611 
(A)At December 31, 2019, borrowings include the Pan-U.S. ABL, which is considered short-term in nature and is included in the category “Less than 1 year”.
(B)Interest disclosed is an undiscounted forecasted interest amount that excludes interest on leases.
NOTE 23 - PENSIONS AND OTHER POST-EMPLOYMENT BENEFIT OBLIGATIONS
The Group operates a number of pensions, other post-employment benefits and other long-term employee benefit plans. Some of these plans are defined contribution plans and some are defined benefit plans, with assets held in separate trustee-administered funds. Benefits paid through pension trusts are sufficiently funded to ensure the payment of benefits to retirees when they become due.
Actuarial valuations are reflected in the Consolidated Financial Statements as described in NOTE 2.6 - Principles governing the preparation of the Consolidated Financial Statements.
23.1 Description of the plans
Pension plans
Constellium’s pension obligations are in the U.S., Switzerland, Germany and France. Pension benefits are generally based on the employee’s service and highest average eligible compensation before retirement and are periodically adjusted for cost of living increases, either by company practice, collective agreement or statutory requirement. Benefit plans in the U.S., Switzerland and France are funded through long-term employee benefit funds.
Other post-employment benefits (OPEB)
The Group provides healthcare and life insurance benefits to retired employees and in some cases to their beneficiaries and covered dependents, mainly in the U.S. Eligibility for coverage depends on certain age and service criteria. These benefit plans are unfunded.
Other long-term employee benefits
Other long-term employee benefits mainly include jubilees in France, Germany and Switzerland and other long-term disability benefits in the U.S. These benefit plans are unfunded.
23.2 Description of risks
The defined benefit obligations expose the Group to a number of risks, including longevity, inflation, interest rate, medical cost inflation, investment performance, and change in law governing the employee benefit obligations. These risks are mitigated when possible by applying an investment strategy for the funded schemes that aims to reduce the volatility of returns and achieve a matching of the underlying liabilities to minimize the long-term costs. This is achieved by investing in a diversified selection of asset classes.
F-51


Investment performance risk
Our pension plan assets consist primarily of funds invested in listed stocks and bonds.
The present value of funded defined benefit obligations is calculated using a discount rate determined by reference to high-quality corporate bond yields. If the return on plan assets is below this rate, it will increase the plan deficit.
Interest rate risk
A decrease in the discount rate will increase the defined benefit obligation. At December 31, 2020, impacts of the change on the defined benefit obligation of a 50 basis points increase / decrease in the discount rates are calculated by using a proxy based on the duration of each scheme:
(in millions of Euros) 50 bp increase in
discount rates
50 bp decrease in
discount rates
France (11) 11 
Germany (9) 10 
Switzerland (26) 28 
United States (33) 33 
Total sensitivity on Defined Benefit Obligations (79) 82 
Longevity risk
The present value of the defined benefit obligation is calculated by reference to the best estimate of the mortality of plan participants. An increase in the life expectancy of the plan participants will increase the plan’s liability.
23.3 Actuarial assumptions
Pension and other post-employment benefit obligations were updated based on the discount rates applicable at December 31, 2020.
At December 31,
2020 2019
Rate of increase in salaries Rate of increase in pensions Discount rate Rate of increase in salaries Rate of increase in pensions Discount rate
Switzerland 1.50% 0.00% 1.50% 0.15%
U.S.
Hourly pension 2.20%
2.45% - 2.65%
2.20%
3.15% - 3.25%
Salaried pension 3.80% 2.55% 3.80% 3.25%
OPEB (A) 3.80%
2.50% - 2.80%
3.80%
3.20% - 3.40%
Other benefits 3.80%
2.20% - 2.55%
3.80%
3.00% - 3.20%
France
1.50% - 3.50%
2.00%
1.50% - 3.50%
2.00%
Retirements 0.50% 0.95%
Other benefits 0.40% 0.80%
Germany 2.50% 1.50% 0.55% 2.75% 1.70% 1.00%
(A)The other main financial assumptions used for the OPEB healthcare plans, which are predominantly in the U.S. were:
Medical trend rate: i) pre-65: 6.25% starting in 2020 decreasing gradually to 4.50% in 2029 and stable onwards and ii) post-65: 6.00% starting in 2020 decreasing gradually to 4.50% in 2029 and stable onwards, and
Claims costs are based on company experience.
For both pension and healthcare plans, the post-employment mortality assumptions allow for future improvements in life expectancy.
F-52


23.4 Amounts recognized in the Consolidated Statement of Financial Position
At December 31,
2020 2019
(in millions of Euros) Pension Benefits Other Benefits Total Pension Benefits Other Benefits Total
Present value of funded obligation 772    772  768    768 
Fair value of plan assets (458)   (458) (445)   (445)
Deficit of funded plans 314    314  323    323 
Present value of unfunded obligation 134  216  350  127  220  347 
Net liability arising from defined benefit obligation 448  216  664  450  220  670 
23.5 Movement in net defined benefit obligations
At December 31, 2020
Defined benefit obligations Plan Assets Net defined benefit liability
(in millions of Euros) Pension benefits Other benefits Total
At January 1, 2020 895  220  1,115  (445) 670 
Included in the Consolidated Income Statement
Current service cost 21  28  —  28 
Interest cost / (income) 13  19  (8) 11 
Past service cost —  2  —  2 
Immediate recognition of gains arising over the year —  2  —  2 
Administration expenses —  —    2 
Included in the Statement of Comprehensive Income / (loss)
Remeasurements due to:
—actual return less interest on plan assets —  —    (28) (28)
—changes in financial assumptions 51  16  67  —  67 
—changes in demographic assumptions (6) (4) (10) —  (10)
—experience losses (4) (3) —  (3)
Effects of changes in foreign exchange rates (27) (17) (44) 20  (24)
Included in the Consolidated Statement of Cash Flows
Benefits paid (41) (18) (59) 34  (25)
Contributions by the Group —  —    (28) (28)
Contributions by the plan participants 5  (5)  
At December 31, 2020 906  216  1,122  (458) 664 
F-53


At December 31, 2019
Defined benefit obligations Plan Assets Net defined benefit liability
(in millions of Euros) Pension benefits Other benefits Total
At January 1, 2019 789  201  990  (380) 610 
Included the Consolidated Income Statement
Current service cost 17  24  —  24 
Interest cost / (income) 18  26  (10) 16 
Past service cost (2) (1) —  (1)
Immediate recognition of gains arising over the year —  — 
Administration expenses —  —  — 
Included in the Statement of Comprehensive Income / (loss)
Remeasurements due to:
—actual return less interest on plan assets —  —  —  (54) (54)
—changes in financial assumptions 101  25  126  —  126 
—changes in demographic assumptions (2) (2) (4) —  (4)
—experience losses (3) (6) (9) —  (9)
Effects of changes in foreign exchange rates 16  19  (11)
Included in the Consolidated Statement of Cash Flows
Benefits paid (43) (20) (63) 38  (25)
Contributions by the Group —  —  —  (25) (25)
Contributions by the plan participants (5) — 
At December 31, 2019 895  220  1,115  (445) 670 
23.6 Benefit plan amendments     
In 2018, the Group announced a plan to transfer certain participants in the Constellium Rolled Products Ravenswood Retiree Medical and Life Insurance Plan (“the Plan”) from a company-sponsored program to a third-party health network that provides similar benefits at a lower cost. This change in benefits resulted in the recognition of a gain of €36 million from negative past service cost, which was reduced by €3 million in 2019 and €2 million in 2020 to reflect delays in the estimated implementation timetable (see 23.7 Ravenswood OPEB dispute).
During the year ended December 31, 2019, the Group decided to terminate the medical care plan for the active participants of one of its French entities effective October 1, 2019. This resulted in both a decrease of the defined benefit obligation and the recognition of a €2 million gain from negative past service cost. In addition, the Group offered a lump sum option to Constellium Rolled Products Ravenswood former employees with deferred benefits. This resulted in both a decrease of the defined benefit obligation and the recognition of a €3 million gain from negative past service cost.
23.7 Ravenswood OPEB disputes
The United Steelworkers Local Union 5668 (the “Union”) is contesting the OPEB amendments and filed a lawsuit against Constellium Rolled Products Ravenswood, LLC ("Ravenswood") in a federal district court in West Virginia (the “District Court”) seeking to enjoin the Plan changes and to compel arbitration. The District Court issued an order in December 2018, enjoining Ravenswood from implementing the OPEB amendments pending resolution in arbitration. In September 2019, the arbitrator issued a decision ruling against Ravenswood and sustaining the Union’s grievance. Ravenswood filed a motion in the District Court to vacate this decision, which was denied in June 2020. In July 2020, Ravenswood appealed that denial to the Fourth Circuit Court of Appeals and that court decision is still pending. The Group intends to continue to vigorously defend this matter as it believes it has a strong legal position and it is probable that Ravenswood will ultimately prevail and be able to implement the OPEB amendments.
Additionally, during 2019, the Union filed a grievance disputing the existing limitation of Ravenswood’s liability for the healthcare costs of pre-Medicare retirees. An arbitration was held in August 2020, briefs were submitted and the arbitrator
F-54


issued his decision on November 4, 2020 denying the Union's grievance. The Union had until February 2, 2021 to appeal such decision but it did not, thus this matter is now considered fully closed.
23.8 Net defined benefit obligations by country
At December 31,
2020 2019
(in millions of Euros) Defined benefit obligations Plan assets Net defined benefit liability Defined benefit obligations Plan assets Net defined benefit liability
France 168  (5) 163  161  (3) 158 
Germany 143  (1) 142  144  (1) 143 
Switzerland 310  (223) 87  299  (214) 85 
United States 500  (229) 271  510  (227) 283 
Other countries —  1  — 
Total 1,122  (458) 664  1,115  (445) 670 
23.9 Plan asset categories
At December 31,
2020 2019
(in millions of Euros) Quoted in an active market Unquoted in an active market Total Quoted in an active market Unquoted in an active market Total
Cash & cash equivalents —  8  — 
Equities 109  64  173  119  51  170 
Bonds 106  103  209  102  105  207 
Property 46  54  14  37  51 
Other 13  14  11  12 
Total fair value of plan assets 232  226  458  241  204  445 
23.10 Cash flows
Expected contributions to pension and other benefit plans amount to €24 million and €15 million, respectively, for the year ending December 31, 2021.
Future benefit payments expected to be paid either by pension funds or directly by the Company to beneficiaries are as follows:
(in millions of Euros) Estimated benefits payments
Year ended December 31,
2021 49 
2022 48 
2023 49 
2024 53 
2025 52 
2026 to 2030 275 
The weighted-average maturity of the defined benefit obligations was 14.2 years and 14.1 years at December 31, 2020 and 2019, respectively.
F-55


NOTE 24 - PROVISIONS
(in millions of Euros) Close down and environmental remediation costs Restructuring
costs
Legal claims
and other costs
Total
At January 1, 2020 90  28  122 
Allowance 13  22 
Amounts used (1) (10) (1) (12)
Unused amounts reversed (2) (1) (7) (10)
Unwinding of discounts —  —  2 
Effects of changes in foreign exchange rates (3) —  —  (3)
Transfer —  —  —   
At December 31, 2020 88  6  27  121 
Current 12  23 
Non-Current 81  15  98 
Total Provisions 88  6  27  121 
(in millions of Euros) Close down and environmental remediation costs Restructuring
costs
Legal claims
and other costs
Total
At January 1, 2019 83  54  140 
IFRIC 23 application —  —  (20) (20)
Allowance 9 
Amounts used (2) (1) (4) (7)
Unused amounts reversed (1) —  (4) (5)
Unwinding of discounts —  —  4 
Effects of changes in foreign exchange rates —  —  2 
Transfer —  (4) (1)
At December 31, 2019 90  4  28  122 
Current 14  23 
Non-Current 83  14  99 
Total Provisions 90  28  122 
Close down, environmental and remediation costs
The Group records provisions for the estimated present value of the costs of its environmental clean-up obligations and close down and restoration efforts based on the net present value of estimated future costs of the dismantling and demolition of infrastructure and the removal of residual material of disturbed areas. At December 31, 2020, the average discount rate was negative. An increase in the discount rate by 500 basis points would not change the provision by more than €1 million.
These provisions are expected to be settled over the next 40 years depending on the nature of the disturbance and the technical remediation plans.
Restructuring costs
For the year ended December 31, 2020, restructuring costs amounted to €13 million related to headcount reductions in Europe and in the U.S.
F-56


Legal claims and other costs
At December 31,
(in millions of Euros) 2020 2019
Litigation 21  21 
Disease claims (A) 5 
Other 1 
Total Provisions for legal claims and other costs 27  28 
(A)Since the early 1990s, certain activities of the Group’s businesses have been subject to claims and lawsuits in France relating to occupational diseases resulting from alleged asbestos exposure, such as mesothelioma and asbestosis. It is not uncommon for the investigation and resolution of such claims to go on over many years as the latency period for developing such diseases is typically between 25 and 40 years. For any such claim, it is up to the social security authorities in each jurisdiction to determine if a claim qualifies as an occupational illness claim. If so determined, the Group must settle the case or defend its position in court. At December 31, 2020, seven cases in which gross negligence is alleged (“faute inexcusable”) remain outstanding (seven at December 31, 2019), the average amount per claim being around €0.3 million. The average settlement amount per claim in 2020 was around €0.7 million and in 2019 was less than €0.1 million. It is not anticipated that the resolution of such litigation and proceedings will have a material effect on the future results from continuing operations, financial position, or cash flows of the Group.
Contingencies
The Group is involved, and may become involved, in various lawsuits, claims and proceedings relating to customer claims, product liability, employee and retiree benefit matters and other commercial matters. The Group records provisions for pending litigation matters when it determines that it is probable that an outflow of resources will be required to settle the obligation, and such amounts can be reasonably estimated. In some proceedings, the issues raised are or can be highly complex and subject to significant uncertainties and amounts claimed are and can be substantial. As a result, the probability of loss and an estimation of damages are and can be difficult to ascertain. In exceptional cases, when the Group considers that disclosures relating to provisions and contingencies may prejudice its position, disclosures are limited to the general nature of the dispute.
The Group was subject to an arbitration by a customer claiming that Constellium had supplied defective products as a result of which the customer alleged it had suffered significant damages. The Group considered that this claim was without merit on both technical and legal grounds and believed it was not probable that the claim would result in a loss. This matter was satisfactorily resolved in 2020.
NOTE 25 - NON-CASH INVESTING AND FINANCING TRANSACTIONS
Property, plant and equipment acquired through leases or financed by third parties amounted to €66 million, €75 million and €28 million for the years ended December 31, 2020, 2019 and 2018, respectively. These leases and financings are excluded from the Statement of Cash Flow as they are non-cash investing transactions.
Fair values of vested Restricted Stock Units and Performance Stock Units amounted to €14 million, €8 million and €8 million for the years ended December 31, 2020, 2019 and 2018, respectively. They are excluded from the Statement of Cash flows as non-cash financing activities.
F-57


NOTE 26 - SHARE CAPITAL
Share capital amounted to €2,799,253.44 at December 31, 2020, divided into 139,962,672 ordinary shares, each with a nominal value of two cents and fully paid-up. All shares are of the same class and have the right to one vote.
(in millions of Euros)
Number of shares Share capital Share premium
At January 1, 2020 137,867,418  420 
New shares issued (A) 2,095,254  —  — 
At December 31, 2020 139,962,672  3  420 
(A)Constellium SE issued and delivered 2,095,254 ordinary shares to certain employees and directors related to share-based compensation plans.
For the year ended December 31, 2020, there were 6,402,289 potential ordinary shares that could have a dilutive impact but were considered antidilutive due to negative earnings.
NOTE 27 - COVID-19-RELATED GOVERNMENT ASSISTANCE
In the year ended December 31, 2020, the Group received government assistance in various forms, including government-guaranteed facilities in France, Germany, and Switzerland (see NOTE 20 - Borrowings), as well as subsidies to compensate for the cost of employees furloughed as a result of the COVID-19 pandemic in various jurisdictions. These subsidies were recognized where there was reasonable assurance that they would be received and all attached conditions would be complied with. For the year ended December 31, 2020, COVID-19-related subsidies in the amount of €22 million were accounted for as a deduction of employee benefit expenses.
NOTE 28 - COMMITMENTS
Non-cancellable lease commitments
Non-cancellable lease commitments relate to the future aggregate minimum lease payments under non-cancellable leases still recognized as expense.
At December 31,
(in millions of Euros) 2020 2019
Less than 1 year 6 
1 to 5 years 11  10 
More than 5 years 5 
Total non-cancellable lease minimum payments 22  16 
Tangible and intangible asset commitments
At December 31,
(in millions of Euros) 2020 2019
Computer Software 1 
Property, plant and equipment 48  89 
Total tangible and intangible asset commitments 49  91 


F-58


NOTE 29 - RELATED PARTIES
Subsidiaries and affiliates
A list of the principal companies controlled by the Group is presented in NOTE 31 - Subsidiaries and Operating Segments. Transactions between consolidated companies are eliminated when preparing the Consolidated Financial Statements.
Shareholders
One of our French entities entered into a fully committed term loan facility with a syndicate of banks (the “PGE French Facility”) on May 13, 2020 for an aggregate amount of up to €180 million, of which 80% is guaranteed by the French State. Bpifrance Financement, an affiliate of one of the shareholders of Constellium SE, Bpifrance Participations S.A., provided €30 million of the PGE French Facility.
On March 28, 2018, Constellium Issoire entered into a three-year, €10 million unsecured revolving credit facility with Bpifrance Financement. At December 31, 2020, the availability under this revolving credit facility amounted to €3 million.
Key management remuneration
The Group’s key management comprises the Board members and the Executive committee members effectively present in 2020.
Executive committee members are those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly reporting to the CEO.
The costs reported below are compensation and benefits for key management:
Short term employee benefits include their base salary plus bonus;
Directors’ fees include annual retainers fees, committee membership fees, chair fees and cash paid in lieu of RSU grant for 2020;
Share-based compensation includes the portion of the IFRS 2 expense as allocated to key management;
Post-employment benefits mainly include pension costs;
Termination benefits include departure costs.
As a result, the aggregate compensation for the Group’s key management is comprised of the following:
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Short-term employee benefits 9 
Directors' fees 1 
Share-based compensation 10  10 
Post-employments benefits   —  — 
Termination benefits   —  — 
Employer social contribution 1 
Total 21  21  17 


F-59


NOTE 30 - SHARE-BASED COMPENSATION
Description of the plans
Performance-Based Restricted Stock Units (equity-settled)
The Company has periodically granted Performance Stock Units (PSUs) to selected employees. These units vest after three years from the grant date if the following conditions are met:
A vesting condition under which the beneficiaries must be continuously employed by the Company through the end of the vesting period; and
For PSUs granted in 2016, a performance condition, contingent on the Total Stockholder Return (TSR) performance of Constellium over the measurement periods compared to the TSR of a specified group of peer companies. These PSUs have vested, depending on the TSR performance at each testing period, based on a vesting multiplier in a range from 0% to 300%;
For PSUs granted from 2017 to 2020, a performance condition, contingent on the TSR performance of Constellium shares over the vesting period compared to the TSR of specified indices. PSUs will ultimately vest based on a vesting multiplier which ranges from 0% to 200%.
The PSUs granted in March 2016, May 2016, August 2016 and November 2016 achieved, respectively, a TSR performance of 115.9%, 98.1%, 191.6% and 223.8% at their first testing period, 229.9%, 217.2%, 282.2% and 148.7% at their second testing period, and 108.4%, 125.4%, 230.4% and 286.4% at their third testing period, which represented respectively 184,469 potential additional shares in 2017, 433,032 potential additional shares in 2018, and 248,230 potential additional shares in 2019.
The PSUs vested in March 2019, May 2019, August 2019 and November 2019 of 684,329 shares, 123,336 shares, 434,256 shares and 516,141 shares, respectively, were granted to beneficiaries.
The PSUs granted in July 2017 achieved a TSR performance of 186.8%. These PSUs vested in July 2020 and 1,458,985 shares were granted to beneficiaries.
The following table lists the inputs to the valuation model used for the PSUs granted in 2020 and 2019:
April 2020 PSUs May 2019 PSUs
Fair value at grant date (in euros) 6.65 10.44
Share price at grant date (in euros) 4.64 7.1
Dividend yield   — 
Expected volatility (A) 63  % 52  %
Risk-free interest rate (US government bond yield) 0.36  % 2.29  %
Model used Monte Carlo Monte Carlo
(A)Volatilities for the Company and companies included in indices were estimated based on observed historical volatilities over a period equal to the PSU vesting period.
Restricted Stock Units Award Agreements (equity-settled)
The Company granted Restricted Stock Units (RSUs) to a certain number of employees subject to the beneficiaries remaining continuously employed within the Group from the grant date through the end of the vesting period. The vesting period is three years.
The fair value of RSUs awarded under the plans described above is the quoted market price at grant date.
Equity Awards Plans (equity-settled)
In 2019, our non-executive Company Board members were granted two RSU awards. These RSUs vest in equal installments on the earlier of (i) the first anniversary or (ii) the date of the annual general meeting of shareholders of that year, and on the earlier of (i) the second anniversary or (ii) the date of the annual general meeting of shareholders of that year, subject to continued service.
F-60


The fair value of RSUs awarded under the plan is the quoted market price at grant date.
In 2020, no RSU awards were granted to our non-executive Company Board members.
Expense recognized during the year
In accordance with IFRS 2, share-based compensation is recognized as an expense over the vesting period. The estimate of this expense is based upon the fair value of a potential ordinary share at the grant date. The total expense related to the potential ordinary shares for the year ended December 31, 2020, 2019 and 2018 amounted to €15 million, €16 million and €12 million, respectively.
Movement of potential shares
The following table illustrates the number and movements in potential shares:
Performance-Based RSU Restricted Stock Units Equity Award Plans
Potential Shares Weighted-Average Grant-Date Fair Value per Share Potential Shares Weighted-Average Grant-Date Fair Value per Share Potential Shares Weighted-Average Grant-Date Fair Value per Share
At January 1, 2019 3,085,164  10.45  1,312,524  8.47  57,913  8.31 
Granted 1,028,342  10.44  899,926  7.10  73,799  8.39 
Over-performance 248,230  8.94  —  —  —  — 
Vested (1,758,062) 7.97  (106,000) 4.55  (42,559) 7.60 
Forfeited (84,380) 8.02  (39,947) 8.31  (9,627) 8.71 
At December 31, 2019 2,519,294  12.11  2,066,503  8.08  79,526  8.71 
Granted (A) 1,049,839  6.65  910,047  4.64  —  — 
Over-performance (B) 677,944  11.52  —  —  —  — 
Vested (1,458,985) 11.52  (589,655) 7.50  (46,614) 8.94 
Forfeited (C) (193,765) 10.94  (154,984) 7.37  —  — 
At December 31, 2020 2,594,327  10.17  2,231,911  6.88  32,912  8.39 
(A)For PSUs, the number of potential shares granted is presented using a vesting multiplier of 100%.
(B)When the achievement of TSR performance exceeds the vesting multiplier of 100%, the additional potential shares are presented as over-performance shares.
(C)For potential shares related to PSUs, 193,765 were forfeited following the departure of certain beneficiaries and none were forfeited in relation to the non-fulfilment of performance conditions.
NOTE 31 - SUBSIDIARIES AND OPERATING SEGMENTS
The following Group’s affiliates are legal entities included in the Consolidated Financial Statements of the Group at December 31, 2020.
Entity Country % Group Interest Consolidation
Method
Cross Operating Segment
Constellium Singen GmbH (AS&I and P&ARP) Germany 100  % Consolidated
Constellium Valais S.A. (AS&I and A&T) Switzerland 100  % Consolidated
AS&I
Constellium Automotive USA, LLC U.S. 100  % Consolidated
Constellium Engley (Changchun) Automotive Structures Co Ltd. China 54  % Consolidated
Constellium Extrusions Decin S.r.o. Czech Republic 100  % Consolidated
Constellium Extrusions Deutschland GmbH Germany 100  % Consolidated
F-61


Constellium Extrusions Landau GmbH Germany 100  % Consolidated
Constellium Extrusions Burg GmbH Germany 100  % Consolidated
Constellium Extrusions France S.A.S. France 100  % Consolidated
Constellium Extrusions Levice S.r.o. Slovakia 100  % Consolidated
Constellium Automotive Mexico, S. DE R.L. DE C.V. Mexico 100  % Consolidated
Constellium Automotive Mexico Trading, S. DE R.L. DE C.V. Mexico 100  % Consolidated
Astrex Inc Canada 50  % Consolidated
Constellium Automotive Zilina S.r.o. Slovakia 100  % Consolidated
Constellium Automotive Nanjing Co Ltd China 100  % Consolidated
Constellium Automotive Spain SL Spain 100  % Consolidated
Constellium UK Limited United Kingdom 100  % Consolidated
A&T
Constellium Issoire S.A.S. France 100  % Consolidated
Constellium Montreuil Juigné S.A.S. France 100  % Consolidated
Constellium China Limited China 100  % Consolidated
Constellium Japan KK Japan 100  % Consolidated
Constellium Rolled Products Ravenswood, LLC U.S. 100  % Consolidated
Constellium Ussel S.A.S. France 100  % Consolidated
AluInfra Services SA (A) Switzerland 50  % Consolidated
P&ARP
Constellium Deutschland GmbH Germany 100  % Consolidated
Constellium Rolled Products Singen GmbH KG Germany 100  % Consolidated
Constellium Property and Equipment Company, LLC U.S. 100  % Consolidated
Constellium Neuf Brisach S.A.S. France 100  % Consolidated
Constellium Muscle Shoals LLC U.S. 100  % Consolidated
Constellium Holding Muscle Shoals LLC U.S. 100  % Consolidated
Constellium Muscle Shoals Funding II LLC U.S. 100  % Consolidated
Listerhill Total Maintenance Center LLC U.S. 100  % Consolidated
Constellium Metal Procurement LLC U.S. 100  % Consolidated
Constellium Bowling Green LLC U.S. 100  % Consolidated
Rhenaroll France 50  % Equity
Holdings & Corporate
C-TEC Constellium Technology Center S.A.S. France 100  % Consolidated
Constellium Finance S.A.S. France 100  % Consolidated
Constellium France III France 100  % Consolidated
Constellium France Holdco S.A.S. France 100  % Consolidated
Constellium International France 100  % Consolidated
Constellium Paris S.A.S. France 100  % Consolidated
Constellium Germany Holdco GmbH & Co. KG Germany 100  % Consolidated
Constellium Germany Verwaltungs GmbH Germany 100  % Consolidated
Constellium U.S. Holdings I, LLC U.S. 100  % Consolidated
Constellium US Intermediate Holdings LLC U.S. 100  % Consolidated
Constellium Switzerland AG Switzerland 100  % Consolidated
Constellium Treuhand UG Germany 100  % Consolidated
Engineered Products International S.A.S. France 100  % Consolidated
(A)AluInfra Services SA, the joint venture created with Novelis in July 2018, is consolidated as a joint operation and is immaterial to the Group Consolidated Financial Statements.
F-62


NOTE 32 - PARENT COMPANY
Statement of Financial Position of Constellium SE (parent company only).
At December 31,
(in millions of Euros) 2020 2019
Assets
Current assets
Cash and cash equivalents   — 
Trade receivables and other 172  200 
Other financial assets 34  37 
206  237 
Non-current assets
Property, plant and equipment   — 
Financial assets 2,011  2,002 
Investments in subsidiaries 173  159 
Trade receivables and other 38  27 
Deferred income tax assets 15 
2,237  2,189 
Total Assets 2,443  2,426 
Liabilities
Current liabilities
Trade payables and other 6 
Income tax payable 13  45 
Other financial liabilities 30  33 
49  84 
Non-current liabilities
Borrowings 1,901  1,954 
Income tax payable 77  19 
1,978  1,973 
Total Liabilities 2,027  2,057 
Equity
Share capital 3 
Share premium 429  429 
Accumulated retained earnings (116) (153)
Other reserves 68  53 
Net income 32  37 
Total Equity 416  369 
Total Equity and Liabilities 2,443  2,426 
F-63


Statement of Comprehensive income / (loss) of Constellium SE (parent company only).
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Revenue
Gross profit 3 
Selling and administrative expenses (14) (19) (15)
Employee benefit expenses (3) (3) (3)
Loss from recurring operations (14) (19) (15)
Other income   —  — 
Other expense   (3) (3)
Loss from operations (14) (22) (18)
Financial result - net 31  41  80 
Income before income tax 17  19  62 
Income tax benefit 15  18  25 
Net income 32  37  87 
Other comprehensive income / (loss)   —  — 
Total comprehensive income 32  37  87 
F-64


Statement of Cash Flows of Constellium SE (parent company only)
Year ended December 31,
(in millions of Euros) 2020 2019 2018
Net income 32  37  87 
Adjustments
Finance cost - net (31) (41) (80)
Dividends received   —  — 
Income tax benefit (15) (18) (25)
Change in working capital
Trade receivables and other (2) 27  — 
Trade payables and other   — 
Interest paid (114) (115) (102)
Interest received 139  143  134 
Income tax received 18  50  — 
Net cash flows from operating activities 27  85  14 
Investments in subsidiaries   —  (1)
Current account with subsidiaries and related parties 29  (135) (13)
Loans granted to subsidiaries and related parties (290) —  — 
Repayment of loans granted to subsidiaries and related parties 150  150  — 
Exit fees received from subsidiaries   —  — 
Net cash flows (used in) / from investing activities (111) 15  (14)
Net proceeds received from issuance of shares   —  — 
Proceeds from issuance of Senior Notes 290  —  — 
Repayment of Senior Notes (200) (100) — 
Payment of exit fees   —  — 
Payment of deferred financing costs (6) —  — 
Realized foreign exchange gains / (losses)   —  — 
Other financing activities   —  — 
Net cash flows from / (used in) financing activities 84  (100) — 
Net increase in cash and cash equivalents   —  — 
Cash and cash equivalents - beginning of year   —  — 
Effect of exchange rate changes on cash and cash equivalents   —  — 
Cash and cash equivalents - end of year   —  — 
Basis of preparation
The parent company only financial information of Constellium SE, presented above, is prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board and as endorsed by the European Union. Accounting policies adopted in the preparation of this condensed parent company only financial information are the same as those adopted in the consolidated financial statements and described in NOTE 2 - Summary of Significant Accounting Policies, except that the cost method has been used to account for investments in subsidiaries.
As at December 31, 2020, there were no material contingencies at Constellium SE.
A description of Constellium SE's parent company only borrowings and related maturity dates is provided in NOTE 20 - Borrowings. Other financial liabilities represent interest payable on borrowings.
Non-current financial assets represent loans to Constellium International and Constellium France Holdco, and current other financial assets represent related interest receivables.
F-65


NOTE 33 - ACQUISITION OF CONSTELLIUM-BOWLING GREEN
Constellium-UACJ ABS LLC was a joint venture in which Constellium held a 51% interest and was created in 2014. The joint venture started its operations in 2016, operating a facility located in Bowling Green, Kentucky and supplying aluminium sheet to the North American automotive industry. At creation date, we determined that, under the terms of the joint venture agreement, we did not control Constellium-UACJ ABS LLC because our existing rights associated with the decision-making process did not give us the ability to direct the relevant activities of the joint venture unilaterally and as a result, Constellium did not have power over the joint venture until January 10, 2019.
The acquisition of 49% of Constellium-UACJ ABS LLC was completed on January 10, 2019, strengthening our position in the North American Auto Body Sheet market. The entity was renamed Constellium Bowling Green LLC ("Bowling Green") and is consolidated since 2019.
In accordance with IFRS 3 - Business combinations, Constellium has recognized the assets acquired and liabilities assumed, measured at fair value at the acquisition date. The following table reflects the goodwill arising as a result of the allocation of purchase price to the Bowling Green assets acquired and liabilities assumed at January 10, 2019:
(in millions of Euros) Fair Value
Cash and cash equivalents
Trade receivables and other 49 
Inventories 65 
Property, plant and equipment 165 
Deferred tax assets
Trade payables and other (41)
Borrowings (75)
Net asset acquired at fair value 170 
Goodwill 24 
Total Consideration 194 
Total consideration includes €87 million of cash consideration paid for the 49% stake in Constellium-UACJ ABS LLC, €69 million for the fair value of Constellium’s previously held interest in Constellium-UACJ ABS LLC and €38 million from the effective settlement of preexisting trade receivables with Constellium-UACJ ABS LLC.
Property, Plant and Equipment, Inventories and Borrowings were remeasured at fair value. The €24 million of goodwill is the result of expected synergies and will be amortized over 15 years for tax purposes.
Considering the industries served, its major customers and product lines, Bowling Green and its related assets and liabilities are included in the Packaging and Automotive Rolled Products (P&ARP) operating segment.
Acquisition costs were recognized as expenses in Other gains and losses - net in the Consolidated Income Statement (€1 million in 2019).
For the year-ended December 31, 2019, Bowling Green revenue was €333 million and net loss was €48 million.
NOTE 34 - SUBSEQUENT EVENTS
In the first quarter of 2021, Constellium SE completed a $500 million offering of 3.750% Senior Sustainability-Linked Notes due 2029. The net proceeds from the offering, together with cash on hand, were used to repurchase or redeem the $650 million of 6.625% Senior Notes due 2025, and to pay related fees and expenses.
In the first quarter of 2021, the Secured Inventory Facility maturity date was extended to April 2023.
F-66
1 Exhibit 2.1 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the ordinary shares and the Articles of Association of Constellium SE (“Constellium” or the “Company”) is a summary and does not purport to be complete. This summary is subject to, and qualified in its entirety by reference to, the complete text of the Company’s Articles of Association, which are incorporated by reference as Exhibit 1.1 of the Company’s Annual Report on Form 20-F to which this description is also an exhibit. The Company encourages you to read the Company’s Articles of Association carefully. As of December 31, 2020, Constellium had the following series of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act: Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Ordinary Shares, nominal value €0.02 per share CSTM New York Stock Exchange General On June 28, 2019, Constellium N.V. converted its corporate form from a Dutch public limited liability company (Naamloze Vennootschap) into a Societas Europaea (SE) and changed its name to Constellium SE, with its head office remaining in Amsterdam, the Netherlands. On December 12, 2019, Constellium SE completed its re-domicile and the relocation of its head office to Paris, France (the “Transfer”). Effective as of December 12, 2019, the Company’s existing articles of association were amended by means of a deed of amendment to reflect the Company’s re-domicile to Paris, France (as further amended from time to time, the “Articles of Association”). The Company’s number with the Paris Trade and Companies Register is 831 763 743. The object of the Company, directly or indirectly, in any form, in France and in all countries, is: • to incorporate, to participate in, to finance, to collaborate with, to manage, to supervise businesses, companies and other enterprises and provide advice and other services; • to acquire, use and/or assign industrial and intellectual property rights and real property; • to finance and/or acquire companies and any businesses; • to borrow, to lend and to raise funds, including through the issue of bonds, debt instruments or other securities or evidence of indebtedness, as well as to enter into agreements in connection with the aforementioned activities; • to invest funds; • to provide guarantees and security for debts of legal persons or of other companies with which the Company is affiliated in a Group or for the debts of third parties; • to undertake all that which is connected to the foregoing or in furtherance thereof, all of the above being understood in the broadest sense of the words. Outstanding Capital Stock As of December 31, 2020, the Company’s issued and paid-up share capital amounted to €2,799,253.44 consisting of 139,962,672 ordinary shares, each with a nominal value of €0.02. French law does not recognize the concept of authorized capital and any capital increase will have to be decided at an extraordinary shareholders’ meeting of the Company. Each of the ordinary shares has one vote. Form of Shares Pursuant to our Articles of Association, our ordinary shares are available in the form of an entry in a share register without issuance of a share certificate, and may be registered either on the U.S. Register maintained by our transfer agent, Computershare Trust Company, N.A. (“Computershare”) or on accounts maintained in France in accordance with French requirements (such accounts being collectively referred to as the “French Register”).


 
2 The U.S. Register Shares registered on the U.S. Register are either in the name of Cede & co., acting on behalf of DTC, or in the name of holders who want to be directly recorded on the U.S. Register. Only shares registered on the U.S. Register in the name of Cede & co are eligible for direct trading on the NYSE. Shares registered on the U.S. Register are in “au porteur” form. The ordinary shares of Constellium are admitted to the operations of the central depositary Euroclear France. CACEIS Corporate Trust (“CACEIS”) acts in France as a registered intermediary (“intermédiaire inscrit”) for the account of the owners of the shares registered on the U.S. Register in accordance with articles L. 228-1 et seq. of the French Code de commerce (the “French Commercial Code”). The French Register Shares registered on the French Register may be in “au nominatif” form (i.e., registered on an account maintained by or on behalf of the Company) or in “au porteur” form (i.e., registered on an account maintained by an authorized intermediary in accordance with Article L. 211-3 of the French code monétaire et financier to comply with French requirements). With respect to shares held in “au nominatif” form, each shareholder may elect to give instructions directly to the issuer or its agent (“au nominatif pur”) or through an authorized intermediary with which it has opened a securities account (“nominatif administré”). The accounts on which shares are held in any such forms (“nominatif pur,” “nominatif administré,” “au porteur”) are collectively referred to as the French Register. Each shareholder has the option to have its shares registered on the U.S. Register or on the French Register and, in the latter case, to have its shares held in “au nominatif” or in “au porteur” form. Any shareholder seeking to transfer its shares from one register to another will have to give proper instructions, at its own cost, to its broker or the Company, as the case may be. Restrictions on share transfer and ownership Our ordinary shares are freely transferable except as otherwise restricted under U.S. or other applicable laws, which may include securities laws, antitrust laws or laws restricting foreign investment. Under current French laws and regulations related to foreign investments, the acquisition, directly or indirectly, of 25% or more of the voting rights of a French company by a non-French investor, or a French investor domiciled outside of France or controlled by one of the former, is subject to prior approval of the French Ministry of the Economy, if the company is involved, even occasionally, in activities which may impact public order, public security or national defense interests. Certain activities of certain French subsidiaries of Constellium SE may qualify as such activities and, therefore, the acquisition, directly or indirectly, of 25% or more of the voting rights of Constellium SE may require such prior approval. Issuance of Ordinary Shares As indicated under “Form of Shares”, our shares may be held in either registered (“au nominatif”) or bearer (“au porteur”) form, at the shareholder’s discretion. Shares must be issued for a subscription price at least equal to their nominal value, which must be fully paid unless otherwise agreed. Shares paid in cash must be paid up to at least 25% of their nominal value and, as the case may be, the whole of any issue premium at the time of issuance. In order to be traded on the NYSE, shares must be held through a participant in the system managed by the Depositary Trust Company (“DTC”). To that end, shares that are DTC-eligible are recorded in the U.S. Register maintained by Computershare. The U.S. Register includes all shares traded on the NYSE and the shares registered directly with this U.S. Register. Shares recorded in the U.S. Register are in bearer (“au porteur”) form, meaning that a registered intermediary for the account of our beneficial owners (the “French Intermediary”) is registered in France for the account of the owners of the shares registered on the U.S. Register in accordance with articles L. 228-1 et seq. of the French Commercial Code. Shares other than those recorded in the U.S. Register shall be recorded on the French Register, which shares may not be traded on the NYSE (see “Form of Shares”). Any shareholder wishing to hold its shares on one or another register shall, at its own expense, provide instructions to this end to its account holder or to the Company, as applicable.


 
3 As of December 31, 2020, 139,952,113 shares of the Company were recorded in the U.S. Register and 10,559 shares of the Company were recorded on the French Register. As a French company that has listed securities in the United States, we are subject to U.S. securities laws and regulations regarding trading in the Company’s ordinary shares. Under U.S. securities laws and regulations, persons are prohibited from trading on the basis of material, non-public information. We apply the Company’s Insider Trading Policy consistent with U.S. laws and regulations and make this policy available to our directors and employees to whom these laws and regulations may apply. The rules on insider dealing, unlawful disclosure of inside information and market manipulation under Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014 on market abuse (and the texts adopted for its implementation) apply to the Company as issuer of debt securities that are admitted to trading on the Euro MTF market of the Luxembourg Stock Exchange. Share-Based Compensation Our share-based compensation plan is the Constellium SE 2013 Equity Incentive Plan (the “Plan”). The principal purposes of the Plan are to focus our officers and employees on business performance to help create shareholder value, to encourage innovative approaches to the business of the Company and to encourage ownership of our ordinary shares by officers and employees. The Plan is also intended to recognize and retain our key employees needed to sustain and ensure our future and business competitiveness. The Plan provides for a variety of awards, including “incentive stock options” (within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) (“ISOs”), nonqualified stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), performance-based restricted stock units (“PSUs”), other stock- based awards or any combination of those awards. To date, we have only awarded RSUs and PSUs under the Plan. The Plan provides that awards may be made under the Plan for 10 years following approval by the Company’s board of directors (the “Board of Directors”) of the Plan in 2013. We have reserved a total of 14,292,291 ordinary shares (of which 7,292,291 ordinary shares were originally reserved, and an additional 7,000,000 ordinary shares were reserved to be awarded under the Plan, following approval at our annual general meeting of shareholders in 2018 (the “2018 Share Authorization”)). The number of ordinary shares authorized and available is subject to adjustment in certain circumstances to prevent dilution or enlargement. At the Company’s shareholders meeting held on November 25, 2019, we ratified the 2018 Share Authorization in order to make new awards under the Plan following the Transfer. Following such ratification, the authorization is valid until January 24, 2022. Awards made following such ratification and Transfer are subject to compliance with mandatory provisions of the French Commercial Code that now apply, as further described below. Administration The Plan is administered by the Human Resources and Remuneration Committee of our Board of Directors. The Board of Directors or the Human Resources and Remuneration Committee may delegate administration to one or more members of our Board of Directors. The Human Resources and Remuneration Committee has the power to interpret the Plan and to adopt rules for the administration, interpretation and application of the Plan according to its terms. The Board of Directors, acting on the recommendation of our Human Resources and Remuneration Committee, determines the number of our ordinary shares that will be subject to each award granted under the Plan and may take into account the recommendations of our senior management in determining the award recipients and the terms and conditions of such awards. Subject to certain exceptions as may be required pursuant to Rule 16b-3 under the Exchange Act, if applicable, our Board of Directors may, at any time and from time to time, exercise any and all rights and duties of the Human Resources and Remuneration Committee under the Plan. Following the Transfer, in accordance with the French Commercial Code: • the Human Resources and Remuneration Committee no longer has the power to make awards of any type; • the Board of Directors has exclusive power to make awards that are to be settled with shares; • the Board of Directors has exclusive power to make awards to the Company’s CEO and to any deputy chief executive officer (Directeur Général Délégué), irrespective of the form of settlement; and • the Company’s senior management has exclusive power to make awards to officers and employees that are cash-


 
4 settled (other than to the Company’s CEO and any deputy chief executive officer (Directeur Général Délégué)). Eligibility Officers and employees are eligible to be granted awards under the Plan. Our Human Resources and Remuneration Committee makes recommendations regarding: • which officers and employees are to be granted awards; • the type of award that is granted; • the number of our ordinary shares subject to the awards; and • the terms and conditions of such awards, consistent with the Plan. Following the Transfer, the power to make new awards and set their terms are as described above under “Administration.” Furthermore, in accordance with the French Commercial Code, following the Transfer, the Company is no longer permitted to grant restricted stock, and only officers (including the CEO), the Chairman of the Board of Directors and employees are eligible to receive share-settled awards after the Transfer. Except for the Chairman of the Board of Directors, other non-executive members of the Board of Directors and consultants are no longer eligible to receive share-settled awards. Stock Options Subject to the terms and provisions of the Plan, stock options to purchase our ordinary shares may be granted to eligible individuals at any time and from time to time as determined by our Board of Directors. Stock options may be granted as ISOs, which are intended to qualify for favorable treatment to the recipient under U.S. federal tax law, or as nonqualified stock options, which do not qualify for this favorable tax treatment. Subject to the limits provided in the Plan, our Board of Directors has the authority to determine the number of stock options granted to each recipient. Each stock option award is evidenced by a stock option agreement that specifies the stock option exercise price, whether the stock options are intended to be incentive stock options or nonqualified stock options, the duration of the stock options, the number of shares to which the stock options pertain, and such additional limitations, terms and conditions as our Board of Directors may determine. Our Board of Directors determines the exercise price for each stock option granted, except that the stock option exercise price may not be less than 100% of the fair market value of an ordinary share on the date of grant. All stock options granted under the Plan expire no later than 10 years from the date of grant. Stock options are nontransferable except by will or by the laws of descent and distribution or, in the case of nonqualified stock options, as otherwise expressly permitted by our Board of Directors. The granting of a stock option does not accord the recipient the rights of a shareholder, and such rights accrue only after the exercise of a stock option and the registration of ordinary shares in the recipient’s name. Following the Transfer, stock options may only be granted if the Company’s shareholders specifically authorize the Board of Directors to make such grants. As of the date of this document, we have not requested such shareholders’ authorization, but may do so at a future date. Stock Appreciation Rights The Company's senior management may grant SARs under the Plan. SARs may be “tandem SARs,” which are granted in conjunction with a stock option, or “free-standing SARs,” which are not granted in conjunction with a stock option. A SAR entitles the holder to receive from us, upon exercise, an amount equal to the excess, if any, of the aggregate fair market value of a specified number of our ordinary shares to which such SAR pertains over the aggregate exercise price for the underlying shares. The exercise price of a free-standing SAR may not be less than 100% of the fair market value of an ordinary share on the date of grant. A tandem SAR may be granted at the grant date of the related stock option. A tandem SAR may be exercised only at such time or times and to the extent that the related stock option is exercisable and has the same exercise price as the related stock option. A tandem SAR terminates or is forfeited upon the exercise or forfeiture of the related stock option, and the related stock option terminates or is forfeited upon the exercise or forfeiture of the tandem SAR.


 
5 Each SAR is evidenced by an award agreement that specifies the exercise price, the number of ordinary shares to which the SAR pertains and such additional limitations, terms and conditions as the Company's senior management may determine. We may make payment of the amount to which the participant exercising the SARs is entitled by delivering ordinary shares, cash or a combination of stock and cash as set forth in the award agreement relating to the SARs. SARs are not transferable except by will or the laws of descent and distribution or, with respect to SARs that are not granted in “tandem” with a stock option, as expressly permitted by the Company’s senior management. Following the Transfer, the power to make new grants of free-standing SARs and set the terms of free-standing SARs are as described above under “Administration” with respect to cash-settled awards. No tandem SARs may be granted unless the shareholders specifically authorize the Board of Directors to make grants of stock options, as described above under “Stock Options”. Restricted Stock The Plan provides for the award of ordinary shares that are subject to forfeiture and restrictions on transferability to the extent permitted by applicable law and as set forth in the Plan, the applicable award agreement and as may be otherwise determined by our Board of Directors. Except for these restrictions and any others imposed by our Board of Directors to the extent permitted by applicable law, upon the grant of restricted stock, the recipient will have rights of a shareholder with respect to the restricted stock, including the right to vote the restricted stock and to receive all dividends and other distributions paid or made with respect to the restricted stock on such terms as set forth in the applicable award agreement. During the restriction period set by our Board of Directors, the recipient is prohibited from selling, transferring, pledging, exchanging or otherwise encumbering the restricted stock to the extent permitted by applicable law. Following the Transfer, under the terms of the French Commercial Code, the Company is no longer permitted to grant restricted stock. Restricted Stock Units (RSUs) The Plan authorizes our Board of Directors to grant RSUs. RSUs are not ordinary shares and do not entitle the recipient to the rights of a shareholder, although the award agreement may provide for rights with respect to dividend equivalents. The recipient may not sell, transfer, pledge or otherwise encumber RSUs granted under the Plan prior to their vesting. RSUs may be settled in cash, ordinary shares or a combination thereof as provided in the applicable award agreement, in an amount based on the fair market value of an ordinary share on the settlement date. Following the Transfer, the Board of Directors has exclusive power to make new grants of RSUs and set their terms, in accordance with the French Commercial Code and as described above under “Administration” and “Eligibility”. Performance-Based Restricted Stock Units (PSUs) The Plan authorizes the Board of Directors to grant PSUs. The value of a PSU is conditioned upon the achievement of performance goals set by our Board of Directors in granting the PSUs and may be paid in cash, ordinary shares, other property or a combination thereof. Each PSU award is evidenced by an award agreement, which may contain terms relating to the termination of a participant’s employment. Following the Transfer, the Board of Directors has exclusive power to make new grants of PSUs and set their terms, in accordance with the French Commercial Code and as described above under “Administration” and “Eligibility”. Other Stock-Based Awards The Plan provides for the award of ordinary shares and other awards that are valued by reference to our ordinary shares, including unrestricted stock, dividend equivalents and convertible debentures.


 
6 Following the Transfer, grants of other stock-based awards may only be made in accordance with the French Commercial Code. Performance Goals The Plan provides that performance goals may be established by our Board of Directors in connection with the grant of any award under the Plan. Termination without Cause following a Change in Control The Company has a double trigger in place for its awards. Upon a termination of employment by the Company without “cause” (as defined in the Plan) of a plan participant occurring upon or during the two years immediately following the date of a “change in control”, unless otherwise provided in the applicable award agreement, (i) all awards held by such participant will vest in full (in the case of any awards that are subject to performance goals, at target) and be free of restrictions, and (ii) any option or SAR held by the participant as of the date of the change in control that remains outstanding as of the date of such termination of employment may thereafter be exercised until (A) in the case of ISOs, the last date on which such ISOs would otherwise be exercisable or (B) in the case of nonqualified options and SARs, the later of (x) the last date on which such nonqualified option or SAR would otherwise be exercisable and (y) the earlier of (I) the second anniversary of such change in control and (II) the expiration of the term of such nonqualified option or SAR. With respect to new share-settled awards made following the Transfer, the Company’s ability to deliver shares is subject to the minimum vesting and, if applicable, holding period requirements set forth under the French Commercial Code, as described below. Application of the French Commercial Code Following the Transfer, the French Commercial Code applies to new share-settled awards and requires in particular that: • awards be made by the Board of Directors, pursuant to an authorization of the shareholders which may be valid for a maximum of up to 38 months; • the total number of shares subject to outstanding awards plus shares subject to a mandatory holding condition under French tax law (if any) may not exceed 10% of share capital, as measured on the relevant grant date; • only officers (including the CEO), the Chairman of the Board of Directors and employees are eligible to receive share-settled awards (as described above under “Eligibility”); and • persons holding more than 10% of the Company’s share capital prior to grant or as a result of the award are ineligible. Pursuant to the French Commercial Code, awards are subject to a two-year minimum vesting period, or a one-year minimum vesting period followed by a mandatory one-year holding period, subject in both cases to exceptions for death and disability. The foregoing requirement pursuant to the French Commercial Code is satisfied with respect to awards under the Plan, which are subject to a minimum 36-month vesting period. Amendments Our Board of Directors or our Human Resources and Remuneration Committee may amend, alter or discontinue the Plan, but no amendment, alteration or discontinuation will be made that would materially impair the rights of a participant with respect to a previously granted award without such participant’s consent, unless such an amendment is made to comply with applicable law, including, without limitation, Section 409A of the Code, stock exchange rules or accounting rules. In addition, no such amendment will be made without the approval of the Company’s shareholders to the extent such approval is required by applicable law or the listing standards of the applicable stock exchange.


 
7 Rights of Shareholders and Shareholders’ Meetings Under French law and in general, each shareholder is entitled to one vote per share at any general shareholders’ meeting. A general shareholders’ meeting is held annually to, inter alia, approve the annual financial statements. General shareholders’ meetings (including annual meetings) can be ordinary and/or extraordinary, depending upon the resolutions submitted to the vote. At an extraordinary general shareholders’ meeting (which votes upon any proposal to change the articles of association, including any change in the rights of shareholders), majority is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/4 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting. If the quorum at the second meeting is not reached, the second meeting can be postponed to a date no later than two months after the date on which the second meeting was convened. The quorum for such second or postponed meeting, as the case may be, to be validly held is 1/5 of the voting shares. At an ordinary shareholders’ meeting (which votes upon any proposal within the competence of a general shareholders’ meeting other than an extraordinary shareholders meeting such as approval of annual financial statements or appointment of directors), majority is simple majority (more than 50%) of the votes validly cast. Majority at special meetings is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/5 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting; no quorum is required for such second meeting. Special meetings bring together the holders of shares of a specified class, should it be created, to decide on an amendment to the rights relating to the shares of this class. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/3 of the voting shares, and, failing which, 1/5 for the meeting held on the date set by the second convening notice or in the case of postponement of the second meeting. French law does not provide for cumulative voting. The right to participate in a shareholders’ meeting is granted to all the shareholders whose shares are fully paid up and for whom a right to attend shareholders’ meetings has been established by registration of their shares in their names or names of the authorized intermediary acting on their behalf on the second business day prior to the shareholders’ meeting at 0:00 (zero hour) (Paris time) (the “French Record Date”), either in the registered (“au nominatif”) shares accounts held by the company (or an agent acting on its behalf) or in the bearer (“au porteur”) shares accounts held by the authorized intermediary. Shareholders holding shares registered on the U.S. Register (which include all shares which are listed on the NYSE, held through a DTC participant and shares directly recorded in the name of their holder with Computershare) vote through a process similar to the one that was in place before the Transfer with the following main differences: • their voting instructions will be transmitted to the Company via the French Intermediary, acting as intermediary for the account of all shareholders registered on the U.S. Register, in accordance with articles L. 228-1 et seq. of the French Commercial Code; • the French Record Date will be set; • an additional record date will be fixed for all shareholders registered on the U.S. Register, which date will be the 25th day before the meeting (the “U.S. Mailing Record Date”); and • shareholders who purchase shares between the U.S. Mailing Record Date and the French Record Date will be entitled to participate and vote at the shareholders’ meeting as long as they continue to be shareholders on the French Record Date. However, given the short time between the French Record Date and the shareholders’ meeting date, shareholders as of the French Record Date may not have received the notices and information received by shareholders holding shares registered on the U.S. Register as of the U.S. Mailing Record Date. To the extent that shareholders as of the U.S. Mailing Record Date have sent voting instructions and sold or otherwise transferred their shares as of the French Record Date, such voting instructions will be invalidated or modified by the Company, as the case may be, in accordance with articles R. 225-85 and R. 225-86 of the French Commercial Code.


 
8 Shareholder Proposals and Action by Written Consent Pursuant to French law, the board of directors is required to convene an annual ordinary general meeting of shareholders for approval of the annual financial statements. This meeting must be held within six months after the end of each prior fiscal year. The board of directors may also convene an ordinary or extraordinary meeting of shareholders upon proper notice at any time during the year. If the board of directors fails to convene a shareholders’ meeting, the auditors may call the meeting. In a bankruptcy, the liquidator or court-appointed agent may also call a shareholders’ meeting in some instances. Any of the following may request the court to appoint an agent: • one or several shareholders holding at least 5% of the share capital, or •  any interested party or the workers committee in cases of urgency. Shareholders holding a majority of the capital or voting rights after a public take-over bid or exchange offer or the transfer of a controlling block of shares may also convene a shareholders’ meeting. In general, shareholders can only take action at shareholders’ meetings on matters listed on the agenda for the meeting. As an exception to this rule, shareholders may take action with respect to the dismissal and appointment of directors. Additional draft resolutions to be submitted for approval by the shareholders at any shareholders’ meeting may be proposed to the board of directors within the proscribed time limit (which is no later than 20 days after the publication of the convening notice (avis de réunion) and in any event no sooner than 25 days prior to the date of the shareholders’ meeting) by one or several shareholders holding a specified percentage of shares. The convening notice (avis de réunion) must be published in France with the BALO at least 35 days prior to the date of the shareholders’ meeting and can be consulted at https://www.journal-officiel.gouv.fr/balo/. As the U.S. Mailing Record Date is fixed at the 25th day before the shareholders’ meeting, shareholders wishing to submit additional resolutions will need to submit them before receiving the meeting materials sent to them on or around the U.S. Mailing Record Date, otherwise their submissions will not be considered. The percentage of shares required to be held by one or several shareholders to be able to submit additional draft resolutions depends on the amount of the share capital of the Company; based on the Company’s issued share capital of €2,799,253.44 as of December 31, 2020, this percentage would be 2.90%. Under French law, shareholders’ action by written consent is not permitted in a Societas Europaea. Shareholder Suits French law provides that a shareholder, or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a company in the company’s interest if it fails to bring such legal action itself. If so, any damages awarded by the court are paid to the company and any legal fees relating to such action are borne by the relevant shareholder or the group of shareholders. The plaintiff must remain a shareholder throughout the duration of the legal action. There is no other case where shareholders may initiate a derivative action to enforce a right of a company. A shareholder may alternatively or cumulatively bring an individual legal action against the directors, provided he or she has suffered distinct damages from those suffered by the company. In this case, any damages awarded by the court are paid to the relevant shareholder. Repurchase of Shares; Pre-emptive Rights; Shareholder Vote on Certain Reorganizations Under French law, a private company (which our Company is for French law purposes for so long as it is listed on the NYSE only) may not subscribe for newly issued shares in its capital but may, however, acquire its own shares for the following purposes only: • With a view to distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, restricted free share or share option plan, not to exceed 10% of the share capital; • In payment or in exchange for assets acquired by the company within two years of their repurchase, not to


 
9 exceed 5% of the share capital; • To sell the relevant shares to any shareholders willing to purchase them as part of a process organized by the company within five years, not to exceed 10% of the share capital. Shares acquired but not used in accordance with the above purposes must be cancelled. As of the date of this document, the Company does not have in place an authorization granted to the Board of Directors to purchase its own shares. The Company may also acquire its own shares to decrease its share capital, provided that such decision is not driven by losses and that a purchase offer is made to all shareholders on a pro rata basis, with the approval of the shareholders at the extraordinary general meeting deciding the capital reduction. Under French law, in case of issuance of additional shares or other securities giving right, immediately or in the future, to new shares for cash or set-off against cash debts, the existing shareholders have preferential subscription rights to these securities on a pro rata basis unless such rights are waived by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the extraordinary meeting deciding or authorizing the capital increase. In case such rights are not waived by the extraordinary general meeting, each shareholder may individually either exercise, or assign or not exercise its preferential rights. Generally, under French law, completion of a legal merger (fusion), demerger (scission), dissolution, sale, lease or exchange of all or substantially all of a company’s assets, requires: •  the approval of the board of directors; and •  the approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting, or in the case of a legal merger (fusion) with a non-EU company, approval of all the shareholders of the company. Anti-Takeover Provisions and Shareholder Disclosure Thresholds Anti-Takeover Provisions French law does not contain provisions restricting or making difficult to change the composition of the board of directors following a change of control. French law allows shareholders at general meetings to delegate the authority to the board of directors to issue shares or warrants to subscribe for shares, which may make it more difficult for a shareholder to obtain control over our general meeting of shareholders. The shareholders’ meeting of June 29, 2020 delegated the authority to our Board of Directors to decide the issuance, in the event of a public bid on the Company’s shares, of warrants each enabling the subscription of one or more ordinary shares, up to €1,378,674.18 (representing 49.99% of the Company’s share capital at the time of that shareholders’ meeting) and to freely allot said warrants to all of the Company’s shareholders having that capacity before the expiration of the public offering period. The Board of Directors had decided that any such issue of free warrants to subscribe to new shares in the event of a public tender on the Company would in any event be limited to 40% of the share capital for the 12-month period. This delegation has certain similarities to a rights plan in the U.S., both allowing the board of directors to issue free warrants to subscribe to new shares to existing shareholders in case an unsolicited public tender offer is launched on the Company. It aims to give the board of directors the possibility to negotiate with the bidder to induce the bidder to raise the offer price and/or improve the terms of the offer. It could only be triggered in the event of a public bid for the shares and if the warrants are issued, they will be issued to all those shareholders who hold shares before the expiry of the public offer period. This delegation has been given for a twelve-month period expiring on June 28, 2021.


 
10 Crossing of Threshold Notifications According to the Articles of Association, any natural persons or legal entities acting alone or in concert, who come to own, directly or indirectly, a number of shares equal to or greater than 5%, 10%, 15%, 20%, 25%, 30%, 33 1/3%, 50%, 66 2/3% or 90% of the total number of shares or voting rights must, within five (5) trading days after the shareholding threshold is crossed, upwards or downwards, notify the Company, by certified letter with acknowledgment of receipt, of the total number of shares or voting rights that they own alone, directly or indirectly, or in concert. The notification includes information on (i) the number of securities held giving deferred rights to the shares to be issued and the corresponding voting rights, and (ii) the number of shares already issued or the voting rights they may acquire. Furthermore, according to the Articles of Association, any persons or entities who hold a number of shares equal to or greater than 10%, 15%, 20% or 25% of the total number of shares or voting rights in the Company shall inform the Company of the objectives they intend to pursue over the six (6) months to come. Following a period of six (6) months, any persons or entities who continue to hold a number of shares or voting rights equal to or greater than the fractions mentioned hereinabove, shall renew their statement of intent, in compliance with the aforementioned terms, for each new period of six (6) months. This statement shall specify whether the shareholder is acting alone or in concert, if he plans to discontinue or continue his purchases, to acquire or not the control of the Company, to request his appointment or that of one or several persons as director. The Company reserves the right to share with the public and shareholders either the objectives that it has been notified of, or the relevant person’s failure to comply with the aforementioned obligation. For the application of the preceding subparagraphs, the shares or voting rights listed in paragraphs 1 to 8 of Article L. 233-9 I of the French Commercial Code shall be considered equivalent to the shares or voting rights held by a shareholder. Mandatory Takeover Bid According to the Articles of Association, any natural or legal persons, acting alone or in concert under Article L. 233-10 of the French Commercial Code, who comes into possession, otherwise than following a voluntary takeover bid, directly or indirectly, of more than 30% of the capital or voting rights of the Company, shall file a draft takeover bid on all the capital and securities granting access to the capital or voting rights, and on terms that comply with applicable United States securities law, rules of the SEC and NYSE rules. The same requirement applies to natural or legal persons, acting alone or in concert, who directly or indirectly own a number between 30% and half of the total number of equity securities or voting rights of the company and who, in less than twelve consecutive months, increase the holding, in capital or voting rights, of at least 1% of the total number of equity securities or voting rights of the Company. When a draft offer is submitted, the price proposed must be at least equal to the highest price paid by the offeror, acting alone or in concert within the meaning of Article L. 233-10 of the French Commercial Code, over a period of twelve (12) months preceding the event giving rise to the obligation to submit the draft offer. In the event of a clear change in the characteristics of the Company, if the market for its securities so justifies or in the absence of a transaction by the offeror, acting alone or in concert, over the Company’s shares during the twelve-month period mentioned in the first paragraph, the price will be fixed by an expert appointed in accordance with Article 1592 of the French Civil Code and determined according to objective evaluation criteria usually used, the characteristics of the Company and the market of its securities, it being specified that the expert will be required to take into account, in its assessment, the criteria identified by the Commission des Opérations de Bourse, the AMF and the French courts.


 
11 The obligation to file a draft public offer does not apply if the person or persons concerned justify to the Company the fulfillment of one of the conditions listed in Articles 234-7 and 234-9 of the AMF General Regulations. In the event of disagreement between the parties, an expert will be appointed by the president of the commercial court, ruling in the form of interim relief, for the purpose of determining whether or not it is necessary to file a draft public offer, it being specified that the expert will be required to apply the relevant provisions of the AMF General Regulations as well as the criteria issued by the French Conseil des Marchés Financiers, the AMF and the French courts. Any breach of the obligation to file a takeover bid as provided in the Articles of Association may give rise to claims for damages or, as the case may be, action for injunctive relief. Dividends Our Board of Directors periodically explores the potential adoption of a dividend program; however, no assurances can be made that any future dividends will be paid on the ordinary shares. Any proposal to declare and pay future dividends to holders of our ordinary shares will be at the discretion of our Board of Directors and will depend on many factors, including our financial condition, earnings, capital requirements, level of indebtedness, statutory future prospects and contractual restrictions applying to the payment of dividends and other considerations that our Board of Directors deems relevant. Under French law, dividends are approved by the shareholders’ meeting. All calculations to determine the amounts available for dividends or other distributions will be based on our statutory financial statements which are, as a holding company, different from our consolidated financial statements and which are prepared in accordance with French GAAP because we are a French company. Dividends may only be paid by a French Societas Europaea out of “distributable profits,” plus any distributable reserves and “distributable premium” that the shareholders decide to make available for distribution, other than those reserves that are specifically required by law. “Distributable profits” consist of the unconsolidated net profits of the relevant company for each fiscal year, as increased or reduced by any profit or loss carried forward from prior years. “Distributable premium” refers to the contribution paid by the shareholders in addition to the par value of their shares for their subscription that the shareholders decide to make available for distribution. Except in the case of a share capital reduction, no distribution can be made to the shareholders when the net equity is, or would become, lower than the amount of the share capital plus the reserves which cannot be distributed in accordance with the law or the articles of association. Dividends may be paid in cash or, if the shareholders’ meeting so decides, in kind, provided that all the shareholders receive a whole number of assets of the same nature paid in lieu of cash. Our Articles of Association provide that each shareholder may be given the choice to receive his dividend in cash or in shares subject to a decision of the shareholders’ meeting taken by ordinary resolution. Under French law, the board of directors may distribute interim dividends after the end of the fiscal year but before the approval by the shareholders of the financial statements for the relevant fiscal year when the interim balance sheet, established during such year and certified by the auditors, reflects that the company has earned distributable profits since the close of the last fiscal year, after recognizing the necessary depreciation and provisions and after deducting prior losses, if any, and the sums to be allocated to reserves, as required by French law or articles of association, and including any retained earnings. The amount of such interim dividends may not exceed the amount of the profit so defined. Generally, we rely on dividends paid to Constellium SE, or funds otherwise distributed or advanced to Constellium SE by its subsidiaries to fund the payment of dividends, if any, to our shareholders. In addition, restrictions contained in the agreements governing our outstanding indebtedness limit our ability to pay dividends on our ordinary shares and limit the ability of our subsidiaries to pay dividends to us. Future indebtedness that we may incur may contain similar restrictions.


 
12 According to our Articles of Association, distributions payable in cash shall be approved in euros and paid (i) in euros for all the holders of shares under the French Register and (ii) in USD for all the holders of shares under the U.S. Register. For the purposes of the payment of the dividend in dollars, the general shareholders’ meeting or, as the case may be, our Board of Directors, shall set the reference date to be considered for the EUR/USD exchange rate. Cash dividends and other distributions that have not been collected within five years after the date on which they became due and payable will revert to the French State. We have historically not paid dividends to our shareholders. Liquidation Rights and Dissolution In the event of our dissolution and liquidation, and after we have paid all debts and liquidation expenses, all assets available for distribution shall be distributed to holders of our shares pro rata based on the amount paid upon the shares held by such holders. Our Corporate Governance As a foreign private issuer listed on the NYSE, we are subject to NYSE corporate governance listing standards. However, NYSE rules permit a foreign private issuer like us to follow the corporate governance practices of its home country. Following the Transfer, we intend to rely on the NYSE Listed Company Manual with respect to our corporate governance to the extent possible under French law. The following are the significant ways in which our corporate governance practices differ from those required for U.S. companies listed on the NYSE following the Transfer. • Audit Committee-The Board’s audit committee is responsible for selecting our statutory auditors and making a recommendation to our Board regarding the terms of their compensation. As required by French law, the actual appointment of the statutory auditors has to be made by the shareholders at a general meeting of the shareholders. • Committee Powers-While the NYSE Listed Company Manual empowers board committees with decision-making authority that can be delegated by a company’s board, under French law, committees of the Company recommend to the full Board, which will be the decision-making body (not its committees). • Executive Sessions/Communications with Independent Directors-French law does not require for our independent directors to meet regularly without management, nor does it require the independent directors to meet alone in executive session at least once a year, as required by the NYSE Listed Company Manual. However, if our independent directors decide to engage in either or both of these activities, they will be permitted to do so. In practice, our independent directors regularly meet among themselves for discussions, but we do not expect them to be under any requirement to do so under our Articles of Association or French law. In addition, French law does not require a method for interested parties to communicate with our independent directors. • Equity Compensation Plans-French law requires shareholder approval at a general meeting of the shareholders to adopt an equity compensation plan, which is consistent with the shareholder vote required by the NYSE Listed Company Manual. It is common practice after obtaining such shareholder approval for the shareholders of a French company to then delegate to such company’s board of directors the authority to decide on the specific terms of the granting of equity compensation, within the limits of the shareholders’ authorization. The shareholders of the Company at the general meeting held on November 25, 2019 voted on such an authorization (effective as of December 12, 2019) to delegate such authority to the Board of Directors. • Corporate Governance Guidelines-A Board Internal Charter is required by the NYSE Listed Company Manual for U.S. companies listed on the NYSE that would set forth certain corporate governance practices of a listed company’s board. Our Board Internal Charter after the Transfer covers all items required by the NYSE Listed Company Manual subject to certain differences set forth by French law, particularly with respect to Committee powers (as described above) and conflict of interest


 
13 transactions (as described below). • Conflicts of Interest-Pursuant to French law and the Articles of Association, any agreement (directly or through an intermediary) between the Company and any director of the Company that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions will be subject to the prior authorization of the Board, excluding the participation and vote of the interested director. As required by French law, any such agreement will also be subject to approval at the next ordinary shareholders’ meeting (by a simple majority, excluding the vote of interested persons). If the transaction has not been pre-approved by the Board, it can be nullified if it has prejudicial consequences for the Company. If it is not approved by the shareholders, interested directors may be held liable for any prejudicial consequences for the Company of the unapproved transaction; such transaction will nevertheless remain valid, unless it is nullified in case of fraud. The foregoing requirements also apply to agreements between the Company and another entity if one of the Company’s directors is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the Company’s directors has an indirect interest. Aside from the foregoing requirements, there are no specific provisions prohibiting conflicted directors to participate or vote at a Board meeting. However, as a general rule under French law, directors must act in the interest of the Company. Differences in Corporate Law We are incorporated under the laws of France. The following discussion summarizes material differences between the rights of holders of our ordinary shares and the rights of holders of the common stock of a typical corporation incorporated under the laws of the state of Delaware, which result from differences in governing documents and the laws of France and Delaware. This discussion does not purport to be a complete statement of the rights of holders of our ordinary shares under applicable French law and our Articles of Association or the rights of holders of the common stock of a typical corporation under applicable Delaware law and a typical certificate of incorporation and bylaws. Delaware France Duties of directors The board of directors of a Delaware corporation bears the ultimate responsibility for managing the business and affairs of a corporation. There is generally only one board of directors. In discharging this function, directors of a Delaware corporation owe fiduciary duties of care and loyalty to the corporation and to its shareholders. The duty of care generally requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. In general, but subject to certain exceptions, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Delaware courts have also imposed a heightened standard of conduct upon directors of a Delaware corporation who take any action designed to defeat a threatened change in control of the corporation. In France, a company organized as a "Societas Europaea" can have a two-tier board structure: a management board comprising managing directors (Directoire) and a supervisory board comprising the non-executive directors (Conseil de Surveillance), or a single-tier board of directors (Conseil d’Administration). The single-tier board of directors of such French company will be comprised of non- executive directors and, if any, executive directors. Under French law, the board of directors supervises the management of the executive officers, sets the guidelines for the company’s activities and oversees their implementation. Subject to the powers expressly assigned by law to the shareholders’ meetings and within the limit of the corporate purpose, it hears any issue relevant to the company’s smooth operation and, by means of its deliberations, settles the matters of concern to it, taking into consideration the social and environmental impact of the company's activity. The board of directors proceeds with the controls and checks what it deems advisable. Moreover, the board of directors exercises the special powers conferred on it by law. As of the date of this document, we have a one tier Board of


 
14 In addition, under Delaware law, when the board of directors of a Delaware corporation approves the sale or break-up of a corporation, the board of directors may, in certain circumstances, have a duty to obtain the highest value reasonably available to the shareholders. Directors consisting of one executive director (the CEO) and nine non-executive directors. Under French law, each director has a duty towards the company to properly perform his/her duties. Furthermore, each director has a duty to act in the corporate interest of the company. The corporate interest extends to the interests of all corporate stakeholders, such as shareholders, creditors, employees, customers and suppliers. In its relations with third parties, the company shall be bound even by the decisions of the board of directors that do not come under the corporate purpose, unless the company can prove that the third party knew that the decision exceeded that purpose or that it could not have been unaware of this in light of the circumstances; publication of the articles of association alone does not constitute sufficient proof. Any board resolution regarding a change in the company’s Articles of Association requires shareholders’ approval. The board of directors may decide in its sole discretion, within the confines of French law and the Articles of Association, to incur additional indebtedness subject to any contractual restrictions pursuant to existing financing arrangements. There is no obligation for directors to hold shares in the company unless required by the articles of association. According to our Articles of Association, there is no such obligation. Director terms The Delaware General Corporation Law generally provides for a one-year term for directors, but permits directorships to be divided into up to three classes with up to three-year terms, with the years for each class expiring in different years, if permitted by the certificate of incorporation, an initial bylaw or a bylaw adopted by the shareholders. A director elected to serve a term on a “classified” board may not be removed by shareholders without cause. There is no limit to the number of terms a director may serve. Under French law, a director of a company is appointed for a maximum term of six years. In practice, the articles of association set the directors’ precise term. According to our Articles of Association, the term of office of a Director is of three (3) years and can be renewed without limitation. Directors may be appointed for a shorter term so that the renewal of the Directors’ terms of office may be spread out over time. According to our Articles of Association, the number of Directors who are more than seventy-five (75) years old may not exceed one third of the directors in office. Director election and vacancies The Delaware General Corporation Law provides that vacancies and newly created directorships may be filled by a majority of the directors then in office (even though less than a quorum) or by a sole remaining director unless (a) otherwise provided in the certificate of incorporation or Under French law, new members of the board of directors of a company are appointed by the general meeting of shareholders by a simple majority. The board of directors which convenes the shareholders' meeting proposes candidates; shareholders may also propose candidates under


 
15 by-laws of the corporation or (b) the certificate of incorporation directs that a particular class of stock is to elect such director, in which case a majority of the other directors elected by such class, or a sole remaining director elected by such class, will fill such vacancy. certain conditions. The shareholders at the meeting may vote for other candidates than those proposed on the agenda, by a simple majority. Vacancies on the board of directors occurring between shareholders’ meetings may be filled at a board meeting by a majority of the remaining directors, subject to ratification at the next shareholders’ meeting. Conflict of interest transactions Under the Delaware General Corporation Law, transactions with directors must be approved by disinterested directors or by the shareholders, or otherwise proven to be fair to the company as of the time it is approved. Such transaction may be void or voidable, unless (1) the material facts of any interested directors’ interests are disclosed or are known to the board of directors and the board in good faith authorizes the contract or transaction by an affirmative votes of a majority of the disinterested directors, even though the disinterested directors constitute less than a quorum; (2) the material facts of any interested directors’ interests are disclosed or are known to the shareholders entitled to vote thereon, and the transaction is specifically approved in good faith by vote of the shareholders; or (3) the transaction is fair to the company as of the time it is approved. Interested directors may be counted in determining the presence of a quorum at a meeting of the board of directors or of a committee which authorizes the contract or transaction. Pursuant to French law and the Articles of Association, any agreement between (directly or through an intermediary) a company and any of its directors, its executive corporate officers (“Directeur Général”or any “Directeur Général Délégué”), its shareholders holding more than 10% of its voting rights or companies controlling such shareholders, that is not entered into (i) in the ordinary course of business and (ii) under normal terms and conditions, is subject to a prior authorization of the board of directors, excluding the participation and vote of the interested director. Such agreement is also subject to approval at the next ordinary shareholders’ meeting (by a simple majority), excluding the votes of any interested persons. The foregoing requirements also apply to agreements between the company and another entity if one of the company’s directors, or executive corporate officers (“Directeur Général”or any “Directeur Général Délégué”) is an owner, a general partner, manager, director, general manager, member of the executive or supervisory board of the other entity, as well as to agreements in which one of the company’s directors, executive corporate officers (“Directeur Général”or any “Directeur Général Délégué”), shareholders holding more than 10% of its voting rights or companies controlling such shareholders has an indirect interest. If the transaction has not been pre-approved by the board of directors, it can be nullified if it has prejudicial consequences for the company. If an agreement is not then approved by the shareholders, the interested person may be held liable for any prejudicial consequences for the company of the unapproved transaction; such transaction will nevertheless remain valid unless it is nullified in case of fraud. Aside from the above rule, there are no specific provisions prohibiting conflicted directors to participate or vote at board meetings. However, as a general rule, directors must act in the interest of the company. Proxy voting by directors A director of a Delaware corporation may not issue a proxy representing the director’s voting rights as a director. According to French law and our Articles of Association, a director may grant to another director a proxy to represent him or her at a meeting of the board of directors. No director can hold more than one proxy at any meeting. Voting rights Under the Delaware General Corporation Law, each shareholder is entitled to one vote per share of stock, unless the certificate of incorporation provides otherwise. Under French law and in general, each shareholder is entitled to one vote per share at any general shareholders’ meeting. A general shareholders’ meeting is held annually


 
16 In addition, the certificate of incorporation may provide for cumulative voting at all elections of directors of the corporation, or at elections held under specified circumstances. Either the certificate of incorporation or the bylaws may specify the number of shares or the amount of other securities that must be represented at a meeting in order to constitute a quorum, but in no event will a quorum consist of less than one-third of the shares entitled to vote at a meeting, except that, where a separate vote by a class or series or classes or series is required, a quorum will consist of no less than 1/3 of the shares of such class or series or classes or series. Shareholders as of the record date for the meeting are entitled to vote at the meeting, and the board of directors may fix a record date that is no more than 60 days nor less than 10 days before the date of the meeting, and if no record date is set then the record date is the close of business on the day next preceding the day on which the meeting is held. The determination of the shareholders of record entitled to notice or to vote at a meeting of shareholders shall apply to any adjournment of the meeting, but the board of directors may fix a new record date for the adjourned meeting. to, inter alia, approve the annual financial statements. General shareholders’ meetings (including annual meetings) can be ordinary and/or extraordinary, depending upon the resolutions submitted to the vote. At an extraordinary general shareholders’ meeting (which votes upon any proposal to change the articles of association, including any change in the rights of shareholders), majority is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/4 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting. If the quorum at the second meeting is not reached, the second meeting can be postponed to a date no later than two months after the date on which the second meeting was convened. The quorum for such second or postponed meeting, as the case may be, to be validly held is 1/5 of the voting shares. At an ordinary shareholders’ meeting (which votes upon any proposal within the competence of a general shareholders’ meeting other than an extraordinary shareholders meeting such as approval of annual financial statements or appointment of directors), majority is simple majority (more than 50%) of the votes validly cast. Majority at special meetings is 2/3 of the votes validly cast. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/5 of the voting shares. If this quorum is not reached, a second meeting is convened with an agenda identical to the first meeting; no quorum is required for such second meeting. Special meetings bring together the holders of shares of a specified class, should it be created, to decide on an amendment to the rights relating to the shares of this class. The quorum necessary for such a meeting to be validly held on the date set by the first convening notice is 1/3 of the voting shares, and, failing which, 1/5 for the meeting held on the date set by the second convening notice or in the case of postponement of the second meeting. French law does not provide for cumulative voting. The right to participate in a shareholders’ meeting is granted to all the shareholders whose shares are fully paid up and for whom a right to attend shareholders’ meetings has been established by registration of their shares in their names or names of the authorized intermediary acting on their behalf on the second business day prior to the shareholders’ meeting at 0:00 (zero hour) (Paris time) (the “French Record Date”), either in the registered (“au nominatif”) shares accounts held by the company (or an agent acting on


 
17 its behalf) or in the bearer (“au porteur”) shares accounts held by the authorized intermediary. Shareholders holding shares registered on the U.S. Register (which include all shares which are listed on the NYSE, held through a DTC participant and shares directly recorded in the name of their holder with Computershare) vote through a process similar to the one that was in place before the Transfer with the following main differences: • their voting instructions will be transmitted to the Company via the French Intermediary, acting as intermediary for the account of all shareholders registered on the U.S. Register, in accordance with articles L. 228-1 et seq. of the French Commercial Code; • the French Record Date will be set; • an additional record date will be fixed for all shareholders registered on the U.S. Register, which date will be the 25th day before the meeting (the “U.S. Mailing Record Date”); and • shareholders who purchase shares between the U.S. Mailing Record Date and the French Record Date will be entitled to participate and vote at the shareholders’ meeting as long as they continue to be shareholders on the French Record Date. However, given the short time between the French Record Date and the shareholders’ meeting date, shareholders as of the French Record Date may not have received the notices and information received by shareholders holding shares registered on the U.S. Register as of the U.S. Mailing Record Date. To the extent that shareholders as of the U.S. Mailing Record Date have sent voting instructions and sold or otherwise transferred their shares as of the French Record Date, such voting instructions will be invalidated or modified by the Company, as the case may be, in accordance with articles R. 225-85 and R. 225-86 of the French Commercial Code. Shareholder proposals Delaware law does not provide shareholders an express right to put any proposal before a meeting of shareholders, but it provides that a corporation’s bylaws may provide that if the corporation solicits proxies with respect to the election of directors, it may be required to include in its proxy solicitation materials one or more individuals nominated by a shareholder. In keeping with common law, Delaware corporations generally afford shareholders an opportunity to make proposals and nominations, provided that they comply with the notice provisions in the Pursuant to French law, the board of directors is required to convene an annual ordinary general meeting of shareholders for approval of the annual financial statements. This meeting must be held within six months after the end of each prior fiscal year. The board of directors may also convene an ordinary or extraordinary meeting of shareholders upon proper notice at any time during the year. If the board of directors fails to convene a shareholders’ meeting, the auditors may call the


 
18 certificate of incorporation or bylaws. meeting. In a bankruptcy, the liquidator or court-appointed agent may also call a shareholders’ meeting in some instances. Any of the following may request the court to appoint an agent: • one or several shareholders holding at least 5% of the share capital, or •  any interested party or the workers committee in cases of urgency. Shareholders holding a majority of the capital or voting rights after a public take-over bid or exchange offer or the transfer of a controlling block of shares may also convene a shareholders’ meeting. In general, shareholders can only take action at shareholders’ meetings on matters listed on the agenda for the meeting. As an exception to this rule, shareholders may take action with respect to the dismissal and appointment of directors. Additional draft resolutions to be submitted for approval by the shareholders at any shareholders’ meeting may be proposed to the board of directors within the proscribed time limit (which is no later than 20 days after the publication of the convening notice (avis de réunion) and in any event no sooner than 25 days prior to the date of the shareholders’ meeting) by one or several shareholders holding a specified percentage of shares. The convening notice (avis de réunion) must be published in France with the BALO at least 35 days prior to the date of the shareholders’ meeting and can be consulted at https://www.journal-officiel.gouv.fr/balo/. As the U.S. Mailing Record Date is fixed at the 25th day before the shareholders’ meeting, shareholders wishing to submit additional resolutions will need to submit them before receiving the meeting materials sent to them on or around the U.S. Mailing Record Date, otherwise their submissions will not be considered. The percentage of shares required to be held by one or several shareholders to be able to submit additional draft resolutions depends on the amount of the share capital of the Company; based on the Company’s issued share capital of €2,799,253.44 as of December 31, 2020, this percentage would be 2.90%. Action by written consent Unless otherwise provided in the corporation’s certificate of incorporation, any action required or permitted to be taken at any annual or special meeting of shareholders of a corporation may be taken without a meeting, without prior notice and without a vote, if one or more consents in writing, setting forth the action to be so taken, are signed by the holders of outstanding stock having not less than Under French law, shareholders’ action by written consent is not permitted in a Societas Europaea.


 
19 the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Although permitted by Delaware law, publicly listed companies do not typically permit stockholders of a corporation to take action by written consent. Shareholder suits Under the Delaware General Corporation Law, a shareholder may bring a derivative action on behalf of the corporation to enforce the rights of the corporation. An individual also may commence a class action suit on behalf of himself and other similarly situated shareholders where the requirements for maintaining a class action under Delaware law have been met. A person may institute and maintain such a suit only if that person was a shareholder at the time of the transaction which is the subject of the suit. In addition, under Delaware case law, the plaintiff normally must be a shareholder not only at the time of the transaction that is the subject of the suit, but also throughout the duration of the derivative suit. Delaware law also requires that the derivative plaintiff make a demand on the directors of the corporation to assert the corporate claim before the suit may be prosecuted by the derivative plaintiff in court, unless such a demand would be futile. French law provides that a shareholder, or a group of shareholders, may initiate a legal action to seek indemnification from the directors of a company in the company’s interest if it fails to bring such legal action itself. If so, any damages awarded by the court are paid to the company and any legal fees relating to such action are borne by the relevant shareholder or the group of shareholders. The plaintiff must remain a shareholder throughout the duration of the legal action. There is no other case where shareholders may initiate a derivative action to enforce a right of a company. A shareholder may alternatively or cumulatively bring an individual legal action against the directors, provided he or she has suffered distinct damages from those suffered by the company. In this case, any damages awarded by the court are paid to the relevant shareholder. Repurchase of shares Under the Delaware General Corporation Law, a corporation may purchase or redeem its own shares unless the capital of the corporation is impaired or the purchase or redemption would cause an impairment of the capital of the corporation. A Delaware corporation may, however, purchase or redeem out of capital any of its preferred shares or, if no preferred shares are outstanding, any of its own shares if such shares will be retired upon acquisition and the capital of the corporation will be reduced in accordance with specified limitations. Under French law, a private company (which our Company is for French law purposes for so long as it is listed on the NYSE only) may not subscribe for newly issued shares in its capital but may, however, acquire its own shares for the following purposes only: • With a view to distributing within one year of their repurchase the relevant shares to employees or managers under a profit-sharing, restricted free share or share option plan, not to exceed 10% of the share capital; • In payment or in exchange for assets acquired by the company within two years of their repurchase, not to exceed 5% of the share capital; • To sell the relevant shares to any shareholders willing to purchase them as part of a process organized by the company within five years, not to exceed 10% of the share capital. Shares acquired but not used in accordance with the above purposes must be cancelled. As of the date of this document, the Company does not have in place an authorization granted to the Board of Directors to purchase its own shares.


 
20 The Company may also acquire its own shares to decrease its share capital, provided that such decision is not driven by losses and that a purchase offer is made to all shareholders on a pro rata basis, with the approval of the shareholders at the extraordinary general meeting deciding the capital reduction. Anti-takeover provisions In addition to other aspects of Delaware law governing fiduciary duties of directors during a potential takeover, the Delaware General Corporation Law also contains a business combination statute that protects Delaware companies from hostile takeovers and from actions following the takeover by prohibiting some transactions once an acquirer has gained a significant holding in the corporation. Section 203 of the Delaware General Corporation Law prohibits “business combinations,” including mergers, sales and leases of assets, issuances of securities and similar transactions by a corporation or a subsidiary with an interested shareholder that beneficially owns 15% or more of a corporation’s voting stock (or which is an affiliate or associate of the corporation and owned 15% or more of the corporation’s outstanding voting stock within the past three years), within three years after the person becomes an interested shareholder, unless: •  the transaction that will cause the person to become an interested shareholder is approved by the board of directors of the target prior to the transactions; •  after the completion of the transaction in which the person becomes an interested shareholder, the interested shareholder holds at least 85% of the voting stock of the corporation not including shares owned by persons who are directors and also officers of interested shareholders and shares owned by specified employee benefit plans; or •  after the person becomes an interested shareholder, the business combination is approved by the board of directors of the corporation and holders of at least 66.67% of the outstanding voting stock, excluding shares held by the interested shareholder. A Delaware corporation may elect not to be governed by Section 203 by a provision contained in the original certificate of incorporation of the corporation or an amendment to the original certificate of incorporation or to the bylaws of the company, which amendment must be approved by a majority of the shares entitled to vote and may not be further amended by the board of directors of the corporation. Such an amendment is not effective until twelve months following its adoption. French law does not contain provisions restricting or making difficult to change the composition of the board of directors following a change of control. French law allows shareholders at general meetings to delegate the authority to the board of directors to issue shares or warrants to subscribe for shares, which may make it more difficult for a shareholder to obtain control over our general meeting of shareholders. The shareholders’ meeting of June 29, 2020 delegated the authority to our Board of Directors to decide the issuance, in the event of a public bid on the Company’s shares, of warrants each enabling the subscription of one or more ordinary shares, up to €1,378,674.18 (representing 49.99% of the Company’s share capital at the time of that shareholders’ meeting) and to freely allot said warrants to all of the Company’s shareholders having that capacity before the expiration of the public offering period. The Board of Directors had decided that any such issue of free warrants to subscribe to new shares in the event of a public tender on the Company would in any event be limited to 40% of the share capital for the 12-month period. This delegation has certain similarities to a rights plan in the U.S., both allowing the board of directors to issue free warrants to subscribe to new shares to existing shareholders in case an unsolicited public tender offer is launched on the Company. It aims to give the board of directors the possibility to negotiate with the bidder to induce the bidder to raise the offer price and/or improve the terms of the offer. It could only be triggered in the event of a public bid for the shares and if the warrants are issued, they will be issued to all those shareholders who hold shares before the expiry of the public offer period. This delegation has been given for a twelve-month period expiring on June 28, 2021.


 
21 Inspection of books and records Under the Delaware General Corporation Law, any shareholder may inspect for any proper purpose the corporation’s stock ledger, a list of its shareholders and its other books and records during the corporation’s usual hours of business. The board of directors must provide all required information for the shareholders’ meeting. Under French law, shareholders are entitled to review and copy the list of the shareholders (name and address) who hold their shares in nominative form during 15 days prior to any shareholders’ meeting. However, that should not apply to shares held in bearer (“au porteur”) form by U.S. shareholders. Removal of directors Under the Delaware General Corporation Law, any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except (a) unless the certificate of incorporation provides otherwise, in the case of a corporation whose board is classified, shareholders may effect such removal only for cause, or (b) in the case of a corporation having cumulative voting, if less than the entire board is to be removed, no director may be removed without cause if the votes cast against his removal would be sufficient to elect him if then cumulatively voted at an election of the entire board of directors, or, if there are classes of directors, at an election of the class of directors of which he is a part. Under French law, directors may be removed from office, with or without cause, at any shareholders’ meeting without notice or justification, by a simple majority vote of shareholders. Directors cannot be suspended or removed by the board of directors. An executive corporate officer appointed by the board of directors (CEO (Directeur Général) or, if any, deputy chief executive officer (Directeur Général Délégué)) can have his or her executive duties suspended at any time by the board of directors. If such executive corporate officer is also a director, he or she will remain non-executive director as his or her duties as a director can only be removed by a shareholders’ meeting. Preemptive rights Under the Delaware General Corporation Law, shareholders have no preemptive rights to subscribe to additional issues of stock or to any security convertible into such stock unless, and except to the extent that, such rights are expressly provided for in the certificate of incorporation. Under French law, in case of issuance of additional shares or other securities giving right, immediately or in the future, to new shares for cash or set-off against cash debts, the existing shareholders have preferential subscription rights to these securities on a pro rata basis unless such rights are waived by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the extraordinary meeting deciding or authorizing the capital increase. In case such rights are not waived by the extraordinary general meeting, each shareholder may individually either exercise, or assign or not exercise its preferential rights. Dividends Under the Delaware General Corporation Law, a Delaware corporation may, subject to any restrictions contained in its certificate of incorporation, pay dividends out of its surplus (the excess of net assets over capital), or in case there is no surplus, out of its net profits for the fiscal year in which the dividend is declared or the preceding fiscal year (provided that the amount of the capital of the corporation is not less than the aggregate amount of the Our Board of Directors periodically explores the potential adoption of a dividend program; however, no assurances can be made that any future dividends will be paid on the ordinary shares. Any proposal to declare and pay future dividends to holders of our ordinary shares will be at the discretion of our Board of Directors and will depend on many factors, including our financial condition, earnings, capital requirements, level of indebtedness, statutory future


 
22 capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets). In determining the amount of surplus of a Delaware corporation, the assets of the corporation, including stock of subsidiaries owned by the corporation, must be valued at their fair market value as determined by the board of directors, without regard to their historical book value. Dividends may be paid in the form of common stock, property or cash. prospects and contractual restrictions applying to the payment of dividends and other considerations that our Board of Directors deems relevant. Under French law, dividends are approved by the shareholders’ meeting. All calculations to determine the amounts available for dividends or other distributions will be based on our statutory financial statements which are, as a holding company, different from our consolidated financial statements and which are prepared in accordance with French GAAP because we are a French company. Dividends may only be paid by a French Societas Europaea out of “distributable profits,” plus any distributable reserves and “distributable premium” that the shareholders decide to make available for distribution, other than those reserves that are specifically required by law. “Distributable profits” consist of the unconsolidated net profits of the relevant company for each fiscal year, as increased or reduced by any profit or loss carried forward from prior years. “Distributable premium” refers to the contribution paid by the shareholders in addition to the par value of their shares for their subscription that the shareholders decide to make available for distribution. Except in the case of a share capital reduction, no distribution can be made to the shareholders when the net equity is, or would become, lower than the amount of the share capital plus the reserves which cannot be distributed in accordance with the law or the articles of association. Dividends may be paid in cash or, if the shareholders’ meeting so decides, in kind, provided that all the shareholders receive a whole number of assets of the same nature paid in lieu of cash. Our Articles of Association provide that each shareholder may be given the choice to receive his dividend in cash or in shares subject to a decision of the shareholders’ meeting taken by ordinary resolution. Under French law, the board of directors may distribute interim dividends after the end of the fiscal year but before the approval by the shareholders of the financial statements for the relevant fiscal year when the interim balance sheet, established during such year and certified by the auditors, reflects that the company has earned distributable profits since the close of the last fiscal year, after recognizing the necessary depreciation and provisions and after deducting prior losses, if any, and the sums to be allocated to reserves,


 
23 as required by French law or articles of association, and including any retained earnings. The amount of such interim dividends may not exceed the amount of the profit so defined. Generally, we rely on dividends paid to Constellium SE, or funds otherwise distributed or advanced to Constellium SE by its subsidiaries to fund the payment of dividends, if any, to our shareholders. In addition, restrictions contained in the agreements governing our outstanding indebtedness limit our ability to pay dividends on our ordinary shares and limit the ability of our subsidiaries to pay dividends to us. Future indebtedness that we may incur may contain similar restrictions. According to our Articles of Association, distributions payable in cash shall be approved in euros and paid (i) in euros for all the holders of shares under the French Register and (ii) in USD for all the holders of shares under the U.S. Register. For the purposes of the payment of the dividend in dollars, the general shareholders’ meeting or, as the case may be, our Board of Directors, shall set the reference date to be considered for the EUR/USD exchange rate. Cash dividends and other distributions that have not been collected within five years after the date on which they became due and payable will revert to the French State. We have historically not paid dividends to our shareholders. Shareholder vote on certain reorganizations Under the Delaware General Corporation Law, the vote of a majority of the outstanding shares of capital stock entitled to vote thereon generally is necessary to approve a merger or consolidation or the sale of substantially all of the assets of a corporation. The Delaware General Corporation Law permits a corporation to include in its certificate of incorporation a provision requiring for any corporate action the vote of a larger portion of the stock or of any class or series of stock than would otherwise be required. Under the Delaware General Corporation Law, no vote of the shareholders of a surviving corporation to a merger is needed; however, unless required by the certificate of incorporation, if (a) the agreement of merger does not amend in any respect the certificate of incorporation of the surviving corporation, (b) the shares of stock of the surviving corporation are not changed in the merger and (c) the number of ordinary shares of the surviving corporation into which any other shares, securities or obligations to be issued in the merger may be converted does not exceed 20% of the surviving corporation’s common shares outstanding immediately prior to the Generally, under French law, completion of a legal merger (fusion), demerger (scission), dissolution, sale, lease or exchange of all or substantially all of a company’s assets, requires: •  the approval of the board of directors; and •  the approval by a two-thirds majority of the votes held by the shareholders present, represented by proxy or voting by mail at the relevant meeting, or in the case of a legal merger (fusion) with a non-EU company, approval of all the shareholders of the company.


 
24 effective date of the merger. In addition, shareholders may not be entitled to vote in certain mergers with other corporations that own 90% or more of the outstanding shares of each class of stock of such corporation, but the shareholders will be entitled to appraisal rights. Compensation of board of directors Under the Delaware General Corporation Law, the shareholders do not generally have the right to approve the compensation policy for the board of directors or the senior management of the corporation, although certain aspects of the compensation policy may be subject to shareholder vote due to the provisions of federal securities and tax law, as well as stock exchange requirements. The board of directors determines the remuneration of executive directors (i.e. the CEO (“Directeur Général”) and, if any, Deputy Chief Executive Officers (“Directeurs Généraux Délégués”), who may (but are not required to) be directors). French law does not provide for any specific rules on remuneration of executive directors for French companies not listed on a EU-regulated market. Executive directors may be granted free shares and stock options of the Company. With respect to the remuneration of non-executive directors, the ordinary shareholders’ meeting votes an envelope of fixed annual fees to be allocated to directors for each year. The board of directors will then decide the allocation of these fees among directors. These fees include all cash remunerations granted to directors in such capacity. Non- executive directors may not be granted any share-settled awards (such as free shares or stock options) in such capacity. In addition to the fixed amount of fees approved at the shareholders meeting, the board of directors may grant fees to the chairman of the board in such capacity, and may also, exceptionally, grant additional fees to certain directors in remuneration for separate, specific missions or tasks assigned to them. Non-executive directors are not eligible to receive awards that are to be settled with shares. However, the board of directors may grant share-settled awards (such as free shares or stock options) to the chairman of the board in such capacity.


 
07/16927352_14 1 Execution version 13 May 2020 CONSTELLIUM INTERNATIONAL as Company and BNP PARIBAS as Coordinator and BNP PARIBAS BPIFRANCE FINANCEMENT SOCIETE GENERALE As Original Lenders and BNP PARIBAS as Agent and Security Agent EUR 180,000,000 TERM FACILITY AGREEMENT FOR A LOAN GUARANTEED BY THE FRENCH STATE (PGE GRANDE ENTREPRISE) Herbert Smith Freehills Paris LLP


 
07/16927352_14 2 TABLE OF CONTENTS Clause Headings Page SECTION 1 INTERPRETATION .......................................................................................................................................1 1. DEFINITIONS AND INTERPRETATION .......................................................................................................................................1 SECTION 2 THE FACILITY .....................................................................................................................................21 2. THE FACILITY .....................................................................................................................................21 3. PURPOSE .....................................................................................................................................22 4. CONDITIONS OF UTILISATION .....................................................................................................................................22 SECTION 3 UTILISATION .....................................................................................................................................23 5. UTILISATION .....................................................................................................................................23 SECTION 4 REPAYMENT, PREPAYMENT AND CANCELLATION .....................................................................................................................................24 6. REPAYMENT .....................................................................................................................................24 7. PREPAYMENT AND CANCELLATION .....................................................................................................................................25 SECTION 5 COSTS OF UTILISATION .....................................................................................................................................32 8. INTEREST .....................................................................................................................................32 9. INTEREST PERIODS .....................................................................................................................................33 10. CHANGES TO THE CALCULATION OF INTEREST .....................................................................................................................................34 11. FEES .....................................................................................................................................35 SECTION 6 ADDITIONAL PAYMENT OBLIGATIONS .....................................................................................................................................36 12. TAX GROSS-UP AND INDEMNITIES .....................................................................................................................................36 13. INCREASED COSTS .....................................................................................................................................41 14. OTHER INDEMNITIES .....................................................................................................................................42 15. MITIGATION BY THE LENDERS .....................................................................................................................................43 16. COSTS AND EXPENSES .....................................................................................................................................44


 
07/16927352_14 3 SECTION 7 REPRESENTATIONS, UNDERTAKINGS AND EVENTS OF DEFAULT .....................................................................................................................................44 17. REPRESENTATIONS .....................................................................................................................................44 18. INFORMATION UNDERTAKINGS .....................................................................................................................................49 19. FINANCIAL COVENANTS .....................................................................................................................................52 20. GENERAL UNDERTAKINGS .....................................................................................................................................52 21. EVENTS OF DEFAULT .....................................................................................................................................58 SECTION 8 CHANGES TO PARTIES .....................................................................................................................................62 22. CHANGES TO THE LENDERS .....................................................................................................................................62 23. TRANSFERS BY THE COMPANY .....................................................................................................................................66 SECTION 9 THE FINANCE PARTIES .....................................................................................................................................66 24. ROLE OF THE AGENT AND THE REFERENCE BANKS .....................................................................................................................................66 25. ROLE OF THE SECURITY AGENT .....................................................................................................................................74 26. CONDUCT OF BUSINESS BY THE FINANCE PARTIES .....................................................................................................................................77 27. SHARING AMONG THE FINANCE PARTIES .....................................................................................................................................77


 
07/16927352_14 4 SECTION 10 ADMINISTRATION .....................................................................................................................................78 28. PAYMENT MECHANICS .....................................................................................................................................78 29. SET-OFF .....................................................................................................................................81 30. NOTICES .....................................................................................................................................81 31. CALCULATIONS AND CERTIFICATES .....................................................................................................................................83 32. PARTIAL INVALIDITY .....................................................................................................................................83 33. REMEDIES, WAIVERS AND HARDSHIP .....................................................................................................................................83 34. AMENDMENTS AND WAIVERS .....................................................................................................................................83 35. CONFIDENTIAL INFORMATION .....................................................................................................................................86 36. CONFIDENTIALITY OF FUNDING RATES AND REFERENCE BANK QUOTATIONS .............................................................................................................90 37. FRENCH DATA PROTECTION LAW .....................................................................................................................................91 38. ELECTRONIC SIGNATURE .....................................................................................................................................92 SECTION 11 GOVERNING LAW AND ENFORCEMENT .....................................................................................................................................92 39. GOVERNING LAW .....................................................................................................................................92 40. JURISDICTION .....................................................................................................................................92 SCHEDULE 1 THE ORIGINAL LENDERS .....................................................................................................................................93 SCHEDULE 2 CONDITIONS PRECEDENT .....................................................................................................................................94 SCHEDULE 3 REQUESTS .....................................................................................................................................96 SCHEDULE 4 FORM OF TRANSFER AGREEMENT .....................................................................................................................................98 SCHEDULE 5 FORM OF COMPLIANCE CERTIFICATE ...................................................................................................................................100 SCHEDULE 6 EXISTING FINANCIAL INDEBTEDNESS AND EXISTING SECURITY ...................................................................................................................................101 SCHEDULE 7 FORM OF CONFIDENTIALITY UNDERTAKING ...................................................................................................................................103 SCHEDULE 8 TIMETABLES ...................................................................................................................................108


 
07/16927352_14 5 SCHEDULE 9 LIST OF APPROVED NUMBERING SERVICE PROVIDERS ...................................................................................................................................109


 
07/16927352_14 1 THIS AGREEMENT is dated 13 May 2020 and made between: (1) CONSTELLIUM INTERNATIONAL, a French société par actions simplifiée having its registered office at 40-44 rue Washington, 75008 Paris, France and registered under number 832 509 418 RCS Paris (the “Company”); (2) BNP PARIBAS, a French société anonyme having its registered office at 16 boulevard des Italiens, 75009 Paris, France and registered under number 662 042 449 RCS Paris, as documentation agent and coordinator (the “Coordinator”); (3) THE FINANCIAL INSTITUTIONS listed in Schedule 1 (The Original Lenders) as lenders (the “Original Lenders”); and (4) BNP PARIBAS, a French société anonyme having its registered office at 16 boulevard des Italiens, 75009 Paris, France and registered under number 662 042 449 RCS Paris, as agent of the other Finance Parties (the “Agent”) and security agent (the “Security Agent”). WHEREAS: (A) the Company wishes to benefit from a loan guaranteed by the French State (acting through Bpifrance Financement SA) pursuant to and in accordance with the provisions of a ministerial order (arrêté ministériel) dated 23 March 2020 and supplemental ministerial orders dated respectively 17 April 2020, 2 May 2020 and 6 May 2020 (together, the “PGE Order”), each taken as per the terms of Article 4 of law n°2020-289 of 23 March 2020 (as modified) (a “PGE Loan”); (B) the Original Lenders have agreed to grant a PGE Loan to the Company, subject to the terms of this agreement (together with its Schedules, the “Agreement”); (C) the Company acknowledges that the guarantee to be provided by the French State (acting through Bpifrance Financement SA) in respect of 80% of the principal outstanding amount of the PGE Loan, as per the terms of the regulations referred to in paragraph (A) above, is a key condition (condition essentielle et déterminante) of the Lenders' decision to grant a PGE Loan to the Company; and (D) this Agreement records the terms and conditions applicable to that PGE Loan. IT IS AGREED as follows: Section 1 INTERPRETATION 1. DEFINITIONS AND INTERPRETATION 1.1 Definitions In this Agreement: “Accounting Principles” means generally accepted accounting principles in France, including IFRS. “Administrative Parties” means the Finance Parties and the Coordinator. “Affiliate” means, in relation to any person, a Subsidiary of that person or a Holding Company of that person or any other Subsidiary of that Holding Company. “Anti-Corruption Regulations” means (i) the French legal and regulatory provisions relating to combatting corruption and trafficking in influence , including but not limited to those set forth in Book IV, Title III “Des atteintes à l’autorité de l’Etat” and Title IV “Des atteintes à la confiance publique” of the French Code pénal and (ii) the foreign regulations relating to combatting corruption having an extraterritorial application, in particular the American (Foreign Corrupt Practices Act) and the British (UK Bribery Act) ones, to the extent these measures are applicable.


 
07/16927352_14 2 “Authorisation” means an authorisation, consent, approval, resolution, licence, exemption, filing, notarisation or registration. “Availability Period” means the period from and including the date of publication of the ministerial order (arrêté ministériel) approving the French State Guarantee to and including the date falling three Business Days following such date of publication. “Available Commitment” means a Lender's Commitment under the Facility minus: (a) the amount in euro of its participation in the Loan; and (b) in relation to the proposed Utilisation, the amount in euro of its participation in the Loan due to be made under the Facility on or before the proposed Utilisation Date. “Available Facility” means, in relation to the Facility, the aggregate for the time being of each Lender's Available Commitment. “Bank Accounts Pledge” means any first ranking pledge (nantissement de comptes bancaires) granted by the Company over all its bank accounts in France and (subject to customary guarantee limitations) Constellium Issoire and Constellium Neuf Brisach over all their bank accounts in France (in each case other than the “Excluded Bank Accounts” as defined in the relevant Security Documents) for the benefit of the Finance Parties, pursuant to the terms of the relevant Security Documents. “Basel Committee” means the Basel Committee on Banking Supervision. “Basel III” means: (a) the agreements on capital requirements, a leverage ratio and liquidity standards contained in “Basel III: A global regulatory framework for more resilient banks and banking systems”, “Basel III: International framework for liquidity risk measurement, standards and monitoring” and “Guidance for national authorities operating the countercyclical capital buffer” published by the Basel Committee in December 2010; and (b) the rules for global systemically important banks contained in “Global systemically important banks: assessment methodology and the additional loss absorbency requirement – Rules text” published by the Basel Committee in November 2011, each in the form existing on the date of this Agreement, excluding any change in (or in the interpretation, administration or application of) such agreements and rules after the date hereof. “Break Costs” means the amount (if any) by which: (a) the interest (excluding any Margin) which a Lender should have received for the period from the date of receipt of all or any part of its participation in the Loan or Unpaid Sum to the last day of the current Interest Period in respect of the Loan or Unpaid Sum, had the principal amount or Unpaid Sum received been paid on the last day of that Interest Period; exceeds: (b) the amount which that Lender would be able to obtain by placing an amount equal to the principal amount or Unpaid Sum received by it on deposit with a leading bank for a period starting on the Business Day following receipt or recovery and ending on the last day of the current Interest Period. “Business Day” means a day (other than a Saturday or Sunday) on which banks are open for general business in Paris and (in relation to any date for payment or purchase of euro) any TARGET Day. “Code” means the US Internal Revenue Code of 1986.


 
07/16927352_14 3 “Commitment” means: (a) in relation to an Original Lender, the amount in euro set opposite its name under the heading “Commitment” in Schedule 1 (The Original Lenders) and the amount of any other Commitment transferred to it under this Agreement; and (b) in relation to any other Lender, the amount in euro of any Commitment transferred to it under this Agreement, to the extent not cancelled, reduced or transferred by it under this Agreement. “Compliance Certificate” means a certificate substantially in the form set out in Schedule 5 (Form of Compliance Certificate). “Confidential Information” means all information relating to Constellium SE, the Company, the Group, the Finance Documents or the Facility of which a Finance Party becomes aware in its capacity as, or for the purpose of becoming, a Finance Party or which is received by a Finance Party in relation to, or for the purpose of becoming a Finance Party under, the Finance Documents or the Facility from either: (a) any member of the Group or any of its advisers; or (b) another Finance Party, if the information was obtained by that Finance Party directly or indirectly from any member of the Group or any of its advisers, in whatever form, and includes information given orally and any document, electronic file or any other way of representing or recording information which contains or is derived or copied from such information but excludes: (i) information that: (1) is or becomes public information other than as a direct or indirect result of any breach by that Finance Party of Clause 35 (Confidential Information); or (2) is identified in writing at the time of delivery as non-confidential by any member of the Group or any of its advisers; or (3) is known by that Finance Party before the date the information is disclosed to it in accordance with paragraphs (a) or (b) above or is lawfully obtained by that Finance Party after that date, from a source which is, as far as that Finance Party is aware, unconnected with the Group and which, in either case, as far as that Finance Party is aware, has not been obtained in breach of, and is not otherwise subject to, any obligation of confidentiality; and (ii) any Funding Rate or Reference Bank Quotation. “Confidentiality Undertaking” means a confidentiality undertaking substantially in the form set out in Schedule 7 (Form of Confidentiality Undertaking) or in any other form agreed between the Company and the Agent. “Consolidated EBITDA” means, on a consolidated basis for Constellium SE and the Group and in relation to a Relevant Period, the consolidated operating profit of Constellium SE and the Group before taxation (excluding the results from discontinued operations): (a) before deducting any interest, commission, fees, discounts, prepayment fees, premiums or charges and other finance payments whether paid, payable or capitalised by Constellium SE or any member of the Group (calculated on a consolidated basis) in respect of that Relevant Period; (b) not including any accrued interest owing to Constellium SE or any member of the Group; (c) after adding back any amount attributable to the amortisation, depreciation or impairment of assets of Constellium SE or members of the Group (and taking no


 
07/16927352_14 4 account of the reversal of any previous impairment charge made in that Relevant Period); (d) before taking into account any Exceptional Items; (e) plus or minus Constellium SE's and the Group's share of the profits or losses (after finance costs and tax) of Non-Group Entities after deducting the amount of any profit of any Non-Group Entity to the extent that the amount of the profit included in the financial statements of the Group exceeds the amount actually received in cash by Constellium SE or members of the Group through distributions by the Non-Group Entity; (f) before taking into account any unrealised gains or losses on any derivative instrument (other than any derivative instrument which is accounted for on a hedge accounting basis) and unrealised gains or losses from the re- measurement of monetary assets and liabilities; (g) before taking into account any gain or loss arising from an upward or downward revaluation of any other asset at any time after December 2019; (h) before taking into account any Pension Items; (i) excluding the charge to profit represented by the expensing of share-based compensation instruments; and (j) metal price lag, in each case, to the extent added, deducted or taken into account, as the case may be, for the purposes of determining operating profits of Constellium SE and the Group before taxation. “Consolidated Net Finance Expenses” means, for any Relevant Period, the sum of: (a) Constellium SE and the Group's consolidated Net Financial Interest for that Relevant Period; and (b) the aggregate amount of any other financial expenses invoiced or paid by Constellium SE or any member of the Group for that Relevant Period. “Constellium France Holdco” means Constellium France Holdco, a société par actions simplifiée incorporated in France, having its registered office at 40-44 rue Washington, 75008 Paris France, registered under number 522 728 120 RCS Paris, which is a Subsidiary of the Company. “Constellium Issoire” means Constellium Issoire, a French société par actions simplifiée having its registered office at Zone Industrielle Les Listes Rue Yves, Lamourdedieu, 63500 Issoire, France, registered under number 672 014 081 RCS Clermont-Ferrand, which is a Subsidiary of the Company. “Constellium Neuf Brisach” means Constellium Neuf Brisach, a French société par actions simplifiée having its registered office at ZIP Rhenane Nord RD 52, 68600 Biesheim, France, registered under number 807 641 360 RCS Colmar, which is a Subsidiary of the Company. “Constellium SE” means Constellium SE, a société européenne incorporated in France having its registered office at Washington Plaza, 40-44 rue Washington, 75008 Paris France, registered under number 831 763 743 RCS Paris, which is a Holding Company of the Company. “CRD IV Directive” means directive 2013/36/EU of the European Parliament and of the Council of 26 June 2013 on access to the activity of credit institutions and the prudential supervision of credit institutions and investment firms in the form existing on the date of this Agreement, excluding any change in (or in the interpretation, administration or application of) such directive after the date hereof. “CRR Regulation” means regulation No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment


 
07/16927352_14 5 firms, in the form existing on the date of this Agreement, excluding any change in (or in the interpretation, administration or application of) such regulation after the date hereof. “Debt Capital Markets Issue” means any listed or unlisted, public or private issuance of bonds, Euro PP bonds, US PPs, Schuldschein notes, or any similar securities issuance by the Company, or any other member of the Group (or, for the purpose of Clause 21.17 (Debt Capital Market Issue), Constellium SE) to third party investors. “Default” means an Event of Default or any event or circumstance specified in Clause 21 (Events of Default) which would (with the expiry of a grace period, the giving of notice, the making of any determination under the Finance Documents or any combination of any of the foregoing) be an Event of Default. “Disruption Event” means either or both of: (a) a material disruption to those payment or communications systems or to those financial markets which are, in each case, required to operate in order for payments to be made in connection with the Facility (or otherwise in order for the transactions contemplated by the Finance Documents to be carried out) which disruption is not caused by, and is beyond the control of, any of the Parties; or (b) the occurrence of any other event which results in a disruption (of a technical or systems-related nature) to the treasury or payments operations of a Party preventing that, or any other Party: (i) from performing its payment obligations under the Finance Documents; or (ii) from communicating with other Parties in accordance with the terms of the Finance Documents, and which (in either such case) is not caused by, and is beyond the control of, the Party whose operations are disrupted. “Eligible Institution” means any Lender or other bank, financial institution, trust, fund or other entity selected by the Company and which, in each case, is not a member of the Group. “Environment” means humans, animals, plants and all other living organisms including the ecological systems of which they form part and the following media: (a) air (including, without limitation, air within natural or man-made structures, whether above or below ground); (b) water (including, without limitation, territorial, coastal and inland waters, water under or within land and water in drains and sewers); and (c) land (including, without limitation, land under water). “Environmental Claim” means any claim, proceeding, formal notice or investigation by any person in respect of any Environmental Law. “Environmental Law” means any applicable law or regulation which relates to: (a) the pollution or protection of the Environment; (b) the conditions of the workplace; or (c) the generation, handling, storage, use, release or spillage of any substance which, alone or in combination with any other, is capable of causing harm to the Environment, including, without limitation, any waste. “Environmental Permits” means any permit and other Authorisation and the filing of any notification, report or assessment required under any Environmental Law for the operation of the business of any member of the Group conducted on or from the properties owned or used by any member of the Group.


 
07/16927352_14 6 “Equity Capital Markets Issue” means any listed equity capital market, listed equity-linked capital market issue (whether by way of shares, preferential shares or equity warrants) or any listed hybrid capital issue. “Equivalent Working Capital Financing” means (i) any replacement facility to the Factoring Agreement and/or the Inventory Facility Agreement and/or (ii) any new off balance sheet trade receivable purchase program entered into by a Material Subsidiary. “EURIBOR” means, in relation to the Loan in euro: (a) the applicable Screen Rate as of the Specified Time for euro and for a period equal in length to the Interest Period of the Loan; or (b) as otherwise determined pursuant to Clause 10.1 (Unavailability of Screen Rate), and if, in either case, that rate is less than zero, EURIBOR shall be deemed to be zero. “Event of Default” means any event or circumstance specified as such in Clause 21 (Events of Default). “Exceptional Items” means any exceptional, infrequent, non-recurring or extraordinary items which represent gains or losses including those arising on: (a) the restructuring of the activities of an entity and reversals of any provisions for the cost of restructuring; (b) disposals, revaluations, write downs or impairment of non-current assets or any reversal of any write down or impairment; (c) disposals of assets associated with discontinued operations; (d) effects of certain purchase accounting adjustments; and (e) start-up and development costs or acquisition, integration and separation costs. “Extension” has the meaning given to it in Clause 6.2 (Extension option). “Facility” means the term loan facility made available under this Agreement as described in Clause 2 (The Facility). “Facility Office” means the office or offices notified by a Lender to the Agent in writing on or before the date it becomes a Lender (or, following that date, by not less than five Business Days' written notice) as the office or offices through which it will perform its obligations under this Agreement, provided that a Lender shall not nominate more than two Facility Offices simultaneously. “Factoring Agreement” means the factoring agreement entered into between, inter alia, Constellium Neuf Brisach and Constellium Issoire as sellers and Factofrance as factor on 4 January 2011, as amended and restated on 3 December 2015 and as amended and/or restated from time to time (including, for the avoidance of doubt, as amended after the date hereof in order to provide for the transfer of receivables on a full recourse basis). “FATCA” means: (a) sections 1471 to 1474 of the Code or any associated regulations; (b) any treaty, law or regulation of any other jurisdiction, or relating to an intergovernmental agreement between the US and any other jurisdiction, which (in either case) facilitates the implementation of any law or regulation referred to in paragraph (a) above; or (c) any agreement pursuant to the implementation of any treaty, law or regulation referred to in paragraphs (a) or (b) above with the US Internal Revenue Service, the US government or any governmental or taxation authority in any other jurisdiction.


 
07/16927352_14 7 “FATCA Application Date” means: (a) in relation to a “withholdable payment” described in section 1473(1)(A)(i) of the Code (which relates to payments of interest and certain other payments from sources within the US), 1 July 2014;or (b) in relation to a “passthru payment” described in section 1471(d)(7) of the Code not falling within paragraph (a) above, the first date from which such payment may become subject to a deduction or withholding required by FATCA. “FATCA Deduction” means a deduction or withholding from a payment under a Finance Document required by FATCA. “FATCA Exempt Party” means a Party that is entitled to receive payments free from any FATCA Deduction. “Fee Letter” means any letter or letters dated on or about the date of this Agreement between the Company and any Administrative Party setting out any of the fees referred to in Clause 11 (Fees). “Fight Against Money Laundering and Financing of Terrorism Regulations” means (i) any French legal and regulatory provisions relating to fight against money laundering, including but not limited to those set forth in Book III, Title II “Des autres atteintes aux biens” of the French Code pénal, and those relating to fight against financing of terrorism in particular those included in Book IV, Title II “Du Terrorisme” of the French Code pénal and those included in Book V, Title VI “Obligations relatives à la lutte contre le blanchiment des capitaux, le financement des activités terroristes, les lotteries, jeux et paris prohibés et l’évasion et la fraude fiscale” of the French Code monétaire et financier and (ii) the foreign regulations relating to fight against money laundering and financing of terrorism, to the extent these measures are applicable. “Finance Document” means this Agreement, any Fee Letter, any Security Document and any other document designated as such by the Agent and the Company. “Finance Lease” means any lease or hire purchase contract, a liability under which would, in accordance with the Accounting Principles, be treated as a balance sheet liability (other than a lease or hire purchase contract which would, in accordance with the Accounting Principles in force prior to 1 January 2019, have been treated as an operating lease). “Finance Party” means the Agent, the Security Agent, the Coordinator, or a Lender. “Financial Indebtedness” means any indebtedness for or in respect of: (a) moneys borrowed; (b) any amount raised by acceptance under any acceptance credit facility or dematerialised equivalent; (c) any amount raised pursuant to any note purchase facility or the issue of bonds, notes, debentures, loan stock or any similar instrument (but not Trade Instruments); (d) the amount of any liability in respect of any Finance Lease (e) receivables sold or discounted (other than any receivables to the extent they are sold on a non-recourse basis pursuant to the Factoring Agreement or pursuant to any Equivalent Working Capital Financing); (f) any amount raised under any other transaction (including any forward sale or purchase agreement) of a type not referred to in any other paragraph of this definition having the commercial effect of a borrowing; (g) any derivative transaction entered into in connection with protection against or benefit from fluctuation in any rate or price (and, when calculating the value of any derivative transaction, only the marked to market value (or, if any actual amount is due as a result of the termination or close-out of that derivative transaction, that amount) shall be taken into account);


 
07/16927352_14 8 (h) any counter-indemnity obligation in respect of a guarantee, indemnity, bond, standby or documentary letter of credit or any other instrument (but not, in any case, Trade Instruments) issued by a bank or financial institution in respect of an underlying liability of an entity which is not Constellium SE or a member of the Group which liability would fall within one of the other paragraphs of this definition; and (i) (without double counting) the amount of any liability in respect of any guarantee or indemnity for any of the items referred to in paragraphs (a) to (h) above. “French State Guarantee” means the guarantee granted by the French State (acting through Bpifrance Financement SA) in accordance with law n° 2020-289 dated 23 March 2020 and a ministerial order (arrêté) dated 23 March 2020 in respect of 80% of the initial amount outstanding of the Loan. “French Subsidiary” means any Subsidiary of the Company incorporated under the laws of France. “Funding Rate” means any individual rate notified by a Lender to the Agent pursuant to paragraph 10.4.1(B) of Clause 10.4 (Cost of funds). “Group” means the Company and its Subsidiaries for the time being. “High Yield Financings” means the following high yield bonds issues made by Constellium SE: (a) the USD 400,000,000 unsecured senior notes due 2024 and EUR 300M unsecured senior notes due 2021, each issued on May 2014; (b) the USD 650,000,000 unsecured senior notes due 2025 issued on February 2017; (c) the USD 500,000,000 unsecured notes and EUR 400,000,000 unsecured notes due 2026 issued on November 2017; and (d) any other notes issued by Constellium SE for the purpose of refinancing any of the notes listed in (a) to (c) above. “Holding Company” means, in relation to a company or corporation, any other company or corporation in respect of which it is a Subsidiary. “IFRS” means international accounting standards within the meaning of the IAS Regulation 1606/2002 to the extent applicable to the relevant financial statements. “Initial Material Subsidiaries” means Constellium France Holdco, Constellium Issoire and Constellium Neuf Brisach. “Initial Termination Date” means the date falling one year after the Utilisation Date. “Intellectual Property” means, in relation to the Company or any Material Subsidiary: (a) any patents, trademarks, service marks, designs, business names, copyrights, database rights, design rights, domain names, moral rights, inventions, confidential information, knowhow and other intellectual property rights and interests (which may now or in the future subsist), whether registered or unregistered; and (b) the benefit of all applications and rights to use such assets of the Company or any Material Subsidiary (which may now or in the future subsist). “Interest Cover Ratio” means, in respect of any Relevant Period, the ratio of Consolidated EBITDA to Consolidated Net Finance Expenses for that Relevant Period. “Interest Period” means, in relation to the Loan, each period determined in accordance with Clause 9 (Interest Periods) and, in relation to an Unpaid Sum, each period determined in accordance with Clause 8.3 (Default interest).


 
07/16927352_14 9 “Interpolated Screen Rate” means, in relation to the Loan, the rate (rounded to the same number of decimal places as to the two relevant Screen Rates) which results from interpolating on a linear basis between: (a) the applicable Screen Rate for the longest period (for which that Screen Rate is available) which is less than the Interest Period of the Loan; and (b) the applicable Screen Rate for the shortest period (for which that Screen Rate is available) which exceeds the Interest Period of the Loan, each as of the Specified Time for euro. “Inventory Facility Agreement” means the facility agreement dated 21 April 2017, between; among others, Constellium Issoire and Constellium Neuf Brisach as borrowers, Factofrance as agent, and certain financial institutions named therein, as amended from time to time. “Joint Venture” means any joint venture entity, whether a company, unincorporated firm, undertaking, association, joint venture or partnership or any other entity. “Lender” means: (a) any Original Lender; and (b) any entity (excluding, for the avoidance of doubt, any natural person) which has become a Party as a “Lender” in accordance Clause 22 (Changes to the Lenders), which in each case has not ceased to be a Party as such in accordance with the terms of this Agreement. “Legal Reservations” has the meaning given to this term in Clause 17.2 (Binding obligations). “Letter to the Trésor” means the attestation et engagement sur l’honneur dated 5 May 2020 addressed by the legal representatives of the Company to the Trésor on or prior to the Signing Date together with a copy the draft of the Agreement. “Leverage” means, in respect of any Relevant Period, the ratio of Total Net Debt on the Testing Date to Consolidated EBITDA for that Relevant Period. “LMA” means the Loan Market Association. “Loan” means the Loan made or to be made under the Facility or the principal amount outstanding for the time being of that Loan. “Majority Lenders” means a Lender or Lenders whose Commitments aggregate more than 66⅔ per cent. of the Total Commitments (or, if the Total Commitments have been reduced to zero, aggregated more than 66⅔ per cent. of the Total Commitments immediately prior to the reduction). “Management Business Plan” means the business plan of the Group prepared by the Company and approved by the Agent (acting on behalf of all the Lenders) on or before the date of this Agreement. “Margin” means: (a) until the Initial Termination Date: the Opening Margin; and, thereafter (b) if the Company exercises its rights under Clause 6.2 (Extension option): the Opening Margin, increased by 50 bps per annum for each year of the Extension (the “Extension Margin”), provided that: (i) if the Leverage (as set out in any Compliance Certificate) is less than 4.0x but in excess of 3.0x, the Extension Margin will be reduced by 10 bps per annum for the period (the “relevant period”) starting on the first day of the Interest Period falling immediately after the date on which the relevant Compliance Certificate is delivered to the Agent pursuant to Clause 18.2 (Compliance Certificate) until the end of the Interest Period


 
07/16927352_14 10 during which a new Compliance Certificate is delivered to the Agent pursuant to Clause 18.2 (Compliance Certificate); and (ii) if the Leverage (as set out in any Compliance Certificate) is equal to or less than 3.0x, the Extension Margin will be reduced by 20 bps per annum during the relevant period, subject always to the provisions of paragraph (c) below; and (c) the Extension Margin (as adjusted pursuant to paragraph (b) above) shall be reviewed upwards by five basis points (a “Step-Up”) per notch downgrade of the corporate rating assigned by Moody's or S&P to Constellium SE, provided that: (i) any Step-Up shall apply to the Interest Period immediately following the publication of the relevant rating downgrade (the “reset date”); (ii) if the effect of the above would be to cause the Margin to increase by more than one Step-Up in relation to any Interest Period, then the Margin will increase by one Step-Up only in relation to that Interest Period; and (iii) for the avoidance of doubt, any Step-Up shall be cancelled in case of subsequent upgrade of the corporate rating assigned by Moody's or S&P to Constellium SE. “Material Adverse Effect” means a material adverse effect on: (a) the business, operation, property or financial condition of the Company and the Group taken as a whole; or (b) the ability of the Company to perform or comply with its payment or other material obligations under the Finance Documents, provided that the consequences of the Covid-19 outbreak on the financial condition of the Company and the Group shall be deemed to have no such material adverse effect. “Material Subsidiaries” means: (a) the Initial Material Subsidiaries; and (b) as from the Compliance Certificate delivered in relation to the financial year ending on 31 December 2020, as the case may be, any other French Subsidiary of the Company designated by the Company as a Material Subsidiary in the most recent Compliance Certificate, so that the Material Subsidiaries account for at least 85% of the portion of the Consolidated EBITDA generated by the French Subsidiaries. “Month” means a period starting on one day in a calendar month and ending on the numerically corresponding day in the next calendar month, except that: (a) (subject to paragraph (c) below) if the numerically corresponding day is not a Business Day, that period shall end on the next Business Day in that calendar month in which that period is to end if there is one, or if there is not, on the immediately preceding Business Day; (b) if there is no numerically corresponding day in the calendar month in which that period is to end, that period shall end on the last Business Day in that calendar month; and (c) if an Interest Period begins on the last Business Day of a calendar month, that Interest Period shall end on the last Business Day in the calendar month in which that Interest Period is to end. The above rules will only apply to the last Month of any period. “Net Financial Interest” means, for any Relevant Period, the aggregate amount of the interests received or paid on loans, receivables and debts measured at amortised cost, calculated on a consolidated basis, in respect of that Relevant Period, provided that all off


 
07/16927352_14 11 balance sheet liabilities in respect of factoring facilities granted to Constellium SE or members of the Group shall not be taken into account for the purpose of this definition. “New Lender” has the meaning given to that term in Clause 22 (Changes to the Lenders). “Non-Group Entity” means any investment or entity (which is not itself Constellium SE or a member of the Group) (including associates and Joint Ventures) in which any member of the Group or Constellium SE has an ownership interest. “Non-Cooperative Jurisdiction” means a “non-cooperative state or territory” (Etat ou territoire non coopératif) as set out in the list referred to in article 238-0 A of the French Code général des impôts, as such list may be amended from time to time. “Opening Margin” means 130 bps per annum. “Original Financial Statements” means: (a) the audited consolidated financial statements of Constellium SE for the financial year ended 31 December 2019; (b) the audited financial statements of the Company and Constellium France Holdco for the financial year ended 31 December 2019; and (c) the unaudited financial statements of Constellium Issoire and Constellium Neuf Brisach, to the extent available on or before the date of this Agreement, for the financial year ended 31 December 2019 or otherwise, the audited financial statements of Constellium Issoire and Constellium Neuf Brisach for the financial year ended 31 December 2018. “Other PGE Loan” means any PGE Loan granted to the Company other than the Loan. “Participating Member State” means any member state of the European Union that has the euro as its lawful currency in accordance with legislation of the European Union relating to Economic and Monetary Union. “Party” means a party to this Agreement. “Pension Items” means any income or charge attributable to a post-employment benefit scheme other than the current service costs attributable to the scheme. “Permitted Acquisition” means any acquisition of fixed assets which is: (a) an acquisition by a member of the Group of an asset sold, leased, transferred or otherwise disposed of by another member of the Group in circumstances constituting a Permitted Disposal; (b) an acquisition of shares or securities pursuant to a Permitted Share Issue; (c) any acquisition of any shares or securities owned by minority shareholders in members of the Group; (d) an acquisition of securities which are cash equivalent investments for treasury management purposes; (e) an acquisition or redemption of shares (directly or indirectly) of directors and employees whose appointment and/or contract is terminated up to an aggregate principal amount which does not at any time exceed €5,000,000 (or its equivalent in other currencies); (f) any acquisition of shares following the conversion of an intra-Group loan into equity; (g) an acquisition of the share capital or analogous ownership interests in a limited liability entity (including by way of formation) which has not traded prior to the close of the acquisition; and (h) an acquisition of all or part of the issued share capital of a limited liability company or (if the acquisition is made by a limited liability company whose sole purpose is to make the acquisition) a business or undertaking carried on as a going concern, provided that:


 
07/16927352_14 12 (i) the proposed acquisition takes place after the Initial Termination Date; and (j) immediately following the completion of the proposed acquisition, the Leverage for the most recent Relevant Period (calculated on a pro forma basis, taking into account the consideration for the proposed acquisition and the financial statements of the target company (consolidated if it has Subsidiaries) for such period) is not greater than 4.0x, provided that this condition shall not apply so long as the aggregate consideration paid for all such acquisitions (together with the consideration paid for joint venture investments referred to in paragraph (d) of the definition of Permitted Joint Venture) is not greater than €30,000,000 (or its equivalent in any other currency or currencies) at any time over the life of the Loan. “Permitted Disposal” means any sale, lease, licence, transfer or other disposal which, except in the case of paragraph (b), is on arm's length terms: (a) of assets (including, for the avoidance of doubt, metal, spare parts and tooling but excluding any other piece of machinery), made by any member of the Group in the ordinary course of trading of the disposing entity; (b) whether or not made on an arm's length basis, of any asset by a member of the Group to another member of the Group, except (without prejudice to the other limbs of this definition) for the disposal of any fixed asset by a Material Subsidiary to a member of the Group which is not incorporated in France; (c) of assets pursuant to the Factoring Agreement, the Inventory Facility Agreement or any Equivalent Working Capital Financing; (d) of an intra-Group loan as a result of the conversion of such intra-Group loan into equity pursuant to paragraph (f) of the definition of Permitted Acquisition; (e) of Treasury Transactions; (f) of assets which are seized, expropriated, or acquired by compulsory purchase by or by the order of any central or local governmental agency or authority which individually or together would not result in a breach of Clause 21.12 (Expropriation); (g) of assets (other than shares or businesses) in exchange for other assets comparable or superior as to type, value and quality (other than an exchange of a non-cash asset for cash); (h) of obsolete or redundant vehicles, plant and equipment for cash; (i) of cash equivalent investments for cash or in exchange for other cash equivalent investments; (j) constituted by a licence of intellectual property rights permitted by Clause 20.18 (Intellectual Property); (k) of assets to a Joint Venture, to the extent permitted by Clause 20.9 (Joint ventures) or of an interest in a Joint Venture to the extent required by the terms of the arrangements in relation to that Joint Venture between the Joint Venture parties; (l) arising as a result of any Permitted Security or Permitted Transaction; and (m) of assets for cash where the higher of the market value and net consideration receivable (when aggregated with the higher of the market value and net consideration receivable for any other sale, lease, licence, transfer or other disposal not allowed under the preceding paragraphs or as a Permitted Transaction) does not exceed €30,000,000 (or its equivalent) in total during the term of this Agreement and does not exceed €10,000,000 (or its equivalent) in any financial year of the Company.


 
07/16927352_14 13 “Permitted Financial Indebtedness” means Financial Indebtedness: (a) incurred by any member of the Group and existing on the date of this Agreement, as listed in Schedule 6 (Existing Financial Indebtedness and Existing Security) in respect of the Company, the Initial Material Subsidiaries and any Subsidiary that raised Financial Indebtedness under state support schemes similar to the Loan documented under the Agreement; (b) arising under the Finance Documents, the Factoring Agreement, the Inventory Facility Agreement or an Equivalent Working Capital Financing; (c) arising under (i) a foreign exchange transaction for spot or forward delivery entered into in connection with protection against fluctuation in currency rates where that foreign exchange exposure arises in the ordinary course of trade, but not a foreign exchange transaction for investment or speculative purposes or (ii) commodities derivative transactions (including any forward or futures relating to metal or other commodities) entered into in the normal course of business; (d) arising under a Permitted Loan or a Permitted Guarantee or as permitted by Clause 20.19 (Treasury Transactions); (e) of any person acquired by a member of the Group after the Signing Date pursuant to a Permitted Acquisition which is incurred under arrangements in existence at the date of acquisition, but not incurred or increased or having its maturity date extended in contemplation of, or since, that acquisition, and outstanding only for a period of three months following the date of acquisition; (f) Financial Indebtedness arising as a result of daylight exposures of any member of the Group in respect of banking arrangements entered into in the ordinary course of its treasury activities; (g) local working capital and overdraft facilities provided to members of the Group provided that such local working capital and overdraft facilities provided to Company and the Material Subsidiaries (other than those mentioned in paragraph (b) above, as well as any intra-group facility) shall not exceed an aggregate amount of up to €30,000,000 at any time; (h) any earn out arrangement in relation to a Permitted Acquisition (to the extent that the earn out arrangement itself constitutes Financial Indebtedness); (i) under Finance Leases of vehicles, plant, equipment or computers, provided that the aggregate capital value of all such items so leased under outstanding leases by the Company and the Material Subsidiaries does not exceed €30,000,000 (or its equivalent in other currencies) at any time; and (j) not permitted by the preceding paragraphs or as a Permitted Transaction provided that the outstanding principal amount of which does not exceed €50,000,000 (or its equivalent in other currencies) in aggregate for the Company and the Material Subsidiaries at any time. “Permitted Guarantee” means: (a) any guarantee which, if it were a loan, would be a Permitted Loan to the extent the issuer of the relevant guarantee would have been entitled to make a loan in an equivalent amount under the definition of Permitted Loan to the person whose obligations are so guaranteed; (b) any guarantee of any person acquired by a member of the Group after the Signing Date pursuant to a Permitted Acquisition which is incurred under arrangements in existence at the date of acquisition, but not incurred or increased or having its maturity date extended in contemplation of, or since, that acquisition, and outstanding only for a period of three months following the date of acquisition; (c) guarantees of Treasury Transactions which are permitted under this Agreement;


 
07/16927352_14 14 (d) guarantees to landlords and/or lessors under financial lease transactions and counter indemnities in favour of financial institutions which have guaranteed rent obligations of a member of the Group; (e) the endorsement of negotiable instruments in the ordinary course of trade; (f) any performance or similar bond guaranteeing performance by a member of the Group under any contract entered into in the ordinary course of trade; (g) any guarantee given by a member of the Group in respect of the obligations or Financial Indebtedness of another member of the Group, provided that a Material Subsidiary may issue guarantees under this paragraph (g) in respect of the obligations of another member of the Group incorporated under the laws of France only; (h) any guarantee given by a member of the Group in respect of the obligations of a Joint Venture, to the extent permitted by Clause 20.9 (Joint ventures); (i) any guarantee permitted under Clause 20.15 (Financial Indebtedness); (j) any guarantee given by a member of the Group in respect of the High Yield Financings; (k) any guarantee given in respect of the netting or set-off arrangements permitted pursuant to paragraph (f) of the definition of “Permitted Security”; and (l) any indemnity given in the ordinary course of the documentation of an acquisition or disposal transaction which is a Permitted Acquisition or Permitted Disposal which indemnity is in a customary form and subject to customary limitations. “Permitted Joint Venture” means (i) any investment (in any form) in any Joint Venture existing on the date of this Agreement (whether or not such investment was provided for in the relevant existing joint venture agreement), and (ii) any investment in any other Joint- Venture where: (a) the Joint Venture is a limited liability corporation and is incorporated, or established, and carries on its principal business, in the European Union, the United Kingdom or the United States of America; (b) the Joint Venture is engaged in a business substantially the same as that carried on by the Group; (c) the completion of any such investment takes place after the Initial Termination Date; and (d) immediately following the completion of the proposed investment, the Leverage for the most recent Relevant Period (calculated on a pro forma basis, taking into account the consideration for the proposed investment) is not greater than 4.0x, provided that this condition shall not apply so long as the aggregate consideration paid for all such joint venture investment (together with the consideration paid for acquisitions referred to paragraph (c) of the definition of Permitted Acquisition) is not greater than €30,000,000 (or its equivalent in any other currency or currencies). “Permitted Loan” means: (a) any trade credit extended by any member of the Group to its customers on normal commercial terms and in the ordinary course of its trading activities; (b) Financial Indebtedness which is referred to in the definition of, or otherwise constitutes, Permitted Financial Indebtedness (except under paragraph (d) of that definition); (c) a loan made to a Joint Venture to the extent permitted under Clause 20.9 (Joint ventures); (d) a loan made by a member of the Group to another member of the Group, provided that a Material Subsidiary (other than Constellium France Holdco) may


 
07/16927352_14 15 not grant loans to a member of the Group which is not incorporated under the laws of France save in the context of the cash pooling arrangements of the Group; (e) a loan made by a member of the Group to an employee or director of any member of the Group if the amount of such loans made by the Company and the Material Subsidiaries when aggregated with the amount of all loans to employees and directors by the Company and the Material Subsidiaries does not exceed €5,000,000 (or its equivalent in other currencies) at any time; and (f) any other loan so long as the aggregate amount of the Financial Indebtedness under any such loans made by the Company and the Material Subsidiaries does not exceed €10,000,000 (or its equivalent in other currencies) at any time. “Permitted Payment” means a payment to Constellium SE (including by way of cash dividends, interim dividends or distribution of reserves, repayment of equity, reduction of capital, loan, fee, charge or the cash payment of interest on, or repayment or prepayment of principal in respect of, shareholder debt, redemption, set-off, share buy-back, acquisition of liabilities or other discharge), provided that: (a) it is to fund the service of the financing costs of Constellium SE in respect of its Financial Indebtedness; (b) it is to fund administrative costs, directors’ and employees’ remuneration, taxes, professional fees, regulatory costs, corporate maintenance costs and other similar costs incurred by Constellium SE up to aggregate amount per financial year of the Company not in excess of €5,000,000 (or its equivalent in other currencies); or (c) it is to fund a share buy-back or share issuance by Constellium SE in the context of a free share plan or any other employment benefit scheme. “Permitted Security” means: (a) any Security or Quasi-Security granted by a member of the Group and existing as at the date of this Agreement as listed, in respect of the Company and the Initial Material Subsidiaries only, in Schedule 6 (Existing Financial Indebtedness and Existing Security); (b) any lien arising by operation of law and in the ordinary course of trading and not as a result of any default or omission by any member of the Group; (c) any netting or set-off arrangement entered into by any member of the Group in the ordinary course of its banking arrangements for the purpose of netting debit and credit balances of members of the Group; (d) any payment or close out netting or set-off arrangement pursuant to any Treasury Transaction or foreign exchange transaction entered into by a member of the Group which constitutes Permitted Financial Indebtedness, excluding any Security or Quasi-Security under a credit support arrangement; (e) any Security or Quasi-Security over or affecting any asset acquired by a member of the Group after the Signing Date pursuant to a Permitted Acquisition if: (i) the Security or Quasi-Security was not created in contemplation of the acquisition of that asset by a member of the Group; (ii) the principal amount secured has not been increased in contemplation of or since the acquisition of that asset by a member of the Group; and (iii) the Security or Quasi-Security is removed or discharged within three months of the date of acquisition of such asset;


 
07/16927352_14 16 (f) any Security or Quasi-Security over or affecting any asset of any company which becomes a member of the Group after the Signing Date, where the Security or Quasi-Security is created prior to the date on which that company becomes a member of the Group if: (i) the Security or Quasi-Security was not created in contemplation of the acquisition of that company; (ii) the principal amount secured has not increased in contemplation of or since the acquisition of that company; and (iii) the Security or Quasi-Security is removed or discharged within three months of that company becoming a member of the Group; (g) any Security or Quasi-Security arising under any retention of title, hire purchase or conditional sale arrangement or arrangements having similar effect in respect of goods supplied to a member of the Group in the ordinary course of trading and on the supplier's standard or usual terms and not arising as a result of any default or omission by any member of the Group; (h) any Quasi-Security arising as a result of a disposal which is a Permitted Disposal; (i) any Security or Quasi-Security arising as a consequence of any Finance Lease permitted pursuant to paragraph (i) of the definition of Permitted Financial Indebtedness; (j) any Security arising under or in connection with the Factoring Agreement or the Inventory Facility Agreement or any Equivalent Working Capital Financing; (k) any Security (other than Security over the assets pledged pursuant to the Transaction Security) arising under or in connection with the High Yield Financings; (l) any Security securing indebtedness the outstanding principal amount of which (when aggregated with the outstanding principal amount of any other indebtedness which has the benefit of Security given by the Company or any Material Subsidiary other than any permitted under paragraphs (a) to (k) above) does not exceed €10,000,000 (or its equivalent in other currencies) at any time over the life of the Loan, provided that no Security or Quasi-Security over the shares of Constellium France Holdco shall be permitted at any time. “Permitted Share Issue” means an issue of: (a) ordinary shares by the Company to Constellium SE, paid for in full in cash upon issue and which by their terms are not redeemable and where (i) such shares are of the same class and on the same terms as those initially issued by the Company and (ii) such issue does not lead to a Change of Control of the Company; and (b) shares by a member of the Group (other than the Company) to its immediate Holding Company (where if the existing shares of the relevant member of the Group are the subject of the Transaction Security the newly-issued shares also become subject to the Transaction Security on the same terms). “Permitted Transaction” means: (a) any disposal required, Financial Indebtedness incurred, guarantee, indemnity or Security or Quasi-Security given, or other transaction arising, under the Finance Documents, the Factoring Agreement, the Inventory Facility Agreement, any Equivalent Working Capital Financing or the High Yield Financings; (b) the solvent liquidation or reorganisation of any member of the Group (other than the Company) so long as, in the case of a Material Subsidiary (i) any payments or assets distributed as a result of such liquidation or reorganisation are distributed to other members of the Group and (ii) any such distribution is made to other French Subsidiaries or the Company; or


 
07/16927352_14 17 (c) transactions (other than (i) any sale, lease, license, transfer or other disposal and (ii) the granting or creation of Security, (iii) the incurring or permitting to subsist of Financial Indebtedness or (iv) the issue of shares or warrants granting access to shares) conducted in the ordinary course of trading on arm's length terms. “Person” has the meaning given to that term in Clause 17.16 (Sanctions, anti-money laundering and anti-corruption laws). “PGE Q&A” means the document entitled “FAQ – Prêt Garanti par l’Etat” dated 22 April 2020 published by the French ministry of finance. “Qualifying Lender” has the meaning given to it in Clause 12 (Tax gross-up and indemnities). “Quasi-Security” has the meaning given to it in Clause 20.5 (Negative pledge). “Quotation Day” means, in relation to any period for which an interest rate is to be determined, two TARGET Days before the first day of that period (unless market practice differs in the Relevant Market for that currency, in which case the Quotation Day for that currency will be determined by the Agent in accordance with market practice in the Relevant Market (and if quotations would normally be given on more than one day, the Quotation Day will be the last of those days)). “Reference Bank Quotation” means any quotation supplied to the Agent by a Reference Bank. “Reference Bank Rate” means, in relation to EURIBOR, the arithmetic means of the rates (rounded upwards to four decimal places) as supplied to the Agent at its request by the Reference Banks (a) (other than where paragraph (b) below applies) as the rate at which the relevant Reference Bank believes one prime bank is quoting to another prime bank for interbank term deposits in euro within the Participating Member States for the relevant period; or (b) if different, as the rate (if any and applied to the relevant Reference Bank and the relevant period) which contributors to the applicable Screen Rate are asked to submit to the relevant administrators. “Reference Banks” means the principal office in Paris of financial institutions to be appointed by the Agent in consultation with the Company. “Related Fund” in relation to a fund (the “first fund”), means a fund which is managed or advised by the same investment manager or investment adviser as the first fund or, if it is managed by a different investment manager or investment adviser, a fund whose investment manager or investment adviser is an Affiliate of the investment manager or investment adviser of the first fund. “Relevant Market” means, in relation to euro, the European interbank market. “Relevant Period” means each period of twelve months ending on each Testing Date. “Repayment Date” means any date where a repayment instalment of the Loan is paid in accordance with Clause 6.2 (Extension option). “Termination Date” means the Initial Termination Date or the extended termination date determined pursuant to Clause 6.2 (Extension option). “Repeating Representations” means each of the representations set out in Clause 17 (Representations) except those made under Clauses 17.8 (Deduction of Tax) to 17.15 (Environmental laws) and under Clauses 17.17 (Security and financial indebtedness) to 17.24 (No proceedings). “Representative” means any delegate, agent (mandataire), manager, administrator, nominee, attorney, trustee or custodian. “Sanctions” means any economic or trade sanctions or restrictive measures enacted, administered, imposed or enforced by the U.S. Department of the Treasury’s Office of


 
07/16927352_14 18 Foreign Assets Control (OFAC) and/or the U.S. Department of State and/or the United Nations Security Council and/or the European Union (any present or future member state thereof) and/or the French Republic and/or Her Majesty’s Treasury and/or other relevant sanctions authority enacting restrictive measures, to the extent these measures are applicable. “Sanctioned Country” means any country or territory that is subject to general restrictions relating to exports, imports, financings or investments under the Sanctions. As at the date hereof, the Sanctioned Countries are North Korea, Cuba, Iran, Sudan, Syria and the territory of Crimea, it being specified that this list may be amended from time to time in accordance with the terms of this Agreement. “Sanctioned Person” has the meaning given to that term in Clause 17.16 (Sanctions, anti- money laundering and anti-corruption laws). “Screen Rate” means the euro interbank offered rate administered by the European Money Markets Institute (or any other person which takes over the administration of that rate) for the relevant period displayed (before any correction, recalculation or republication by the administrator) on page EURIBOR01 of the Thomson Reuters screen (or any replacement Thomson Reuters page which displays that rate or on the appropriate page of such other information service which publishes that rate from time to time in place of Thomson Reuters. If such page or service ceases to be available, the Agent may specify another page or service displaying the relevant rate after consultation with the Company. “Security” means a mortgage, charge, pledge, lien or other security interest securing any obligation of any person or any other agreement or arrangement having a similar effect. “Security Documents” means: (a) the first ranking bank accounts pledge agreements entered into between the Company, Constellium Issoire or Constellium Neuf Brisach as pledgor, the Security Agent and the Original Lenders as beneficiaries, documenting the Bank Accounts Pledges, together with the related notification(s) of pledge; (b) the first ranking share pledges agreements entered into between Constellium France Holdco as pledgor, the Security Agent and the Original Lenders as beneficiaries, together with each related déclaration de nantissement de compte de titres financiers, documenting the Share Pledges; and (c) any other document designated as such by the Company and the Security Agent. “Selection Notice” means a notice substantially in the form set out in Part D of Schedule 3 (Requests) given in accordance with Clause 9 (Interest Periods). “Share Pledges” means: (a) the first ranking French law share pledge (nantissement de compte-titres) relating to the shares of Constellium Issoire, granted by Constellium France Holdco (subject to customary guarantee limitations) for the benefit of the Finance Parties pursuant to the terms of the relevant Security Document; and (b) the first ranking French law share pledge (nantissement de compte-titres) relating to the shares of Constellium Neuf Brisach, granted by Constellium France Holdco (subject to customary guarantee limitations) for the benefit of the Finance Parties pursuant to the terms of the relevant Security Document. “Signing Date” means the date of execution of the Agreement. “Specified Time” means a day or time determined in accordance with Schedule 8 (Timetables). “Subsidiary” means in relation to any company, another company which is controlled by it within the meaning of article L.233-3 of the French Code de commerce. “TARGET2” means the Trans-European Automated Real-time Gross Settlement Express Transfer payment system which utilises a single shared platform and which was launched on 19 November 2007.


 
07/16927352_14 19 “TARGET Day” means any day on which TARGET2 is open for the settlement of payments in euro. “Tax” means any tax, levy, impost, duty or other charge or withholding of a similar nature (including any penalty or interest payable in connection with any failure to pay or any delay in paying any of the same). “TEG Letter” means the lettre de taux effectif global referred to in Clause 8.5 (Effective Global Rate (Taux Effectif Global)). “Termination Date” means the Initial Termination Date, as such date may be extended pursuant to the provisions of Clause 6.2 (Extension option). “Testing Date” means 30 June and 31 December of each year. “Total Commitments” means the aggregate of the Commitments, being € 180,000,000 at the date of this Agreement. “Total Net Debt” means, at any time, the aggregate outstanding amount in principal, capital or nominal amount (and any fixed or minimum premium payable on prepayment or redemption) of any Financial Indebtedness of Constellium SE and the members of the Group, but: (a) excluding any Financial Indebtedness in respect of (i) commodities derivative transactions (including any forward or futures relating to metal or other commodities) and (ii) foreign exchange transactions related to operational transactions undertaken in the general course of business, in each case entered into by Constellium SE or any other member of the Group; (b) excluding any such obligations to Constellium SE or any other member of the Group; (c) including, in the case of Finance Leases only, their capitalised value; (d) excluding all off balance sheet liabilities in respect of factoring facilities granted to Constellium SE or the members of the Group; and (e) deducting the aggregate amount of cash and cash equivalent investments held by Constellium SE or any member of the Group at that time, and so that no amount shall be included or excluded more than once. “Trade Instruments” means any performance bonds, advance payment bonds or documentary letters of credit issued in respect of the obligations of any member of the Group arising in the ordinary course of trading of that member of the Group. “Transaction Security” means: (a) the Share Pledges; and (b) the Bank Accounts Pledges. “Transfer Agreement” means an agreement substantially in the form set out in Schedule 4 (Form of Transfer Agreement) or any other form agreed between the Agent and the Company. “Transfer Date” means, in relation to a transfer, the later of: (a) the proposed Transfer Date specified in the relevant Transfer Agreement; and (b) the date on which the Agent executes the Transfer Agreement. “Treasury Transaction” means any derivative transaction entered into in connection with protection against or benefit from fluctuation in any rate or price. “Unpaid Sum” means any sum due and payable but unpaid by the Company under the Finance Documents. “US” means the United States of America.


 
07/16927352_14 20 “US Tax Obligor” means: (a) the Company if resident for tax purposes in the US; or (b) some or all of the Company’s payments under the Finance Documents are from sources within the US for US federal income tax purposes. “Utilisation” means the utilisation of the Facility. “Utilisation Date” means the date of the Utilisation, being the date on which the Loan is to be made. “Utilisation Request” means a notice substantially in the form set out in Part C of Schedule 3 (Requests). “VAT” means: (a) any tax imposed in compliance with the Council Directive of 28 November 2006 on the common system of value added tax (EC Directive 2006/112); and (b) any other tax of a similar nature, whether imposed in a member state of the European Union, in substitution for, or levied in addition to, such tax referred to in paragraph (a) above, or imposed elsewhere. 1.2 Construction 1.2.1 Unless a contrary indication appears, any reference in this Agreement to: (A) the “Agent”, the “Security Agent”, the “Coordinator”, any “Finance Party”, any “Lender” or any “Party” shall be construed so as to include its successors in title, permitted transferees to, or of, its rights and/or obligations under the Finance Documents; (B) “assets” includes present and future properties, revenues and rights of every description; (C) “bps” means a reference to basis points; (D) “cash equivalent investments” means équivalents de trésorerie (as construed pursuant to the Accounting Principles); (E) “corporate reconstruction” includes in relation to any company any contribution of part of its business in consideration of shares (apport partiel d'actifs) and any demerger (scission) implemented in accordance with articles L.236 1 to L.236 24 of the French Code de commerce; (F) “Covid-19” means the public health emergency (état d’urgence sanitaire), as declared by article 4 of French law no. 2020-290 dated 23 March 2020 (and any other similar circumstances occurring concomitantly in a country where a member of the Group is incorporated or has business or trading activities); (G) a “Finance Document” or any other agreement or instrument is a reference to that Finance Document or other agreement or instrument as amended or novated, supplemented, extended or restated; (H) a “fixed asset” means an “actif immobilisé” as this terms in construed under the Accounting Principles (I) a “group of Lenders” includes all the Lenders; (J) “gross negligence” means “faute lourde”; (K) a “guarantee” includes any type of “sûreté personnelle”; (L) “indebtedness” includes any obligation (whether incurred as principal or as surety) for the payment or repayment of money, whether present or future, actual or contingent;


 
07/16927352_14 21 (M) “merger” includes any fusion implemented in accordance with articles L.236-1 to L.236-24 of the French Code de commerce; (N) a “person” includes any individual, firm, company, corporation, government, state or agency of a state or any association, trust, joint venture, consortium, partnership or other entity (whether or not having separate legal personality); (O) a “regulation” includes any regulation, rule, official directive, request or guideline (whether or not having the force of law) of any governmental, intergovernmental or supranational body, agency, department or of any regulatory, self-regulatory or other authority or organisation (and for the avoidance of doubt, the general terms (conditions générales) applicable to the French State Guarantee); (P) a “security interest” includes any type of security (sûreté réelle) and transfer by way of security; (Q) a “transfer” includes any means of transfer of rights and/or obligations under French law; (R) “trustee, fiduciary and fiduciary duty” has in each case the meaning given to such term under any applicable law; (S) “wilful misconduct” means “dol”; (T) a provision of law is a reference to that provision as amended, re- enacted or codified from time to time; and (U) unless a contrary indication appears, a time of day is a reference to Paris time. 1.2.2 The determination of the extent to which a rate is “for a period equal in length” to an Interest Period shall disregard any inconsistency arising from the last day of that Interest Period being determined pursuant to the terms of this Agreement. 1.2.3 Section, Clause and Schedule headings are for ease of reference only. 1.2.4 Unless a contrary indication appears, a term used in any other Finance Document or in any notice given under or in connection with any Finance Document has the same meaning in that Finance Document or notice as in this Agreement. 1.2.5 A Default (other than an Event of Default) is “continuing” if it has not been remedied or waived and an Event of Default is “continuing” if it has not been remedied or waived. 1.3 Currency symbols and definitions “€”, “EUR” and “euro” denote the single currency of the Participating Member States. Section 2 THE FACILITY 2. THE FACILITY 2.1 The Facility Subject to the terms of this Agreement, the Lenders make available to the Company a euro term loan facility in an aggregate amount equal to the Total Commitments. 2.2 Finance Parties' rights and obligations 2.2.1 The obligations of each Finance Party under the Finance Documents are several (conjointes et non solidaires). Failure by a Finance Party to perform its obligations


 
07/16927352_14 22 under the Finance Documents does not affect the obligations of any other Party under the Finance Documents. No Finance Party is responsible for the obligations of any other Finance Party under the Finance Documents. 2.2.2 The rights of each Finance Party under or in connection with the Finance Documents are separate and independent rights and any debt arising under the Finance Documents to a Finance Party from the Company is a separate and independent debt in respect of which a Finance Party shall be entitled to enforce its rights in accordance with paragraph 2.2.3 below. The rights of each Finance Party include any debt owing to that Finance Party under the Finance Documents and, for the avoidance of doubt, any part of the Loan or any other amount owed by the Company which relates to a Finance Party's participation in the Facility or its role under a Finance Document (including any such amount payable to the Agent on its behalf) is a debt owing to that Finance Party by the Company. 2.2.3 A Finance Party may, except as specifically provided in the Finance Documents, separately enforce its rights under or in connection with the Finance Documents. 3. PURPOSE 3.1 Purpose The Company shall apply all amounts borrowed by it under the Facility towards the financing of the working capital and liquidity needs of the members of the Group incorporated under the laws of France. 3.2 Monitoring No Finance Party is bound to monitor or verify the application of any amount borrowed pursuant to this Agreement. 4. CONDITIONS OF UTILISATION 4.1 Initial conditions precedent 4.1.1 Conditions precedent to the entry into force of the Agreement The Agreement will not enter into force unless the Agent has received all of the documents and other evidence listed in Part A of Schedule 2 (Conditions precedent ) in form and substance satisfactory to the Agent and all the Lenders. The Agent shall notify the Company and the Lenders promptly upon being so satisfied. 4.1.2 Conditions precedent to the delivery of the Utilisation Request The Company may not deliver the Utilisation Request unless the Agent has received all of the documents and other evidence listed in Part B of Schedule 2 (Conditions precedent ) in form and substance satisfactory to the Agent (acting upon the instructions of the Lenders). The Agent shall notify the Company promptly upon being so satisfied. 4.1.3 Notification Other than to the extent that the Lenders notify the Agent in writing to the contrary before the Agent gives the notification described in paragraphs 4.1.1 and 4.1.2 above, the Lenders authorise (but do not require) the Agent to give that notification. The Agent shall not be liable for any damages, costs or losses whatsoever as a result of giving any such notification, unless directly caused by its gross negligence or wilful misconduct.


 
07/16927352_14 23 4.2 Further conditions precedent The Lenders will only be obliged to comply with Clause 5.4 (Lenders' participation) if on the date of the Utilisation Request and on the proposed Utilisation Date: 4.2.1 no Default is continuing or would result from the proposed Loan; and 4.2.2 the Repeating Representations to be made by the Company are true in all material respects. 4.3 Conditions precedent for the sole benefit of the Lenders The conditions precedent provided for in Clause 4.1 (Initial conditions precedent) and Clause 4.2 (Further conditions precedent) are stipulated for the sole benefit of the Lenders. 4.4 Maximum number of Loans 4.4.1 The Company may not deliver a Utilisation Request if as a result of the proposed Utilisation, more than one Loan would be outstanding. 4.4.2 The Company may not request that the Loan be divided. Section 3 UTILISATION 5. UTILISATION 5.1 Delivery of a Utilisation Request The Company may utilise the Facility by delivery to the Agent of a duly completed Utilisation Request not later than the Specified Time. 5.2 Completion of a Utilisation Request 5.2.1 Each Utilisation Request is irrevocable and will not be regarded as having been duly completed unless: (A) the proposed Utilisation Date is a Business Day within the Availability Period applicable to the Facility; (B) the currency and amount of the Utilisation comply with Clause 5.3 (Currency and amount); and (C) the proposed Interest Period complies with Clause 9 (Interest Periods). 5.2.2 Only one Loan may be requested in the Utilisation Request. 5.3 Currency and amount 5.3.1 The currency specified in a Utilisation Request must be euro. 5.3.2 The amount of the proposed Loan must be equal to the amount of the Total Commitments. 5.4 Lenders' participation 5.4.1 If the conditions set out in this Agreement have been met, each Lender shall make its participation in each Loan available by the Utilisation Date through its Facility Office. 5.4.2 The amount of each Lender's participation in the Loan will be equal to the proportion borne by its Available Commitment to the Available Facility immediately prior to making the Loan.


 
07/16927352_14 24 5.5 Cancellation of Commitment The Commitments which, at that time, are unutilised shall be immediately cancelled at the end of the Availability Period. Section 4 REPAYMENT, PREPAYMENT AND CANCELLATION 6. REPAYMENT 6.1 Repayment of the Loan 6.1.1 Subject to the provisions of Clause 6.2 (Extension option) and subject to any prepayment made by the Company pursuant to Clause 7 (Prepayment and Cancellation), the Company shall repay the full principal amount of the Loan on the Initial Termination Date. 6.1.2 The Company may not reborrow any part of the Facility which is repaid. 6.2 Extension option 6.2.1 The Company may request an extension of the Initial Termination Date by notifying the Agent in writing (an “Extension Request”) between 90 days and 30 days before the Initial Termination Date for an additional period of one year, two years, three years, four years or five years (the “Extension”). 6.2.2 Within 10 Business Days from receipt of an Extension Request from the Company, the Agent shall notify the Lenders of the receipt of such Extension Request and notify the Company of the Extension. For the avoidance of doubt, no Lender may refuse an Extension, unless all or part of the fees referred to in Clause 11.3 (French State Guarantee fees) and payable by the Company on the Initial Termination Date have not been paid to the Agent (for the account of the Lenders) on that date in accordance with the terms of that Clause. (For the avoidance of doubt, no Extension may take effect until all such fees are paid by the Company.) 6.2.3 If the Company opts for a one-year Extension, the principal amount of the Loan will be repaid in full on the second anniversary date of the Utilisation Date. 6.2.4 If the Company opts for a two-year Extension, the principal amount of the Loan will be repaid as follows: Repayment Date Portion of the Loan to be repaid (%) Second anniversary date of the Utilisation Date 20% Third anniversary date of the Utilisation Date 80% 6.2.5 If the Company opts of a three-year Extension, the principal amount of the Loan will be repaid as follows: Repayment Date Portion of the Loan to be repaid (%) Second anniversary date of the Utilisation Date 20% Third anniversary date of the Utilisation Date 20%


 
07/16927352_14 25 Repayment Date Portion of the Loan to be repaid (%) Fourth anniversary date of the Utilisation Date 60% 6.2.6 If the Company opts for a four-year Extension, the principal amount of the Loan will be repaid as follows: Repayment Date Portion of the Loan to be repaid (%) Second anniversary date of the Utilisation Date 20% Third anniversary date of the Utilisation Date 20% Fourth anniversary date of the Utilisation Date 20% Fifth anniversary date of the Utilisation Date 40% 6.2.7 If the Company opts for a five-year Extension, the principal amount of the Loan will be repaid as follows: Repayment Date Portion of the Loan to be repaid (%) Second anniversary date of the Utilisation Date 20% Third anniversary date of the Utilisation Date 20% Fourth anniversary date of the Utilisation Date 20% Fifth anniversary date of the Utilisation Date 20% Sixth anniversary date of the Utilisation Date 20% 6.2.8 The Extension (regardless of its length) and the agreed amortisation schedule shall apply to the Loan as a whole and to all Lenders existing on the Initial Termination Date (subject to any transfer pursuant to the terms of Clause 22 (Changes to the Lenders)). 7. PREPAYMENT AND CANCELLATION 7.1 Illegality If, in any applicable jurisdiction, it becomes unlawful for any Lender to perform any of its obligations as contemplated by this Agreement or to fund or maintain its participation in the Loan or it becomes unlawful for any Affiliate of a Lender for that Lender to do so: 7.1.1 that Lender shall promptly notify the Agent upon becoming aware of that event; 7.1.2 upon the Agent notifying the Company, each Available Commitment of that Lender will be immediately cancelled; and 7.1.3 to the extent that the Lender's participation has not been transferred pursuant to paragraph 7.11.4 of Clause 7.11 (Right of replacement or repayment and


 
07/16927352_14 26 cancellation in relation to a single Lender), the Company shall repay that Lender's participation in the Loan on the last day of the Interest Period for each Loan occurring after the Agent has notified the Company or, if earlier, the date specified by the Lender in the notice delivered to the Agent (being no earlier than the last day of any applicable grace period permitted by law) and that Lender's corresponding Commitment(s) shall be immediately cancelled in the amount of the participations repaid. 7.2 Change of control If, at any time: 7.2.1 one or several persons (acting in concert as the case may be) acquires more than 50% of the shares and voting rights of Constellium SE; 7.2.2 Constellium SE ceases to hold 100% of the shares and voting rights of the Company; 7.2.3 the Company ceases to hold 100% of the shares and voting rights of Constellium France Holdco; or 7.2.4 Constellium France Holdco ceases to hold 100% of the shares and voting rights of Constellium Issoire or Constellium Neuf Brisach, then: (A) the Company shall promptly notify the Agent upon becoming aware of that event; (B) a Lender shall not be obliged to fund a Utilisation; and (C) if a Lender so requires and notifies the Agent within ten Business Days of the Company notifying the Agent of the event, the Agent shall, by not less than three Business Days' notice to the Company, cancel each Available Commitment of that Lender and declare the participation of that Lender in the Loan, together with accrued interest, and all other amounts accrued or outstanding under the Finance Documents immediately due and payable, whereupon each such Available Commitment will be immediately cancelled, any Commitment of that Lender shall immediately cease to be available for further utilisation and the Loan, accrued interest and other amounts shall become immediately due and payable. 7.3 Debt Capital Markets Issue – Equity Capital Markets Issue 7.3.1 For the purposes of this Clause 7.3: “Issue Proceeds” means the proceeds of any Debt Capital Markets Issue or any Equity Capital Markets Issue and after deducting: (A) any reasonable expenses which are incurred by any member of the Group to persons who are not members of the Group; and (B) any Tax incurred and required to be paid by a member of the Group (as reasonably determined by the relevant member of the Group on the basis of existing rates and taking into account any available credit, deduction or allowance), in each case in relation to any such proceeds. 7.3.2 If any member of the Group receives any Issue Proceeds after 31 December 2021, the Company shall prepay the Loan in an amount equal to any Issue Proceeds on the last day of the Interest Period during which such Issue Proceeds have been received by the relevant member of the Group. 7.3.3 If any Debt Capital Markets Issue or any Equity Capital Markets Issue occurs between the Signing Date and 31 December 2021 and such Issue Proceeds exceed € 300,000,000, the Company shall apply the Issue Proceeds arising


 
07/16927352_14 27 thereunder in excess of € 300,000,000 in prepayment of the Loan on the last day of the first Interest Period after 31 December 2021. 7.4 Disposals 7.4.1 For the purposes of this Clause 7.4: “Disposal” means a sale, lease, licence, transfer, loan or other disposal by the Company or any French Subsidiary of any asset, undertaking or business (whether by a voluntary or involuntary single transaction or series of transactions) falling within paragraph (f), (j) or (m) of the definition of Permitted Disposal. “Disposal Proceeds” means the consideration received by the Company or any French Subsidiary (as applicable) from a third party for any Disposal made it except for Excluded Disposal Proceeds and after deducting: (A) any reasonable expenses which are incurred by the seller with respect to that Disposal to persons who are not members of the Group; and (B) any Tax incurred and required to be paid by the seller in connection with that Disposal (as reasonably determined by the seller, on the basis of existing rates and taking account of any available credit, deduction or allowance). “Excluded Disposal Proceeds” means, for any financial year of the Company, Disposal Proceeds that do not exceed: (A) 1,000,000 Euros (or its equivalent in another currency or currencies) individually; and (B) 20,000,000 Euros (or its equivalent in another currency or currencies) in aggregate with any other Disposal Proceeds received in the relevant financial year. 7.4.2 To the extent not reinvested in the purchase of assets or reinvestment in the business of the Group within 12 months after the end of the financial year of the Company during which the Company or the relevant French Subsidiary (as applicable) received such Disposal Proceeds (or committed to be reinvested within 12 months and actually reinvested within 24 months of the end of such financial year), the Company shall apply all Disposal Proceeds in prepayment of the Loan. 7.4.3 The prepayment shall occur on the last day of the relevant Interest Period during which the relevant 12-month period ends. 7.5 Termination of the Factoring Agreement and/or the Inventory Facility Agreement If, at any time, the Factoring Agreement and/or the Inventory Facility Agreement is terminated before its stated maturity date for any reason whatsoever (unless replaced by an Equivalent Working Capital Financing): 7.5.1 the Company shall promptly notify the Agent upon becoming aware of that event; 7.5.2 no Lender shall be obliged to fund the Loan; and 7.5.3 if a Lender so requires and notifies the Agent within five Business Days of the Company notifying the Agent of the event, the Agent shall, by not less than 90 days' notice to the Company, cancel each Available Commitment of that Lender and declare the participation of that Lender in the Loan, together with accrued interest, and all other amounts accrued or outstanding under the Finance Documents immediately due and payable, whereupon each such Available Commitment will be immediately cancelled, any Commitment of that Lender shall immediately cease to be available for further utilisation and all such outstanding Loan, accrued interest and other amounts shall become immediately due and payable.


 
07/16927352_14 28 7.6 Insurance proceeds 7.6.1 For the purposes of this Clause 7.6: “Excluded Insurance Proceeds” means: (A) insurance proceeds that do not exceed: (1) 1,000,000 Euros (or its equivalent in another currency or currencies) individually; and (2) 20,000,000 Euros (or its equivalent in another currency or currencies) in aggregate with any other insurance proceeds received in the relevant financial year; and (B) any proceeds of an insurance claim which the Company notifies the Agent are, or are to be, applied: (1) to meet a third party claim; (2) to cover operating losses in respect of which the relevant insurance claim was made; or (3) in the replacement, reinstatement and/or repair of the assets or otherwise in amelioration of the loss in respect of which the relevant insurance claim was made, in each case of this paragraph 7.6.1(B), as soon as possible but in any event within 12 months of the end of the financial year of the Company during which the Company or the relevant French Subsidiary (as applicable) received such proceeds (or such proceeds are committed to be reinvested within 12 months and actually reinvested within 24 months of the end of such financial year) or such longer period as the Majority Lenders may agree, after receipt. “Insurance Proceeds” means the proceeds of any insurance claim under any insurance (other than in relation to third party liabilities, or in relation to consequential loss policies that are applied to cover operating losses, loss of profits or business interruption, in relation to directors liability insurance or in relation to insurance for the reimbursement of legal fees) maintained by the Company or any French Subsidiary except for Excluded Insurance Proceeds and after deducting (i) any reasonable expenses in relation to that claim which are incurred by any member of the Group to persons who are not members of the Group and (ii) any tax incurred or reasonably expected to be incurred in connection with that claim. 7.6.2 The Company shall prepay the Loan in an amount equal to all Insurance Proceeds. The prepayment shall occur on the last day of the relevant Interest Period during which the relevant 12-month period referred to in the definition of Excluded Insurance Proceeds ends. 7.7 Excess Cash Flow 7.7.1 For the purposes of this Clause: “Excess Cash Flow” means, for any financial year of Constellium Issoire and Constellium Neuf Brisach for which it is being calculated, and for the first time for the financial year ending 31 December 2022, the aggregated Free Cash Flow of Constellium Issoire and Constellium Neuf Brisach (as set out in the latest available annual financial statements of each of Constellium Issoire and Constellium Neuf Brisach, as reported to Constellium SE for inclusion in the audited annual consolidated financial statements of Constellium SE); and


 
07/16927352_14 29 “Free Cash Flow” means the net cash flow from operating activities less capital expenditure, equity contributions and loans to joint ventures and other investing activities. 7.7.2 Subject to the provisions of paragraph 7.7.3 below, the Company shall apply an amount equal to 50% of the Excess Cash Flow towards repayment of the Loan, on or before the last day of the Interest Period during which the audited annual financial statements of Constellium Issoire and Constellium Neuf Brisach are approved (and for the first time on or before the last day of the Interest Period during which the annual financial statements for the financial year ending 31 December 2022 are approved). 7.7.3 The Company shall have no obligation to make any mandatory prepayment of the Loan referred under paragraph 7.7.2 above before 31 December 2022. 7.8 French State Guarantee If at any time, (i) the French State Guarantee in relation to the Loan is no longer valid or in force or (ii) if the Company receives reasonably satisfactory evidence that the Loan is no longer eligible to the French State Guarantee (other than by reason of a transfer of a Lender's Commitment or participation in the Loan or any other reason directly attributable to any Finance Party), or (iii) the Company is in breach of the undertakings taken in the Letter to the Trésor, for any reason whatsoever: 7.8.1 the Company shall promptly notify the Agent upon becoming aware of that event; 7.8.2 no Lender shall be obliged to fund a Utilisation; and 7.8.3 if a Lender so requires and notifies the Agent within five Business Days of the Company notifying the Agent of the event, the Agent shall, by not less than 90 days' notice to the Company, cancel each Available Commitment of that Lender and declare the participation of that Lender in the Loan, together with accrued interest, and all other amounts accrued or outstanding under the Finance Documents immediately due and payable, whereupon each such Available Commitment will be immediately cancelled, any Commitment of that Lender shall immediately cease to be available for further utilisation and all such outstanding Loan, accrued interest and other amounts shall become immediately due and payable. 7.9 Voluntary cancellation The Company may, if it gives the Agent not less than five Business Days' (or such shorter period as the Majority Lenders may agree) prior notice, cancel the whole or any part (being a minimum amount of €5,000,000) of the Available Facility. Any cancellation under this Clause 7.9 shall reduce the Commitments of the Lenders rateably. 7.10 Voluntary prepayment of the Loan 7.10.1 The Company may, if it gives the Agent not less than five Business Days' (or such shorter period as the Majority Lenders may agree) prior notice, prepay the whole or any part of the Loan (but, if in part, being an amount that reduces the amount of the Loan by a minimum amount of €5,000,000). 7.10.2 The Loan may only be prepaid after the last day of the Availability Period (or, if earlier, the day on which the applicable Available Facility is zero). 7.10.3 Any prepayment under this Clause 7.3 shall satisfy the obligations under Clause 6.1 (Repayment of the Loan).


 
07/16927352_14 30 7.11 Right of replacement or repayment and cancellation in relation to a single Lender 7.11.1 If: (A) any sum payable to any Lender by the Company is required to be increased under Clause 12.2.3 (Tax gross-up) or under an equivalent provision of any Finance Document; or (B) any Lender claims indemnification from the Company under Clause 12.3 (Tax indemnity) or Clause 13.1 (Increased Costs); or (C) any amount payable to any Lender by the Company under a Finance Document is not, or will not be (when the relevant corporate income tax is calculated) treated as a deductible charge or expense for French tax purposes for the Company by reason of that amount being (i) paid or accrued to a Lender incorporated, domiciled, established or acting through the Facility Office situated in a Non-Cooperative Jurisdiction, or (ii) paid to an account opened in the name of or for the benefit of that Lender in a financial institution situated in a Non-Cooperative Jurisdiction, the Company may, whilst the circumstance giving rise to the requirement for that increase, indemnification or non-deductibility for French tax purposes continues, give the Agent notice of cancellation of the Commitment of that Lender and its intention to procure the repayment of that Lender's participation in the Loan or give the Agent notice of its intention to replace that Lender in accordance with Clause 7.11.4 below. 7.11.2 On receipt of a notice of cancellation referred to in Clause 7.11.1 above, the Available Commitment(s) of that Lender shall be immediately reduced to zero. 7.11.3 On the last day of each Interest Period which ends after the Company has given notice of cancellation under Clause 7.11.1 above (or, if earlier, the date specified by the Company in that notice), the Company shall repay that Lender's participation in the Loan and that Lender's corresponding Commitment(s) shall be immediately cancelled in the amount of the participations repaid. 7.11.4 If: (A) any of the circumstances set out in Clause 7.11.1 above apply to a Lender; or (B) the Company becomes obliged to pay any amount in accordance with Clause 7.1 (Illegality) to any Lender, the Company may, on 10 Business Days' prior notice to the Agent and that Lender, replace that Lender by requiring that Lender to (and, to the extent permitted by law, that Lender shall) transfer pursuant to Clause 22 (Changes to the Lenders) all (and not part only) of its rights and obligations under this Agreement to an Eligible Institution which confirms its willingness to assume and does assume all the obligations of the transferring Lender in accordance with Clause 22 (Changes to the Lenders) for a purchase price in cash payable at the time of the transfer in an amount equal to the outstanding principal amount of such Lender's participation in the outstanding Loan and all accrued interest (to the extent that the Agent has not given a notification under Clause 22.9 (Pro rata interest settlement)), Break Costs and other amounts payable in relation thereto under the Finance Documents. 7.11.5 The replacement of a Lender pursuant to Clause 7.11.4 above shall be subject to the following conditions: (A) the Company shall have no right to replace the Agent; (B) neither the Agent nor any Lender shall have any obligation to find a replacement Lender;


 
07/16927352_14 31 (C) in no event shall the Lender replaced under Clause 7.11.4 above be required to pay or surrender any of the fees received by such Lender pursuant to the Finance Documents; and (D) the Lender shall only be obliged to transfer its rights and obligations pursuant to paragraph 7.11.4 above once it is satisfied that it has complied with all necessary “know your customer” or other similar checks under all applicable laws and regulations in relation to that transfer. 7.11.6 A Lender shall perform the checks described in paragraph 7.11.5(D) above as soon as reasonably practicable following delivery of a notice referred to in paragraph 7.11.4 above and shall notify the Agent and the Company when it is satisfied that it has complied with those checks. 7.12 Mandatory prepayment and cancellation in relation to a single Lender If it becomes unlawful for the Company to perform any of its obligations to any Lender under paragraph 12.2.3 of Clause 12.2 (Tax gross-up) or under an equivalent provision of any Finance Document, 7.12.1 the Company shall promptly notify the Agent upon becoming aware of that event; 7.12.2 upon the Agent notifying that Lender, its Commitment(s) will be immediately cancelled; and 7.12.3 the Company shall repay that Lender's participation in the Loan on the last day of each Interest Period which ends after the Company has given notice under Clause 7.12.1 above or, if earlier, the date specified by that Lender in a notice delivered to the Agent (being no earlier than the last day of any applicable grace period permitted by law). 7.13 Restrictions 7.13.1 Any notice of cancellation or prepayment given by any Party under this Clause 6.2.8 shall be irrevocable and, unless a contrary indication appears in this Agreement, shall specify the date or dates upon which the relevant cancellation or prepayment is to be made and the amount of that cancellation or prepayment. 7.13.2 Any prepayment under this Agreement shall be made together with accrued interest on the amount prepaid and, subject to any Break Costs, without premium or penalty. 7.13.3 The Company may not reborrow any part of the Facility which is prepaid. 7.13.4 The Company shall not repay or prepay all or any part of the Loan or cancel all or any part of the Commitments except at the times and in the manner expressly provided for in this Agreement. 7.13.5 No amount of the Total Commitments cancelled under this Agreement may be subsequently reinstated. 7.13.6 If the Agent receives a notice under this Clause 6.2.8 it shall promptly forward a copy of that notice to either the Company or the affected Lender, as appropriate. 7.13.7 If all or part of any Lender's participation in the Loan under the Facility is repaid or prepaid and is not available for redrawing (other than by operation of Clause 4.2 (Further conditions precedent)), an amount of that Lender's Commitment (equal to the amount in euro of the participation which is repaid or prepaid) in respect of that Facility will be deemed to be cancelled on the date of repayment or prepayment. 7.13.8 If, and to the extent that, at any time, any prepayment (other than prepayments pursuant to Clauses 7.1 (Illegality), 7.2 (Change of control) or 7.5 (Termination of the Factoring Agreement and/or the Inventory Facility Agreement) or 7.8 (French State Guarantee)) would be unlawful (including, without limitation, with respect to financial assistance, distributable profit rules, corporate benefits restrictions,


 
07/16927352_14 32 restrictions on upstreaming of cash to enable a prepayment to be made or give rise to a breach of any fiduciary and statutory duties of the directors (or in other circumstances where they are under a material risk of personal liability) of the relevant member of the Group), then there shall be no obligation to make that prepayment. 7.13.9 The Company shall ensure that all French Subsidiaries will use their reasonable endeavors to overcome any restrictions in paragraph 7.13.8 and/or make the relevant prepayment using the other available cash resources of the French Subsidiaries. If at any time those restrictions are removed any relevant proceeds will be applied in prepayment of the Facility at the end of the next Interest Period. 7.14 Application of prepayments Any prepayment of the Loan pursuant to Clause 7.3 (Debt Capital Markets Issue – Equity Capital Markets Issue), 7.4 (Disposals), 7.6 (Insurance proceeds) and 7.7 (Excess Cash Flow) shall be applied pro rata to each Lender's participation in the Loan. Section 5 COSTS OF UTILISATION 8. INTEREST 8.1 Calculation of interest The rate of interest on the Loan for each Interest Period is the percentage rate per annum which is the aggregate of the applicable: 8.1.1 Margin; and 8.1.2 EURIBOR. 8.2 Payment of interest The Company shall pay accrued interest on the Loan on the last day of each Interest Period (and, if the Interest Period is longer than six Months, on the dates falling at six- monthly intervals after the first day of the Interest Period). 8.3 Default interest 8.3.1 If the Company fails to pay any amount payable by it under a Finance Document on its due date, interest shall accrue to the fullest extent permitted by law and without notice (mise en demeure) on the overdue amount from the due date up to the date of actual payment (both before and after judgment) at a rate which, subject to Clause 8.3.2 below, is one per cent. per annum higher than the rate which would have been payable if the overdue amount had, during the period of non-payment, constituted the Loan in the currency of the overdue amount for successive Interest Periods, each of a duration selected by the Agent (acting reasonably). Any interest accruing under this Clause 8.3 shall be immediately payable by the Company on demand by the Agent. 8.3.2 If any overdue amount consists of all or part of the Loan which became due on a day which was not the last day of an Interest Period relating to the Loan: (A) the first Interest Period for that overdue amount shall have a duration equal to the unexpired portion of the current Interest Period relating to the Loan; and (B) the rate of interest applying to the overdue amount during that first Interest Period shall be one per cent. per annum higher than the rate which would have applied if the overdue amount had not become due.


 
07/16927352_14 33 8.3.3 Default interest (if unpaid) arising on an overdue amount will be compounded with the overdue amount only if, within the meaning of Article 1343-2 of the French Code civil, such interest is due for a period of at least one year, but will remain immediately due and payable. 8.4 Notification of rates of interest 8.4.1 The Agent shall promptly notify the relevant Lenders and the Company of the determination of a rate of interest under this Agreement. 8.4.2 The Agent shall promptly notify the Company of each Funding Rate relating to the Loan. 8.5 Effective Global Rate (Taux Effectif Global) For the purposes of articles L. 314-1 to L. 314-5 and R. 314-1 et seq. of the French Code de la consommation and article L. 313-4 of the French Code monétaire et financier, the Parties acknowledge that (i) the effective global rate (taux effectif global) calculated on the date of this Agreement, based on assumptions as to the period rate (taux de période) and the period term (durée de période) and on the assumption that the interest rate and all other fees, costs or expenses payable under this Agreement will be maintained at their original level throughout the term of this Agreement, is set out in a letter from the Agent to the Company and (ii) that letter forms part of this Agreement. the Company acknowledges receipt of that letter. 9. INTEREST PERIODS 9.1 Selection of Interest Periods 9.1.1 The Company may select an Interest Period for the Loan in the Utilisation Request for the Loan or (if the Loan has already been borrowed) in a Selection Notice. 9.1.2 Each Selection Notice for the Loan is irrevocable and must be delivered to the Agent by the Company not later than the Specified Time. 9.1.3 If the Company fails to deliver a Selection Notice to the Agent in accordance with Clause 9.1.2 above, the relevant Interest Period will, subject to Clause 9.2 (Changes to Interest Periods), be six Months. 9.1.4 Subject to this Clause 9 the Company may select an Interest Period of one, three or six Months or of any other period agreed between the Company, the Agent and all the Lenders in relation to the relevant Loan. 9.1.5 An Interest Period for the Loan shall not extend beyond the Termination Date. 9.1.6 Each Interest Period for the Loan shall start on the Utilisation Date or (if already made) on the last day of its preceding Interest Period. 9.2 Changes to Interest Periods If the Agent makes any of the changes to an Interest Period referred to in this Clause 9.2, it shall promptly notify the Company and the Lenders. 9.3 Non-Business Days If an Interest Period would otherwise end on a day which is not a Business Day, that Interest Period will instead end on the next Business Day in that calendar month (if there is one) or the preceding Business Day (if there is not).


 
07/16927352_14 34 10. CHANGES TO THE CALCULATION OF INTEREST 10.1 Unavailability of Screen Rate 10.1.1 Interpolated Screen Rate: If no Screen Rate is available for the Interest Period of the Loan, the applicable EURIBOR shall be the Interpolated Screen Rate for a period equal in length to the Interest Period of the Loan. 10.1.2 Reference Bank Rate: If no Screen Rate is available for EURIBOR for: (A) the currency of the Loan; or (B) the Interest Period of the Loan and it is not possible to calculate the Interpolated Screen Rate, the applicable EURIBOR shall be the Reference Bank Rate as of the Specified Time for the currency of the Loan and for a period equal in length to the Interest Period of the Loan. 10.1.3 Cost of funds: If paragraph 10.1.2 above applies but no Reference Bank Rate is available for the relevant currency or Interest Period there shall be no EURIBOR for the Loan and Clause 10.4 (Cost of funds) shall apply to the Loan for that Interest Period. 10.2 Calculation of Reference Bank Rate 10.2.1 Subject to paragraph 10.2.2, if EURIBOR is to be determined on the basis of a Reference Bank Rate but a Reference Bank does not supply a quotation by the Specified Time, the Reference Bank Rate shall be calculated based on the quotations of the remaining Reference Banks. 10.2.2 If at or about 11.30 a.m. on the Quotation Day, none or only one of the Reference Banks supplies a quotation, there shall be no Reference Bank Rate for the relevant Interest Period. 10.3 Market disruption If before close of business in Paris on the Quotation Day for the relevant Interest Period, the Agent receives notifications from a Lender or Lenders (whose participations in the Loan exceed 40 per cent. of the Loan) that the cost to it of funding its participation in the Loan from whatever source it may reasonably select would be in excess of EURIBOR then Clause 10.4 (Cost of funds) shall apply to the Loan for the relevant Interest Period. 10.4 Cost of funds 10.4.1 If this Clause 10.4 applies, the rate of interest on each Lender's share of the relevant Loan for the relevant Interest Period shall be the percentage rate per annum which is the sum of: (A) the Margin; and (B) the rate notified to the Agent by that Lender as soon as practicable and in any event by close of business on the date falling five Business Days after the Quotation Day (or, if earlier, on the date falling three Business Days before the date on which interest is due to be paid in respect of that Interest Period), to be that which expresses as a percentage rate per annum the cost to the relevant Lender of funding its participation in the Loan from whatever source it may reasonably select. 10.4.2 If this Clause 10.4 applies and the Agent or the Company so requires, the Agent and the Company shall enter into negotiations (for a period of not more than thirty days) with a view to agreeing a substitute basis for determining the rate of interest. 10.4.3 Any alternative basis agreed pursuant to Clause 10.4.2 above shall, with the prior consent of all the Lenders and the Company, be binding on all Parties.


 
07/16927352_14 35 10.4.4 If this Clause 10.4 applies pursuant to Clause 10.3 (Market disruption) and: (A) a Lender's Funding Rate is less than EURIBOR; or (B) a Lender does not supply a quotation by the time specified in paragraph 10.4.1(B) above, the cost to that Lender of funding its participation in the Loan for that Interest Period shall be deemed, for the purposes of paragraph 10.4.4(A) above, to be EURIBOR. 10.5 Notification to Company If Clause 10.4 (Cost of funds) applies the Agent shall, as soon as is practicable, notify the Company. 10.6 Modification and/or discontinuation of certain benchmark rates Without prejudice to any other provisions of this Agreement (including in particular this Clause 10 and Clause 34.4 (Replacement of Screen Rate), each Party acknowledges and agrees for the benefit of the other parties that: 10.6.1 IBOR benchmarks (i) may be subject to methodological or other changes which could affect their value, or (ii) may not comply with applicable laws and regulations (such as the Regulation (EU) 2016/1011 of the European Parliament and of the Council, as amended (EU Benchmarks Regulation)) and/or (iii) may be permanently discontinued; and 10.6.2 the occurrence of any of the aforementioned events and/or a Screen Rate Replacement Event may have adverse consequences which may materially impact the economics of the financing transaction contemplated under this Agreement. 10.7 Break Costs 10.7.1 the Company shall, within three Business Days of demand by a Finance Party, pay to that Finance Party its Break Costs attributable to all or any part of the Loan or Unpaid Sum being paid by the Company on a day other than the last day of an Interest Period for the Loan or Unpaid Sum. 10.7.2 Each Lender shall, as soon as reasonably practicable after a demand by the Agent, provide a certificate confirming the amount of its Break Costs for any Interest Period in which they accrue. 11. FEES 11.1 Fees to Administrative Parties The Company shall pay to the relevant Administrative Parties the fees in the amount and at the times agreed in separate Fee Letter. 11.2 Agency fee The Company shall pay to each of the Agent (for its own account) and the Security Agent (for its own account) an agency fee in the amount and at the times agreed in a Fee Letter. 11.3 French State Guarantee fees 11.3.1 Each Lender shall pay to the Agent, as soon as possible after the date of the Utilisation Request and at the latest on the Utilisation Date, a guarantee fee equal to 0.50% of 80% of its Commitment. 11.3.2 The Agent (for the account of each Lender) shall pay, on the Utilisation Date, to Bpifrance Financement SA, for the account of the French State in its capacity as issuer of the French State Guarantee, a guarantee fee equal to 0.50% of 80% of the outstanding principal amount of the Loan as at the Utilisation Date. For the


 
07/16927352_14 36 avoidance of doubt, if a Lender does not pay that guarantee fee to the Agent by the Utilisation Date, the Agent shall not be obliged to pay to Bpifrance Financement SA, for the account of the French State in its capacity as issuer of the French State Guarantee, the portion of the guarantee fee due by that Lender pursuant to paragraph 11.3.1. The other Lenders will not lose the benefit of the French State Guarantee over the portion of the Loan funded by them. 11.3.3 The Company shall pay to the Agent (for the account of the Lenders), on the Initial Termination Date, a guarantee fee equal to the sum of (i) all amounts paid by the Lenders under paragraph 11.3.1 above and (ii) 0.50% of 20% of the Loan as at the Utilisation Date. The Agent shall , promptly upon receipt of such amounts, allocate them amongst the Lenders pro rata their respective Commitment on the Utilisation Date. 11.3.4 If the Company exercises its rights under Clause 6.2 (Extension option), it shall pay to the Agent (for the account of the Lenders) an additional guarantee fee as per the table below (the “Additional Guarantee Fee”) calculated on a pro rata temporis basis on the outstanding principal amount of the Loan as at the first anniversary of the Signing Date as reduced thereafter in accordance with the amortisation scheduled set out in Clause 6.2 (Extension option): For the first additional year 1.00% For the second additional year 1.00% For the third additional year 2.00% For the fourth additional year 2.00% For the fifth additional year 2.00% 11.3.5 80% of the Additional Guarantee Fee shall be payable upfront on the Initial Termination Date and the remaining 20% be payable on a pro rata temporis basis for any relevant additional year on the first day of that additional year. 11.3.6 The 80% of the Additional Guarantee Fee payable on the Initial Termination Date shall be equal to the amount payable by the Agent (for the account of each Lender) on or around that date to Bpifrance Financement SA for the account of the French State, in its capacity as issuer of the French State Guarantee as per the PGE Order. Section 6 ADDITIONAL PAYMENT OBLIGATIONS 12. TAX GROSS-UP AND INDEMNITIES 12.1 Definitions In this Agreement: “Protected Party” means a Finance Party which is or will be subject to any liability, or required to make any payment, for or on account of Tax in relation to a sum received or receivable (or any sum deemed for the purposes of Tax to be received or receivable) under a Finance Document. “Qualifying Lender” means a Lender which:


 
07/16927352_14 37 12.1.1 fulfils the conditions imposed by French Law in order for a payment of interest not to be subject to (or as the case may be, to be exempt from) any Tax Deduction; or 12.1.2 is a Treaty Lender. “Tax Credit” means a credit against, relief or remission for, or repayment of any Tax. “Tax Deduction” means a deduction or withholding for or on account of Tax from a payment under a Finance Document, other than a FATCA Deduction. “Tax Payment” means either the increase in a payment made by the Company to a Finance Party under Clause 12.2 (Tax gross-up) or a payment under Clause 12.3 (Tax indemnity). “Treaty Lender” means a Lender which: 12.1.3 is treated as resident of a Treaty State for the purposes of the Treaty; 12.1.4 does not carry on business in France through a permanent establishment with which that Lender's participation in the Loan is effectively connected; 12.1.5 is acting from the Facility Office situated in its jurisdiction of incorporation; and 12.1.6 fulfils any other conditions which must be fulfilled under the Treaty by residents of the Treaty State for such residents to obtain exemption from Tax imposed on interest by France, subject to the completion of any necessary procedural formalities. “Treaty State” means a jurisdiction having a double taxation agreement (with France (the “Treaty”), which makes provision for full exemption from Tax imposed by France on interest payments. Unless a contrary indication appears, in this Clause 12 a reference to “determines” or “determined” means a determination made in the absolute discretion of the person making the determination. 12.2 Tax gross-up 12.2.1 The Company shall make all payments to be made by it without any Tax Deduction, unless a Tax Deduction is required by law. 12.2.2 The Company shall promptly upon becoming aware that the Company must make a Tax Deduction (or that there is any change in the rate or the basis of a Tax Deduction) notify the Agent accordingly. Similarly, a Lender shall notify the Agent on becoming so aware in respect of a payment payable to that Lender. If the Agent receives such notification from a Lender it shall notify the Company. 12.2.3 If a Tax Deduction is required by law to be made by the Company, the amount of the payment due from the Company shall be increased to an amount which (after making any Tax Deduction) leaves an amount equal to the payment which would have been due if no Tax Deduction had been required. 12.2.4 A payment shall not be increased under Clause 12.2.3 above by reason of a Tax Deduction on account of Tax imposed by France, if on the date on which the payment falls due: (A) the payment could have been made to the relevant Lender without a Tax Deduction if the Lender had been a Qualifying Lender, but on that date that Lender is not or has ceased to be a Qualifying Lender other than as a result of any change after the date it became a Lender under this Agreement in (or in the interpretation, administration, or application of) any law or double taxation agreement, or any published practice or published concession of any relevant taxing authority; or (B) the relevant Lender is a Treaty Lender and the Company making the payment is able to demonstrate that the payment could have been made


 
07/16927352_14 38 to the Lender without the Tax Deduction had that Lender complied with its obligations under Clause 12.2.7 below, provided that the exclusion for changes after the date a Lender became a Lender under this Agreement in Clause 12.2.4(A) above shall not apply in respect of any Tax Deduction on account of Tax imposed by France on a payment made to a Lender if such Tax Deduction is imposed solely because this payment is made to an account opened in the name of or for the benefit of that Lender in a financial institution situated in a Non-Cooperative Jurisdiction. 12.2.5 If the Company is required to make a Tax Deduction, the Company shall make that Tax Deduction and any payment required in connection with that Tax Deduction within the time allowed and in the minimum amount required by law. 12.2.6 Within thirty days of making either a Tax Deduction or any payment required in connection with that Tax Deduction, the Company shall deliver to the Agent for the Finance Party entitled to the payment evidence reasonably satisfactory to that Finance Party that the Tax Deduction has been made or (as applicable) any appropriate payment paid to the relevant taxing authority. 12.2.7 A Treaty Lender and the Company which makes a payment to which that Treaty Lender is entitled shall co-operate in completing any procedural formalities necessary for the Company to obtain authorisation to make that payment without a Tax Deduction. 12.3 Tax indemnity 12.3.1 The Company shall (within three Business Days of demand by the Agent) pay to a Protected Party an amount equal to the loss, liability or cost which that Protected Party determines will be or has been (directly or indirectly) suffered for or on account of Tax by that Protected Party in respect of a Finance Document. 12.3.2 Clause 12.3.1 above shall not apply: (A) with respect to any Tax assessed on a Finance Party: (1) under the law of the jurisdiction in which that Finance Party is incorporated or, if different, the jurisdiction (or jurisdictions) in which that Finance Party is treated as resident for tax purposes; or (2) under the law of the jurisdiction in which that Finance Party's Facility Office is located in respect of amounts received or receivable in that jurisdiction, if that Tax is imposed on or calculated by reference to the net income received or receivable (but not any sum deemed to be received or receivable) by that Finance Party; or (B) to the extent a loss, liability or cost: (1) is compensated for by an increased payment under Clause 12.2 (Tax gross-up); (2) would have been compensated for by an increased payment under Clause 12.2 (Tax gross-up) but was not so compensated solely because one of the exclusions in Clause 12.2.4 of Clause 12.2 (Tax gross-up) applied; or (3) relates to a FATCA Deduction required to be made by a Party. 12.3.3 A Protected Party making, or intending to make a claim under Clause 12.3.1 above shall promptly notify the Agent of the event which will give, or has given, rise to the claim, following which the Agent shall notify the Company. 12.3.4 A Protected Party shall, on receiving a payment from the Company under this Clause 12.3, notify the Agent.


 
07/16927352_14 39 12.4 Tax Credit If the Company makes a Tax Payment and the relevant Finance Party determines that: 12.4.1 a Tax Credit is attributable to an increased payment of which that Tax Payment forms part, to that Tax Payment or to a Tax Deduction in consequence of which that Tax Payment was required; and 12.4.2 that Finance Party has obtained and utilised that Tax Credit, the Finance Party shall pay an amount to the Company which that Finance Party determines will leave it (after that payment) in the same after-Tax position as it would have been in had the Tax Payment not been required to be made by the Company. 12.5 Lender Status Confirmation 12.5.1 Each Lender which is not an Original Lender shall indicate, in the documentation which it executes on becoming a Party as a Lender, and for the benefit of the Agent and without liability to the Company, which of the following categories it falls in: (A) not a Qualifying Lender; (B) a Qualifying Lender (other than a Treaty Lender); or (C) a Treaty Lender. If such a Lender fails to indicate its status in accordance with this paragraph 12.5.1 then that Lender shall be treated for the purposes of this Agreement (including by the Company) as if it is not a Qualifying Lender until such time as it notifies the Agent which category applies (and the Agent, upon receipt of such notification, shall inform the Company). For the avoidance of doubt, the documentation which a Lender executes on becoming a Party as a Lender shall not be invalidated by any failure of a Lender to comply with this paragraph 12.5.1. 12.5.2 Such a Lender shall also specify, in the documentation which it executes on becoming a Party as a Lender, whether it is incorporated or acting through the Facility Office situated in a Non-Cooperative Jurisdiction. For the avoidance of doubt, the documentation which a Lender executes on becoming a Party as a Lender shall not be invalidated by any failure of a Lender to comply with this paragraph 12.5.2. 12.6 Stamp taxes The Company shall pay and, within three Business Days of demand, indemnify each Finance Party against any cost, loss or liability that Finance Party incurs in relation to all stamp duty, registration and other similar Taxes payable in respect of any Finance Document. 12.7 Value added tax 12.7.1 All amounts expressed to be payable under a Finance Document by any Party to a Finance Party which (in whole or in part) constitute the consideration for any supply for VAT purposes are deemed to be exclusive of any VAT which is chargeable on that supply, and accordingly, subject to paragraph 12.7.2 below, if VAT is or becomes chargeable on any supply made by any Finance Party to any Party under a Finance Document and such Finance Party is required to account to the relevant tax authority for the VAT, that Party must pay to such Finance Party (in addition to and at the same time as paying any other consideration for such supply) an amount equal to the amount of the VAT (and such Finance Party must promptly provide an appropriate VAT invoice to that Party). 12.7.2 If VAT is or becomes chargeable on any supply made by any Finance Party (the “Supplier”) to any other Finance Party (the “Recipient”) under a Finance


 
07/16927352_14 40 Document, and any Party other than the Recipient (the “Relevant Party”) is required by the terms of any Finance Document to pay an amount equal to the consideration for that supply to the Supplier (rather than being required to reimburse or indemnify the Recipient in respect of that consideration): (A) (where the Supplier is the person required to account to the relevant tax authority for the VAT) the Relevant Party must also pay to the Supplier (at the same time as paying that amount) an additional amount equal to the amount of the VAT. The Recipient must (where this paragraph 12.7.2(A) applies) promptly pay to the Relevant Party an amount equal to any credit or repayment the Recipient receives from the relevant tax authority which the Recipient reasonably determines relates to the VAT chargeable on that supply; and (B) (where the Recipient is the person required to account to the relevant tax authority for the VAT) the Relevant Party must promptly, following demand from the Recipient, pay to the Recipient an amount equal to the VAT chargeable on that supply but only to the extent that the Recipient reasonably determines that it is not entitled to credit or repayment from the relevant tax authority in respect of that VAT. 12.7.3 Where a Finance Document requires any Party to reimburse or indemnify a Finance Party for any cost or expense, that Party shall reimburse or indemnify (as the case may be) such Finance Party for the full amount of such cost or expense, including such part thereof as represents VAT, save to the extent that such Finance Party reasonably determines that it is entitled to credit or repayment in respect of such VAT from the relevant tax authority. 12.7.4 In relation to any supply made by a Finance Party to any Party under a Finance Document, if reasonably requested by such Finance Party, that Party must promptly provide such Finance Party with details of that Party's VAT registration and such other information as is reasonably requested in connection with such Finance Party's VAT reporting requirements in relation to such supply. 12.8 FATCA information 12.8.1 Subject to paragraph 12.8.3 below, each Party shall, within ten Business Days of a reasonable request by another Party: (A) confirm to that other Party whether it is: (1) a FATCA Exempt Party; or (2) not a FATCA Exempt Party; (B) supply to that other Party such forms, documentation and other information relating to its status under FATCA as that other Party reasonably requests for the purposes of that other Party's compliance with FATCA; and (C) supply to that other Party such forms, documentation and other information relating to its status as that other Party reasonably requests for the purposes of that other Party's compliance with any other law, regulation, or exchange of information regime. 12.8.2 If a Party confirms to another Party pursuant to paragraph 12.8.1(A) above that it is a FATCA Exempt Party and it subsequently becomes aware that it is not or has ceased to be a FATCA Exempt Party, that Party shall notify that other Party reasonably promptly. 12.8.3 Paragraph 12.8.1 above shall not oblige any Finance Party to do anything, and paragraph 12.8.1(C) above shall not oblige any other Party to do anything, which would or might in its reasonable opinion constitute a breach of: (A) any law or regulation;


 
07/16927352_14 41 (B) any fiduciary duty; or (C) any duty of confidentiality. 12.8.4 If a Party fails to confirm whether or not it is a FATCA Exempt Party or to supply forms, documentation or other information requested in accordance with paragraph 12.8.1(A)(1) or 12.8.1(A)(2) above (including, for the avoidance of doubt, where paragraph 12.8.3 above applies), then such Party shall be treated for the purposes of the Finance Documents (and payments under them) as if it is not a FATCA Exempt Party until such time as the Party in question provides the requested confirmation, forms, documentation or other information. 12.8.5 If the Company is a US Tax Obligor or the Agent reasonably believes that its obligations under FATCA or any other applicable law or regulation require it, each Lender shall, within ten Business Days of: (A) where the Company is a US Tax Obligor and the relevant Lender is an Original Lender, the date of this Agreement; (B) where the Company is a US Tax Obligor on a date on which any other Lender becomes a Party as a Lender, that date; or (C) where the Company is not a US Tax Obligor, the date of a request from the Agent, supply to the Agent: (1) a withholding certificate on Form W-8, Form W-9 or any other relevant form; or (2) any withholding statement or other document, authorisation or waiver as the Agent may require to certify or establish the status of such Lender under FATCA or that other law or regulation. 12.8.6 The Agent shall provide any withholding certificate, withholding statement, document, authorisation or waiver it receives from a Lender pursuant to paragraph 12.8.5 above to the Company. 12.8.7 If any withholding certificate, withholding statement, document, authorisation or waiver provided to the Agent by a Lender pursuant to paragraph 12.8.5 above is or becomes materially inaccurate or incomplete, that Lender shall promptly update it and provide such updated withholding certificate, withholding statement, document, authorisation or waiver to the Agent unless it is unlawful for the Lender to do so (in which case the Lender shall promptly notify the Agent). The Agent shall provide any such updated withholding certificate, withholding statement, document, authorisation or waiver to the Company. 12.8.8 The Agent may rely on any withholding certificate, withholding statement, document, authorisation or waiver it receives from a Lender pursuant to paragraph 12.8.5 or 12.8.6 above without further verification. The Agent shall not be liable for any action taken by it under or in connection with paragraphs 12.8.5, 12.8.6 or 12.8.7 above. 12.9 FATCA Deduction 12.9.1 Each Party may make any FATCA Deduction it is required to make by FATCA, and any payment required in connection with that FATCA Deduction, and no Party shall be required to increase any payment in respect of which it makes such a FATCA Deduction or otherwise compensate the recipient of the payment for that FATCA Deduction. 12.9.2 Each Party shall promptly, upon becoming aware that it must make a FATCA Deduction (or that there is any change in the rate or the basis of such FATCA Deduction), notify the Party to whom it is making the payment and, in addition, shall notify the Company and the Agent and the Agent shall notify the other Finance Parties.


 
07/16927352_14 42 13. INCREASED COSTS 13.1 Increased Costs 13.1.1 Subject to Clause 13.3 (Exceptions) the Company shall, within three Business Days of a demand by the Agent, pay for the account of a Finance Party the amount of any Increased Costs incurred by that Finance Party or any of its Affiliates as a result of (i) the introduction of or any change in (or in the interpretation, administration or application of) any law or regulation or (ii) compliance with any law or regulation made after the date of this Agreement. 13.1.2 In this Agreement “Increased Costs” means: (A) a reduction in the rate of return from the Facility or on a Finance Party's (or its Affiliate's) overall capital; (B) an additional or increased cost; or (C) a reduction of any amount due and payable under any Finance Document, which is incurred or suffered by a Finance Party or any of its Affiliates to the extent that it is attributable to that Finance Party having entered into its Commitment or funding or performing its obligations under any Finance Document. 13.2 Increased Cost claims A Finance Party intending to make a claim pursuant to Clause 13.1 (Increased Costs) shall notify the Agent of the event giving rise to the claim, following which the Agent shall promptly notify the Company. 13.3 Exceptions 13.3.1 Clause 13.1 (Increased Costs) does not apply to the extent any Increased Cost is: (A) attributable to a Tax Deduction required by law to be made by the Company; (B) attributable to a FATCA Deduction required to be made by a Party; (C) resulting from the application by the relevant Finance Party of (i) Basel III, (ii) CRR Regulation and (iii) CRD IV Directive; (D) an increase in the rate of corporate income taxes applicable to the relevant Finance Party; (E) compensated for by Clause 12.3 (Tax indemnity) (or would have been compensated for under Clause 12.3 (Tax indemnity) but was not so compensated solely because any of the exclusions in Clause 12.3.2 of Clause 12.3 (Tax indemnity) applied); or (F) attributable to the wilful breach by the relevant Finance Party or its Affiliates of any law or regulation. 13.3.2 In this Clause 13.3, a reference to a “Tax Deduction” has the same meaning given to that term in Clause 12.1 (Definitions). 14. OTHER INDEMNITIES 14.1 Currency indemnity 14.1.1 If any sum due from the Company under the Finance Documents (a “Sum”), or any order, judgment or award given or made in relation to a Sum, has to be converted from the currency (the “First Currency”) in which that Sum is payable into another currency (the “Second Currency”) for the purpose of:


 
07/16927352_14 43 (A) making or filing a claim or proof against the Company; (B) obtaining or enforcing an order, judgment or award in relation to any litigation or arbitration proceedings, the Company shall as an independent obligation within three Business Days of demand, indemnify to the extent permitted by law each Finance Party to whom that Sum is due against any cost, loss or liability arising out of or as a result of the conversion including any discrepancy between (A) the rate of exchange used to convert that Sum from the First Currency into the Second Currency and (B) the rate or rates of exchange available to that person at the time of its receipt of that Sum. 14.1.2 The Company waives any right it may have in any jurisdiction to pay any amount under the Finance Documents in a currency or currency unit other than that in which it is expressed to be payable. 14.2 Other indemnities The Company shall, within ten Business Days of demand, indemnify each Finance Party against any documented cost, loss or liability incurred by that Finance Party as a result of: 14.2.1 the occurrence of any Event of Default; 14.2.2 a failure by the Company to pay any amount due under a Finance Document on its due date, including without limitation, any cost, loss or liability arising as a result of Clause 27 (Sharing among the Finance Parties); 14.2.3 funding, or making arrangements to fund, its participation in the Loan requested by the Company in a Utilisation Request but not made by reason of the operation of any one or more of the provisions of this Agreement (other than by reason of default or negligence by that Finance Party alone); or 14.2.4 the Loan (or part of the Loan) not being prepaid in accordance with a notice of prepayment given by the Company. Under no circumstances shall the Company be liable to any Finance Party under Clause 14.2 for any indirect damages of any kind or nature whatsoever or any loss of business or business opportunity or any loss of goodwill. 14.3 Indemnity to the Agent The Company shall, within ten Business Days, indemnify the Agent against any documented cost, loss or liability incurred by the Agent (acting reasonably) as a result of: 14.3.1 investigating any event which it reasonably believes is a Default; 14.3.2 acting or relying on any notice, request or instruction which it reasonably believes to be genuine, correct and appropriately authorised; or 14.3.3 instructing lawyers, accountants, tax advisers, surveyors or other professional advisers or experts as permitted under this Agreement. Under no circumstances shall the Company be liable to the Agent under Clause 14.3 for any indirect damages of any kind or nature whatsoever or any loss of business or business opportunity or any loss of goodwill. 15. MITIGATION BY THE LENDERS 15.1 Mitigation 15.1.1 Each Finance Party shall, in consultation with the Company, take all reasonable steps to mitigate any circumstances which arise and which would result in any amount becoming payable under or pursuant to, or cancelled pursuant to, any of Clause 7.1 (Illegality), Clause 12 (Tax gross-up and indemnities) or Clause 13 (Increased Costs) or in any amount payable under a Finance Document by the Company becoming not deductible from the Company’s taxable income for


 
07/16927352_14 44 French tax purposes by reason of that amount being (i) paid or accrued to a Finance Party incorporated, domiciled, established or acting through the Facility Office situated in a Non-Cooperative Jurisdiction or (ii) paid to an account opened in the name of or for the benefit of that Finance Party in a financial institution situated in a Non-Cooperative Jurisdiction, including (but not limited to) transferring its rights and obligations under the Finance Documents to another Affiliate or Facility Office. 15.1.2 Clause 15.1.1 above does not in any way limit the obligations of the Company under the Finance Documents. 15.2 Limitation of liability 15.2.1 The Company shall, within 10 Business Days, indemnify each Finance Party for all documented costs and expenses reasonably incurred by that Finance Party as a result of steps taken by it under Clause 15.1 (Mitigation). 15.2.2 A Finance Party is not obliged to take any steps under Clause 15.1 (Mitigation) if, in the opinion of that Finance Party (acting reasonably), to do so might be prejudicial to it. 16. COSTS AND EXPENSES 16.1 Transaction expenses The Company shall, within ten Business Days of demand, pay the Agent and the Coordinator the amount of all documented costs and expenses (including legal fees) reasonably incurred by any of them in connection with the negotiation, preparation, printing, execution and syndication of: 16.1.1 this Agreement and any other documents referred to in this Agreement; and 16.1.2 any other Finance Documents executed after the date of this Agreement. 16.2 Amendment costs If: 16.2.1 the Company requests an amendment, waiver or consent; or 16.2.2 an amendment is required pursuant to Clause 28.9 (Change of currency), the Company shall, within ten Business Days of demand, reimburse the Agent for the amount of all documented costs and expenses (including legal fees) reasonably incurred by the Agent in responding to, evaluating, negotiating or complying with that request or requirement. 16.3 Enforcement costs The Company shall, within ten Business Days of demand, pay to each Finance Party the amount of all documented costs and expenses (including legal fees) incurred by that Finance Party in connection with the enforcement of, or the preservation of any rights under, any Finance Document. Section 7 REPRESENTATIONS, UNDERTAKINGS AND EVENTS OF DEFAULT 17. REPRESENTATIONS The Company makes the representations set out in this Clause 17 to each Finance Party on the date of this Agreement.


 
07/16927352_14 45 17.1 Status 17.1.1 It is a corporation, duly incorporated and validly existing under the law of its jurisdiction of incorporation. 17.1.2 It and each of its Subsidiaries has the power to own its assets and carry on its business as it is being conducted. 17.2 Binding obligations The obligations expressed to be assumed by it in each Finance Document are, subject to perfection requirements and any general principles of law limiting its obligations which are specifically referred to in any legal opinion delivered pursuant to Clause 4 (Conditions of Utilisation) (the “Legal Reservations”), legal, valid, binding and enforceable obligations in accordance with their respective terms. 17.3 Non-conflict with other obligations Subject to perfection requirements and Legal Reservations, the entry into and performance by it of, and the transactions contemplated by, the Finance Documents do not and will not conflict with: 17.3.1 any law or regulation applicable to it; 17.3.2 its or any of its Subsidiaries' constitutional documents; or 17.3.3 any agreement or instrument binding upon it or any of its Material Subsidiaries or any of its or any of its Material Subsidiaries' assets except is such conflict does not have or is reasonably unlikely to have a Material Adverse Effect. 17.4 Power and authority It has the power to enter into, perform and deliver, and has taken all necessary action to authorise its entry into, performance and delivery of, the Finance Documents to which it is a party and the transactions contemplated by those Finance Documents. 17.5 Validity and admissibility in evidence Subject to perfection requirements and Legal Reservations , all Authorisations required: 17.5.1 to enable it lawfully to enter into, exercise its rights and comply with its obligations in the Finance Documents to which it is a party; and 17.5.2 to make the Finance Documents to which it is a party admissible in evidence in its jurisdiction of incorporation, have been obtained or effected and are in full force and effect. 17.6 Insolvency No: 17.6.1 corporate action, legal proceeding or other procedure or step described in paragraph 21.7.1 of Clause 21.7 (Insolvency proceedings); or 17.6.2 creditors' process described in Clause 21.8 (Creditors' process), has been taken or, to the knowledge of the Company, threatened in relation to it or a Material Subsidiary; and none of the circumstances described in Clause 21.6 (Insolvency) applies to it or a Material Subsidiary. 17.7 Governing law and enforcement 17.7.1 The choice of French law as the governing law of the Finance Documents will be recognised and enforced in France. 17.7.2 Any judgment obtained in France in relation to a Finance Document will be recognised and enforced in France.


 
07/16927352_14 46 17.8 Deduction of Tax It is not required to make any Tax Deduction (as defined in Clause 12.1 (Definitions)) from any payment it may make under any Finance Document to a Lender which is a Qualifying Lender. 17.9 Taxation 17.9.1 It is not (and none of its Material Subsidiaries is) materially overdue in the filing of Tax returns and it is not (and none of its Material Subsidiaries is) materially overdue in the payment of any Taxes. 17.9.2 To the best of its knowledge, no claims or investigations are being, or are reasonably likely to be, made or conducted against it (or any of its Material Subsidiaries) with respect to Taxes which might reasonably be expected to have a Material Adverse Effect. 17.9.3 It is resident for Tax purposes only in France. 17.10 No filing or stamp taxes Under the law of its jurisdiction of incorporation it is not necessary that the Finance Documents be filed, recorded or enrolled with any court or other authority in that jurisdiction or that any stamp, registration or similar tax be paid on or in relation to the Finance Documents or the transactions contemplated by the Finance Documents. 17.11 No default 17.11.1 No Event of Default is continuing or might reasonably be expected to result from the making of the Utilisation. 17.11.2 To the best of the knowledge and belief of the Company, no other event or circumstance is outstanding which constitutes a default under any other agreement or instrument which is binding on it or any of its Material Subsidiaries or to which its (or any of its Material Subsidiaries') assets are subject which might reasonably be expected to have a Material Adverse Effect. 17.12 No misleading information To its best knowledge and belief, all information furnished in writing by it to the Finance Parties for the purposes of or in connection with the Finance Documents, is true and accurate in every material respect on the date on which such information is provided or stated and does not contain any material misstatement of fact. 17.13 Financial statements 17.13.1 The Original Financial Statements were prepared in accordance with the Accounting Principles consistently applied unless expressly disclosed to the Agent in writing to the contrary before the date of this Agreement. 17.13.2 The Original Financial Statements fairly present its financial condition as at the end of the relevant financial year and its results of operations during the relevant financial year (consolidated in the case of Constellium SE) unless expressly disclosed to the Agent in writing to the contrary before the date of this Agreement. 17.14 No breach of laws 17.14.1 It has not (and none of its Material Subsidiaries has) breached any law or regulation which breach has or is reasonably likely to have a Material Adverse Effect. 17.14.2 No labour disputes are current or, to the best of its knowledge and belief (having made due and careful enquiry), threatened against it or any Material Subsidiary which have or are reasonably likely to have a Material Adverse Effect.


 
07/16927352_14 47 17.15 Environmental laws 17.15.1 Each of it and its Material Subsidiary is in compliance with Clause 20.3.1 and to the best of its knowledge and belief (having made due and careful enquiry) no circumstances have occurred which would prevent such compliance in a manner or to an extent which has or is reasonably likely to have a Material Adverse Effect. 17.15.2 No Environmental Claim has been commenced or (to the best of its knowledge and belief (having made due and careful enquiry)) is threatened against it or any Material Subsidiary where that claim has or is reasonably likely to have a Material Adverse Effect. 17.16 Sanctions, anti-money laundering and anti-corruption laws Neither the Company, nor any of its Subsidiaries, directors or officers, or, to the best of its knowledge, any Affiliate or employee of the Company: 17.16.1 is an individual or entity (a “Person”), that is, or is owned or controlled by Persons that are: (A) the target of any Sanctions (a “Sanctioned Person”) or (B) located, organised or resident in a country or territory that is, or whose government is in, a Sanctioned Country; or 17.16.2 has engaged in any activity or conduct which would violate any applicable Anti- Corruption Regulations, Fight Against Money Laundering and Financing of Terrorism Regulations or Sanctions in any applicable jurisdiction and the Company has, to the extent required by applicable laws, instituted and maintains policies and procedures designed to prevent violation of such laws, regulations and rules. 17.17 Security and financial indebtedness 17.17.1 No Security or Quasi-Security exists over all or any of the present or future assets of the Company or any Material Subsidiary other than as permitted by this Agreement. 17.17.2 Neither the Company nor any Material Subsidiary has any Financial Indebtedness outstanding other than as permitted by this Agreement. 17.18 Legal and beneficial ownership It and each of its Subsidiaries is the sole legal and beneficial owner of the respective assets over which it purports to grant Security. 17.19 Shares The shares which are subject to the Transaction Security are fully paid and not subject to any option to purchase or similar rights. The constitutional documents of companies whose shares are subject to the Transaction Security do not and could not restrict or inhibit any transfer of those shares on creation or enforcement of the Transaction Security, other than to the extent such restrictions or inhibitions are required by applicable law and other than “clauses d'agrément” provided that in such case the relevant corporate bodies of the relevant entity have given their consent to the proposed Transaction Security. There are no agreements in force which provide for the issue or allotment of, or grant any person the right to call for the issue or allotment of, any share capital of any Material Subsidiary (including any option or right of pre-emption or conversion). 17.20 Intellectual property It and each of its Material Subsidiaries: 17.20.1 is the sole legal and beneficial owner of or has licensed to it on normal commercial terms all the Intellectual Property which is material in the context of


 
07/16927352_14 48 its business and which is required by it in order to carry on its business as it is being conducted; 17.20.2 does not (nor does any of its Material Subsidiaries), in carrying on its businesses, infringe any Intellectual Property of any third party in a manner that would reasonably be expected to have a Material Adverse Effect; and 17.20.3 has taken all formal or procedural actions (including payment of fees) required to maintain any material Intellectual Property owned by, which is required to conduct the business of the Group and where failure to do so would reasonably be expected to have a Material Adverse Effect. 17.21 Group structure chart The Group Structure Chart delivered to the Agent pursuant to Clause 4.1 (Initial conditions precedent) is true, complete and accurate in all material respects and shows the following information: 17.21.1 each member of the Group, including current name and jurisdiction of incorporation (in the case of a member of the Group which is not the Company); and 17.21.2 all minority interests in any Material Subsidiary and any person in which any Material Subsidiary holds shares in its issued share capital or equivalent ownership interest of such person. 17.22 French State Guarantee criteria 17.22.1 The Company complies with all the criteria set out under French law applicable to borrowers applying for a PGE Loan guaranteed by the French State as contemplated under this Agreement; in particular: (A) the Company's and its French Subsidiaries' consolidated annual turnover (without tax) for their last financial year (as determined in accordance with the PGE Q&A) exceeded € 1,500,000,000; (B) the Company's and its French Subsidiaries' currently have less than 5,000 employees in France; and (C) the Company is not (and was not, on 31 December 2019) an “undertaking in difficulty” (as this term is construed under article 2 of Commission Regulation (EU) No 651/2014 of 17 June 2014). 17.22.2 The Company has not requested any Other PGE Loan the amount of which would result in the aggregate amount of loans guaranteed by the French State authorised by the PGE Order for the Company being exceeded. 17.22.3 The Company acknowledges that, on 19 March 2020, the European Commission has approved the French State guaranteeing PGE Loan provided that the borrower is not, on 31 December 2019, an undertaking in difficulty within the meaning set forth in paragraph 18 of Article 2 of the Commission Regulation (EU) No 651/2014 of 17 June 2014. If the borrower does not comply with such criteria, the State aid received from the borrower can be challenged and such State aid could have to be recovered. 17.23 Pari passu ranking Its payment obligations under the Finance Documents rank at least pari passu with the claims of all its other unsecured and unsubordinated creditors, except for obligations mandatorily preferred by law applying to companies generally. 17.24 No proceedings There are no current actions, suits or proceedings pending against or affecting it or any of its Material Subsidiary, in or before any judicial or administrative court, arbitrator or regulatory authority that might reasonably be expected to have a Material Adverse Effect.


 
07/16927352_14 49 17.25 Centre of main interests Its centre of main interests (as that term is used in Article 3 1. of Council Regulation (EC) no 1346/2000 of 29 May 2000 on insolvency proceedings (the “Regulation”) or, for insolvency proceedings opened after 26 June 2017, Regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast) (the “Regulation (recast)”)) is situated in its jurisdiction of incorporation and it has no establishment (as that term is used in Article 2, point (h) of the Regulation or, for insolvency proceedings opened after 26 June 2017, in Article 2, point (10) of the Regulation (recast)) in any jurisdiction other than its jurisdiction of incorporation. 17.26 Repetition The Repeating Representations are deemed to be made by the Company by reference to the facts and circumstances then existing on the date of each Utilisation Request and the first day of each Interest Period. 18. INFORMATION UNDERTAKINGS The undertakings in this Clause 18 remain in force from the date of this Agreement for so long as any amount is outstanding under the Finance Documents or any Commitment is in force. 18.1 Financial statements The Company shall supply to the Agent in sufficient copies for all the Lenders: 18.1.1 as soon as the same become available, but in any event within 180 days after the end of the financial year of each entity: (A) the audited financial statements for that financial year of the Company, Constellium SE, Constellium France Holdco, Constellium Issoire and Constellium Neuf Brisach; (B) the audited consolidated financial statements of Constellium SE for that financial year; and (C) the unaudited financial statements for that financial year, and for the first time for the financial year ending 31 December 2022, of Constellium Issoire and Constellium Neuf Brisach, as reported to Constellium SE for inclusion in the audited annual consolidated financial statements of Constellium SE; 18.1.2 as soon as the same become available, but in any event within 60 days after the end of the quarter of each entity, the quarterly management accounts for the Company, Constellium SE and Constellium France Holdco; and 18.1.3 as soon as the same become available, but in any event within 30 days after the end of each month (other than for the month of January), the monthly unaudited and unreviewed financial statements of Constellium Issoire and Constellium Neuf Brisach. 18.2 Compliance Certificate 18.2.1 The Company shall supply to the Agent, with each set of financial statements delivered pursuant to Clause 18.1.1(A) of Clause 18.1 (Financial statements), a Compliance Certificate (i) setting out (in reasonable detail) computations as to compliance with Clause 19 (Financial Covenants) as at the closing date of the relevant financial year, (ii) as from the Compliance Certificate delivered in relation to the financial year ending on 31 December 2020, providing an updated list of the Material Subsidiaries and confirming that such entities represent at least 85% of the portion of the Consolidated EBITDA generated by the French Subsidiaries, and (iii) as from the Compliance Certificate delivered in relation to the financial


 
07/16927352_14 50 year ending on 31 December 2022, the Free Cash Flow (as this term is defined in section 7.7.1) of each Constellium Issoire and Constellium Neuf Brisach. 18.2.2 Each Compliance Certificate shall be signed by the president or the general manager (directeur général) of the Company or the treasurer of the Group. 18.3 Requirements as to financial statements 18.3.1 Each set of financial statements delivered by the Company pursuant to Clause 18.1 (Financial statements) shall be certified by an officer of the relevant company as fairly presenting its financial condition as at the closing date of the relevant financial year. 18.3.2 The Company shall procure that each set of financial statements of the Company delivered pursuant to Clause 18.1 (Financial statements) is prepared using the Accounting Principles, accounting practices and financial reference periods consistent with those applied in the preparation of the Original Financial Statements for the Company unless, in relation to any set of financial statements, it notifies the Agent that there has been a change in the Accounting Principles, the accounting practices or reference periods and its auditors (or, if appropriate, the auditors of the Company) deliver to the Agent: (A) a description of any change necessary for those financial statements to reflect the Accounting Principles, accounting practices and reference periods upon which the Company’s Original Financial Statements were prepared; and (B) sufficient information, in form and substance as may be reasonably required by the Agent, to enable the Lenders to determine whether Clause 19 (Financial Covenants) has been complied with and make an accurate comparison between the financial position indicated in those financial statements and the Company’s Original Financial Statements. Any reference in this Agreement to those financial statements shall be construed as a reference to those financial statements as adjusted to reflect the basis upon which the Original Financial Statements were prepared. 18.4 Information: miscellaneous The Company shall supply to the Agent (in sufficient copies for all the Lenders, if the Agent so requests): 18.4.1 promptly upon request of the Agent (acting reasonably), all documents dispatched by the Company to its creditors generally in their capacity as such at the same time as they are dispatched, excluding for the avoidance of doubt any information provided to holders of equity or instruments that may give access to equity in such capacity; 18.4.2 any information in respect of any event or circumstances that affect or would reasonably be expected to affect, the eligibility of the Loan to the French State Guarantee; 18.4.3 promptly upon becoming aware of them, the details of any litigation, arbitration or administrative proceedings which are current, threatened or pending against the Company or any Material Subsidiary, and which might reasonably be expected to have a Material Adverse Effect; 18.4.4 promptly upon becoming aware of them, the details of any judgment or order of a court, arbitral body or agency which is made against the Company or any Material Subsidiary, and which might have a Material Adverse Effect; 18.4.5 promptly, upon becoming aware of them, evidence of any upgrade or downgrade of the corporate rating assigned by Moody's or S&P to Constellium SE; and


 
07/16927352_14 51 18.4.6 promptly upon request of the Agent (acting reasonably), such further information regarding the financial condition, business and operations of the Group which may have a material impact on the ability of the Company to perform its obligations under the Finance Documents. 18.5 Notification of default 18.5.1 The Company shall notify the Agent of any Default (and the steps, if any, being taken to remedy it) promptly upon becoming aware of its occurrence. 18.5.2 Promptly upon a request by the Agent, if the Agent has reasonable grounds for believing that a Default has occurred and is continuing, the Company shall supply to the Agent a certificate signed by an officer on its behalf certifying that, to the best of its knowledge, no Default is continuing (or if a Default is continuing, specifying the Default and the steps, if any, being taken to remedy it). 18.6 Liquidity forecasts The Company shall supply to the Agent (in sufficient copies for all the Lenders): 18.6.1 on a monthly basis, except January and July of each year, indirect forecast by each French Subsidiary, which covers a monthly free cash flow projection until 31 December; 18.6.2 for each month for which no indirect forecast is submitted (i.e. January and July of each year), or when the horizon of the forecast is shorter than three months, the direct forecast for each French Subsidiary, which covers in and out flows for the next three months; and 18.6.3 on a monthly basis and with respect to Constellium SE only, a liquidity picture as at end of the previous month. 18.7 Direct electronic delivery by Company The Company may satisfy its obligation under this Agreement to deliver any information in relation to a Lender by delivering that information directly to that Lender in accordance with Clause 30.5 (Electronic communication) to the extent that Lender and the Agent agree to this method of delivery. 18.8 “Know your customer” checks 18.8.1 If: (A) the introduction of or any change in (or in the interpretation, administration or application of) any law or regulation made after the date of this Agreement; (B) any change in the status of the Company (or of a Holding Company of the Company) after the date of this Agreement; or (C) a proposed transfer by a Lender of any of its rights and/or obligations under this Agreement to a party that is not a Lender prior to such transfer, obliges the Agent or any Lender (or, in the case of paragraph (C) above, any prospective new Lender) to comply with “know your customer” or similar identification procedures in circumstances where the necessary information is not already available to it, the Company shall promptly upon the request of the Agent or any Lender supply, or procure the supply of, such documentation and other evidence as is reasonably requested by the Agent (for itself or on behalf of any Lender) or any Lender (for itself or, in the case of the event described in paragraph (C) above, on behalf of any prospective new Lender) in order for the Agent, such Lender or, in the case of the event described in paragraph (C) above, any prospective new Lender to carry out and be satisfied it has complied with all necessary “know your customer” or other similar checks under all


 
07/16927352_14 52 applicable laws and regulations pursuant to the transactions contemplated in the Finance Documents. 18.8.2 Each Lender shall promptly upon the request of the Agent supply, or procure the supply of, such documentation and other evidence as is reasonably requested by the Agent (for itself) in order for the Agent to carry out and be satisfied it has complied with all necessary “know your customer” or other similar checks under all applicable laws and regulations pursuant to the transactions contemplated in the Finance Documents. 19. FINANCIAL COVENANTS 19.1 Leverage The Company shall ensure that, on each Testing Date, Leverage shall not exceed the ratio set out below: Testing Date Ratio 31 December 2020 Not tested 30 June 2021 6.5x 31 December 2021 5.00x 30 June 2022 4.50x 31 December 2022 4.25x 30 June 2023 4.0x 31 December 2023 4.0x 30 June 2024 4.0x 31 December 2024 4.0x 30 June 2025 4.0x 31 December 2025 4.0x 30 June 2026 4.0x 31 December 2026 4.0x 19.2 Interest Cover Ratio The Company shall procure that the Interest Cover Ratio (calculated on a last twelve month basis) is at least equal to 1.75x on 30 June 2021, 2.0x on 31 December 2021 and 30 June 2022, 2.5x on 31 December 2022 and 30 June 2023 and to 3.0x on any subsequent Testing Date. 20. GENERAL UNDERTAKINGS The undertakings in this Clause 20 remain in force from the date of this Agreement for so long as any amount is outstanding under the Finance Documents or any Commitment is in force. 20.1 Authorisations The Company shall promptly obtain, comply with and do all that is necessary to maintain in full force and effect, any Authorisation required under any law or regulation of its jurisdiction of incorporation to enable it to perform its obligations under the Finance


 
07/16927352_14 53 Documents and to ensure the legality, validity, enforceability or admissibility in evidence in its jurisdiction of incorporation of any Finance Document. 20.2 Compliance with laws The Company shall comply in all respects with all laws to which it may be subject, if failure so to comply would materially impair its ability to perform its obligations under the Finance Documents. 20.3 Environmental compliance – Environmental Claims 20.3.1 The Company shall (and shall ensure that each Material Subsidiary will): (A) comply with all Environmental Law; (B) obtain, maintain and ensure compliance with all requisite Environmental Permits; (C) implement procedures to monitor compliance with and to prevent liability under any Environmental Law, where failure to do so has or is reasonably likely to have a Material Adverse Effect. 20.3.2 The Company shall promptly upon becoming aware of the same, inform the Agent in writing of: (A) any Environmental Claim against it or any Material Subsidiary which is current, pending or threatened; and (B) any facts or circumstances which are reasonably likely to result in any Environmental Claim being commenced or threatened against it or any Material Subsidiary, where the claim has or is reasonably likely to have a Material Adverse Effect. 20.4 Sanctions, anti-money laundering and anti-corruption laws 20.4.1 The Company undertakes to comply with all Sanctions and shall not use the proceeds of the Facility, or lend, contribute or otherwise make available such proceeds to any Subsidiary, Joint Venture partner or any other Person: (A) to fund any activities or business of or with a Person, or in a country or territory that, at the time of such funding, is a Sanctioned Person or a Sanctioned Country; or (B) in any other manner that would result in a violation of Sanctions by any Person (including any Person participating in the Facility, whether as underwriter, advisor, lender, hedge provider, facility or security agent or otherwise). 20.4.2 The Company undertakes to comply with all Anti-Corruption Regulations and shall not use the proceeds of the Facility, or lend, contribute or otherwise make available such proceeds to any Subsidiary, Joint Venture partner, any other Person or in transactions that constitute or result in an act of corruption or of trafficking in influence. 20.4.3 Insofar as the Company is subject to the provisions of article 17 of Law n°2016- 1691 relating to transparency, anti-corruption and modernisation of the economy (loi relative à la transparence, à la lutte contre la corruption et à la modernisation de la vie économique), the Company undertakes that it has taken all reasonable measures and, in particular, has adopted and implemented appropriate procedures and codes of conduct with the objective of preventing any violation of such combatting corruption and trafficking in influence laws and regulations.


 
07/16927352_14 54 20.4.4 The Company undertakes to immediately notify the Lenders of: (A) any indictment or any equivalent measure for a violation of Anti- Corruption Regulations; (B) any conviction - whether it is in first or last instance - against the Company or anyone acting on his behalf for a violation of Anti-Corruption Regulations; (C) any designation in the publicly available lists of debarred entities of the following international organizations: World Bank, African Development Bank, Asian Development Bank, European Bank for Reconstruction and Development, and Inter-American Development Bank; (D) any signing of a transactional prosecution agreement for a violation of Anti-Corruption Regulations from the Company or anyone acting on his behalf. 20.4.5 The Company undertakes to comply with all Fight Against Money Laundering and Financing of Terrorism Regulations and shall not use the proceeds of the Facility, or lend, contribute or otherwise make available such proceeds to any Subsidiary, Joint Venture partner, any other Person or in transactions that would contravene any of those regulations. 20.5 Negative pledge In this Clause 20.5, “Quasi-Security” means an arrangement or transaction described in Clause 20.5.2 below. Except as permitted under paragraph 20.5.3 below: 20.5.1 the Company shall not, and shall ensure that no Material Subsidiary will, create or permit to subsist any Security over any of its assets; and 20.5.2 the Company shall not, and shall ensure that no Material Subsidiary will: (A) sell, transfer or otherwise dispose of any of its assets on terms whereby they are or may be leased to or re-acquired by the Company or any other Material Subsidiary; (B) sell, transfer or otherwise dispose of any of its receivables on recourse terms; (C) enter into any arrangement under which money or the benefit of a bank or other account may be applied, set-off or made subject to a combination of accounts; or (D) enter into any other preferential arrangement having a similar effect, in circumstances where the arrangement or transaction is entered into primarily as a method of raising Financial Indebtedness or of financing the acquisition of an asset. 20.5.3 Clauses 20.5.1 and 20.5.2 above do not apply to any Security or (as the case may be) Quasi-Security which qualifies as Permitted Security or Permitted Transaction. 20.6 Disposals 20.6.1 Except as permitted under paragraph 20.6.2 below, the Company shall not, and shall ensure that no Material Subsidiary will, enter into a single transaction or a series of transactions (whether related or not) and whether voluntary or involuntary to sell, lease, transfer or otherwise dispose of any asset. 20.6.2 Clause 20.6.1 above does not apply to any sale, lease, transfer or other disposal which is a Permitted Disposal or a Permitted Transaction.


 
07/16927352_14 55 20.7 Merger 20.7.1 Except as permitted under paragraph 20.7.2 below, the Company shall not, and shall ensure that no Material Subsidiary will, enter into any amalgamation, demerger, merger or corporate reconstruction. 20.7.2 Paragraph 20.7.1 above does not apply to any Permitted Transaction. 20.8 Acquisitions 20.8.1 Except as permitted under paragraph 20.8.2 below, the Company shall ensure that neither the Company nor any Material Subsidiary will: (A) acquire a company or any shares or securities or a business or undertaking (or, in each case, any interest in any of them); or (B) incorporate a company. 20.8.2 Paragraph 20.8.1 above does not apply to an acquisition of a company, of shares, securities or a business or undertaking (or, in each case, any interest in any of them) or the incorporation of a company which is: (A) a Permitted Acquisition; (B) a Permitted Share Issue; (C) a Permitted Joint Venture; or (D) a Permitted Transaction. 20.9 Joint ventures 20.9.1 Except as permitted under paragraph 20.9.2 below, the Company shall not (and shall ensure that no Material Subsidiary will): (A) enter into, invest in or acquire (or agree to acquire) any shares, stocks, securities or other interest in any Joint Venture; or (B) transfer any assets or lend to or guarantee or give an indemnity for or give Security for the obligations of a Joint Venture or maintain the solvency of or provide working capital to any Joint Venture (or agree to do any of the foregoing). 20.9.2 Paragraph 20.9.1 above does not apply to any transaction which is a Permitted Acquisition, a Permitted Disposal, a Permitted Loan, a Permitted Transaction or a Permitted Joint Venture. 20.10 Taxation 20.10.1 The Company shall (and shall ensure that each Material Subsidiary will) pay and discharge all Taxes imposed upon it or its assets within the time period allowed without incurring penalties unless and only to the extent that: (A) such payment is being contested in good faith; (B) adequate reserves are being maintained for those Taxes and the costs required to contest them which have been disclosed in its latest financial statements delivered to the Agent under Clause 18.1 (Financial statements); and (C) such payment can be lawfully withheld. 20.10.2 Neither the Company nor any Material Subsidiary may change its residence for Tax purposes. 20.11 Change of business The Company shall procure that no substantial change is made to the general nature of the business of the Company or the Group from that carried on at the date of this Agreement.


 
07/16927352_14 56 20.12 Pari passu ranking The Company shall ensure that at all times any unsecured and unsubordinated claims of a Finance Party against it under the Finance Documents rank at least pari passu with the claims of all its other unsecured and unsubordinated creditors except those creditors whose claims are mandatorily preferred by laws of general application to companies. 20.13 Loans or credit 20.13.1 Except as permitted under paragraph 20.13.2 below, the Company shall not (and shall ensure that no Material Subsidiary) be a creditor in respect of any Financial Indebtedness. 20.13.2 Paragraph 20.13.1 above does not apply to: (A) a Permitted Loan; or (B) a Permitted Transaction. 20.14 No guarantees or indemnities 20.14.1 Except as permitted under paragraph 20.14.2 below, the Company shall not (and shall ensure that no Material Subsidiary will) incur or allow to remain outstanding any guarantee in respect of any obligation of any person. 20.14.2 Paragraph 20.14.1 does not apply to a guarantee which is: (A) a Permitted Guarantee; or (B) a Permitted Transaction. 20.15 Financial Indebtedness 20.15.1 Except as permitted under paragraph 20.15.2 below, the Company shall not (and shall ensure that no Material Subsidiary will) incur or allow to remain outstanding any Financial Indebtedness. 20.15.2 Paragraph 20.15.1 above does not apply to Financial Indebtedness which is: (A) Permitted Financial Indebtedness; or (B) a Permitted Transaction. 20.16 Insurance 20.16.1 The Company shall (and shall ensure that each Material Subsidiary will) maintain insurances on and in relation to its business and assets against those risks and to the extent as is usual for companies carrying on the same or substantially similar business. 20.16.2 All insurances must be with reputable independent insurance companies or underwriters. 20.17 Access If an Event of Default is continuing or the Agent reasonably suspects an Event of Default is continuing or may occur the Company shall, and shall ensure that each Material Subsidiary will, (not more than once in every financial year unless the Agent suspects and Event of Default is continuing or may occur)) permit the Agent and/or the Security Agent and/or accountants or other professional advisers and contractors of the Agent or Security Agent free access at all reasonable times and on reasonable notice at the risk and cost of the Company to (i) the premises, assets, books, accounts and records of each Material Subsidiary and (ii) meet and discuss matters with key managers of the Company.


 
07/16927352_14 57 20.18 Intellectual Property The Company shall (and shall procure that each Material Subsidiary will): 20.18.1 preserve and maintain the subsistence and validity of the Intellectual Property necessary for its business and where failure to do so would reasonably be expected to have a Material Adverse Effect; 20.18.2 use reasonable endeavours to prevent any infringement in any material respect of the Intellectual Property which is required to conduct its business and where failure to do so would reasonably be expected to have a Material Adverse Effect; 20.18.3 make registrations and pay all registration fees and taxes necessary to maintain the Intellectual Property which is required to conduct its business in full force and effect and record its interest in that Intellectual Property where failure to do so would reasonably be expected to have a Material Adverse Effect; 20.18.4 not use or permit the Intellectual Property necessary for its business to be used in a way or take any step or omit to take any step in respect of that Intellectual Property which may materially and adversely affect the existence or value of that Intellectual Property or imperil its right to use such property where failure to do so would reasonably be expected to have a Material Adverse Effect; and 20.18.5 not discontinue the use of the Intellectual Property necessary for its business and where failure to do so would reasonably be expected to have a Material Adverse Effect. 20.19 Treasury Transactions The Company shall not (and will procure that no Material Subsidiary will) enter into any Treasury Transaction, other than: 20.19.1 Treasury Transactions entered into for the purposes of hedging exchange rate liabilities in respect of any amount outstanding under any Permitted Financial Indebtedness which is not denominated in euro (including, without limitation, both the interest and principal liabilities) and any arrangement replacing or extending such Treasury Transactions on terms permitted by the Finance Documents); 20.19.2 Treasury Transactions entered into for the purposes of hedging interest rate liabilities under any Permitted Financial Indebtedness with a floating interest rate and any arrangement replacing or extending such Treasury Transactions on terms permitted by the Finance Documents; and 20.19.3 any Treasury Transaction arising in the ordinary course of trading activities of a member of the Group and not for speculative purposes. 20.20 Further assurance 20.20.1 The Company shall (and shall procure that each Subsidiary will) promptly do all such acts or execute all such documents (including assignments, transfers, mortgages, charges, notices and instructions) as the Security Agent may reasonably specify (and in such form as the Security Agent may reasonably require in favour of the Security Agent or its nominee(s)): (A) to perfect the Security created or intended to be created under or evidenced by the Security Documents (which may include the execution of a mortgage, charge, assignment or other Security over all or any of the assets which are, or are intended to be, the subject of the Transaction Security) or for the exercise of any rights, powers and remedies of the Security Agent or the Finance Parties provided by or pursuant to the Finance Documents or by law; (B) to confer on the Security Agent or confer on the Finance Parties Security over any property and assets of the Company located in any jurisdiction


 
07/16927352_14 58 equivalent or similar to the Security intended to be conferred by or pursuant to the Security Documents; and/or (C) to facilitate the realisation of the assets which are, or are intended to be, the subject of the Transaction Security. 20.20.2 The Company shall (and shall procure that each Subsidiary will) take all such action as is available to it (including making all filings and registrations) as may be necessary for the purpose of the creation, perfection, protection or maintenance of any Security conferred or intended to be conferred on the Security Agent or the Finance Parties by or pursuant to the Finance Documents. 21. EVENTS OF DEFAULT Each of the events or circumstances set out in this Clause 21 is an Event of Default (save for Clause 21.18 (Acceleration). 21.1 Non-payment The Company does not pay on the due date any amount payable pursuant to a Finance Document (except an amount the non-payment of which requires the Company to make a prepayment under Clause 7.12 (Mandatory prepayment and cancellation in relation to a single Lender) at the place and in the currency in which it is expressed to be payable unless: 21.1.1 its failure to pay is caused by: (A) administrative or technical error; or (B) a Disruption Event; and 21.1.2 payment is made within five Business Days of its due date. 21.2 Financial covenants 21.2.1 Any requirement of Clause 19 (Financial Covenants) is not satisfied. 21.2.2 If the financial covenant set out in Clause 19 (Financial Covenants) has been breached, but is complied with when tested in the next Testing Date (the “Second Period”), then, the prior breach of such financial covenant or any Event of Default arising therefrom shall no longer be outstanding or continuing for the purposes of the Finance Documents unless the Agent has taken any action referred to in Clause 21.18 (Acceleration) before delivery of the Compliance Certificate in respect of the Second Period. 21.3 Other obligations 21.3.1 The Company does not comply with any provision of the Finance Documents (other than those referred to in Clause 21.1 (Non-payment) and Clause 21.2 (Financial covenants)). 21.3.2 No Event of Default under Clause 21.3.1 above will occur if the failure to comply is capable of remedy and is remedied within ten Business Days of the earlier of (A) the Agent giving notice to the Company and (B) the Company becoming aware of the failure to comply. 21.4 Misrepresentation 21.4.1 Any representation or statement made or deemed to be made by the Company in the Finance Documents or any other document delivered by or on behalf of the Company under or in connection with any Finance Document is or proves to have been incorrect or misleading in any material respect when made or deemed to be made. 21.4.2 No Event of Default under Clause 21.4.1 above will occur if the misrepresentation is capable of remedy and is remedied within ten Business Days of the earlier of


 
07/16927352_14 59 (A) the Agent giving notice to the Company and (B) the Company becoming aware of the failure to comply. 21.5 Cross default 21.5.1 Any Financial Indebtedness of Constellium SE, the Company or any Material Subsidiary is not paid when due nor within any originally applicable grace period. 21.5.2 Any Financial Indebtedness of Constellium SE, the Company or any Material Subsidiary is declared to be or otherwise becomes due and payable prior to its specified maturity as a result of an event of default (however described) other than with respect to any Financial Indebtedness arising under a Treasury Transaction. 21.5.3 Any commitment for any Financial Indebtedness of Constellium SE, the Company or any Material Subsidiary is cancelled or suspended by a creditor as a result of an event of default (however described). 21.5.4 Any creditor of Constellium SE, the Company or any Material Subsidiary becomes entitled to declare any Financial Indebtedness of such relevant person due and payable prior to its specified maturity as a result of an event of default (however described). 21.5.5 No Event of Default will occur under this Clause 21.5 if (i) the aggregate amount of Financial Indebtedness or commitment for Financial Indebtedness falling within Clauses 21.5.1 to 21.5.4 above is less than €50,000,000 (or its equivalent in any other currency or currencies); or (ii) in relation to Financial Indebtedness owed by a member of the Group to another member of the Group or to Constellium SE. 21.6 Insolvency 21.6.1 Constellium SE, the Company or any Material Subsidiary: (A) is unable or admits inability to pay its debts as they fall due; (B) suspends making payments on any of its debts; or (C) by reason of actual or anticipated financial difficulties, commences negotiations with one or more of its creditors (excluding any Finance Party in its capacity as such) with a view to rescheduling any of its Financial Indebtedness, unless in the case of (A) and (B) above, it is in relation to Financial Indebtedness the principal amount of which does not exceed € 50,000,000 (or its equivalent in any other currency or currencies). 21.6.2 Constellium SE, the Company or a Material Subsidiary which conducts business in France is in a state of cessation des paiements, or becomes insolvent for the purpose of any insolvency law. 21.6.3 A moratorium is declared in respect of any indebtedness of Constellium SE, the Company or a Material Subsidiary. 21.7 Insolvency proceedings 21.7.1 Any corporate action, legal proceedings or other procedure or step is taken in relation to: (A) the suspension of payments or a moratorium of any Financial Indebtedness in respect of Constellium SE, the Company or a Material Subsidiary unless it is in relation to Financial Indebtedness the principal amount of which does not exceed €50,000,000 (or its equivalent in any other currency or currencies); (B) dissolution, the opening of proceedings for sauvegarde (including, for the avoidance of doubt, sauvegarde accélérée and sauvegarde financière accélérée), redressement judiciaire or liquidation judiciaire or


 
07/16927352_14 60 reorganisation (in the context of a mandat ad hoc or of a conciliation or otherwise) in respect of Constellium SE, the Company or a Material Subsidiary other than a solvent liquidation or reorganisation of any such person; (C) a composition, compromise, assignment or arrangement with any creditor of Constellium SE, the Company or a Material Subsidiary unless it is in relation to Financial Indebtedness the principal amount of which does not exceed €50,000,000 (or its equivalent in any other currency or currencies); (D) the appointment of a liquidator (other than in respect of a solvent liquidation of Constellium SE, the Company or a Material Subsidiary) receiver, administrator, administrative receiver, provisional administrator, mandataire ad hoc, conciliateur or other similar officer in respect of Constellium SE, the Company or a Material Subsidiary or any of its assets; (E) the enforcement of any Security over any assets of Company or Constellium SE, the Company or a Material Subsidiary, 21.7.2 Constellium SE, the Company or a Material Subsidiary applies for mandat ad hoc or conciliation in accordance with articles L.611-3 to L.611-15 of the French Code de commerce. 21.7.3 A judgement opening proceedings for sauvegarde (including, for the avoidance of doubt, sauvegarde accélérée and sauvegarde financière accélérée), redressement judiciaire or liquidation judiciaire or ordering a cession totale ou partielle de l'entreprise is entered in relation to Constellium SE, the Company or a Material Subsidiary under articles L.620-1 to L.670-8 of the French Code de commerce. 21.7.4 Any procedure, judgment or step is taken in any jurisdiction which has effects similar to those referred to in Clauses 21.7.1, 21.7.2 and 21.7.3 above. 21.7.5 This Clause 21.7 shall not apply to any redressement judiciaire or liquidation judiciaire petition which is frivolous or vexatious and is discharged, stayed or dismissed within twenty days of commencement. 21.8 Creditors' process Any of the enforcement proceedings provided for in the French Code des Procédures Civiles d'Exécution, or any expropriation, attachment, sequestration, distress or execution affects any asset or assets of the Company or a Material Subsidiary having an aggregate value of €5,000,000 and is not discharged within 45 days days, provided that if during that timeframe the Company demonstrates to the Agent in a manner satisfactory to the Agent that such seizure or attachment is unjustified, this shall not constitute an Event of Default. 21.9 Unlawfulness and invalidity 21.9.1 It is or becomes unlawful for the Company or Constellium France Holdco to perform any of its obligations under the Finance Documents or any Transaction Security created or expressed to be created or evidenced by the Security Documents ceases to be effective and this could reasonably be expected to materially adversely affect the interests of the Finance Parties under the Finance Documents. 21.9.2 Any obligation or obligations of the Company or of Constellium France Holdco under any Finance Documents are not or cease to be legal, valid, binding or enforceable and the cessation individually or cumulatively materially and adversely affects the interests of the Lenders under the Finance Documents. 21.9.3 Any Finance Document ceases to be in full force and effect or any Transaction Security ceases to be legal, valid, binding, enforceable or effective or is alleged


 
07/16927352_14 61 by a party to it (other than a Finance Party) to be ineffective and this, could reasonably be expected to materially adversely affect the interests of the Finance Parties under the Finance Documents. 21.10 Cessation of business The Company or any Material Subsidiary suspends or ceases to carry on (or threatens to suspend or cease to carry on) all or part of its business other than as a result of a Permitted Transaction or a Permitted Disposal and unless such suspension of business lasts less than 90 days. 21.11 Audit qualification Constellium SE's or the Company's statutory auditors qualify their respective audited annual (consolidated as the case may be) financial statements to the extent such reservation reflects serious deficiencies in accounting (which excludes any observation in the auditor's report in connection with the implementation of new accounting standards or with major accounting estimates that would trigger going concern issues (as defined in the relevant Accounting Principles)). 21.12 Expropriation The authority or ability of the Company or any Material Subsidiary to conduct its business is limited or wholly or substantially curtailed by any seizure expropriation, nationalisation, intervention, restriction or other action by or on behalf of any governmental, regulatory or other authority or other person in relation to the Company or any Material Subsidiary or any of its assets. 21.13 Litigation Any action, suit or proceeding is pending against or affecting the Company or any of its Material Subsidiary, in or before any judicial or administrative court, arbitrator or regulatory authority to the extent that it is reasonably expected to have a Material Adverse Effect. 21.14 Material Adverse Effect Any event or circumstance occurs which has a Material Adverse Effect. 21.15 Dividends 21.15.1 Constellium SE makes any dividend distribution (whether in the form of dividends, interim dividends or distribution of reserves) to its shareholders during the financial year ending 31 December 2020 which is not a Permitted Payment. 21.15.2 The Company makes any dividend distribution (whether in the form of dividends, interim dividends or distribution of reserves) or otherwise makes a payment to Constellium SE which is not a Permitted Payment. 21.16 French State Guarantee The Lenders lose the benefit of the French State Guarantee other than as a result of an action or omission of the Lenders. 21.17 Debt Capital Market Issue If Constellium SE makes any Debt Capital Markets Issue after the Initial Termination Date, Constellium SE fails to apply (through the Company) the net proceeds of any such issue in priority towards the voluntary prepayment of the Loan in accordance with the terms of this Agreement. 21.18 Acceleration On and at any time after the occurrence of an Event of Default which is continuing the Agent may without mise en demeure or any other judicial or extra judicial step, and shall if


 
07/16927352_14 62 so directed by the Majority Lenders, by notice to the Company but subject to the mandatory provisions of articles L.611-16 and L.620-1 to L.670-8 of the French Code de commerce: 21.18.1 cancel each Available Commitment of each Lender whereupon each such Available Commitment shall immediately be cancelled and each Facility shall immediately cease to be available for further utilisation; 21.18.2 declare that all or part of the Loan, together with accrued interest, and all other amounts accrued or outstanding under the Finance Documents be immediately due and payable, whereupon they shall become immediately due and payable. Section 8 CHANGES TO PARTIES 22. CHANGES TO THE LENDERS 22.1 Transfers by the Lenders 22.1.1 Subject to this Clause 22, a Lender (the “Existing Lender”) may transfer any of its rights (including such as relate to that Lender's participation in each Loan) and/or obligations, to another bank or financial institution or to a trust, fund or other entity which is regularly engaged in or established for the purpose of making, purchasing or investing in loans, securities or other financial assets (the “New Lender”). 22.1.2 The consent of the Finance Parties is hereby given to a transfer by an Existing Lender to a New Lender. 22.2 Company consent 22.2.1 The consent of the Company is required for a transfer by an Existing Lender, provided that the Company hereby consents to a transfer: (A) to another Lender or an Affiliate of any Lender; or (B) made at a time when an Event of Default is continuing. 22.2.2 Notwithstanding the above, no transfer, sub-participation or subcontracting in relation to a Utilisation by and/or Commitment to the Company may be effected to a New Lender incorporated or acting through the Facility Office situated in a Non- Cooperative Jurisdiction without the prior consent of the Company. In case of a transfer of obligations, the New Lender shall be a credit institution duly authorised to lend in France in accordance with French law. 22.2.3 The consent of the Company to a transfer must not be unreasonably withheld or delayed. Provided that, during such period of time, the Company has been provided with (i) the name of the New Lender, (ii) its place of incorporation, (iii) its rating and (iv) the list of sanctions laws or regulations applicable to the New Lender, the Company will be deemed to have given its consent ten (10) Business Days after the Existing Lender has requested it unless consent is expressly refused by the Company within that time. 22.2.4 The consent of the Company to a transfer must not be unreasonably withheld or delayed. The Company will be deemed to have given its consent five Business Days after the Existing Lender has requested it unless consent is expressly refused by the Company within that time. 22.3 Other conditions of transfer 22.3.1 Subject to any applicable laws and regulations regarding procedures for specific transfer, a transfer will only be effective if the procedure set out in Clause 22.6 (Procedure for transfer) is complied with.


 
07/16927352_14 63 22.3.2 If: (A) a Lender transfers any of its rights and/or obligations under the Finance Documents or changes its Facility Office; and (B) as a result of circumstances existing at the date the transfer or change occurs, the Company would be obliged to make a payment to the New Lender or Lender acting through its new Facility Office under Clause 12 (Tax gross-up and indemnities) or Clause 13 (Increased Costs), then the New Lender or Lender acting through its new Facility Office is only entitled to receive payment under those Clauses to the same extent as the Existing Lender or Lender acting through its previous Facility Office would have been if the transfer or change had not occurred. This Clause 22.3.2 shall not apply in respect of a transfer made in the ordinary course of the primary syndication of any Facility. 22.3.3 Each New Lender, by executing the relevant Transfer Agreement, confirms, for the avoidance of doubt, that the Agent has authority to execute on its behalf any amendment or waiver that has been approved by or on behalf of the requisite Lender or Lenders in accordance with this Agreement on or prior to the date on which the transfer becomes effective and that it is bound by that decision to the same extent as the Existing Lender would have been had it remained a Lender. 22.4 Transfer fee The New Lender shall, on the date upon which a transfer takes effect, pay to the Agent (for its own account) a fee of €3,000. 22.5 Limitation of responsibility of Existing Lenders 22.5.1 Unless expressly agreed to the contrary, an Existing Lender makes no representation or warranty and assumes no responsibility to a New Lender for: (A) the legality, validity, effectiveness, adequacy or enforceability of the Finance Documents or any other documents; (B) the financial condition of the Company; (C) the performance and observance by the Company of its obligations under the Finance Documents or any other documents; (D) the accuracy of any statements (whether written or oral) made in or in connection with any Finance Document or any other document; or (E) the existence of any transferred rights or receivables or their accessories including without limitation as to the transfer or the continued benefit of the French State Guarantee with respect thereto, and any representations or warranties implied by law are excluded. 22.5.2 Each New Lender confirms to the Existing Lender and the other Finance Parties that it: (A) has made (and shall continue to make) its own independent investigation and assessment of the financial condition and affairs of the Company and its related entities in connection with its participation in this Agreement and has not relied exclusively on any information provided to it by the Existing Lender in connection with any Finance Document; and (B) will continue to make its own independent appraisal of the creditworthiness of the Company and its related entities whilst any amount is or may be outstanding under the Finance Documents or any Commitment is in force.


 
07/16927352_14 64 22.5.3 Nothing in any Finance Document obliges an Existing Lender to: (A) accept a re-transfer from a New Lender of any of the rights and obligations transferred under this Clause 22; or (B) support any losses directly or indirectly incurred by the New Lender by reason of the non-performance by the Company of its obligations under the Finance Documents or otherwise. 22.6 Procedure for transfer 22.6.1 Subject to the conditions set out in Clause 22.2 (Company consent) and Clause 22.3 (Other conditions of transfer) and subject to any applicable laws and regulations regarding procedures for specific transfer, a transfer of rights and/or obligations is effected as against the Existing Lender, the New Lender, the Agent and the other Finance Parties in accordance with Clause 22.6.3 below when the Agent executes an otherwise duly completed Transfer Agreement delivered to it by the Existing Lender and the New Lender. The Agent shall, subject to Clause 22.6.2 below, as soon as reasonably practicable after receipt by it of a duly completed Transfer Agreement appearing on its face to comply with the terms of this Agreement and delivered in accordance with the terms of this Agreement, execute that Transfer Agreement. 22.6.2 The Agent shall only be obliged to execute a Transfer Agreement delivered to it by the Existing Lender and the New Lender once it is satisfied it has complied with all necessary “know your customer” or other similar checks under all applicable laws and regulations in relation to the transfer to such New Lender. 22.6.3 Subject to Clause 22.9 (Pro rata interest settlement), as from the Transfer Date: (A) to the extent that in the Transfer Agreement the Existing Lender seeks to transfer its rights and its obligations under the Finance Documents, the Existing Lender shall be discharged to the extent provided for in the Transfer Agreement from further obligations towards the Company and the other Finance Parties under the Finance Documents and the Company and the other Finance Parties hereby consent to such discharge; (B) the rights and/or obligations of the Existing Lender with respect to the Company shall be transferred to the New Lender, to the extent provided for in the Transfer Agreement; (C) the Agent, the New Lender and other Lenders shall acquire the same rights and assume the same obligations between themselves as they would have had had the New Lender been an Original Lender with the rights and/or obligations acquired or assumed by it as a result of the transfer and to that extent the Agent and the Existing Lender shall each be released from further obligations to each other under the Finance Documents; and (D) the New Lender shall become a Party as a “Lender”. 22.7 Copy of Transfer Agreement to Company The Agent shall, as soon as reasonably practicable after it has executed a Transfer Agreement, send to the Company a copy of that Transfer Agreement.


 
07/16927352_14 65 22.8 Security over Lenders' rights 22.8.1 In addition to the other rights provided to Lenders under this Clause 22, each Lender may without consulting with or obtaining consent from the Company, at any time transfer, charge, pledge or otherwise create Security in or over (whether by way of collateral or otherwise) all or any of its rights under any Finance Document to secure obligations of that Lender including, without limitation: (A) any transfer, charge, pledge or other Security to secure obligations to a federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank) including, without limitation, any transfer of rights to a special purpose vehicle where Security over securities issued by such special purpose vehicle is to be created in favour of a federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank); and (B) any transfer, charge, pledge or other Security granted to any holders (or trustee or representatives of holders) of obligations owed, or securities issued, by that Lender as security for those obligations or securities, except that no such transfer, charge, pledge or Security shall: (1) release a Lender from any of its obligations under the Finance Documents or substitute the beneficiary of the relevant transfer, charge, pledge or Security for the Lender as a party to any of the Finance Documents; or (2) require any payments to be made by the Company other than or in excess of, or grant to any person any more extensive rights than, those required to be made or granted to the relevant Lender under the Finance Documents. 22.8.2 The limitations on transfers by a Lender set out in any Finance Document, in particular in Clause 22.1 (Transfers by the Lenders), Clause 22.2 (Company consent) and Clause 22.4 (Transfer fee) shall not apply to the creation of Security pursuant to paragraph 22.8.1 above. 22.8.3 The limitations and provisions referred to in paragraph 22.8.2 above shall further not apply to any transfer of rights under the Finance Documents or of the securities issued by the special purpose vehicle, made by a federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank) to a third party in connection with the enforcement of Security created pursuant to paragraph 22.8.1 above. 22.9 Pro rata interest settlement 22.9.1 If the Agent has notified the Lenders that it is able to distribute interest payments on a “pro rata basis” to Existing Lenders and New Lenders then (in respect of any transfer pursuant to Clause 22.6 (Procedure for transfer) the Transfer Date of which, in each case, is after the date of such notification and is not on the last day of an Interest Period): (A) any interest or fees in respect of the relevant participation which are expressed to accrue by reference to the lapse of time shall continue to accrue in favour of the Existing Lender up to but excluding the Transfer Date (“Accrued Amounts”) and shall become due and payable to the Existing Lender (without further interest accruing on them) on the last day of the current Interest Period (or, if the Interest Period is longer than six Months, on the next of the dates which falls at six Monthly intervals after the first day of that Interest Period); and (B) the rights transferred by the Existing Lender will not include the right to the Accrued Amounts, so that, for the avoidance of doubt:


 
07/16927352_14 66 (1) when the Accrued Amounts become payable, those Accrued Amounts will be payable to the Existing Lender; and (2) the amount payable to the New Lender on that date will be the amount which would, but for the application of this Clause 22.9, have been payable to it on that date, but after deduction of the Accrued Amounts. 22.9.2 In this Clause 22.9 references to “Interest Period” shall be construed to include a reference to any other period for accrual of fees.] 22.9.3 An Existing Lender which retains the right to the Accrued Amounts pursuant to this Clause 22.9 but which does not have a Commitment shall be deemed not to be a Lender for the purposes of ascertaining whether the agreement of any specified group of Lenders has been obtained to approve any request for a consent, waiver, amendment or other vote of Lenders under the Finance Documents. 23. TRANSFERS BY THE COMPANY The Company may not transfer any of its rights and/or obligations under the Finance Documents. Section 9 THE FINANCE PARTIES 24. ROLE OF THE AGENT AND THE REFERENCE BANKS 24.1 Appointment of the Agent 24.1.1 Each of the Lenders appoints the Agent to act as its agent under and in connection with the Finance Documents. 24.1.2 Each of the Lenders authorises the Agent to perform the duties, obligations and responsibilities and to exercise the rights, powers, authorities and discretions specifically given to the Agent under or in connection with the Finance Documents together with any other incidental rights, powers, authorities and discretions. 24.1.3 Subject to the provisions of paragraph 24.1.5 below, the Agent will exercise (acting upon the instructions of the Lenders) any rights, powers, authorities and discretions in relation to the French State Guarantee. 24.1.4 If the French State Guarantee is called upon, and for the sole purpose of the French State Guarantee, the participation of each Lender in the Loan will be deemed to constitute a separate loan. 24.1.5 If the Agent, acting reasonably, considers that any action required under this Agreement on behalf of the Lenders in respect of the French State Guarantee (including in particular any payment to be made in connection therewith or any call (whether partial or total) to be made thereunder) conflict with, or are not required under, the general terms (conditions générales) applicable to the French State Guarantee: (i) the Agent shall inform the Lenders of the same promptly, and (ii) each relevant Lender shall perform such action directly in its own name and on its own behalf. 24.1.6 The Lenders agree to hold the Agent harmless if it chooses to exercise its right under paragraph 24.1.5 above, save in the case of gross negligence or wilful misconduct. 24.2 Instructions 24.2.1 The Agent shall:


 
07/16927352_14 67 (A) unless a contrary indication appears in a Finance Document, exercise or refrain from exercising any right, power, authority or discretion vested in it as Agent in accordance with any instructions given to it by: (1) all Lenders if the relevant Finance Document stipulates the matter is an all Lender decision; and (2) in all other cases, the Majority Lenders; and (B) not be liable for any act (or omission) if it acts (or refrains from acting) in accordance with paragraph 24.2.1(A) above. 24.2.2 The Agent shall be entitled to request instructions, or clarification of any instruction, from the Majority Lenders (or, if the relevant Finance Document stipulates the matter is a decision for any other Lender or group of Lenders, from that Lender or group of Lenders) as to whether, and in what manner, it should exercise or refrain from exercising any right, power, authority or discretion. The Agent may refrain from acting unless and until it receives any such instructions or clarification that it has requested. 24.2.3 Save in the case of decisions stipulated to be a matter for any other Lender or group of Lenders under the relevant Finance Document and unless a contrary indication appears in a Finance Document, any instructions given to the Agent by the Majority Lenders shall override any conflicting instructions given by any other Parties and will be binding on all Finance Parties. 24.2.4 The Agent may refrain from acting in accordance with any instructions of any Lender or group of Lenders until it has received any indemnification and/or security that it may in its discretion require (which may be greater in extent than that contained in the Finance Documents and which may include payment in advance) for any cost, loss or liability which it may incur in complying with those instructions. 24.2.5 In the absence of instructions, the Agent may act (or refrain from acting) as it considers to be in the best interest of the Lenders. 24.2.6 The Agent is not authorised to act on behalf of a Lender (without first obtaining that Lender's consent) in any legal or arbitration proceedings relating to any Finance Document. 24.3 Duties of the Agent 24.3.1 The Agent's duties under the Finance Documents are solely mechanical and administrative in nature. 24.3.2 Subject to Clause 24.3.3 below, the Agent shall promptly forward to a Party the original or a copy of any document which is delivered to the Agent for that Party by any other Party. 24.3.3 Without prejudice to Clause 22.7 (Copy of Transfer Agreement to Company), Clause 24.3.1 above shall not apply to any Transfer Agreement. 24.3.4 Except where a Finance Document specifically provides otherwise, the Agent is not obliged to review or check the adequacy, accuracy or completeness of any document it forwards to another Party. 24.3.5 If the Agent receives notice from a Party referring to this Agreement, describing a Default and stating that the circumstance described is a Default, it shall promptly notify the other Finance Parties. 24.3.6 If the Agent is aware of the non-payment of any principal, interest, commitment fee or other fee payable to a Finance Party (other than the Agent or the Coordinator ) under this Agreement it shall promptly notify the other Finance Parties.


 
07/16927352_14 68 24.3.7 The Agent shall have only those duties, obligations and responsibilities expressly specified in the Finance Documents to which it is expressed to be a party (and no others shall be implied). 24.4 Role of the Coordinator Except as specifically provided in the Finance Documents, the Coordinator has no obligations of any kind to any other Party under or in connection with any Finance Document. 24.5 No fiduciary duties 24.5.1 Nothing in any Finance Document constitutes the Agent as a trustee or fiduciary of any other person. 24.5.2 The Agent shall not be bound to account to any Lender for any sum or the profit element of any sum received by it for its own account. 24.6 Business with the Group The Agent may accept deposits from, lend money to and generally engage in any kind of banking or other business with any member of the Group. 24.7 Rights and discretions 24.7.1 The Agent may: (A) rely on any representation, communication, notice or document believed by it to be genuine, correct and appropriately authorised; (B) assume that: (1) any instructions received by it from the Majority Lenders, any Lenders or any group of Lenders are duly given in accordance with the terms of the Finance Documents; and (2) unless it has received notice of revocation, that those instructions have not been revoked; and (C) rely on a certificate from any person: (1) as to any matter of fact or circumstance which might reasonably be expected to be within the knowledge of that person; or (2) to the effect that such person approves of any particular dealing, transaction, step, action or thing, (3) as sufficient evidence that that is the case and, in the case of paragraph 24.7.1(C)(1) above, may assume the truth and accuracy of that certificate. 24.7.2 The Agent may assume (unless it has received notice to the contrary in its capacity as agent for the Lenders) that: (A) no Default has occurred (unless it has actual knowledge of a Default arising under Clause 21.1 (Non-payment)); (B) any right, power, authority or discretion vested in any Party or any group of Lenders has not been exercised; and (C) any notice or request made by the Company (other than a Utilisation Request or Selection Notice) is made on behalf of and with the consent and knowledge of the Company. 24.7.3 The Agent may engage and pay for the advice or services of any lawyers, accountants, tax advisers, surveyors or other professional advisers or experts. 24.7.4 Without prejudice to the generality of paragraph 24.7.3 above or paragraph 24.7.5 below, the Agent may at any time engage and pay for the services of any


 
07/16927352_14 69 lawyers to act as independent counsel to the Agent (and so separate from any lawyers instructed by the Lenders) if the Agent in its reasonable opinion deems this to be necessary. 24.7.5 The Agent may rely on the advice or services of any lawyers, accountants, tax advisers, surveyors or other professional advisers or experts (whether obtained by the Agent or by any other Party) and shall not be liable for any damages, costs or losses to any person, any diminution in value or any liability whatsoever arising as a result of its so relying, unless directly caused by its gross negligence or wilful misconduct. 24.7.6 The Agent may act in relation to the Finance Documents through its officers, employees and agents. 24.7.7 Unless a Finance Document expressly provides otherwise the Agent may disclose to any other Party any information it reasonably believes it has received as agent under this Agreement. 24.7.8 Notwithstanding any other provision of any Finance Document to the contrary, the Agent is not obliged to do or omit to do anything if it would, or might in its reasonable opinion, constitute a breach of any law or regulation or a breach of a fiduciary duty or duty of confidentiality. 24.7.9 Notwithstanding any provision of any Finance Document to the contrary, the Agent is not obliged to expend or risk its own funds or otherwise incur any financial liability in the performance of its duties, obligations or responsibilities or the exercise of any right, power, authority or discretion if it has grounds for believing the repayment of such funds or adequate indemnity against, or security for, such risk or liability is not reasonably assured to it. 24.8 Responsibility for documentation The Agent is not responsible or liable for: 24.8.1 the adequacy, accuracy or completeness of any information (whether oral or written) supplied by the Agent, the Company or any other person in or in connection with any Finance Document or the transactions contemplated in the Finance Documents or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document; or 24.8.2 the legality, validity, effectiveness, adequacy or enforceability of any Finance Document or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document; or 24.8.3 any determination as to whether any information provided or to be provided to any Finance Party is non-public information the use of which may be regulated or prohibited by applicable law or regulation relating to insider dealing or otherwise. 24.9 No duty to monitor The Agent shall not be bound to enquire: 24.9.1 whether or not any Default has occurred; 24.9.2 as to the performance, default or any breach by any Party of its obligations under any Finance Document; or 24.9.3 whether any other event specified in any Finance Document has occurred. 24.10 Exclusion of liability 24.10.1 Without limiting paragraph 24.10.3 below (and without prejudice to any other provision of any Finance Document excluding or limiting the liability of the Agent), the Agent will not be liable for:


 
07/16927352_14 70 (A) any damages, costs or losses to any person, any diminution in value, or any liability whatsoever arising as a result of taking or not taking any action under or in connection with any Finance Document, unless directly caused by its gross negligence or wilful misconduct; (B) exercising, or not exercising, any right, power, authority or discretion given to it by, or in connection with, any Finance Document or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with, any Finance Document, other than by reason of gross negligence or wilful misconduct; or (C) without prejudice to the generality of paragraphs 24.10.1(A) and 24.10.1(B) above, any damages, costs or losses to any person, any diminution in value or any liability whatsoever (including, without limitation, for negligence or any other category of liability whatsoever but not including any claim based on the fraud of the Agent) arising as a result of: (1) any act, event or circumstance not reasonably within its control; or (2) the general risks of investment in, or the holding of assets in, any jurisdiction, including (in each case and without limitation) such damages, costs, losses, diminution in value or liability arising as a result of: nationalisation, expropriation or other governmental actions; any regulation, currency restriction, devaluation or fluctuation; market conditions affecting the execution or settlement of transactions or the value of assets (including any Disruption Event); breakdown, failure or malfunction of any third party transport, telecommunications, computer services or systems; natural disasters or acts of God; war, terrorism, insurrection or revolution; or strikes or industrial action. 24.10.2 No Party (other than the Agent) may take any proceedings against any officer, employee or agent of the Agent in respect of any claim it might have against the Agent or in respect of any act or omission of any kind by that officer, employee or agent in relation to any Finance Document and any officer, employee or agent of the Agent may rely on this paragraph 24.10.2. 24.10.3 The Agent will not be liable for any delay (or any related consequences) in crediting an account with an amount required under the Finance Documents to be paid by the Agent if the Agent has taken all necessary steps as soon as reasonably practicable to comply with the regulations or operating procedures of any recognised clearing or settlement system used by the Agent for that purpose. 24.10.4 Nothing in this Agreement shall oblige the Agent to carry out: (A) any “know your customer” or other checks in relation to any person; or (B) any check on the extent to which any transaction contemplated by this Agreement might be unlawful for any Lender or for any Affiliate of any Lender, on behalf of any Lender and each Lender confirms to the Agent that it is solely responsible for any such checks it is required to carry out and that it may not rely on any statement in relation to such checks made by the Agent or the Coordinator. 24.10.5 Without prejudice to any provision of any Finance Document excluding or limiting the Agent's liability, any liability of the Agent arising under or in connection with any Finance Document shall be limited to the amount of actual loss which has been suffered (as determined by reference to the date of default of the Agent or, if later, the date on which the loss arises as a result of such default) but without reference to any special conditions or circumstances known to the Agent at any


 
07/16927352_14 71 time which increase the amount of that loss. In no event shall the Agent be liable for any loss of profits, goodwill, reputation, and business opportunity or anticipated saving, or for special, punitive, indirect or consequential damages, whether or not the Agent has been advised of the possibility of such loss or damages. 24.11 Lenders' indemnity to the Agent Each Lender shall (in proportion to its share of the Total Commitments or, if the Total Commitments are then zero, to its share of the Total Commitments immediately prior to their reduction to zero) indemnify the Agent, within three Business Days of demand, against any cost, loss or liability (including, without limitation, for negligence or any other category of liability whatsoever) incurred by the Agent (otherwise than by reason of the Agent's gross negligence or wilful misconduct) (or, in the case of any cost, loss or liability pursuant to Clause 28.10 (Disruption to Payment Systems etc.) notwithstanding the Agent's negligence, gross negligence or any other category of liability whatsoever but not including any claim based on the fraud of the Agent) in acting as Agent under the Finance Documents (unless the Agent has been reimbursed by the Company pursuant to a Finance Document). 24.12 Resignation of the Agent 24.12.1 The Agent may resign and appoint one of its Affiliates acting through an office in France as successor by giving notice to the Lenders and the Company. 24.12.2 Alternatively the Agent may resign by giving 30 days' notice to the Lenders and the Company, in which case the Majority Lenders (after consultation with the Company) may appoint a successor Agent, which shall not be incorporated or acting through an office situated in a Non-Cooperative Jurisdiction. 24.12.3 The Company may, on no less than 30 days' prior notice to the Agent, require the Lenders to replace the Agent and appoint a replacement Agent if any amount payable under a Finance Document by the Company established in France becomes not deductible from the Company’s taxable income for French tax purposes by reason of that amount (i) being paid or accrued to an Agent incorporated or acting through an office situated in a Non-Cooperative Jurisdiction or (ii) paid to an account opened in the name of that Agent in a financial institution situated in a Non-Cooperative Jurisdiction. In this case, the Agent shall resign and a replacement Agent shall be appointed by the Majority Lenders (after consultation with the Company) within 30 days after notice of replacement was given. 24.12.4 If the Majority Lenders have not appointed a successor Agent in accordance with Clause 24.12.2 above within 20 days after notice of resignation was given, the retiring Agent (after consultation with the Company) may appoint a successor Agent (acting through an office in France). 24.12.5 If the Agent wishes to resign because (acting reasonably) it has concluded that it is no longer appropriate for it to remain as agent and the Agent is entitled to appoint a successor Agent under paragraph 24.12.4 above, the Agent may (if it concludes (acting reasonably) that it is necessary to do so in order to persuade the proposed successor Agent to become a party to this Agreement as Agent) agree with the proposed successor Agent amendments to this Clause 24 and any other term of this Agreement dealing with the rights or obligations of the Agent consistent with then current market practice for the appointment and protection of corporate trustees together with any reasonable amendments to the agency fee payable under this Agreement which are consistent with the successor Agent's normal fee rates and those amendments will bind the Parties. 24.12.6 The retiring Agent shall, at its own cost, make available to the successor Agent such documents and records and provide such assistance as the successor Agent may reasonably request for the purposes of performing its functions as


 
07/16927352_14 72 Agent under the Finance Documents. The Company shall, within three Business Days of demand, reimburse the retiring Agent for the amount of all costs and expenses (including legal fees) properly incurred by it in making available such documents and records and providing such assistance. 24.12.7 The Agent's resignation notice shall only take effect upon the appointment of a successor. 24.12.8 Upon the appointment of a successor, the retiring Agent shall be discharged from any further obligation in respect of the Finance Documents (other than its obligations under paragraph 24.12.6 above) but shall remain entitled to the benefit of Clause 14.3 (Indemnity to the Agent) and this Clause 24 (and any agency fees for the account of the retiring Agent shall cease to accrue from (and shall be payable on) that date). Any successor and each of the other Parties shall have the same rights and obligations amongst themselves as they would have had if such successor had been an original Party. 24.12.9 After consultation with the Company, the Majority Lenders may, by notice to the Agent, require it to resign in accordance with Clause 24.12.2 above. In this event, the Agent shall resign in accordance with Clause 24.12.2 above. 24.12.10 The Agent shall resign in accordance with paragraph 24.12.2 above (and, to the extent applicable, shall use reasonable endeavours to appoint a successor Agent pursuant to paragraph 24.12.4 above) if on or after the date which is three months before the earliest FATCA Application Date relating to any payment to the Agent under the Finance Documents, either: (A) the Agent fails to respond to a request under Clause 12.8 (FATCA information) and the Company or a Lender reasonably believes that the Agent will not be (or will have ceased to be) a FATCA Exempt Party on or after that FATCA Application Date; (B) the information supplied by the Agent pursuant to Clause 12.8 (FATCA information) indicates that the Agent will not be (or will have ceased to be) a FATCA Exempt Party on or after that FATCA Application Date; or (C) the Agent notifies the Company and the Lenders that the Agent will not be (or will have ceased to be) a FATCA Exempt Party on or after that FATCA Application Date, and (in each case) the Company or a Lender reasonably believes that a Party will be required to make a FATCA Deduction that would not be required if the Agent were a FATCA Exempt Party, and the Company or that Lender, by notice to the Agent, requires it to resign. 24.13 Confidentiality 24.13.1 In acting as agent for the Finance Parties, the Agent shall be regarded as acting through its agency division which shall be treated as a separate entity from any other of its divisions or departments. 24.13.2 If information is received by another division or department of the Agent, it may be treated as confidential to that division or department and the Agent shall not be deemed to have notice of it. 24.14 Relationship with the Lenders 24.14.1 Subject to Clause 22.9 (Pro rata interest settlement), the Agent may treat the person shown in its records as Lender at the opening of business (in the place of the Agent's principal office as notified to the Finance Parties from time to time) as the Lender acting through its Facility Office: (A) entitled to or liable for any payment due under any Finance Document on that day; and


 
07/16927352_14 73 (B) entitled to receive and act upon any notice, request, document or communication or make any decision or determination under any Finance Document made or delivered on that day, unless it has received not less than five Business Days prior notice from that Lender to the contrary in accordance with the terms of this Agreement. 24.14.2 Any Lender may by notice to the Agent appoint a person to receive on its behalf all notices, communications, information and documents to be made or despatched to that Lender under the Finance Documents. Such notice shall contain the address, fax number and (where communication by electronic mail or other electronic means is permitted under Clause 30.5 (Electronic communication)) electronic mail address and/or any other information required to enable the transmission of information by that means (and, in each case, the department or officer, if any, for whose attention communication is to be made) and be treated as a notification of a substitute address, fax number, electronic mail address (or such other information), department and officer by that Lender for the purposes of Clause 30.2 (Addresses) and Clause 30.5.1(B) of Clause 30.5 (Electronic communication) and the Agent shall be entitled to treat such person as the person entitled to receive all such notices, communications, information and documents as though that person were that Lender. 24.15 Credit appraisal by the Lenders Without affecting the responsibility of the Company for information supplied by it or on its behalf in connection with any Finance Document, each Lender confirms to the Agent that it has been, and will continue to be, solely responsible for making its own independent appraisal and investigation of all risks arising under or in connection with any Finance Document including but not limited to: 24.15.1 the financial condition, status and nature of each member of the Group; 24.15.2 the legality, validity, effectiveness, adequacy or enforceability of any Finance Document and any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document; 24.15.3 whether that Lender has recourse, and the nature and extent of that recourse, against any Party or any of its respective assets under or in connection with any Finance Document, the transactions contemplated by the Finance Documents or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document; and 24.15.4 the adequacy, accuracy or completeness of any information provided by the Agent, any Party or by any other person under or in connection with any Finance Document, the transactions contemplated by any Finance Document or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document. 24.16 Agent's management time Any amount payable to the Agent under Clause 14.3 (Indemnity to the Agent), Clause 16 (Costs and Expenses) and Clause 24.11 (Lenders' indemnity to the Agent) shall include the cost of utilising the Agent's management time or other resources and will be calculated on the basis of such reasonable daily or hourly rates as the Agent may notify to the Company and the Lenders, and is in addition to any fee paid or payable to the Agent under Clause 11 (Fees). 24.17 Deduction from amounts payable by the Agent If any Party owes an amount to the Agent under the Finance Documents the Agent may, after giving notice to that Party, deduct an amount not exceeding that amount from any payment to that Party which the Agent would otherwise be obliged to make under the


 
07/16927352_14 74 Finance Documents and apply the amount deducted in or towards satisfaction of the amount owed. For the purposes of the Finance Documents that Party shall be regarded as having received any amount so deducted. 24.18 Role of Reference Banks 24.18.1 No Reference Bank is under any obligation to provide a quotation or any other information to the Agent. 24.18.2 No Reference Bank will be liable for any action taken by it under or in connection with any Finance Document, or for any Reference Bank Quotation, unless directly caused by its gross negligence or wilful misconduct. 24.18.3 No Party (other than the relevant Reference Bank) may take any proceedings against any officer, employee or agent of any Reference Bank in respect of any claim it might have against that Reference Bank or in respect of any act or omission of any kind by that officer, employee or agent in relation to any Finance Document, or to any Reference Bank Quotation, and any officer, employee or agent of each Reference Bank may rely on this Clause 24.18. 25. ROLE OF THE SECURITY AGENT 25.1 Appointment 25.1.1 Each of the Finance Parties (other than the Security Agent): (A) irrevocably appoints the Security Agent to act as security agent pursuant to articles 1984 et seq. of the French Code civil in respect of the Security Documents; (B) irrevocably authorises the Security Agent acting without limitation and notwithstanding any other rights conferred upon the Security Agent under this Agreement to: (1) execute, in its name and for the benefit of each other Secured Party, each Security Document and all notices, acknowledgements or other documents to be signed by all beneficiaries under any of the Security Documents; (2) manage and enforce the Transaction Security, and to this end sign any document or deed or initiate any procedure to this effect in accordance with the provisions of this Agreement and the Security Documents; (3) take any action and exercise all the rights and prerogatives expressly granted to it by the Finance Parties under this Agreement and the Security Documents; (4) take any measure of publicity or any protective measure, carry out any other formality necessary for the validity and enforceability of the Transaction Security and, more generally, take any necessary measure to preserve the rights of the Finance Parties under the Transaction Security; and (5) fully and irrevocably release (i) a Transaction Security after full repayment and payment of all sums due in respect of the obligations secured by such Transaction Security and (ii) any Transaction Security the release of which is authorised in accordance with the relevant Security Documents or this Agreement, subject to compliance with the conditions referred to in the relevant Security Documents, which the relevant Finance Parties already accept. 25.1.2 The Security Agent's mission will be of a purely technical and administrative nature.


 
07/16927352_14 75 25.1.3 Notwithstanding the provisions of paragraph 1 of article 1161 of the French Civil Code, each of the Finance Parties authorises the Security Agent to act in its own name and in the name and on behalf of each of the Finance Parties. 25.2 Discretionary rights and powers of the Security Agent 25.2.1 The Security Agent may legitimately rely on: (A) any declaration, notification or document that reasonably appears to it to be authentic, accurate and duly authorised; and (B) any statement made by an administrator, an authorised representative or an agent of a person on matters of which it may reasonably assume that such person is aware or is able to verify the accuracy of the statement. 25.2.2 The Security Agent may legitimately assume, unless otherwise notified, that a right, prerogative or power belonging to a Party or to the Majority Lenders has not been exercised. 25.2.3 The Security Agent may hire and remunerate legal counsel, accountants, analysts and other experts, rely on their advices and rely on the results of their services. 25.2.4 The Security Agent may act through its agents or representatives. 25.2.5 The Security Agent may disclose to any other Party any information that it reasonably considers it has received as agent (mandataire) under this Agreement. 25.3 Exclusion of liability 25.3.1 Without prejudice to the provisions of Clause 25.3.2. below, the Security Agent shall not be held liable for acts performed pursuant to this Agreement and the Security Documents, or relating thereto, except in the event of its gross negligence or fraud. 25.3.2 No Party may invoke the liability of any corporate officer, agent or representative of the Security Agent in connection with the incurrence of the Security Agent's liability or for any act or omission in connection with this Agreement and the Security Documents. These persons may avail themselves of the provisions of this Clause. 25.3.3 The Security Agent is not liable for any delay in crediting an account of any amount to be paid by it under this Agreement (or any consequences that may result from such delay) if it has carried out all the necessary steps, within reasonable delays, to comply with the regulations and operational procedures of any reputable payment or settlement system. 25.3.4 The Security Agent is not responsible for: (A) the accuracy or completeness of the oral or written information received from the Company or any other person regarding the Security Documents, and transmitted by the Security Agent; or (B) the legality, validity, adequacy or possibility of enforcing the rights arising from the Security Documents or any other agreement or document relating to or prepared for the signature or execution of the Security Documents. 25.3.5 In no circumstances shall the Security Agent be held liable in respect of any act or omission performed in accordance with instructions given to it. 25.3.6 Notwithstanding any provision to the contrary in this Agreement, the Security Agent shall have no obligation to do anything or refrain from doing anything if it may result in a breach of any law, regulation or confidentiality obligation or undertaking.


 
07/16927352_14 76 25.4 Indemnity to the Security Agent Within three (3) Business Days of a request to this effect from the Security Agent, the Finance Parties shall indemnify the Security Agent for all reasonable and justified expenses, losses and liabilities incurred by it in connection with the performance of its mandate as Security Agent (subject to the delivery by the Security Agent of the supporting documents relating thereto), except in the event of gross negligence or fraud by the Security and unless the Security Agent has already been reimbursed by the Company in accordance with the provisions of the Security Documents or this Agreement. 25.5 Instructions to the Security Agent 25.5.1 Unless expressly provided otherwise, the Security Agent shall exercise its mandate in compliance with the instructions of the other Finance Parties. The Security Agent shall also refrain from exercising any right or power given to it in the event of receipt of an instruction from the Instructing Group to that effect. 25.5.2 As long as it has not received the guarantees that it may request to indemnify it for any costs, losses and liabilities (plus any VAT which may be due) that it may incur by complying with the instructions of the Finance Parties, the Security Agent shall be entitled to refrain from executing such instructions. 25.6 Resignation of the Security Agent 25.6.1 The Security Agent may, with reasonable prior notice to the Finance Parties, resign and substitute to it any entity of the group of the Security Agent acting through its agency located in France. 25.6.2 The Security Agent may also inform the Finance Parties of its intention to resign without appointing a successor, in which case the Majority Lenders may appoint its successor by mutual agreement. 25.6.3 If, within thirty (30) calendar days after the Security Agent has informed the Finance Parties of its intention to resign, the Majority Lenders have not appointed a successor in accordance with Clause 25.6.2 above, the resigning Security Agent may appoint the new Security Agent (which shall exercise its functions through its agency located in France). 25.6.4 The resigning Security Agent shall make available to its successor, at its own costs, all documents, books and records and shall provide it with all assistance that its successor may reasonably request for the purpose of performing its functions as Security Agent under this Agreement and the Security Documents. 25.6.5 The resignation of the Security Agent shall take effect only from the appointment of its successor and the accession of such successor, as new Security Agent, to this Agreement. 25.6.6 The Majority Lenders may request, by a common decision, that the Security Agent resigns in compliance with the conditions set out in Article 25.6.1 above. The Security Agent, once informed of such decision of the Majority Lenders, shall resign in compliance with the conditions set out in Clause 25.6.1; provided that, in that case, the costs referred to in Article 25.6.4 shall be borne by the Finance Parties. 25.7 Termination of the mandate of the Security Agent As from the date on which all obligations secured by the Security Documents will be fully and irrevocably discharged in accordance with the terms of such Security Documents, the mandate of the Security Agent under this Agreement shall automatically terminate. 25.8 Analysis by each Finance Party 25.8.1 Without prejudice to the Company’s responsibility for the information provided by it or on its behalf in connection with the preparation and negotiation of the


 
07/16927352_14 77 Finance Documents, each of the Finance Parties confirms to the Security Agent that it has carried out its own analysis, under its own responsibility, independently and for its own account, of the risks resulting from the Finance Documents, in particular with regard to: 25.8.2 the financial situation, status and features of the members of the Group; 25.8.3 the legality, validity, adequacy and enforceability of the rights arising from the Security Documents, this Agreement and any other deed or document relating to or prepared for the signature of the Security Documents; 25.8.4 the remedies and rights, including their nature and scope, that the Finance Parties may have against the Company or any of its assets under the Security Documents, the transactions envisaged thereunder or the other agreements or documents relating to or prepared for the signature of the Security Documents and this Agreement; and 25.8.5 the adequacy, accuracy and/or exhaustiveness of the information provided by the Security Agent, a Party or another person in connection with the Security Documents, the transactions arranged thereby or any other agreement or document relating to or prepared for the signature of the Security Documents. 26. CONDUCT OF BUSINESS BY THE FINANCE PARTIES 26.1 No provision of this Agreement will: 26.1.1 interfere with the right of any Finance Party to arrange its affairs (tax or otherwise) in whatever manner it thinks fit; 26.1.2 oblige any Finance Party to investigate or claim any credit, relief, remission or repayment available to it or the extent, order and manner of any claim; or 26.1.3 oblige any Finance Party to disclose any information relating to its affairs (tax or otherwise) or any computations in respect of Tax. 26.2 Any Lender is entitled to exercise any of its rights and discretion under the Finance Documents through any agent (including any entity appointed to act as servicer on its behalf). 27. SHARING AMONG THE FINANCE PARTIES 27.1 Payments to Finance Parties If a Finance Party (a “Recovering Finance Party”) receives or recovers any amount from the Company other than in accordance with Clause 28 (Payment Mechanics) (a “Recovered Amount”) and applies that amount to a payment due under the Finance Documents then such Recovering Finance Party shall be deemed to have been substituted for the Agent for purposes of receiving or recovering a Sharing Payment (as defined below) and: 27.1.1 the Recovering Finance Party shall, within three Business Days, notify details of the receipt or recovery to the Agent; 27.1.2 the Agent shall determine whether the receipt or recovery is in excess of the amount the Recovering Finance Party would have been paid had the receipt or recovery been received or made by the Agent and distributed in accordance with Clause 28 (Payment Mechanics), without taking account of any Tax which would be imposed on the Agent in relation to the receipt, recovery or distribution; and 27.1.3 the Recovering Finance Party shall, within three Business Days of demand by the Agent, pay to the Agent an amount (the “Sharing Payment”) equal to such receipt or recovery less any amount which the Agent determines may be retained by the Recovering Finance Party as its share of any payment to be made, in accordance with Clause 28.5 (Partial payments).


 
07/16927352_14 78 27.2 Redistribution of payments The Agent shall treat the Sharing Payment as if it had been paid by the Company and distribute it between the Finance Parties (other than the Recovering Finance Party) (the “Sharing Finance Parties”) in accordance with Clause 28.5 (Partial payments) towards the obligations of the Company to the Sharing Finance Parties. 27.3 Recovering Finance Party's rights On a distribution by the Agent under Clause 27.2 (Redistribution of payments) of a payment received by a Recovering Finance Party from the Company, as between the Company and the Recovering Finance Party, an amount of the Recovered Amount equal to the Sharing Payment will be treated as not having been paid by the Company to the Recovering Finance Party. 27.4 Reversal of redistribution If any part of the Sharing Payment received or recovered by a Recovering Finance Party becomes repayable and is repaid by that Recovering Finance Party, then: 27.4.1 each Sharing Finance Party shall, upon request of the Agent, pay to the Agent for the account of that Recovering Finance Party an amount equal to the appropriate part of its share of the Sharing Payment (together with an amount as is necessary to reimburse that Recovering Finance Party for its proportion of any interest on the Sharing Payment which that Recovering Finance Party is required to pay) (the “Redistributed Amount”); and 27.4.2 as between the Company and each relevant Sharing Finance Party, an amount equal to the relevant Redistributed Amount will be treated as not having been paid by the Company to the relevant Sharing Finance Party. 27.5 Exceptions 27.5.1 This Clause 27 shall not apply to the extent that the Recovering Finance Party would not, after making any payment pursuant to this Clause, have a valid and enforceable claim against the Company. 27.5.2 A Recovering Finance Party is not obliged to share with any other Finance Party any amount which the Recovering Finance Party has received or recovered as a result of taking legal or arbitration proceedings, if: (A) it notified that other Finance Party of the legal or arbitration proceedings; and (B) that other Finance Party had an opportunity to participate in those legal or arbitration proceedings but did not do so as soon as reasonably practicable having received notice and did not take separate legal or arbitration proceedings. Section 10 ADMINISTRATION 28. PAYMENT MECHANICS 28.1 Payments to the Agent 28.1.1 On each date on which the Company or a Lender is required to make a payment under a Finance Document, the Company or Lender shall make the same available to the Agent (unless a contrary indication appears in a Finance Document) for value on the due date at the time and in such funds specified by the Agent as being customary at the time for settlement of transactions in the relevant currency in the place of payment.


 
07/16927352_14 79 28.1.2 Payment shall be made to such account in the principal financial centre of the country of that currency (or, in relation to euro, in a principal financial centre in such Participating Member State or London, as specified by the Agent), other than a Non-Cooperative Jurisdiction, and with such bank as the Agent, in each case specifies. 28.2 Distributions by the Agent Each payment received by the Agent under the Finance Documents for another Party shall, subject to Clause 28.3 (Distributions to the Company) and Clause 28.4 (Clawback) be made available by the Agent as soon as practicable after receipt to the Party entitled to receive payment in accordance with this Agreement (in the case of a Lender, for the account of its Facility Office), to such account as that Party may notify to the Agent by not less than five Business Days' notice with a bank specified by that Party in the principal financial centre of the country of that currency (or, in relation to euro, in the principal financial centre of a Participating Member State or London as specified by that Party), other than a Non-Cooperative Jurisdiction. 28.3 Distributions to the Company The Agent may (with the consent of the Company or in accordance with Clause 29 (Set- off)) apply any amount received by it for the Company in or towards payment (on the date and in the currency and funds of receipt) of any amount due from the Company under the Finance Documents or in or towards purchase of any amount of any currency to be so applied. 28.4 Clawback 28.4.1 Where a sum is to be paid to the Agent under the Finance Documents for another Party, the Agent is not obliged to pay that sum to that other Party (or to enter into or perform any related exchange contract) until it has been able to establish to its satisfaction that it has actually received that sum. 28.4.2 If the Agent pays an amount to another Party and it proves to be the case that the Agent had not actually received that amount, then the Party to whom that amount (or the proceeds of any related exchange contract) was paid by the Agent shall on demand refund the same to the Agent together with interest on that amount from the date of payment to the date of receipt by the Agent, calculated by the Agent to reflect its cost of funds. 28.5 Partial payments 28.5.1 If the Agent receives a payment that is insufficient to discharge all the amounts then due and payable by the Company under the Finance Documents, the Agent shall apply that payment towards the obligations of the Company under the Finance Documents in the following order: (A) first, in or towards payment pro rata of any unpaid amount owing to the Agent under the Finance Documents; (B) secondly, in or towards payment pro rata of any accrued interest, fee or commission due but unpaid under this Agreement; (C) thirdly, in or towards payment pro rata of any principal due but unpaid under this Agreement; and (D) fourthly, in or towards payment pro rata of any other sum due but unpaid under the Finance Documents. 28.5.2 The Agent shall, if so directed by the Majority Lenders, vary the order set out in Clause 28.5.1(B) to 28.5.1(D) above. 28.5.3 Clauses 28.5.1 and 28.5.2 above will override any appropriation made by the Company.


 
07/16927352_14 80 28.6 No set-off by the Company All payments to be made by the Company under the Finance Documents shall be calculated and be made without (and free and clear of any deduction for) set-off or counterclaim. 28.7 Business Days 28.7.1 Any payment under the Finance Documents which is due to be made on a day that is not a Business Day shall be made on the next Business Day in the same calendar month (if there is one) or the preceding Business Day (if there is not). 28.7.2 During any extension of the due date for payment of any principal or an Unpaid Sum under this Agreement interest is payable on the principal or Unpaid Sum at the rate payable on the original due date. 28.8 Currency of account 28.8.1 Subject to Clauses 28.8.2 and 28.8.5 below, euro is the currency of account and payment for any sum due from the Company under any Finance Document. 28.8.2 A repayment of the Loan or Unpaid Sum or a part of the Loan or Unpaid Sum shall be made in the currency in which the Loan or Unpaid Sum is denominated, pursuant to this Agreement, on its due date. 28.8.3 Each payment of interest shall be made in the currency in which the sum in respect of which the interest is payable was denominated, pursuant to this Agreement, when that interest accrued. 28.8.4 Each payment in respect of costs, expenses or Taxes shall be made in the currency in which the costs, expenses or Taxes are incurred. 28.8.5 Any amount expressed to be payable in a currency other than euro shall be paid in that other currency. 28.9 Change of currency 28.9.1 Unless otherwise prohibited by law, if more than one currency or currency unit are at the same time recognised by the central bank of any country as the lawful currency of that country, then: (A) any reference in the Finance Documents to, and any obligations arising under the Finance Documents in, the currency of that country shall be translated into, or paid in, the currency or currency unit of that country designated by the Agent (after consultation with the Company); and (B) any translation from one currency or currency unit to another shall be at the official rate of exchange recognised by the central bank for the conversion of that currency or currency unit into the other, rounded up or down by the Agent (acting reasonably). 28.9.2 If a change in any currency of a country occurs, this Agreement will, to the extent the Agent (acting reasonably and after consultation with the Company) specifies to be necessary, be amended to comply with any generally accepted conventions and market practice in the Relevant Market and otherwise to reflect the change in currency. 28.10 Disruption to Payment Systems etc. If either the Agent determines (in its discretion) that a Disruption Event has occurred or the Agent is notified by the Company that a Disruption Event has occurred: 28.10.1 the Agent may, and shall if requested to do so by the Company, consult with the Company with a view to agreeing with the Company such changes to the operation or administration of the Facility as the Agent may deem necessary in the circumstances;


 
07/16927352_14 81 28.10.2 the Agent shall not be obliged to consult with the Company in relation to any changes mentioned in Clause 28.10.1 if, in its opinion, it is not practicable to do so in the circumstances and, in any event, shall have no obligation to agree to such changes; 28.10.3 the Agent may consult with the Finance Parties in relation to any changes mentioned in Clause 28.10.1 but shall not be obliged to do so if, in its opinion, it is not practicable to do so in the circumstances; 28.10.4 any such changes agreed upon by the Agent and the Company shall (whether or not it is finally determined that a Disruption Event has occurred) be binding upon the Parties as an amendment to (or, as the case may be, waiver of) the terms of the Finance Documents notwithstanding the provisions of Clause 34 (Amendments and Waivers); 28.10.5 the Agent shall not be liable for any damages, costs or losses to any person, any diminution in value or any liability whatsoever (including, without limitation for negligence, gross negligence or any other category of liability whatsoever but not including any claim based on the fraud of the Agent) arising as a result of its taking, or failing to take, any actions pursuant to or in connection with this Clause 28.10; and 28.10.6 the Agent shall notify the Finance Parties of all changes agreed pursuant to Clause 28.10.4 above. 29. SET-OFF A Finance Party may set off any matured obligation due from the Company under the Finance Documents (to the extent beneficially owned by that Finance Party) against any matured obligation owed by that Finance Party to the Company under the Finance Documents, regardless of the place of payment, booking branch or currency of either obligation. If the obligations are in different currencies, the Finance Party may convert either obligation at a market rate of exchange in its usual course of business for the purpose of the set-off. 30. NOTICES 30.1 Communications in writing Any communication to be made under or in connection with the Finance Documents shall be made in writing and, unless otherwise stated, may be made by fax or letter. 30.2 Addresses The address and fax number (and the department or officer, if any, for whose attention the communication is to be made) of each Party for any communication or document to be made or delivered under or in connection with the Finance Documents is: 30.2.1 in the case of the Company, that identified with its name below; 30.2.2 in the case of each Lender, that notified in writing to the Agent on or prior to the date on which it becomes a Party; and 30.2.3 in the case of the Agent, that identified with its name below, or any substitute address or fax number or department or officer as the Party may notify to the Agent (or the Agent may notify to the other Parties, if a change is made by the Agent) by not less than five Business Days' notice. 30.3 Delivery 30.3.1 Any communication or document made or delivered by one person to another under or in connection with the Finance Documents will only be effective: (A) if by way of fax, when received in legible form; or


 
07/16927352_14 82 (B) if by way of letter, when it has been left at the relevant address or five Business Days after being deposited in the post postage prepaid in an envelope addressed to it at that address; and, if a particular department or officer is specified as part of its address details provided under Clause 30.2 (Addresses), if addressed to that department or officer. 30.3.2 Any communication or document to be made or delivered to the Agent will be effective only when actually received by the Agent and then only if it is expressly marked for the attention of the department or officer identified with the Agent's signature below (or any substitute department or officer as the Agent shall specify for this purpose). 30.3.3 All notices from or to the Company shall be sent through the Agent. 30.3.4 Any communication or document which becomes effective, in accordance with paragraphs 30.3.1 to 30.3.3 above, after 5.00 p. m. in the place of receipt shall be deemed only to become effective on the following day. 30.4 Notification of address and fax number Promptly upon changing its address or fax number, the Agent shall notify the other Parties. 30.5 Electronic communication 30.5.1 Any communication or document to be made or delivered by one Party to another under or in connection with the Finance Documents may be made or delivered by electronic mail or other electronic means (including, without limitation, by way of posting to a secure website) if those two Parties: (A) notify each other in writing of their electronic mail address and/or any other information required to enable the transmission of information by that means; and (B) notify each other of any change to their address or any other such information supplied by them by not less than five Business Days' notice. 30.5.2 Any such electronic communication or delivery as specified in paragraph 30.5.1 above to be made between the Company and a Finance Party may only be made in that way to the extent that those two Parties agree that, unless and until notified to the contrary, this is to be an accepted form of communication or delivery. 30.5.3 Any such electronic communication or document as specified in paragraph 30.5.1 above made or delivered by one Party to another will be effective only when actually received (or made available) in readable form and in the case of any electronic communication or document made or delivered by a Party to the Agent only if it is addressed in such a manner as the Agent shall specify for this purpose. 30.5.4 Any electronic communication or document which becomes effective, in accordance with paragraph 30.5.3 above, after 5.00 p. m. in the place in which the Party to whom the relevant communication or document is sent or made available has its address for the purpose of this Agreement shall be deemed only to become effective on the following day. 30.5.5 Any reference in a Finance Document to a communication being sent or received or a document being delivered shall be construed to include that communication or document being made available in accordance with this Clause 30.5. 30.6 English language 30.6.1 Any notice given under or in connection with any Finance Document must be in English.


 
07/16927352_14 83 30.6.2 All other documents provided under or in connection with any Finance Document must be: (A) in English; or (B) if not in English, and if so required by the Agent, accompanied by a certified English translation and, in this case, the English translation will prevail unless the document is a constitutional, statutory or other official document. 31. CALCULATIONS AND CERTIFICATES 31.1 Accounts In any litigation or arbitration proceedings arising out of or in connection with a Finance Document, the entries made in the accounts maintained by a Finance Party are prima facie evidence of the matters to which they relate. 31.2 Certificates and Determinations Any certification or determination by a Finance Party of a rate or amount under any Finance Document is, in the absence of manifest error, conclusive evidence of the matters to which it relates. 31.3 Day count convention Any interest, commission or fee accruing under a Finance Document will accrue from day to day and is calculated on the basis of the actual number of days elapsed and a year of 360 days or, in any case where the practice in the Relevant Market differs, in accordance with that market practice. 32. PARTIAL INVALIDITY If, at any time, any provision of a Finance Document is or becomes illegal, invalid or unenforceable in any respect under any law of any jurisdiction, neither the legality, validity or enforceability of the remaining provisions nor the legality, validity or enforceability of such provision under the law of any other jurisdiction will in any way be affected or impaired. 33. REMEDIES, WAIVERS AND HARDSHIP 33.1 Remedies and waivers No failure to exercise, nor any delay in exercising, on the part of any Finance Party, any right or remedy under a Finance Document shall operate as a waiver of any such right or remedy or constitute an election to affirm any of the Finance Documents. No election to affirm any Finance Document on the part of any Finance Party shall be effective unless it is in writing. No single or partial exercise of any right or remedy shall prevent any further or other exercise or the exercise of any other right or remedy. The rights and remedies provided in each Finance Document are cumulative and, subject to Clause 33.2 (No hardship), not exclusive of any rights or remedies provided by law. 33.2 No hardship Each Party hereby acknowledges that the provisions of article 1195 of the French Code civil shall not apply to it with respect to its obligations under the Finance Documents and that it shall not be entitled to make any claim under article 1195 of the French Code civil. 34. AMENDMENTS AND WAIVERS 34.1 Required consents 34.1.1 Subject to Clause 34.2 (All Lender matters


 
07/16927352_14 84 34.1.2 ) and Clause 34.3 (Other exceptions) any term of the Finance Documents may be amended or waived only with the consent of the Majority Lenders and the Company and any such amendment or waiver will be binding on all Parties. 34.1.3 The Agent may effect, on behalf of any Finance Party, any amendment or waiver permitted by this Clause 34. 34.1.4 Paragraph 22.9.3 of Clause 22.9 (Pro rata interest settlement) shall apply to this Clause 34. 34.2 All Lender matters Subject to Clause 34.4 (Replacement of Screen Rate), an amendment or waiver of any term of any Finance Document that has the effect of changing or which relates to: 34.2.1 the definition of “Majority Lenders” in Clause 1.1 (Definitions); 34.2.2 an extension to the date of payment of any amount under the Finance Documents; 34.2.3 a reduction in the Margin or a reduction in the amount of any payment of principal, interest, fees or commission payable; 34.2.4 a change in currency of payment of any amount under the Finance Documents; 34.2.5 an increase in any Commitment, an extension of any Availability Period or any requirement that a cancellation of Commitments reduces the Commitments of the Lenders rateably under the Facility; 34.2.6 the nature or scope of the French State Guarantee; 34.2.7 any provision which expressly requires the consent of all the Lenders; 34.2.8 the events or circumstances specified in Clause 21 (Events of Default) or the terms thereof (provided that, for the avoidance of doubt, any waiver of an Event of Default remains a decision of the Majority Lenders); or 34.2.9 Clause 2.2 (Finance Parties' rights and obligations), Clause 7.1 (Illegality), Clause 22 (Changes to the Lenders), this Clause 34, Clause 39 (Governing Law) or Clause 40 (Jurisdiction), shall not be made without the prior consent of all the Lenders. 34.3 Other exceptions An amendment or waiver which relates to the rights or obligations of the Agent or a Reference Bank (each in their capacity as such) may not be effected without the consent of the Agent or that Reference Bank, as the case may be. 34.4 Replacement of Screen Rate 34.4.1 Subject to Clause 34.3 (Other exceptions), if a Screen Rate Replacement Event has occurred in relation to EURIBOR, any amendment or waiver which relates to: (A) providing for the use of a Replacement Benchmark in relation to EURIBOR; and (B) (1) aligning any provision of any Finance Document to the use of that Replacement Benchmark; (2) enabling that Replacement Benchmark to be used for the calculation of interest under this Agreement (including, without limitation, any consequential changes required to enable that Replacement Benchmark to be used for the purposes of this Agreement);


 
07/16927352_14 85 (3) implementing market conventions applicable to that Replacement Benchmark; (4) providing for appropriate fallback (and market disruption) provisions for that Replacement Benchmark; or (5) adjusting the pricing to reduce or eliminate, to the extent reasonably practicable, any transfer of economic value from one Party to another as a result of the application of that Replacement Benchmark (and if any adjustment or method for calculating any adjustment or method for calculating any adjustment has been formally designated, nominated or recommended by the Relevant Nominating Body, the adjustment shall be determined on the basis of that designation, nomination or recommendation). may be made with the consent of the Agent (acting on the instructions of the Majority Lenders) and the Company. 34.4.2 In this Clause 34.4: “Relevant Nominating Body” means any applicable central bank, regulator or other supervisory authority or a group of them, or any working group or committee sponsored or chaired by, or constituted at the request of, any of them or the Financial Stability Board. “Replacement Benchmark” means a benchmark rate which is: (A) formally designated, nominated or recommended as the replacement for a Screen Rate by: (1) the administrator of that Screen Rate (provided that the market or economic reality that such benchmark rate measures is the same as that measured by that Screen Rate); or (2) any Relevant Nominating Body, and if replacements have, at the relevant time, been formally designated, nominated or recommended under both paragraphs, the “Replacement Benchmark” will be the replacement under paragraph 34.4.2 above; (B) in the opinion of the Majority Lenders and the Company, generally accepted in the international or any relevant domestic syndicated loan markets as the appropriate successor to a Screen Rate; or (C) in the opinion of the Majority Lenders and the Company, an appropriate successor to a Screen Rate. “Screen Rate Replacement Event” means, in relation to a Screen Rate: (A) the methodology, formula or other means of determining that Screen Rate has, in the opinion of the Majority Lenders and the Company, materially changed; (B) (1) (a) the administrator of that Screen Rate or its supervisor publicly announces that such administrator is insolvent; or (b) information is published in any order, decree, notice, petition or filing, however described, of or filed with a court, tribunal, exchange, regulatory authority or similar administrative, regulatory or judicial body which reasonably confirms that the administrator of that Screen Rate is insolvent,


 
07/16927352_14 86 provided that, in each case, at that time, there is no successor administrator to continue to provide that Screen Rate; (2) the administrator of that Screen Rate publicly announces that it has ceased or will cease to provide that Screen Rate permanently or indefinitely and, at that time, there is no successor administrator to continue to provide that Screen Rate; (3) the supervisor of the administrator of that Screen Rate publicly announces that such Screen Rate has been or will be permanently or indefinitely discontinued; or (4) the administrator of that Screen Rate or its supervisor announces that that Screen Rate may no longer be used; or (C) the administrator of that Screen Rate determines that that Screen Rate should be calculated in accordance with its reduced submissions or other contingency or fallback policies or arrangements and either: (1) the circumstance(s) or event(s) leading to such determination are not (in the opinion of the Majority Lenders and the Company) temporary; or (2) that Screen Rate is calculated in accordance with any such policy or arrangement for a period no less than 15 Business Days, or (D) in the opinion of the Majority Lenders and the Company, that Screen Rate is otherwise no longer appropriate for the purposes of calculating interest under this Agreement. 34.5 PGE Loan regulations If, after the Signing Date, any law or regulation relating to PGE Loans (other than those in force on the date of this Agreement) become applicable to the Loan or this Agreement, the Parties shall enter into all necessary amendment agreements in order to ensure that this Agreement and the Loan continue to comply with the laws and regulations applicable to PGE Loans. 35. CONFIDENTIAL INFORMATION 35.1 Confidentiality Each Finance Party agrees to keep all Confidential Information confidential and not to disclose it to anyone, save to the extent permitted by Clause 35.2 (Disclosure of Confidential Information) and Clause 35.3 (Disclosure to numbering service providers), and to ensure that all Confidential Information is protected with security measures and a degree of care that would apply to its own confidential information. 35.2 Disclosure of Confidential Information Any Finance Party may, without prejudice to the provisions of article L.511-33 of the French Code monétaire et financier, disclose: 35.2.1 to any of its Affiliates and Related Funds and any of its or their officers, directors, employees, professional advisers, auditors, partners and Representatives such Confidential Information as that Finance Party shall consider appropriate if any person to whom the Confidential Information is to be given pursuant to this Clause 35.2.1 is informed in writing of its confidential nature and that some or all of such Confidential Information may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to the Confidential Information; 35.2.2 to any person:


 
07/16927352_14 87 (A) to (or through) whom it transfers (or may potentially transfer) all or any of its rights and/or obligations under one or more Finance Documents or which succeeds (or which may potentially succeed) it as Agent and, in each case, to any of that person's Affiliates, Related Funds, Representatives and professional advisers; (B) with (or through) whom it enters into (or may potentially enter into), whether directly or indirectly, any sub-participation in relation to, or any other transaction under which payments are to be made or may be made by reference to, one or more Finance Documents and/or the Company and to any of that person's Affiliates, Related Funds, Representatives and professional advisers; (C) appointed by any Finance Party or by a person to whom paragraph (A) or (B) above applies to receive communications, notices, information or documents delivered pursuant to the Finance Documents on its behalf (including, without limitation, any person appointed under Clause 24.14.2 of Clause 24.14 (Relationship with the Lenders)); (D) who invests in or otherwise finances (or may potentially invest in or otherwise finance), directly or indirectly, any transaction referred to in paragraph (A) or (B) above; (E) to whom information is required or requested to be disclosed by any court of competent jurisdiction or any governmental, banking, taxation or other regulatory authority or similar body, the rules of any relevant stock exchange or pursuant to any applicable law or regulation; (F) to whom information is required to be disclosed in connection with, and for the purposes of, any litigation, arbitration, administrative or other investigations, proceedings or disputes; (G) to whom or for whose benefit that Finance Party transfers, charges, pledges or otherwise creates Security (or may do so) pursuant to Clause 22.8 (Security over Lenders' rights]) including to a federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank) to (or through) whom it creates Security pursuant to Clause 22.8 (Security over Lenders' rights) and any federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank) may disclose such Confidential Information to a third party to whom it transfers (or may potentially or transfer) rights under the Finance Documents or the securities issued by the special purpose vehicle in connection with the enforcement of such Security; (H) who is a Party; or (I) with the consent of the Company; in each case, such Confidential Information as that Finance Party shall consider appropriate if: (1) in relation to paragraphs (A), (B) and (C) above, the person to whom the Confidential Information is to be given has entered into a Confidentiality Undertaking except that there shall be no requirement for a Confidentiality Undertaking if the recipient is a professional adviser and is subject to professional obligations to maintain the confidentiality of the Confidential Information; (2) in relation to paragraph (D) above, the person to whom the Confidential Information is to be given has entered into a Confidentiality Undertaking or is otherwise bound by requirements of confidentiality in relation to the Confidential Information they receive and is informed that some or all of such Confidential Information may be price-sensitive information;


 
07/16927352_14 88 (3) in relation to paragraphs 35.2.2(E), 35.2.2(G) and 35.2.2(F) above, the person to whom the Confidential Information is to be given is informed of its confidential nature and that some or all of such Confidential Information may be price-sensitive information except that there shall be no requirement to so inform if, in the opinion of that Finance Party, it is not practicable so to do in the circumstances; and 35.2.3 to any person appointed by that Finance Party or by a person to whom Clause 35.2.2(A) or Clause 35.2.2(B) above applies to provide administration or settlement services in respect of one or more of the Finance Documents including without limitation, in relation to the trading of participations in respect of the Finance Documents, such Confidential Information as may be required to be disclosed to enable such service provider to provide any of the services referred to in this Clause 35.2.3 if the service provider to whom the Confidential Information is to be given has entered into a confidentiality agreement substantially in the form of the LMA Master Confidentiality Undertaking for Use With Administration/Settlement Service Providers or such other form of confidentiality undertaking agreed between the Company and the relevant Finance Party; and 35.2.4 to any rating agency (including its professional advisers) such Confidential Information as may be required to be disclosed to enable such rating agency to carry out its normal rating activities in relation to the Finance Documents and/or the Company if the rating agency to whom the Confidential Information is to be given is informed of its confidential nature and that some or all of such Confidential Information may be price-sensitive information. 35.3 Disclosure to numbering service providers 35.3.1 Any Finance Party may, without prejudice to the provisions of article L.511-33 of the French Code monétaire et financier, disclose to any national or international numbering service provider appointed by that Finance Party to provide identification numbering services in respect of this Agreement, the Facility and/or the Company the following information: (A) names of the Company; (B) country of domicile of the Company; (C) place of incorporation of the Company; (D) date of this Agreement; (E) Clause 39 (Governing Law); (F) the names of the Agent and the Coordinator; (G) date of each amendment and restatement of this Agreement; (H) amount of, and name of, the Facility (and any tranches); (I) amount of Total Commitments; (J) currency of the Facility; (K) type of Facility; (L) ranking of Facility; (M) Termination Date for Facility; (N) changes to any of the information previously supplied pursuant to paragraphs (A) to (M) above; and (O) such other information agreed between such Finance Party and the Company,


 
07/16927352_14 89 to enable such numbering service provider to provide its usual syndicated loan numbering identification services. 35.3.2 The Parties acknowledge and agree that each identification number assigned to this Agreement, the Facility and/or the Company by a numbering service provider and the information associated with each such number may be disclosed to users of its services in accordance with the standard terms and conditions of that numbering service provider. 35.3.3 The Company represents that none of the information set out in paragraphs (A) to (O)) of Clause 35.3.1 above is, nor will at any time be, unpublished price- sensitive information. 35.3.4 A Finance Party may only appoint a numbering service provider from the list of providers set out in Schedule 9 (List of approved numbering service providers) or any successors in title or transferee of the numbering service provision business of such a person (each, an “Approved Numbering Service Provider”). 35.3.5 If a Finance Party wishes to appoint any numbering service provider which is not an Approved Numbering Service Provider, it shall notify the Agent of such wish and the Agent shall then notify the Company thereof. 35.3.6 The consent of the Company is required to the appointment of any numbering service provider which is not an Approved Numbering Service Provider, but the Company hereby agrees in principle to consent to such appointment so notified to it and undertakes not to unreasonably withhold or delay its consent following notification. 35.4 Entire agreement Without prejudice to the provisions of article L.511-33 of the French Code monétaire et financier, this Clause 35 constitutes the entire agreement between the Parties in relation to the obligations of the Finance Parties under the Finance Documents regarding Confidential Information and supersedes any previous agreement, whether express or implied, regarding Confidential Information. 35.5 Inside information Each of the Finance Parties acknowledges that some or all of the Confidential Information is or may be price-sensitive information and that the use of such information may be regulated or prohibited by applicable legislation including securities law relating to insider dealing and market abuse and each of the Finance Parties undertakes not to use any Confidential Information for any unlawful purpose. 35.6 Notification of disclosure Each of the Finance Parties agrees (to the extent permitted by law and regulation) to inform the Company: 35.6.1 of the circumstances of any disclosure of Confidential Information made pursuant to Clause 35.2.2(E) (Disclosure of Confidential Information) except where such disclosure is made to any of the persons referred to in that Clause during the ordinary course of its supervisory or regulatory function; and 35.6.2 upon becoming aware that Confidential Information has been disclosed in breach of this Clause 35. 35.7 Continuing obligations The obligations in this Clause 35 are continuing and, in particular, shall survive and remain binding on each Finance Party for a period of twelve months from the earlier of: 35.7.1 the date on which all amounts payable by the Company under or in connection with this Agreement have been paid in full and all Commitments have been cancelled or otherwise cease to be available; and


 
07/16927352_14 90 35.7.2 the date on which such Finance Party otherwise ceases to be a Finance Party. 36. CONFIDENTIALITY OF FUNDING RATES AND REFERENCE BANK QUOTATIONS 36.1 Confidentiality and disclosure 36.1.1 The Agent and the Company agree to keep each Funding Rate (and, in the case of the Agent, each Reference Bank Quotation) confidential and not to disclose it to anyone, save to the extent permitted by paragraphs 36.1.2, 36.1.3 and 36.1.4 below. 36.1.2 The Agent may, without prejudice to the provisions of article L. 511-33 of the French Code monétaire et financier, disclose: (A) any Funding Rate (but not, for the avoidance of doubt, any Reference Bank Quotation) to the Company pursuant to Clause 8.4 (Notification of rates of interest); and (B) any Funding Rate or any Reference Bank Quotation to any person appointed by it to provide administration services in respect of one or more of the Finance Documents to the extent necessary to enable such service provider to provide those services if the service provider to whom that information is to be given has entered into a confidentiality agreement substantially in the form of the LMA Master Confidentiality Undertaking for Use With Administration/Settlement Service Providers or such other form of confidentiality undertaking agreed between the Agent and the relevant Lender or Reference Bank, as the case may be. 36.1.3 The Agent may, without prejudice to the provisions of article L. 511-33 of the French Code monétaire et financier, disclose any Funding Rate or any Reference Bank Quotation, and the Company may disclose any Funding Rate, to: (A) any of its Affiliates and any of its or their officers, directors, employees, professional advisers, auditors, partners and Representatives if any person to whom that Funding Rate or Reference Bank Quotation is to be given pursuant to this paragraph (A) is informed in writing of its confidential nature and that it may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of that Funding Rate or Reference Bank Quotation or is otherwise bound by requirements of confidentiality in relation to it; (B) any person to whom information is required or requested to be disclosed by any court of competent jurisdiction or any governmental, banking, taxation or other regulatory authority or similar body, the rules of any relevant stock exchange or pursuant to any applicable law or regulation if the person to whom that Funding Rate or Reference Bank Quotation is to be given is informed in writing of its confidential nature and that it may be price-sensitive information except that there shall be no requirement to so inform if, in the opinion of the Agent or the Company, as the case may be, it is not practicable to do so in the circumstances; (C) any person to whom information is required to be disclosed in connection with, and for the purposes of, any litigation, arbitration, administrative or other investigations, proceedings or disputes if the person to whom that Funding Rate or Reference Bank Quotation is to be given is informed in writing of its confidential nature and that it may be price-sensitive information except that there shall be no requirement to so inform if, in the opinion of the Agent or the Company, as the case may be, it is not practicable to do so in the circumstances; and (D) any person with the consent of the relevant Lender or Reference Bank, as the case may be.


 
07/16927352_14 91 36.1.4 The Agent's obligations in this Clause 36 relating to Reference Bank Quotations are without prejudice to its obligations to make notifications under Clause 8.4 (Notification of rates of interest) provided that (other than pursuant to paragraph 36.1.2(A) above) the Agent shall not include the details of any individual Reference Bank Quotation as part of any such notification. 36.2 Related obligations 36.2.1 The Agent and the Company acknowledge that each Funding Rate (and, in the case of the Agent, each Reference Bank Quotation) is or may be price-sensitive information and that its use may be regulated or prohibited by applicable legislation including securities law relating to insider dealing and market abuse and the Agent and the Company undertake not to use any Funding Rate or, in the case of the Agent, any Reference Bank Quotation for any unlawful purpose. 36.2.2 The Agent and the Company agree (to the extent permitted by law and regulation) to inform the relevant Lender or Reference Bank, as the case may be: (A) of the circumstances of any disclosure made pursuant to paragraph 36.1.3(B) of Clause 36.1 (Confidentiality and disclosure) except where such disclosure is made to any of the persons referred to in that paragraph during the ordinary course of its supervisory or regulatory function; and (B) upon becoming aware that any information has been disclosed in breach of this Clause 36. 36.3 No Event of Default No Event of Default will occur under Clause 21.3 (Other obligations) by reason only of the Company's failure to comply with this Clause 36. 37. FRENCH DATA PROTECTION LAW 37.1 Pursuant to the General Data Protection Regulation 2016/679 of April 27, 2016 (the “GDPR”) and the French law no. 78-17 dated 6 January 1978, each Finance Party may process personal data relating to Constellium SE, the Company or to a member of the Group including its respective beneficial owners, officers and personnel for purposes solely related to the execution and administration of this Agreement, or to comply with their legal and regulatory obligations. Each party undertakes to comply with the applicable data protection laws and regulations, including Law No. 78-17 of 6 January 1978 and the GDPR, as may be amended and updated (the “Data Protection Rules”). 37.2 The web site of each Original Lender is as follows:. (A) for BNP Paribas: https://cib.bnpparibas.com/about/privacy-policy_a-38- 60.html; (B) for Bpifrance Financement: https://www.bpifrance.fr/Qui-sommes- nous/Ethique-et-conformite/; and (C) for Société Générale: https://static.societegenerale.fr/com/COM/multi_marche/rgpd-charte- donnees/pdf/politique-protection-donnees-personnelles--eie.pdf. 37.3 Personal data may be transferred by the Finance Parties to any Affiliate or third parties, including regulators and supervisory authorities, transferees, subcontractors, partners and companies involved in brokerage activities with each Finance Party in France or abroad, including outside the European Economic Area. The personal data may be retained for the duration of this Agreement, the applicable limitation period and/or the documented retention period of any Finance Party. 37.4 The signatories of this Agreement acknowledge that personal data may be transferred, upon the request of official agencies and local administrative or judicial authorities, within the European Economic Area and outside the European Economic Area.


 
07/16927352_14 92 37.5 Data subjects have certain rights under the Data Protection Rules which include the right to access and to request a copy of their personal data, the restriction on the processing of their personal data and/or the rectification or erasure of their personal data. Data subjects may also communicate instructions on the fate of their personal data in case of death. These rights may be exercised by sending a request by mail or e-mail to the following addresses: 37.5.1 for BNP Paribas: gdpr.desk.cib@bnpparibas.com; 37.5.2 for Bpifrance Financement: Délégué à la protection des données, 27-31 avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France; and 37.5.3 for Société Générale:.protectiondesdonnees@societegenerale.fr. 37.6 In addition to the rights referred to in Clause 37.5 above, the data subjects are also entitled to lodge a complaint with their respective supervisory authority. 37.7 Where used in this clause the terms: “personal data” and “data subject” shall have the meaning ascribed to such terms in the GDPR. 38. ELECTRONIC SIGNATURE 38.1 The Parties hereby agree to sign electronically (by way of a signature électronique qualifiée) this Agreement, in accordance with the provisions of Electronic Signature Laws and Regulations, through the “Conseil National des Barreaux” and its service provider, which will ensure the security and integrity of the digital copies of this Agreement in accordance with the Electronic Signature Laws and Regulations. 38.2 Each Party hereby irrevocably and unconditionally waives any right such party may have to initiate any claim and/or legal action, directly or indirectly arising out of or relating to the reliability of said electronic signature process and/or the evidence of its intention to enter into this Agreement in this respect. For the purpose of this Clause 38: “EIDAS Regulation” means the Regulation (UE) N°910/2014 of the European Parliament and of the Council dated 23 July 2014 on electronic identification and trust services for electronic transactions in the internal market. “Electronic Signature Laws and Regulations” means articles 1366 and 1367 of the French Civil Code, the decree n°2017-1416 dated 28 September 2017 on the electronic signature and the EIDAS Regulation. Section 11 GOVERNING LAW AND ENFORCEMENT 39. GOVERNING LAW This Agreement and any non-contractual obligations arising out of or in connection with it are governed by French law. 40. JURISDICTION The Tribunal de Commerce de Paris has exclusive jurisdiction to settle any dispute arising out of or in connection with this Agreement (including a dispute relating to the existence, validity or termination of this Agreement or any non-contractual obligation arising out or in connection with this Agreement) (a “Dispute”). This Agreement has been entered into on the date stated at the beginning of this Agreement in the form of an acte d'avocat électronique.


 
07/16927352_14 93 SCHEDULE 1 THE ORIGINAL LENDERS Name of Original Lender Commitment (EUR) BNP PARIBAS société anonyme having its registered office at 16 boulevard des Italiens, 75009 Paris, France and registered under number 662 042 449 RCS Paris 100,000,000 SOCIETE GENERALE société anonyme having its registered office at 29 boulevard Haussmann, 75009 Paris, France and registered under number 552 120 222 RCS Paris 50,000,000 BPIFRANCE FINANCEMENT société anonyme having its registered office at 27-31 avenue du Général Leclerc, 94700 Maisons-Alfort, France and registered under number 320 252 489 RCS Créteil 30,000,000 Total 180,000,000


 
07/16927352_14 94 SCHEDULE 2 CONDITIONS PRECEDENT PART A CONDITIONS PRECEDENT TO ENTRY INTO FORCE OF THE AGREEMENT 1. THE COMPANY 1.1 An electronic copy of a K-bis extract for the Company, not more than 15 days old. 1.2 A scanned copy of the up to date statuts of the Company. 1.3 An electronic copy of a certificat en matière de procedures collectives of the Company, not more than 15 days old. 1.4 A copy of the decisions of the relevant corporate body of the Company authorising the entry into by the Company and approving the terms of the Finance Documents. 1.5 Evidence that the person(s) who has(ve) signed the Finance Documents on behalf of the Company was duly authorised so to sign. 1.6 A specimen of the signature of each person referred to in paragraph 1.8. 1.7 A certificate of an authorised signatory of the Company confirming that borrowing or securing, as appropriate, the Total Commitments, would not cause any borrowing, securing or similar limit binding on the Company to be exceeded. 1.8 A certificate of an authorised signatory of the Company certifying that each copy document relating to it specified in this Schedule 2 (Conditions precedent ) is correct, complete and in full force and effect as at a date no earlier than the date of this Agreement. 2. LEGAL OPINIONS 2.1 A legal opinion of Herbert Smith Freehills Paris LLP, legal advisers to the Coordinator and the Agent in France, in relation to the validity and enforceability of this Agreement and the Security Documents, substantially in the form distributed to the Original Lenders prior to signing this Agreement. 2.2 A legal opinion of Clifford Chance Europe LLP, legal advisers to the Company in France, in relation to the existence, capacity and authorisations of the Company, Constellium France Holdco, Constellium Issoire and Constellium Neuf Brisach to sign the Finance Documents to which they are a party, substantially in the form distributed to the Original Lenders prior to signing this Agreement. 3. OTHER DOCUMENTS AND EVIDENCE 3.1 A copy of the Original Financial Statements of the Company. 3.2 Copies of the Security Documents duly executed by all parties thereto. 3.3 Copies of the share transfer registers (registres de mouvements de titres) and shareholders’ accounts (comptes d’actionnaires) of each of Constellium Issoire and Constellium Neuf Brisach, evidencing the creation of the Share Pledges. 3.4 A copy of the TEG Letter duly countersigned by the Company. 3.5 A copy of each Fee Letter duly executed by all parties thereto. 3.6 A certificate of a legal representative of the Company confirming that the eligibility criteria of the French State Guarantee set forth by the French law n° 2020-289 dated 23 March 2020 and the PGE Order (as construed by the “Dossier de presse” published by the French Ministry of Economy and Finance on 22 April 2020), are fulfilled, including a confirmation that the limit of the maximum of facility agreements guaranteed by the French State Guarantee granted to the Company is complied with.


 
07/16927352_14 95 3.7 A funds flow memorandum evidencing that the proceeds of the Loan will be downstreamed to the Initial Material Subsidiaries (other than Constellium France Holdco). 3.8 Any document or presentation prepared by the Company, showing the respective working capital and liquidity needs of the Company and/or its French Subsidiaries and the amounts under the Loan to be allocated to each of the Company and/or such French Subsidiary in order to finance such working capital and liquidity needs. 3.9 A copy of the Letter to the Trésor. 3.10 Evidence that the fees, costs and expenses then due from the Company pursuant to Clause 11 (Fees) and Clause 16 (Costs and Expenses) have been paid or will be paid by the Utilisation Date. PART B CONDITIONS PRECEDENT TO THE DELIVERY OF THE UTILISATION REQUEST 1. THE COMPANY 1.1 An electronic copy of a K-bis extract for the Company, not more than 15 days old, certified as being a true copy. 1.2 A scanned copy of the up to date statuts of the Company, certified as being a true copy. 1.3 An electronic copy of a certificat en matière de procédures collectives of the Company, not more than 15 days old, certified as being a true copy. 2. OTHER DOCUMENTS AND EVIDENCE 2.1 A copy of the ministerial order (arrêté ministériel) approving the French State Guarantee. 2.2 Evidence that the fees, costs and expenses then due from the Company pursuant to Clause 11 (Fees) and Clause 16 (Costs and Expenses) have been paid or will be paid by the Utilisation Date.


 
07/16927352_14 96 SCHEDULE 3 REQUESTS PART C UTILISATION REQUEST From: Constellium International To: [Agent] Dated: [] Dear Sirs, Constellium International – EUR 180,000,000 facility agreement dated 13 May 2020 (the “Agreement”) 1. We refer to the Agreement. This is a Utilisation Request. Terms defined in the Agreement have the same meaning in this Utilisation Request unless given a different meaning in this Utilisation Request. 2. We wish to borrow the Loan on the following terms: Proposed Utilisation Date: [ ] (or, if that is not a Business Day, the next Business Day) Currency of Loan: Euro Amount: [ ] or, if less, the Available Facility Interest Period: [ ] 3. We confirm that each condition specified in Clause 4.2 (Further conditions precedent) of the Agreement is satisfied on the date of this Utilisation Request. 4. The proceeds of this Loan should be credited to [account]. 5. This Utilisation Request is irrevocable. Yours faithfully ………………………………… authorised signatory for Constellium International


 
07/16927352_14 97 PART D SELECTION NOTICE From: Constellium International To: [Agent] Dated: [] Dear Sirs, Constellium International – EUR 180,000,000 facility agreement dated 13 May 2020 (the “Agreement”) 1. We refer to the Agreement. This is a Selection Notice. Terms defined in the Agreement have the same meaning in this Selection Notice unless given a different meaning in this Selection Notice. 2. We refer to the following Loan[s] in euro with an Interest Period ending on [ ]1 3. [We request that the above Loan[s] be divided into [ ] Loans with the following Interest Periods:] 4. This Selection Notice is irrevocable. Yours faithfully ..................................... authorised signatory for Constellium International 1 Insert details of all Facility The Loans in the same currency which have an Interest Period ending on the same date.


 
07/16927352_14 98 SCHEDULE 4 FORM OF TRANSFER AGREEMENT This Transfer Agreement is made on [ ] BETWEEN: (1) [ ] (the “Existing Lender”) AND (2) [ ] (the “New Lender”) WHEREAS: (A) The Existing Lender has entered into a euro term loan facility in an aggregate amount equal to EUR 180,000,000 under the facility agreement dated 13 May 2020, between Constellium International as Company, the financial institutions listed in Schedule 1 thereto as Original Lenders, BNP Paribas acting as Coordinator and BNP Paribas acting as Agent of the Lenders and Security Agent (the “Facility Agreement”). (B) The Existing Lender wishes to transfer and the New Lender wishes to acquire [all] [the part specified in Schedule 1 to this Transfer Agreement] of the Existing Lender's Commitment, rights [and obligations] referred to in Schedule 1 to this Transfer Agreement. (C) Terms defined in the Facility Agreement have the same meaning when used in this Transfer Agreement. IT IS AGREED AS FOLLOWS: 1. [The Existing Lender and the New Lender agree to the transfer (cession) of] / [the Existing Lender confirms that, by a separate agreement, it will transfer (céder) on the Transfer Date to the New Lender]2 [all] / [the part specified in Schedule 1 to this Transfer Agreement] of the Existing Lender's Commitment, rights [and obligations] referred to in Schedule 1 to this Transfer Agreement3 in accordance with Clause 22.6 (Procedure for transfer) of the Facility Agreement.4 2. The proposed Transfer Date is [ ]5. 3. The Facility Office and address, fax number and attention details for notices of the New Lender for the purposes of Clause 30.2 (Addresses) of the Facility Agreement are set out in Schedule 1 to this Transfer Agreement. 4. The New Lender expressly acknowledges the limitations on the Existing Lender's obligations set out in Clause 22.5 (Limitation of responsibility of Existing Lenders) of the Facility Agreement. 5. The New Lender confirms, for the benefit of the Agent and without liability to the Company, that it is: 5.1 a Qualifying Lender other than a Treaty Lender; 2 Use this option if the transfer is made by way of a separate agreement (e.g. pursuant to articles L. 214- 169 or L. 313-23 et seq. of the French Code monétaire et financier or pursuant to articles 2011 et seq. of the French Code civil). 3 Please note that the following language should be added where Security have been granted”, together with the Existing Lender's rights and benefits under all Transaction Security [to be defined] granted by the Company,”. 4 In the case of a transfer of rights and/or obligations by the Existing Lender under this Transfer Agreement, the New Lender should, if it considers it necessary to make the transfer effective as against the Company, arrange for such transfer to be notified to the Company or acknowledged by the Company. 5 Please note that in case of a transfer made, for example, by way of bordereau FCT, bordereau Dailly or contrat de fiducie, it is assumed that the Transfer Date will be the date affixed on such bordereau FCT or bordereau Dailly or agreed in such contrat de fiducie.


 
07/16927352_14 99 5.2 a Treaty Lender; 5.3 not a Qualifying Lender.6 and that it is [not]7 incorporated or acting through the Facility Office situated in a Non- Cooperative Jurisdiction. 6. The New Lender confirms to the other Finance Parties represented by the Agent that it has become entitled to the same rights and that it will assume the same obligations to those Parties as it would have been under if it had been an Original Lender. 7. The Existing Lender and the New Lender will confirm to the Agent the allocation of the relevant portion of the French State Guarantee fee referred to in Clause 11.3 (French State Guarantee fees) between them. 8. This Transfer Agreement and any non-contractual obligations arising out of or in connection with it are governed by French law. The Tribunal de Commerce de Paris shall have jurisdiction in relation to any dispute concerning it. 9. This Transfer Agreement has been entered into on the date stated at the beginning of this Transfer Agreement. SCHEDULE COMMITMENT/RIGHTS [AND OBLIGATIONS] TO BE TRANSFERRED [insert relevant details] [Facility Office address, fax number and attention details for notices and account details for payments,] [Existing Lender] [New Lender] By: By: This Transfer Agreement is accepted by the Agent and the Transfer Date is confirmed as [ ]. [Agent] By: 6 Delete as applicable. Each New Lender is required to confirm which of these three categories it falls within. 7 Delete as applicable. Each New Lender is required to confirm whether it falls within one of these categories or not.


 
07/16927352_14 100 SCHEDULE 5 FORM OF COMPLIANCE CERTIFICATE To: [ ] as Agent From: [Company] Dated: [ ] Dear Sirs Constellium International – EUR 180,000,000 facility agreement dated 13 May 2020 (the “Agreement”) 1. We refer to the Agreement. This is a Compliance Certificate. Terms defined in the Agreement have the same meaning when used in this Compliance Certificate unless given a different meaning in this Compliance Certificate. 2. We confirm that: [Insert details of covenants to be certified] 3. [We confirm that no Default is continuing.]8 Signed : ….................. [President/General Manager] of [Company] 8 If this statement cannot be made, the Compliance Certificate should identify any Default that is continuing and the steps, if any, being taken to remedy it.


 
07/16927352_14 101 SCHEDULE 6 EXISTING FINANCIAL INDEBTEDNESS AND EXISTING SECURITY 1. Existing Financial Indebtedness of Constellium International, Constellium France Holdco, Constellium Issoire, Constellium Neuf Brisach and any Subsidiary that raised Financial Indebtedness under state support schemes similar to the Loan documented under the Agreement: Name Financial Indebtedness Total principal amount of Financial Indebtedness Constellium International Constellium France Holdco Constellium Issoire Constellium Neuf Brisach Each of Constellium International, Constellium France Holdco, Constellium Issoire and Constellium Neuf Brisach (alongside a number of other Constellium SE’s subsidiaries acting as guarantors) is guarantor of payment obligations of Constellium SE under the following bond borrowings: - senior unsecured bonds of USD 400,000,000 bearing interest at a rate of 5.750% per annum due on 15 May 2024 and senior unsecured bonds of EUR 300,000,000 bearing interest at a rate of 4.625% per annum due on 15 May 2021, issued by Constellium SE on 7 May 2014; - senior unsecured bonds of USD 650,000,000 bearing interest at a rate of 6.625% per annum due on 1 March 2025, issued by Constellium SE on 16 February 2017; - senior unsecured bonds of USD 500,000,000 bearing interest at a rate of 5.875% per annum due on 15 February 2026 and senior unsecured bonds of EUR 400,000,000 bearing interest at a rate of 4.250% per annum due on 15 February 2026, issued by Constellium SE on 9 November 2017. The guarantee given by each of Constellium International, Constellium France Holdco, Constellium Issoire and Constellium Neuf Brisach in respect of each of these bond borrowings is limited, at a given date, to the fraction of the amount of the bond borrowing concerned directly or indirectly on-lent by Constellium SE to, respectively, each of Constellium International, Constellium France Holdco, Constellium Issoire and Constellium Neuf Brisach and/or to subsidiaries thereof and still outstanding at said date. - - - Constellium International Constellium International is a guarantor under parent company guarantees issued by Constellium International to various counterparties of its subsidiaries to facilitate metal, energy and other supplies contracted by such subsidiaries as well as derivatives and various financial (in particular leasing) arrangements entered into by such subsidiaries. - - - Constellium Issoire Constellium Issoire is a borrower under a EUR 100,000,000 asset- based revolving credit facility agreement dated 21 April 2017, between; among others, Constellium Issoire and Constellium Neuf Brisach as borrowers, Factofrance as agent, and certain financial institutions named therein, as amended from time to time (the “Inventory Facility Agreement”). This facility matures on April 21, 2021. Undrawn


 
07/16927352_14 102 Name Financial Indebtedness Total principal amount of Financial Indebtedness Constellium Issoire Constellium Issoire is a borrower under a three-year revolving credit facility entered into with Bpifrance Financement on March 28, 2018 with a maximum initial amount of commitment of EUR 10,000,000 (subject to quarterly reductions of the commitment). Undrawn Constellium Issoire various Finance Leases EUR 6 129 526 (as of 31 December 2019) Constellium Neuf Brisach Constellium Neuf Brisach is a borrower under the Inventory Facility Agreement. Undrawn Constellium Neuf Brisach liabilities in respect of Finance Leases – cf. notes to the audited financial statements of Constellium Neuf Brisach for the financial year 2019, section “Crédit-bail / Redevances restant à payer” EUR 9 051 000 (as of 31 December 2019) 2. Existing Security or Quasi-Security granted by Constellium International, Constellium France Holdco, Constellium Issoire, Constellium Neuf Brisach: Name of security provider Security Total principal amount of indebtedness secured Constellium Issoire Possessory and non-possessory pledges of eligible inventory securing the obligations of Constellium Issoire as borrower under the Inventory Facility Agreement Undrawn facility Constellium Issoire Collection bank accounts under the Factoring Agreement pledged to the factor – i.e. BNP Paribas bank accounts N° FR76 30004 0132 8000 1272 3010 04 and FR76 3000 4013 2800 0101 6232 741 - - - Constellium Neuf Brisach Possessory and non-possessory pledges of eligible inventory securing obligations of Constellium Neuf Brisach as borrower under the Inventory Facility Agreement Undrawn facility Constellium Neuf Brisach Securities under the “credit-bail immobilier” agreement with Alsabail dated 18 December 2014, transferred to Constellium Neuf Brisach by Constellium France as part of the contribution of assets (“apport partiel d’actifs”) completed on 31 March 2015, as disclosed to the Lenders before the Signing. - - - Constellium Neuf Brisach Collection bank accounts under the Factoring Agreement pledged to the factor – i.e. BNP Paribas bank accounts N° FR76 3000 4013 2800 0127 2310 704 and N° FR76 3000 4013 2800 0101 6242 441 - - -


 
07/16927352_14 103 SCHEDULE 7 FORM OF CONFIDENTIALITY UNDERTAKING [on Agent's letterhead] CONFIDENTIALITY UNDERTAKING From: [name of Agent] [address] To: [name of potential participant] [address] France (the “Participant”) Date [__] Dear Sirs We refer to the facility agreement dated 13 May 2020 (the “Facility Agreement”) between (i) Constellium International as Company, (ii) the Lenders and (iii) BNP Paribas as Agent, pursuant to which the Lenders have agreed to make available to the Company a term loan facility in a maximum principal amount of EUR 180,000,000 (the “Facility”) Terms and expressions beginning with a capital letter and not expressly defined in this letter shall have the meaning given to them in the Facility Agreement. We understand that you are considering participating in the Facillity. In respect of the Participation and in consideration of us agreeing to make available to you certain information, by your signature of a copy of this letter you agree as follows: 1. DEFINITIONS In this letter (including the acknowledgement set out below) terms defined in this letter shall, unless the context otherwise requires, have the same meaning and: “Affiliate” means, in relation to any person, a Subsidiary of that person or a Holding Company of that person or any other Subsidiary of that Holding Company. “Confidential Information” means all information relating to the Company, the Group, the Finance Documents or the Facility of which a Lender becomes aware in its capacity as, or for the purpose of becoming, a Lender or which is received by a Lender in relation to, or for the purpose of becoming a Lender under, the Finance Documents or the Facility from either: (a) any member of the Group or any of its advisers; or (b) another Finance Party, if the information was obtained by that Finance Party directly or indirectly from any member of the Group or any of its advisers,


 
07/16927352_14 104 in whatever form, and includes information given orally and any document, electronic file or any other way of representing or recording information which contains or is derived or copied from such information but excludes information that: (i) is or becomes public information other than as a direct or indirect result of any breach of this letter of confidentiality undertaking; or (ii) is identified in writing at the time of delivery as non-confidential by any member of the Group or any of its advisers; or (iii) is known by you before the date the information is disclosed to you in accordance with paragraphs (i) or (ii) above or is lawfully obtained by you after that date, from a source which is, as far as you are aware, unconnected with the Group and which, in either case, as far as that you are aware, has not been obtained in breach of, and is not otherwise subject to, any obligation of confidentiality. “Finance Document” means the documents designated as such in the Facility Agreement. “Group” means the Company and its Subsidiaries. “Holding Company” means, in relation to a company or corporation, any other company or corporation in respect of which it is a Subsidiary. “Participation” means (i) the transfer of all or any of rights and/or obligations of a Lender under one or more Finance Documents; (ii) the entering into, whether directly or indirectly, any sub-participation in relation to, or any other transaction under which payments are to be made or may be made by reference to, one or more Finance Documents and/or the Company and to any of that person's Affiliates[, Related Funds, Representatives] and professional advisers or (iii) the investment in or otherwise financing, directly or indirectly, any transaction referred to in paragraph (i) or (ii) above. “Participant Group” means the Participant, its Subsidiary and any Affiliate. “Permitted Purpose” means access to Confidential Information in order to consider and evaluate whether to enter into the Facilit. [“Related Fund” in relation to a fund (the “first fund”), means a fund which is managed or advised by the same investment manager or investment adviser as the first fund or, if it is managed by a different investment manager or investment adviser, a fund whose investment manager or investment adviser is an Affiliate of the investment manager or investment adviser of the first fund.] [“Representative” means any delegate, agent, manager, administrator, nominee, attorney, trustee or custodian.] “Subsidiary” means in relation to any company, another company which is controlled by it within the meaning of article L.233-3 of the French Code de Commerce. 2. CONFIDENTIALITY You undertake: 2.1 to keep all Confidential Information confidential and not to disclose it to anyone, save to the extent permitted by Clause 3 below and to ensure that all Confidential Information is protected with security measures and a degree of care that would apply to your own confidential information; 2.2 to use the Confidential Information only for the Permitted Purpose; and 2.3 to use all reasonable endeavours to ensure that any person to whom you pass any Confidential Information (unless disclosed under paragraphs 3.2 and 3.3 below) acknowledges and complies with the provisions of this letter as if that person were also a party to it. 3. PERMITTED DISCLOSURE We agree that you may disclose such Confidential Information:


 
07/16927352_14 105 3.1 to members of the Participant Group and their officers, directors, employees, professional advisers and auditors, to the extent necessary for the Permitted Purpose, if any person to whom the Confidential Information is to be given pursuant to this paragraph 3.1 is informed in writing of its confidential nature and that some or all of such Confidential Information may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to the Confidential Information; 3.2 to whom information is required or requested to be disclosed by any court of competent jurisdiction or any governmental, banking, taxation or other regulatory authority or similar body, the rules of any relevant stock exchange or pursuant to any applicable law or regulation; 3.3 to whom information is required to be disclosed in connection with, and for the purposes of, any litigation, arbitration, administrative or other investigations, proceedings or disputes; and 3.4 with the prior written consent of us and the Company. 4. NOTIFICATION OF DISCLOSURE You agree (to the extent permitted by law and regulation) to inform us: 4.1 of the circumstances of any disclosure of Confidential Information made pursuant to paragraphs 3.2 and 3.3 except where such disclosure is made to any of the persons referred to in those paragraphs during the ordinary course of its supervisory or regulatory function; and 4.2 upon becoming aware that Confidential Information has been disclosed in breach of this letter. 5. RETURN OF COPIES If we so request in writing, you shall return or destroy all Confidential Information supplied to you by us and destroy or permanently erase (to the extent technically practicable) all copies of Confidential Information made by you and use your reasonable endeavours to ensure that anyone to whom you have supplied any Confidential Information destroys or permanently erases (to the extent technically practicable) such Confidential Information and any copies made by them, in each case save to the extent that you or the recipients are required to retain any such Confidential Information by any applicable law, rule or regulation or by any competent judicial, governmental, supervisory or regulatory body or in accordance with internal policy, or where the Confidential Information has been disclosed under paragraphs 3.2 and 3.3 above. 6. DURATION 6.1 The obligations in this letter are continuing and, in particular, shall survive the termination of any discussions or negotiations between you and us. 6.2 Notwithstanding the previous sentence, these obligations shall cease on the earlier of: 6.2.1 the date on which you become a party to the Facility Agreement or otherwise acquire (by transfer or sub participation) an interest, direct or indirect in the Facility; or 6.2.2 the date falling [twelve] months after the date of your final receipt (in whatever manner) of any Confidential Information. 7. NO REPRESENTATION AND CONSEQUENCES OF BREACH You acknowledge and agree that neither we nor any of our officers, employees or advisers nor any members of the Group: 7.1 make any representation or warranty, express or implied, as to, or assume any responsibility for, the accuracy, reliability or completeness of any of the Confidential


 
07/16927352_14 106 Information or any other information supplied by us or any member of the Group or the assumptions on which it is based; 7.2 shall be under any obligation to update or correct any inaccuracy in the Confidential Information or any other information supplied by us or any member of the Group; and 7.3 be otherwise liable to you or any other person in respect of the Confidential Information or any such information. 8. ENTIRE AGREEMENT, NO WAIVER, AMENDMENTS 8.1 Subject to the provisions of article L.511-33 of the French Code monétaire et financier, this letter constitutes the entire agreement between us in relation to your obligations regarding Confidential Information and supersedes any previous agreement, whether express or implied, regarding Confidential Information; 8.2 No failure to exercise, nor any delay in exercising any right or remedy under this letter will operate as a waiver of any such right or remedy. No single or partial exercise of any right or remedy will prevent any further or other exercise; and 8.3 The terms of this letter and your obligations under this letter may only be amended or modified by written agreement between us. 9. INSIDE INFORMATION You acknowledge that some or all of the Confidential Information is or may be price- sensitive information and that the use of such information may be regulated or prohibited by applicable legislation including securities law relating to insider dealing and market abuse and you undertake not to use any Confidential Information for any unlawful purpose. 10. NATURE OF UNDERTAKINGS The undertakings given by you under this letter are given to us and (without implying any fiduciary obligations on our part) are also given for the benefit of the Company and each other member of the Group. 11. GOVERNING LAW AND JURISDICTION This letter and the agreement constituted by your acknowledgement of its terms are governed by French law. The Tribunal de Commerce de Paris has exclusive jurisdiction to settle any dispute arising out of or in connection with this letter. Please acknowledge your agreement to the above by signing and returning the enclosed copy. Yours faithfully The Agent For and on behalf of [the relevant Lender] ______________________


 
07/16927352_14 107 We acknowledge and agree to the above: The Potential Participant ______________________ By: Title: Date: [__]


 
07/16927352_14 108 SCHEDULE 8 TIMETABLES Loan in euro Delivery of a duly completed Utilisation Request (Clause 5.1 (Delivery of a Utilisation Request) or a Selection Notice (Clause 9.1 (Selection of Interest Periods)) D - 3 EURIBOR is fixed Quotation Day 11:00 am (Brussels time) Reference Bank Rate calculated by reference to available quotations in accordance with Clause 10.2 (Calculation of Reference Bank Rate) D – 3 (promptly)


 
07/16927352_14 109 SCHEDULE 9 LIST OF APPROVED NUMBERING SERVICE PROVIDERS  EUROCLEAR  The Depository Trust & Clearing Corporation (DTCC)  Markit


 
Document original électronique sécurisé et signé sur le service eActe du Conseil National des Barreaux sous le contrôle d’avocats inscrits à un Barreau Français Nombre de page(s) signée(s) au total : dont page(s) de signature Acte d’Avocat électronique Identifiant unique de l’Acte : Type d'acte : 20200506235545-wO7EfMxA7G51k2sr0Droit bancaire 116 2 Scellé par le Conseil National des Barreaux Le 13/05/2020 à 19:33 CEST serialNumber 39B4 Signé par Luc VICENZOTTI En représentation de Bpifrance Financement - Original Lender Le 13/05/2020 à 19:46 CEST serialNumber 4CB8C1 Signé par Erick Caussou En représentation de BNP PARIBAS - Agent Le 13/05/2020 à 20:08 CEST serialNumber 4CB96E Signé par Erick Caussou En représentation de BNP PARIBAS - Coordinator Le 13/05/2020 à 20:10 CEST serialNumber 4CB982 Signé par Christian Leroy En représentation de BNP PARIBAS - Original Lender Le 13/05/2020 à 20:17 CEST serialNumber 4CB9B4 Signé par Géraldine BARREAULT En représentation de Société Générale - Original Lender Le 13/05/2020 à 20:24 CEST serialNumber 4CB9E9


 
Document original électronique sécurisé et signé sur le service eActe du Conseil National des Barreaux sous le contrôle d’avocats inscrits à un Barreau Français Nombre de page(s) signée(s) au total : dont page(s) de signature Acte d’Avocat électronique Identifiant unique de l’Acte : Type d'acte : 20200506235545-wO7EfMxA7G51k2sr0Droit bancaire 116 2 Signé par Erick Caussou En représentation de BNP PARIBAS - Security Agent Le 13/05/2020 à 20:13 CEST serialNumber 4CB992 Signé par Laurent SCHMITT En représentation de Constellium International - Company Le 13/05/2020 à 20:32 CEST serialNumber 4CBA20 Contre-signé par Me Eric FISZELSON Le 13/05/2020 à 20:39 CEST serialNumber 34079A


 
3956191v2 [Execution] AMENDMENT NO. 3 TO AMENDED AND RESTATED CREDIT AGREEMENT This AMENDMENT NO. 3 TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment No. 3”), dated as of September 25, 2020, by and among Constellium Muscle Shoals LLC, a Delaware limited liability company (f/k/a Wise Alloys LLC) (“Muscle Shoals”), Constellium Rolled Products Ravenswood, LLC, a Delaware limited liability company (“Ravenswood”), Constellium Bowling Green LLC, a Delaware limited liability company (f/k/a Constellium-UACJ ABS LLC) (“Bowling Green” and together with Muscle Shoals and Ravenswood, the “Borrowers” and each, a “Borrower”), Constellium Holdings Muscle Shoals LLC, a Delaware limited liability company (f/k/a Wise Metals Group LLC) (“Muscle Shoals Holdings”), Constellium US Holdings I, LLC, a Delaware limited liability company (“Ravenswood Holdings”), Constellium Property and Equipment Company, LLC, a Delaware limited liability company (“CPEC”), Wells Fargo Bank, National Association (“Wells Fargo”), as Administrative Agent and Collateral Agent (in such capacities, the “Administrative Agent”), and the Lenders signatory hereto, amends that certain Amended and Restated Credit Agreement, dated as of February 20, 2019, as amended by Amendment No. 1 to Amended and Restated Credit Agreement, dated as of May 10, 2019 and Amendment No. 2 to Amended and Restated Credit Agreement, dated as of April 24, 2020 (the “Existing Credit Agreement”, and as amended hereby, the “Credit Agreement”), by and among the Borrowers, Muscle Shoals Holdings, Ravenswood Holdings, CPEC, Constellium International S.A.S. (the “Parent Guarantor”), acting as successor by merger to Constellium Holdco II B.V., the Administrative Agent, and the Lenders from time to time party thereto. WHEREAS, the Borrowers have requested that the Administrative Agent and the Lenders agree to make certain amendments to the Existing Credit Agreement; and WHEREAS, the Lenders party hereto and the Administrative Agent have so agreed, subject to the terms and conditions set forth herein. NOW, THEREFORE, in consideration of the premises set forth above, the terms and conditions contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree to enter into this Amendment No. 3. 1. Definitions. (a) Additional Definitions. The Credit Agreement and the other Loan Documents shall be deemed and are hereby amended to include, in addition and not in limitation, the following defined terms: "Amendment No. 3" means Amendment No. 3 to Amended and Restated Credit Agreement, dated September 25, 2020, by and among Administrative Agent, Lenders, and Loan Parties, as the same now exists or may hereafter be amended, modified, supplemented, extended, renewed, restated or replaced. “Amendment No. 3 Fees” shall have the meaning set forth in Section 5 of Amendment No. 3. "Amendment No. 3 Effective Date" means the first date on which the conditions precedent set forth in Section 3 of Amendment No. 3 are satisfied in accordance with Section 3 of Amendment No. 3 “Sanctioned Country” means a country or territory which is the subject or target of any Sanctions.


 
2 3956191v2 (b) Amendments to Definitions. The definition of the term “Term Loan Commitment Expiration Date” as set forth in Section 1.01 of the Credit Agreement is hereby deleted in its entirety and replaced with the following: “Term Loan Commitment Expiration Date” means May 1, 2021. (c) Interpretation. For purposes of this Amendment No. 3, all terms used herein which are not otherwise defined herein, including but not limited to, those terms used in the recitals hereto, shall have the respective meanings assigned thereto in the Credit Agreement as amended by this Amendment No. 3. 2. Term Loans. (a) Section 2.15(b) of the Credit Agreement is hereby amended by deleting the reference to “January 1, 2021” in the first sentence thereof and replacing it with the following: “July 1, 2021”. (b) Section 2.12(g) of the Credit Agreement is hereby amended to add the following at the end thereof: The Borrowers agree to pay (or cause to be paid) to the Administrative Agent, for the account of each of the Term Loan Lenders in accordance with the agreements among them (as applicable), a funding fee equal to 0.30% of the aggregate principal amount of Term Loans funded by such Term Loan Lender on each Term Loan Funding Date (the “Term Loan Commitment Fee”), which Term Loan Commitment Fee shall be earned and due and payable in full on each such Term Loan Funding Date. (c) Section 3 of the Amendment No. 2 Fee Letter is hereby deleted in its entirety and replaced with the following: “[reserved].” 3. Conditions Precedent to Amendment. The amendments set forth in Sections 1 and 2 shall become effective as of the date on which all of the following conditions precedent have been satisfied: (a) Administrative Agent shall have received each of the following documents, in form and substance reasonably satisfactory to Administrative Agent, duly executed and delivered, and each such document shall be in full force and effect: (i) this Amendment No. 3 executed and delivered by duly authorized officers of each Loan Party, the Lenders and the Administrative Agent; (ii) the consent and reaffirmation agreement, substantially in the form of Exhibit A attached hereto (the "Consent and Reaffirmation"), executed and delivered by the Parent Guarantor; (iii) the Amendment No. 3 Fee Letter executed and delivered by the Borrowers; (b) no material adverse change in the business, property, operations or condition of the Borrowers and their respective Subsidiaries, taken as a whole (other than resulting from any event, development or circumstance related to the COVID-19 pandemic that was disclosed in writing to the Administrative Agent and Lenders, or otherwise publicly disclosed, in each case, on or prior to April 10, 2020), or the validity or enforceability of any of the material Loan Documents or the rights and remedies of Administrative Agent and Lenders thereunder shall have occurred since December 31, 2019; (c) no Defaults or Events of Default under any of the Loan Documents shall exist or have occurred on the Amendment No. 3 Effective Date; and


 
3 3956191v2 (d) Borrowers shall have paid, or shall concurrently pay, costs, Fees (including all of the Fees referred to herein and in the Amendment No. 3 Fee Letter which are due and payable on the Amendment No. 3 Effective Date) and expenses due and payable on the Amendment No. 3 Effective Date, provided, that for costs and expenses, invoices, shall have been delivered to Borrowers not less than three (3) Business Days prior to the Amendment No. 3 Effective Date. 4. Representations and Warranties. Each Loan Party party hereto hereby represents and warrants that, as of the date hereof and as of the Amendment No. 3 Effective Date: (a) this Amendment No. 3 and the Credit Agreement constitute the legal, valid and binding obligation of such Loan Party, enforceable against such Loan Party in accordance with their respective terms, subject to (i) the effects of bankruptcy, insolvency, moratorium, reorganization, fraudulent conveyance or other similar laws affecting creditors’ rights generally, (ii) general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) and (iii) implied covenants of good faith and fair dealing; (b) the execution, delivery and performance of this Amendment No. 3 and its performance of the Credit Agreement have been duly authorized by all necessary corporate, stockholder, partnership or limited liability company action, and do not and will not: (i) violate (A) any provision of law, statute, rule or regulation, or of the certificate or articles of incorporation or other constitutive documents (including any partnership, limited liability company or operating agreements) or bylaws of such Loan Party, (B) any applicable order of any court or any rule, regulation or order of any Governmental Authority or (C) any provision of any indenture, certificate of designation for preferred stock, agreement or other instrument to which such Loan Party is a party or by which any of them or any of their property is or may be bound, (ii) be in conflict with, result in a breach of or constitute (alone or with notice or lapse of time or both) a default under, give rise to a right of or result in any cancellation or acceleration of any right or obligation (including any payment) or to a loss of a material benefit under any such indenture, certificate of designation for preferred stock, agreement or other instrument, where any such conflict, violation, breach or default referred to in clause (i) or (ii) of this Section 3(b), would reasonably be expected to have, individually or in the aggregate a Material Adverse Effect, or (iii) result in the creation or imposition of any Lien upon or with respect to any property or assets now owned or hereafter acquired by any such Loan Party, other than the Liens created by the Loan Documents and Permitted Liens; (c) as of the Amendment No. 3 Effective Date, the information included in the Beneficial Ownership Certification is true and correct in all respects; and (d) after giving effect to this Amendment No. 3, (i) no Default or Event of Default has occurred and is continuing and (ii) each representation and warranty of such Loan Party contained in the Credit Agreement and in each other Loan Document to which it is a party is true and correct in all material respects (without duplication of any materiality qualifier contained therein), except to the extent that such representation or warranty expressly relates to an earlier date (in which event such representation or warranty is true and correct in all material respects (without duplication of any materiality qualifier contained therein) as of such earlier date). 5. Amendment Fee. Borrowers shall pay (or cause to be paid) to the Administrative Agent, for the account of each of the Term Loan Lenders in accordance with the agreements among them (as applicable), closing fees (the “Amendment No. 3 Fees”) in an aggregate amount equal to 0.075% multiplied by the aggregate amount of Term Loan Commitments for the Term Facility on the Amendment No. 3 Effective Date. The entire amount of the Amendment No. 3 Fees will be fully earned and shall be due and payable in full in cash on the Amendment No. 3 Effective Date. 6. Ratification. Each Loan Party hereby (a) ratifies and reaffirms all of its payment and performance obligations, contingent or otherwise, under each of the Credit Agreement and each other Loan Document to which


 
4 3956191v2 it is a party, (b) ratifies and reaffirms the grant of liens or security interests over its property pursuant to the Loan Documents and confirms that such liens and security interests continue to secure the ABL Finance Obligations, (c) agrees that such ratification and reaffirmation is not a condition to the continued effectiveness of the Loan Documents and (d) agrees that neither such ratification and reaffirmation, nor the Administrative Agent’s nor any Lender’s solicitation of such ratification and reaffirmation, constitutes a course of dealing giving rise to any obligation or condition requiring a similar or any other ratification or reaffirmation from each party to the Credit Agreement with respect to any amendment, consent or waiver with respect to the Credit Agreement or other Loan Documents. 7. Miscellaneous. (a) Headings. The various headings of this Amendment No. 3 are inserted for convenience of reference only, are not part of this Amendment No. 3 and shall not affect the meaning or interpretation of this Amendment No. 3 or any provisions hereof. (b) Counterparts. This Amendment No. 3, any documents executed in connection herewith and any notices delivered under this Amendment No. 3 or the Credit Agreement, may be executed by the parties hereto by means of (i) an electronic signature that complies with the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, or any other relevant and applicable electronic signatures law; (ii) an original manual signature; or (iii) a faxed, scanned, or photocopied manual signature. Each electronic signature or faxed, scanned, or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature. Administrative Agent reserves the right, in its reasonable discretion, to accept, deny, or condition acceptance of any electronic signature on this Amendment No. 3 or on any notice delivered to Administrative Agent under this Amendment No. 3. This Amendment No. 3 and any notices delivered hereunder and under the other Loan Documents may be executed in any number of counterparts, each of which shall be deemed to be an original, and all of which when taken together shall be deemed to be one and the same instrument. Delivery of an executed counterpart of a signature page of this Amendment No. 3 and any notices as set forth herein will be as effective as delivery of a manually executed counterpart of Amendment No. 3 or notice. (c) Interpretation. No provision of this Amendment No. 3 shall be construed against or interpreted to the disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such party’s having or being deemed to have structured, drafted or dictated such provision. (d) Governing Law. THE LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO THE CONFLICTS OF LAWS PRINCIPLES THEREOF THAT WOULD REQUIRE THE APPLICATION OF LAWS OF ANOTHER JURISDICTION) SHALL GOVERN ALL MATTERS ARISING OUT OF, IN CONNECTION WITH, OR RELATING TO, THIS AMENDMENT NO. 3. (e) Effect. Except as expressly provided in this Amendment No. 3, all of the terms, conditions and provisions of the Existing Credit Agreement and the other Loan Documents shall remain the same. This Amendment No. 3 shall constitute a Loan Document for purposes of the Credit Agreement. (f) No Other Waiver. Except as specifically set forth in this Amendment No. 3, the execution, delivery and effectiveness of this Amendment No. 3 shall not (a) limit, impair, constitute a waiver by, or otherwise affect any right, power or remedy of, the Administrative Agent or any Lender under the Credit Agreement or any other Loan Document, (b) constitute a waiver of any provision in the Credit Agreement or any other Loan Document or of any Default or Event of Default that may have occurred and be continuing or (c) alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or in any of the other Loan Documents, all of which are ratified and affirmed in all respects and shall continue in full force and effect.


 
5 3956191v2 [SIGNATURE PAGES FOLLOW]


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement IN WITNESS WHEREOF, the parties hereto have executed this Amendment No. 3 as of the day and year first above written. CONSTELLIUM HOLDINGS MUSCLE SHOALS LLC By: /s/ Terrence Woods Name: Terrence Woods Title: Chief Financial Officer CONSTELLIUM MUSCLE SHOALS LLC By: /s/ Terrence Woods Name: Terrence Woods Title: Chief Financial Officer CONSTELLIUM US HOLDINGS I, LLC By: /s/ Ryan Wentling Name: Ryan Wentling Title: Chief Financial Officer CONSTELLIUM ROLLED PRODUCTS RAVENSWOOD, LLC By: /s/ Derek Scantlin Name: Derek Scantlin Title: Chief Financial Officer CONSTELLIUM BOWLING GREEN LLC By: /s/ Mathieu Hiriart Name: Mathieu Hiriart Title: Chief Financial Officer CONSTELLIUM PROPERTY AND EQUIPMENT COMPANY, LLC By: /s/ Rina E. Teran Name: Rina E. Teran Title: Vice President and Secretary


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, Collateral Agent, L/C Issuer, Swing Line Lender and Lender By: /s/ Marc J. Breier Name: Marc J. Breier Title: Authorized Signatory


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement BANK OF AMERICA, N.A., as Lender By: /s/ Douglas Cowan Name: Douglas Cowan Title: Senior Vice President


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement DEUTSCHE BANK AG NEW YORK BRANCH, as Lender By: /s/ Michael Strobel Name: Michael Strobel Title: Vice President By: /s/ Philip Tancorra Name: Philip Tancorra Title: Vice President


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement GOLDMAN SACHS BANK USA, as Lender By: /s/ Mahesh Mohan Name: Mahesh Mohan Title: Authorized Signatory


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement JPMORGAN CHASE BANK, N.A., as Lender By: /s/ James Shender Name: James Shender Title: Executive Director


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement BMO HARRIS BANK N.A., as Lender By: /s/ Quinn Heiden Name: Quinn Heiden Title: Managing Director


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement BARCLAYS BANK PLC, as Lender By: /s/ Craig Malloy Name: Craig Malloy Title: Director


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement HSBC BANK USA, N.A., as Lender By: /s/ Frederic Fournier Name: Frederic Fournier Title: Senior Vice President


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement CITIBANK, N.A., as Lender By: /s/ Sumeet Singal Name: Sumeet Singal Title: Vice President


 
Signature Page to Amendment No. 3 to Amended and Restated Credit Agreement CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as Lender By: /s/ William O’Daly Name: William O’Daly Title: Authorized Signatory By: /s/ D. Andrew Maletta Name: D. Andrew Maletta Title: Authorized Signatory


 
3956191v2 EXHIBIT A Consent and Reaffirmation Constellium International S.A.S. (the “Parent Guarantor”) hereby acknowledges receipt of a copy of the foregoing Amendment No. 3 dated as of the date hereof (the “Amendment No. 3”) by and among Constellium Muscle Shoals LLC (f/k/a Wise Alloys LLC) (“Muscle Shoals”), Constellium Rolled Products Ravenswood, LLC (“Ravenswood”), Constellium Bowling Green LLC (f/k/a Constellium-UACJ ABS LLC) (“Bowling Green” and together with Muscle Shoals and Ravenswood, the “Borrowers” and each, a “Borrower”), Constellium Holdings Muscle Shoals LLC (f/k/a Wise Metals Group LLC) (“Muscle Shoals Holdings”), Constellium US Holdings I, LLC (“Ravenswood Holdings”), Constellium Property and Equipment Company, LLC (“CPEC”), Wells Fargo Bank, National Association, as Administrative Agent and Collateral Agent (in such capacities, the “Administrative Agent”), and the Lenders signatory thereto, amending that certain Amended and Restated Credit Agreement, dated as of February 20, 2019 and as amended by Amendment No. 1 thereto, dated May 10, 2019 and Amendment No. 2 thereto, dated April 24, 2020 (the “Existing Credit Agreement”; the Existing Credit Agreement as amended by the Amendment No. 3, and as further amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among the Borrowers, Muscle Shoals Holdings, Ravenswood Holdings, CPEC, the Administrative Agent, and the Lenders from time to time party thereto. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Credit Agreement. The Parent Guarantor hereby (1) ratifies and reaffirms all of its obligations and covenants, including, without limitation, the ABL Credit Obligations applicable to it, under the Credit Agreement, provided, that, notwithstanding anything to the contrary set forth in the Credit Agreement, the “ABL Credit Obligations” of Parent Guarantor under the Credit Agreement shall not include Term Loan A-2 Obligations, (2) ratifies and reaffirms all of its obligations and covenants under that certain Amended and Restated Guarantee and Collateral Agreement, dated as of February 20, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “Guarantee and Collateral Agreement”), by and among the Borrowers, Muscle Shoals Holdings, Ravenswood Holdings, CPEC, the Parent Guarantor, the Administrative Agent and each subsidiary of a Borrower identified therein, provided, that, notwithstanding anything to the contrary set forth in the Guarantee and Collateral Agreement, the “Obligations” and “Guaranteed Obligations” of Parent Guarantor thereunder shall not include Term Loan A-2 Obligations, (3) agrees that neither such ratification and reaffirmation provided for in clauses (1) and (2), nor the Administrative Agent’s or any Lender’s solicitation of such ratification and reaffirmation, constitutes a course of dealing giving rise to any obligation or condition requiring a similar or any other ratification or reaffirmation from the Parent Guarantor with respect to any subsequent modifications to the Credit Agreement or the other Loan Documents, (4) agrees that none of the terms and conditions of the Amendment No. 3 shall limit or diminish its payment and performance obligations, contingent or otherwise, under the Credit Agreement and the Guarantee and Collateral Agreement and (5) agrees that both the Credit Agreement and the Guarantee and Collateral Agreement, as modified by the provisos in clauses (1) and (2) above, remain in full force and effect and each is hereby reaffirmed, ratified and confirmed. Dated: September ___, 2020 [Signature Page Follows]


 
Schedule 2-1 (Amendment No. 3 to Amended and Restated Credit Agreement) 3956191v2 CONSTELLIUM INTERNATIONAL S.A.S., as Parent Guarantor By:_____________________________________ Name: Title:


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 
”FORM OF” 2020 LTIP Award Letter Last Name, First Name April 7, 2020 2020 Long Term Incentive Award Letter Dear First Name, I am pleased to inform you that you have received a Grant of Units in the amounts set forth below. These Units entitle you to receive Constellium Shares (or a cash equivalent, at Constellium’s discretion), subject to the terms and conditions set forth in this Award Letter, in the Constellium 2020 Long Term Incentive Award Agreement (the “2020 Award Agreement”) and the Constellium SE 2013 Equity Incentive Plan, as may be amended from time to time (the “Plan”). Capitalized Terms used in this Award Letter, unless so defined herein, shall have the meanings found in the 2020 Award Agreement or Plan. Grant Date April 7, 2020 Total Units Granted TOTAL (= YYY,YYY + ZZZ,ZZZ) Restricted Stock Units (RSUs) YYY,YYY Performance Share Units (PSUs) – Base Amount ZZZ,ZZZ Indices/Comparator Group S&P MidCap 400 Materials Index; S&P SmallCap 600 Materials Index Initial price on the Grant Date CSTM share price: $5.61 (20-day average) Vesting Date April 7, 2023 Vesting Period / Performance Period From the Grant Date through the Vesting Date Please note that the vesting of the RSUs and PSUs and the delivery of Shares (or a cash equivalent in respect of such RSUs and PSUs) are subject to the satisfaction of the Continued Service Condition. The vesting of the PSUs is, in addition, subject to the satisfaction of the Performance Condition. The level of achievement of the Performance Condition shall be determined by comparing the Constellium TSR to the average of the TSRs of the two Indices (i.e., the Comparator Group) at the end of the relevant Performance Period as follows: Performance Condition Achievement Level Number of Shares underlying PSUs Constellium TSR is below the average of the two 25th percentile TSRs of the Comparator Group PSU Base Amount x 0% Constellium TSR is at the average of the two 25th percentile TSRs of the Comparator Group PSU Base Amount x 25% Constellium TSR is between the average of the two 25th percentile TSRs & the average of the two median TSRs of the Comparator Group PSU Base Amount x (linear interpolation between 25% and 100%) Constellium TSR is at the average of the two median TSRs of the Comparator Group PSU Base Amount x 100% Constellium TSR is between the average of the two median TSRs & the average of the two 75th percentile TSRs of the Comparator Group PSU Base Amount x (linear interpolation between 100% and 200%) Constellium TSR is at or above the average of the two 75th percentile TSRs of the Comparator Group PSU Base Amount x 200%


 
2020 LTIP Award Letter Last Name, First Name Notwithstanding the foregoing, if the Constellium TSR is negative, the number of Shares (or a cash equivalent) eligible to be delivered in respect of the PSUs shall be capped at 100% of the Base Amount. By electronic acceptance of this award, you acknowledge that you have received a copy of, or have online access to, the 2020 Award Agreement and the Plan, and hereby accept the Units granted, subject to all the terms and provisions of this Award Letter, the 2020 Award Agreement and the Plan. The Board or the Committee shall determine whether an event has occurred resulting in the forfeiture of your Units and any Shares issuable thereunder and all such determinations shall be final and conclusive. You also acknowledge that this award and similar awards are made on a selective basis and are, therefore, to be kept confidential. Very truly yours, Ryan Jurkovic Senior Vice President Chief Human Resources Officer


 
”FORM OF” 2020 LTIP Award Letter Last Name, First Name April 7, 2020 2020 Long Term Incentive Award Letter Dear First Name, I am pleased to inform you that you have received a Grant of Units in the amounts set forth below. These Units entitle you to receive Constellium Shares (or a cash equivalent, at Constellium’s discretion), subject to the terms and conditions set forth in this Award Letter, in the Constellium 2020 Long Term Incentive Award Agreement (the “2020 Award Agreement”) and the Constellium SE 2013 Equity Incentive Plan, as may be amended from time to time (the “Plan”). Capitalized Terms used in this Award Letter, unless so defined herein, shall have the meanings found in the 2020 Award Agreement or Plan. Grant Date April 7, 2020 Restricted Stock Units (RSUs) Y,YYY Vesting Date April 7, 2023 Vesting Period From the Grant Date through the Vesting Date Please note that the vesting of the RSUs and the delivery of Shares (or a cash equivalent in respect of such RSUs) are subject to the satisfaction of the Continued Service Condition. By electronic acceptance of this award, you acknowledge that you have received a copy of, or have online access to, the 2020 Award Agreement and the Plan, and hereby accept the Units granted, subject to all the terms and provisions of this Award Letter, the 2020 Award Agreement and the Plan. The Board or the Committee shall determine whether an event has occurred resulting in the forfeiture of your Units and any Shares issuable thereunder and all such determinations shall be final and conclusive. You also acknowledge that this award and similar awards are made on a selective basis and are, therefore, to be kept confidential. Very truly yours, Ryan Jurkovic Senior Vice President Chief Human Resources Officer


 
Exhibit 12.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jean-Marc Germain, certify that: 1. I have reviewed this annual report on Form 20-F of Constellium SE (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 4. The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; 5. The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. Date: March 16, 2021 By: /s/ Jean-Marc Germain Name: Jean-Marc Germain Title: Chief Executive Officer


 
Exhibit 12.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Peter R. Matt, certify that: 1. I have reviewed this annual report on Form 20-F of Constellium SE (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 4. The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; 5. The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. Date: March 16, 2021 By: /s/ Peter R. Matt Name: Peter R. Matt Title: Executive Vice President and Chief Financial Officer


 
Exhibit 13.1 Certification by the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Constellium SE (the “Company”) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jean-Marc Germain, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 16, 2021 By: /s/ Jean-Marc Germain Name: Jean-Marc Germain Title: Chief Executive Officer


 
Exhibit 13.2 Certification by the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Annual Report of Constellium SE (the “Company”) on Form 20-F for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter R. Matt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: March 16, 2021 By: /s/ Peter R. Matt Name: Peter R. Matt Title: Executive Vice President and Chief Financial Officer


 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-191905, 333-201141 and 333-225926) and Form F-3 (No. 333-250089) of Constellium SE of our report dated March 16, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. Neuilly-sur-Seine, France PricewaterhouseCoopers Audit /s/ Pierre Marty Pierre Marty Partner March 16, 2021


 
Subsidiaries of Constellium SE as of December 31, 2020 Subsidiary Jurisdiction Alcan International Network (Thailand) Co. Ltd. Thailand Alcan International Network México S.A. de C.V. Mexico AluInfra Services SA Switzerland Astrex Inc. Canada Constellium Automotive México, S. DE R.L. DE C.V Mexico Constellium Automotive México Trading, S. DE R.L. DE C.V. Mexico Constellium Automotive (Nanjing) Co., Ltd. China Constellium Automotive Spain, S.L. Spain Constellium Automotive USA, LLC Delaware Constellium Automotive Žilina, s.r.o. Slovak Republic Constellium Bowling Green LLC (f/k/a Constellium-UACJ ABS LLC) Delaware Constellium China China Constellium Deutschland GmbH Germany Constellium Engley (Changchun) Automotive Structures Co Ltd. China Constellium Extrusions Burg GmbH Germany Constellium Extrusions Decin s.r.o. Czech Republic Constellium Extrusions Deutschland GmbH Germany Constellium Extrusions France France Constellium Extrusions Landau GmbH Germany Constellium Extrusions Levice S.r.o. Slovak Republic Constellium Finance France Constellium France III France Constellium France Holdco France Constellium Germany Holdco GmbH & Co. KG Germany Constellium Germany Verwaltungs GmbH Germany Constellium Holdings Muscle Shoals (f/k/a Wise Metals Group LLC) Delaware Constellium International France Constellium Issoire France Constellium Japan KK Japan Constellium Metal Procurement LLC Constellium Montreuil Juigné Delaware France Constellium Muscle Shoals LLC (f/k/a Wise Alloys LLC) Delaware Constellium Muscle Shoals Funding II LLC (f/k/a Wise Alloys Funding II LLC) Delaware Constellium Neuf Brisach France Constellium Paris France Constellium Property and Equipment Company, LLC Delaware Constellium Rolled Products Ravenswood, LLC Delaware Constellium Rolled Products Singen GmbH & Co. KG Germany Constellium Singen GmbH Germany Constellium Switzerland AG Switzerland Constellium Treuhand UG (haftunsgbeschränkt) Germany Constellium UK Limited United Kingdom Constellium US Holdings I, LLC Delaware Constellium US Intermediate Holdings LLC Delaware Constellium Ussel France Constellium Valais SA Switzerland C-TEC Constellium Technology Center SAS France Engineered Products International SAS France Listerhill Total Maintenance Center LLC Delaware